Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),0.7276306205005916,1.9403929351626148,0.0,0.3537252011547202,0.18,10/31,16.01%,NR1D1;CCDC88C;PLK1;BTRC;FBXL3;DERL1;MUL1;PEX2;EP300;PYHIN1
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),0.6111809288753666,1.850458741697339,0.0,0.6462287328788158,0.47,12/68,11.49%,LEPR;G0S2;KSR2;PPARGC1A;ADIPOR1;ELOVL6;PDGFC;ESRRG;SIRT6;PRKAB1;HSF1;CPT2
prerank,PanglaoDB_Augmented_2021__Acinar Cells,0.7607946306096137,1.822414997153686,0.0,0.6802407714513851,0.62,5/19,3.60%,CPA1;ACE2;CEL;ANXA4;AMY2B
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),0.7650200341544313,1.8220167703694985,0.0,0.5169829863030526,0.62,2/21,1.05%,RGCC;DACH1
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),0.5842718949319011,1.816070902398588,0.0,0.44351698298630315,0.63,12/78,10.05%,LEPR;G0S2;KSR2;PPARGC1A;ADIPOR1;ELOVL6;ACACB;PDGFC;ESRRG;SIRT6;PRKAB1;HSF1
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),-0.8005796189017594,-1.812808727918411,0.0,0.008424810112992833,0.02,19/38,14.65%,IFI6;GBP2;SP100;MX1;HLA-A;IFIT1;IFITM3;IRF1;IFI35;BST2;ISG15;IFIT3;HLA-C;STAT1;IRF7;HLA-B;HLA-E;IFIT2;HLA-F
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),-0.8005796189017594,-1.812808727918411,0.0,0.008424810112992833,0.02,19/38,14.65%,IFI6;GBP2;SP100;MX1;HLA-A;IFIT1;IFITM3;IRF1;IFI35;BST2;ISG15;IFIT3;HLA-C;STAT1;IRF7;HLA-B;HLA-E;IFIT2;HLA-F
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.8757853587650171,1.7960217884936909,0.05714285714285714,0.4965757631595111,0.72,4/7,8.15%,TWSG1;RUNX1;TARM1;HMGB1
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),-0.7936689055146858,-1.7868816029387993,0.0,0.008424810112992833,0.03,3/43,0.12%,CD24;GGT5;CXCL2
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),0.6480030290538936,1.7656866714487656,0.0,0.662748865899778,0.89,13/40,17.32%,NUP42;NUP37;NUP54;AAAS;NUP214;NDC1;RAE1;NUP188;EP300;NUP85;NUP205;NUP210;JMJD8
prerank,GO_Biological_Process_2021__retinal rod cell differentiation (GO:0060221),0.8928694484380573,1.7588917980900187,0.0,0.617318500092132,0.89,3/8,6.73%,SOX8;SOX9;RORB
prerank,GO_Biological_Process_2021__DNA topological change (GO:0006265),0.8698152802860775,1.7538675445977505,0.02564102564102564,0.5789604788130677,0.9,4/8,12.09%,TOP3B;HMGB1;TOP1MT;ERCC3
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),0.7738641582982425,1.7499095325989023,0.0,0.5523555064185247,0.91,5/11,14.34%,AUP1;VCP;UGGT1;DERL1;POMT2
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),0.8096360753865499,1.7453086322268208,0.0,0.5380086101479136,0.92,3/15,3.97%,ITGA1;BMP2;PPP1R15B
prerank,GO_Biological_Process_2021__genetic imprinting (GO:0071514),0.952922965134534,1.744302715933007,0.0,0.5011107016358537,0.92,2/6,2.91%,DIRAS3;KDM1B
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.9445846341866643,1.7331059535577502,0.0,0.5326808502596231,0.93,1/9,0.67%,RGCC
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),0.8527936060630945,1.7306473637047193,0.0,0.5121241236498284,0.93,1/12,1.28%,LIMD1
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),0.845302443602165,1.7191793390055585,0.0,0.5432856294658396,0.96,5/13,12.09%,TOP3B;MTERF1;HMGB1;TOP1MT;ERCC3
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),0.6805243040176245,1.719110772978263,0.0,0.5093302776242246,0.96,11/37,16.65%,NUP42;NUP37;NUP54;AAAS;NUP214;NDC1;RAE1;NUP188;NUP85;NUP205;NUP210
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),0.6480128517954052,1.7084340850919117,0.0,0.5425920506400459,0.96,13/39,17.32%,NUP42;NUP37;NUP54;AAAS;NUP214;NDC1;RAE1;NUP188;EP300;NUP85;NUP205;NUP210;JMJD8
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),0.7738217515739119,1.7077107768824173,0.0,0.5147155170648814,0.96,3/21,7.02%,ATP6V0D2;ATP6V1A;ATP6V1G1
prerank,GO_Biological_Process_2021__protein import (GO:0017038),0.6219635318959964,1.7074366758103972,0.0,0.4883412696103628,0.96,19/79,13.05%,RANBP17;NXT2;NUP62CL;ABCD2;GDAP1;SAMM50;PPP1R10;ABCD1;PEX13;AKT1;IPO5;IPO8;RAB8B;NUP214;TOMM22;ABCD3;PEX2;NXT1;RANBP6
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),0.7557863276879678,1.7047119016489618,0.0,0.47752902155887234,0.96,2/29,2.62%,ACP3;ABCA1
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),0.7055222917803343,1.6973972464660685,0.0,0.47122133440541397,0.97,11/33,16.65%,NUP42;NUP37;NUP54;AAAS;NUP214;NDC1;RAE1;NUP188;NUP85;NUP205;NUP210
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.7055222917803343,1.6973972464660685,0.0,0.47122133440541397,0.97,11/33,16.65%,NUP42;NUP37;NUP54;AAAS;NUP214;NDC1;RAE1;NUP188;NUP85;NUP205;NUP210
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),0.7304264068467887,1.6943191489961755,0.0,0.46374675201555293,0.97,2/31,2.62%,ACP3;ABCA1
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),0.8628754164118027,1.6767046318306558,0.0,0.5328552709702516,0.98,2/9,3.51%,DGKB;DGKE
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),0.6998440792553121,1.6708398775837487,0.0,0.5420158466924636,0.99,11/35,16.65%,NUP42;NUP37;NUP54;AAAS;NUP214;NDC1;RAE1;NUP188;NUP85;NUP205;NUP210
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),0.6775230839201923,1.669168156343758,0.07142857142857142,0.5332041123915088,0.99,7/23,20.44%,DERL2;AUP1;VCP;DERL1;TMEM129;PREB;SEL1L
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),0.7381191557919698,1.6667597482859509,0.06451612903225806,0.5305878017320803,0.99,9/21,17.48%,GDAP1;PLD6;MFF;CHCHD3;OPA1;THG1L;MIEF2;VPS11;MIGA1
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),0.9195830786969339,1.6664010407444387,0.0,0.5140676687111182,1.0,4/12,5.02%,TFB2M;FASTKD1;TFB1M;MTERF1
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),-0.7801821067941095,-1.6663639004522943,0.0,0.25695670844628143,0.53,18/43,12.99%,TRIM22;GBP2;SP100;CIITA;B2M;GBP1;HLA-A;ICAM1;TRIM5;CD44;IRF1;HLA-C;IFNGR2;HLA-DRA;STAT1;IRF7;HLA-B;HLA-E
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),0.7239967159426869,1.6651701700676944,0.0,0.5066620918396524,1.0,6/25,8.06%,LIMD1;MEN1;GREM1;SOX9;RORB;RANBP3L
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),0.8151082284142618,1.6572429518282235,0.02702702702702703,0.542378641770571,1.0,3/11,8.63%,WNT7A;CXXC4;STIL
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.7252798442600835,-1.6481755714076014,0.0,0.34204729058750905,0.69,22/62,12.99%,TRIM22;GBP2;SP100;TLR2;CIITA;B2M;GBP1;HLA-A;ICAM1;TRIM5;CD44;IRF1;CCL2;HLA-C;WNT5A;IFNGR2;RPL13A;HLA-DRA;STAT1;IRF7;HLA-B;HLA-E
prerank,GO_Biological_Process_2021__glycerolipid metabolic process (GO:0046486),0.8632416797519002,1.6455700726694658,0.046511627906976744,0.5946620937526624,1.0,1/10,0.21%,DGKB
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),0.915608756119381,1.643904092973924,0.0,0.5862825148946625,1.0,3/6,7.41%,ERCC8;LIG4;ERCC6
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),0.6015968678798636,1.6419338858217778,0.0,0.5812966592402745,1.0,23/52,23.51%,LCMT2;THUMPD1;ADAT2;TFB1M;FTSJ1;PUS7L;APOBEC3F;NSUN6;TRIT1;TRMT61A;THG1L;TRMT1;DTWD1;DTWD2;NSUN3;ANKRD16;CDKAL1;JMJD6;RBM15;URM1;MEPCE;NSUN2;ADARB1
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),0.6079885165665881,1.6417994458142793,0.07692307692307693,0.5654001235651807,1.0,17/48,20.22%,ABCD2;ABCD1;ACADM;MCAT;EHHADH;CPT2;ETFDH;ABCD3;PEX2;SCP2;ECHDC1;ACOX1;ACADS;SLC25A17;BDH2;ACAD10;DECR1
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),0.6886765280097704,1.638937429639135,0.03571428571428571,0.5667377398720682,1.0,6/23,13.02%,ABCD2;PEX11A;MFF;ABCD1;ABCD3;PEX2
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),0.7374692294602044,1.6375613183256883,0.03225806451612903,0.558175344129831,1.0,8/18,19.95%,FAM47E;PLK1;MSH2;NIPBL;PPHLN1;TASOR;MCM9;WAPL
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,-0.6538090473879036,-1.635112692707185,0.0,0.3861371301788383,0.83,51/147,15.48%,IFI44L;SOCS3;MX1;CIITA;C1R;B2M;HLA-A;CMPK2;ICAM1;IFIT1;IFITM3;P2RY14;IRF1;IFI35;STAT4;IL15;NLRC5;BST2;NOD1;CCL2;ISG15;WARS1;HELZ2;PARP14;PLSCR1;IFIT3;GPR18;PSMB9;IL4R;STAT1;DDX60;HERC6;BTG1;EPSTI1;IRF7;HLA-B;APOL6;MTHFD2;USP18;IFI44;IFIT2;NAMPT;CFH;PIM1;RNF213;MVP;IL7;IFIH1;SERPING1;ZNFX1;SP110
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),0.7305496055465545,1.632630034029036,0.03333333333333333,0.5728730388763557,1.0,5/23,6.76%,CHAMP1;ZNF207;SGO2;PLK1;NSL1
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),0.8915596710371179,1.6307547729519103,0.0,0.5671059905152599,1.0,1/8,0.13%,LEPR
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.6989927429011592,-1.6281054094230252,0.0,0.3851341765939581,0.87,27/65,17.56%,TYMP;ZFP36;ADGRE5;IRF1;IFI35;HELZ2;RPS6KA1;IL4R;HLA-C;TMC6;PIM3;ANO9;MMP25;IRF7;SIGIRR;TC2N;HLA-E;JUNB;ST6GALNAC2;RHBDF2;CD55;HLA-F;B3GALT4;IFIH1;SBNO2;ARRDC2;PRKCD
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),-0.8037367476630628,-1.6279487739483578,0.013513513513513514,0.33804550578383746,0.87,6/18,9.86%,GRIN2D;GRIN2A;SLC8A3;PLK2;SLC24A2;SLC24A1
prerank,GO_Biological_Process_2021__glucose transmembrane transport (GO:1904659),0.828942984154265,1.6275594510843978,0.027777777777777776,0.5710534065979063,1.0,1/12,0.43%,SLC2A5
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),-0.6793373424602936,-1.6244731991461694,0.0,0.31920669428117293,0.87,22/117,11.95%,GGT5;LEF1;ANXA1;IL1R1;SP100;MX1;TIMP2;POU4F1;CIITA;IFITM3;APP;BST2;ISG15;PLSCR1;TIMP1;CHI3L1;STAT1;IL1RAPL1;NLRP12;SRF;SIGIRR;OSMR
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),0.591670871576056,1.6198384076772214,0.0,0.6084753700632639,1.0,24/55,26.22%,METTL8;LCMT2;TFB2M;TYW3;TFB1M;FTSJ1;ZCCHC4;NSUN6;TRMT61A;CBLL1;MTO1;NSUN3;FBL;TRMT5;VIRMA;RBM15;FBLL1;MEPCE;NSUN2;TRDMT1;BUD23;TRMT13;ALKBH8;ZC3H13
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),0.807365119920813,1.6179758384645526,0.0,0.6065756732746985,1.0,1/12,0.62%,PTCD2
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),0.7468891596413516,1.6173931389613576,0.08823529411764706,0.5953726371084027,1.0,5/15,13.38%,DERL2;AUP1;VCP;DERL1;TMEM129
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,-0.7159822730527788,-1.6171153666658693,0.0,0.3563694677795968,0.94,46/81,22.46%,IFI44L;GBP2;MX1;B2M;GMPR;CMPK2;TRIM5;IFITM3;IRF1;IFI35;IL15;BST2;ISG15;WARS1;HELZ2;PARP14;PLSCR1;IFIT3;PSMB9;IL4R;HLA-C;PARP9;TMEM140;DDX60;LPAR6;HERC6;EPSTI1;IRF7;USP18;IFI44;IFIT2;IL7;IFIH1;SP110;PROCR;C1S;PSME1;CD74;RIPK2;SAMD9L;NMI;PARP12;STAT2;NCOA7;RSAD2;OGFR
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),0.7960281981267604,1.6170643213565603,0.06896551724137931,0.582475934996279,1.0,1/16,0.35%,ATP6V0D2
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.6964405722976319,-1.613117770225714,0.0,0.34618310646116013,0.95,47/85,24.36%,RPL3;RPL19;RPS27A;RPS27;RPS14;RPS4X;RPL27A;RPL7A;RPL35;RPL37A;RPL21;RPL27;RPL13A;RPL9;RPS13;RPS16;RPL24;RPS3A;RPLP1;RPL10A;RPS18;RPL10;RPS11;RPS8;RPLP2;RPL38;RPS7;RPL8;RPS15;RPL5;RPS21;RPL12;RPS23;RPL18A;RPS9;RPL23;RPS6;RPS25;RPL7;RPL4;RPL41;RPS20;RPL11;RPL15;RPL36;RPL29;RPS12
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),0.7482346957126567,1.6089381965927303,0.0,0.6227295062286771,1.0,6/20,13.18%,BMP2;GPATCH2;PPP6R1;PPP1R26;ZCCHC9;PPP1R36
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),0.7276175289428418,1.605552429126157,0.0,0.6309611066751292,1.0,2/16,12.76%,LIMD1;IQCJ-SCHIP1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid biosynthetic process (GO:0045723),0.8768059724795599,1.6053572581726026,0.029411764705882353,0.6172445608778437,1.0,3/9,7.04%,ABCD2;MID1IP1;ABCD1
prerank,GO_Biological_Process_2021__cellular modified amino acid catabolic process (GO:0042219),-0.9126070979451504,-1.602454365308259,0.0,0.3889454002165025,0.97,1/10,0.07%,GGT5
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),0.8470937886820358,1.6020092794644711,0.0,0.6255320455772098,1.0,1/11,0.61%,POLD3
prerank,GO_Biological_Process_2021__positive regulation of cell aging (GO:0090343),-0.8948541307871729,-1.5998994589180044,0.0,0.3758761435027573,0.97,3/9,4.45%,CDKN2A;B2M;ARG2
prerank,GO_Biological_Process_2021__regulation of extracellular exosome assembly (GO:1903551),0.9188213920311182,1.5960432211859648,0.02857142857142857,0.656715778105358,1.0,1/5,2.81%,SDC4
prerank,GO_Biological_Process_2021__regulation of mast cell chemotaxis (GO:0060753),0.9390026760698633,1.5937935015002191,0.0,0.6602500222495485,1.0,2/5,1.91%,VEGFD;VEGFC
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),0.6390098008842028,1.593728681943137,0.0,0.647317118113138,1.0,17/44,22.14%,NUP42;NUP37;RUBCNL;NUP54;AAAS;NUP214;NDC1;RAE1;NUP188;EP300;NUP85;NUP205;NUP210;JMJD8;NOA1;NUP153;NUP50
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),0.8875348781944535,1.591533829423895,0.03225806451612903,0.6484962021169871,1.0,1/7,0.78%,ASCL1
prerank,GO_Biological_Process_2021__mitral valve development (GO:0003174),-0.9467053319358927,-1.5893220182550285,0.016666666666666666,0.43026708791356255,0.99,1/6,1.07%,EFNA1
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),0.8930191746745224,1.5849672617437007,0.0,0.6697162915911938,1.0,1/8,0.31%,ACE2
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),0.8930191746745224,1.5849672617437007,0.0,0.6697162915911938,1.0,1/8,0.31%,ACE2
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.7585610419712814,1.5849429732409426,0.0,0.6573141380432088,1.0,2/12,3.97%,ITGA1;PPP1R15B
prerank,GO_Biological_Process_2021__DNA replication checkpoint signaling (GO:0000076),0.748249788994317,1.5848913396224906,0.03333333333333333,0.6458576924580242,1.0,5/12,21.06%,DNA2;HUS1;RAD9B;CLSPN;TICRR
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),0.5351220558686638,1.5814150276941425,0.0,0.6600764914405046,1.0,25/83,23.89%,DERL2;USP13;TMUB2;RNF103-CHMP3;AUP1;VCP;ECPAS;UGGT1;STT3B;DERL1;TMEM129;ERLIN1;POMT2;FBXO27;UBE4A;RHBDD1;DNAJB14;RHBDD2;RCN3;SEL1L;TMUB1;DNAJC18;UGGT2;UBQLN1;DNAJB2
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.6773584503958131,-1.5800774458516655,0.0,0.48189913846319005,0.99,21/77,14.76%,IFI6;IFI44L;MX1;TLR2;TRIM5;IFIT1;IFITM3;IRF1;NLRC5;BST2;ISG15;PLSCR1;IFIT3;TLR3;STAT1;APOBEC3H;IRF7;MAP3K14;RNASE1;IFIT2;IFIH1
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),0.9135775484785021,1.5800628620700004,0.0,0.6554179503177204,1.0,1/7,0.15%,SPSB4
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),-0.8546406067125639,-1.5794742031461968,0.0,0.4575724992619233,0.99,1/14,0.33%,RASGRP1
prerank,GO_Biological_Process_2021__cholesterol catabolic process (GO:0006707),0.8100805846540158,1.5779684592838943,0.12121212121212122,0.6456522576487723,1.0,2/7,9.64%,CEL;CYP46A1
prerank,GO_Biological_Process_2021__sterol catabolic process (GO:0016127),0.8100805846540158,1.5779684592838943,0.12121212121212122,0.6456522576487723,1.0,2/7,9.64%,CEL;CYP46A1
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),0.6797976761278005,1.5778924272498982,0.03571428571428571,0.6351181336117766,1.0,10/25,19.71%,ABCD2;GDAP1;ABCD1;PEX13;RAB8B;ABCD3;PEX2;SLC25A17;PEX12;PEX6
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),0.7009758472284804,1.57557080941985,0.08333333333333333,0.6396493549254336,1.0,7/20,13.02%,ABCD2;GDAP1;ABCD1;PEX13;RAB8B;ABCD3;PEX2
prerank,GO_Biological_Process_2021__DNA ligation (GO:0006266),0.8969646972888875,1.5754045403116843,0.030303030303030304,0.6306490248875098,1.0,1/6,3.02%,LIG4
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),0.6981374110536969,1.5738380325902193,0.0,0.6303564482116167,1.0,3/28,7.02%,ATP6V0D2;ATP6V1A;ATP6V1G1
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",0.7164574964314846,1.570238989858616,0.06666666666666667,0.6432526795037161,1.0,7/17,20.44%,DERL2;AUP1;VCP;DERL1;TMEM129;RHBDD1;SEL1L
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),-0.8105901020332774,-1.5701119877631713,0.039473684210526314,0.5044974526486297,1.0,3/25,3.19%,LEF1;SP100;MSX2
prerank,GO_Biological_Process_2021__regulation of necrotic cell death (GO:0010939),0.8679218578937785,1.5692727323561793,0.0,0.640263544575319,1.0,1/6,0.53%,SLC6A13
prerank,GO_Biological_Process_2021__positive regulation of cellular senescence (GO:2000774),-0.9078723537921193,-1.568968110185743,0.0,0.48723485153475227,1.0,3/8,4.45%,CDKN2A;B2M;ARG2
prerank,GO_Biological_Process_2021__cerebral cortex neuron differentiation (GO:0021895),0.8625265638129688,1.5678802445416948,0.025,0.6404569929998343,1.0,2/5,11.36%,ASCL1;TOX
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),-0.7934203818002379,-1.5675040130150701,0.0,0.4757800658548059,1.0,3/28,3.91%,GGT5;AWAT1;ALOX12
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),0.6839030127789414,1.5660433189849408,0.0,0.6449088627252534,1.0,10/19,25.31%,AUP1;VCP;UGGT1;DERL1;POMT2;DNAJB14;DNAJC18;UGGT2;DNAJB12;KLHL15
prerank,GO_Biological_Process_2021__ectoderm development (GO:0007398),0.8915502661570682,1.565768352246112,0.02127659574468085,0.6358250504919122,1.0,1/8,1.88%,AMER2
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),-0.8567355525871564,-1.5631809054764858,0.0,0.49664255616092756,1.0,3/17,2.39%,SLC28A2;RPE65;B2M
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),-0.6763972991287044,-1.5631001349433686,0.0,0.4737952734973589,1.0,48/87,24.63%,RPL3;RPL19;RPS27A;RPS27;RPS14;RPS4X;RPL27A;RPL7A;RPL35;RPL37A;RPL21;RPL27;RPL13A;RPL9;RPS13;RPS16;RPL24;RPS3A;RPLP1;RPL10A;RPS18;RPL10;RPS11;RPS8;RPL38;RPL26L1;RPS7;RPL8;RPS15;RPL5;RPS21;RPL12;RPS23;RPL18A;RPS9;RPL23;RPS6;RPS25;RPL7;RPL4;RPL41;RPS20;RPL11;RPL15;RPL36;RPL29;RPS12;DRG1
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),-0.7230546810581477,-1.5623895384983089,0.0,0.45838625932965554,1.0,11/37,10.13%,GBP2;SP100;TLR2;CIITA;GBP1;IFITM3;BST2;CCL2;WNT5A;RPL13A;STAT1
prerank,GO_Biological_Process_2021__mitochondrial DNA metabolic process (GO:0032042),0.8276643271537368,1.5607565635196208,0.046511627906976744,0.6508622569742093,1.0,3/7,12.45%,DNA2;PRIMPOL;MGME1
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),-0.7506160083505611,-1.5580965007133503,0.012987012987012988,0.47435343897068344,1.0,5/45,2.90%,ANXA1;PIF1;BLM;RECQL4;RPS27A
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),0.8198849117287432,1.5558421135833087,0.027777777777777776,0.6831560890433195,1.0,2/7,2.91%,DIRAS3;KDM1B
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),-0.7485544208434097,-1.5531233313668809,0.013157894736842105,0.49811689793070135,1.0,8/34,9.56%,GGT5;ANXA1;WNT8B;IGFBP5;CCL2;ALPL;CYP1B1;TLR3
prerank,GO_Biological_Process_2021__stem cell development (GO:0048864),0.7899237484751523,1.5522889916000493,0.0,0.6957617580675997,1.0,6/10,14.45%,WNT7A;SOX8;PEF1;KLHL12;CDH2;TAPT1
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),0.5436587270685821,1.5506068348579602,0.0,0.6976247022773648,1.0,23/91,19.82%,NUP62CL;U2AF1;NUP42;NUP37;NUP54;WDR33;AAAS;NUP214;EIF4E;NDC1;NXT1;RAE1;NUP188;SMG7;NUP85;NUP205;NUP210;THOC1;AGFG1;THOC3;SMG1;CPSF2;DDX25
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),0.6735908633641182,1.5496655514862743,0.047619047619047616,0.6955228928922107,1.0,3/12,9.56%,SLC19A1;SLC25A24;SLC25A41
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,-0.6639655197427072,-1.549531821685853,0.0,0.510206500442846,1.0,27/80,17.74%,ECM2;COL4A1;ANGPTL2;COL4A2;SPARC;CALD1;C1R;COL5A1;ASPN;ABCA8;SULF1;IGFBP5;THY1;THBS2;PODN;ELN;BGN;MYH11;ITGA8;LMOD1;PRRX1;SFRP4;SLIT3;ITGA11;PCDH18;DLC1;C1S
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),-0.813843939008288,-1.5480743602515787,0.029850746268656716,0.5032203886722258,1.0,2/16,0.89%,LEF1;HPN
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),-0.8374819724060745,-1.5477574126303366,0.029411764705882353,0.4883269565493995,1.0,2/12,1.73%,THBS1;MET
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),0.6874423305816295,1.5475917151323115,0.043478260869565216,0.7021187854521189,1.0,11/27,19.71%,ABCD2;GDAP1;ABCD1;PEX13;RAB8B;ABCD3;PEX2;SLC25A17;ZFAND6;PEX12;PEX6
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),0.7287502172365758,1.547130230049957,0.07142857142857142,0.6947525745756812,1.0,8/18,17.48%,GDAP1;PLD6;MFF;CHCHD3;OPA1;THG1L;MIEF2;MIGA1
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),-0.6693844480736444,-1.5460189199401502,0.0,0.48833810047812026,1.0,47/88,24.36%,RPL3;RPL19;RPS27A;RPS27;RPS14;RPS4X;RPL27A;RPL7A;RPL35;RPL37A;RPL21;RPL27;RPL13A;RPL9;RPS13;RPS16;RPL24;RPS3A;RPLP1;RPL10A;RPS18;RPL10;RPS11;RPS8;RPLP2;RPL38;RPS7;RPL8;RPS15;RPL5;RPS21;RPL12;RPS23;RPL18A;RPS9;RPL23;RPS6;RPS25;RPL7;RPL4;RPL41;RPS20;RPL11;RPL15;RPL36;RPL29;RPS12
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),-0.9080792356398593,-1.5450974438317147,0.034482758620689655,0.480504687134143,1.0,2/8,1.06%,ANXA1;CDKN2A
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),-0.6770673078416255,-1.5443987470052898,0.0,0.4712277123200658,1.0,17/74,12.80%,OPTC;COL8A1;COL4A1;COL4A2;COL5A1;COL4A4;COL6A2;COL27A1;COL24A1;SCX;CYP1B1;P4HA2;COL10A1;COL11A2;P3H2;COL9A2;P4HA3
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),0.6341568764013461,1.5390541992741633,0.0,0.744505623280608,1.0,24/60,22.39%,LCMT2;RPP40;THUMPD1;RTRAF;ADAT2;FTSJ1;TSEN2;TSEN15;NSUN6;TRIT1;ADAT1;TRMT61A;THG1L;TRMT1;KARS1;DTWD1;DTWD2;ZBTB8OS;ANKRD16;TRPT1;CDKAL1;URM1;FARS2;POP1
prerank,GO_Biological_Process_2021__positive regulation of axon extension involved in axon guidance (GO:0048842),0.9163328017907896,1.5387942185539658,0.02564102564102564,0.7376636937167618,1.0,1/5,1.38%,DSCAM
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),-0.6533990285546197,-1.5386385259924442,0.0,0.504945070643248,1.0,21/84,14.76%,IFI6;IFI44L;MX1;TLR2;TRIM5;IFIT1;IFITM3;IRF1;NLRC5;BST2;ISG15;PLSCR1;IFIT3;TLR3;STAT1;APOBEC3H;IRF7;MAP3K14;RNASE1;IFIT2;IFIH1
prerank,PanglaoDB_Augmented_2021__Keratinocytes,-0.7636714879340052,-1.5376537867791802,0.0,0.4944310435062669,1.0,7/24,8.46%,CD24;IL13RA1;GPR87;ICAM1;CCL2;DUOXA1;FLG
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.6991840456069338,1.537336858534603,0.05,0.7379740266694385,1.0,2/16,4.21%,RGCC;SERPINF2
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),0.6484541210474597,1.5365578703786067,0.0,0.7336267560463039,1.0,5/13,17.79%,SLC19A1;SLC25A24;SLC25A41;SLC25A5;SLC25A17
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),0.65869960249162,1.5360321912511257,0.08333333333333333,0.7275175050672563,1.0,7/27,15.93%,NCSTN;MID1IP1;MSH2;MAPK8;MSH3;ABL2;POT1
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),-0.8859430726973287,-1.5359742181718072,0.01639344262295082,0.4957873102858207,1.0,4/9,6.97%,SP100;MX1;IFIT1;ISG15
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),-0.800737684220755,-1.534613553186707,0.028985507246376812,0.4918602374791404,1.0,1/16,0.03%,ENPP2
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.9038665436061117,-1.5340008466390511,0.0,0.4840655182065311,1.0,2/11,0.17%,PRAME;KLF2
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),-0.8750448762788626,-1.533994142831971,0.013888888888888888,0.4706192538119053,1.0,3/9,6.95%,ANXA1;MSMP;CCL2
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),-0.7544366315352717,-1.5336910957611702,0.0,0.45994909265528444,1.0,4/29,9.31%,ENPP2;CLRN1;FSCN1;VIL1
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),-0.6971121006125355,-1.533541788810503,0.0,0.4491754023400917,1.0,12/50,10.74%,MX1;ZFP36;TRIM5;IFIT1;IFITM3;PROX1;BST2;ISG15;PLSCR1;HEXIM1;STAT1;APOBEC3H
prerank,GO_Biological_Process_2021__mitochondrial transcription (GO:0006390),0.9219016361857204,1.5327680053027937,0.0,0.742554185330018,1.0,3/9,5.02%,TFB2M;TFB1M;MTERF1
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),0.7724433055161523,1.5320764526424455,0.030303030303030304,0.7379782808331123,1.0,5/13,18.79%,EIF3E;EIF4EBP2;EIF2AK4;C8ORF88;EIF4EBP1
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),-0.9069543390890791,-1.5315350086247805,0.0,0.4534276006967169,1.0,1/12,0.21%,ANXA1
prerank,GO_Biological_Process_2021__immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.9985407484751139,-1.531064874809336,0.0,0.4441981132075471,1.0,1/5,0.04%,CD24
prerank,GO_Biological_Process_2021__aldehyde biosynthetic process (GO:0046184),-0.9879505131187081,-1.5302666769077518,0.0,0.4378846427021398,1.0,1/5,0.03%,CACNA1H
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.906296357595403,-1.5298365723449547,0.015873015873015872,0.43106945078146663,1.0,3/9,6.15%,THBS1;APLNR;IL12A
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),-0.7941890412586146,-1.5290477885648586,0.016129032258064516,0.42653050269733495,1.0,5/17,10.13%,IFITM3;IRF1;BST2;PLSCR1;STAT1
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),-0.8033813938346646,-1.5284167869552072,0.0379746835443038,0.42162345156386866,1.0,2/15,2.07%,THBS1;P2RY12
prerank,MSigDB_Hallmark_2020__Inflammatory Response,-0.6429859430555424,-1.5280442246479171,0.0,0.41506231156678025,1.0,40/118,19.78%,RASGRP1;SLC28A2;IL1R1;HPN;APLNR;SCN1B;GPR183;MET;TLR2;ICAM1;PDPN;IRF1;KCNJ2;IL15;BST2;CCL2;IL4R;MMP14;TIMP1;LDLR;IFNGR2;TLR3;BEST1;ITGA5;SLC7A2;IRF7;OSMR;CD55;NAMPT;VIP;HRH1;IL18;MSR1;CDKN1A;SPHK1;GPC3;EMP3;PTAFR;CLEC5A;RIPK2
prerank,GO_Biological_Process_2021__defense response to fungus (GO:0050832),0.8892222865252823,1.5277445865081156,0.041666666666666664,0.7566244339806248,1.0,2/5,6.33%,BCL10;FAM3A
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.6564294624004624,-1.5248792378066454,0.0,0.4309473520841769,1.0,49/105,24.36%,RPL3;RPL19;RPS27A;RPS27;RPS14;RPS4X;RPL27A;RPL7A;RPL35;HELZ2;RPL37A;RPL21;RPL27;RPL13A;RPL9;RPS13;RPS16;RPL24;RPS3A;RPLP1;RPL10A;RPS18;RPL10;RPS11;RPS8;RPLP2;RPL38;RPS7;RPL8;RPS15;RPL5;RPS21;RPL12;RPS23;RPL18A;RPS9;RPL23;RPS6;RPS25;EIF4A3;RPL7;RPL4;RPL41;RPS20;RPL11;RPL15;RPL36;RPL29;RPS12
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),0.7468877484108892,1.5238496729298823,0.03571428571428571,0.776284289896783,1.0,6/12,14.45%,SOX8;PEF1;KLHL12;CDH2;HEYL;TAPT1
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),0.8636171359535418,1.5219103381235137,0.02127659574468085,0.7826770287993583,1.0,5/7,12.50%,NUDT16L1;ERCC6;HSF1;TFIP11;CYREN
prerank,GO_Biological_Process_2021__negative regulation of glycogen biosynthetic process (GO:0045719),0.9284441141764717,1.5211231086081922,0.023809523809523808,0.7698449006563606,1.0,1/5,3.43%,PASK
prerank,GO_Biological_Process_2021__negative regulation of glycogen metabolic process (GO:0070874),0.9284441141764717,1.5211231086081922,0.023809523809523808,0.7698449006563606,1.0,1/5,3.43%,PASK
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.8109597261736243,-1.5193746015934837,0.0,0.4653363202836042,1.0,6/19,10.13%,SOCS3;NLRC5;PARP14;PARP9;IFNGR2;STAT1
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),-0.6178057150871972,-1.5192822290931507,0.0,0.45581733048838313,1.0,45/142,19.61%,GGT5;RPL3;RPL19;RPS27A;RPS27;RPS14;RPS4X;RPL27A;RPL7A;RPL35;WARS1;RPL37A;RPL21;RPL27;RPL13A;RPL9;CARNS1;RPS13;RPS16;RPL24;RPS3A;RPLP1;RPL10A;RPS18;RPL10;RPS11;RPS8;RPLP2;RPL38;RPS7;RPL8;RPS15;RPL5;MRPL23;RPS21;RPL12;RPS23;RPL18A;RPS9;GGTA1;COPS5;RPL23;RPS6;RPS25;EEF1A2
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),0.5267862764846883,1.5191250399468268,0.0,0.7760928801558983,1.0,21/70,25.77%,DERL2;TMUB2;RNF103-CHMP3;AUP1;VCP;ECPAS;STT3B;DERL1;TMEM129;ERLIN1;FBXO27;UBE4A;DNAJB14;RHBDD2;SEL1L;TMUB1;DNAJC18;UBQLN1;DNAJB2;DNAJB12;UBE2J2
prerank,GO_Biological_Process_2021__platelet activating factor metabolic process (GO:0046469),0.8356640756624107,1.5178415666642235,0.10256410256410256,0.7762387949281199,1.0,2/6,10.57%,CHPT1;PLA2G4C
prerank,"GO_Biological_Process_2021__energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.7596973191082087,1.5175485072525559,0.05714285714285714,0.7710907055941144,1.0,5/9,23.06%,ATP5PB;ATP5MC2;ATP5MC1;ATP5F1A;ATP5F1C
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),-0.9190938853330848,-1.5172029571739343,0.013513513513513514,0.4649119703169923,1.0,3/9,0.43%,KLF2;EPN1;THBS1
prerank,PanglaoDB_Augmented_2021__Fibroblasts,-0.6110719523945679,-1.5169966941235524,0.0,0.4583096701468102,1.0,51/165,17.74%,KLF2;COL8A1;IL1R1;COL4A1;ANGPTL2;FOSB;COL4A2;SPARC;FOSL2;C1R;COL5A1;ADAMTS10;CD44;LAMB1;COL4A4;PI16;ASPN;SPON2;CTHRC1;COL6A2;SULF1;FBLN7;SRPX2;THY1;COX7A1;THBS2;PODN;MMP14;CYP1B1;ELN;KLF4;BGN;LMOD1;IGFBP7;PRRX1;GSTM5;ITGBL1;P4HTM;LRRK1;CD55;FN1;HHIP;SLIT3;IGF1;NR4A1;PCDH18;COPZ2;ITIH5;PLAC9;PRKCD;C1S
prerank,GO_Biological_Process_2021__camera-type eye photoreceptor cell differentiation (GO:0060219),0.9237710737235711,1.516056150109727,0.0,0.7741289482583016,1.0,3/5,5.40%,DSCAM;SOX8;SOX9
prerank,GO_Biological_Process_2021__protein retention in ER lumen (GO:0006621),-0.8927828870187526,-1.5141774736437763,0.015151515151515152,0.46964186571056127,1.0,1/7,3.67%,KDELR3
prerank,GO_Biological_Process_2021__N-acetylneuraminate metabolic process (GO:0006054),-0.8939510122155649,-1.5137716569136563,0.0,0.46287850947731785,1.0,1/10,0.14%,ST6GAL1
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,-0.6604338113239584,-1.5129032114308867,0.0,0.4609801759939475,1.0,23/83,13.79%,COL4A1;ANGPTL2;COL4A2;SPARC;CALD1;C1R;COL5A1;CSPG4;SPON2;COL6A2;SULF1;SRPX2;IGFBP5;THY1;THBS2;PODN;MMP14;TIMP1;BGN;LMOD1;SFRP2;PRRX1;FN1
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),-0.7204140380256587,-1.5126402796531044,0.0,0.45462771609742814,1.0,2/29,2.07%,CLIC1;P2RY12
prerank,GO_Biological_Process_2021__very long-chain fatty acid catabolic process (GO:0042760),0.8483879104469855,1.5118928058871421,0.10810810810810811,0.795290188883815,1.0,4/6,13.61%,ABCD2;ABCD1;ABCD3;ACOX1
prerank,PanglaoDB_Augmented_2021__Osteoblasts,-0.634932766064385,-1.5106095349739825,0.010869565217391304,0.46137323746062575,1.0,34/118,15.36%,SOCS3;COL4A1;ANGPTL2;COL4A2;SPARC;CALD1;C1R;COL5A1;CD44;ITGA2;COL6A2;SULF1;PHEX;NOD1;SRPX2;IGFBP5;THY1;THBS2;PODN;MMP14;WNT5A;ALPL;BGN;ITGA5;COL11A2;OLFML1;OSMR;LMOD1;IGFBP7;EMP1;PRRX1;FN1;RUNX2;SFRP4
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),-0.8407765768357955,-1.5104975837955938,0.0,0.45343531572429285,1.0,4/14,9.65%,GBP1;CD160;THY1;CEACAM1
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),-0.7427054583791912,-1.5096712085890818,0.014705882352941176,0.4539051202982631,1.0,3/24,4.45%,CDKN2A;B2M;ARG2
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),-0.6922410272041757,-1.507949093269259,0.027777777777777776,0.45769959769035207,1.0,8/52,12.46%,ENPP2;AGPAT4;PLB1;PLAAT4;ANGPTL3;PLPPR1;LPCAT4;PLPPR5
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),0.5478461950120993,1.5076473454168757,0.05555555555555555,0.8200924225282719,1.0,5/48,3.98%,LEPR;CEBPA;MCU;PDK4;ADIPOR1
prerank,GO_Biological_Process_2021__protein repair (GO:0030091),0.8361888647666453,1.5076210805272179,0.06521739130434782,0.8118022312916635,1.0,2/6,8.65%,MSRB1;MSRB3
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),0.7244069017969876,1.5067128554996618,0.05128205128205128,0.8099877480692702,1.0,5/13,15.49%,ZNF304;TRIM28;SIRT6;PPHLN1;TASOR
prerank,GO_Biological_Process_2021__DNA unwinding involved in DNA replication (GO:0006268),-0.8343200686240118,-1.5062171492875185,0.014492753623188406,0.4632217628228602,1.0,2/14,1.44%,BLM;RECQL4
prerank,GO_Biological_Process_2021__cleavage furrow formation (GO:0036089),0.8750663067957669,1.5061541298511758,0.0,0.8056601636877342,1.0,2/6,10.15%,SNX18;SPIRE2
prerank,GO_Biological_Process_2021__high-density lipoprotein particle remodeling (GO:0034375),-0.9094989845082914,-1.5054382894625,0.014925373134328358,0.461539180690124,1.0,1/8,2.30%,ABCA5
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),0.6388650949961829,1.5046091788236189,0.034482758620689655,0.808434599308409,1.0,13/30,23.43%,MTHFS;SLC39A8;OAT;GLUD1;GLS;RIMKLB;GLUL;DDAH1;ALDH4A1;CAD;PRODH;GOT2;GCLC
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),-0.8161997353471717,-1.5045602262067783,0.02857142857142857,0.45963554190229755,1.0,2/16,7.01%,S100A10;THY1
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),-0.7952661983873576,-1.5041583504324638,0.0,0.45493974610161303,1.0,4/18,6.95%,CXCL2;DUSP1;DOCK8;CCL2
prerank,GO_Biological_Process_2021__intestinal epithelial cell differentiation (GO:0060575),-0.9800449332450115,-1.5029774870532955,0.0,0.4553409275355651,1.0,1/5,1.01%,NPY
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),-0.7430300300382999,-1.5027750230433934,0.0,0.4503324280710701,1.0,11/30,17.72%,RASGRP1;IL1R1;HLA-A;IL12A;ISG15;TLR3;ZFPM1;BTN3A1;IL18;FADD;SLC11A1
prerank,PanglaoDB_Augmented_2021__Stromal Cells,-0.6463328327455722,-1.5025132994151935,0.0,0.44534842381912887,1.0,27/89,15.73%,COL4A1;ANGPTL2;COL4A2;SPARC;TLR2;C1R;COL5A1;ICAM1;COL6A2;SULF1;SRPX2;THY1;THBS2;PODN;B4GALNT1;MMP14;LDB2;ELN;TLR3;BGN;LMOD1;IGFBP7;PRRX1;CFH;SERPING1;SNED1;AEBP1
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),0.741383815122661,1.5024690294815608,0.07692307692307693,0.8157336271527221,1.0,5/15,16.34%,NXT2;XPO1;AAAS;NXT1;NUP205
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),-0.6486347573975035,-1.5015980267296887,0.0,0.44779142236937663,1.0,8/74,9.31%,ENPP2;THBS1;SPARC;PROX1;RAB11A;WNT5A;EGF;VIL1
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),-0.6901451761044022,-1.5013902754248971,0.013888888888888888,0.4423654026493849,1.0,8/36,10.74%,MX1;IFIT1;IFITM3;PROX1;BST2;ISG15;PLSCR1;APOBEC3H
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),-0.7539568292159031,-1.5011611350886052,0.013513513513513514,0.43809012587562735,1.0,5/25,5.54%,GGT5;ANXA1;POU4F1;RAMP3;WNT8B
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),0.7241416649433192,1.500895525138505,0.05555555555555555,0.8201367523276497,1.0,6/13,18.29%,RAD54B;TPRKB;SMC6;RAD52;MSH3;DMC1
prerank,PanglaoDB_Augmented_2021__Plasma Cells,-0.690928798848254,-1.4998691517736396,0.0,0.4421193828861892,1.0,15/39,21.14%,CD24;TAGAP;P2RY10;IGHG1;KLF4;PRDM1;PDK1;CD9;SSR4;PPIB;CCR10;MAN1A1;CD74;CD37;NAPSB
prerank,PanglaoDB_Augmented_2021__Parietal Cells,-0.6357851837148888,-1.4996917327517623,0.0,0.43688658157377125,1.0,7/101,6.16%,CACNA1H;CD24;CP;KCNQ1;ANK3;MAOB;PODXL
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),-0.8888537339567254,-1.4994713696157556,0.0,0.431563864520492,1.0,3/9,3.58%,CIITA;TRIM5;IFITM3
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,-0.6419471311666506,-1.49882719308618,0.0,0.43095243952989737,1.0,26/80,19.51%,COL4A1;ANGPTL2;COL4A2;SPARC;CALD1;C1R;COL5A1;SULF1;IGFBP5;THY1;THBS2;PODN;RASL12;LDB2;ELN;GFAP;BGN;LMOD1;PRRX1;FN1;SLIT3;PCDH18;C1S;TNS2;COL12A1;AQP1
prerank,GO_Biological_Process_2021__venous blood vessel morphogenesis (GO:0048845),-0.9167900449023675,-1.4980012851130642,0.016129032258064516,0.4307039909820446,1.0,2/6,3.97%,CCBE1;PROX1
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),0.658360955184448,1.4979195317108207,0.03225806451612903,0.83492752287943,1.0,4/21,10.41%,MEN1;LIG4;HSF1;ATR
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),0.6505444735923763,1.4978560078758438,0.03571428571428571,0.8267956148848716,1.0,7/27,15.98%,RNF6;FOXP1;AR;RNF14;HEYL;EP300;NCOA2
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),-0.6722898189846405,-1.4968797712743058,0.0,0.4328530817513345,1.0,7/36,16.54%,CLIC1;P2RY12;CD99;GATA1;FN1;MYH9;TLN1
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),-0.7668819466179452,-1.4966616142351687,0.014285714285714285,0.4285420077475688,1.0,7/20,13.79%,COL8A1;COL4A2;DUSP1;LAMB1;MMP14;ITGA5;FN1
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),0.8599256537516838,1.4960298153170581,0.058823529411764705,0.8310941660614863,1.0,1/8,0.78%,ASCL1
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),-0.7394829945660513,-1.4959405493839097,0.014492753623188406,0.4277808187636757,1.0,6/23,13.79%,COL8A1;COL4A2;LAMB1;MMP14;ITGA5;FN1
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,-0.6476724751737617,-1.495284934587981,0.0,0.42616409597541677,1.0,17/69,11.95%,COL4A1;ANGPTL2;COL4A2;CALD1;C1R;MATN2;ASPN;SULF1;SRPX2;IGFBP5;THBS2;PODN;RASL12;ELN;BGN;MYH11;LMOD1
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),-0.6402598258721606,-1.4951677323487735,0.0,0.42145652642176973,1.0,48/97,24.36%,RPL3;RPL19;RPS27A;RPS27;RPS14;RPS4X;RPL27A;RPL7A;RPL35;RPL37A;RPL21;RPL27;RPL13A;RPL9;RPS13;RPS16;RPL24;RPS3A;RPLP1;RPL10A;RPS18;RPL10;RPS11;RPS8;RPLP2;RPL38;RPS7;RPL8;RPS15;RPL5;RPS21;RPL12;RPS23;RPL18A;RPS9;MAN1A1;RPL23;RPS6;RPS25;RPL7;RPL4;RPL41;RPS20;RPL11;RPL15;RPL36;RPL29;RPS12
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),0.5427310975377395,1.4946629866558372,0.08695652173913043,0.833724223184688,1.0,12/42,13.93%,ERCC8;MEN1;PRIMPOL;TYR;MAPK10;ERCC6;ERCC2;DRD2;MAPK8;ERCC3;DCT;FECH
prerank,GO_Biological_Process_2021__C21-steroid hormone biosynthetic process (GO:0006700),-0.9055685696566039,-1.494377792005825,0.03125,0.42060064665371816,1.0,1/9,0.03%,CACNA1H
prerank,GO_Biological_Process_2021__positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.8734959151077455,-1.4939200789726519,0.014705882352941176,0.41692279046673286,1.0,4/10,9.49%,CACNA1H;KCNB1;SYT4;SYT1
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.8501593503555989,-1.4938253961709296,0.014705882352941176,0.41291970553804386,1.0,2/12,1.73%,NR4A3;MET
prerank,"GO_Biological_Process_2021__fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",0.8836132385938196,1.4899252059618937,0.027777777777777776,0.8384126442898006,1.0,3/6,7.19%,ELOVL4;ELOVL6;ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, monounsaturated fatty acid (GO:0034625)",0.8836132385938196,1.4899252059618937,0.027777777777777776,0.8384126442898006,1.0,3/6,7.19%,ELOVL4;ELOVL6;ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, saturated fatty acid (GO:0019367)",0.8836132385938196,1.4899252059618937,0.027777777777777776,0.8384126442898006,1.0,3/6,7.19%,ELOVL4;ELOVL6;ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, unsaturated fatty acid (GO:0019368)",0.8836132385938196,1.4899252059618937,0.027777777777777776,0.8384126442898006,1.0,3/6,7.19%,ELOVL4;ELOVL6;ELOVL2
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),0.8194504116464525,1.489895629656886,0.03571428571428571,0.8306495642500802,1.0,5/12,11.80%,ELOVL4;ELOVL6;ABCD1;ELOVL2;HACD2
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),-0.8256972912190382,-1.4893200053524043,0.046875,0.43685722683470163,1.0,4/12,10.13%,SOCS3;PARP9;IFNGR2;STAT1
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),-0.919261899355778,-1.4885406427848866,0.0,0.43697358477631504,1.0,1/7,0.21%,ANXA1
prerank,GO_Biological_Process_2021__skin development (GO:0043588),-0.6964527630277155,-1.4863830953580948,0.0,0.44801936636594036,1.0,11/44,10.72%,ANXA1;DHCR24;MET;COL5A1;ALOX12;LSR;FLG;WNT5A;ABCA12;CLIC4;FA2H
prerank,GO_Biological_Process_2021__positive regulation of necrotic cell death (GO:0010940),0.8907501436149476,1.4863635383424714,0.05,0.8472430012132114,1.0,1/5,0.53%,SLC6A13
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.5556553256191237,1.4861826775404918,0.0,0.8412723140749676,1.0,7/60,3.98%,LEPR;NR1D1;PPARGC1A;CEBPA;MCU;PDK4;ADIPOR1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),0.835231875650023,1.485571017247157,0.06060606060606061,0.8377379590757148,1.0,3/9,4.47%,EFNB2;BMP2;GREM1
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),0.762531189781438,1.4853081214913413,0.0,0.8323231724973018,1.0,7/15,17.59%,PRDX6;LYPLA2;GDE1;PLA2G4C;MGLL;ABHD6;GPCPD1
prerank,GO_Biological_Process_2021__cellular response to hydroxyurea (GO:0072711),-0.9009474552545768,-1.485265868690865,0.0136986301369863,0.45087601416475764,1.0,1/8,0.78%,BLM
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),-0.8258182825659222,-1.4847522017660129,0.0,0.4496497490539199,1.0,2/14,6.87%,CD24;SRPX2
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),0.7041980561209504,1.4845134757386387,0.058823529411764705,0.8304957241542751,1.0,4/15,6.53%,SLC39A10;FOXP1;RUNX1;LPXN
prerank,GO_Biological_Process_2021__smooth muscle cell differentiation (GO:0051145),-0.9254945973837982,-1.4844302453049478,0.014925373134328358,0.4465149359886202,1.0,2/9,0.92%,TMEM204;APLNR
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,-0.6258614887452048,-1.4843816532567728,0.0,0.4416323755822266,1.0,26/103,15.34%,ENPP2;NPY;RIMBP2;TAGLN3;CDH22;CHGB;CCK;PCSK2;STMN2;SH3GL2;SYT4;LRRTM1;ELAVL4;SYP;GAP43;PLPPR1;SST;HPCA;SCG5;CA10;CPLX2;KCNB2;CALY;GLP1R;GDAP1L1;GAD2
prerank,GO_Biological_Process_2021__inorganic ion transmembrane transport (GO:0098660),-0.9438332784892521,-1.4833820040818848,0.0,0.4436751123550271,1.0,1/8,0.03%,CACNA1H
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),0.8070442429549028,1.4828696737174552,0.03125,0.8362187869403254,1.0,3/10,8.18%,CEBPA;ZC3H8;AR
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),0.5274009395665804,1.482551402506967,0.0,0.831195071342162,1.0,32/93,22.95%,MRPL10;MRPS30;MRPL15;PTCD3;MRRF;FASTKD2;MTIF2;GATC;MRPS9;MRPS2;MRPL37;QRSL1;MRPL58;MRPL52;GFM2;MRPL50;MRPS35;MRPL42;MRPS27;MRPL18;MRPL47;MRPS31;MRPL41;MRPS14;NOA1;LARS2;MRPL9;MRPS7;MRPL1;MRPS11;MTRF1;MRPL4
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),0.7985974584484812,1.482011691365933,0.09090909090909091,0.8284863464711353,1.0,2/8,7.02%,ATP6V1A;ATP6V1G1
prerank,GO_Biological_Process_2021__phosphatidylcholine catabolic process (GO:0034638),-0.9586951071688605,-1.4818430108704612,0.0,0.44866794301749613,1.0,1/6,0.03%,ENPP2
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),0.6152985141947784,1.4818340992368877,0.045454545454545456,0.8228006322717949,1.0,6/29,15.71%,ITGA1;PPP1R15B;PPP6R1;PPP1R1B;MAGI2;STYXL1
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell apoptotic process (GO:0034393),-0.8920862119360278,-1.4818173990671484,0.0,0.444293008046732,1.0,2/7,6.15%,CDKN2A;IL12A
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),0.5687738036823974,1.481619947718779,0.0,0.817095991063723,1.0,14/61,14.56%,LCMT2;THUMPD1;ADAT2;TYW3;FTSJ1;PUS10;TPRKB;NSUN6;TRIT1;TRMT61A;THG1L;TRMT1;DTWD1;DTWD2
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),-0.7778534999404845,-1.481181453741894,0.028985507246376812,0.4436761412766335,1.0,2/16,2.43%,ANXA1;ZFP36
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),0.7825144960685797,1.4807403820770084,0.17142857142857143,0.8169748828221172,1.0,1/7,1.60%,NCSTN
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),-0.7325862805891791,-1.4806318832916603,0.05263157894736842,0.44352548723884855,1.0,4/24,9.49%,CACNA1H;KCNB1;SYT4;SYT1
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception of sound (GO:0050910),-0.9023030622394514,-1.4804722803370312,0.0,0.44059964378162525,1.0,1/9,0.89%,HPN
prerank,GO_Biological_Process_2021__negative regulation of metallopeptidase activity (GO:1905049),-0.8908885122335084,-1.479247271127875,0.0,0.4453620672363159,1.0,2/5,8.62%,TIMP2;TIMP1
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),0.8287690384080679,1.4784913302533984,0.07407407407407407,0.8281931392420613,1.0,4/8,14.90%,ZC3H8;SNAPC5;SNAPC3;SNAPC1
prerank,GO_Biological_Process_2021__venous blood vessel development (GO:0060841),-0.9488961951997061,-1.4784521021308796,0.017857142857142856,0.4469537281820053,1.0,3/6,3.97%,CCBE1;APLNR;PROX1
prerank,PanglaoDB_Augmented_2021__Pericytes,-0.6139793018174335,-1.477284579696033,0.0,0.45103132903888443,1.0,39/111,19.51%,ECM2;COL4A1;APLNR;ANGPTL2;COL4A2;SPARC;C1R;ICAM1;CSPG4;P2RY14;ASPN;ABCA8;COL6A2;IGFBP5;THY1;COX7A1;THBS2;PODN;ZIC1;RASL12;LDB2;ALPL;ELN;BGN;LMOD1;PRRX1;SERPING1;GLI1;SLIT3;PCDH18;SLC38A11;C1S;MCAM;NOTCH3;PDE5A;PTH1R;TNS2;PDZD2;AQP1
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),0.620896564813497,1.4769186795843023,0.04,0.8330419629228615,1.0,7/26,14.48%,WNT7A;ZNF358;SALL1;INTU;NIPBL;AFF3;HDAC2
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),-0.7426989245877066,-1.4764812158043483,0.06756756756756757,0.45261862494803334,1.0,6/28,10.53%,KLF2;EPN1;THBS1;CEACAM1;KLF4;ITGA5
prerank,GO_Biological_Process_2021__somite development (GO:0061053),0.8398038479001625,1.476311641814539,0.03571428571428571,0.8312319197374793,1.0,1/8,0.09%,MEOX2
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),0.5742322230489069,1.4757847909221034,0.0,0.827349751293717,1.0,15/70,18.33%,RANBP17;NUP62CL;U2AF1;RITA1;NUP42;RANBP3L;XPO1;NUP214;EIF4E;RAE1;NUP188;XPO7;THOC1;THOC3;MALT1
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.6319080369422528,-1.4754331121678554,0.0,0.4555354397459661,1.0,19/65,19.78%,ENPP2;EFNA1;CD44;CSPG4;IL15;APP;ITGA5;GATA1;TNFRSF14;SFRP2;DMTN;IGF1;PRKCD;FGF7;PTPRC;RELN;TGFB1;CD74;RIPK2
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",-0.9318505920442234,-1.4745907464850803,0.0,0.4567932043264714,1.0,2/7,3.46%,P2RY12;SHTN1
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),0.7476207700135791,1.4742664136860508,0.10256410256410256,0.8313200524656685,1.0,3/10,13.02%,PLD6;VAT1;MUL1
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),-0.7696933425965424,-1.4741392183470587,0.0,0.4554402298707017,1.0,8/21,14.71%,CACNA1H;SCN1B;KCNJ2;SCN9A;YWHAH;SCN2A;SCN1A;CACNA1C
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.7324186270551636,-1.4734809960447126,0.0,0.4553527269895048,1.0,5/23,9.37%,P2RY6;APLNR;CEMIP;THY1;HAP1
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),0.6828126749341331,1.4733832446542168,0.08333333333333333,0.8298937411706898,1.0,3/28,7.02%,ATP6V0D2;ATP6V1A;ATP6V1G1
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),0.726229824744963,1.4733384928136743,0.043478260869565216,0.823631207084312,1.0,5/12,19.25%,CBFA2T3;VCP;IFNLR1;IDE;NOA1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.7410875936487221,-1.4730865730573366,0.045454545454545456,0.4528130950051294,1.0,6/19,11.66%,NR4A3;CD44;SKAP1;CCL2;THY1;PRKCQ
prerank,GO_Biological_Process_2021__collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),-0.9816300281927148,-1.4730846773186914,0.0,0.4484591229377724,1.0,1/5,1.35%,COL4A2
prerank,GO_Biological_Process_2021__negative regulation of fibroblast migration (GO:0010764),0.8810696849651842,1.4730505885244098,0.0,0.8193955371388416,1.0,1/5,2.11%,MACIR
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),-0.7634801713374687,-1.472850821199824,0.0410958904109589,0.4458730456942969,1.0,4/20,8.05%,CDKN2A;SUV39H1;CENPV;POLE3
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),-0.7843667346281752,-1.4728367842346504,0.013513513513513514,0.4419846135693693,1.0,4/24,1.44%,ANXA1;PIF1;BLM;RECQL4
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),-0.8651929104972104,-1.472386934644207,0.0,0.4414757972294469,1.0,4/11,6.66%,CIITA;TRIM5;IFITM3;BST2
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),-0.9223255617397258,-1.472243446655106,0.0,0.43848016338085855,1.0,1/8,0.14%,ST6GAL1
prerank,GO_Biological_Process_2021__B cell proliferation (GO:0042100),-0.8700263405467032,-1.4720036091487236,0.0,0.43561678712685886,1.0,1/8,0.33%,RASGRP1
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),0.6678631707431313,1.4708163166211792,0.13333333333333333,0.8293623030679934,1.0,9/17,21.73%,GREM1;SOX9;TRPS1;SOX5;ADAMTS12;MDK;EFEMP1;BMPR1B;TGFBR1
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),0.8070028330683409,1.4700250146923246,0.03571428571428571,0.8288391043157264,1.0,4/11,11.80%,ELOVL4;ELOVL6;ELOVL2;HACD2
prerank,GO_Biological_Process_2021__hexose transmembrane transport (GO:0008645),0.7570070553466702,1.4696863112858845,0.10810810810810811,0.824661119851833,1.0,1/16,0.43%,SLC2A5
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),0.88524712815604,1.4694753657434667,0.027777777777777776,0.8197160929871423,1.0,2/6,1.91%,VEGFD;VEGFC
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),-0.7752856382060982,-1.4684923327873312,0.05555555555555555,0.4560119946614484,1.0,4/17,9.78%,CD24;WNT5A;PARP9;KLF4
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),0.5966287401892078,1.4684333982385134,0.07692307692307693,0.8202054635166852,1.0,23/63,20.22%,ABCD2;CEL;LPIN3;ABCD1;ACADM;PEX13;ABHD1;MCAT;PHYH;EHHADH;CPT2;ABCD3;PEX2;SCP2;ECHDC1;ACOX1;AIG1;PLA2G15;ACADS;SLC25A17;BDH2;ACAD10;DECR1
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),-0.5968609819723706,-1.4683526239152442,0.0,0.45281456877581305,1.0,26/140,13.25%,IFI6;TRIM22;SP100;C3;MX1;TLR2;CIITA;B2M;TRIM61;SFTPD;TRIM5;IFIT1;IFITM3;SLA;COLEC12;APP;NLRC5;BST2;ISG15;TLR3;TRIM17;PTK6;IRF7;SYK;HLA-E;ALPK1
prerank,GO_Biological_Process_2021__negative regulation of lens fiber cell differentiation (GO:1902747),0.8619656258734625,1.468017321093259,0.046511627906976744,0.816084342051,1.0,3/5,12.02%,SPRED1;SPRY1;SPRED2
prerank,GO_Biological_Process_2021__membrane lipid catabolic process (GO:0046466),-0.8993366374043708,-1.467805460327555,0.0,0.45193088534697273,1.0,3/9,8.93%,ENPP2;PDXDC1;CYP1B1
prerank,GO_Biological_Process_2021__regulation of interleukin-5 production (GO:0032674),-0.9719110554897945,-1.4672686512993367,0.0,0.4528521825337917,1.0,1/6,0.16%,LEF1
prerank,GO_Biological_Process_2021__leukotriene biosynthetic process (GO:0019370),-0.8817816777431089,-1.467130981967177,0.0,0.4493971078693809,1.0,1/10,0.07%,GGT5
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),-0.7655325509246369,-1.4658684130980466,0.043478260869565216,0.4531815248606406,1.0,9/20,14.65%,B2M;HLA-A;CD160;WNT5A;TNFRSF14;HLA-E;SCIMP;CD55;HLA-F
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),-0.6959040607146127,-1.4656632119785693,0.027777777777777776,0.4510178517386681,1.0,4/27,10.64%,LEF1;HPN;LRRC19;POU2F3
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),-0.7224874798864184,-1.465242500174227,0.05263157894736842,0.44975524757054053,1.0,3/25,8.71%,ABCA5;ABCA8;ABCA12
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),0.8925375177937105,1.4652086952837573,0.05263157894736842,0.8309090259041992,1.0,2/6,3.86%,RGCC;ATF5
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),-0.7027440415312952,-1.4650171297627848,0.01282051282051282,0.4485140434730592,1.0,4/33,6.19%,SCN1B;PKP2;ANK3;CHRM1
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),-0.8202199317220404,-1.4638020998303414,0.016129032258064516,0.45147070664332195,1.0,2/10,1.77%,COL4A1;TGFBR2
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),-0.8699226849269243,-1.4637328335479276,0.058823529411764705,0.44827010476216034,1.0,1/8,2.26%,SUV39H1
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),0.8143046486389957,1.4631848566898433,0.02564102564102564,0.8377543011963502,1.0,3/7,16.01%,PDE12;RO60;PYHIN1
prerank,GO_Biological_Process_2021__L-methionine salvage (GO:0071267),-0.8957282794637297,-1.463157177553706,0.03076923076923077,0.4478378400559497,1.0,2/6,5.64%,APIP;BHMT
prerank,GO_Biological_Process_2021__negative regulation of interleukin-12 production (GO:0032695),-0.9642396153591937,-1.4621780121481784,0.0,0.4512107317893047,1.0,1/6,0.43%,THBS1
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),0.5780298567550516,1.460962622768444,0.0,0.8495006810537002,1.0,13/66,15.20%,ATP6V0D2;ATP6V1A;EIF2S1;ATP6V1G1;MIOS;SESN2;EIF2AK4;MAPK8;WDR24;EIF2AK3;DAP;PRKD1;SESN3
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,-0.6136973901580306,-1.4608533909655117,0.037037037037037035,0.45569318440440104,1.0,26/100,14.13%,COL4A1;ANGPTL2;COL4A2;SPARC;CALD1;C1R;COL5A1;COL6A2;SULF1;SRPX2;IGFBP5;CCL2;THY1;THBS2;PODN;RASL12;LDB2;TIMP1;SYP;GFAP;BGN;LMOD1;IGFBP7;PRRX1;FN1;MEG3
prerank,GO_Biological_Process_2021__protein K11-linked deubiquitination (GO:0035871),0.7809664657019603,1.460648061624479,0.038461538461538464,0.8449881349313628,1.0,3/9,10.54%,OTUD3;TNFAIP3;OTUB2
prerank,GO_Biological_Process_2021__serine family amino acid catabolic process (GO:0009071),0.820111007874915,1.4604074928419564,0.08823529411764706,0.8399494743138841,1.0,1/8,0.88%,DAO
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.7208957587479714,-1.4603728115428372,0.024691358024691357,0.4554153402208949,1.0,3/30,8.67%,LEF1;PDE6B;WNT5A
prerank,GO_Biological_Process_2021__forebrain neuron differentiation (GO:0021879),0.8091178700048799,1.4594723732914059,0.05,0.8405622654999272,1.0,3/6,9.01%,ERBB4;SALL1;ZSWIM6
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),0.5080040070064492,1.4586754044347052,0.0,0.8401945299955249,1.0,24/93,19.82%,U2AF1;NUP42;NUP37;NUP54;WDR33;AAAS;NUP214;EIF4E;NDC1;NXT1;RAE1;NUP188;SMG7;NUP85;IWS1;NUP205;NUP210;THOC1;AGFG1;PCID2;THOC3;SMG1;CPSF2;DDX25
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),0.7694685497037184,1.4585571024741617,0.03571428571428571,0.8353935601739138,1.0,2/10,1.91%,VEGFD;VEGFC
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),-0.7380728516021818,-1.4578807439074202,0.043478260869565216,0.4682172468396897,1.0,7/23,21.93%,IFI6;IL12A;VWCE;IFIH1;GSDME;EIF5A;LGALS8
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),-0.8844409403782154,-1.4578745224998568,0.0,0.46450123694413664,1.0,4/10,9.31%,ENPP2;CD44;PDPN;VIL1
prerank,PanglaoDB_Augmented_2021__Spermatocytes,0.6918243816676025,1.457605145436508,0.03333333333333333,0.8357380632916102,1.0,2/17,4.59%,PRNT;GCNA
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",0.5398806112895784,1.4569515807693192,0.0,0.8346506696423778,1.0,15/75,15.49%,DIRAS3;KDM1B;KAT2B;SMYD5;ERCC6;DNMT3B;EED;RBBP4;KAT2A;POLR1F;PPHLN1;DDX21;AEBP2;EP300;TASOR
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),0.6528340162083539,1.4560578481964674,0.06666666666666667,0.8338618123374895,1.0,10/25,17.64%,SAMM50;DMAC2L;LETM1;CHCHD3;ATP5PB;DNAJC11;APOOL;ATP5MC2;ATP5MC1;ATP5F1A
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),0.5782682654834341,1.4557090683695861,0.0,0.8302690464239043,1.0,13/65,15.20%,ATP6V0D2;ATP6V1A;EIF2S1;ATP6V1G1;MIOS;SESN2;EIF2AK4;MAPK8;WDR24;EIF2AK3;DAP;PRKD1;SESN3
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),0.8208062334419207,1.4554124181947945,0.08571428571428572,0.8262595781451276,1.0,3/8,12.02%,SPRED1;SPRY1;SPRED2
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),0.8030688967927958,1.454700005396996,0.05263157894736842,0.8251737031647006,1.0,2/8,10.07%,ABCA1;PRKACB
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),-0.809723980226236,-1.4546027608811403,0.04285714285714286,0.48107655857814197,1.0,2/13,2.43%,ANXA1;ZFP36
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),0.7457948702803056,1.453860525391101,0.07142857142857142,0.8261248395991349,1.0,3/8,16.11%,METAP1D;NAA30;METAP1
prerank,GO_Biological_Process_2021__mitochondrial DNA repair (GO:0043504),0.8312471170135556,1.4538541300772607,0.024390243902439025,0.8205803775884022,1.0,3/5,12.45%,DNA2;PRIMPOL;MGME1
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),0.6014064303560971,1.4538026268899968,0.04,0.8152005405073398,1.0,5/33,16.51%,PTCD2;RBM23;PAPOLA;IWS1;QKI
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium morphogenesis (GO:2000394),-0.9170808852229055,-1.4533119257341751,0.0,0.4865327840253361,1.0,1/7,0.03%,ENPP2
prerank,GO_Biological_Process_2021__telomeric loop disassembly (GO:0090657),-0.896113624510041,-1.452986766095714,0.031746031746031744,0.48472047022195985,1.0,2/8,1.44%,BLM;RECQL4
prerank,GO_Biological_Process_2021__positive regulation of fatty acid beta-oxidation (GO:0032000),0.7880956344368463,1.4513351970243258,0.0,0.8263799146691527,1.0,4/8,7.04%,ABCD2;PLIN5;AKT2;ABCD1
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),-0.7744702459863011,-1.4504841108272781,0.015151515151515152,0.4976470527513228,1.0,1/15,0.43%,THBS1
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.6954765356576071,-1.450299303609318,0.04054054054054054,0.49545600847707477,1.0,7/27,14.65%,B2M;HLA-A;MFSD6;HLA-C;HLA-B;HLA-E;HLA-F
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,-0.6158659568045757,-1.450061623646254,0.0,0.4936172834385346,1.0,21/92,13.89%,COL4A1;ANGPTL2;COL4A2;CALD1;C1R;MATN2;ASPN;ABCA8;IGFBP5;COX7A1;THBS2;PODN;RASL12;CYP1B1;ELN;BGN;RASD1;MYH11;LMOD1;PRRX1;RNASE1
prerank,GO_Biological_Process_2021__protein depalmitoylation (GO:0002084),0.7866090689762459,1.4496931710359122,0.08888888888888889,0.8270482895776905,1.0,5/8,18.13%,ABHD17A;LYPLA2;ABHD17B;ABHD17C;LYPLAL1
prerank,GO_Biological_Process_2021__macromolecule depalmitoylation (GO:0098734),0.7866090689762459,1.4496931710359122,0.08888888888888889,0.8270482895776905,1.0,5/8,18.13%,ABHD17A;LYPLA2;ABHD17B;ABHD17C;LYPLAL1
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),0.607334840994449,1.449511341533464,0.07142857142857142,0.8222079038828625,1.0,5/17,21.16%,SDC4;SNF8;SMPD3;VPS4B;CHMP6
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),0.581318251031871,1.449441732144767,0.038461538461538464,0.817429974777645,1.0,17/39,29.13%,SMARCAD1;ERCC6;HNRNPC;RBBP4;HDAC2;SMARCA2;MBD3;MTA2;PBRM1;CHD4;ACTR6;ARID1B;SMARCC1;INO80;MBD2;CHD8;VPS72
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),0.5288795984417923,1.4493843882139832,0.08,0.8122772493972052,1.0,12/44,18.00%,LEPR;FLT3;RABL3;PBX1;MSH2;TOX;KAT7;CHD7;SLC25A5;CEBPG;DCAF1;GPR89B
prerank,GO_Biological_Process_2021__mitochondrial DNA replication (GO:0006264),0.8613943933892513,1.449361313920551,0.06976744186046512,0.807190163830529,1.0,4/7,12.45%,DNA2;PRIMPOL;POLG2;MGME1
prerank,PanglaoDB_Augmented_2021__Tuft Cells,-0.7023950466932233,-1.4480378763858794,0.028985507246376812,0.5050451957209915,1.0,10/33,13.79%,CD24;P2RY13;IL13RA1;IGHG1;IL4R;POU2F3;IRF7;CTSS;GFI1B;IRAG2
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),0.8124957353136499,1.4479107014255965,0.05714285714285714,0.8106920080018722,1.0,2/9,1.91%,VEGFD;VEGFC
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),-0.7415556845999846,-1.4476184363655864,0.02631578947368421,0.5040425572825639,1.0,3/24,5.35%,ANXA1;THBS1;DUOX1
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.8395099261061045,-1.4474925281376585,0.06896551724137931,0.5011825927218181,1.0,2/8,7.76%,SOCS3;PARP14
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.508322191043962,1.4474140078893252,0.0,0.807903567804274,1.0,22/88,19.82%,U2AF1;NUP42;NUP37;NUP54;WDR33;AAAS;NUP214;EIF4E;NDC1;NXT1;RAE1;NUP188;SMG7;NUP85;NUP205;NUP210;THOC1;AGFG1;THOC3;SMG1;CPSF2;DDX25
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),-0.624039507262194,-1.4473872551599283,0.0,0.4984266335966202,1.0,13/99,6.95%,GGT5;CXCL2;ANXA1;THBS1;TLR2;CIITA;CD44;ADGRE5;SIGLEC1;PRDX5;TPST1;NOD1;CCL2
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),0.8386519514963469,1.4470722543651442,0.02857142857142857,0.8049799229162828,1.0,1/6,13.12%,WASL
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),0.7503244990896963,1.4453446100597949,0.07142857142857142,0.810796298394539,1.0,4/11,10.76%,ARV1;ABCA1;RELCH;STARD4
prerank,GO_Biological_Process_2021__negative regulation of transcription by competitive promoter binding (GO:0010944),0.9036546504491376,1.4445001376931736,0.0,0.8116700069231649,1.0,1/6,1.05%,DACH1
prerank,GO_Biological_Process_2021__negative regulation of erythrocyte differentiation (GO:0045647),-0.9217572639408922,-1.4428783967863126,0.0196078431372549,0.5273193191161573,1.0,1/5,2.43%,ZFP36
prerank,GO_Biological_Process_2021__membrane biogenesis (GO:0044091),-0.9171297124977986,-1.4418595230727722,0.0,0.5307630371185486,1.0,2/7,2.68%,TLCD2;ANK3
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),0.6083239738978173,1.441345110635173,0.043478260869565216,0.8255535546534538,1.0,13/33,22.20%,TFB2M;PTCD3;FASTKD2;GATC;MRPS2;QRSL1;GFM2;MRPL47;MRPS14;NOA1;LARS2;MRPS7;MRPS11
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),-0.7689370714225678,-1.440922997618085,0.06060606060606061,0.5339753747875314,1.0,1/18,0.03%,ENPP2
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),0.6595943157611089,1.4397189836884157,0.07692307692307693,0.8313039964285768,1.0,3/18,8.44%,DGKB;DGKE;MOGAT1
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),0.6565887030365357,1.4397076110999583,0.058823529411764705,0.8262657903896157,1.0,5/21,16.90%,MYO10;CCDC88C;MAP6;KIF1B;CCDC88A
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),0.49755330018202293,1.4392951732832775,0.08333333333333333,0.8231732901756279,1.0,14/107,9.79%,ATP6V0D2;TBC1D4;PDK4;TRIB3;PDE3B;ATP6V1A;LPIN3;KAT2B;AKT2;ATP6V1G1;AP3S1;AKT1;INSIG2;RAB8B
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),-0.9178883286423745,-1.439158727649123,0.057692307692307696,0.541474581405068,1.0,2/6,1.06%,ANXA1;CDKN2A
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),0.5679713535543441,1.4385962456089445,0.06451612903225806,0.8219915429873623,1.0,19/49,23.09%,ASCL1;NCSTN;BMP2;POFUT1;KAT2B;MAML3;PBX1;NOTCH2;DTX4;HEYL;EP300;MDK;HEY2;HES5;MIB1;ZNF423;RBPJ;JAG1;ITCH
prerank,GO_Biological_Process_2021__negative regulation of p38MAPK cascade (GO:1903753),-0.8953804873357626,-1.4381559964530493,0.030303030303030304,0.5444458847488702,1.0,1/6,1.53%,DUSP1
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta production (GO:0071635),-0.9294994970888589,-1.437596839125068,0.03333333333333333,0.544883493505114,1.0,1/6,0.04%,CD24
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),0.7409155237268176,1.4362237581335018,0.10526315789473684,0.8303796274360122,1.0,4/10,16.13%,PSMD10;PSMD11;POMP;PSMG2
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),-0.7780486898913439,-1.4356140478513002,0.057971014492753624,0.5573335920902951,1.0,5/18,7.31%,APLNR;RAMP3;CEMIP;THY1;TRPC3
prerank,GO_Biological_Process_2021__regulation of cell cycle checkpoint (GO:1901976),0.8030723205838826,1.4355530944002823,0.05263157894736842,0.8308597635680173,1.0,2/6,12.14%,RFWD3;FEM1B
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),0.7342472094467194,1.4352419147315458,0.05128205128205128,0.8234493549148346,1.0,3/11,17.05%,AP3S1;AP3B1;BLOC1S4
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),0.7342472094467194,1.4352419147315458,0.05128205128205128,0.8234493549148346,1.0,3/11,17.05%,AP3S1;AP3B1;BLOC1S4
prerank,GO_Biological_Process_2021__vasodilation (GO:0042311),-0.8541346010037326,-1.434748223132391,0.028169014084507043,0.55907975999833,1.0,1/9,0.17%,KLF2
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.7333685479313578,-1.434497038864812,0.05555555555555555,0.5571414080930226,1.0,2/23,5.63%,KLF2;ATF3
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),0.8054453167587496,1.4341724367820048,0.06521739130434782,0.8245150932103765,1.0,3/7,7.41%,ERCC8;LIG4;ERCC6
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),0.7350397774288965,1.434154567312028,0.03125,0.8198277505642414,1.0,1/13,1.37%,FAM47E
prerank,GO_Biological_Process_2021__respiratory chain complex IV assembly (GO:0008535),0.6702180514940899,1.433777410540708,0.06976744186046512,0.8169926230914393,1.0,5/16,18.92%,COX10;COX18;SMIM20;COX19;FASTKD3
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),0.6143371348114552,1.4325855960113174,0.06896551724137931,0.8189321470250159,1.0,10/31,16.55%,SAMM50;MAIP1;CHCHD3;TMEM11;OPA1;BAD;DNAJC11;APOOL;SLC25A5;MTX2
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),-0.7636989632569167,-1.4323361026718562,0.07575757575757576,0.5688477951635846,1.0,2/13,0.78%,ANXA1;BLM
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),0.5593760536286042,1.4322873077229323,0.038461538461538464,0.8159797253910023,1.0,5/27,14.37%,ITGA1;PPP1R15B;PPP2R5A;SMPD1;MAGI2
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),-0.8450919773983092,-1.4320662882622406,0.05454545454545454,0.5668120545408104,1.0,2/7,10.13%,IFIT1;STAT1
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),-0.8267071246905946,-1.4317150204308866,0.03389830508474576,0.5652592190676948,1.0,1/10,0.92%,APLNR
prerank,GO_Biological_Process_2021__response to increased oxygen levels (GO:0036296),0.8482018238355452,1.4317112416752178,0.05263157894736842,0.8158277455576273,1.0,2/5,7.02%,ATP6V1A;ATP6V1G1
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),0.6892082928973478,1.4315678811173427,0.09090909090909091,0.8120851906371871,1.0,4/14,11.88%,MGAM;PGM2;AGL;PYGM
prerank,PanglaoDB_Augmented_2021__B Cells,-0.6395164320184039,-1.4315111714963649,0.012195121951219513,0.5628225494277226,1.0,18/71,15.01%,CD24;CD5;TAGAP;TMC8;P2RY10;IGHG1;IFIT3;RCSD1;ARHGAP9;WAS;HLA-DRA;ACAP1;CRELD2;CTSS;BIRC3;CD55;IRAG2;SP140
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),0.631065889523928,1.430627947760588,0.037037037037037035,0.8137047708557015,1.0,6/17,26.07%,RAB33B;PDE4DIP;MYO5A;MAP2K2;STX18;CAMSAP2
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),-0.7357186692327066,-1.428547718028561,0.02666666666666667,0.5816488902010253,1.0,9/20,20.76%,RFTN1;SYK;LAT2;BMX;PTPRC;PRKCB;SH2B2;PIK3CD;BLNK
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),0.5504394576691999,1.4284810263407643,0.0,0.8174915613596977,1.0,16/50,22.14%,NUP42;NUP37;NUP54;IPO8;AAAS;NUP214;NDC1;RAE1;POLR2C;NUP188;NUP85;NUP205;NUP210;PUM2;NUP153;NUP50
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),0.5504394576691999,1.4284810263407643,0.0,0.8174915613596977,1.0,16/50,22.14%,NUP42;NUP37;NUP54;IPO8;AAAS;NUP214;NDC1;RAE1;POLR2C;NUP188;NUP85;NUP205;NUP210;PUM2;NUP153;NUP50
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),-0.6188301567448528,-1.4279322679361162,0.02631578947368421,0.5820372125744454,1.0,15/70,12.08%,MET;STMN2;PSRC1;PROX1;APP;BAIAP2L1;CAV3;CDC42EP1;BAIAP2;VIL1;SYNPO2L;DCTN1;PFN2;LMOD1;CDC42EP3
prerank,GO_Biological_Process_2021__vitamin A metabolic process (GO:0006776),-0.8811510359565873,-1.427875142549426,0.015384615384615385,0.5789839897389681,1.0,2/7,4.92%,RPE65;RBP2
prerank,GO_Biological_Process_2021__regulation of lens fiber cell differentiation (GO:1902746),0.8565888070387775,1.4277774371287062,0.025,0.8165879326741682,1.0,3/6,12.02%,SPRED1;SPRY1;SPRED2
prerank,GO_Biological_Process_2021__positive regulation of regulated secretory pathway (GO:1903307),-0.805296930583058,-1.4277008287077844,0.029411764705882353,0.576466255378575,1.0,3/15,6.99%,CACNA1H;KCNB1;SYT4
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),-0.6898659455523071,-1.4261166507703529,0.05555555555555555,0.5852507700571256,1.0,3/21,9.08%,KIF14;CENPV;SVIL
prerank,GO_Biological_Process_2021__peptidyl-amino acid modification (GO:0018193),0.838213517324223,1.425944251418877,0.05714285714285714,0.8240949673812681,1.0,1/6,1.58%,METAP1D
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),0.7107185924467387,1.4256639263934265,0.1,0.8215386099561238,1.0,6/17,11.71%,ABCD2;ACACB;MID1IP1;ABCD1;CPT2;ABCD3
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),-0.8010367807309204,-1.4247284786428236,0.05333333333333334,0.5929435711137988,1.0,5/18,9.24%,CCBE1;C3;SULF1;CYP1B1;BRCA1
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,-0.5876076662100808,-1.4246661898450939,0.0,0.5894666819443384,1.0,34/147,14.01%,CXCL2;KLF2;SOCS3;EFNA1;FOSB;NR4A3;DUSP1;GPR183;TLR2;FOSL2;ZFP36;ICAM1;BTG3;CD44;IRF1;MAFF;PLK2;ATF3;TRIP10;CCL2;LDLR;IFNGR2;GADD45A;KLF4;FOS;BTG1;SPSB1;TNIP2;CCND1;JUNB;GADD45B;BIRC3;IFIT2;NAMPT
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.845285547036813,-1.4245446251036638,0.04838709677419355,0.582804902120327,1.0,1/9,2.43%,ZFP36
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),-0.845285547036813,-1.4245446251036638,0.04838709677419355,0.582804902120327,1.0,1/9,2.43%,ZFP36
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.7947771775449999,-1.4238325873868427,0.043478260869565216,0.5846500301054273,1.0,4/13,14.05%,HPN;PIEZO2;SCN1A;LHFPL5
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),-0.7801372154608274,-1.423718750047245,0.0,0.5818384484285676,1.0,2/14,4.66%,CACNA1H;ERVW-1
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",0.6294277387717526,1.4236231189037254,0.0,0.8307762156850049,1.0,7/27,15.49%,SMYD5;DNMT3B;EED;RBBP4;PPHLN1;AEBP2;TASOR
prerank,GO_Biological_Process_2021__protein localization to microtubule cytoskeleton (GO:0072698),0.8144167255205327,1.4236061940659683,0.10256410256410256,0.8264559652289462,1.0,3/7,4.98%,CHAMP1;CRIPT;MID1
prerank,GO_Biological_Process_2021__negative regulation of PERK-mediated unfolded protein response (GO:1903898),0.8919667758735013,1.4234167812256722,0.0,0.822763944849595,1.0,2/5,9.06%,PPP1R15B;NCK1
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),-0.5788452675834764,-1.4232269046166481,0.0,0.5813642258096298,1.0,31/155,12.07%,ECM2;THBS1;COL8A1;COL4A1;COL4A2;SPARC;COL5A1;ADAMTS10;ICAM1;CD44;LAMB1;ITGA2;COL4A4;COL6A2;MMP21;COL27A1;THSD4;APP;COL24A1;MMP19;ADAMTSL2;MMP14;MARCOL;ELN;BGN;MMP25;ITGA5;COL10A1;COL11A2;ITGA8;COL9A2
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),-0.6750369410408472,-1.4231950543517486,0.04,0.578035582752564,1.0,5/25,14.46%,KIF14;CENPV;HTR2B;SVIL;FGF1
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transport (GO:0010765),-0.841256550052386,-1.4229945524332264,0.03389830508474576,0.5764534183448409,1.0,3/8,2.68%,SCN1B;PKP2;ANK3
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),-0.6311460755017136,-1.4229938569676055,0.011627906976744186,0.5729384584768846,1.0,17/62,20.75%,CD24;SOCS3;VRK2;IFNGR2;STAT1;SIGIRR;SYK;USP18;BIRC3;IL7;FADD;CDC37;TNFRSF1A;PTPRC;SPHK1;CD74;AGPAT2
prerank,GO_Biological_Process_2021__skeletal muscle fiber development (GO:0048741),0.8197427205636458,1.4224028304495915,0.022222222222222223,0.8238149938513369,1.0,2/5,5.14%,MYORG;SELENON
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),0.6355700828669204,1.4221335335778744,0.15,0.8208238642180046,1.0,2/24,0.56%,SLC6A13;SLC26A7
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),0.636401241227077,1.4217357841540792,0.03571428571428571,0.8182938459101503,1.0,7/23,19.04%,GPATCH2;PPP1R26;PPP1R1B;ZCCHC9;PPP1R36;STYXL1;PPP4R4
prerank,GO_Biological_Process_2021__arachidonic acid secretion (GO:0050482),-0.9010866849562844,-1.4204701027150781,0.09433962264150944,0.5858288140619053,1.0,1/5,0.21%,ANXA1
prerank,GO_Biological_Process_2021__arachidonate transport (GO:1903963),-0.9010866849562844,-1.4204701027150781,0.09433962264150944,0.5858288140619053,1.0,1/5,0.21%,ANXA1
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.7170736387599815,1.420056405639287,0.058823529411764705,0.8251926007606591,1.0,7/12,27.25%,ZNF304;TRIM28;PPHLN1;TASOR;RESF1;SETDB1;ATF7IP
prerank,GO_Biological_Process_2021__calcium ion export (GO:1901660),0.832288589084649,1.419999734890777,0.10526315789473684,0.8213198731138546,1.0,2/7,7.38%,SLC35G1;LETM1
prerank,GO_Biological_Process_2021__uridine transport (GO:0015862),-0.9328546087553026,-1.4193488000572922,0.0,0.5841035508516984,1.0,1/5,0.39%,SLC28A2
prerank,GO_Biological_Process_2021__nucleoside transport (GO:0015858),-0.9328546087553026,-1.4193488000572922,0.0,0.5841035508516984,1.0,1/5,0.39%,SLC28A2
prerank,GO_Biological_Process_2021__pyrimidine nucleoside transport (GO:0015864),-0.9328546087553026,-1.4193488000572922,0.0,0.5841035508516984,1.0,1/5,0.39%,SLC28A2
prerank,GO_Biological_Process_2021__pancreas development (GO:0031016),-0.8644509349586118,-1.4192080947832506,0.07042253521126761,0.5814605709161466,1.0,3/8,5.70%,MET;PROX1;CCDC39
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),-0.6681173572727646,-1.4189038959883145,0.025974025974025976,0.5805236114701436,1.0,8/37,11.66%,ANXA1;HLA-A;DOCK8;IL15;CCL2;THY1;PDCD1LG2;PRKCQ
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),-0.6638630953809002,-1.4188355158629289,0.0,0.5776872701897529,1.0,12/46,17.72%,RASGRP1;IL1R1;HLA-A;IL12A;ISG15;TLR3;PDCD1LG2;ZFPM1;BTN3A1;IL18;FADD;SLC11A1
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),-0.7555215458298694,-1.4188255832486807,0.047619047619047616,0.5744941323871471,1.0,3/13,3.55%,COL4A1;HPN;LAMB1
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),0.7774050479690369,1.4187400026978554,0.06666666666666667,0.8242544394384503,1.0,3/9,9.28%,DSCAM;RORB;CEP290
prerank,GO_Biological_Process_2021__triglyceride biosynthetic process (GO:0019432),0.7466877094643688,1.4185715953646727,0.10344827586206896,0.8210576239332801,1.0,4/13,8.44%,AGMO;GK;LPIN3;MOGAT1
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),0.4850473325867951,1.4182421284502822,0.0,0.8190098888274677,1.0,25/89,23.13%,CHRAC1;SMARCAD1;KAT2B;SOX9;ERCC6;HNRNPC;KDM5A;RBBP4;KAT2A;BAZ1A;HDAC2;SMARCA2;DR1;MBD3;PADI4;TADA2B;MTA2;BAHD1;PBRM1;CHD4;RUVBL1;BAZ2B;ARID1B;DAXX;ZBTB1
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903589),-0.9112728203019146,-1.4180736817969257,0.01694915254237288,0.5771963296378596,1.0,1/5,0.92%,APLNR
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),-0.5788340946467115,-1.416295152460342,0.0,0.5865593509525981,1.0,31/155,12.07%,ECM2;THBS1;COL8A1;COL4A1;COL4A2;SPARC;COL5A1;ADAMTS10;ICAM1;CD44;LAMB1;ITGA2;COL4A4;COL6A2;MMP21;COL27A1;THSD4;APP;COL24A1;MMP19;ADAMTSL2;MMP14;MARCOL;ELN;BGN;MMP25;ITGA5;COL10A1;COL11A2;ITGA8;COL9A2
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),0.6767395391425219,1.416283269075599,0.125,0.8267007742842853,1.0,2/13,6.78%,CSPG5;MFF
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),0.6496885795855583,1.4158457272101483,0.12903225806451613,0.8251976627484872,1.0,4/13,19.24%,SDC4;SNF8;SMPD3;VPS4B
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),-0.6654478356789928,-1.4151700427160732,0.013157894736842105,0.5908855456521792,1.0,9/44,12.08%,ARHGAP4;SHTN1;PDPN;ARHGEF3;EPS8L2;CDC42EP1;WAS;ARHGDIG;CDC42EP3
prerank,GO_Biological_Process_2021__proton-transporting V-type ATPase complex assembly (GO:0070070),-0.9280926483290766,-1.414291851289364,0.04838709677419355,0.5941633030536133,1.0,1/5,1.98%,ALDOB
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),0.7634102737028778,1.4137949476085212,0.09090909090909091,0.8323673439759676,1.0,2/8,7.02%,ATP6V1A;ATP6V1G1
prerank,PanglaoDB_Augmented_2021__Alpha Cells,-0.5961135843821938,-1.4134630818846388,0.0,0.5976408836896658,1.0,23/101,15.21%,KCNT2;RIMBP2;DEPP1;CHGB;PGR;PCSK2;STMN2;RCAN2;PROX1;GC;SH3GL2;IGFBP5;SYT4;GRIA3;LDB2;EDIL3;PLPPR1;SST;SCG5;SHC2;KCNB2;GLP1R;F10
prerank,GO_Biological_Process_2021__somatic hypermutation of immunoglobulin genes (GO:0016446),-0.8820335103612629,-1.4131884825506913,0.04477611940298507,0.5962318129128112,1.0,2/7,8.40%,POLQ;PMS2
prerank,GO_Biological_Process_2021__response to potassium ion (GO:0035864),-0.9117347835474279,-1.4129355163774946,0.03389830508474576,0.5918778198719165,1.0,1/5,0.03%,CACNA1H
prerank,GO_Biological_Process_2021__cellular response to potassium ion (GO:0035865),-0.9117347835474279,-1.4129355163774946,0.03389830508474576,0.5918778198719165,1.0,1/5,0.03%,CACNA1H
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),-0.8012421825788122,-1.412929213213382,0.039473684210526314,0.5886257439385543,1.0,5/17,9.24%,CCBE1;C3;SULF1;CYP1B1;BRCA1
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),-0.7809239442130288,-1.4128058714798504,0.015625,0.5860076935971901,1.0,3/13,8.78%,ZFP36;IFITM3;HEXIM1
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),0.6980518959386245,1.4127672753833969,0.10714285714285714,0.8350895500782581,1.0,7/12,24.73%,ADRA1A;LMBRD2;DRD2;ZDHHC21;ADRB2;ADRB1;RAPGEF2
prerank,"GO_Biological_Process_2021__positive regulation of phagocytosis, engulfment (GO:0060100)",-0.9185928829128376,-1.4118254119690012,0.01639344262295082,0.5906066611276879,1.0,1/5,0.71%,C3
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.5823864978121523,-1.411639448920328,0.024390243902439025,0.5886437595705155,1.0,23/87,19.78%,ENPP2;SOCS3;EFNA1;CD44;CSPG4;IL12A;IL15;PARP14;PARP9;ITGA5;GATA1;TNFRSF14;PTK6;IGF1;DOK7;IL18;TNFRSF1A;FGF7;PTPRC;RELN;TGFB1;CD74;RIPK2
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),-0.7074662942516272,-1.4116216336700953,0.04,0.5854790081749751,1.0,1/31,0.07%,GGT5
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),0.6171246809664237,1.4114605969114669,0.03571428571428571,0.8386688471224126,1.0,6/21,8.18%,CEBPA;ZC3H8;BRF2;TENM1;POLR3F;AR
prerank,GO_Biological_Process_2021__telomeric D-loop disassembly (GO:0061820),-0.9052291682487852,-1.4112318606218586,0.016666666666666666,0.5845556749523103,1.0,2/7,1.44%,BLM;RECQL4
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),-0.6917354896676116,-1.410524658084362,0.025974025974025976,0.5867790618060008,1.0,3/29,2.07%,THBS1;MET;P2RY12
prerank,GO_Biological_Process_2021__regulation of bone remodeling (GO:0046850),0.8776969218860188,1.4100405469669202,0.04878048780487805,0.8435662422486182,1.0,2/6,4.47%,LEPR;GREM1
prerank,GO_Biological_Process_2021__regulation of acrosome reaction (GO:0060046),-0.8914854241866234,-1.4096028444782138,0.03278688524590164,0.5902270407732175,1.0,2/7,1.69%,CACNA1H;SERPINA10
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),-0.7677829467738724,-1.4093467131134247,0.06779661016949153,0.589248955745062,1.0,3/15,7.89%,C3;APP;SRRM4
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),-0.7480764855245181,-1.4092452877156283,0.08641975308641975,0.5868696259338726,1.0,1/17,0.43%,THBS1
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),0.6520985607543324,1.40897237212471,0.08571428571428572,0.8474048897427057,1.0,7/13,20.03%,RARB;SALL1;NIPBL;RBPMS2;ID2;GLI3;PCSK5
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),-0.6943730105740025,-1.4088814935757334,0.06578947368421052,0.5867090417751416,1.0,4/28,5.90%,CP;B2M;SLC39A14;TMC8
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),-0.6773176105819034,-1.4087230600897171,0.05063291139240506,0.5846730914685286,1.0,4/32,3.36%,ANXA1;GBP1;ZFP36;SFTPD
prerank,GO_Biological_Process_2021__regulation of respiratory system process (GO:0044065),0.7964471732447158,1.4079757786914242,0.08333333333333333,0.8489270790122851,1.0,2/6,10.08%,NLGN3;ATP1A2
prerank,GO_Biological_Process_2021__sympathetic ganglion development (GO:0061549),0.8884996712451229,1.4074529371599018,0.06896551724137931,0.8471665215438181,1.0,1/6,0.78%,ASCL1
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),0.5949545958892324,1.4072464729331216,0.08333333333333333,0.8440294762262162,1.0,4/28,6.14%,PRDX6;ZPR1;HSPA1A;SF3B4
prerank,GO_Biological_Process_2021__phenol-containing compound biosynthetic process (GO:0046189),0.8639840650286779,1.4072349911708368,0.022222222222222223,0.8400643313457883,1.0,3/5,12.34%,TYR;MOXD1;DCT
prerank,GO_Biological_Process_2021__regulation of aldosterone biosynthetic process (GO:0032347),0.8907695716056276,1.4061393382128429,0.14634146341463414,0.8421840816790385,1.0,1/5,2.60%,BMP2
prerank,PanglaoDB_Augmented_2021__T Memory Cells,-0.638830404297726,-1.40556484531745,0.08433734939759036,0.6051966687354028,1.0,13/44,11.51%,LEF1;SP100;CD5;TAGAP;SKAP1;ARHGAP15;SLA;TMC8;GPR171;P2RY10;ARHGAP9;ACAP1;EPSTI1
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),-0.7681775689915128,-1.405300253159754,0.07352941176470588,0.604080487178799,1.0,3/20,3.13%,ANXA1;THBS1;RHOBTB2
prerank,GO_Biological_Process_2021__positive regulation of heart rate by epinephrine-norepinephrine (GO:0001996),0.7989635763904733,1.4048279664029364,0.15789473684210525,0.8462456827921173,1.0,1/6,2.97%,ADRA1A
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.897212775020609,-1.4033832392061238,0.05172413793103448,0.6150541219735431,1.0,2/6,3.11%,LRRC55;NOS1AP
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),-0.6837743871632318,-1.4029843747831507,0.04225352112676056,0.6150539037820454,1.0,13/33,24.31%,ALDOB;HK2;LDHA;GAPDHS;ENOSF1;ENO4;PGK1;GPI;PFKL;PGAM1;PFKFB2;ENO2;NEU4
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),0.6507197665330201,1.4026934190547808,0.05714285714285714,0.8544344847914717,1.0,6/12,27.64%,SAXO2;PCM1;DAG1;SAXO1;CLASP2;BICD2
prerank,GO_Biological_Process_2021__amino sugar catabolic process (GO:0046348),0.727097604047954,1.4024805798561948,0.08888888888888889,0.8514670913510051,1.0,1/7,3.42%,ALDH1A1
prerank,GO_Biological_Process_2021__regulation of transmembrane transporter activity (GO:0022898),0.722294008376566,1.4014994380311638,0.13157894736842105,0.8532347041342349,1.0,1/7,0.31%,ACE2
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),0.7173503315633973,1.4010576891371103,0.13157894736842105,0.8519694794140178,1.0,7/11,27.25%,ZNF304;TRIM28;PPHLN1;TASOR;RESF1;SETDB1;ATF7IP
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid transport (GO:0015812),0.8571538851659287,1.4005705234788381,0.11904761904761904,0.8503329005006843,1.0,1/5,0.53%,SLC6A13
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),0.6128301221955854,1.4005524176475277,0.08,0.8464229561779196,1.0,3/30,7.02%,ATP6V0D2;ATP6V1A;ATP6V1G1
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),-0.6961112766293595,-1.40053349169325,0.0379746835443038,0.6310948666460087,1.0,10/29,19.36%,NEFL;GRIN2A;APP;CCL2;GRIA3;GRIA1;GRIN2B;NLGN1;CAPN1;RELN
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,-0.6412445343768329,-1.4002515462532945,0.06493506493506493,0.6303790079520769,1.0,18/38,20.10%,GBP2;SP100;GPR183;TLR2;CIITA;TYMP;IRF1;IGSF6;CTSS;HLA-E;APOL6;BIRC3;IFIH1;SRGN;PTPRC;PTAFR;CLEC5A;SAMD9L
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),-0.8465737077917299,-1.3998970956295707,0.0273972602739726,0.6295439356933895,1.0,1/9,0.78%,BLM
prerank,GO_Biological_Process_2021__negative regulation of T-helper cell differentiation (GO:0045623),-0.8761883130852217,-1.3995386181980753,0.06896551724137931,0.6287171726114056,1.0,1/6,0.21%,ANXA1
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),0.5040206563380321,1.399265653186124,0.10526315789473684,0.8499529341520935,1.0,26/78,22.95%,MRPL10;MRPS30;MRPL15;PTCD3;MRRF;MRPS9;MRPS2;MRPL37;MRPL58;MRPL52;GFM2;MRPL50;MRPS35;MRPL42;MRPS27;MRPL18;MRPL47;MRPS31;MRPL41;MRPS14;MRPL9;MRPS7;MRPL1;MRPS11;MTRF1;MRPL4
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.6764546489464505,-1.3986333188002145,0.05128205128205128,0.63190246545522,1.0,3/39,6.87%,ANXA1;THBS1;SRPX2
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),0.5272419214193234,1.3985742870034137,0.1,0.8508048463671584,1.0,14/67,15.60%,RANBP17;NXT2;NUP62CL;KPNA2;PPP1R10;NUP54;AKT1;IPO5;IPO8;NUP214;NXT1;RANBP6;NUP188;NUP85
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.7025617255286439,-1.3980644382282137,0.02666666666666667,0.6327737920827672,1.0,11/27,18.14%,ANXA1;NPY;HTR2B;CHRM1;CCL2;CHRM3;HRH1;CNR1;HTR1E;CHRM5;HTR2A
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.7179990199343486,-1.397908579655958,0.08823529411764706,0.6305392196332087,1.0,9/23,16.37%,RASGRP1;HLA-A;CD160;IL12A;HLA-DRA;HLA-B;HLA-E;HLA-F;FADD
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),-0.782844178746425,-1.3978153594357758,0.08450704225352113,0.6279154815435001,1.0,2/12,2.43%,ANXA1;ZFP36
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),0.7515189534035802,1.3977261583183938,0.06666666666666667,0.8517116018587157,1.0,5/12,17.63%,WNT7A;SALL1;INTU;HDAC2;GLI3
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),0.5886728284540698,1.3974595957642397,0.03571428571428571,0.8493024457506331,1.0,4/22,9.17%,MSH4;POLD3;PMS1;MSH2
prerank,GO_Biological_Process_2021__regulation of water loss via skin (GO:0033561),-0.7956126419222919,-1.3970593754512133,0.05555555555555555,0.6275466045035579,1.0,9/12,17.80%,MET;ALOX12;LSR;FLG;ABCA12;FA2H;STMN1;HRNR;FLG2
prerank,GO_Biological_Process_2021__establishment of skin barrier (GO:0061436),-0.7956126419222919,-1.3970593754512133,0.05555555555555555,0.6275466045035579,1.0,9/12,17.80%,MET;ALOX12;LSR;FLG;ABCA12;FA2H;STMN1;HRNR;FLG2
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.8113971615545386,-1.3969078946335842,0.04477611940298507,0.625906685942684,1.0,2/13,6.87%,ANXA1;SRPX2
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),0.6981858617319852,1.3967515819106013,0.13793103448275862,0.849710801087858,1.0,1/9,0.67%,RGCC
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),0.6717730722490681,1.3964498906968366,0.09090909090909091,0.8484457622102731,1.0,9/19,22.53%,SOX8;BMP2;LIG4;STIL;CHD7;HINFP;MBNL1;TGFBR1;WNT7B
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),-0.8157686667504349,-1.395520109331861,0.046153846153846156,0.6336344027087769,1.0,4/11,9.65%,CD24;APOLD1;MAFF;CEACAM1
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),0.7610765599490971,1.3955080753328846,0.11428571428571428,0.8499623829347758,1.0,1/10,1.39%,SLIT1
prerank,GO_Biological_Process_2021__regulation of skeletal muscle contraction (GO:0014819),-0.8614476778380253,-1.3954900877281537,0.07142857142857142,0.6308578048895824,1.0,4/6,9.67%,KCNJ2;SLC8A3;CAV3;C12ORF57
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.7643592605005106,-1.39453265843891,0.04411764705882353,0.6346956471854697,1.0,5/15,14.65%,RASGRP1;CD160;IL12A;HLA-E;HLA-F
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),0.5036249250593746,1.3941747259394106,0.058823529411764705,0.8538553755524456,1.0,28/84,22.95%,MRPL10;MRPS30;MRPL15;PTCD3;MRRF;APEH;MRPS9;MRPS2;MRPL37;MRPL58;MRPL52;GFM2;MRPL50;MRPS35;MRPL42;MRPS27;MRPL18;MRPL47;MRPS31;MRPL41;MRPS14;MRPL9;MRPS7;ABCE1;MRPL1;MRPS11;MTRF1;MRPL4
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),-0.8729546536774584,-1.394146744652875,0.08620689655172414,0.6346822750689083,1.0,1/7,0.21%,ANXA1
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),-0.7104325740837639,-1.3936541037021675,0.029411764705882353,0.6353018780980794,1.0,3/25,6.16%,COL4A1;MET;PODXL
prerank,GO_Biological_Process_2021__kinetochore organization (GO:0051383),-0.8208882501346453,-1.3928004173656185,0.04838709677419355,0.63894704735455,1.0,3/8,11.23%,CENPH;CENPE;NUF2
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),-0.6972935527927289,-1.3925365354570025,0.07792207792207792,0.6383263104216431,1.0,8/23,19.13%,C3;C1R;CD55;CFH;SERPING1;SUSD4;C1S;C1QB
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),-0.817883221045693,-1.3924989857532644,0.09523809523809523,0.6358001372772971,1.0,1/8,0.43%,THBS1
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),0.5262227318589894,1.3924698739981434,0.0,0.8600317627937376,1.0,15/52,16.99%,RGCC;ERCC8;PPP1R10;EGFR;BRCC3;UBE2N;TRIM28;ERCC6;HMGB1;SIRT6;TOX;EYA2;POT1;EYA1;CEBPG
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),-0.6470021542659667,-1.3922065932820877,0.047619047619047616,0.6346560871755478,1.0,12/61,10.13%,KLF2;EPN1;THBS1;ISM1;COL4A2;SPARC;SERPINF1;CD160;SULF1;THBS2;KLF4;STAT1
prerank,MSigDB_Hallmark_2020__Apoptosis,-0.5738847741277395,-1.3920649604738242,0.011764705882352941,0.6326336768334527,1.0,22/123,16.03%,LEF1;ANXA1;TIMP2;BTG3;CD44;IFITM3;IRF1;ATF3;APP;TIMP1;BRCA1;NEFH;GADD45A;BGN;EMP1;CCND1;GADD45B;BIRC3;BCL2L2;AIFM3;CDK2;IL18
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),-0.696772431662424,-1.3920098765069517,0.05194805194805195,0.6298988163933547,1.0,4/24,3.58%,TRIM22;CIITA;TRIM5;IFITM3
prerank,GO_Biological_Process_2021__inhibition of cysteine-type endopeptidase activity (GO:0097340),0.8515005407069302,1.3918457525335366,0.030303030303030304,0.8591683886563654,1.0,1/5,2.03%,CARD18
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),-0.7811565226317563,-1.3917510974324443,0.06493506493506493,0.6284908344292653,1.0,1/12,0.43%,THBS1
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),0.6972068972587782,1.3916943732493694,0.06060606060606061,0.8561359184871254,1.0,5/13,7.94%,ABCD2;PLIN5;AKT2;ABCD1;AKT1
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell differentiation (GO:0046639),0.8142943740340214,1.391533746109334,0.1935483870967742,0.8530700860387236,1.0,3/5,17.63%,RUNX1;HMGB1;GLI3
prerank,GO_Biological_Process_2021__pteridine-containing compound biosynthetic process (GO:0042559),0.8475233019146873,1.3913999243239354,0.1282051282051282,0.8497915328994881,1.0,3/5,14.59%,MTHFS;QDPR;DHFR
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),-0.862881045392003,-1.3905831304252567,0.058823529411764705,0.6341861585508995,1.0,2/7,6.88%,NR4A3;IGFBP5
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),-0.7158766729644833,-1.390226326034143,0.075,0.6346690285121268,1.0,2/20,2.03%,NR4A3;KCNQ1
prerank,GO_Biological_Process_2021__negative regulation of phospholipase activity (GO:0010519),-0.8289953718624119,-1.3901782211823919,0.09259259259259259,0.632125214397292,1.0,2/6,8.02%,ANXA1;ANGPTL3
prerank,GO_Biological_Process_2021__protein localization to nuclear envelope (GO:0090435),0.8548602873079549,1.390092433623969,0.06976744186046512,0.8541795301163665,1.0,3/6,7.16%,INTS13;PLK1;NUP54
prerank,GO_Biological_Process_2021__regulation of DNA damage checkpoint (GO:2000001),0.7329332861575671,1.39006831493731,0.15151515151515152,0.8505683078488628,1.0,4/9,19.43%,RFWD3;FEM1B;THOC1;CCAR2
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.6574425336123862,-1.389956503834461,0.05194805194805195,0.6310333217669364,1.0,9/32,21.20%,CDKN2A;GPNMB;CCL2;KLF4;PLK3;GFI1B;CDKN1A;WEE1;CDKN2D
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell differentiation (GO:0045628),-0.8719978474135639,-1.3899031866474423,0.05,0.628790383233283,1.0,1/5,0.21%,ANXA1
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),0.7732023735715535,1.3897953347990748,0.1282051282051282,0.8488221800284674,1.0,1/8,0.74%,NGF
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),-0.813178288495706,-1.3894194017431472,0.045454545454545456,0.6292885819355399,1.0,2/11,4.49%,DUSP1;DOCK8
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),-0.7484647043989074,-1.3890871436271848,0.1,0.6288174349975223,1.0,4/16,7.01%,APLNR;RAMP3;CEMIP;THY1
prerank,GO_Biological_Process_2021__CD40 signaling pathway (GO:0023035),-0.8623329366086059,-1.3890849403017476,0.06896551724137931,0.626059463791393,1.0,2/5,12.64%,ITGA5;TNIP2
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 beta production (GO:0032691),0.7049279604529367,1.3890673731483658,0.11428571428571428,0.8482690762956103,1.0,3/11,5.79%,CARD18;TNFAIP3;GIT1
prerank,PanglaoDB_Augmented_2021__Monocytes,-0.6064529227577967,-1.3889912357185428,0.013333333333333334,0.6241717396377137,1.0,22/62,13.79%,P2RY13;MX1;MYO1F;TLR2;TYMP;GBP1;ICAM1;IFIT1;CD44;IFITM3;TAGAP;IGSF6;PLSCR1;IFIT3;DYSF;HLA-DRA;TNFRSF14;CLEC12A;IRF7;PILRA;CTSS;FN1
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),0.6912863314331514,1.3888316826994733,0.1388888888888889,0.8456682900948642,1.0,2/8,10.35%,ANKRD2;SESN2
prerank,GO_Biological_Process_2021__protein localization to microtubule (GO:0035372),0.7612661464460122,1.3886481152556995,0.15,0.8430314384733988,1.0,3/8,4.98%,CHAMP1;CRIPT;MID1
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,-0.5645557681692974,-1.3883381592534476,0.011627906976744186,0.6253773176483767,1.0,46/156,20.95%,ECM2;THBS1;COL4A1;COL4A2;SPARC;CALD1;COL5A1;MATN2;CD44;ITGA2;CDH6;CTHRC1;COL6A2;IL15;THY1;THBS2;MMP14;TIMP1;WNT5A;EDIL3;ELN;GADD45A;BGN;BASP1;ITGA5;PFN2;SNTB1;PRRX1;GADD45B;FN1;SFRP4;SLIT3;BDNF;TPM4;DPYSL3;PPIB;PDLIM4;OXTR;EMP3;LAMA3;COL12A1;TGFB1;LAMA1;LGALS1;SPP1;SFRP1
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),-0.7710854413095357,-1.3879491237726898,0.0410958904109589,0.6257336238468314,1.0,3/15,3.08%,IL1R1;B2M;HLA-A
prerank,GO_Biological_Process_2021__sialylation (GO:0097503),-0.8588857539851679,-1.3877008910016557,0.109375,0.6247069326457574,1.0,1/6,0.14%,ST6GAL1
prerank,GO_Biological_Process_2021__amyloid-beta formation (GO:0034205),0.7766398955611589,1.387010442724233,0.05555555555555555,0.8486148974448219,1.0,1/7,1.60%,NCSTN
prerank,GO_Biological_Process_2021__regulation of macrophage apoptotic process (GO:2000109),-0.8650564322040484,-1.3869219274121596,0.057692307692307696,0.6277749063595776,1.0,2/5,11.73%,CDKN2A;IRF7
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.6464164353067202,-1.3867795901558453,0.06493506493506493,0.6262442183991339,1.0,8/29,21.20%,CDKN2A;GPNMB;CCL2;KLF4;GFI1B;CDKN1A;WEE1;CDKN2D
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.6232782628339,1.3867755628233702,0.03333333333333333,0.8462774125171358,1.0,6/22,19.24%,VPS37A;SNF8;PTPN23;VPS37B;UBAP1L;VPS4B
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication (GO:0090329),-0.8041308630180075,-1.3863961043531046,0.07575757575757576,0.6265190703602671,1.0,1/9,0.78%,BLM
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),-0.6271242469761054,-1.3858571283285095,0.05128205128205128,0.6276483534179661,1.0,6/47,6.95%,ANXA1;GBP2;IL1R1;GBP1;APP;CCL2
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),-0.7297903147795748,-1.3853713204160092,0.11764705882352941,0.6288747498268195,1.0,1/16,2.43%,ZFP36
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),-0.715608373870062,-1.3851362175890427,0.0410958904109589,0.6278253452270627,1.0,2/19,6.83%,CD24;SCX
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),-0.6859974906109938,-1.3840820737775146,0.05970149253731343,0.6322132609896505,1.0,9/25,16.41%,GBP2;TLR2;HLA-A;IL12A;TNFRSF14;ROMO1;HLA-E;LYG1;GBP7
prerank,GO_Biological_Process_2021__regulation of cortisol biosynthetic process (GO:2000064),0.9059840201744498,1.3840734587408325,0.023255813953488372,0.8571610195517495,1.0,1/5,2.60%,BMP2
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,-0.692663248406868,-1.383757345227574,0.016666666666666666,0.6317554483480501,1.0,8/29,12.79%,P2RY13;MYO1F;TLR2;SIGLEC1;IGSF6;CLEC12A;PILRA;CTSS
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),-0.6779663598303771,-1.3837517654177776,0.056338028169014086,0.6292039718828134,1.0,1/23,0.03%,CACNA1H
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),0.6218763092181545,1.3833630462900832,0.09375,0.8589403091330865,1.0,6/24,11.02%,RANBP17;NUP42;STYX;RANBP3L;XPO1;NUP214
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.5843248445783642,1.3830295780420518,0.1,0.8571605351187831,1.0,7/31,17.10%,RNF6;RUNX1;AR;RNF14;EP300;NCOA2;UFM1
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),-0.6372741182046255,-1.3829720580279252,0.08108108108108109,0.6318955717393923,1.0,6/34,15.34%,ECM2;PDPN;THY1;EMP2;MINK1;DMTN
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),-0.7973731188972863,-1.3828663326084984,0.029411764705882353,0.630161928451678,1.0,1/13,1.01%,NPY
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),-0.6840959390140756,-1.3814478903491627,0.08571428571428572,0.6375923915841215,1.0,8/21,23.94%,ALDOB;HK2;GAPDHS;PGK1;GPI;PFKL;PGAM1;ENO2
prerank,GO_Biological_Process_2021__angiotensin maturation (GO:0002003),0.8489809103287,1.380765599911121,0.04878048780487805,0.8626019849313105,1.0,1/7,0.31%,ACE2
prerank,GO_Biological_Process_2021__regulation of angiotensin levels in blood (GO:0002002),0.8489809103287,1.380765599911121,0.04878048780487805,0.8626019849313105,1.0,1/7,0.31%,ACE2
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),0.7164385830834556,1.3804151521912902,0.12903225806451613,0.8535761976582567,1.0,2/12,5.44%,ZNF207;PLK1
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),0.7164385830834556,1.3804151521912902,0.12903225806451613,0.8535761976582567,1.0,2/12,5.44%,ZNF207;PLK1
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),0.7164385830834556,1.3804151521912902,0.12903225806451613,0.8535761976582567,1.0,2/12,5.44%,ZNF207;PLK1
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),-0.6540586347297723,-1.3801117489885395,0.047619047619047616,0.6448934239145617,1.0,10/37,17.15%,SLC32A1;SYN3;SYT1;CPLX1;RIMS2;SYN2;CPLX2;GAD1;GAD2;CDK5
prerank,GO_Biological_Process_2021__adenosine metabolic process (GO:0046085),0.9187436876550741,1.3800938854288414,0.08333333333333333,0.8520294449630014,1.0,2/5,4.46%,ACP3;NT5C1A
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),0.532232712658953,1.379734290966511,0.05,0.8507174382559363,1.0,4/30,9.14%,WNT7A;SOX21;PSMD11;GPM6A
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),-0.7188052308569237,-1.3796212137904789,0.05405405405405406,0.6455253895113899,1.0,3/23,8.71%,ABCA5;ABCA8;ABCA12
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,-0.5962463501283861,-1.3794848984129542,0.012658227848101266,0.6436964228842136,1.0,23/73,17.74%,COL4A1;ANGPTL2;SPARC;CALD1;C1R;COL5A1;ABCA8;COL6A2;THY1;THBS2;GALNT15;PODN;LDB2;ELN;BGN;LMOD1;IGFBP7;PRRX1;SERPING1;AEBP1;ITGA11;PCDH18;C1S
prerank,GO_Biological_Process_2021__T-helper 1 type immune response (GO:0042088),-0.8447916730570267,-1.3793870154266663,0.09375,0.6416783799367809,1.0,1/6,0.16%,LEF1
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),-0.7257772890408314,-1.3791466928758485,0.1,0.6410637638990974,1.0,3/17,6.53%,CACNA1H;ANK3;SCN9A
prerank,GO_Biological_Process_2021__cellular hypotonic response (GO:0071476),-0.8527861162406745,-1.3788640871575844,0.09090909090909091,0.6408584556751389,1.0,1/5,5.69%,SLC4A11
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),-0.7724387893591609,-1.3784226429107345,0.07352941176470588,0.6412589530228212,1.0,2/15,9.37%,NEFL;HAP1
prerank,GO_Biological_Process_2021__negative regulation of chondrocyte differentiation (GO:0032331),0.6603235187018793,1.3783656892044434,0.16666666666666666,0.8557207688347384,1.0,5/9,21.73%,GREM1;SOX9;ADAMTS12;EFEMP1;TGFBR1
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),-0.5558026335121994,-1.3776771710727946,0.0,0.6436621789898851,1.0,42/217,13.14%,OPTC;ECM2;THBS1;COL8A1;COL4A1;COL4A2;SPARC;TIMP2;COL5A1;ADAMTS10;ICAM1;CD44;LAMB1;ITGA2;COL4A4;SCUBE3;COL6A2;MMP21;COL27A1;THSD4;APP;COL24A1;SCX;MMP19;ADAMTSL2;MMP14;TIMP1;CYP1B1;MARCOL;ELN;BGN;P4HA2;MMP25;ITGA5;COL10A1;COL11A2;P3H2;ITGA8;COL9A2;CTSS;P4HA3;ADAM19
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),0.5629718090280512,1.3773463082906052,0.047619047619047616,0.8583702171901526,1.0,7/32,14.97%,SDC4;RAB27A;CADPS2;SNF8;SMPD3;STXBP5;RAB9A
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),0.7265288894148609,1.377236395024721,0.11428571428571428,0.8554576282268467,1.0,5/9,26.05%,CHPT1;PLA2G4C;GNPAT;AGPS;FAR1
prerank,GO_Biological_Process_2021__pericardium morphogenesis (GO:0003344),-0.8971818398606233,-1.377070716775277,0.07547169811320754,0.6453138149394788,1.0,1/5,0.90%,FLRT3
prerank,GO_Biological_Process_2021__positive regulation of acrosome reaction (GO:2000344),-0.905248768155803,-1.377062613553148,0.06666666666666667,0.6428063779126028,1.0,1/5,0.03%,CACNA1H
prerank,"GO_Biological_Process_2021__Notch receptor processing, ligand-dependent (GO:0035333)",0.8064149930544185,1.3766759533935473,0.21875,0.8546446704451859,1.0,1/5,1.60%,NCSTN
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),-0.8040571082518069,-1.3757422640876427,0.07575757575757576,0.6495693789472632,1.0,5/10,16.02%,TLR2;B2M;RPS27A;UBC;PGK1
prerank,GO_Biological_Process_2021__regulation of steroid biosynthetic process (GO:0050810),0.8265694988755528,1.3753922074153673,0.13157894736842105,0.8577564031693384,1.0,2/6,8.15%,BMP2;AKR1C3
prerank,GO_Biological_Process_2021__mitotic cell cycle checkpoint signaling (GO:0007093),-0.7594360897504535,-1.3748776853902496,0.08,0.6535151532180143,1.0,4/16,10.35%,PLK2;ZWILCH;PLK3;WEE2
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),-0.5386155203360955,-1.3745378888954793,0.0,0.6535620203219382,1.0,46/268,17.02%,OPTC;COL8A1;COL4A1;COL4A2;MYO1F;B2M;COL5A1;STMN2;RPS27A;RHOBTB2;NEFL;CLRN1;COL4A4;KIF14;COL6A2;POF1B;COL27A1;APP;COL24A1;SCX;MYO15A;RND2;CYP1B1;GFAP;PLK3;DCTN1;P4HA2;COL10A1;COL11A2;P3H2;MYH11;LMOD1;COL9A2;EMP2;NLRP5;P4HA3;MYO1E;UBC;STMN4;B4GALT7;RHOF;ELMO1;KIF2C;TPM4;STMN1;PPIB
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.6762915665433707,-1.374463107500853,0.08108108108108109,0.6513880315270584,1.0,11/24,20.95%,SOCS3;THY1;PARP14;PTK6;SFRP2;SH3BP5;MVP;DMTN;PRKCD;PTPRC;SFRP1
prerank,GO_Biological_Process_2021__proline transport (GO:0015824),-0.8758365358254074,-1.3737728033928784,0.03508771929824561,0.6529715760935063,1.0,1/5,1.68%,SLC6A15
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),-0.7634062669262875,-1.3729914168428414,0.041666666666666664,0.6564223202654185,1.0,6/15,12.21%,KLF2;HPN;APP;EGF;KLF4;PAX8
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.7340314633858955,-1.3728604419810213,0.12,0.6549079401628798,1.0,3/16,6.88%,P2RY6;NR4A3;IGFBP5
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),-0.6923974921899368,-1.372825320562169,0.08695652173913043,0.6501518861342303,1.0,8/20,23.94%,ALDOB;HK2;GAPDHS;PGK1;GPI;PFKL;PGAM1;ENO2
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),-0.6923974921899368,-1.372825320562169,0.08695652173913043,0.6501518861342303,1.0,8/20,23.94%,ALDOB;HK2;GAPDHS;PGK1;GPI;PFKL;PGAM1;ENO2
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.6823026277411978,-1.3726772811295413,0.04,0.6484869935838158,1.0,8/29,18.57%,SCN1B;ANK3;CAV3;GLRX;YWHAH;HECW2;SCN3B;FGF12
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.7185454801237486,1.372215503563364,0.06451612903225806,0.8717922364959425,1.0,3/13,8.97%,ZNF207;PLK1;FBXO5
prerank,GO_Biological_Process_2021__homocysteine metabolic process (GO:0050667),0.7342143086994843,1.3720537590944786,0.23333333333333334,0.8693585033874328,1.0,3/10,15.35%,BLMH;CTH;TST
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),-0.6876419924018802,-1.3717475408586322,0.0684931506849315,0.6521120944819209,1.0,9/25,19.13%,C3;C1R;HLA-DRA;CD55;CFH;SERPING1;SUSD4;C1S;C1QB
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),-0.7848575231508843,-1.371605438100056,0.10714285714285714,0.6506740562455818,1.0,2/10,4.66%,CACNA1H;ERVW-1
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),-0.6912498383247307,-1.37157812821763,0.05555555555555555,0.64839484274116,1.0,3/24,3.97%,PKP2;TGFBR2;PROX1
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),-0.7188288106686307,-1.371564725260606,0.08955223880597014,0.6461326382927415,1.0,2/20,0.21%,CXCL2;ANXA1
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,-0.6413089543447565,-1.3715480564980862,0.045454545454545456,0.6439185722049542,1.0,20/35,23.75%,MYO1F;TLR2;CIITA;TAGAP;GPNMB;SIGLEC1;IGSF6;HLA-DRA;CTSS;HLA-F;ACHE;PTPRC;PTAFR;PRKCB;CD74;NAPSB;SPI1;WDFY4;HLA-DRB1;ALOX5
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),0.6167362081023263,1.3713949432238381,0.08695652173913043,0.8695789340031895,1.0,1/24,0.52%,WNT7A
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),0.7571490390789108,1.3712277494102894,0.13513513513513514,0.8673873269987189,1.0,4/7,16.79%,MSH2;MSH3;POT1;GTF2H2
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),-0.71167011504189,-1.3711915104263503,0.06944444444444445,0.6436554926326525,1.0,2/22,3.34%,MET;ICAM1
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),-0.7632630988474648,-1.3706076570855923,0.07142857142857142,0.6449176597565918,1.0,5/15,12.41%,S100A10;RFTN1;CAV3;FA2H;EMP2
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),-0.7983356585419896,-1.3702209784921595,0.04,0.6453962070751165,1.0,3/12,13.09%,TJP3;LSR;ARHGEF18
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),0.6626763348725022,1.3701520485832177,0.2,0.8708148918925103,1.0,5/11,12.63%,WNT7A;CEL;NLGN3;NRXN1;NLGN4Y
prerank,GO_Biological_Process_2021__regulation of interleukin-4 production (GO:0032673),-0.7781162245950111,-1.3693839847379834,0.09836065573770492,0.6485252180386242,1.0,5/14,12.99%,LEF1;ZFPM1;PRKCQ;SYK;HLA-E
prerank,GO_Biological_Process_2021__response to fructose (GO:0009750),0.8657079647099052,1.3689241454010868,0.05405405405405406,0.8744282541766476,1.0,1/5,0.43%,SLC2A5
prerank,GO_Biological_Process_2021__purine nucleobase transport (GO:0006863),-0.9289625240857166,-1.3688201988266189,0.0,0.6498480355405238,1.0,1/5,0.39%,SLC28A2
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),-0.6188488651659526,-1.3688068037181906,0.039473684210526314,0.6476381301406128,1.0,7/49,7.99%,MX1;IFIT1;IFITM3;PROX1;BST2;ISG15;PLSCR1
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),0.7887033367944123,1.3686664421579648,0.15,0.8723492352332586,1.0,3/7,14.90%,RAB22A;ALS2;PICALM
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),-0.8594715506667946,-1.3686037340514363,0.01694915254237288,0.6441177926821741,1.0,3/7,2.90%,TLR2;B2M;RPS27A
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),-0.8594715506667946,-1.3686037340514363,0.01694915254237288,0.6441177926821741,1.0,3/7,2.90%,TLR2;B2M;RPS27A
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),0.42059313275318955,1.3677234375038305,0.0,0.8737139024944185,1.0,50/276,16.00%,TBC1D4;RANBP17;NXT2;NUP62CL;NUP42;TMED5;ARFIP1;TRAK2;SCFD2;TBC1D12;COX18;RAB23;MAIP1;PPP1R10;ARL5A;AP1S3;AKT2;RABL3;AKT1;RANBP3L;STX7;IPO5;IPO8;ARFIP2;RAB1B;XPO1;C17ORF75;SNF8;DNAJC27;RAB22A;NUP214;COPB2;AP3B1;RAB28;TBC1D5;NXT1;RANBP6;SCFD1;TBC1D8B;NUP188;RAB21;XPO7;SNX27;NAPB;SEC31B;ARCN1;NUP85;SEC23IP;HERC2;RIC1
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),0.6081712882462471,1.3675504467089772,0.06896551724137931,0.8711284134169707,1.0,5/28,14.90%,ZC3H8;SNAPC5;RO60;SNAPC3;SNAPC1
prerank,PanglaoDB_Augmented_2021__Neutrophils,-0.6680130165975383,-1.3673988667934505,0.04477611940298507,0.650498377969033,1.0,14/41,12.79%,CD24;CXCL2;P2RY13;MYO1F;TLR2;NR1I3;TAGAP;ARG2;DOCK8;IGSF6;CEACAM1;CLEC12A;PILRA;CTSS
prerank,GO_Biological_Process_2021__I-kappaB phosphorylation (GO:0007252),-0.8388332367517093,-1.367252716149366,0.09375,0.6494652900008956,1.0,4/7,14.22%,TLR2;PRDX4;TLR3;DAB2IP
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),-0.8431173414594854,-1.366623133368419,0.08955223880597014,0.6492500462521702,1.0,5/6,14.65%,HLA-A;HLA-C;HLA-B;HLA-E;HLA-F
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",-0.8431173414594854,-1.366623133368419,0.08955223880597014,0.6492500462521702,1.0,5/6,14.65%,HLA-A;HLA-C;HLA-B;HLA-E;HLA-F
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),-0.7797805748254476,-1.3665207274448383,0.08571428571428572,0.6452570996435324,1.0,5/12,14.65%,RASGRP1;CD160;IL12A;HLA-E;HLA-F
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.7797805748254476,-1.3665207274448383,0.08571428571428572,0.6452570996435324,1.0,5/12,14.65%,RASGRP1;CD160;IL12A;HLA-E;HLA-F
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),0.5477897022557241,1.366250758848003,0.1111111111111111,0.8746326534469155,1.0,20/49,17.90%,ABCD2;PPARGC1A;ADIPOR1;ABCD1;ACADM;PEX13;CYP4V2;MCAT;PHYH;EHHADH;CPT2;ABCD3;ADH5;PEX2;SCP2;ECHDC1;ACOX1;ACADS;SLC25A17;BDH2
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.7410638030361241,-1.3662047127976154,0.0625,0.6451209349551238,1.0,4/17,9.65%,GBP1;CD160;THY1;CEACAM1
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),-0.7048538013541912,-1.3659702094373518,0.07462686567164178,0.6444240718008554,1.0,2/17,5.35%,ANXA1;DUOX1
prerank,GO_Biological_Process_2021__collagen-activated signaling pathway (GO:0038065),-0.8747152435002209,-1.36416569274541,0.07575757575757576,0.6554855756444634,1.0,2/7,3.56%,COL4A2;ITGA2
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),0.7249959930547965,1.36407548556912,0.09375,0.8830619853760854,1.0,1/14,0.52%,WNT7A
prerank,GO_Biological_Process_2021__liver development (GO:0001889),-0.7100769791251326,-1.3639338990919312,0.0410958904109589,0.6542877791236839,1.0,5/23,7.72%,ANXA1;MET;PROX1;CCDC39;LSR
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.696184165253164,1.363819008617766,0.058823529411764705,0.881249323076447,1.0,5/13,23.50%,SNF8;VTA1;LEPROTL1;CHMP6;TMEM50B
prerank,PanglaoDB_Augmented_2021__Merkel Cells,0.5169943527817701,1.3630832826771644,0.11538461538461539,0.882399017446215,1.0,5/29,6.75%,ACE2;GOLT1A;EFNA2;ARHGEF16;SLC26A3
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.45070817415827047,1.3629349206221975,0.0,0.8800357313693411,1.0,35/89,24.72%,CEBPA;PSMD10;TRIB3;CBFA2T3;PLK1;HSPA1A;KEAP1;BAG2;VCP;COMMD1;CSNK1E;RNF14;XPO1;RCHY1;TRIB2;EIF3H;FHIT;COP1;RNF217;ZYG11B;MDM2;CCAR2;UBQLN4;SUMO2;NUB1;SMAD7;DDA1;ARAF;N4BP1;SIRT2;DNAJB2;HFE;HSPBP1;ANKIB1;HECTD1
prerank,GO_Biological_Process_2021__neurotransmitter receptor diffusion trapping (GO:0099628),0.7657949919252738,1.362794857062069,0.10810810810810811,0.8741349642763625,1.0,2/7,9.98%,CACNG2;GPHN
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),0.7657949919252738,1.362794857062069,0.10810810810810811,0.8741349642763625,1.0,2/7,9.98%,CACNG2;GPHN
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 trimethylation (GO:1900112),0.8187892512436515,1.3626026798223645,0.07894736842105263,0.8720839553101465,1.0,1/5,6.52%,ZNF304
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),-0.8450683073263456,-1.3625656536490047,0.07246376811594203,0.660791790424983,1.0,2/7,3.08%,B2M;HLA-A
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),-0.6684405366258674,-1.362337871591267,0.05405405405405406,0.6603127123508674,1.0,5/34,15.52%,S100A10;SKAP1;THY1;EMP2;CCL28
prerank,GO_Biological_Process_2021__bundle of His cell to Purkinje myocyte communication (GO:0086069),-0.8957880048394754,-1.3617710066148863,0.05,0.6619576663263955,1.0,2/5,7.56%,PKP2;CTNNA3
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),0.6915251625011283,1.3610939000152613,0.10256410256410256,0.8773075382255847,1.0,3/9,19.43%,MFF;ERBB4;CCAR2
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),-0.6577707824464557,-1.3607892256728056,0.08571428571428572,0.6670654632765219,1.0,7/32,9.89%,GRIN2D;GRIN2A;SLC8A3;HTR2B;SLC24A2;SLC24A1;ITPR3
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),0.7708107937116668,1.3606764681998662,0.1111111111111111,0.8769795521908562,1.0,2/8,8.53%,KDM1B;KDM5A
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.5274820427205043,-1.3604894129263354,0.01020408163265306,0.6667140825035562,1.0,69/376,14.65%,CXCL2;ANXA1;IFI6;TRIM22;GBP2;IL1R1;SP100;SOCS3;MX1;IL13RA1;CIITA;B2M;GBP1;RPS27A;HLA-A;ICAM1;TRIM5;IFIT1;CD44;IFITM3;IRF1;INPP5D;ST18;SLA;IFI35;STAT4;DUOX1;FSCN1;IL12A;IL15;BST2;NOD1;CCL2;ISG15;LMNB1;IFIT3;PSMB6;PSMB9;IL4R;HLA-C;TIMP1;IFNGR2;CEACAM1;HLA-DRA;STAT1;TNFRSF14;TCP1;IL27RA;FOS;IRF7;HLA-B;OSMR;SYK;TNIP2;MAP3K14;HLA-E;CCND1;UBC;JUNB;BIRC3;FN1;PSMC3;CA1;IFIT2;PIM1;IL17RE;GREM2;IL7;HLA-F
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),0.7426786341514762,1.360249003260903,0.08108108108108109,0.8758477843976278,1.0,1/6,2.24%,PPARGC1A
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),-0.6441285074915057,-1.359865148159056,0.0410958904109589,0.6684066071216089,1.0,11/29,23.81%,CDKN2A;B2M;ARG2;IL15;WNT5A;IFIH1;PRKCD;ECHDC3;RSAD2;IER5;CGAS
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.8013947666451542,-1.3597924010348088,0.06557377049180328,0.6666775757781574,1.0,6/9,16.03%,TGFBR2;HLA-A;SYK;HLA-E;CD55;IL18
prerank,GO_Biological_Process_2021__macrophage migration (GO:1905517),-0.8296679201819761,-1.359201403161487,0.057971014492753624,0.668901364293282,1.0,3/8,6.95%,P2RY12;SFTPD;CCL2
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),-0.7570656397023512,-1.359069903267862,0.05555555555555555,0.667495428276716,1.0,4/14,9.21%,FLRT3;P2RY12;GAP43;APOD
prerank,GO_Biological_Process_2021__response to interleukin-4 (GO:0070670),-0.9041823344375703,-1.3590609542216412,0.04838709677419355,0.6652763352862658,1.0,1/5,0.16%,LEF1
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),-0.7166404789688547,-1.3590506292823432,0.09090909090909091,0.6631286778871138,1.0,1/16,0.43%,THBS1
prerank,GO_Biological_Process_2021__long-term synaptic depression (GO:0060292),-0.8410269019147096,-1.3578194629278686,0.08333333333333333,0.669138429977772,1.0,3/7,9.86%,PLK2;SLC24A2;SLC24A1
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),0.8982770462126994,1.3577861939216767,0.07692307692307693,0.8855178573897403,1.0,1/5,3.50%,MITF
prerank,GO_Biological_Process_2021__alpha-beta T cell activation (GO:0046631),-0.8513976225592862,-1.3574399038091935,0.09259259259259259,0.669491576979164,1.0,2/6,3.08%,ANXA1;HLA-A
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),-0.6249159608863444,-1.3571261126538499,0.039473684210526314,0.6690026954177898,1.0,7/37,13.58%,MX1;RAMP3;CAV3;CEACAM1;ARR3;SYK;CD9
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),0.6952577454056602,1.3566296407766183,0.0975609756097561,0.888364436893239,1.0,4/9,19.46%,RALB;PIP4K2B;PIP4K2C;RAB3GAP1
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),0.744405678308455,1.3565721744609995,0.16216216216216217,0.8856086995943271,1.0,3/10,14.74%,BMP2;ERLIN1;NFKB1
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),-0.650873402728708,-1.356493808462591,0.11688311688311688,0.6711393433721246,1.0,8/29,18.57%,SCN1B;PKP2;ANK3;ATP1A1;YWHAH;SCN3B;NOS1;FGF12
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),-0.7032739740112248,-1.356387183098107,0.08823529411764706,0.6696194783868199,1.0,11/23,23.94%,ALDOB;HK2;LDHA;GAPDHS;ENO4;PGK1;GPI;PFKL;PGAM1;PFKFB2;ENO2
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.6412970866891484,1.3561653561415237,0.1724137931034483,0.884164045053636,1.0,8/15,28.05%,RTRAF;TSEN2;TSEN15;ZBTB8OS;TRPT1;C2ORF49;CLP1;DDX1
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),0.5431831514301422,1.354790559522099,0.08,0.8883697114874561,1.0,6/36,13.03%,NXT2;RITA1;SNRPF;XPO1;AAAS;NXT1
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),-0.7740598339461072,-1.3543768665441795,0.09859154929577464,0.6801648506683656,1.0,3/10,11.09%,MX1;STAT1;IL27RA
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),-0.5952230056204922,-1.354078917500858,0.03529411764705882,0.6804484338474278,1.0,15/82,18.88%,CD24;IFI6;POU4F1;HIC1;CYP1B1;BRCA1;MLLT11;SCN2A;PDK1;DAB2IP;BCL2L2;PRKCD;CDKN1A;PML;BOK
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),0.6360917858533295,1.3536708308776049,0.11538461538461539,0.8906224825060598,1.0,6/18,21.63%,LIMD1;HELZ;AGO3;CNOT1;CNOT8;TNRC6B
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.7744467472769551,-1.3533056105638275,0.1,0.683263112987396,1.0,3/15,9.78%,KLF2;NOS1AP;KLF4
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.7508836153316769,-1.35301366565742,0.14516129032258066,0.6826840429346016,1.0,2/12,5.69%,SULT1C3;TPST1
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),-0.6914999397373158,-1.3528502880924145,0.1111111111111111,0.6813701945280893,1.0,3/24,9.78%,KLF2;NOS1AP;KLF4
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),0.7871701767195097,1.3527207139543511,0.1,0.8922204948870657,1.0,3/7,13.12%,JAM2;AKT1;WASL
prerank,GO_Biological_Process_2021__mitochondrial ribosome assembly (GO:0061668),0.8302015668535988,1.3526718433625011,0.1,0.8892557595714472,1.0,3/5,11.84%,MTERF3;FASTKD2;MRPS2
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),0.7080256490266167,1.3524290133316073,0.09090909090909091,0.8874825835423088,1.0,5/7,26.16%,AKT1;BAD;CLOCK;RFX3;RHEB
prerank,MSigDB_Hallmark_2020__Coagulation,-0.6067536749233875,-1.3523934739442545,0.05813953488372093,0.6825732076983029,1.0,17/85,15.36%,ANXA1;THBS1;C3;HPN;SPARC;C1R;ITGA2;MAFF;F8;MMP14;TIMP1;CD9;FN1;CFH;SERPING1;F10;PRSS23
prerank,PanglaoDB_Augmented_2021__Osteoclasts,-0.5709500566754239,-1.3522321770035628,0.0375,0.6816214917547525,1.0,28/87,20.70%,IL1R1;P2RY6;IL13RA1;TLR2;ITGA2;SERPINF1;SIGLEC1;SLC39A14;CCL2;MMP19;DYSF;MMP14;ITPR3;CHI3L1;FAM20C;RNASE1;SERPING1;SNX10;RASSF4;CTSZ;EGFL7;PTH1R;C1QB;F13A1;CLEC5A;CEBPD;SPP1;NUMB
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),-0.725263427322372,-1.3520158476652668,0.12121212121212122,0.6809197009652345,1.0,1/17,0.32%,IFI6
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.7680430867965401,-1.3517913865165534,0.14516129032258066,0.6803574218172034,1.0,4/13,9.29%,ANK3;TESC;GLRX;ATP1B1
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),0.6124952219637112,1.3516757271342563,0.1111111111111111,0.8891718655400247,1.0,5/17,22.24%,ARV1;GNB3;PANK2;ABCB11;TTC39B
prerank,MSigDB_Hallmark_2020__Complement,-0.5601925546869415,-1.3516710960625407,0.0,0.679260408982387,1.0,27/145,15.55%,CP;RASGRP1;C3;COL4A2;TIMP2;C1R;IRF1;MAFF;PHEX;CTSC;PLSCR1;F8;PSMB9;MMP14;TIMP1;WAS;F5;IRF7;CTSS;CD55;FN1;CFH;PIM1;GNG2;SERPING1;F10;ATOX1
prerank,MSigDB_Hallmark_2020__Allograft Rejection,-0.564553861041552,-1.3515507509665927,0.03488372093023256,0.6777142631977262,1.0,42/108,19.78%,GBP2;CDKN2A;TLR2;B2M;FYB1;HLA-A;ICAM1;STAT4;GCNT1;IL12A;IL15;CCL2;THY1;WARS1;IGSF6;IL4R;TIMP1;BRCA1;IFNGR2;TLR3;WAS;HLA-DRA;STAT1;RPL9;IL27RA;IRF7;PRKCG;CTSS;RPS3A;HLA-E;TPD52;IL7;IL18;ACHE;RPS9;SRGN;CD4;PTPRC;TGFB1;PRKCB;CD74;RIPK2
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),0.7002554034801547,1.3513270321406832,0.16666666666666666,0.8874116085361164,1.0,4/9,12.63%,CEL;NLGN3;NRXN1;NLGN4Y
prerank,GO_Biological_Process_2021__cellular response to interleukin-4 (GO:0071353),-0.873362693105191,-1.35128769195789,0.06060606060606061,0.6773279876556938,1.0,1/6,0.16%,LEF1
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),0.4562518508362134,1.351087733512748,0.0625,0.8854226154927141,1.0,16/70,18.85%,TBC1D4;TRIB3;PDE3B;LPIN3;KAT2B;AKT2;AKT1;INSIG2;RAB8B;EPM2AIP1;GPLD1;PIK3R1;DENND4C;MYO5A;RAB31;RAB8A
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure (GO:0003073),0.7611680608717394,1.350689199561757,0.10526315789473684,0.8843130028868005,1.0,4/9,15.44%,SLC2A5;DRD2;SPX;GPR37L1
prerank,GO_Biological_Process_2021__regulation of triglyceride catabolic process (GO:0010896),0.7982340495896719,1.3506464580109079,0.10810810810810811,0.8813908418263403,1.0,3/6,14.51%,PLIN5;ABHD5;GPLD1
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),-0.8041067471907769,-1.3506018041289032,0.07575757575757576,0.6805167029561457,1.0,2/11,9.78%,KLF2;KLF4
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),0.7342350441381666,1.349862614641496,0.1388888888888889,0.8829286532466539,1.0,3/10,11.42%,SOX9;NUDT21;SOX5
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),0.8604263932741419,1.3493071465530626,0.05405405405405406,0.8823150929286916,1.0,1/5,10.47%,NIPBL
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),-0.7102832954253806,-1.3486564456624344,0.1111111111111111,0.690993889393734,1.0,5/20,13.66%,TLR2;IRF1;TLR3;IRF7;BIRC3
prerank,GO_Biological_Process_2021__hypotonic response (GO:0006971),-0.8223122193102044,-1.348324475538467,0.10714285714285714,0.6908874154925381,1.0,1/5,5.69%,SLC4A11
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),-0.7162929489383231,-1.3482091416719946,0.046153846153846156,0.6893554657346049,1.0,1/17,0.03%,ENPP2
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),-0.6206881470321151,-1.3481124931522763,0.06756756756756757,0.6878857457258649,1.0,3/52,2.55%,ENPP2;PLB1;PLAAT4
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),0.681533318569002,1.3480166653374583,0.12121212121212122,0.8849292488818437,1.0,2/13,5.29%,YAE1;LTO1
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),0.7081320235295081,1.347421531903276,0.08108108108108109,0.8851160649086529,1.0,5/12,20.79%,PSMD10;KEAP1;NFKBIB;NFKBIE;PKD2
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),0.5323547527558542,1.347407574354841,0.1,0.882194606020689,1.0,6/43,8.09%,POLD3;APEX2;DNA2;RFC3;ERCC6;PRMT6
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),-0.7231377315209737,-1.3467221581777111,0.07142857142857142,0.6949812205359821,1.0,2/21,7.01%,S100A10;THY1
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.6765691394356711,-1.346004787187986,0.1527777777777778,0.6978202190174903,1.0,3/19,11.75%,PLB1;DBI;LPCAT4
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.8045407399081097,-1.345283002768315,0.15254237288135594,0.7010068006092737,1.0,3/7,14.01%,TLR2;CCL2;NAMPT
prerank,GO_Biological_Process_2021__ribosome disassembly (GO:0032790),0.7788635167187723,1.3449805542162971,0.15,0.8927104579274764,1.0,4/7,14.72%,MRRF;MTIF2;DENR;GFM2
prerank,GO_Biological_Process_2021__response to magnesium ion (GO:0032026),-0.885687335088141,-1.3448986000940406,0.029850746268656716,0.7013654419066534,1.0,2/7,2.68%,THBS1;ANK3
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),0.6729237618548642,1.3438730313082305,0.17647058823529413,0.8947854381311381,1.0,3/12,12.25%,PIK3R4;TRAPPC8;PIK3C3
prerank,PanglaoDB_Augmented_2021__Myocytes,-0.5745771945309848,-1.3438169664737134,0.05952380952380952,0.7074507470574998,1.0,15/82,15.71%,COL4A1;ANGPTL2;FABP3;LAMB1;SULF1;COX7A1;CAV3;PLD1;RASL12;IL4R;PRKCQ;LMOD1;PRRX1;ITGA3;TNNT1
prerank,PanglaoDB_Augmented_2021__Glomus Cells,-0.5670463253757033,-1.343681520140056,0.023809523809523808,0.7063402147494482,1.0,28/118,18.96%,IL1R1;COL4A1;ANGPTL2;COL4A2;CALD1;GFRA2;IGFBP5;THY1;EFNB3;MAP1B;ARHGEF17;GAP43;EDIL3;BGN;SCARA3;LMOD1;SHC2;NUAK1;DAB2IP;ADCY5;AMOTL2;CRMP1;DPYSL3;DCLK1;NOS1;TNFRSF1A;LARP6;PTH1R
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),-0.7028715115066715,-1.3433358304766636,0.11764705882352941,0.7065504358982124,1.0,6/19,10.57%,ARHGEF3;P2RY10;GPR18;LPAR4;SYNPO2L;LPAR6
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix disassembly (GO:0090091),-0.8173014168882106,-1.3430853385380392,0.047619047619047616,0.7059117571200673,1.0,2/7,5.71%,PDPN;FSCN1
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),-0.7305901874050539,-1.342832701428709,0.09230769230769231,0.7057378927479712,1.0,1/12,0.92%,APLNR
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,-0.5730557374302948,-1.3425643856644678,0.024390243902439025,0.7053863740060363,1.0,32/124,19.35%,LEF1;COL4A1;ANGPTL2;COL4A2;SPARC;CALD1;C1R;COL5A1;SULF1;SRPX2;IGFBP5;THY1;FILIP1L;THBS2;PODN;LDB2;BGN;RASD1;ITGA8;LMOD1;SFRP2;PRRX1;FN1;FGF1;AMOTL2;PCDH18;DLC1;C1S;PML;TNS2;SNCG;COL12A1
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),-0.8011754750716729,-1.3423884586581323,0.1,0.7044515694782558,1.0,1/10,2.39%,B2M
prerank,GO_Biological_Process_2021__negative regulation of cartilage development (GO:0061037),0.6640364543196353,1.341629051590337,0.18421052631578946,0.9040213485254263,1.0,5/8,21.73%,GREM1;SOX9;ADAMTS12;EFEMP1;TGFBR1
prerank,GO_Biological_Process_2021__chromatin organization involved in regulation of transcription (GO:0034401),0.6639674488108657,1.3414783747614236,0.13157894736842105,0.9018646077747613,1.0,2/12,8.78%,FAM47E;SERTAD2
prerank,GO_Biological_Process_2021__peroxisomal transport (GO:0043574),0.7349601291238215,1.340867008417827,0.16666666666666666,0.9026841312042292,1.0,5/8,25.88%,ABCD1;ZFAND6;PEX12;PEX6;PEX16
prerank,GO_Biological_Process_2021__T cell proliferation (GO:0042098),-0.7705407857455627,-1.3408163780381865,0.1388888888888889,0.713393634658336,1.0,3/11,12.36%,RASGRP1;DOCK8;BTN3A1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.7884731740502177,-1.3408135964950563,0.07246376811594203,0.7112766111612028,1.0,2/10,6.88%,NR4A3;IGFBP5
prerank,MSigDB_Hallmark_2020__Glycolysis,-0.5439503738450336,-1.3407046071848594,0.022727272727272728,0.709651520116588,1.0,19/168,10.14%,CACNA1H;IL13RA1;MET;PKP2;ALDOB;GPR87;COL5A1;CD44;KDELR3;HK2;LDHA;SLC16A3;GMPPB;TPST1;CHST4;VLDLR;GAPDHS;GLRX;P4HA2
prerank,GO_Biological_Process_2021__positive regulation of protein maturation (GO:1903319),-0.8314447565425975,-1.3405686839930595,0.1,0.7087151456544808,1.0,1/7,0.30%,CCBE1
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.6391507616579997,1.3401399568940437,0.12903225806451613,0.9033597444874394,1.0,12/23,29.11%,AUP1;VCP;UGGT1;DERL1;POMT2;FBXL17;ZYG11B;UGGT2;KLHL15;YME1L1;ATXN3;NGLY1
prerank,GO_Biological_Process_2021__negative regulation of cell communication (GO:0010648),-0.7824139577156348,-1.3397446410245308,0.09230769230769231,0.7125734482176885,1.0,4/10,18.04%,NLRP12;PTK6;HHIP;GLRA1
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,-0.6445969259069899,-1.3394878454537278,0.041666666666666664,0.7120089520123113,1.0,8/31,14.58%,SLC28A2;ABO;ALDOB;SLC18A2;VIL1;SLC3A1;ADH4;CYP3A4
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),0.7311307528887087,1.3391252489569052,0.08333333333333333,0.9055015836732255,1.0,1/7,0.74%,NGF
prerank,GO_Biological_Process_2021__endothelial cell morphogenesis (GO:0001886),-0.8734113345562211,-1.3390723180227728,0.04838709677419355,0.7124946659168643,1.0,1/5,1.73%,MET
prerank,PanglaoDB_Augmented_2021__Airway Epithelial Cells,-0.662932361004214,-1.3390194357543996,0.056338028169014086,0.7106911351069501,1.0,8/34,7.59%,CP;C1ORF87;FMO6P;POF1B;DUOX1;ZNF750;FUT2;DUOXA1
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),-0.7784779346325494,-1.3378111185795167,0.08955223880597014,0.7171743502951518,1.0,2/11,6.37%,ANXA1;IL15
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,-0.5956462989562192,-1.33776977071157,0.03571428571428571,0.7154417925279956,1.0,11/63,12.41%,COL4A1;COL4A2;CALD1;COL5A1;COL6A2;IGFBP5;BGN;RSPO3;ITGA8;LMOD1;IGFBP7
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),-0.6732837265989078,-1.337455730617569,0.0958904109589041,0.7153698411734267,1.0,5/26,7.56%,SCN1B;PKP2;KCNQ1;KCNJ2;CTNNA3
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),0.5903293048875551,1.3374340381203698,0.06451612903225806,0.911751671041641,1.0,6/17,16.07%,CEL;LPIN3;CYP4F3;CYP4F12;ACOX1;PLA2G15
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),0.6284172302249013,1.3369837108020366,0.11428571428571428,0.9107008663699482,1.0,6/17,19.24%,PLK1;HSPA1A;CEP97;CHMP2B;HNRNPU;VPS4B
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),-0.5184639863631902,-1.3369539587872699,0.010416666666666666,0.7171895932632004,1.0,76/326,19.61%,CP;C3;CHGB;RPL3;SERPINA10;RPL19;RPS27A;SFTPD;LAMB1;RPS27;RPS14;RPS4X;RPL27A;PHEX;ATP23;RPL7A;RPL35;APP;IGFBP5;WARS1;DENND3;RPL37A;NOTUM;USP6;TIMP1;RPL21;RPL27;RPL13A;F5;ST3GAL6;RPL9;FAM20C;CHRM3;SERPIND1;RPS13;RPS16;RPL24;IGFBP7;UBE2S;RPS3A;RPLP1;RPL10A;FN1;RPS18;RPL10;RPS11;DAB2IP;RPS8;RPLP2;RPL38;RPS7;SHISA5;RPL8;RPS15;B4GALT7;RPL5;PRSS23;BAP1;MRPL23;IGF1;RPS21;SEC11C;RPL12;RPS23;RPL18A;RPS9;COPS5;TMEM208;ITIH2;LTBP1;PAPPA;RPL23;RPS6;GPC3;RPS25;EEF1A2
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),-0.707907645253537,-1.336596881285284,0.1323529411764706,0.7177742290453314,1.0,6/17,12.47%,CCL2;PLN;CAV3;PLPP4;EGF;GRM6
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),0.5702169509339796,1.336075225544474,0.05555555555555555,0.9126146590635739,1.0,6/18,18.10%,SLC6A13;SLC47A1;SFXN2;SLC6A1;SLC22A2;SLC25A38
prerank,GO_Biological_Process_2021__lung epithelium development (GO:0060428),0.7929844563145074,1.3359926198663348,0.1590909090909091,0.9099807546628994,1.0,2/6,10.32%,ASCL1;FOXJ1
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",-0.8312146429500086,-1.335553526450135,0.06060606060606061,0.7220916957715887,1.0,6/7,14.65%,B2M;HLA-A;HLA-C;HLA-B;HLA-E;HLA-F
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),-0.8573570260254574,-1.3355292169753867,0.01818181818181818,0.7201508205256534,1.0,2/5,10.13%,COL4A1;STAT1
prerank,GO_Biological_Process_2021__regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),0.7718658212429008,1.3346887063638486,0.029411764705882353,0.9126526018037452,1.0,3/8,9.06%,PLIN5;LMO3;PTGIS
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),-0.8161886559422821,-1.3346706901914402,0.05970149253731343,0.7241937638338624,1.0,4/10,11.09%,STAT4;IL12A;STAT1;IL27RA
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),-0.6019129594870745,-1.3342758039174178,0.06578947368421052,0.7248483896353978,1.0,12/60,17.32%,SLC28A2;SLC6A15;SLC32A1;SYN3;SLC18A2;SYT1;CPLX1;SYN2;SLC38A1;GAD1;GAD2;PPFIA1
prerank,PanglaoDB_Augmented_2021__Chondrocytes,-0.5707966435751709,-1.3342654791168846,0.060240963855421686,0.7228197398663164,1.0,29/109,15.73%,COL4A1;ANGPTL2;COL4A2;SPARC;CALD1;C1R;COL5A1;CSPG4;CHAD;COL6A2;SULF1;IGFBP5;THY1;THBS2;PODN;MMP14;ELN;BGN;STAT1;COL10A1;LMOD1;IGFBP7;EMP1;PRRX1;GADD45B;FN1;RUNX2;SLIT3;AEBP1
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),0.657957660239728,1.334126311413721,0.1875,0.9135047922841845,1.0,4/15,11.88%,MGAM;PGM2;AGL;PYGM
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),0.5832132270076588,1.3337948075790207,0.16666666666666666,0.9121063386972564,1.0,8/25,22.67%,MEN1;WDR82;KMT2A;TET3;BEND3;ASH2L;KMT2C;SETD4
prerank,GO_Biological_Process_2021__negative regulation of dendritic spine development (GO:0061000),-0.8716380518633065,-1.3333604992234622,0.09259259259259259,0.7273258924976899,1.0,2/7,2.22%,EFNA1;GRIN3A
prerank,GO_Biological_Process_2021__forelimb morphogenesis (GO:0035136),0.7789229876137312,1.332630461613946,0.15789473684210525,0.911522633744856,1.0,2/5,2.65%,WNT7A;ZNF358
prerank,GO_Biological_Process_2021__embryonic forelimb morphogenesis (GO:0035115),0.7789229876137312,1.332630461613946,0.15789473684210525,0.911522633744856,1.0,2/5,2.65%,WNT7A;ZNF358
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),0.5336566809974543,1.3322008925622433,0.10526315789473684,0.9104555893974813,1.0,13/31,25.74%,DNA2;ERCC6;ATR;INTS7;HUS1;RAD9B;ATRIP;HINFP;CLSPN;RAD1;USP28;MAP3K20;CLOCK
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),0.603801751573782,1.3317638641926062,0.09375,0.9097943347164128,1.0,5/18,19.52%,GPATCH2;PPP1R26;ZCCHC9;PPP1R36;PPP1R8
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.5971030203336212,-1.3316019046206231,0.11494252873563218,0.7377589414332214,1.0,8/63,10.10%,GGT5;GBP2;GBP1;ZFP36;CCL2;YBX3;BRCA1;CHI3L1
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,-0.5661214730855343,-1.331344550190536,0.033707865168539325,0.7373623578439864,1.0,19/107,12.41%,THBS1;C3;COL4A1;APLNR;ANGPTL2;COL4A2;CALD1;C1R;CLDN16;CDH6;MAOB;IGFBP5;RASL12;LDB2;NRGN;BGN;SPSB1;LMOD1;IGFBP7
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),-0.6518049370604838,-1.3311558928816587,0.07792207792207792,0.7365861601056595,1.0,3/26,1.77%,COL4A1;MET;TGFBR2
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),0.534676967638438,1.330829307049978,0.14814814814814814,0.9118318340955157,1.0,7/31,13.58%,LCMT2;TYW3;FTSJ1;TRMT1L;NSUN6;TRMT61A;TRMT1
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),0.5045161400318083,1.3303221247573653,0.08695652173913043,0.911610690802649,1.0,16/67,15.18%,SPSB4;PEF1;PSMD10;BCL10;TRIB3;PLK1;DCUN1D2;UBE2N;DCUN1D1;COMMD1;UBE2D1;DERL1;RCHY1;DCUN1D5;MARCHF7;NDFIP1
prerank,GO_Biological_Process_2021__toll-like receptor 3 signaling pathway (GO:0034138),-0.7725478440686913,-1.3299295755810214,0.0958904109589041,0.7426922293677044,1.0,7/11,16.37%,RFTN1;COLEC12;TLR3;SCARA3;TNIP2;SCIMP;FADD
prerank,GO_Biological_Process_2021__positive regulation of coagulation (GO:0050820),-0.8265067074466677,-1.329910983558599,0.16923076923076924,0.7386617922945093,1.0,1/6,0.43%,THBS1
prerank,GO_Biological_Process_2021__positive regulation of hemostasis (GO:1900048),-0.8265067074466677,-1.329910983558599,0.16923076923076924,0.7386617922945093,1.0,1/6,0.43%,THBS1
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),-0.826452832506112,-1.3299007102601044,0.12307692307692308,0.7366871072753426,1.0,2/7,9.78%,KLF2;KLF4
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),-0.6520201681292928,-1.3298708160608692,0.08955223880597014,0.7348175859726291,1.0,9/37,13.68%,SLC6A15;SLC25A45;PDPN;SLC38A4;SLC3A1;SLC7A14;SLC7A2;SLC38A1;SLC43A2
prerank,GO_Biological_Process_2021__negative regulation of membrane protein ectodomain proteolysis (GO:0051045),-0.8988816319682449,-1.329862366567349,0.019230769230769232,0.732794207766892,1.0,2/5,8.62%,TIMP2;TIMP1
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),-0.6673055488107154,-1.3291363625315802,0.09859154929577464,0.7364220128768291,1.0,4/27,5.70%,APLNR;TGFBR2;MMP21;CCDC39
prerank,GO_Biological_Process_2021__cell cycle checkpoint signaling (GO:0000075),-0.7780455521830731,-1.3291131143195782,0.1076923076923077,0.7345454246716051,1.0,4/9,19.03%,PLK2;ZWILCH;WEE2;WEE1
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.8245331187035501,-1.3290023387489525,0.05172413793103448,0.7332377553037355,1.0,3/9,13.41%,RPS27A;ISG15;UBC
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),0.6583347515425438,1.3289611313561174,0.14705882352941177,0.9165695814040113,1.0,8/12,22.88%,AKT2;AKT1;ERBB4;ZNF703;CSF1R;ID2;WNT7B;LATS1
prerank,GO_Biological_Process_2021__constitutive secretory pathway (GO:0045054),0.8402677148338736,1.3286937863052204,0.15384615384615385,0.9155034639829316,1.0,3/5,8.75%,TMEM167B;TRAPPC11;TMEM167A
prerank,GO_Biological_Process_2021__dense core granule cytoskeletal transport (GO:0099519),-0.8084790794088349,-1.3279982382251667,0.13846153846153847,0.7380644253534024,1.0,1/7,6.99%,SYT4
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,-0.5924324392476374,-1.3277941002677536,0.037037037037037035,0.737286610300513,1.0,18/74,10.53%,CD24;ST6GAL1;IL1R1;CDKN2A;PGR;ICAM1;ITGA2;PSCA;POF1B;OVOL2;BAIAP2L1;ANLN;CRYBA1;PLEKHG6;BRCA1;CEACAM1;F5;ITGA5
prerank,GO_Biological_Process_2021__endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),0.7714373388532496,1.327772333783506,0.05263157894736842,0.91740933272857,1.0,3/7,19.24%,VCP;CHMP2B;VPS4B
prerank,GO_Biological_Process_2021__thiamine-containing compound metabolic process (GO:0042723),0.8165849367819475,1.327401063649335,0.12195121951219512,0.9169993326076594,1.0,3/5,8.95%,ACP3;TPK1;SLC25A19
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),-0.6374964667904612,-1.3272508178877276,0.1111111111111111,0.73902895944604,1.0,9/36,17.15%,SLC32A1;SYN3;SYT1;CPLX1;SYN2;CPLX2;GAD1;GAD2;CDK5
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),0.7488863302686293,1.326913544024169,0.16666666666666666,0.9166352713901594,1.0,1/8,2.62%,ABCA1
prerank,GO_Biological_Process_2021__icosanoid secretion (GO:0032309),-0.8464464757529654,-1.32637655290323,0.15384615384615385,0.7439153366986404,1.0,1/6,0.21%,ANXA1
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),-0.8068731377686633,-1.3263725265712933,0.045454545454545456,0.7418883194324316,1.0,4/11,13.37%,CD24;PODXL;BASP1;MYO1E
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),-0.8947099684042759,-1.326354727788123,0.01818181818181818,0.739963892587376,1.0,2/5,3.30%,TYMS;CMPK2
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.7479817499417565,-1.326296253089432,0.09836065573770492,0.7383923681959383,1.0,3/10,9.11%,HTR2B;CHRM1;GAP43
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),-0.8896381783317013,-1.3259514076236836,0.07272727272727272,0.7385370703106015,1.0,2/5,7.31%,MLIP;TRPC3
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),0.5863315697466325,1.3259219024181508,0.08695652173913043,0.9189512948680076,1.0,9/21,31.14%,NOL11;UBTF;EIF2AK3;DHX33;WDR43;WDR75;PWP1;MTOR;ATF4
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.4694174172638397,1.3258467222745198,0.058823529411764705,0.916430700070518,1.0,19/66,23.99%,LIMD1;MEN1;BMP2;GREM1;SOX9;RORB;RANBP3L;FBXO5;ACVR2A;PRKD1;GDF10;ZHX3;BMPR1B;HGF;PTK2;WNT7B;BMP7;CRIM1;FERMT2
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),0.4901161686941771,1.3253484551722001,0.05555555555555555,0.9160718780208086,1.0,19/50,22.14%,NUP42;NUP37;NUP54;TRIM28;AAAS;NUP214;NDC1;ZNF451;RAE1;NUP188;KIAA1586;NUP85;NUP205;NUP210;EYA1;PIAS4;NUP153;SUMO2;NUP50
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.7604554802112335,-1.3249761474189559,0.13513513513513514,0.7431772522046266,1.0,2/10,14.53%,NR4A3;PINK1
prerank,GO_Biological_Process_2021__organophosphate catabolic process (GO:0046434),-0.866153407053186,-1.3249316937637077,0.047619047619047616,0.7415418213164633,1.0,2/7,8.02%,ENPP2;ANGPTL3
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.651741629245349,1.324925423654284,0.07407407407407407,0.9152447058905334,1.0,6/16,18.78%,RTRAF;TSEN2;TSEN15;ZBTB8OS;ERN1;TRPT1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial fusion (GO:0010637),0.7346420270757519,1.3249060652895581,0.125,0.9124608968778926,1.0,2/7,13.02%,VAT1;MUL1
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),0.6868660259803623,1.3245503024214536,0.16216216216216217,0.9111825133591303,1.0,1/10,1.58%,METAP1D
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),-0.7478266147671109,-1.3240700266102343,0.1111111111111111,0.7448390431532564,1.0,4/15,13.46%,CD44;PDPN;CEACAM1;TMEFF2
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),-0.6308069299207941,-1.3240482393895723,0.06666666666666667,0.7431628621330123,1.0,5/36,12.32%,KLF2;APP;LDLR;KLF4;LTBP4
prerank,GO_Biological_Process_2021__nucleotide transport (GO:0006862),0.7418124545135305,1.324039306747582,0.10526315789473684,0.9105902164880381,1.0,2/6,21.70%,SLC25A19;ABCC5
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),0.6516472216691394,1.324024107557118,0.12903225806451613,0.9078045475406495,1.0,2/11,7.35%,PLIN5;ABHD5
prerank,GO_Biological_Process_2021__response to ethanol (GO:0045471),-0.7991779994671664,-1.3239657401376423,0.12307692307692308,0.7418326131493956,1.0,6/11,18.04%,GRIN3A;GRIN2A;ADCY7;GLRA2;GRIN2B;GLRA1
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell differentiation (GO:0035886),-0.8400851787048074,-1.3225915796459677,0.09230769230769231,0.748799811611988,1.0,1/6,0.92%,APLNR
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),-0.6985787938124751,-1.3223085148034905,0.10144927536231885,0.7488024861171456,1.0,3/23,2.07%,THBS1;GPR183;P2RY12
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),0.5656155885167968,1.3221298201987282,0.09090909090909091,0.9146395264437663,1.0,5/18,16.44%,MCU;MFF;RALA;MUL1;MIEF2
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),-0.6527736053609983,-1.3221051564753203,0.12658227848101267,0.7484931164672972,1.0,13/25,21.23%,SCN1B;PKP2;KCNQ1;KCNJ2;ATP1A1;GJC1;CAV3;SCN1A;CACNA1C;SCN3B;FGF12;RYR2;KCNE4
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),0.5839766992564276,1.3214000382720164,0.08695652173913043,0.9146299064045722,1.0,8/23,18.26%,PRELID2;MTTP;SLC25A19;SCP2;PRELID3B;PCTP;NPC2;TRIAP1
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),-0.6340174369317173,-1.321190461332033,0.08433734939759036,0.7525645023096896,1.0,5/41,9.23%,TLR2;BST2;PLSCR1;DYSF;EGF
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.6494673312938267,1.3209775957882246,0.15625,0.9135738213018478,1.0,7/12,30.36%,KAT2B;NAA30;EP300;NAA50;NAA15;NAA25;NAA35
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),-0.7153243641262518,-1.3204020351513512,0.08450704225352113,0.7557941493471728,1.0,3/18,5.35%,THBS1;P2RY12;DUOX1
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),-0.7014130316896134,-1.320011259118799,0.1917808219178082,0.7565081458942542,1.0,2/18,9.56%,POU4F1;TLR3
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),-0.7518707087726195,-1.3199468399720147,0.125,0.7550129565659599,1.0,1/16,0.43%,THBS1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),0.8011878568616635,1.3197385973087015,0.12903225806451613,0.917198262267395,1.0,1/6,0.67%,RGCC
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.6946150465696737,-1.3196819760466827,0.13432835820895522,0.7549553730757886,1.0,2/18,2.25%,MET;MRAP2
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),0.4677201907396806,1.3195917203599963,0.18181818181818182,0.9147678190765506,1.0,24/74,19.38%,ABCD2;GDAP1;ZDHHC14;ZDHHC11;TRAM1;ABCD1;PEX13;VPS37A;RAB8B;ZDHHC18;ABCD3;VPS37B;TAOK2;PEX2;SSR1;ZDHHC21;ZDHHC20;ICMT;RAB3IP;GOLGA7;ZDHHC11B;SLC25A17;PEX12;PIKFYVE
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.7462529726516528,-1.3190066524109068,0.04411764705882353,0.7570701108568847,1.0,2/15,8.62%,TIMP2;TIMP1
prerank,GO_Biological_Process_2021__adiponectin-activated signaling pathway (GO:0033211),0.8436534658315882,1.3188990730220405,0.05128205128205128,0.9155460090394159,1.0,1/5,3.98%,ADIPOR1
prerank,GO_Biological_Process_2021__regulation of nitric oxide mediated signal transduction (GO:0010749),-0.8744918132979964,-1.3188969950609877,0.06451612903225806,0.7559571173076635,1.0,2/5,3.11%,THBS1;NOS1AP
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043),-0.8840642307669303,-1.318894562048319,0.07692307692307693,0.7539986791799234,1.0,2/5,5.63%,THBS1;ATF3
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),-0.7358126003575597,-1.3185268903007574,0.10526315789473684,0.753857233599041,1.0,6/16,15.40%,IFI6;EGF;CEACAM1;WDR54;RHBDF2;RHBDF1
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),-0.6621968876044753,-1.3175539896997712,0.06329113924050633,0.7586888921600068,1.0,10/31,16.37%,CD24;ANXA1;IL15;PDCD1LG2;IL27RA;SYK;IGF1;HHLA2;IL18;FADD
prerank,GO_Biological_Process_2021__ATP transport (GO:0015867),0.717040038521437,1.3175241129119855,0.17647058823529413,0.9211990070287236,1.0,4/9,17.79%,SLC25A24;SLC25A41;SLC25A5;SLC25A17
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),-0.630263386179803,-1.3172064946117923,0.0975609756097561,0.7589909265034289,1.0,5/33,10.25%,ANXA1;SFTPD;GPNMB;IL15;PDCD1LG2
prerank,GO_Biological_Process_2021__autonomic nervous system development (GO:0048483),0.6910088146095107,1.3169891294263458,0.15151515151515152,0.9210460045451754,1.0,2/12,1.72%,ASCL1;SOX8
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),-0.7236221371925136,-1.3165233131858496,0.13432835820895522,0.7617324466778289,1.0,6/14,20.54%,ITGA2;SCX;ITGA8;ITGA3;CRB2;ITGB4
prerank,GO_Biological_Process_2021__regulation of interleukin-13 production (GO:0032656),-0.7953280474883142,-1.3165142034413964,0.1694915254237288,0.7598920159972334,1.0,1/8,0.16%,LEF1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),0.736968232118892,1.316153260950424,0.05405405405405406,0.9223736043589446,1.0,1/7,2.67%,MCU
prerank,GO_Biological_Process_2021__positive regulation of T-helper cell differentiation (GO:0045624),-0.7667406629543081,-1.3157743216265891,0.0967741935483871,0.7627891850263818,1.0,1/8,0.21%,ANXA1
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,-0.5445944657664873,-1.3155775032679478,0.03409090909090909,0.762155913351741,1.0,40/127,19.51%,COL4A1;ANGPTL2;OGN;COL4A2;CALD1;C1R;COL5A1;ABCA8;SPON2;NEXN;SULF1;IGFBP5;THY1;COX7A1;THBS2;PODN;GJC1;PLN;RASL12;LDB2;HEXIM1;ELN;BGN;MYH11;ITGA8;LMOD1;PRRX1;HHIP;SLIT3;OBSCN;ITGA9;PCDH18;SLC38A11;C1S;NOTCH3;PRXL2C;TNS2;SNCG;COL12A1;AQP1
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),-0.7179812793452175,-1.3148097844715356,0.1044776119402985,0.7660162372788205,1.0,1/12,0.92%,APLNR
prerank,PanglaoDB_Augmented_2021__Macrophages,-0.5557404952367335,-1.3146245893756259,0.08536585365853659,0.7655486313560805,1.0,21/80,13.03%,CXCL2;P2RY6;NR4A3;MYO1F;TLR2;ADGRE5;TAGAP;GPNMB;SIGLEC1;SLA;GPR34;GPR171;CCL2;IGSF6;PARP14;IL4R;HLA-DRA;CLEC12A;SYK;CTSS;SCIMP
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108),0.8040017012819605,1.3144180424651797,0.0967741935483871,0.9292662635062084,1.0,2/6,9.28%,THEM4;NAIF1
prerank,GO_Biological_Process_2021__gland development (GO:0048732),-0.6220444333003772,-1.3142853033796318,0.05405405405405406,0.7661896752760706,1.0,6/41,7.72%,ANXA1;SIX3;MET;PROX1;GCM2;LSR
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),-0.7076917503599272,-1.3136853430427369,0.1267605633802817,0.7685676268570817,1.0,2/15,6.95%,CXCL2;CCL2
prerank,GO_Biological_Process_2021__glomerular epithelial cell differentiation (GO:0072311),-0.8951316242906275,-1.3132613496322834,0.04838709677419355,0.767861264584204,1.0,1/5,0.04%,CD24
prerank,GO_Biological_Process_2021__renal filtration cell differentiation (GO:0061318),-0.8951316242906275,-1.3132613496322834,0.04838709677419355,0.767861264584204,1.0,1/5,0.04%,CD24
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),0.6657536682099846,1.313170735848536,0.18421052631578946,0.9327265352693767,1.0,4/11,22.88%,KEAP1;NFKBIE;PKD2;LATS1
prerank,GO_Biological_Process_2021__proline metabolic process (GO:0006560),0.8370036847024452,1.3130954469499472,0.16279069767441862,0.9302598046950138,1.0,1/5,0.88%,DAO
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),-0.7268013681117205,-1.3126987903333307,0.19402985074626866,0.7702382645803698,1.0,5/14,10.13%,TYMS;DUOX1;AKR1C1;TRPC3;STAT1
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),-0.6977587342060488,-1.3124963636843492,0.14285714285714285,0.7697461170070611,1.0,1/16,0.43%,THBS1
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),-0.6513415578489192,-1.3118669908108676,0.11688311688311688,0.7703579470565407,1.0,8/23,17.96%,ACOT1;ACSM5;GLYAT;DBI;ACOT4;ACOT2;ACOT8;OXSM
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),-0.6513415578489192,-1.3118669908108676,0.11688311688311688,0.7703579470565407,1.0,8/23,17.96%,ACOT1;ACSM5;GLYAT;DBI;ACOT4;ACOT2;ACOT8;OXSM
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),-0.843049921887999,-1.3115424246064102,0.05172413793103448,0.7708701253388444,1.0,3/7,9.53%,PKP2;NEFL;GFAP
prerank,GO_Biological_Process_2021__signal complex assembly (GO:0007172),0.8265354026523635,1.3113239193238957,0.14285714285714285,0.9356457990130425,1.0,2/5,13.89%,NCK1;NCK2
prerank,GO_Biological_Process_2021__DNA damage induced protein phosphorylation (GO:0006975),0.7173316731267192,1.3109847380503232,0.21621621621621623,0.934845174480332,1.0,1/8,12.39%,MAPK12
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),0.5201945857569942,1.309949073843007,0.15384615384615385,0.9371174497151931,1.0,9/51,10.41%,RGCC;NAF1;GREM1;CCT7;RFC3;POLG2;MAP3K4;CCT3;ATR
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),0.6424643750601424,1.309938394608543,0.11428571428571428,0.93442541474816,1.0,7/20,13.32%,PPP1R3D;PASK;PPP1R3G;AKT2;AKT1;EPM2AIP1;PPP1R3F
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),-0.822308222528223,-1.3094143759387487,0.12280701754385964,0.7836321525100075,1.0,1/7,1.77%,TGFBR2
prerank,GO_Biological_Process_2021__negative regulation of insulin secretion (GO:0046676),-0.7382994754259867,-1.3091954592602124,0.17333333333333334,0.7832790821062574,1.0,3/13,9.58%,KCNB1;PIM3;BMP8A
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),-0.5695659096175086,-1.3091645796003668,0.0958904109589041,0.7816029608267725,1.0,12/53,16.30%,MET;PSRC1;BAIAP2L1;CAV3;CDC42EP1;BAIAP2;DCTN1;PFN2;LMOD1;CDC42EP3;PINK1;FES
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),-0.6242839779912107,-1.3090967779832958,0.08695652173913043,0.7802654405383828,1.0,2/27,6.46%,THBS1;SEMA3B
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),-0.7157086033135138,-1.3089388035374847,0.11940298507462686,0.7793258332884374,1.0,2/14,4.04%,MET;GPNMB
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),-0.7026291290772251,-1.308832775247628,0.11267605633802817,0.7782264229497015,1.0,6/22,12.96%,EFNA1;P2RY12;TESC;CYP1B1;SYK;SFRP2
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),-0.8376419504396577,-1.308350783225856,0.08064516129032258,0.779469171184101,1.0,4/6,14.53%,TOMM7;HK2;ATP5IF1;PINK1
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),0.651989189156314,1.3081613676542636,0.14285714285714285,0.9411803287361582,1.0,2/11,15.10%,TBCCD1;ARCN1
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure by hormone (GO:0001990),0.8638731062899225,1.307534727499155,0.06382978723404255,0.9417733409929293,1.0,1/5,0.31%,ACE2
prerank,GO_Biological_Process_2021__regulation of ketone biosynthetic process (GO:0010566),0.7341868495606956,1.3070942815143087,0.2,0.9406473119360298,1.0,2/7,12.46%,AKR1C3;SIRT5
prerank,GO_Biological_Process_2021__chitin metabolic process (GO:0006030),-0.8472585727491463,-1.307071292014546,0.140625,0.7854452508248816,1.0,2/5,10.10%,CHI3L2;CHI3L1
prerank,GO_Biological_Process_2021__chitin catabolic process (GO:0006032),-0.8472585727491463,-1.307071292014546,0.140625,0.7854452508248816,1.0,2/5,10.10%,CHI3L2;CHI3L1
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),0.4754004643294273,1.3065570126161588,0.08333333333333333,0.9403234710858387,1.0,12/51,16.79%,GDAP1;ABCB10;SLC25A24;COX18;MAIP1;MFF;TOMM22;BAD;TIMM23;SLC25A5;MTX2;FLVCR1
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),0.5877902827427259,1.3063492997096886,0.09375,0.9387322646029115,1.0,4/17,18.58%,ADAMTS9;STT3B;FBXO27;AOAH
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),-0.6179362298158178,-1.3055549398060469,0.1038961038961039,0.7932141869428687,1.0,6/37,12.46%,MTMR7;MTMR11;PLPP4;PLPPR1;SGPP2;PLPPR5
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),-0.7604665856132695,-1.305387884281925,0.09859154929577464,0.7923990678083116,1.0,2/11,5.54%,NR4A3;WNT8B
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),-0.7040478670649742,-1.3053372743942,0.0821917808219178,0.7908587974098154,1.0,2/18,8.71%,ABCA8;ABCA12
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),-0.5760950163018261,-1.3052620293852748,0.13924050632911392,0.7895481515965467,1.0,13/56,22.17%,THBS1;CDKN2A;SKAP1;THY1;EMP2;MINK1;PLET1;CCL28;SEMA3E;PIK3CB;DAPK3;SFRP1;VCL
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),0.5856752104193226,1.3044096397173133,0.05555555555555555,0.9454160256712419,1.0,6/22,19.24%,PLK1;HSPA1A;CEP97;CHMP2B;HNRNPU;VPS4B
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),0.7275602095336957,1.3043880948685749,0.19444444444444445,0.94283342635543,1.0,4/7,16.54%,PHF14;BRPF1;KAT7;BRPF3
prerank,GO_Biological_Process_2021__regulation of MHC class I biosynthetic process (GO:0045343),-0.8483295642073302,-1.3042040464235236,0.16393442622950818,0.7946933922133839,1.0,3/5,10.60%,CIITA;NLRC5;NLRP12
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),-0.6094468154904735,-1.3039383390027905,0.14492753623188406,0.794606374356477,1.0,1/33,0.03%,CACNA1H
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),0.5882327061902458,1.3036514329551265,0.21428571428571427,0.9434900179754903,1.0,8/33,23.08%,KAT2B;MAML3;ENHO;ROBO1;EP300;POGLUT1;RBPJ;JAG1
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),-0.7510962160328684,-1.3034433541720034,0.14285714285714285,0.7961044375344275,1.0,7/14,19.49%,RFTN1;IL12A;IL15;PRKCQ;IL18;SPHK1;TGFB1
prerank,GO_Biological_Process_2021__mitotic DNA replication checkpoint signaling (GO:0033314),0.7228685268401475,1.3028891993077625,0.13513513513513514,0.9447309296191685,1.0,3/7,21.06%,HUS1;CLSPN;TICRR
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),0.5804392979040341,1.3025757499206838,0.11428571428571428,0.9433062973764638,1.0,8/21,23.89%,VCP;VTA1;LEPROTL1;CHMP2B;VPS4B;CHMP6;TMEM50B;SORT1
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),-0.6496894320492684,-1.3019667985184316,0.06666666666666667,0.8037989259111239,1.0,2/26,2.68%,AMN;ANK3
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),0.6093503589878605,1.301757946835802,0.15625,0.9443846950820203,1.0,5/16,16.08%,THEM4;NAIF1;BAD;MUL1;SLC25A5
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),-0.6302773298098526,-1.301516158043561,0.09859154929577464,0.8047490418358795,1.0,3/35,2.41%,THBS1;CDKN2A;GBP1
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K27 methylation (GO:0061087),0.8162082475547779,1.3013177400616596,0.12195121951219512,0.944057578070845,1.0,1/5,6.52%,ZNF304
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),0.682225951290297,1.3012031362468564,0.1891891891891892,0.9417943170783906,1.0,3/12,4.47%,SOX8;BMP2;GREM1
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),-0.634549370682196,-1.3011076182170804,0.136986301369863,0.8060730848535366,1.0,5/29,9.87%,GGT5;OGN;CSPG4;OMD;BGN
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),0.7555560295986499,1.3007751376591936,0.20930232558139536,0.9413218175396866,1.0,1/6,5.44%,PLK1
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),0.69330367089939,1.3001735967040728,0.12121212121212122,0.9415842655710361,1.0,2/14,7.35%,ABCA1;ABHD5
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),-0.7003236865744622,-1.3001228941028018,0.08695652173913043,0.8106495353534945,1.0,2/17,7.01%,ICAM1;THY1
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.7401139688606302,-1.2997291853096118,0.12121212121212122,0.8112398330920441,1.0,5/11,12.96%,P2RY12;SKAP1;PODXL;SYK;SFRP2
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),-0.7270023551906113,-1.2997059432188593,0.08571428571428572,0.8094541735323866,1.0,3/16,14.99%,RPS27;RPS14;RPS15
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),0.5541655071861902,1.299489727516906,0.1111111111111111,0.9421526843011698,1.0,8/28,14.48%,RGCC;SERPINF2;RUNX1;RAB27A;AKT1;ADGRB1;ZBTB20;HDAC2
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),-0.5976838138306612,-1.299226694093948,0.10666666666666667,0.8104391105416714,1.0,10/43,16.37%,RASGRP1;THBS1;TLR2;APP;WNT5A;TLR3;SYK;HLA-E;IFIH1;FADD
prerank,GO_Biological_Process_2021__positive regulation of steroid metabolic process (GO:0045940),0.7524823575922379,1.299036522041203,0.08571428571428572,0.9416065213836919,1.0,1/5,10.76%,STARD4
prerank,GO_Biological_Process_2021__positive regulation of calcium ion import (GO:0090280),-0.7826011654863115,-1.298546996115856,0.16666666666666666,0.8137224889275952,1.0,3/7,12.47%,RAMP3;CCL2;GRM6
prerank,GO_Biological_Process_2021__protein K27-linked ubiquitination (GO:0044314),0.7905792079315042,1.2984726683034802,0.175,0.9417130949497209,1.0,2/6,3.16%,RNF6;UBE2T
prerank,GO_Biological_Process_2021__cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),-0.8603496386531712,-1.2982353289415924,0.1896551724137931,0.8140644606384428,1.0,2/5,7.56%,PKP2;CTNNA3
prerank,GO_Biological_Process_2021__primary miRNA processing (GO:0031053),0.6983976195568304,1.2981241544337483,0.15384615384615385,0.9404852660307412,1.0,2/10,10.34%,PUS10;DROSHA
prerank,GO_Biological_Process_2021__carbohydrate transport (GO:0008643),0.7867975832660815,1.297613719999603,0.24242424242424243,0.9399103352126875,1.0,1/6,0.43%,SLC2A5
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),-0.6865899516638133,-1.2974748612737392,0.15384615384615385,0.817206580960305,1.0,1/18,0.07%,GGT5
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),-0.624027030347618,-1.2973326928100073,0.1,0.8160142064431527,1.0,16/31,30.10%,SYT1;CPLX1;RIMS2;UNC13C;STX19;CPLX2;CDK5;SYT2;SYT5;STX1B;DOC2B;RIMS1;STX3;STX4;RAB3A;RIMS3
prerank,GO_Biological_Process_2021__protein import into peroxisome matrix (GO:0016558),0.6892016160014511,1.297267947768161,0.27586206896551724,0.9390733323991822,1.0,7/11,28.54%,PEX13;PEX2;PEX12;PEX6;PEX5L;PEX16;PEX5
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),0.6254655680756449,1.297222762425222,0.12121212121212122,0.9366537511345877,1.0,4/12,14.51%,PPARGC1A;AKT2;AKT1;GPLD1
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),0.6840784753414426,1.2969561401750362,0.16666666666666666,0.9327190865127334,1.0,1/11,3.57%,INPP1
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),0.6840784753414426,1.2969561401750362,0.16666666666666666,0.9327190865127334,1.0,1/11,3.57%,INPP1
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.8305162513279915,-1.2967332552307564,0.17647058823529413,0.8181231690975981,1.0,3/5,14.01%,TLR2;CCL2;NAMPT
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.6204721659635389,-1.2965423285667161,0.13432835820895522,0.8174789766683463,1.0,5/24,10.11%,MET;STMN2;PSRC1;CAV3;DCTN1
prerank,GO_Biological_Process_2021__Schwann cell development (GO:0014044),-0.8168130864271872,-1.296390829066917,0.21666666666666667,0.8149986996893137,1.0,1/6,4.56%,CNTNAP1
prerank,GO_Biological_Process_2021__peripheral nervous system axon ensheathment (GO:0032292),-0.8168130864271872,-1.296390829066917,0.21666666666666667,0.8149986996893137,1.0,1/6,4.56%,CNTNAP1
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),-0.7649256417359299,-1.2963172133081065,0.2413793103448276,0.8138443860986977,1.0,1/9,4.56%,CNTNAP1
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),0.6814236922100128,1.2956541763879197,0.2631578947368421,0.9373080690483576,1.0,5/15,19.21%,PRKRA;DROSHA;AGO3;PUM2;TSN
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),-0.5152632582218769,-1.2956339625442417,0.0,0.816570382484953,1.0,83/290,22.08%,CXCL2;LEF1;ANXA1;GBP2;IL1R1;SOCS3;IL13RA1;DUSP1;TLR2;POU4F1;GBP1;ZFP36;RPS27A;ICAM1;IFIT1;IRF1;INPP5D;DOCK8;SLA;STAT4;DUOX1;FSCN1;IL12A;CCL2;YBX3;IL4R;TIMP1;WNT5A;BRCA1;IFNGR2;RPL13A;ST3GAL6;CHI3L1;STAT1;IL1RAPL1;NLRP12;IL27RA;FOS;SIGIRR;OSMR;SYK;CCND1;UBC;JUNB;FN1;PIM1;DAB2IP;GREM2;IL7;SBNO2;PTPN7;IL18;VAV1;GBP7;IL3RA;DPYSL3;NUMBL;MYLK3;PLP2;TNFRSF1A;CDKN1A;CD4;IL1RAP;F13A1;PTAFR;PIK3CB;TGFB1;HYAL1;CEBPD;DAPK3;PIK3CD;NDN;ERBIN;GPER1;SFRP1;SHMT1;F3;GSDME;STAT6;STAT2;LAMA5;AKAP6;BCL6
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),-0.5981064858245959,-1.2955899009059275,0.1643835616438356,0.8150522916163433,1.0,7/45,14.22%,ENPP2;RAB11A;VIL1;CEACAM1;PFN2;EMP2;DAB2IP
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),-0.77192294820478,-1.2953732025945244,0.14285714285714285,0.8144238988045328,1.0,1/9,0.32%,IFI6
prerank,GO_Biological_Process_2021__establishment of protein localization to peroxisome (GO:0072663),0.7292136665065351,1.2951195400353361,0.1935483870967742,0.9374614851397605,1.0,4/7,25.88%,ZFAND6;PEX12;PEX6;PEX16
prerank,GO_Biological_Process_2021__mast cell activation involved in immune response (GO:0002279),-0.8788398997879379,-1.2947326873292762,0.08196721311475409,0.814742180723171,1.0,1/5,1.48%,NR4A3
prerank,GO_Biological_Process_2021__mast cell degranulation (GO:0043303),-0.8788398997879379,-1.2947326873292762,0.08196721311475409,0.814742180723171,1.0,1/5,1.48%,NR4A3
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),0.48524671226835236,1.294697969672832,0.14285714285714285,0.9370176851241847,1.0,25/78,23.93%,MRPL10;MRPS30;MRPL15;PTCD3;MRPS9;MRPS2;MRPL37;MRPL58;MRPL52;GFM2;MRPL50;MRPS35;MRPL42;MRPS27;MRPL18;MRPL47;MRPS31;MRPL41;MRPS14;MRPL9;MRPS7;MRPL1;MRPS11;MRPL4;MRPL13
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),-0.6236155999199519,-1.2944762248981325,0.0958904109589041,0.8146905743202256,1.0,11/34,16.03%,THBS1;OGN;NR4A3;IL12A;IGFBP5;APOD;ELN;STAT1;VIP;IGF1;IL18
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",-0.6119267831095568,-1.2943413182685444,0.16901408450704225,0.8135932312504434,1.0,7/24,18.47%,THBS1;RHOBTB2;XKR4;MYH9;ELMO1;MSR1;RHOBTB1
prerank,GO_Biological_Process_2021__regulation of phospholipase activity (GO:0010517),-0.7870172595820443,-1.2939287945268216,0.12857142857142856,0.8145501093030549,1.0,2/10,8.02%,RASGRP1;ANGPTL3
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in immune response (GO:0002718),-0.7610273461829746,-1.2938592032748337,0.2542372881355932,0.8132497600308318,1.0,3/7,13.03%,WNT5A;TNFRSF14;SCIMP
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),-0.6733151966069063,-1.2934199711861836,0.14285714285714285,0.8145053526056906,1.0,4/22,10.49%,ANXA1;FLG;WNT5A;CLIC4
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.7643636427845303,-1.2933324937864425,0.21311475409836064,0.813267463927608,1.0,4/9,20.30%,PKP2;CTNNA3;CACNA1C;RYR2
prerank,GO_Biological_Process_2021__regulation of sensory perception of pain (GO:0051930),0.7492646746942677,1.2928181841072384,0.17142857142857143,0.943007001691267,1.0,3/9,6.40%,ACP3;TMEM100;SCN11A
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),-0.6316907444949974,-1.2925225147625685,0.13333333333333333,0.8170561379225728,1.0,7/38,8.93%,CCBE1;COL4A1;APLNR;TGFBR2;PROX1;ANGPTL3;CYP1B1
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),-0.7114478061111257,-1.2925124851505114,0.16666666666666666,0.8153302312692152,1.0,5/13,15.34%,CD44;PDPN;VIL1;WAS;DMTN
prerank,GO_Biological_Process_2021__small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.6951374155301846,1.2924968688745473,0.14285714285714285,0.942179806387379,1.0,5/9,24.02%,NAF1;NUFIP1;ZNHIT3;RUVBL1;ZNHIT6
prerank,GO_Biological_Process_2021__negative regulation of regulated secretory pathway (GO:1903306),-0.8005093388888764,-1.292080749678191,0.08064516129032258,0.8163828217492567,1.0,1/7,6.99%,SYT4
prerank,GO_Biological_Process_2021__peptidyl-lysine hydroxylation (GO:0017185),0.7070238332253337,1.2915797124113348,0.21951219512195122,0.9441667968530937,1.0,4/7,27.05%,P3H4;JMJD6;VIPAS39;PLOD1
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),-0.6450603735752964,-1.2915011470786661,0.13513513513513514,0.8185702420207227,1.0,1/25,0.04%,CD24
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.7568862720086141,-1.2910831628555897,0.1111111111111111,0.8194991730928228,1.0,3/11,16.12%,DUSP1;CCNB1;ANAPC15
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),-0.727378491230206,-1.2908614141452956,0.19298245614035087,0.8190105689977449,1.0,2/11,10.13%,IRF1;STAT1
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,-0.6094901233729956,-1.290211693219591,0.11392405063291139,0.8209921784560108,1.0,12/35,15.01%,GBP2;IL1R1;GPR183;CD5;TAGAP;SLA;GPR171;P2RY10;CTSS;HLA-E;HLA-F;SP140
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),-0.6280627240620288,-1.2901625429267223,0.1891891891891892,0.8194099928360107,1.0,1/28,0.17%,KLF2
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),0.5845903131043252,1.290134893745234,0.1724137931034483,0.9496456124809391,1.0,3/21,7.45%,IBA57;CIAO3;LYRM4
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),-0.5609952933432817,-1.2899982311329272,0.09195402298850575,0.818776995126104,1.0,12/92,11.87%,CACNA1H;LEF1;TGFBR2;POU4F1;RAMP3;IGFBP5;CCL2;CYP1B1;KLF4;IL1RAPL1;NLRP12;SIGIRR
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),-0.7598984700270246,-1.2894480420081411,0.14285714285714285,0.8212254181695662,1.0,1/11,1.73%,MET
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),0.5041247501068302,1.2893703568015618,0.1111111111111111,0.9508662891747468,1.0,13/67,15.60%,RANBP17;NXT2;NUP62CL;SNRPF;PPP1R10;AKT1;IPO5;IPO8;NUP214;NXT1;RANBP6;NUP188;NUP85
prerank,PanglaoDB_Augmented_2021__Neurons,-0.5006617464626103,-1.288910625368107,0.021505376344086023,0.822688225968322,1.0,70/259,18.91%,NPY;TAGLN3;CDH22;CCK;PCSK2;STMN2;NRN1;PPP1R14C;MATN2;NEFM;TCEAL3;TESC;PROX1;SNCB;ZDHHC22;SH3GL2;KCNK1;BEX1;SLC32A1;SLITRK1;SPOCK3;SYT4;LRRTM1;GRIA3;ELAVL4;SRRM4;ZIC1;IFIT3;NRGN;SYP;GAP43;NEFH;HAP1;ARHGDIG;TCEAL6;CPLX1;NCALD;VSNL1;HPCA;RIT2;CA10;CPLX2;TCEAL2;OGFOD1;SCN2A;SCN1A;PCP4;GAD1;MEG3;CALY;C11ORF87;STMN4;GNG2;GDAP1L1;GAD2;IGF1;SYNPR;SCN3B;CDK5;RGS7BP;CNTN2;SLC11A1;KCNC1;GABRG2;RGS17;TCEAL5;NMT1;RAB3C;MAP7D2;GABRA1
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated autophagy (GO:1904714),-0.7427539827285199,-1.2888831908490983,0.21428571428571427,0.8209692957166526,1.0,4/8,24.43%,GFAP;PLK3;EEF1A2;CTSA
prerank,GO_Biological_Process_2021__negative regulation of glial cell apoptotic process (GO:0034351),-0.794716160997106,-1.2886922615763203,0.2,0.8205581902009086,1.0,3/7,17.56%,CCL2;PRKCH;PRKCD
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),-0.6003429929784934,-1.288621856368632,0.10666666666666667,0.8192351144148433,1.0,14/43,22.67%,NR4A3;ALDOB;HK2;LDHA;SLC16A3;GAPDHS;PDHX;ENO4;PGK1;GPI;LDHC;PFKL;PGAM1;PFKFB2
prerank,GO_Biological_Process_2021__glucosamine-containing compound catabolic process (GO:1901072),-0.7811607444755357,-1.2886053121560537,0.13114754098360656,0.8175712913548068,1.0,2/8,10.10%,CHI3L2;CHI3L1
prerank,GO_Biological_Process_2021__regulation of glucan biosynthetic process (GO:0010962),0.8146722953604583,1.2884466718493428,0.16666666666666666,0.9527404573088105,1.0,4/7,13.32%,PPP1R3D;PPP1R3G;AKT1;PPP1R3F
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),0.7873225664544283,1.2882605916384395,0.1282051282051282,0.9510204849904202,1.0,3/7,14.11%,LIG4;MSH2;MSH3
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),-0.8056246660167461,-1.2880567531585974,0.109375,0.8193901170587047,1.0,1/8,0.14%,ST6GAL1
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),-0.7153605000350585,-1.2880185496970735,0.22807017543859648,0.8179873284492245,1.0,3/10,13.58%,CNTNAP1;TENM4;CD9
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),-0.7479445061613205,-1.2878111947944009,0.16129032258064516,0.8173696418012014,1.0,1/12,0.43%,THBS1
prerank,GO_Biological_Process_2021__kinetochore assembly (GO:0051382),-0.7732229234795838,-1.2872756455077103,0.1774193548387097,0.8191229540761359,1.0,1/6,6.56%,CENPE
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan metabolic process (GO:0050655),0.8012091123490346,1.2870843900030373,0.2127659574468085,0.953832515508052,1.0,2/6,12.93%,CSGALNACT1;DSE
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.6204016010204436,1.2869573481557461,0.24,0.9519005618898313,1.0,2/15,6.14%,PRDX6;SF3B4
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.7640782090342382,-1.2865634130692831,0.18333333333333332,0.8221135367434613,1.0,4/8,13.75%,TGFBR2;HLA-DRA;PRKCQ;CD55
prerank,GO_Biological_Process_2021__maintenance of synapse structure (GO:0099558),-0.8056936160332173,-1.2865610688627553,0.11864406779661017,0.8204288908112145,1.0,2/6,10.11%,CBLN2;DCTN1
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),-0.7289813269188021,-1.2863757273944099,0.1044776119402985,0.8199370098242174,1.0,4/13,12.79%,HPN;LMO2;GATA1;CTSS
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translational elongation (GO:1900247),0.7705925255076107,1.2854584981612682,0.23255813953488372,0.9560013103208238,1.0,4/8,15.76%,DPH5;DPH3;CPEB3;DPH1
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),0.42948885338879705,1.2853726622809052,0.05263157894736842,0.953712034782745,1.0,34/81,24.06%,ERCC8;MEN1;PRIMPOL;CDC25A;EIF2S1;EGFR;MAP3K4;ERCC6;AKT1;MSH2;YY1;ERCC2;ATR;PTPRK;EIF2AK4;MAPK8;ERCC3;CAT;SMPD1;POLK;EP300;GTF2H2;RHBDD1;TRIAP1;NOC2L;CCAR2;USP47;MAP4K3;UBE2A;N4BP1;PARP1;ZBTB1;ERCC4;USP28
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),0.48986738690152376,1.2852527470196948,0.11764705882352941,0.9519401225525774,1.0,15/47,24.13%,ANKRD50;SNF8;CMTM6;ACAP2;VPS39;VPS50;PTPN23;WASHC2C;SNX27;EPS15;EIPR1;SNX17;VPS29;DENND1A;SNX3
prerank,GO_Biological_Process_2021__N-acylphosphatidylethanolamine metabolic process (GO:0070292),-0.8037912524174438,-1.2852118441252642,0.15254237288135594,0.8254879900500979,1.0,1/7,2.55%,PLAAT4
prerank,GO_Biological_Process_2021__positive regulation of mast cell activation (GO:0033005),-0.855212709954664,-1.2849118599780096,0.13793103448275862,0.8253630850187437,1.0,1/5,1.48%,NR4A3
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),0.5697921739831739,1.2848168850740667,0.17391304347826086,0.9487474189688712,1.0,2/16,0.72%,WNT7A;SLITRK2
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),0.5697921739831739,1.2848168850740667,0.17391304347826086,0.9487474189688712,1.0,2/16,0.72%,WNT7A;SLITRK2
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),0.47355877464346297,1.2839318836280134,0.07692307692307693,0.950009940550658,1.0,10/63,14.91%,DNA2;KPNA2;PDE12;DNASE1L2;GTF2F2;HNRNPC;LSM8;POLR2C;EXD2;HNRNPU
prerank,GO_Biological_Process_2021__Golgi disassembly (GO:0090166),-0.8398117157313632,-1.2832418103756986,0.09375,0.8342346929259726,1.0,1/6,9.99%,PLK3
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),0.831632472110462,1.2823074674503285,0.225,0.955122317836307,1.0,2/5,2.60%,RGCC;BMP2
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),0.686341191661358,1.282241686080043,0.21621621621621623,0.952835685833003,1.0,4/9,15.27%,KAT2B;KAT2A;EP300;KAT7
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),0.48283890425383996,1.2821665583093678,0.06666666666666667,0.9508806898685185,1.0,15/56,23.45%,CDKL1;TESK1;TBC1D19;ODAD3;CEP97;TBC1D5;KCTD17;TAPT1;CCDC88A;CEP120;TBC1D22B;EVI5L;TBC1D7;SAXO1;ARHGAP35
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),-0.6108045178012818,-1.2820334504940711,0.1,0.8398627299322433,1.0,5/40,11.42%,ANXA1;STAT4;IGFBP5;STAT1;EIF2B2
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),-0.8305593513457888,-1.282017952152456,0.13559322033898305,0.8381441892158019,1.0,1/6,4.47%,ITM2A
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),0.6527225237874248,1.2818394547901328,0.2727272727272727,0.9498570355526893,1.0,3/13,11.69%,PPARGC1A;ENOX2;ETFDH
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),0.6951472483194168,1.2816362750379213,0.21621621621621623,0.9486973501898875,1.0,3/9,13.42%,PGAP1;GAS1;SCFD1
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),0.3881414059156036,1.2813691717127496,0.0,0.947508427923709,1.0,98/352,21.74%,PTCD2;TTC29;ATAD3C;ABCD2;LIMD1;CSPG5;TFB2M;REEP6;PPARGC1A;PEX11A;LIG4;PI4K2A;TMED5;AFG1L;TFB1M;ALAS1;TNFAIP3;MTERF1;CATIP;PLIN5;GORASP2;ABCD1;POLG2;SYNE1;TRAPPC11;BLZF1;AUP1;ZFYVE16;FMNL3;STX7;DIAPH3;TTC17;DNAJC28;TRAPPC12;TMEM11;GABPB1;BRWD1;MICAL2;ATL2;ESRRA;ABCD3;TRAPPC8;OPA1;EIF2AK3;VAPA;SIRT5;GOLGA5;BRWD3;PEX2;VAPB;WASL;DYRK3;CHMP2B;PRKD1;MICAL1;SEC31B;PRDX3;MTFR1;GOLGA8N;SEC23IP;PDZD8;NRF1;FGD4;MIEF2;HPS3;MTX2;MDK;TNIK;ABI2;VPS11;EPS15;YTHDF2;NECTIN2;RAB31;TOR1B;MSTO1;PEX12;VPS4B;COG1;PIKFYVE;RAB3GAP1;KLHL20;PEX6;TMED3;RAB18;MARK1;ZMYM3;FMNL2;PKD2;PYROXD2;MAST2;UBXN2B;TMED2;CHMP6;SEC61A1;TMCC1;STRIP2;GOLPH3
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),-0.7587902521654754,-1.2812287576489523,0.1323529411764706,0.8414700340857243,1.0,4/8,23.27%,SIX3;DAB2IP;RYR2;COL4A3
prerank,GO_Biological_Process_2021__negative regulation of sphingolipid biosynthetic process (GO:0090155),-0.794134656025429,-1.2809688511269122,0.18518518518518517,0.8413836620828853,1.0,2/5,18.85%,ORMDL2;SPHK1
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),0.4276944727243537,1.2806547136525466,0.09090909090909091,0.9483997691067424,1.0,18/82,15.03%,ETV5;PPARGC1A;SOD3;PRDX6;SLC25A24;EIF2S1;HSPA1A;KEAP1;BRF2;ADNP2;ERMP1;RAD52;SESN2;PRDX1;PIK3CA;CAT;PRKD1;PRDX3
prerank,GO_Biological_Process_2021__retinal rod cell development (GO:0046548),0.7656638144110306,1.280642521691764,0.0967741935483871,0.9459554398049209,1.0,1/6,6.73%,RORB
prerank,GO_Biological_Process_2021__synaptonemal complex assembly (GO:0007130),-0.7291992461666832,-1.280233548943822,0.15873015873015872,0.8422342595386518,1.0,5/10,17.82%,STAG3;SYCE2;SYCE1;TEX11;REC8
prerank,GO_Biological_Process_2021__synaptonemal complex organization (GO:0070193),-0.7291992461666832,-1.280233548943822,0.15873015873015872,0.8422342595386518,1.0,5/10,17.82%,STAG3;SYCE2;SYCE1;TEX11;REC8
prerank,GO_Biological_Process_2021__myotube cell development (GO:0014904),0.6656160439329122,1.2801624382974188,0.21428571428571427,0.9453073424966317,1.0,2/6,5.14%,MYORG;SELENON
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),-0.6057967412454985,-1.28013905367394,0.12658227848101267,0.8409684149115646,1.0,7/46,8.70%,CD24;FABP3;ABCA5;AKR1C1;ANGPTL3;CAV3;LDLR
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.6957039060953479,-1.2795214688531364,0.15789473684210525,0.8434463541247303,1.0,4/14,13.75%,TRIM5;SIGIRR;SCIMP;CD55
prerank,GO_Biological_Process_2021__catecholamine biosynthetic process (GO:0042423),0.754708488255186,1.2793778088123777,0.14705882352941177,0.9466509648654481,1.0,2/7,10.06%,DAO;MOXD1
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.5977368146316248,-1.2793643429593131,0.09876543209876543,0.8426736784744245,1.0,6/42,9.78%,IFI6;THBS1;DHCR24;CD44;RPS6KA1;KLF4
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),-0.7381130274260317,-1.2786246977012543,0.16071428571428573,0.8458369522571562,1.0,1/9,1.77%,TGFBR2
prerank,GO_Biological_Process_2021__dicarboxylic acid biosynthetic process (GO:0043650),0.7635109298161031,1.2782369788844983,0.23529411764705882,0.9500058200990878,1.0,3/7,12.79%,GLUD1;GLS;KYNU
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),-0.7378822380463805,-1.2778583550717537,0.16417910447761194,0.848987127597723,1.0,3/13,9.95%,ANXA1;RAB11FIP5;RIMS2
prerank,GO_Biological_Process_2021__phospholipid homeostasis (GO:0055091),-0.7591660344893488,-1.277693082437087,0.21212121212121213,0.8486777724567741,1.0,3/8,8.02%,TLCD2;FABP3;ANGPTL3
prerank,GO_Biological_Process_2021__mitochondrial cytochrome c oxidase assembly (GO:0033617),0.6331645547760226,1.2776487682507658,0.18604651162790697,0.9501158856761796,1.0,4/14,18.92%,COX18;SMIM20;COX19;FASTKD3
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),0.6301657507920093,1.2774043586834922,0.21212121212121213,0.9489445306374231,1.0,5/12,28.89%,USP13;UBQLN1;NFE2L2;ATXN3;UBQLN2
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),0.55345112042269,1.277252677490458,0.1111111111111111,0.9471230517837583,1.0,5/20,12.45%,SAMM50;COX18;MAIP1;TOMM22;BAD
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),-0.5686473195542185,-1.2771644766929422,0.07228915662650602,0.8503846991372459,1.0,8/59,9.89%,CACNA1H;KCNQ1;SLC8A3;ATP1A1;PLN;CAV3;ATP1B1;ITPR3
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),-0.6610880113156422,-1.2769291962882048,0.1323529411764706,0.8500390714006514,1.0,4/26,11.04%,KCNQ1;KCNJ13;KCNJ2;CHRM3
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),0.6826631392017055,1.2763757837561163,0.15789473684210525,0.9489272655320055,1.0,1/12,3.57%,INPP1
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.7201394397382136,-1.2762964334738756,0.1095890410958904,0.852549264863476,1.0,2/12,5.11%,THBS1;SULF1
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),-0.5484492165909336,-1.2761312446327242,0.05952380952380952,0.852131562227896,1.0,25/95,19.29%,KCNT2;HPN;LRRC55;KCNQ1;KCNV1;KCNB1;KCNJ13;KCNJ2;KCNK1;SLC24A2;ATP1A1;KCNH8;ATP1B1;SLC9A2;SLC24A1;KCNG1;KCNB2;KCNAB3;KCNV2;KCNC1;KCNK10;KCNK12;KCNH7;SLC9A5;SLC12A7
prerank,GO_Biological_Process_2021__positive regulation of leukocyte differentiation (GO:1902107),0.765795452132988,1.2760762830090835,0.21212121212121213,0.9483518310678803,1.0,2/6,8.15%,AGER;HMGB1
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),0.47335931713246143,1.2753786730119776,0.1,0.9496640936252283,1.0,25/68,27.61%,INTS13;ZC3H8;SNAPC5;GTF2F2;INTS7;GTF2A2;INTS8;POLR2C;SNAPC3;SNAPC1;TAF8;POU2F1;RPRD1B;INTS14;INTS11;CCNT2;GTF2B;CCNT1;TAF13;INTS4;INTS6;RPAP2;POLR2A;INTS9;RPRD2
prerank,GO_Biological_Process_2021__axo-dendritic transport (GO:0008088),-0.7825890525368665,-1.275116933634744,0.25862068965517243,0.8574182513155713,1.0,2/6,10.11%,APP;DCTN1
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),-0.7565496594991794,-1.275018194197452,0.16071428571428573,0.8564077382207613,1.0,5/9,13.44%,P4HA2;P3H2;OGFOD1;P4HA3;P4HTM
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),-0.655885484298917,-1.2746244771052064,0.17647058823529413,0.8573574071607187,1.0,2/24,3.83%,MTMR7;MTMR11
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),-0.671125777432111,-1.2742044471903475,0.15942028985507245,0.858063485288762,1.0,3/22,8.93%,ENPP2;ANGPTL3;CYP1B1
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),0.7255009469224233,1.2741791299088678,0.21739130434782608,0.9537727640721883,1.0,6/8,27.02%,NOTCH2;HEYL;HEY2;RBPJ;JAG1;HEY1
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),-0.660172838648841,-1.2741663557578091,0.15492957746478872,0.8565280577757137,1.0,8/17,18.57%,SCN1B;PKP2;KCNJ2;ATP1A1;SCN1A;CACNA1C;SCN3B;FGF12
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.6743929274104913,-1.274083239378011,0.17333333333333334,0.8554081490839971,1.0,2/16,5.11%,THBS1;SULF1
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),-0.6326426639292079,-1.274002794692669,0.125,0.854207666183833,1.0,6/31,10.49%,ANXA1;OVOL3;OVOL2;FLG;WNT5A;CLIC4
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),-0.5585027736509979,-1.2739107868240613,0.1,0.8530799659575647,1.0,13/68,16.37%,RASGRP1;THBS1;TLR2;ZFP36;ARG2;APP;WNT5A;TLR3;SYK;HLA-E;IFIH1;IGF1;FADD
prerank,GO_Biological_Process_2021__potassium ion export across plasma membrane (GO:0097623),-0.7731240038024519,-1.2738156795087034,0.1875,0.8519398524321807,1.0,2/8,2.03%,KCNT2;KCNQ1
prerank,GO_Biological_Process_2021__negative regulation of protein maturation (GO:1903318),0.7014299638262441,1.2735020392605976,0.275,0.9540760414025667,1.0,2/7,14.12%,GAS1;SERPINE2
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),-0.6904152441015458,-1.2734571988208878,0.09090909090909091,0.8526483022187787,1.0,7/18,19.49%,TGFBR2;GRIN3A;GRIN2A;GRIN2B;SLIT3;GLRA1;TGFB1
prerank,GO_Biological_Process_2021__regulation of glycogen metabolic process (GO:0070873),0.7945195240742741,1.2733965814774297,0.1951219512195122,0.9520649837233585,1.0,5/9,13.32%,PPP1R3D;PPP1R3G;RUBCNL;AKT1;PPP1R3F
prerank,GO_Biological_Process_2021__tricuspid valve development (GO:0003175),-0.839341553477595,-1.2733173087606122,0.1896551724137931,0.8519188246322754,1.0,1/5,1.77%,TGFBR2
prerank,GO_Biological_Process_2021__rDNA heterochromatin assembly (GO:0000183),-0.8024681555121391,-1.2729367882528493,0.208955223880597,0.8527592796371346,1.0,1/8,2.26%,SUV39H1
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,-0.5321477607492805,-1.2728132731977457,0.07142857142857142,0.8517298048365011,1.0,37/117,18.91%,NPY;TAGLN3;CDH22;CCK;STMN2;SNCB;SH3GL2;PLP1;SLITRK1;SYT4;LRRTM1;ELAVL4;NRGN;GAP43;ZNF536;GFAP;ARHGDIG;TCEAL6;SST;HPCA;RIT2;CA10;CPLX2;TCEAL2;SCN2A;C11ORF87;STMN4;GAD2;SYNPR;SCN3B;RGS7BP;CNTN2;KCNC1;GABRG2;TCEAL5;RAB3C;GABRA1
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),-0.7093215263422177,-1.2721919846370693,0.23809523809523808,0.8542119719944666,1.0,3/13,16.04%,PLN;CAV3;HECW2
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),-0.6392355967369053,-1.2720386188740527,0.18032786885245902,0.8534349393587214,1.0,8/17,29.74%,GBP1;RIT2;NEUROD2;MAPT;ITPR1;CD22;PLEK;SLC8A2
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.7303377991854285,-1.2718840873973007,0.08450704225352113,0.8525105471480844,1.0,5/12,14.65%,B2M;HLA-A;HLA-DRA;HLA-E;HLA-F
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.7019768592149752,-1.2718250220168243,0.1388888888888889,0.8511393805045177,1.0,7/18,24.87%,TMEM204;ITGA5;DAB2IP;MMRN2;PRKCB;NIBAN2;EMILIN1
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),0.7040654026936967,1.2715376026046366,0.20512820512820512,0.9585457613873308,1.0,4/9,16.21%,ACACB;MID1IP1;CPT2;CPT1A
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5022789153929281,1.2712654280566351,0.21212121212121213,0.9574811893483873,1.0,2/24,0.67%,MEOX2;RGCC
prerank,PanglaoDB_Augmented_2021__Adipocytes,-0.5376923334997703,-1.2710106338926035,0.07777777777777778,0.8548684791334072,1.0,28/129,15.21%,ECM2;IL1R1;C3;ANGPTL2;TLR2;C1R;SERPINF1;ASPN;ABCA8;COL6A2;MAOB;TRIP10;SRPX2;COX7A1;THBS2;PODN;TIMP1;CYP1B1;BGN;RSPO3;EPSTI1;OLFML1;LMOD1;IGFBP7;APOL6;CFH;SERPING1;F10
prerank,GO_Biological_Process_2021__regulation of microtubule-based movement (GO:0060632),-0.7476987070825815,-1.270839427801563,0.22857142857142856,0.8541793669591394,1.0,3/8,14.95%,NEFH;HAP1;DRC1
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),-0.7309974071195862,-1.2706894779845341,0.16883116883116883,0.8533934621936717,1.0,3/16,9.78%,KLF2;NOS1AP;KLF4
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),-0.6392363055486918,-1.27023113492446,0.2112676056338028,0.8545802965499666,1.0,4/25,11.67%,APLNR;TGFBR2;CCDC39;SRF
prerank,GO_Biological_Process_2021__cytochrome complex assembly (GO:0017004),0.7949733916005811,1.2702223687311602,0.1794871794871795,0.9602028914338335,1.0,2/5,5.66%,COX10;COX18
prerank,GO_Biological_Process_2021__regulation of metallopeptidase activity (GO:1905048),-0.7905907104994355,-1.2695661739528228,0.14705882352941177,0.8572657270858101,1.0,4/6,16.19%,TIMP2;TIMP1;SVBP;DDRGK1
prerank,GO_Biological_Process_2021__neutrophil activation (GO:0042119),-0.7984860587318577,-1.2691024206552144,0.1724137931034483,0.858539259929528,1.0,3/6,17.56%,IL15;SYK;PRKCD
prerank,GO_Biological_Process_2021__positive regulation of hormone metabolic process (GO:0032352),-0.7979970782245323,-1.2687277380870297,0.13114754098360656,0.8593799956470248,1.0,2/6,12.21%,HPN;PAX8
prerank,GO_Biological_Process_2021__positive regulation of myotube differentiation (GO:0010831),-0.8309177486773701,-1.2685201666230432,0.14285714285714285,0.8588051073076944,1.0,1/6,8.55%,MMP14
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),0.5206394690340596,1.2684491451572533,0.10810810810810811,0.966278648318121,1.0,4/28,5.55%,DGKB;GK;DGKE;LYPLA2
prerank,GO_Biological_Process_2021__regulation of cGMP-mediated signaling (GO:0010752),-0.8625464320983343,-1.2683232253525842,0.1323529411764706,0.858560269511046,1.0,1/5,0.43%,THBS1
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),-0.6505146832540106,-1.268236710295663,0.1746031746031746,0.8574166455384338,1.0,3/18,16.30%,SEPTIN5;RIMS2;NLGN1
prerank,GO_Biological_Process_2021__thyroid hormone generation (GO:0006590),-0.7826390371013978,-1.268121618270681,0.08196721311475409,0.8565713429417502,1.0,2/6,14.11%,DUOX1;DIO1
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),-0.7686188503923808,-1.2680050774073852,0.19047619047619047,0.8556804236619994,1.0,1/8,3.97%,PROX1
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),-0.7195176882890701,-1.2677695069614727,0.11290322580645161,0.8554923010490793,1.0,4/11,17.18%,CNTNAP1;PLP1;TENM4;MYRF
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),-0.6447989107250953,-1.2676554444820876,0.14285714285714285,0.8544283335404448,1.0,3/24,3.97%,APLNR;TGFBR2;PROX1
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),-0.7738583683739593,-1.267534538050401,0.22950819672131148,0.8535790784673605,1.0,2/8,6.49%,C3;APP
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),0.6316449435028963,1.2674983228944015,0.06060606060606061,0.9682597529044308,1.0,2/13,3.32%,FHDC1;TMED5
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),0.682551915316897,1.2674647054419894,0.24324324324324326,0.9660424236537921,1.0,3/8,9.31%,CASS4;MCU;EFS
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),-0.7000050529583453,-1.2671718669013012,0.13432835820895522,0.854350129577473,1.0,4/19,8.07%,PKP2;NOS1AP;CTNNA3;CAV3
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),-0.6963959270637875,-1.2671017000338072,0.18181818181818182,0.8530846516139123,1.0,2/14,3.37%,TRIM22;TRIM5
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.5077334368781659,1.2670367123067954,0.13043478260869565,0.9655407706817325,1.0,14/30,26.74%,EXOSC1;DCP1B;EXOSC6;DIS3;EDC3;LSM7;LSM5;PATL1;CNOT8;EXOSC8;DCP1A;EXOSC5;LSM1;DDX6
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),0.5879180342283556,1.2665632537564264,0.11538461538461539,0.9655750989665567,1.0,8/25,14.10%,TRIB3;PLK1;DCUN1D2;UBE2N;DCUN1D1;FBXO5;FEM1B;DCUN1D5
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.6121129667580611,1.2664088032293856,0.1794871794871795,0.9638130245869869,1.0,2/9,7.04%,ABCD2;ABCD1
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),-0.7118030900920578,-1.2662454072830076,0.24324324324324326,0.8566082741465009,1.0,3/13,10.23%,C3;NR4A3;ACSL5
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),-0.696920993879603,-1.2659389594269068,0.18181818181818182,0.8568224819496453,1.0,1/14,2.41%,GBP1
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),-0.7276686506094662,-1.2656620373601812,0.22857142857142856,0.8572284408113604,1.0,3/12,10.11%,CCNB2;CCNB1;DCTN1
prerank,GO_Biological_Process_2021__positive regulation of homotypic cell-cell adhesion (GO:0034112),-0.8189708079214717,-1.265338711978085,0.25,0.8574726886106165,1.0,2/5,3.84%,ANK3;PDPN
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),0.8136523496833357,1.264928623774652,0.16666666666666666,0.9679660265369929,1.0,3/6,10.91%,LIG4;MSH2;EXOSC6
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),-0.6435163093750611,-1.2648312759449065,0.1232876712328767,0.8589949180293055,1.0,4/29,9.31%,SPARC;CD44;PDPN;VIL1
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),0.6314957659901933,1.2648036813245713,0.2777777777777778,0.96597499720167,1.0,1/17,0.92%,SRPRB
prerank,GO_Biological_Process_2021__superoxide anion generation (GO:0042554),-0.8192532452575007,-1.2647866821767817,0.2,0.8576711992302855,1.0,2/6,5.35%,ALOX12;DUOX1
prerank,GO_Biological_Process_2021__positive regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035360),0.8170556289403514,1.2647361780025537,0.17777777777777778,0.9639936330572955,1.0,2/5,9.06%,LMO3;PTGIS
prerank,GO_Biological_Process_2021__negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665),-0.8224571169282877,-1.2644126478279296,0.125,0.858406928337077,1.0,1/5,11.87%,SIGIRR
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),0.6290209621052824,1.264409372320728,0.16666666666666666,0.9629112828230236,1.0,3/13,13.45%,BMP2;SOX9;HEYL
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),-0.5935407966823172,-1.2643003494883611,0.15492957746478872,0.8574390232168801,1.0,4/50,9.21%,THBS1;S100A10;THY1;APOD
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.6176464011567042,-1.264163005591132,0.13414634146341464,0.8567127526765989,1.0,5/33,9.24%,THBS1;SP100;ICAM1;TMC8;BRCA1
prerank,GO_Biological_Process_2021__entry of bacterium into host cell (GO:0035635),-0.7723417597775376,-1.264059731653985,0.1694915254237288,0.8557041625104658,1.0,1/8,1.73%,MET
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),-0.7255465108849256,-1.2637512617198938,0.16176470588235295,0.8560112879535459,1.0,5/13,19.36%,ANXA1;GCM2;CD9;MMP24;RELN
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),-0.6424592965085465,-1.263496294107418,0.08571428571428572,0.8564119239018539,1.0,3/18,11.39%,SIX3;PROX1;SHCBP1
prerank,GO_Biological_Process_2021__regulation of sensory perception (GO:0051931),0.7543589948763192,1.2634749798497673,0.1891891891891892,0.9651860723815764,1.0,3/8,6.40%,ACP3;TMEM100;SCN11A
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),-0.6756804384371164,-1.2630281439356459,0.2413793103448276,0.8573149760215997,1.0,4/15,15.88%,GRIN2D;GRIN2A;GRIN2B;GRID2
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),-0.6683480413917408,-1.2625103766177632,0.16417910447761194,0.8591891701614316,1.0,1/22,0.03%,CACNA1H
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),-0.7136861517920691,-1.2623423265317155,0.1232876712328767,0.8587030851481373,1.0,1/15,1.07%,EFNA1
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),0.4730014686654978,1.2622783302531428,0.1,0.9682039009178413,1.0,25/69,27.61%,INTS13;ZC3H8;SNAPC5;GTF2F2;INTS7;GTF2A2;INTS8;POLR2C;SNAPC3;SNAPC1;TAF8;POU2F1;RPRD1B;INTS14;INTS11;CCNT2;GTF2B;CCNT1;TAF13;INTS4;INTS6;RPAP2;POLR2A;INTS9;RPRD2
prerank,GO_Biological_Process_2021__defense response to protozoan (GO:0042832),-0.7853216846764703,-1.2622649618076165,0.20967741935483872,0.8575924272082761,1.0,1/7,0.54%,GBP2
prerank,GO_Biological_Process_2021__negative regulation of sterol biosynthetic process (GO:0106119),0.7441532686465089,1.261983702057832,0.2765957446808511,0.9624593230903783,1.0,1/5,14.18%,ERLIN1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol biosynthetic process (GO:0045541),0.7441532686465089,1.261983702057832,0.2765957446808511,0.9624593230903783,1.0,1/5,14.18%,ERLIN1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol metabolic process (GO:0090206),0.7441532686465089,1.261983702057832,0.2765957446808511,0.9624593230903783,1.0,1/5,14.18%,ERLIN1
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),-0.6187020184079768,-1.2618274280078616,0.17391304347826086,0.8587210441516018,1.0,5/20,17.22%,OGN;OMD;ST3GAL6;B3GNT2;CHST6
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.7358194122097492,-1.2615943114836188,0.14754098360655737,0.8585817595152252,1.0,5/10,23.52%,SP100;FOXM1;TFAP4;RPS6KA6;KAT5
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),-0.7131291716388681,-1.2614225959050742,0.18840579710144928,0.8579290919500947,1.0,4/12,18.04%,NLRP12;PTK6;HHIP;GLRA1
prerank,GO_Biological_Process_2021__drug transport (GO:0015893),0.7621120319073015,1.2612184043434838,0.20512820512820512,0.963636544875141,1.0,4/5,20.15%,SLC19A1;ABCC2;SLC46A1;ABCB11
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,-0.5769458676957613,-1.2609315702314432,0.07228915662650602,0.8588954014825315,1.0,11/68,6.29%,HPN;ALDOB;MATN2;GRAMD2A;ABCA8;PROX1;S100A6;GC;MAOB;BHMT;THSD4
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),-0.7286564878625664,-1.260749629384413,0.21666666666666667,0.8582911061522109,1.0,3/10,17.04%,CAV3;VIP;NOS1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),0.4700021284720022,1.2606423121123247,0.17391304347826086,0.9638687807289243,1.0,7/47,13.02%,PLD6;PPARGC1A;MCU;MFF;RALA;BAD;MUL1
prerank,GO_Biological_Process_2021__tRNA 5'-end processing (GO:0099116),0.7113132740208843,1.2604778551950913,0.23333333333333334,0.9622579311880234,1.0,3/12,14.32%,RPP40;RPP14;RPP25L
prerank,GO_Biological_Process_2021__endocrine system development (GO:0035270),-0.6992999833544628,-1.260161198508887,0.16393442622950818,0.8603837327893932,1.0,3/11,12.21%,SIX3;GCM2;PAX8
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),-0.6613163219007665,-1.2599013256174223,0.14864864864864866,0.8600417164155401,1.0,6/19,18.57%,SCN1B;CAV3;YWHAH;SCN3B;NOS1;FGF12
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.7414651242030624,-1.2597905730548138,0.14516129032258066,0.859083750642837,1.0,3/10,10.23%,TLR2;TLR3;DDX60
prerank,GO_Biological_Process_2021__tyrosine phosphorylation of STAT protein (GO:0007260),-0.8462623150022606,-1.2587808345722085,0.15517241379310345,0.8638741762845613,1.0,2/5,11.10%,IL15;PTK6
prerank,GO_Biological_Process_2021__negative regulation of fatty acid oxidation (GO:0046322),0.6863749078149484,1.2582760247016838,0.23076923076923078,0.969810563355477,1.0,3/8,7.94%,SOX9;PLIN5;AKT1
prerank,GO_Biological_Process_2021__regulation of glial cell apoptotic process (GO:0034350),-0.8125207456306864,-1.2581459450545471,0.22413793103448276,0.8662026937889694,1.0,3/6,17.56%,CCL2;PRKCH;PRKCD
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),-0.7189477814005913,-1.2581237143085096,0.1780821917808219,0.8647323312698473,1.0,2/12,5.71%,PDPN;FSCN1
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),-0.5167236652853895,-1.2581193490533586,0.0759493670886076,0.8631907263406767,1.0,18/123,12.59%,RASGRP1;ARHGAP4;CDKN2A;RASGRP2;SHTN1;PDPN;ARHGEF3;PLK2;EPS8L2;USP50;PLD1;CDC42EP1;WAS;ARHGDIG;RALGDS;RIT2;CDC42EP3;SHC2
prerank,GO_Biological_Process_2021__histone H3-K9 methylation (GO:0051567),-0.7661009715603273,-1.258087495550238,0.16923076923076924,0.8617770373657025,1.0,1/6,2.26%,SUV39H1
prerank,GO_Biological_Process_2021__angiotensin-activated signaling pathway (GO:0038166),0.7977281860862941,1.2577454695106847,0.3,0.969865742936951,1.0,1/5,4.83%,CA2
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),0.7754884169919385,1.2577363071895884,0.3076923076923077,0.9676104105607531,1.0,4/6,18.48%,NBDY;CNOT2;CNOT6L;CNOT1
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),0.46357744733526496,1.257249137977738,0.14285714285714285,0.9673824053299226,1.0,16/59,21.12%,PRDX6;GDE1;CPNE3;PIGP;PLA2G4C;CSF1R;GPLD1;DGKH;CPNE1;PLA2G15;PLCB1;ABHD6;GPCPD1;PON1;PIGF;SERINC5
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),-0.667470663543647,-1.2570136775376364,0.20833333333333334,0.8673891455463927,1.0,1/14,0.33%,RASGRP1
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),0.5840705051178677,1.2567086866812545,0.2,0.9675387047836226,1.0,11/32,23.28%,H2BC18;H2BC21;SOX9;ANP32B;RBBP4;ASF1A;PADI4;H2BC5;KAT6B;DAXX;SART3
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,-0.5630667928864718,-1.256697530497086,0.11764705882352941,0.867755441638262,1.0,15/60,13.87%,THBS1;FOSB;MYO1F;NR1I3;CD44;GAB3;TUBB1;TMCC2;CEACAM1;UROD;GATA1;CLEC12A;GFI1B;CD55;CA1
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),-0.6685720947016486,-1.2564487120300323,0.125,0.8677098199228486,1.0,1/23,0.47%,TMEM204
prerank,GO_Biological_Process_2021__mitotic DNA integrity checkpoint signaling (GO:0044774),0.6173546217785605,1.2563483158021276,0.23076923076923078,0.9671207670555195,1.0,3/10,21.06%,HUS1;CLSPN;TICRR
prerank,GO_Biological_Process_2021__positive regulation of interleukin-17 production (GO:0032740),-0.7885655092323834,-1.2563192147402882,0.20634920634920634,0.8668142916796933,1.0,6/9,19.49%,RFTN1;IL15;PRKCQ;IL18;SPHK1;TGFB1
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),-0.6024585320303112,-1.2562104369444418,0.13636363636363635,0.8659219847611538,1.0,8/38,17.90%,LEF1;ACKR4;PRKCQ;DEFB109B;CCL28;NR4A1;PRKCD;CCR10
prerank,PanglaoDB_Augmented_2021__Beta Cells,-0.5283005944572878,-1.2560150958827803,0.05813953488372093,0.8655320177843842,1.0,31/114,18.71%,SIX3;NPY;RIMBP2;CDH22;CHGB;PCSK2;STMN2;PROX1;SH3GL2;SYT4;LRRTM1;ELAVL4;NKX6-2;SYP;PLPPR1;SST;IGSF21;CA10;CPLX2;TCEAL2;JPH3;PCP4;MEG3;KCNB2;GAD2;NPTX2;SCN3B;KCNC1;TCEAL5;FGF12;RAB3C
prerank,GO_Biological_Process_2021__protein localization to site of double-strand break (GO:1990166),-0.8424058616328405,-1.2559429667267994,0.2413793103448276,0.8645244212723471,1.0,1/5,8.76%,IFFO1
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,-0.5667122915532196,-1.255929837302412,0.10714285714285714,0.8630080083903321,1.0,20/74,20.15%,COL4A1;COL4A2;CALD1;COL5A1;LAMB1;CSPG4;TEAD2;IGFBP5;SCARA3;LMOD1;PRRX1;DAB2IP;GLI1;RHBDF1;AMOTL2;PDGFRL;PCDH18;NOTCH3;COL12A1;ANTXR1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell differentiation (GO:2000727),0.8191175684596842,1.25549272965003,0.21052631578947367,0.9691523776066018,1.0,2/5,4.47%,EFNB2;GREM1
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),-0.514590809206421,-1.2553389057647641,0.10752688172043011,0.8648368467062607,1.0,43/161,19.33%,RPL3;RPL19;ZFP36;RPS27A;RPS27;RPS14;RPS4X;RPL27A;RPL7A;RPL35;HELZ2;RPL37A;RPL21;RPL27;RPL13A;RPL9;PATL2;RPS13;RPS16;RPL24;RPS3A;RPLP1;RPL10A;RPS18;RPL10;RPS11;RPS8;RPLP2;RPL38;RPS7;RPL8;RPS15;RPL5;RPS21;RPL12;RPS23;RPL18A;RPS9;MRTO4;RPL23;RPS6;SAMD4A;RPS25
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),-0.6235170496825865,-1.2551203023885424,0.14285714285714285,0.8646167868902842,1.0,8/25,19.13%,C3;C1R;CD55;CFH;SERPING1;SUSD4;C1S;C1QB
prerank,GO_Biological_Process_2021__mesodermal cell differentiation (GO:0048333),-0.763301021028756,-1.2549261140253376,0.1746031746031746,0.8642326117867437,1.0,4/7,20.54%,ITGA2;ITGA8;ITGA3;ITGB4
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),-0.6597758669434941,-1.2545995765157085,0.21333333333333335,0.8648972911381169,1.0,2/14,8.07%,SCN1B;CAV3
prerank,PanglaoDB_Augmented_2021__Myoblasts,-0.5426421818842285,-1.2544653162477042,0.11904761904761904,0.864125603238515,1.0,26/90,22.42%,COL4A1;ANGPTL2;COL4A2;CALD1;COL5A1;LAMB1;CSPG4;SRPX2;IGFBP5;CCL2;BGN;LMOD1;PRRX1;FN1;RHBDF1;AMOTL2;ACHE;CAPN1;TNS2;COL12A1;ANTXR1;MYOZ2;ANGPT2;PTPN21;SYNC;GPC1
prerank,GO_Biological_Process_2021__L-serine biosynthetic process (GO:0006564),0.7598553097762649,1.2544229138998313,0.23076923076923078,0.9718404867658599,1.0,4/6,22.42%,PSPH;SRR;SERINC5;PHGDH
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),-0.6932076606507052,-1.254340598872603,0.2,0.8632224464624216,1.0,1/18,0.21%,ANXA1
prerank,GO_Biological_Process_2021__tRNA pseudouridine synthesis (GO:0031119),0.7485503847064814,1.2541948320147853,0.1794871794871795,0.9714154607382267,1.0,2/6,23.31%,PUS10;RPUSD4
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),-0.7423326769215174,-1.2537444821713808,0.16129032258064516,0.865314330580787,1.0,5/11,20.75%,WNT5A;IL7;IFIH1;CD74;AGPAT2
prerank,GO_Biological_Process_2021__negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.754196719280912,-1.253573652257889,0.13846153846153847,0.8648283030275749,1.0,4/7,18.80%,CEACAM1;HLA-E;HLA-F;PTPRC
prerank,GO_Biological_Process_2021__regulation of cholesterol esterification (GO:0010872),0.7224655160755826,1.252821995597725,0.2564102564102564,0.9759797871232193,1.0,1/7,10.76%,STARD4
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),-0.7150412249725295,-1.2527324295378828,0.140625,0.8685860567198245,1.0,6/12,13.75%,HLA-A;IL12A;HLA-DRA;SYK;HLA-E;CD55
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),-0.6055526391920443,-1.2526557047754943,0.2,0.8675185401236609,1.0,7/26,13.36%,CACNA1H;SCN1B;SCN9A;YWHAH;ATP5IF1;SCN2A;SCN1A
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.6795493413428549,-1.2523588901129898,0.24324324324324326,0.8678589042185969,1.0,6/11,29.11%,ITM2A;NECAB1;SOAT1;NECAB2;ITM2C;NECAB3
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),-0.6262287058670571,-1.252095708022974,0.14492753623188406,0.8680357768259096,1.0,4/36,2.68%,TLCD2;S100A10;RFTN1;ANK3
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),-0.6304402967714698,-1.2513963299358657,0.1891891891891892,0.8709957532201822,1.0,10/26,18.57%,SCN1B;PKP2;KCNQ1;KCNJ2;ATP1A1;ATP1B1;SCN1A;CACNA1C;SCN3B;FGF12
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),-0.4989803113060603,-1.2513069652620927,0.13043478260869565,0.8700049982652914,1.0,23/155,15.59%,CD24;TMEM204;SP100;TRIM5;SULF1;SLC8A3;OVOL2;APP;IGFBP5;PLSCR1;ZIC1;CAV3;TIMP1;LFNG;NLRP12;RSPO3;PTK6;TSPYL2;IGFBP7;CD55;HHIP;GLI1;ITGA3
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),0.5654910228204229,1.2512618614386455,0.23333333333333334,0.9804914897392325,1.0,6/16,25.15%,UBTF;EIF2AK3;MAF1;DHX33;WDR43;WDR75
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),0.5655927858966878,1.2510407393054632,0.19230769230769232,0.9790439925369587,1.0,3/20,3.89%,TFB2M;THUMPD1;TFB1M
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),0.41582805469077283,1.250614534471924,0.0,0.9784182008544069,1.0,10/74,10.32%,MEOX2;SOX8;BMP2;ZNF358;ANXA4;EHF;SOX9;STIL;SALL1;FOXJ1
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),-0.6903729236499645,-1.250588420123772,0.16666666666666666,0.8728338114973132,1.0,4/12,10.99%,DOCK8;APP;WNT5A;TNFRSF14
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.43721552079052217,1.2505011418650416,0.09523809523809523,0.9768570232419569,1.0,29/67,24.72%,CEBPA;PSMD10;TRIB3;CBFA2T3;PLK1;HSPA1A;KEAP1;BAG2;VCP;SIRT6;CSNK1E;RNF14;RCHY1;TRIB2;COP1;RNF217;ZYG11B;MDM2;SUMO2;NUB1;SMAD7;DDA1;SIRT2;UBQLN1;NFE2L2;DNAJB2;HSPBP1;ANKIB1;HECTD1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),-0.6477398656110805,-1.2504574536366737,0.11764705882352941,0.8721656465843677,1.0,7/25,11.65%,THBS1;SPARC;SULF1;IL12A;CCL2;STAT1;ATP5IF1
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),-0.8591966412826118,-1.2502109729807178,0.11538461538461539,0.872201869197897,1.0,1/5,1.77%,TGFBR2
prerank,GO_Biological_Process_2021__hematopoietic stem cell migration (GO:0035701),0.8085541947757917,1.2501568277903106,0.075,0.976114303327625,1.0,2/5,14.51%,JAM2;GPLD1
prerank,GO_Biological_Process_2021__production of siRNA involved in RNA interference (GO:0030422),0.7422890428566927,1.2499366323180063,0.2653061224489796,0.9748146011755501,1.0,3/7,19.21%,PRKRA;DROSHA;TSN
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",0.6048290241439909,1.2493517800259055,0.047619047619047616,0.9752292009707368,1.0,15/23,28.53%,EAF2;ERCC6;HTATSF1;KAT7;THOC1;HMGN1;CCAR2;ZMYND11;CCNT2;CCNT1;WDR43;LDB1;SCAF8;TSFM;SETD5
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,-0.5532683420177417,-1.2493433386854176,0.10975609756097561,0.8759758369478199,1.0,24/90,19.51%,TEKT2;SIX3;RSPH4A;C1ORF87;ANGPTL2;CFAP126;SPAG17;TMEM212;EFNB3;GFAP;FAM81B;USP18;NME9;CFAP61;DRC1;DRC3;ZBBX;DNAH2;CXCL17;ARMC3;AKAP14;ERICH3;RGS22;AQP1
prerank,GO_Biological_Process_2021__regulation of hepatocyte proliferation (GO:2000345),-0.794632740608518,-1.249088719288174,0.21818181818181817,0.8759470390145628,1.0,2/6,9.65%,HPN;CEACAM1
prerank,GO_Biological_Process_2021__interleukin-21-mediated signaling pathway (GO:0038114),-0.8285425080332023,-1.2489546249001615,0.13793103448275862,0.8737399619254222,1.0,2/5,10.13%,STAT4;STAT1
prerank,GO_Biological_Process_2021__cellular response to interleukin-21 (GO:0098757),-0.8285425080332023,-1.2489546249001615,0.13793103448275862,0.8737399619254222,1.0,2/5,10.13%,STAT4;STAT1
prerank,PanglaoDB_Augmented_2021__Microfold Cells,-0.5406275982734392,-1.2488925449580512,0.11363636363636363,0.8725261172444145,1.0,22/83,18.01%,IL1R1;IL13RA1;FOSL2;TYMP;ZFP36;ICAM1;HELZ2;IL4R;HLA-C;KLF4;SYNGR2;FBP1;JUNB;RHBDF2;MVP;IFIH1;SBNO2;LTBR;CTSZ;IER3;TMBIM1;TNFRSF1A
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),0.4315912235073914,1.2487614020224678,0.08333333333333333,0.9756109214606402,1.0,20/129,15.20%,ATP6V0D2;PDK4;ATP6V1A;PIK3R4;EIF2S1;RALB;ATP6V1G1;GAS2L1;AKR1C3;MIOS;XPR1;SESN2;EIF2AK4;MAPK8;WDR24;EIF2AK3;PIK3C3;DAP;PRKD1;SESN3
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),-0.5815904105271508,-1.2485605969613145,0.05952380952380952,0.8730969449573244,1.0,10/53,10.13%,THBS1;ISM1;COL4A2;SPARC;SERPINF1;CD160;SULF1;THBS2;KLF4;STAT1
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),0.570541534217886,1.2484126906750306,0.2413793103448276,0.9748777855950327,1.0,3/22,7.45%,IBA57;CIAO3;LYRM4
prerank,GO_Biological_Process_2021__excitatory chemical synaptic transmission (GO:0098976),-0.8026832139497095,-1.2483886096900325,0.18333333333333332,0.8727843162854686,1.0,4/7,17.68%,GRIN2D;GRIN2A;GRIN2B;PDLIM4
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),-0.6245808707710638,-1.2482607612237961,0.1527777777777778,0.8719101425159023,1.0,7/30,18.57%,SCN1B;CAV3;YWHAH;CHRM3;SCN3B;PDZK1;FGF12
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),0.6249756647657906,1.248243663978095,0.20588235294117646,0.9735309761764788,1.0,4/15,15.50%,ADAMTS9;STT3B;FBXO27;ADAMTS12
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),0.6122667603401946,1.248216612327517,0.21875,0.9715438782846839,1.0,7/15,22.39%,ADAT1;THG1L;KARS1;YARS2;TRPT1;FARS2;POP1
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),-0.7204281061170349,-1.2481442037114088,0.2318840579710145,0.8711109642986505,1.0,2/10,4.59%,KCNQ1;KCNJ2
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",0.6682898381534262,1.2480953742942384,0.2682926829268293,0.9699035685768688,1.0,1/8,3.52%,DERL2
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),0.4101008243081966,1.247521234880542,0.0625,0.9702623436039688,1.0,64/176,25.46%,SPSB4;RNF6;FBXO45;KLHL8;FEM1C;SPSB2;RNF150;ELOC;WDR91;PSMD11;PLK1;KEAP1;FBXL14;ANAPC1;BTRC;RNF146;RNF14;UBE2G1;FBXO8;PSMD14;UBE2D1;RCHY1;RNF114;RNF11;FBXO10;UBE4A;NDFIP1;RC3H1;UBE3B;CDC26;FBXO21;CNOT4;KCTD21;CDC34;RNF217;RNF34;MDM2;UBQLN4;RC3H2;NEDD4L;MIB1;UBL7;RNF20;RNF130;RNF166;BUB3;UBE2A;NUB1;TRIP12;RLIM;ITCH;FBXL7;PSMF1;UBQLN1;FEM1A;RNF13;UBE3C;ANKIB1;PSMC2;UBE2L5;ARRB1;RNF168;KLHL15;UBR3
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),-0.5718072278339482,-1.2473599573439145,0.18309859154929578,0.874325643381671,1.0,9/56,12.79%,CACNA1H;NR4A3;LMO2;RAMP3;AKR1C1;ATP1A1;GATA1;PAX8;CTSS
prerank,GO_Biological_Process_2021__positive regulation of cell activation (GO:0050867),-0.7825643500826852,-1.2473480514819182,0.1896551724137931,0.8728505141938198,1.0,3/6,16.89%,RPS6KA1;SOX15;SELP
prerank,GO_Biological_Process_2021__tRNA 5'-leader removal (GO:0001682),0.7370419216303891,1.2472222514314302,0.23333333333333334,0.9693966014013715,1.0,3/10,14.32%,RPP40;RPP14;RPP25L
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),0.48713443521548594,1.247065611486673,0.1,0.9678941559709617,1.0,4/26,8.24%,NAF1;PPP1R10;MAP3K4;SIRT6
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),-0.5266914273427783,-1.2467253932100901,0.11904761904761904,0.8757360865922365,1.0,25/123,20.19%,S100A10;PKP2;MRAP2;FYB1;ANK3;RAMP3;TESC;KCNB1;ZDHHC22;RAB11A;CAV3;ABCA12;ATP1B1;FYB2;EMP2;KCNB2;PLEKHF1;SCN3B;PDZK1;TNFRSF1A;RAB3C;TSPAN32;FLOT1;ANK1;KCNIP4
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),-0.5785198276294452,-1.2466925271974028,0.18055555555555555,0.8743923039344056,1.0,5/24,17.22%,OGN;OMD;ST3GAL6;B3GNT2;CHST6
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),-0.5513776054172752,-1.2466335740159777,0.14285714285714285,0.8733101045771673,1.0,19/62,17.72%,GBP2;TLR2;HLA-A;SFTPD;COLEC12;IL12A;NOD1;ISG15;TLR3;TNFRSF14;SYK;ROMO1;HLA-E;LYG1;DEFB109B;GBP7;SELP;PRKCD;SLC11A1
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),-0.7560620835461769,-1.2464252349664415,0.15384615384615385,0.8730013470893301,1.0,2/13,0.89%,CCBE1;HPN
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),-0.6437888262384237,-1.2463540843001526,0.1506849315068493,0.8719251534002668,1.0,9/24,16.37%,B2M;HLA-A;IL12A;HLA-DRA;HLA-B;HLA-E;CD55;HLA-F;FADD
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),-0.7006813904274591,-1.2461572229183704,0.16129032258064516,0.8716766011512231,1.0,4/15,10.13%,P2RY6;DUOX1;TRPC3;STAT1
prerank,PanglaoDB_Augmented_2021__Reticulocytes,0.4453308105872651,1.24600995111775,0.0,0.970446398108609,1.0,26/92,23.49%,ABCB10;RFWD3;RCC2;UCP3;XPO1;UGGT1;STT3B;NDC1;GANAB;DDX21;BRPF1;NUP188;ZDHHC5;NUP85;NUP205;DCAF1;URB2;DHX15;CNOT1;UBAP2L;NUP153;CHD4;NEMP1;RUVBL1;NSUN2;NEU3
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,-0.5106970895156536,-1.2455830705178004,0.14942528735632185,0.8734996303516661,1.0,50/147,20.13%,GGT5;S100A10;COL4A1;APOLD1;APLNR;ANGPTL2;TGFBR2;SPARC;C1R;ICAM1;RAMP3;PDPN;ABCA8;PROX1;USHBP1;PODXL;COX7A1;CASZ1;PODN;F8;RASL12;LDB2;HEXIM1;CYP1B1;BGN;CLIC4;LMOD1;ADIRF;IGFBP7;EMP1;CD9;CD55;RNASE1;CFH;BMX;PCDH12;PRKCH;MFSD2A;EGFL7;PROCR;SRGN;C1S;APLN;MCAM;TNS2;A2M;AQP1;MMRN2;ROBO4;PLEC
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),-0.7462856200677268,-1.245286285535557,0.19672131147540983,0.8737448444580871,1.0,3/11,10.54%,THBS1;RHOBTB2;XKR4
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,-0.5617341202546707,-1.2449887899804304,0.14473684210526316,0.874300218622013,1.0,25/59,22.44%,MYO1F;GPR183;SERPINF1;TAGAP;DOCK8;SLA;BST2;P2RY10;ARHGAP9;WAS;HLA-DRA;IRF7;CTSS;IL3RA;CD4;PTPRC;SLC15A4;PSTPIP1;BLNK;CD37;NAPSB;BCL11A;SPI1;ETV6;WDFY4
prerank,GO_Biological_Process_2021__regulation of microvillus organization (GO:0032530),-0.7886830069509094,-1.244335335138396,0.1935483870967742,0.876899959147842,1.0,3/7,8.36%,FSCN1;PODXL;PLD1
prerank,PanglaoDB_Augmented_2021__Ciliated Cells,-0.5808493227075624,-1.2442943235810715,0.15384615384615385,0.8757435141032568,1.0,19/57,19.25%,TEKT2;RSPH4A;C1ORF87;CFAP126;ECT2L;CCDC39;DCDC2B;TMEM212;ANKUB1;FAM81B;DRC1;CCDC181;DRC3;CFAP73;DNAH3;CXCL17;ARMC3;RSPH10B;AKAP14
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),-0.7518975356861423,-1.2442350051503894,0.171875,0.8746049951024147,1.0,4/9,17.71%,EFNA1;NELL1;DAB2IP;ANXA2
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),-0.6995174476388298,-1.2437821561178468,0.19047619047619047,0.8758713420471117,1.0,6/14,23.64%,TLR3;STAT1;IRF7;IFIH1;RIPK2;HSPD1
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),-0.5914044133103438,-1.2437564739022655,0.14102564102564102,0.8746102372210464,1.0,7/47,8.70%,CD24;FABP3;ABCA5;AKR1C1;ANGPTL3;CAV3;LDLR
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),-0.6867890315467827,-1.2431540974389206,0.18666666666666668,0.8768519974081047,1.0,2/13,9.21%,SP100;APOD
prerank,GO_Biological_Process_2021__tricuspid valve morphogenesis (GO:0003186),-0.817489398734546,-1.2430456762617588,0.21666666666666667,0.8762361377221535,1.0,2/5,11.49%,TGFBR2;ZFPM1
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),-0.5114070129206313,-1.2427829611333727,0.043478260869565216,0.8762918386401686,1.0,18/202,10.39%,EPN1;TLCD2;MX1;A4GALT;ANK3;RPS27A;MYOF;SUN3;SH3GL2;TRIP10;CAV3;DYSF;WNT5A;LDLR;SYP;EGF;SYT1;SYNGR2
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.6829990576037344,-1.2427583072337813,0.1791044776119403,0.8749269742137847,1.0,3/22,3.69%,LEF1;POU4F1;TESC
prerank,MSigDB_Hallmark_2020__Myogenesis,-0.5105865980565542,-1.242593097402436,0.10989010989010989,0.874289535290253,1.0,27/141,18.85%,CACNA1H;APLNR;COL4A2;SPARC;FABP3;PTP4A3;COL6A2;APP;COX7A1;CAV3;SVIL;APOD;SYNGR2;MYH11;IGFBP7;GADD45B;MYH9;IGF1;TNNT1;AEBP1;ACHE;NOS1;AGRN;CDKN1A;TSC2;FDPS;SPHK1
prerank,GO_Biological_Process_2021__ubiquinone metabolic process (GO:0006743),0.6300131434643479,1.2422493198104787,0.21875,0.9864098543876737,1.0,7/14,23.74%,AIFM2;COQ3;COQ2;COQ9;PDSS2;UBIAD1;COQ6
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),-0.569036085967244,-1.242216268404281,0.13924050632911392,0.8749588624762246,1.0,5/53,12.96%,ECM2;P2RY12;IL12A;SYK;SFRP2
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),0.5224424656682147,1.2418919019951278,0.06451612903225806,0.9857279633343634,1.0,14/35,23.01%,NR1D1;ALDH1A1;ID1;NOVA1;PGAM5;LGR4;ABHD6;PCTP;LAMA4;LNPEP;PLCL1;ZNF423;RBPJ;TFE3
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),-0.6476031565960453,-1.241590404653482,0.19047619047619047,0.8771779266330566,1.0,3/17,10.13%,SOCS3;ST18;STAT1
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),-0.7415318732296199,-1.2414214758101352,0.15873015873015872,0.8767612731383576,1.0,2/8,6.49%,GRIN3A;APP
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),0.5449501902942582,1.2412777450524275,0.25,0.986530516143562,1.0,9/18,21.78%,NUDT21;HSF1;CPSF6;CPSF7;ZC3H14;CPEB3;VIRMA;RNF20;CCNT1
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),-0.7180136882234376,-1.240612083655929,0.25396825396825395,0.8802131116741957,1.0,4/10,23.46%,YBX3;BIRC3;NUPR1;CASP8
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),-0.525159402128928,-1.2399937048374003,0.11764705882352941,0.8825367778757877,1.0,4/79,5.54%,CD24;LEF1;RPS27A;WNT8B
prerank,GO_Biological_Process_2021__triglyceride catabolic process (GO:0019433),-0.7160769224338215,-1.239810981672789,0.17567567567567569,0.8821134105073004,1.0,4/11,21.07%,FABP3;LIPI;LIPH;PNPLA3
prerank,GO_Biological_Process_2021__negative regulation of bone remodeling (GO:0046851),0.6938533808208733,1.2396287038059055,0.2702702702702703,0.9911002459439138,1.0,2/7,4.53%,GREM1;TNFAIP3
prerank,GO_Biological_Process_2021__inner ear receptor cell development (GO:0060119),0.7088363934454156,1.2391097642470996,0.2647058823529412,0.9911348833240115,1.0,1/7,6.62%,SLC4A7
prerank,PanglaoDB_Augmented_2021__T Cells,-0.5688499687764017,-1.2390446469804517,0.20512820512820512,0.8849898819020352,1.0,11/55,8.92%,LEF1;CD5;TAGAP;SKAP1;CD160;MAFF;GPR171;THY1;P2RY10;IFIT3;ARHGAP9
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),0.6902626873122367,1.2389997081374662,0.23076923076923078,0.9895776344072025,1.0,2/9,4.47%,EFNB2;GREM1
prerank,GO_Biological_Process_2021__antiviral innate immune response (GO:0140374),-0.7541534632519213,-1.2389302386962264,0.28125,0.8842483109474107,1.0,2/10,3.47%,MX1;IFIT1
prerank,GO_Biological_Process_2021__T cell mediated cytotoxicity (GO:0001913),-0.8197011366612494,-1.2388925308243834,0.16923076923076924,0.883029690867509,1.0,2/5,12.41%,HLA-A;EMP2
prerank,GO_Biological_Process_2021__regulation of mitotic spindle checkpoint (GO:1903504),-0.8141670962074539,-1.238863128264291,0.18333333333333332,0.8803721750975898,1.0,3/6,16.12%,DUSP1;CCNB1;ANAPC15
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid segregation (GO:0033047),-0.8141670962074539,-1.238863128264291,0.18333333333333332,0.8803721750975898,1.0,3/6,16.12%,DUSP1;CCNB1;ANAPC15
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),0.5123284488629805,1.2387681032215847,0.15,0.9882669780482479,1.0,7/30,13.91%,TNFAIP3;USP13;BRCC3;OTUB2;USP27X;PSMD14;SPATA2
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029),0.785592197513193,1.2386238915110124,0.1836734693877551,0.986722877270141,1.0,2/5,16.08%,HSPA1A;SLC25A5
prerank,GO_Biological_Process_2021__artery development (GO:0060840),-0.6344571184098482,-1.2382910020204818,0.1746031746031746,0.8826556316924709,1.0,2/18,8.02%,APLNR;ANGPTL3
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),-0.49101785982120655,-1.2381650496776884,0.0851063829787234,0.8818829907453485,1.0,36/202,21.26%,ENPP2;LEF1;THBS1;SHTN1;LAMB1;PDPN;GPNMB;RAB11A;PODXL;CEMIP;SEMA3B;ANGPTL3;MMP14;EGF;VIL1;FN1;DAB2IP;FGF1;PLET1;F10;DMTN;IGF1;DDRGK1;MGAT5;SEMA3E;PTPRC;SPHK1;RHOD;TGFB1;HYAL1;PIK3CD;SEMA4G;NUMB;FERMT3;GPER1;F3
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),-0.5857462987368806,-1.2381268692883154,0.11538461538461539,0.8806916016827282,1.0,1/40,0.03%,CACNA1H
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.648053532641852,1.2378463852260897,0.34782608695652173,0.9873635127373744,1.0,3/11,8.87%,RPP40;RCL1;TBL3
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),-0.6950976867404431,-1.2378235862596259,0.1388888888888889,0.8807250365948177,1.0,1/12,2.35%,TYMP
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),-0.6416589954614856,-1.2369491272597957,0.2054794520547945,0.8846186065750402,1.0,6/12,27.31%,ANGPTL3;IL18;MTLN;PNPLA8;GCKR;SCARB1
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.6520242504838552,1.2363974077323505,0.2647058823529412,0.9916928043145968,1.0,4/14,14.48%,SMARCAD1;SIRT6;ELK4;HDAC2
prerank,GO_Biological_Process_2021__regulation of neutrophil migration (GO:1902622),0.7380480291206636,1.2363182590364425,0.28205128205128205,0.9898245845547184,1.0,1/6,15.14%,MPP1
prerank,GO_Biological_Process_2021__Cdc42 protein signal transduction (GO:0032488),-0.8262305828229757,-1.2353310577903294,0.11666666666666667,0.8926647517957783,1.0,2/6,9.59%,SHTN1;WAS
prerank,GO_Biological_Process_2021__urogenital system development (GO:0001655),-0.7928421886348596,-1.2351264610731925,0.2,0.8925438252399522,1.0,1/6,0.21%,ANXA1
prerank,GO_Biological_Process_2021__microtubule depolymerization (GO:0007019),-0.69294297452794,-1.2349898628081166,0.2328767123287671,0.8921402120293085,1.0,5/14,16.97%,STMN2;KIF14;STMN4;KIF2C;STMN1
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),0.5072259140413549,1.2348865169320622,0.12,0.9937739688549908,1.0,5/34,16.28%,WNT7A;TMEM106B;TAOK2;WASL;MAP6
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503)",0.7725551605538178,1.2348199659697996,0.20930232558139536,0.9918797718332654,1.0,2/5,16.31%,PDE12;TOE1
prerank,GO_Biological_Process_2021__regulation of mesenchymal cell proliferation (GO:0010464),-0.7249808148294881,-1.2346105225795532,0.22950819672131148,0.8930164138141206,1.0,3/9,10.13%,TGFBR2;WNT5A;STAT1
prerank,GO_Biological_Process_2021__vesicle tethering to Golgi (GO:0099041),0.7483296213808464,1.2346076751864277,0.32,0.9907906039018374,1.0,5/5,25.19%,C17ORF75;TBC1D23;TRIP11;WDR11;FAM91A1
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),-0.6439616245793299,-1.2343989946737914,0.19718309859154928,0.8928283214960684,1.0,2/18,4.75%,PIF1;CENPV
prerank,GO_Biological_Process_2021__positive regulation of autophagosome maturation (GO:1901098),0.7062487126996038,1.2343064560579997,0.36666666666666664,0.9897061509830996,1.0,2/6,21.88%,ADRB2;FYCO1
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),-0.5402034805331337,-1.2342062589603586,0.12048192771084337,0.892654243500865,1.0,9/81,10.97%,CACNA1H;GRIN3A;RAMP3;CDH23;SLC8A3;SLC24A2;TRPC3;SLC24A1;SLC24A5
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),0.5201036734448606,1.2341953810676412,0.25,0.9880093174635581,1.0,10/28,13.61%,ABCD2;ELOVL4;ELOVL6;ABCD1;ELOVL2;ABCD3;HACD2;CYP4F12;PEX2;ACOX1
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),0.5277402364897474,1.2341893881896449,0.13793103448275862,0.985938628483805,1.0,2/21,5.15%,PIK3R4;TRIM24
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",0.6743367336282788,1.2341200560422667,0.2903225806451613,0.9841694223691049,1.0,1/6,1.86%,RPP40
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,-0.5232506325271356,-1.2340982524510853,0.13924050632911392,0.8918645961746484,1.0,32/97,19.63%,CDH22;CCK;PCSK2;KCNQ1;PROX1;KCNB1;ST18;SLC24A2;MYO15A;SRRM4;SYP;MOG;TCEAL6;MOBP;SLC7A14;XKR4;UNC13C;CPLX2;SCN1A;STMN4;GAD2;SYNPR;SCN3B;CNTN2;SGSM1;CNDP1;CNTNAP5;SLC4A10;GABRA1;TAS1R1;SV2B;PRKCB
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.5814923889575125,-1.23405194576371,0.21686746987951808,0.8907297650892487,1.0,6/38,9.78%,IFI6;THBS1;DHCR24;CD44;RPS6KA1;KLF4
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),-0.599587793788424,-1.2338993618210843,0.16666666666666666,0.8901859978820462,1.0,3/29,3.97%,APLNR;TGFBR2;PROX1
prerank,GO_Biological_Process_2021__peroxisome fission (GO:0016559),0.7243745135299071,1.2332530272483828,0.3023255813953488,0.9857652209466101,1.0,2/7,6.78%,PEX11A;MFF
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),0.6411426531802147,1.2331767607366177,0.22580645161290322,0.9839748306870226,1.0,2/18,1.15%,MTHFS;SLC19A1
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),-0.7191231833319862,-1.232995945760484,0.19444444444444445,0.8944162331350747,1.0,4/13,14.50%,ANXA1;RIMS2;LTBP4;VIP
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),-0.6209096865934395,-1.2326177420175426,0.24324324324324326,0.8949863444679355,1.0,1/26,0.14%,ST6GAL1
prerank,GO_Biological_Process_2021__positive regulation of protein glycosylation (GO:0060050),-0.7870656591692726,-1.2323654326494964,0.12903225806451613,0.895209160397636,1.0,1/6,9.68%,SLC51B
prerank,GO_Biological_Process_2021__macromolecule biosynthetic process (GO:0009059),-0.8052785911662619,-1.2322205363066756,0.20588235294117646,0.8943964159798203,1.0,3/5,17.72%,COL5A1;RPS23;SLC11A1
prerank,PanglaoDB_Augmented_2021__Platelets,-0.515079534455845,-1.2322029982476954,0.11764705882352941,0.893016625420459,1.0,22/91,17.65%,THBS1;P2RY13;MYO1F;RASGRP2;SPARC;P2RY12;HLA-A;ITGA2;ADGRE5;ALOX12;TUBB1;NRGN;F5;CLEC12A;CTSS;HLA-E;CD9;LTBR;ABCC4;SELP;PRKCD;SRGN
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),-0.5000036194258006,-1.2321232461962202,0.053763440860215055,0.8921040686681203,1.0,45/210,19.92%,ANXA1;CCBE1;RASGRP1;IL1R1;C3;RFTN1;TLR2;HLA-A;IRF1;SULF1;HTR2B;IL12A;IL15;APP;NOD1;ISG15;WNT5A;CYP1B1;BRCA1;TLR3;CHI3L1;TNFRSF14;ZFPM1;PRKCQ;IRF7;SYK;BTN3A1;HLA-E;SCIMP;IL7;IFIH1;HHLA2;IL18;FADD;CD200;SLC11A1;CXCL17;CD4;PTPRC;SPHK1;TGFB1;FLOT1;CD74;RIPK2;PIK3CD
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),-0.7352133633823021,-1.2319766510440897,0.16176470588235295,0.8916697537301586,1.0,2/9,6.66%,IL12A;BST2
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),-0.6234955194989957,-1.2319362280975037,0.234375,0.8905643954653004,1.0,1/27,0.16%,LEF1
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),0.6322154213889271,1.2319125503564257,0.2619047619047619,0.9870758715654606,1.0,2/9,10.73%,RTRAF;RBFOX1
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.5613976772797917,1.2319017270032833,0.23333333333333334,0.9850872647214322,1.0,5/26,19.05%,PUS10;PRKRA;DROSHA;AGO3;PUM2
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),-0.6290080118669569,-1.2315964859235835,0.19753086419753085,0.8913054186572371,1.0,4/26,6.95%,C3;SFTPD;IL15;CCL2
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),0.5342604565051705,1.2315235089033858,0.2,0.9846412800719283,1.0,14/44,17.64%,SAMM50;DMAC2L;MAIP1;LETM1;CHCHD3;TMEM11;OPA1;ATP5PB;DNAJC11;APOOL;ATP5MC2;ATP5MC1;MTX2;ATP5F1A
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),-0.6003923849369638,-1.2312363519179106,0.22784810126582278,0.8920572729938372,1.0,10/30,20.30%,SCN1B;KCNQ1;RCSD1;ATP1B1;PVALEF;TNNT1;SCN3B;NOS1;STAC2;RYR2
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),-0.6159228555412798,-1.231144751908219,0.20270270270270271,0.8911795632141065,1.0,8/27,19.78%,TLR2;IRF1;ISG15;TLR3;IRF7;IFIH1;FLOT1;RIPK2
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),-0.57757506051556,-1.2308965047873077,0.14814814814814814,0.8913003619695964,1.0,7/45,13.83%,THBS1;NR4A3;TESC;GATA1;ZFPM1;PRKCQ;THPO
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),-0.5425410623510363,-1.2308956504357311,0.1511627906976744,0.8899294371996327,1.0,16/61,21.97%,EFNA1;LAMB1;PROX1;KIF14;POF1B;ATRNL1;ITGA8;TMEFF2;FN1;RADIL;RELN;ANTXR1;MICALL2;FERMT3;LAMA5;SPI1
prerank,GO_Biological_Process_2021__negative regulation of keratinocyte proliferation (GO:0010839),0.7699953533475639,1.2308259809381048,0.1724137931034483,0.985468127371843,1.0,2/5,15.01%,PTPRK;CASK
prerank,GO_Biological_Process_2021__dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),0.7318228998169017,1.2308147769177564,0.32653061224489793,0.9834090949312863,1.0,4/5,26.51%,RPRD1B;CTDP1;SSU72;RPAP2
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",-0.7625531784727629,-1.2304099075309898,0.29850746268656714,0.8913579716757473,1.0,3/7,12.99%,HLA-A;IRF1;HLA-E
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),0.5794264134437516,1.230065310513382,0.17647058823529413,0.9846089677938187,1.0,4/13,23.16%,LPIN3;CEPT1;ETNPPL;CHKA
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),-0.6193828805471815,-1.2300166660642666,0.2702702702702703,0.8921169668566374,1.0,1/27,0.14%,ST6GAL1
prerank,GO_Biological_Process_2021__dendritic cell chemotaxis (GO:0002407),-0.810385325059142,-1.2298664011630993,0.2413793103448276,0.8914282465616329,1.0,1/5,1.68%,GPR183
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),-0.6368628191185928,-1.2297479964516975,0.2345679012345679,0.8907286506963766,1.0,4/17,15.63%,ANK3;TMC8;FAM20A;CIB2
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),-0.5847301030787985,-1.2296542248107405,0.16666666666666666,0.8898884173588363,1.0,8/31,14.90%,SERPINA10;TIMP2;SERPINF1;SPOCK3;TIMP1;SERPIND1;SERPINE3;SERPING1
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),0.579217923258451,1.2296131778690391,0.16666666666666666,0.9842825643621244,1.0,3/16,12.88%,SLC6A13;SLC25A18;SLC6A1
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",0.570357521232283,1.2293225162495793,0.18518518518518517,0.9834419843602002,1.0,8/20,25.83%,DNASE1L2;HMGB1;CASP3;EXOG;DFFB;FBH1;DNASE1L1;ENDOG
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),-0.5955481573625963,-1.2292088692616312,0.11538461538461539,0.8911245687670712,1.0,5/32,10.13%,THBS1;P2RY6;NR4A3;IGFBP5;STAT1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748),-0.7857742759445969,-1.228966746954728,0.2,0.8910757301537965,1.0,1/5,0.30%,CCBE1
prerank,GO_Biological_Process_2021__inhibitory synapse assembly (GO:1904862),-0.7322105761436701,-1.2288912771694986,0.19696969696969696,0.8901096157110803,1.0,4/8,18.91%,WNT5A;GABRB2;GABRG2;GABRA1
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),0.562494212005213,1.2285621111672582,0.17142857142857143,0.9846342259033705,1.0,3/14,11.88%,PGM2;AGL;PYGM
prerank,GO_Biological_Process_2021__regulation of triglyceride metabolic process (GO:0090207),-0.8245817381285825,-1.2285578437198208,0.1206896551724138,0.8906043523734998,1.0,1/5,0.71%,C3
prerank,GO_Biological_Process_2021__cellular lipid biosynthetic process (GO:0097384),0.7297228765853621,1.228299706957097,0.2894736842105263,0.981709819619296,1.0,3/5,26.05%,GNPAT;AGPS;FAR1
prerank,GO_Biological_Process_2021__glycerol ether biosynthetic process (GO:0046504),0.7297228765853621,1.228299706957097,0.2894736842105263,0.981709819619296,1.0,3/5,26.05%,GNPAT;AGPS;FAR1
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.6746517041964675,-1.2282892324168906,0.208955223880597,0.8908012907088187,1.0,4/13,9.29%,KCNQ1;KCNJ2;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),-0.5948518595879446,-1.2281505975792262,0.1111111111111111,0.8902516139857801,1.0,6/29,15.00%,CENPV;CENPH;CENPE;MIS18A;CENPN;CENPU
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),0.6149150280621508,1.2281032348204288,0.2727272727272727,0.9805407997000487,1.0,3/12,8.24%,LIG4;PPP1R10;SIRT6
prerank,GO_Biological_Process_2021__pericardium development (GO:0060039),0.7136325464641916,1.2279537384952908,0.16216216216216217,0.9792349338697459,1.0,1/6,2.60%,BMP2
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),-0.5533986978063012,-1.2279422475757216,0.25333333333333335,0.8901145794533847,1.0,13/54,16.98%,MET;ARHGEF3;EPS8L2;P2RY10;GPR18;LPAR4;SYNPO2L;LPAR6;RIT2;ARHGEF18;ITGA3;STMN1;DLC1
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),0.7104816178034297,1.2278800539055217,0.23076923076923078,0.9775385156811359,1.0,3/7,19.12%,SOX9;SOX5;BMPR1B
prerank,GO_Biological_Process_2021__acute-phase response (GO:0006953),-0.7806536944523237,-1.2278200135855746,0.16129032258064516,0.8895804443967305,1.0,2/6,11.87%,PLSCR1;SIGIRR
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide biosynthetic process (GO:0045019),0.7152881478503252,1.227629617844763,0.2564102564102564,0.9744202586993463,1.0,4/6,27.24%,PTGIS;SIRPA;ROCK2;KHSRP
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide metabolic process (GO:1904406),0.7152881478503252,1.227629617844763,0.2564102564102564,0.9744202586993463,1.0,4/6,27.24%,PTGIS;SIRPA;ROCK2;KHSRP
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),-0.5754865316472252,-1.2275274102898146,0.18309859154929578,0.8896625086646005,1.0,2/32,6.46%,MET;SEMA3B
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),0.6090589714492589,1.2274570260560862,0.23333333333333334,0.9731659400172893,1.0,4/12,19.08%,WDR82;KMT2A;TET3;BEND3
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),0.3810909624924651,1.2272270022852196,0.1,0.9719167937834058,1.0,63/162,30.17%,U2AF1;PPARGC1A;SNRPF;SF3B4;SF3A1;NUDT21;HNRNPC;NUFIP1;RP9;NOVA1;FASTKD2;CSTF3;DROSHA;CPSF6;TFIP11;TSEN2;RNASEL;LSM5;SYNCRIP;HNRNPU;MTPAP;TENT4A;SNRPN;THOC1;DHX15;CDK12;TENT4B;DKC1;CCAR2;RNGTT;NOL9;MBNL1;PDCD7;HNRNPD;ADARB1;RBM39;USB1;YJU2;MAGOH;SNRNP48;SNRPB;SCAF11;ZCCHC8;PRPF18;LSM1;CLP1;KHSRP;HNRNPH1;SRPK2;SCNM1;SRSF9;TENT2;DHX16;SNRNP35;KIN;PRKACA;CELF1;M1AP;PTBP1;MAGOHB;SNRNP40;SRSF2;LSM6
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle cell differentiation (GO:2000726),0.8175039941196338,1.2272076031599157,0.2857142857142857,0.9700009453317673,1.0,1/5,2.60%,BMP2
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.5448719542488775,-1.2269605846014437,0.1511627906976744,0.8911378053661282,1.0,10/61,12.51%,IFI6;THBS1;DHCR24;CD44;NOD1;RPS6KA1;KLF4;NLRP12;SYK;NLRP2
prerank,GO_Biological_Process_2021__calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.7008386604698389,-1.2268412224456122,0.25806451612903225,0.890310955986229,1.0,7/11,25.59%,SYT1;RIMS2;UNC13C;SYT2;SYT5;DOC2B;RIMS1
prerank,GO_Biological_Process_2021__serine family amino acid biosynthetic process (GO:0009070),0.6600583476549426,1.2264571625542606,0.25,0.9711100491660389,1.0,6/11,22.42%,CTH;SEPHS1;PSPH;SRR;SERINC5;PHGDH
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.5701886422112262,1.225900114341742,0.3103448275862069,0.9710715799669937,1.0,6/13,15.50%,SOX8;PEF1;KLHL12;CDH2;TAPT1;FBXL17
prerank,GO_Biological_Process_2021__glial cell migration (GO:0008347),-0.8421870152607374,-1.225481914428,0.1346153846153846,0.8969809932102628,1.0,3/5,13.58%,P2RY12;CCL2;CD9
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),-0.70417679485921,-1.2251042696289303,0.19444444444444445,0.8977513290043104,1.0,3/12,15.51%,NR4A3;IGFBP5;IGF1
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.6542240186955766,-1.2248703472701197,0.13580246913580246,0.8977187934428427,1.0,6/24,18.16%,EFNA1;CTSC;ATP5IF1;PINK1;RHBDF1;PSME1
prerank,GO_Biological_Process_2021__DNA strand elongation (GO:0022616),0.6070001380122809,1.224775203618355,0.3103448275862069,0.9736763304083486,1.0,3/15,11.40%,POLD3;RFC3;DCLRE1B
prerank,GO_Biological_Process_2021__membrane raft assembly (GO:0001765),-0.8271099726636814,-1.224603001536749,0.19672131147540983,0.8979528031878447,1.0,2/6,1.49%,S100A10;RFTN1
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),-0.7077738719208635,-1.224570637284899,0.2698412698412698,0.8968432070810162,1.0,5/9,22.35%,PLSCR1;CD200;CD74;GPER1;MYO18A
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),-0.6641847130767504,-1.2245279518966439,0.18181818181818182,0.895800192419801,1.0,3/15,3.36%,GBP1;ZFP36;SFTPD
prerank,GO_Biological_Process_2021__pentose metabolic process (GO:0019321),0.7347531806116556,1.2244616159469188,0.3142857142857143,0.9729386576816095,1.0,2/6,10.01%,DCXR;FGGY
prerank,PanglaoDB_Augmented_2021__Interneurons,-0.4693125390233346,-1.223991053470717,0.07777777777777778,0.8975896267760266,1.0,68/265,19.63%,GRIN2D;ZIC4;NPY;TAGLN3;CDH22;CCK;PCSK2;L1CAM;STMN2;NRN1;NEFM;RAMP3;TCEAL3;SNCB;ZDHHC22;SH3GL2;SLITRK1;SPOCK3;SYT4;LRRTM1;ELAVL4;VLDLR;NRGN;PDE4A;SYP;GAP43;HAP1;SYT1;TCEAL6;CPLX1;SST;IGSF21;NCALD;CALN1;HPCA;RIT2;CA10;CPLX2;SHISA8;PRKCG;TCEAL2;PLPPR5;TMEM163;EID2;GAD1;SHISA9;C11ORF87;STMN4;VIP;GDAP1L1;GAD2;SYNPR;ELMO1;NOS1;RGS7BP;CNTN2;PRKCD;KCNC1;GABRG2;RGS17;TCEAL5;FGF12;SEMA3E;RAB3C;CACNB1;RELN;SV2B;PRKCB
prerank,GO_Biological_Process_2021__regulation of glial cell proliferation (GO:0060251),-0.7799598686957457,-1.2239010484841575,0.2641509433962264,0.8968134693333749,1.0,3/5,21.86%,CHRM1;PRKCH;HES1
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),-0.5267617308135765,-1.2234839114931946,0.12048192771084337,0.8977019266138926,1.0,23/86,19.51%,HPN;LRRC55;KCNQ1;KCNV1;KCNB1;KCNJ13;KCNJ2;KCNK1;SLC24A2;KCNH8;SLC9A2;SLC24A1;KCNG1;KCNB2;KCNAB3;KCNV2;KCNC1;KCNK10;KCNK12;KCNH7;SLC9A5;KCNMB4;AQP1
prerank,GO_Biological_Process_2021__sulfate transport (GO:0008272),0.6762185107658152,1.223389203811571,0.17073170731707318,0.9757229542113675,1.0,1/12,0.56%,SLC26A7
prerank,GO_Biological_Process_2021__ISG15-protein conjugation (GO:0032020),-0.8094404249800595,-1.2232402537043838,0.22033898305084745,0.8978081224890871,1.0,2/6,11.70%,ISG15;HERC5
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.5131095452918455,1.2231912224198964,0.14285714285714285,0.974845860030371,1.0,14/28,26.74%,EXOSC1;DCP1B;EXOSC6;DIS3;EDC3;LSM7;LSM5;PATL1;CNOT8;EXOSC8;DCP1A;EXOSC5;LSM1;DDX6
prerank,GO_Biological_Process_2021__negative regulation of cell division (GO:0051782),-0.7833679989858721,-1.2229240116598676,0.2028985507246377,0.8982153363239856,1.0,1/6,0.78%,BLM
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),-0.5669852803882212,-1.2225627119652787,0.15584415584415584,0.898709096651624,1.0,8/41,15.94%,RPL3;RPS27;RPS14;RPL24;RPL10;RPS15;RPL5;MRPL20
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),0.59847763060513,1.2219567329651475,0.1875,0.9779461443689323,1.0,5/13,7.35%,ABCD2;PLIN5;AKT2;ABCD1;ABHD5
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),-0.48945496393856663,-1.221775428013426,0.06896551724137931,0.9017926759580651,1.0,35/186,18.26%,CACNA1H;HPN;SCN1B;SLC6A15;LRRC55;KCNQ1;KCNV1;KCNB1;KCNJ2;SLC39A14;KCNK1;SLC8A3;SLC4A11;SLC24A2;SCN9A;TRPC3;ATP1A1;KCNH8;ATP1B1;SLC9A2;SLC24A1;SLC24A5;KCNG1;SCN2A;SCN1A;KCNB2;CACNA1C;KCNAB3;KCNV2;SCN3B;SLC11A1;KCNC1;KCNK10;KCNK12;KCNH7
prerank,GO_Biological_Process_2021__positive regulation of inositol phosphate biosynthetic process (GO:0060732),-0.7878790321277065,-1.221656622186628,0.21311475409836064,0.901029691669103,1.0,4/5,20.91%,P2RY6;HRH1;PTH1R;GPER1
prerank,GO_Biological_Process_2021__negative regulation of neuron projection regeneration (GO:0070571),-0.7676343305405916,-1.22154944672953,0.2,0.9002814492744979,1.0,1/7,7.01%,THY1
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),0.6153765551957777,1.2211941980279453,0.25,0.9791886894313359,1.0,2/10,10.04%,INSC;MAL
prerank,GO_Biological_Process_2021__cellular cation homeostasis (GO:0030003),-0.8290068790697653,-1.2211073855430243,0.14035087719298245,0.9011929646163089,1.0,3/6,5.85%,CLDN16;SLC4A11;LETM2
prerank,GO_Biological_Process_2021__regulation of fertilization (GO:0080154),0.7366206228286245,1.2206527181635396,0.325,0.9793818040363091,1.0,2/5,6.23%,INTS13;LHFPL2
prerank,GO_Biological_Process_2021__regulation of plasminogen activation (GO:0010755),-0.7348089159601847,-1.2204197124230909,0.2537313432835821,0.9035079962241236,1.0,2/10,0.89%,THBS1;HPN
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),-0.6131129837886007,-1.2200379004363135,0.18309859154929578,0.9042505261542795,1.0,7/28,18.59%,THBS1;CDKN2A;APOD;PLET1;DMTN;DLC1;SEMA3E
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),-0.7472527188554648,-1.220008227771617,0.25,0.9017272494762418,1.0,1/8,2.03%,KCNQ1
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),-0.7472527188554648,-1.220008227771617,0.25,0.9017272494762418,1.0,1/8,2.03%,KCNQ1
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),-0.5891473381377043,-1.2198635814944798,0.1891891891891892,0.9012072574173113,1.0,6/36,17.71%,STAT4;IL12A;LMNB1;TCP1;CA1;ANXA2
prerank,GO_Biological_Process_2021__regulation of pseudopodium assembly (GO:0031272),-0.7920073105775485,-1.2197221990096372,0.1206896551724138,0.8992837207726831,1.0,2/6,12.08%,CDC42EP1;CDC42EP3
prerank,GO_Biological_Process_2021__positive regulation of pseudopodium assembly (GO:0031274),-0.7920073105775485,-1.2197221990096372,0.1206896551724138,0.8992837207726831,1.0,2/6,12.08%,CDC42EP1;CDC42EP3
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.689083080595785,-1.2195177966803783,0.1746031746031746,0.8989543363988041,1.0,7/15,16.37%,HLA-A;IL12A;HLA-DRA;HLA-B;HLA-E;HLA-F;FADD
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),0.5790747848837524,1.2184332253195522,0.20833333333333334,0.9869525579985378,1.0,5/15,13.72%,DUSP19;MAP3K4;SASH1;TAOK3;DVL2
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),-0.4883163218948909,-1.2183533396907689,0.08695652173913043,0.9039390786491012,1.0,34/275,14.59%,LEF1;PRAME;ANXA1;IFI6;THBS1;APIP;HPN;DHCR24;MET;POU4F1;RPS27A;NAA38;CD44;PDPN;KIF14;PRDX5;PLK2;HTR2B;SCX;RPS6KA1;IFIT3;WNT5A;PIM3;NUAK2;PLK3;GATA1;RPS3A;UBC;BIRC3;RPL10;PIM1;THOC6;VIP;IL7
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.736205821478693,-1.2183458290409055,0.16071428571428573,0.902670507456394,1.0,5/9,23.52%,SP100;FOXM1;TFAP4;RPS6KA6;KAT5
prerank,GO_Biological_Process_2021__short-chain fatty acid metabolic process (GO:0046459),-0.7387385456585294,-1.2180152077951556,0.16666666666666666,0.903110212461782,1.0,2/8,17.96%,ACOT4;OXSM
prerank,GO_Biological_Process_2021__cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),-0.789237330471665,-1.2178406646991085,0.28125,0.9013324061814815,1.0,1/5,2.43%,ZFP36
prerank,GO_Biological_Process_2021__response to granulocyte macrophage colony-stimulating factor (GO:0097012),-0.789237330471665,-1.2178406646991085,0.28125,0.9013324061814815,1.0,1/5,2.43%,ZFP36
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),-0.627972638547083,-1.2176869802824015,0.16393442622950818,0.9009052379524294,1.0,3/21,8.07%,NR4A3;MLIP;CAV3
prerank,GO_Biological_Process_2021__myelin maintenance (GO:0043217),0.7096563484398566,1.2176186569744163,0.20588235294117646,0.9881694812323359,1.0,2/9,7.04%,ABCD2;ABCD1
prerank,GO_Biological_Process_2021__regulation of transmission of nerve impulse (GO:0051969),-0.7811411893304323,-1.2174737263943225,0.3220338983050847,0.9009669940952699,1.0,3/5,18.57%,TYMP;GLRA1;FGF12
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.6712015935825839,-1.2174462713384426,0.23529411764705882,0.8998963357109513,1.0,2/12,7.76%,SOCS3;PARP14
prerank,GO_Biological_Process_2021__interleukin-2-mediated signaling pathway (GO:0038110),-0.7550227964310028,-1.2174107136420793,0.21311475409836064,0.897545764429738,1.0,1/7,12.20%,SYK
prerank,GO_Biological_Process_2021__cellular response to interleukin-2 (GO:0071352),-0.7550227964310028,-1.2174107136420793,0.21311475409836064,0.897545764429738,1.0,1/7,12.20%,SYK
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane potential (GO:0010918),0.7018463296075912,1.217396594547579,0.21212121212121213,0.987196004705512,1.0,4/6,12.45%,AKT2;AKT1;VCP;BAD
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),0.4873160689097076,1.217382076411006,0.15789473684210525,0.9852449201578638,1.0,8/54,12.10%,RNF6;UBE2T;KBTBD7;TNFAIP3;RNF146;UBE2G1;UBE2D1;FBXO38
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.6451199029036572,-1.2171026407086818,0.23809523809523808,0.8980483919582174,1.0,3/17,12.07%,SULT1C3;TPST1;PAPSS2
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,-0.589217288602494,-1.2168640732402818,0.2077922077922078,0.8979927629920782,1.0,16/41,18.59%,S100A10;IL1R1;GPR87;FOSL2;MAFF;PLEKHG6;KLF4;TMEM40;ADAM19;CD55;IL18;LTBR;IER3;ANXA2;MLANA;CD4
prerank,GO_Biological_Process_2021__negative regulation of appetite (GO:0032099),0.730728983496211,1.2162397555665438,0.24242424242424243,0.9883626312880044,1.0,3/6,19.89%,SPX;MKKS;BBS2
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),-0.5546174349224705,-1.2160806889113276,0.1625,0.9003184810133016,1.0,15/53,19.36%,NEFL;PSCA;GRIN2A;APP;GRIA3;GRIA1;SHISA8;MINK1;SHISA9;DLGAP3;GRIN2B;NPTX2;NLGN1;CAPN1;RELN
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.6367367392596752,1.2160294552256905,0.21212121212121213,0.9872859771520162,1.0,1/12,3.52%,DERL2
prerank,GO_Biological_Process_2021__secretory granule organization (GO:0033363),0.6962193348329567,1.2159847761227507,0.2558139534883721,0.9855360818258813,1.0,1/6,2.62%,ABCA1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),-0.550380404211907,-1.2158924514895026,0.13414634146341464,0.9000183605953247,1.0,6/67,9.23%,THBS1;MET;SPARC;PROX1;WNT5A;EGF
prerank,GO_Biological_Process_2021__cellular response to iron ion (GO:0071281),-0.8154288582945292,-1.2157321752183068,0.21311475409836064,0.8995503616355082,1.0,1/5,2.39%,B2M
prerank,PanglaoDB_Augmented_2021__B Cells Naive,-0.5662801690024122,-1.2156326996392857,0.17073170731707318,0.8987948491831311,1.0,17/57,15.01%,MYO1F;RASGRP2;P2RY14;STAG3;TAGAP;DOCK8;TMC8;P2RY10;GPR18;RCSD1;IL4R;ARHGAP9;WAS;ACAP1;CTSS;BIRC3;SP140
prerank,GO_Biological_Process_2021__snoRNA localization (GO:0048254),0.7095566937302613,1.2156215464200544,0.2894736842105263,0.9849561802454727,1.0,3/6,24.02%,ZNHIT3;FBL;ZNHIT6
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),-0.6700199775215514,-1.2155621838912438,0.22972972972972974,0.8978371815994902,1.0,2/12,3.97%,PKP2;PROX1
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),-0.5657253654933913,-1.2152612797706244,0.16666666666666666,0.8981543647382774,1.0,11/64,14.46%,THBS1;SP100;SPARC;PROX1;WNT5A;EGF;CEACAM1;SVBP;EMP2;DAB2IP;FGF1
prerank,GO_Biological_Process_2021__regulation of relaxation of cardiac muscle (GO:1901897),-0.7981524125002553,-1.215079829038638,0.234375,0.8978594572909474,1.0,1/5,7.82%,PLN
prerank,GO_Biological_Process_2021__melanocyte differentiation (GO:0030318),0.647229791622886,1.2149452080882057,0.1794871794871795,0.9855393081623043,1.0,2/8,4.85%,MITF;USP13
prerank,GO_Biological_Process_2021__protein geranylgeranylation (GO:0018344),0.7361563716098837,1.2148968626915178,0.16279069767441862,0.9836955060901336,1.0,1/5,9.41%,PGGT1B
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.5995713632628353,1.2148756472659266,0.1875,0.9818589917731889,1.0,2/13,12.33%,HUS1;RAD9B
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.5518910520052911,1.2146085548322032,0.18181818181818182,0.9810494123969483,1.0,6/25,8.01%,TRIB3;PLK1;DCUN1D2;UBE2N;DCUN1D1;BTRC
prerank,GO_Biological_Process_2021__aerobic respiration (GO:0009060),0.5662405234821759,1.2142612544608324,0.14285714285714285,0.9806982995975696,1.0,6/20,23.47%,UQCRHL;MTFR1;UQCRC2;SDHB;UQCRB;SLC25A14
prerank,GO_Biological_Process_2021__regulation of macrophage proliferation (GO:0120040),0.6811581321070945,1.2136730458856109,0.2702702702702703,0.9811504219425321,1.0,4/6,29.73%,CSF1R;PTK2;IL33;MAPK1
prerank,GO_Biological_Process_2021__negative regulation of cardiocyte differentiation (GO:1905208),0.8002223619039356,1.2134186147445072,0.15789473684210525,0.9801335852810507,1.0,2/6,5.95%,BMP2;EGFR
prerank,GO_Biological_Process_2021__regulation of vesicle fusion (GO:0031338),-0.7783775696905346,-1.213062721504072,0.26865671641791045,0.9074741131794881,1.0,1/8,0.21%,ANXA1
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),-0.7066245510967586,-1.2129520984577398,0.22857142857142856,0.906652969181229,1.0,2/11,14.80%,SRF;LRPAP1
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),0.637501698612965,1.212479590053781,0.1875,0.982075981860166,1.0,6/12,28.47%,NUDT21;RC3H1;CNOT1;CNOT8;KHSRP;CNOT7
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),-0.5919863562333891,-1.2124739200823695,0.21739130434782608,0.9079940531127829,1.0,8/26,18.01%,ANXA1;IL12A;SYT4;IL1RAPL1;RHBDF2;RHBDF1;GRM7;TNFRSF1A
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),0.5020167164363607,1.212376892429426,0.1724137931034483,0.9805830151902525,1.0,3/26,4.49%,WNT7A;SLITRK2;NLGN3
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),-0.694385148046033,-1.2123738056331532,0.22388059701492538,0.9073532407973499,1.0,3/10,12.20%,ANK3;PRKCQ;SYK
prerank,GO_Biological_Process_2021__regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342),-0.7922241649343559,-1.212363781706085,0.20689655172413793,0.9061192662205909,1.0,1/5,4.81%,SLC39A14
prerank,GO_Biological_Process_2021__phosphatidylglycerol biosynthetic process (GO:0006655),0.6609120531296214,1.2123520452588439,0.3055555555555556,0.9787776277565796,1.0,3/6,26.38%,GPAM;TAMM41;PGS1
prerank,GO_Biological_Process_2021__macrophage chemotaxis (GO:0048246),-0.7712850297636223,-1.2111568267564052,0.2714285714285714,0.9113172947754011,1.0,2/6,6.95%,SFTPD;CCL2
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),-0.6319373712953458,-1.2111402246447258,0.23809523809523808,0.9101286767276949,1.0,2/13,1.77%,APLNR;TGFBR2
prerank,GO_Biological_Process_2021__positive regulation of granulocyte differentiation (GO:0030854),-0.8174207541815555,-1.2110161678214688,0.25,0.9094529195392772,1.0,2/5,3.69%,LEF1;TESC
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),-0.6586852658485252,-1.2109503761739813,0.2,0.9084714129849027,1.0,7/18,16.37%,CD24;PDCD1LG2;IL27RA;IGF1;HHLA2;IL18;FADD
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),0.6190996283977603,1.210908356059175,0.24242424242424243,0.9820876880907466,1.0,2/10,1.15%,SLC6A13;SLC19A1
prerank,GO_Biological_Process_2021__positive regulation of synaptic plasticity (GO:0031915),-0.7599140604897794,-1.2108475865448411,0.20588235294117646,0.9077644276727552,1.0,3/6,19.95%,CPLX2;NEUROD2;ADCY8
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),0.5905484317595605,1.2106745798522478,0.17857142857142858,0.9812109892822833,1.0,4/11,14.27%,ZNF502;VAPA;VPS37B;CHMP2B
prerank,GO_Biological_Process_2021__V(D)J recombination (GO:0033151),0.6559682601133481,1.210537063859446,0.23333333333333334,0.9797840041823612,1.0,3/10,17.22%,LIG4;HMGB1;DCAF1
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),-0.6725709822409573,-1.2104558929918356,0.17391304347826086,0.9088057418947073,1.0,5/14,14.67%,ABO;B3GALT2;FUT2;ST3GAL6;B3GALT4
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),0.3804668600709662,1.2102416306380976,0.0,0.9790993571911676,1.0,18/111,15.81%,BET1;FHDC1;PI4K2A;TMED5;GORASP2;SEC22B;SYNE1;TRAPPC11;BLZF1;DNAJC28;TRAPPC12;ATL2;TRAPPC8;VTI1A;GOLGA5;PRKD1;GOLGA8N;SEC23IP
prerank,GO_Biological_Process_2021__cardiac muscle cell membrane repolarization (GO:0099622),-0.6917511128971606,-1.2100499701195606,0.25,0.9097616626911562,1.0,4/10,9.29%,KCNQ1;KCNJ2;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),0.6148754786713757,1.209867688097118,0.1388888888888889,0.9784961459920001,1.0,3/13,13.45%,BMP2;SOX9;HEYL
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),-0.5598499818343182,-1.2098177021541547,0.1511627906976744,0.909926558181511,1.0,9/54,10.72%,TLCD2;A4GALT;COL5A1;ANK3;MYOF;PLSCR1;CAV3;DYSF;FA2H
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),0.5516888556413605,1.2097406467585827,0.21212121212121213,0.9770826402727909,1.0,5/15,17.64%,DMAC2L;ATP5PB;ATP5MC2;ATP5MC1;ATP5F1A
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),0.5225362242495427,1.2097209593212361,0.25806451612903225,0.9753867769415033,1.0,4/19,5.07%,LEPR;SDHAF4;PPARGC1A;COX10
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),-0.7076341081903227,-1.2093515127390178,0.25,0.9112072516771007,1.0,2/11,5.25%,MET;POF1B
prerank,GO_Biological_Process_2021__pyrimidine nucleotide metabolic process (GO:0006220),0.7263050800918707,1.2090511241496662,0.3023255813953488,0.9760998094761142,1.0,2/5,16.39%,DCK;ENPP3
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.41750650098612696,1.2089677461894315,0.0,0.9746729551711665,1.0,16/76,16.65%,NUP42;NUP37;HSPA1A;BAG2;NUP54;HSF1;AAAS;ATR;NUP214;NDC1;RAE1;NUP188;EP300;NUP85;NUP205;NUP210
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.596421914414895,-1.2089003431326655,0.2054794520547945,0.9123435731554941,1.0,3/30,6.88%,P2RY6;NR4A3;IGFBP5
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.5586798196818449,-1.2088290527715395,0.21621621621621623,0.9115433629070439,1.0,10/45,16.37%,RASGRP1;THBS1;TLR2;APP;WNT5A;TLR3;SYK;HLA-E;IFIH1;FADD
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),-0.6069193337304102,-1.2082933515013192,0.22857142857142856,0.9130856004962261,1.0,4/21,9.29%,KCNT2;KCNQ1;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__hemostasis (GO:0007599),-0.79993631058862,-1.2082810038881973,0.22950819672131148,0.9118776094422298,1.0,2/5,16.43%,P2RY12;GPI
prerank,GO_Biological_Process_2021__regulation of granulocyte differentiation (GO:0030852),-0.758736721860985,-1.20824407270878,0.22413793103448276,0.9108246578807225,1.0,3/7,9.65%,LEF1;TESC;CEACAM1
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),0.47643490225404383,1.207947976642815,0.15,0.9772055380628195,1.0,15/40,27.20%,ZPR1;HSPA1A;RIOK2;EGFR;RIOK1;PIK3R1;NFKB1;ERN1;MAP2K2;WDR43;WDR75;BUD23;RELA;POLR2A;DYRK1A
prerank,PanglaoDB_Augmented_2021__Basophils,-0.5382838174365397,-1.2079012236362963,0.18421052631578946,0.9114059792361473,1.0,20/69,19.58%,P2RY13;MYO1F;GPR183;TLR2;L1CAM;CD44;SIGLEC1;IL4R;CLEC12A;PDK3;IGFBP7;GRM6;CTSS;SLC26A8;IL3RA;FAR2;CD4;F13A1;PTAFR;CLEC5A
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),0.42462673559554065,1.2078928218780547,0.0,0.9758079829858342,1.0,30/75,24.77%,CEBPA;PSMD10;TRIB3;USP13;CBFA2T3;PLK1;HSPA1A;KEAP1;BAG2;VCP;CSNK1E;RNF14;RCHY1;TRIB2;TMTC3;COP1;RNF217;ZYG11B;MDM2;SUMO2;NUB1;SMAD7;DDA1;SIRT2;FBXW7;DNAJB2;HSPBP1;ANKIB1;HECTD1;PSMC2
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),0.6531728121859965,1.207783172080367,0.2894736842105263,0.9743120961915877,1.0,5/12,21.29%,RAB23;EFL1;OPA1;AK4;AK3
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),0.5767941767821344,1.2077662364558965,0.27586206896551724,0.9725373858305524,1.0,6/20,26.60%,AP3B1;BLOC1S4;PIKFYVE;AP1M1;GPR143;RAB32
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),-0.5977742594963563,-1.2076446608320568,0.18309859154929578,0.9115202356092095,1.0,4/29,11.67%,APLNR;TGFBR2;CCDC39;SRF
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.5348964111983139,1.2074297980375637,0.23333333333333334,0.9724216083123632,1.0,9/19,23.89%,HSPA1A;DCUN1D2;DCUN1D1;DCUN1D5;TGFBR1;DAXX;ITCH;UBQLN1;DNAJB2
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),-0.6632433835367768,-1.2073766049415267,0.21333333333333335,0.9114482499484041,1.0,1/16,0.78%,BLM
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,-0.5009431396111228,-1.207353110188079,0.1511627906976744,0.9103204602256691,1.0,10/137,8.00%,CD24;LEF1;COL4A1;COL4A2;LAMB1;TEAD2;PODXL;THY1;GJC1;ZIC1
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),0.523561948590207,1.207200655207903,0.27586206896551724,0.9715848018605067,1.0,7/19,11.71%,ABCD2;ARV1;ACACB;MID1IP1;ABCD1;CPT2;ABCD3
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),-0.6794347914736388,-1.2071604897752404,0.25675675675675674,0.9100649075564694,1.0,2/15,5.54%,SIX3;WNT8B
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway (GO:0007197),-0.7628923334559241,-1.2071315290251385,0.26153846153846155,0.908942116352742,1.0,3/6,18.08%,CHRM1;CHRM3;CHRM5
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),-0.7119879352174061,-1.2069477301933746,0.3230769230769231,0.9087238255210596,1.0,3/9,23.46%,YBX3;BIRC3;CASP8
prerank,GO_Biological_Process_2021__positive regulation of translation in response to stress (GO:0032056),0.7927134693974767,1.2067350938504742,0.2619047619047619,0.9714455448027662,1.0,2/5,10.93%,NCK1;EIF2AK4
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),-0.673384612853696,-1.2066481701417944,0.21951219512195122,0.9090139295203843,1.0,5/19,19.49%,POU4F1;MSX2;GATA1;IGF1;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),-0.6049766626215877,-1.2064355876544994,0.2835820895522388,0.9086808872076704,1.0,4/25,15.80%,LEF1;HLA-DRA;IL7;TESPA1
prerank,GO_Biological_Process_2021__sequestering of actin monomers (GO:0042989),-0.7963248553186757,-1.2063483477801316,0.25,0.9079344199230406,1.0,2/6,7.57%,TMSB10;PFN4
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),-0.8068283530916242,-1.2062391388023466,0.2631578947368421,0.9072244701894453,1.0,1/6,8.07%,CAV3
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),-0.5151302952988407,-1.206004033234729,0.14634146341463414,0.9069526167552516,1.0,25/120,20.19%,S100A10;PKP2;MRAP2;FYB1;ANK3;RAMP3;TESC;KCNB1;ZDHHC22;RAB11A;CAV3;ABCA12;ATP1B1;FYB2;EMP2;KCNB2;PLEKHF1;SCN3B;PDZK1;TNFRSF1A;RAB3C;TSPAN32;FLOT1;ANK1;KCNIP4
prerank,GO_Biological_Process_2021__positive regulation of type I interferon-mediated signaling pathway (GO:0060340),-0.8194669792704289,-1.2059142211557603,0.2857142857142857,0.9062573969709734,1.0,3/5,16.37%,NLRC5;WNT5A;FADD
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),-0.5395851875390163,-1.205833251354771,0.12345679012345678,0.9057128741582133,1.0,5/74,8.80%,GGT5;ANXA1;WNT8B;IL12A;ALPL
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),-0.47833273684421534,-1.2056264554275764,0.08163265306122448,0.9055356281015472,1.0,61/271,19.61%,PIF1;TYMS;BLM;RECQL4;RPL3;RPL19;RPS27A;RPS27;RPS14;HELB;RPS4X;RPL27A;GCNT1;RPL7A;RPL35;SCX;WARS1;RPL37A;POLE3;RPL21;GTPBP2;BRCA1;POLR2I;RPL27;RPL13A;RPL9;RPS13;RPS16;DONSON;PAX8;RPL24;RPA3;RPS3A;RPLP1;RPL10A;RPS18;RPL10;RPS11;RPS8;RPLP2;RPL38;RPS7;RPL8;RPS15;RPL5;MRPL23;RPS21;CDK2;RPL12;RPS23;RPL18A;RPS9;RPA1;COPS5;POLD1;SET;RPL23;RPS6;CDC7;RPS25;EEF1A2
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),-0.5883226583433995,-1.205537125504194,0.20481927710843373,0.9047538285978957,1.0,9/36,21.25%,THBS1;KCNB1;SLC39A14;EIF2B2;PDK3;ADCY8;IRS2;GPER1;PFKL
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),-0.5690507011063182,-1.2050911969661382,0.21794871794871795,0.9057981904164177,1.0,11/34,19.09%,GRIN3A;KCNB1;GRIN2A;APP;GRIA3;GRIK1;GRM6;GRIN2B;GRID2;GRM7;GRIK2
prerank,GO_Biological_Process_2021__enteric nervous system development (GO:0048484),0.7112094956093648,1.2050834196133025,0.3235294117647059,0.9764920447842317,1.0,4/6,20.83%,SOX8;ARX;RHOXF1;EDNRB
prerank,GO_Biological_Process_2021__brain development (GO:0007420),-0.5100955267569237,-1.2050050156829104,0.11494252873563218,0.9049953793133965,1.0,17/118,16.94%,GRIN2D;COL4A1;SIX3;TGFBR2;PROX1;CIC;GRIN2A;ZIC1;NNAT;APOD;HAP1;CA10;B3GNT5;ZFHX2;GRIN2B;MFSD2A;PCDH18
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.7022525496611483,-1.2049151322610647,0.25,0.9042174740706074,1.0,4/14,8.07%,SCN1B;KCNQ1;NOS1AP;CAV3
prerank,GO_Biological_Process_2021__negative regulation of sequestering of triglyceride (GO:0010891),0.722383326646863,1.2048515309494894,0.34210526315789475,0.9754729525976868,1.0,1/5,7.35%,ABHD5
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),-0.6634682394229039,-1.2048000104315064,0.24242424242424243,0.9035892700972988,1.0,6/13,29.70%,PRKCQ;SYK;SELP;PDGFRA;C1QTNF1;PLEK
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),0.6912335597360412,1.2047152319452117,0.2777777777777778,0.9722720910076814,1.0,2/7,6.36%,SLIT1;ALCAM
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),0.6912335597360412,1.2047152319452117,0.2777777777777778,0.9722720910076814,1.0,2/7,6.36%,SLIT1;ALCAM
prerank,GO_Biological_Process_2021__positive regulation of protein depolymerization (GO:1901881),-0.7275172398963028,-1.2045331674056339,0.23809523809523808,0.9037564808155866,1.0,2/8,9.31%,STMN2;VIL1
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),-0.5207602394776302,-1.2042426746051922,0.15,0.9041383917633237,1.0,11/78,10.60%,THBS1;TLR2;P2RY12;IFI35;IL15;APP;PLSCR1;WNT5A;TLR3;DDX60;NLRP12
prerank,GO_Biological_Process_2021__leucine transport (GO:0015820),-0.751708185046548,-1.2039751795117763,0.26785714285714285,0.9044740435669704,1.0,1/6,1.68%,SLC6A15
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),-0.5655649511127008,-1.2036857675313504,0.2028985507246377,0.9046281025215348,1.0,8/38,19.01%,MET;STMN2;PSRC1;CAV3;DCTN1;FES;STMN1;ANKRD53
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),0.5092156010761542,1.203597381161911,0.3125,0.9747060462242356,1.0,4/17,19.66%,NCSTN;NFKB1;RHBDD1;SPPL2A
prerank,GO_Biological_Process_2021__positive regulation of vesicle fusion (GO:0031340),-0.8257893770701935,-1.2035571923677348,0.23214285714285715,0.9040599446552953,1.0,1/6,0.21%,ANXA1
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.7279870610098476,-1.2035414722432523,0.29411764705882354,0.9029414132866438,1.0,1/8,0.68%,SOCS3
prerank,GO_Biological_Process_2021__cilium movement involved in cell motility (GO:0060294),-0.7797472051984118,-1.2034919217619315,0.20754716981132076,0.9020508302023675,1.0,1/7,0.65%,TEKT2
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.6613388864764714,-1.2029788060454794,0.20270270270270271,0.9037237642806659,1.0,4/14,17.02%,SCN1B;KCNJ2;CACNA1C;SCN3B
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),0.6290630341626855,1.2029486531192484,0.24324324324324326,0.9752745445496643,1.0,3/13,17.95%,PRKRA;DROSHA;AGO3
prerank,GO_Biological_Process_2021__positive regulation of integrin activation (GO:0033625),-0.6939152175359428,-1.2028082581063566,0.2459016393442623,0.9033168904507616,1.0,2/11,4.09%,P2RY12;SKAP1
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.5503944528888495,-1.2027680184077878,0.15853658536585366,0.90231732887042,1.0,10/37,19.95%,P2RY12;CHRM1;ADCY7;AKAP5;CHRM3;ADCY5;GRM7;HTR1E;CHRM5;ADCY8
prerank,GO_Biological_Process_2021__regulation of adaptive immune response (GO:0002819),-0.6634177479278915,-1.2025617913318967,0.2222222222222222,0.9021595466813601,1.0,5/12,16.37%,IRF1;SKAP1;ADCY7;IRF7;FADD
prerank,GO_Biological_Process_2021__positive regulation by symbiont of entry into host (GO:0075294),-0.7626306675634721,-1.202391737663605,0.1864406779661017,0.9006400978011624,1.0,4/6,22.98%,CD4;CD74;LGALS1;HLA-DRB1
prerank,GO_Biological_Process_2021__positive regulation of viral entry into host cell (GO:0046598),-0.7626306675634721,-1.202391737663605,0.1864406779661017,0.9006400978011624,1.0,4/6,22.98%,CD4;CD74;LGALS1;HLA-DRB1
prerank,GO_Biological_Process_2021__protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947),0.7130102986202448,1.2023896058131407,0.30952380952380953,0.9756886289026583,1.0,1/5,4.53%,TNFAIP3
prerank,GO_Biological_Process_2021__positive regulation of mRNA 3'-end processing (GO:0031442),0.5966341834853178,1.2021756704048419,0.2413793103448276,0.9747837587472435,1.0,3/10,14.62%,NUDT21;HSF1;CPEB3
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.6812837388138149,-1.2021624082642681,0.234375,0.9006968949372127,1.0,5/12,14.71%,PKP2;ATP1A1;GJC1;ATP1B1;CACNA1C
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),-0.6368717589971082,-1.2020641007381834,0.2647058823529412,0.9001748232223413,1.0,1/14,3.46%,SHTN1
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),-0.625927513490133,-1.201810997264939,0.26153846153846155,0.9003210005183001,1.0,8/16,17.56%,PDPN;ALOX12;CEACAM1;PRKCQ;SYK;CD9;DMTN;PRKCD
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.4854283784146052,1.2016967875289482,0.14285714285714285,0.9747673240571204,1.0,5/31,10.41%,NAF1;CCT7;MAP3K4;CCT3;ATR
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),-0.6609683849370276,-1.2016534816439646,0.17391304347826086,0.9000671968937588,1.0,5/15,14.67%,ABO;B3GALT2;FUT2;ST3GAL6;B3GALT4
prerank,GO_Biological_Process_2021__T-helper cell differentiation (GO:0042093),-0.8033439141497576,-1.2014946439883094,0.21212121212121213,0.8996477820265255,1.0,2/6,1.68%,LEF1;GPR183
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),-0.6688409662603209,-1.2013823194423427,0.27586206896551724,0.8992073280127857,1.0,3/10,9.29%,KCNJ2;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__rRNA transport (GO:0051029),0.7666329649817386,1.2013248788237936,0.18421052631578946,0.9747004686592461,1.0,2/5,17.00%,TST;MRPL18
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),0.4565708635531608,1.2006510649911784,0.2,0.9758935660062741,1.0,8/54,9.56%,SLC6A13;SLC19A1;SLC39A8;SLC25A18;SLC3A2;SFXN2;SLC25A19;SLC25A41
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),0.5801391077809197,1.20040084640622,0.13636363636363635,0.9751458925904014,1.0,6/22,20.74%,PLD6;JAM2;NECTIN2;MKKS;DDX25;FAM9B
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),0.5549131888508272,1.2002199353506982,0.20689655172413793,0.9740495622203319,1.0,2/19,9.13%,ARV1;GNB3
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),0.49277593808210657,1.2001124765517395,0.13043478260869565,0.972681665903708,1.0,5/29,10.41%,NAF1;CCT7;MAP3K4;CCT3;ATR
prerank,GO_Biological_Process_2021__regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),-0.7963839562731782,-1.199855760331999,0.22388059701492538,0.9062309523905127,1.0,1/5,3.11%,NOS1AP
prerank,GO_Biological_Process_2021__cell-cell junction maintenance (GO:0045217),0.7028991305781611,1.199836759580728,0.2647058823529412,0.972219117285757,1.0,3/7,23.99%,CSF1R;PARD6A;FERMT2
prerank,GO_Biological_Process_2021__regulation of podosome assembly (GO:0071801),-0.7535223136497853,-1.1997497623243771,0.2037037037037037,0.9056615663013083,1.0,2/6,14.73%,FSCN1;KIF9
prerank,GO_Biological_Process_2021__telomere maintenance in response to DNA damage (GO:0043247),0.6241343758680984,1.1996565581556586,0.34285714285714286,0.971283969776218,1.0,4/9,23.81%,TFIP11;DCLRE1B;DCLRE1C;DCLRE1A
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),-0.7019205399208659,-1.1996323698333515,0.2054794520547945,0.9050385345597655,1.0,3/12,13.75%,HLA-A;EMP2;CD55
prerank,PanglaoDB_Augmented_2021__Spermatozoa,-0.5397628902844794,-1.1995461216420436,0.1566265060240964,0.9041638367148035,1.0,19/77,19.76%,CP;IL1R1;C3;C1ORF87;KCNJ2;PLD1;HLA-DRA;ST3GAL6;FAM20A;ANKUB1;CTSS;APOL6;RASSF4;MSR1;CLMN;C1QB;LDHC;ERICH3;CD74
prerank,GO_Biological_Process_2021__response to lipoteichoic acid (GO:0070391),-0.7795190051332861,-1.1994820622970264,0.2777777777777778,0.9020807761925026,1.0,1/5,1.93%,TLR2
prerank,GO_Biological_Process_2021__cellular response to lipoteichoic acid (GO:0071223),-0.7795190051332861,-1.1994820622970264,0.2777777777777778,0.9020807761925026,1.0,1/5,1.93%,TLR2
prerank,GO_Biological_Process_2021__calcium ion import across plasma membrane (GO:0098703),-0.7213998992310225,-1.1994753883493607,0.2631578947368421,0.8997346623402463,1.0,3/10,9.86%,SLC8A3;SLC24A2;SLC24A1
prerank,GO_Biological_Process_2021__calcium ion import into cytosol (GO:1902656),-0.7213998992310225,-1.1994753883493607,0.2631578947368421,0.8997346623402463,1.0,3/10,9.86%,SLC8A3;SLC24A2;SLC24A1
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),-0.6707944056286708,-1.1993839654247815,0.273972602739726,0.8990038282391808,1.0,3/13,3.56%,P2RY12;SHTN1;ITGA2
prerank,GO_Biological_Process_2021__homologous chromosome pairing at meiosis (GO:0007129),-0.6224908568230668,-1.1992910444109763,0.2916666666666667,0.8982202543425734,1.0,8/20,17.82%,IHO1;MEIOB;STAG3;RNF212B;SYCE2;SYCE1;TEX11;REC8
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated immunity (GO:0002716),-0.7414347907533223,-1.1991545850840386,0.23728813559322035,0.8980061846864693,1.0,2/5,14.65%,HLA-E;HLA-F
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),0.6096352023171956,1.1989017020628725,0.22857142857142856,0.9726446341979785,1.0,3/15,11.49%,KLRG1;RAB23;VEZF1
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),0.5985605212908472,1.1988862713906623,0.27586206896551724,0.9709659772098947,1.0,3/14,5.79%,PDE12;CBFA2T3;GIT1
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),-0.5812349505510273,-1.1988363899892989,0.23529411764705882,0.8983485101857016,1.0,8/38,13.41%,TLR2;RPS27A;SFTPD;NOD1;TLR3;CTSS;ALPK1;UBC
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),-0.6936911747883198,-1.19862875309285,0.25,0.8983307537925215,1.0,4/13,14.65%,B2M;HLA-A;CD55;HLA-F
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),0.5114573534520622,1.1981388437359086,0.20833333333333334,0.9722477770649322,1.0,4/25,9.13%,ARV1;PDK4;ADIPOR1;GNB3
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),-0.740347282688672,-1.197909664782859,0.3,0.9006937314993823,1.0,1/7,8.07%,CAV3
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),0.6939364377882395,1.1978348472709834,0.24324324324324326,0.9700233400896752,1.0,6/7,29.38%,EEFSEC;SEPSECS;SELENOT;SECISBP2;SECISBP2L;DIO2
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),0.6939364377882395,1.1978348472709834,0.24324324324324326,0.9700233400896752,1.0,6/7,29.38%,EEFSEC;SEPSECS;SELENOT;SECISBP2;SECISBP2L;DIO2
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),0.6150933582155407,1.1977121243353017,0.25,0.9686826114548363,1.0,6/14,29.09%,PRKRA;DROSHA;AGO3;TSN;CLP1;CELF1
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),0.5826140952725469,1.1974124854954802,0.28,0.9681847182943754,1.0,6/18,20.16%,ACVR1C;HMGB1;CASP3;BLCAP;EXOG;DFFB
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),-0.5700267475200613,-1.1970660698817905,0.21794871794871795,0.9036151681887971,1.0,15/37,20.43%,HPN;TIMP2;CD44;SCUBE3;MMP19;MMP14;TIMP1;CTSS;KIF9;ADAMTS4;CAPN1;A2M;CAPNS1;FLOT1;TLL1
prerank,GO_Biological_Process_2021__regulation of PERK-mediated unfolded protein response (GO:1903897),0.6817028461919934,1.1969452926109405,0.2972972972972973,0.9678608386860376,1.0,3/8,9.06%,PPP1R15B;TMEM33;NCK1
prerank,GO_Biological_Process_2021__positive regulation of phospholipid biosynthetic process (GO:0071073),-0.7627979346715433,-1.1968399299121995,0.2786885245901639,0.9036666013476985,1.0,2/6,5.84%,FABP3;HTR2B
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),0.6144497939996216,1.196271448932696,0.20833333333333334,0.9686923274610589,1.0,5/15,23.34%,METTL8;TRMT61A;CBLL1;VIRMA;NSUN2
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),-0.6126140170273865,-1.195357916556604,0.2153846153846154,0.9100852394939033,1.0,7/22,17.39%,IFIT1;PLN;TIMP1;PARP9;ATP5IF1;NOS1;TMBIM1
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),-0.6231414735328026,-1.1950623380959462,0.19696969696969696,0.9104634970120856,1.0,5/27,12.41%,ANXA1;TYMP;TSPYL2;SCG5;IGFBP7
prerank,GO_Biological_Process_2021__positive regulation of glial cell migration (GO:1903977),-0.8106881159637996,-1.1950209502880569,0.1896551724137931,0.9095554610450339,1.0,1/5,2.07%,P2RY12
prerank,GO_Biological_Process_2021__regulation of superoxide anion generation (GO:0032928),-0.691810355496308,-1.1949218220190563,0.25,0.9089625794508517,1.0,5/8,28.41%,SYK;PRKCD;TGFB1;MAPT;GSTP1
prerank,GO_Biological_Process_2021__sulfur amino acid catabolic process (GO:0000098),0.7406161005121825,1.1946048116549628,0.2,0.9736390342802727,1.0,4/8,15.35%,BLMH;CTH;ADO;TST
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),-0.6144637656489149,-1.1945593064405347,0.2361111111111111,0.9096209302560242,1.0,5/27,17.19%,PIF1;ANKRD28;CDK2;RPA1;NOP10
prerank,GO_Biological_Process_2021__positive regulation of tissue remodeling (GO:0034105),-0.7565916354309994,-1.1945542682867794,0.36065573770491804,0.9084914966673691,1.0,3/5,17.39%,IL15;IL18;TMBIM1
prerank,GO_Biological_Process_2021__action potential (GO:0001508),-0.572625883534694,-1.1942435729043042,0.18181818181818182,0.908976833976834,1.0,6/36,6.53%,CACNA1H;KCNQ1;ANK3;KCNB1;KCNJ2;SCN9A
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),0.48027275754062165,1.194150166937373,0.10714285714285714,0.9737475359679089,1.0,16/40,23.56%,SDC4;RALB;CNOT2;G3BP1;KCTD17;TAPT1;PIP4K2B;CNOT6L;CCDC88A;PIP4K2C;CEP120;CNOT1;RAB3GAP1;SAXO1;ARHGAP35;STX18
prerank,GO_Biological_Process_2021__T-tubule organization (GO:0033292),-0.7680669722428537,-1.1941442279149033,0.3088235294117647,0.908366246055542,1.0,3/6,8.18%,MYOF;CAV3;DYSF
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),0.5839583334984862,1.1937587614109981,0.18181818181818182,0.9738556480624121,1.0,6/22,23.34%,METTL8;TRMT61A;CBLL1;DKC1;VIRMA;NSUN2
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),0.5608869565535654,1.1937586809009928,0.2413793103448276,0.9721103870443789,1.0,5/18,21.18%,TSPAN33;BAD;NDC1;NUP205;NUP153
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),-0.5154898231535189,-1.1936748665908192,0.10989010989010989,0.9096758390325559,1.0,18/103,16.30%,CACNA1H;RASGRP2;B2M;ANK3;SYT4;ADCY7;WNT5A;SYT1;CLIC4;GLRA2;FOS;HPCA;MT1H;FBP1;NEUROD2;CPNE9;DMTN;NLGN1
prerank,GO_Biological_Process_2021__megakaryocyte differentiation (GO:0030219),-0.7221211373859749,-1.1934539580671368,0.25757575757575757,0.9096118679937917,1.0,5/9,25.29%,GATA1;ZFPM1;THPO;ZNF385A;SH2B3
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),0.4874749248726423,1.1932976742027797,0.23809523809523808,0.971928987760682,1.0,9/33,19.46%,TBC1D12;RALB;SEC22B;RAB1B;SCFD1;PIP4K2B;PIP4K2C;PIKFYVE;RAB3GAP1
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),-0.6263429509814228,-1.1932877813470526,0.21052631578947367,0.9092593919664829,1.0,5/25,11.42%,ANXA1;RAMP3;STAT4;STAT1;EIF2B2
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),0.7290065840866946,1.1932763303034397,0.2608695652173913,0.970412049101933,1.0,3/7,10.91%,LIG4;MSH2;EXOSC6
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.5520953972622774,1.1931718945111363,0.2222222222222222,0.9689247694320371,1.0,5/14,17.64%,DMAC2L;ATP5PB;ATP5MC2;ATP5MC1;ATP5F1A
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),0.614253718186061,1.1930808525600483,0.23684210526315788,0.9677574847086128,1.0,4/13,21.18%,NUP54;NDC1;NUP205;NUP153
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.5614935926330966,-1.1925792827329964,0.23376623376623376,0.9114491336311221,1.0,8/36,10.60%,TLR2;PTP4A3;IFI35;APP;NOD1;LRRC19;TLR3;NLRP12
prerank,GO_Biological_Process_2021__negative regulation of systemic arterial blood pressure (GO:0003085),0.6923527225203975,1.1924877165856191,0.2391304347826087,0.9683583813275792,1.0,3/6,22.73%,GPR37L1;ADRB2;ADRB1
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),-0.7090739029415024,-1.1924804881090645,0.29850746268656714,0.9109139309133024,1.0,4/9,22.98%,FES;CD4;CD74;HLA-DRB1
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),0.492145698127913,1.1922431095157746,0.19230769230769232,0.9677028024225253,1.0,7/27,19.92%,MEN1;DUSP19;MARVELD3;SIRPA;TAOK3;ZMYND11;FKTN
prerank,GO_Biological_Process_2021__neuromuscular process controlling balance (GO:0050885),-0.7276966229147909,-1.1922230924242927,0.1875,0.9111788940158495,1.0,2/9,4.96%,CLRN1;CDH23
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),0.4463164300454472,1.1919037322114456,0.1,0.9676274478150056,1.0,18/52,19.08%,NUP42;NUP37;ABCD1;NUP54;AAAS;NUP214;NDC1;RAE1;NUP188;EP300;NUP85;NUP205;NUP210;JMJD8;AK4;COX7A2L;SPHK2;BEND3
prerank,GO_Biological_Process_2021__positive regulation of superoxide anion generation (GO:0032930),-0.7060452408450945,-1.1918351425922797,0.27419354838709675,0.9119963321179806,1.0,5/7,28.41%,SYK;PRKCD;TGFB1;MAPT;GSTP1
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),-0.5187042519937187,-1.1916426881222726,0.20512820512820512,0.9117811832627792,1.0,10/66,10.62%,OTOS;HPN;KCNQ1;CLRN1;CDH23;EPS8L2;CEMIP;MYO3A;NDUFB9;COL11A2
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,0.4059836043041884,1.1915186012328138,0.0,0.9674802491490547,1.0,10/93,9.06%,FGF6;NGF;TRIB3;THEM4;EGFR;MAPK10;RALB;UBE2N;AKT1;NCK1
prerank,GO_Biological_Process_2021__hyperosmotic response (GO:0006972),-0.8048615871759581,-1.19130297287793,0.26785714285714285,0.9124260343028713,1.0,4/5,19.51%,YBX3;RCSD1;TLR3;AQP1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.642958670421509,-1.1910606174815006,0.2222222222222222,0.9125499980503635,1.0,2/19,3.97%,PKP2;PROX1
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 type immune response (GO:2000318),-0.7647500523757581,-1.1909661260453035,0.2982456140350877,0.9119327750699605,1.0,2/5,11.66%,NFKBID;PRKCQ
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),-0.6694380467212511,-1.190540764183431,0.27419354838709675,0.9127969923176377,1.0,1/11,0.92%,APLNR
prerank,GO_Biological_Process_2021__basic amino acid transport (GO:0015802),-0.6777743340610715,-1.1904650153056247,0.23076923076923078,0.9120859900899624,1.0,5/8,27.82%,SLC3A1;SLC15A4;CLN3;SLC7A7;SLC7A1
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),-0.7700762889196391,-1.1902824619239887,0.3050847457627119,0.9119356098152831,1.0,3/6,16.71%,EMP2;DMTN;CD63
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),-0.6164490206171288,-1.1899444032936297,0.21621621621621623,0.9124174662497652,1.0,2/17,13.19%,KCNQ1;FBP1
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),0.46603511362690525,1.1898440967669996,0.12903225806451613,0.9720844576299811,1.0,14/41,23.01%,NR1D1;ALDH1A1;ID1;NOVA1;PGAM5;LGR4;ABHD6;PCTP;LAMA4;LNPEP;PLCL1;ZNF423;RBPJ;TFE3
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),-0.707427661318242,-1.1896102850805723,0.27692307692307694,0.9128244944899153,1.0,4/9,17.02%,KCNQ1;GJC1;CACNA1C;SCN3B
prerank,GO_Biological_Process_2021__smooth muscle tissue development (GO:0048745),-0.7459391079403859,-1.1894493764093466,0.28846153846153844,0.912547698897366,1.0,1/7,3.97%,PROX1
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),-0.575285203876967,-1.1893878340852728,0.2159090909090909,0.9117260259266218,1.0,12/35,19.29%,OVOL3;RBP2;OVOL2;ZNF750;WAS;POU2F3;EMP1;GLI1;FLG2;FGF7;ALDH3A2;LAMA3
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),0.6577099362518105,1.189087260783183,0.225,0.9727443031754807,1.0,7/10,30.89%,SESN2;EIF2AK4;SESN3;SESN1;GCN1;MTOR;LARS1
prerank,GO_Biological_Process_2021__peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),0.7607460659761159,1.1889548131030996,0.32558139534883723,0.9696891867282604,1.0,3/6,15.76%,DPH5;DPH3;DPH1
prerank,GO_Biological_Process_2021__peptidyl-diphthamide metabolic process (GO:0017182),0.7607460659761159,1.1889548131030996,0.32558139534883723,0.9696891867282604,1.0,3/6,15.76%,DPH5;DPH3;DPH1
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),0.5935270885357176,1.188903390743327,0.23076923076923078,0.9664889422352109,1.0,2/11,3.34%,NR1D1;PGM2
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),0.5935270885357176,1.188903390743327,0.23076923076923078,0.9664889422352109,1.0,2/11,3.34%,NR1D1;PGM2
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,-0.5037733239854432,-1.1888911296807319,0.15384615384615385,0.9130125994467397,1.0,15/108,9.73%,IFI44L;MX1;SERPINA10;PLAG1;CLDN16;MYOT;STAG3;SNCB;MFSD6;MYO15A;PDE6B;EGF;ZC2HC1C;LFNG;ARHGDIG
prerank,GO_Biological_Process_2021__macrophage activation involved in immune response (GO:0002281),-0.7165814055147219,-1.1888594353676232,0.23333333333333334,0.9120144751386926,1.0,5/8,21.03%,IFI35;DYSF;SYK;SBNO2;NMI
prerank,GO_Biological_Process_2021__regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.6411339069544583,-1.1886470152366069,0.2857142857142857,0.911917752714434,1.0,6/13,23.26%,SYP;SHISA8;SHISA9;SLC4A10;GRIK2;CLN3
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),0.49705826983529455,1.1883159254411948,0.20689655172413793,0.9667016757292546,1.0,8/27,18.26%,PSMD10;HSPA1A;AKT1;VAT1;OPA1;MUL1;SLC25A5;TRIAP1
prerank,GO_Biological_Process_2021__fat-soluble vitamin metabolic process (GO:0006775),-0.6301392292179939,-1.1882033064230468,0.21333333333333335,0.913000952207916,1.0,3/19,4.92%,RPE65;GC;RBP2
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),-0.5475950858872958,-1.188070359731918,0.1875,0.9125383122265097,1.0,9/46,12.05%,ANXA1;SEPTIN5;HAP1;SYT1;CPLX1;RIMS2;IL1RAPL1;SEPTIN4;CPLX2
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),-0.5970221078899824,-1.1880127196781642,0.21739130434782608,0.9116810894214556,1.0,3/35,4.59%,APIP;B2M;KCNJ2
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),-0.6541278206788947,-1.1879771347620016,0.208955223880597,0.9096301759976628,1.0,4/15,16.98%,THBS1;APOD;DMTN;DLC1
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),-0.6541278206788947,-1.1879771347620016,0.208955223880597,0.9096301759976628,1.0,4/15,16.98%,THBS1;APOD;DMTN;DLC1
prerank,MSigDB_Hallmark_2020__UV Response Up,-0.4962286914781934,-1.1877972421910732,0.14772727272727273,0.9093607231075984,1.0,22/137,16.38%,CXCL2;RASGRP1;FOSB;CCK;ICAM1;BTG3;IRF1;CHRNA5;ATF3;POLE3;MMP14;ABCB1;UROD;FOS;BTG1;JUNB;PSMC3;HLA-F;NPTX2;MRPL23;CDK2;NR4A1
prerank,GO_Biological_Process_2021__anterograde dendritic transport (GO:0098937),-0.8057433729044443,-1.1876491332657177,0.26666666666666666,0.9077474149510437,1.0,1/5,9.10%,KIF17
prerank,GO_Biological_Process_2021__anterograde dendritic transport of neurotransmitter receptor complex (GO:0098971),-0.8057433729044443,-1.1876491332657177,0.26666666666666666,0.9077474149510437,1.0,1/5,9.10%,KIF17
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),0.4607288828840613,1.1875256527513818,0.20689655172413793,0.9677432299080159,1.0,6/36,12.14%,RFWD3;KMT5A;SMYD2;UBE2N;FBXO5;FEM1B
prerank,GO_Biological_Process_2021__translation (GO:0006412),-0.4736830535607675,-1.187492744613941,0.10638297872340426,0.9076259847128795,1.0,45/191,19.71%,RPL3;RPL19;RPS27A;RPS27;RPS14;RPS4X;RPL27A;RPL7A;RPL35;WARS1;RPL37A;RPL21;GTPBP2;RPL27;RPL13A;RPL9;RPS13;RPS16;RPL24;RPS3A;RPLP1;RPL10A;RPS18;RPL10;RPS11;RPS8;RPLP2;RPL38;RPL26L1;RPS7;RPL8;RPS15;RPL5;MRPL23;RPS21;RPL12;RPS23;RPL18A;RPS9;COPS5;RPL23;RPS6;RPS25;EEF1A2;GARS1
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),0.6818181274164132,1.1874582092965968,0.3333333333333333,0.9662731431409777,1.0,1/7,2.80%,NAF1
prerank,GO_Biological_Process_2021__mesoderm morphogenesis (GO:0048332),-0.7529999221152143,-1.1873968779667994,0.22727272727272727,0.9069783014657861,1.0,2/6,20.08%,SCX;CRB2
prerank,GO_Biological_Process_2021__regulation of barbed-end actin filament capping (GO:2000812),0.7221659954926901,1.187129143173652,0.2391304347826087,0.9660599928171216,1.0,4/5,26.94%,WASHC2C;CARMIL2;CARMIL1;MTPN
prerank,GO_Biological_Process_2021__cyclic nucleotide transport (GO:0070729),0.7241431308170279,1.1870185156516184,0.25,0.9646450759659987,1.0,1/5,1.15%,SLC19A1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.6240232398272871,-1.1869386027380049,0.14285714285714285,0.9080852241987454,1.0,3/18,11.62%,IFI6;GATA1;UNC5B
prerank,GO_Biological_Process_2021__regulation of microvillus assembly (GO:0032534),-0.8130188297226159,-1.1868377540607273,0.16363636363636364,0.9075209573427427,1.0,5/5,18.72%,FSCN1;PODXL;PLD1;RAP1GAP;ATP8B1
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),-0.6670926340125388,-1.1867511339354793,0.20588235294117646,0.9068037678762604,1.0,1/13,0.78%,BLM
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),-0.6204663226685561,-1.1866067859482365,0.27631578947368424,0.9063657299365877,1.0,8/26,19.31%,CALD1;FSCN1;BAIAP2L1;BAIAP2;DMTN;DPYSL3;ADD2;RHOD
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),-0.6901066955584709,-1.1865549532688011,0.23076923076923078,0.905538816590807,1.0,4/10,16.03%,IL12A;HLA-E;HLA-F;IL18
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),-0.6397324950900045,-1.1863705297613776,0.21818181818181817,0.9053391140036446,1.0,4/15,20.91%,ICAM1;SYK;SELP;FERMT3
prerank,GO_Biological_Process_2021__protein oxidation (GO:0018158),0.6836348091261564,1.1853053916983631,0.34210526315789475,0.9693077927037885,1.0,3/8,21.10%,TMX3;PRDX3;CHCHD4
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),-0.6167142388840291,-1.184888474183492,0.2898550724637681,0.911445708421073,1.0,5/17,12.64%,IL12A;CCL2;THY1;PRKCQ;TNIP2
prerank,GO_Biological_Process_2021__oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.6036679562475368,1.184813303456673,0.23529411764705882,0.9694664590436165,1.0,5/12,22.08%,ALG6;ALG3;ALG11;ALG13;ALG2
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),-0.6118243549223328,-1.1843223653635409,0.25,0.913192160257364,1.0,6/30,12.79%,P2RY6;LRRC55;ANK3;CCL2;HAP1;CTSS
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),0.722566814577353,1.1842569653513668,0.38461538461538464,0.9699529703546974,1.0,3/6,22.60%,EIF2AK4;EIF2AK3;SAXO1
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),-0.6783785851444672,-1.184236596107603,0.23880597014925373,0.9124018292916009,1.0,5/13,17.52%,SP100;SPOCK3;WAS;CD9;SPINT2
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),-0.6719421112790638,-1.1840046131811326,0.23880597014925373,0.9125211699505205,1.0,3/12,8.18%,TLR2;PLSCR1;DYSF
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),0.6204264130099899,1.183869142584855,0.27586206896551724,0.9696884883501998,1.0,4/16,8.17%,MTHFS;OAT;GLUD1;GLS
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 3 signaling pathway (GO:0034139),0.6689035548608314,1.1832348692277095,0.34146341463414637,0.9709911053109154,1.0,2/5,11.34%,TNFAIP3;TIRAP
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),-0.6378166371156616,-1.183104005442889,0.2777777777777778,0.9157473164173541,1.0,6/16,20.70%,MRAP2;GBP1;PPFIA1;TMBIM1;TGFB1;NUMB
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),-0.6177456501256124,-1.1828926602228331,0.2777777777777778,0.9156791803244893,1.0,3/19,12.20%,CXCL2;CCL2;SYK
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),-0.6898536016852792,-1.1828517846896276,0.2571428571428571,0.9147880365754524,1.0,1/12,1.05%,RIMBP2
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),0.6251379486286388,1.182788763080902,0.1724137931034483,0.9710057804491297,1.0,5/13,25.83%,HMGB1;CASP3;EXOG;DFFB;ENDOG
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),-0.5215810280081202,-1.1823238785421728,0.2073170731707317,0.9162133253484159,1.0,18/75,21.26%,PCSK2;C1R;MMEL1;C1RL;PHEX;ATP23;KLK6;MMP14;CTSS;ADAM19;SEC11C;AEBP1;MYRF;SRGN;TMEM208;APH1A;CPXM2;F3
prerank,GO_Biological_Process_2021__benzene-containing compound metabolic process (GO:0042537),-0.7293078720024437,-1.1821209229980223,0.2777777777777778,0.9162361178841484,1.0,1/7,3.79%,KMO
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),-0.6335769929507418,-1.1820236119080412,0.2459016393442623,0.9156310452611347,1.0,3/14,14.59%,MMP14;SYK;IL7
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),-0.6263310539257272,-1.1819802295229582,0.28169014084507044,0.9148453766755904,1.0,3/17,12.20%,CXCL2;CCL2;SYK
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),0.40916105687036436,1.181613093727345,0.23529411764705882,0.9735829561813796,1.0,22/92,19.82%,U2AF1;NUP42;NUP37;NUP54;WDR33;AAAS;NUP214;EIF4E;NDC1;NXT1;RAE1;NUP188;SMG7;NUP85;NUP205;NUP210;THOC1;AGFG1;THOC3;SMG1;CPSF2;DDX25
prerank,GO_Biological_Process_2021__malate metabolic process (GO:0006108),0.6995636124414908,1.1813857160972574,0.2647058823529412,0.9728489556018576,1.0,2/7,17.33%,ME2;FH
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),0.5926160474928016,1.181331693420993,0.2972972972972973,0.9714441842948911,1.0,5/13,24.43%,TMEM33;ATL2;ZFYVE27;RAB18;REEP4
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),-0.6642977972933503,-1.1812252362432878,0.25,0.9177184042508069,1.0,4/11,9.29%,KCNQ1;KCNJ2;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),-0.6396649860475808,-1.1811276560321895,0.29577464788732394,0.9171540887199541,1.0,4/14,17.02%,APP;IGF1;MFSD2A;PPIB
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),-0.6384888598600198,-1.180977724859306,0.15254237288135594,0.9157678003467156,1.0,3/15,11.62%,IFI6;GATA1;UNC5B
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.6384888598600198,-1.180977724859306,0.15254237288135594,0.9157678003467156,1.0,3/15,11.62%,IFI6;GATA1;UNC5B
prerank,GO_Biological_Process_2021__regulation of neuroinflammatory response (GO:0150077),0.6485735996556964,1.1807495898986236,0.3225806451612903,0.9725009461703616,1.0,2/9,1.19%,CD200R1;NR1D1
prerank,GO_Biological_Process_2021__fructose 6-phosphate metabolic process (GO:0006002),-0.7139540600173981,-1.1805317492798901,0.21875,0.9168264418310043,1.0,4/8,21.25%,HK2;FBP1;GFPT2;PFKL
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),0.5007653488245856,1.1803522947149094,0.18518518518518517,0.9723972415573934,1.0,8/24,18.28%,ARFIP1;LLGL1;DISP1;SCFD1;STXBP5;NDFIP1;GAPVD1;P3H1
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),0.5618082374700432,1.180252227197395,0.22580645161290322,0.9710003921994338,1.0,3/18,7.97%,SLC6A13;SLC47A1;SLC3A2
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),0.5943093011715249,1.1802426352826167,0.3170731707317073,0.9693776878320264,1.0,6/12,23.08%,BMP2;NOTCH2;HEYL;HEY2;RBPJ;JAG1
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),-0.6772964983408106,-1.1801811185732045,0.27848101265822783,0.9176214809959764,1.0,1/11,2.44%,STMN2
prerank,GO_Biological_Process_2021__positive regulation of blood coagulation (GO:0030194),-0.6794338551218795,-1.1797841016858779,0.3,0.9185650702482877,1.0,1/10,0.43%,THBS1
prerank,GO_Biological_Process_2021__cysteine metabolic process (GO:0006534),0.7103404036135467,1.179472409937174,0.2894736842105263,0.9704307939527779,1.0,4/6,23.94%,CTH;TST;GCLC;CDO1
prerank,GO_Biological_Process_2021__lymphocyte chemotaxis (GO:0048247),-0.6700603645612174,-1.1791986357098416,0.24615384615384617,0.92013752496863,1.0,3/12,6.95%,MSMP;GPR183;CCL2
prerank,PanglaoDB_Augmented_2021__Leydig Cells,-0.505394983276391,-1.1791102169095455,0.1794871794871795,0.9194849764175648,1.0,33/101,23.62%,COL4A1;ANGPTL2;COL4A2;CALD1;C1R;MATN2;ABCA8;MAOB;IGFBP5;THBS2;RASL12;ADAM21;BGN;LMOD1;SERPING1;F10;IGF1;AMOTL2;NOS1;C1S;MLANA;TNS2;COL12A1;AQP1;ADGRF5;ASS1;CPXM2;PTPN21;FMO2;SVEP1;SLCO2A1;PDGFRA;KIAA1217
prerank,GO_Biological_Process_2021__axon ensheathment in central nervous system (GO:0032291),-0.7235661125230192,-1.179041560610922,0.22950819672131148,0.9187640191195376,1.0,3/7,17.18%,CNTNAP1;PLP1;MYRF
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.5876951253571924,-1.1788530081453772,0.2702702702702703,0.918543870376304,1.0,8/25,20.75%,NLRC5;PARP14;WNT5A;PARP9;IL7;FADD;CD74;AGPAT2
prerank,GO_Biological_Process_2021__mitotic nuclear membrane disassembly (GO:0007077),-0.7371926572587878,-1.178724579446364,0.30303030303030304,0.9179952264422512,1.0,2/10,7.69%,CCNB2;CCNB1
prerank,PanglaoDB_Augmented_2021__Motor Neurons,0.44344310888853933,1.1786300515296961,0.16666666666666666,0.9718710211040228,1.0,6/61,4.98%,SPSB4;MEX3A;CSPG5;EFNA2;POU3F2;MID1
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.6259821879998543,-1.1784361525381273,0.2647058823529412,0.9172101711327133,1.0,1/19,0.43%,THBS1
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.6259821879998543,-1.1784361525381273,0.2647058823529412,0.9172101711327133,1.0,1/19,0.43%,THBS1
prerank,GO_Biological_Process_2021__positive regulation of B cell differentiation (GO:0045579),-0.7870267362223736,-1.178403158935542,0.26785714285714285,0.9162775791286594,1.0,2/5,12.20%,MMP14;SYK
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),-0.5995589644055657,-1.1783524842849737,0.22727272727272727,0.9154662626315122,1.0,2/30,2.39%,C3;B2M
prerank,GO_Biological_Process_2021__heat acclimation (GO:0010286),0.6859362266179792,1.1780913699509672,0.24444444444444444,0.9707516786934514,1.0,1/5,5.62%,HSPA1A
prerank,GO_Biological_Process_2021__cellular heat acclimation (GO:0070370),0.6859362266179792,1.1780913699509672,0.24444444444444444,0.9707516786934514,1.0,1/5,5.62%,HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.5689272626666542,-1.1779852538749802,0.24358974358974358,0.9162526132651723,1.0,3/32,3.84%,LEF1;TGFBR2;PDPN
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),0.5144041384454606,1.1777456095031855,0.1875,0.9706749993161076,1.0,3/22,10.83%,FAM47E;DNMT3B;KMT2A
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),0.6225860579498679,1.1776011950938696,0.24324324324324326,0.9694344068043245,1.0,2/7,7.99%,PPARGC1A;VCP
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),-0.6170858353900183,-1.1774374886366552,0.2361111111111111,0.9175024108718565,1.0,1/21,0.67%,SP100
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),0.5920479918073556,1.1772650083887215,0.17857142857142858,0.9690183612615008,1.0,1/16,0.01%,CPA1
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transporter activity (GO:1901017),-0.7589911877510048,-1.1772456354708156,0.22807017543859648,0.9171671507164605,1.0,1/5,8.07%,CAV3
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.5498204787717332,-1.1772368254660697,0.20253164556962025,0.916151185546427,1.0,6/54,14.67%,LEF1;CDKN2A;CCNB1;SRF;CCND1;RUNX2
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),-0.695956380964138,-1.1771457845254953,0.27692307692307694,0.9155322043750586,1.0,1/10,0.17%,KLF2
prerank,GO_Biological_Process_2021__protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328),0.7676668278484723,1.1770445750446252,0.2702702702702703,0.9664415714867408,1.0,1/5,9.74%,SNF8
prerank,GO_Biological_Process_2021__establishment of protein localization to vacuole (GO:0072666),0.7676668278484723,1.1770445750446252,0.2702702702702703,0.9664415714867408,1.0,1/5,9.74%,SNF8
prerank,GO_Biological_Process_2021__humoral immune response mediated by circulating immunoglobulin (GO:0002455),-0.7966633960030093,-1.176707626384973,0.26229508196721313,0.9166587546099384,1.0,3/5,19.13%,C1R;C1S;C1QB
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),0.5552782068933368,1.176466343789398,0.2692307692307692,0.9670983047724341,1.0,10/18,25.77%,EXOSC6;INTS7;INTS8;INTS6L;TOE1;INTS14;EXOSC8;USB1;EXOSC5;INTS6
prerank,GO_Biological_Process_2021__removal of superoxide radicals (GO:0019430),0.7352076857799903,1.176262758344745,0.3333333333333333,0.9663267238508062,1.0,2/6,12.69%,SOD3;PRDX1
prerank,"GO_Biological_Process_2021__fructose 1,6-bisphosphate metabolic process (GO:0030388)",-0.7710081510617812,-1.1761776871891165,0.28846153846153844,0.9182058816373286,1.0,3/5,21.25%,ALDOB;FBP1;PFKL
prerank,GO_Biological_Process_2021__regulation of interleukin-1 production (GO:0032652),-0.6981234920980461,-1.1761337300679,0.3076923076923077,0.9173015827928521,1.0,3/9,10.60%,ANXA1;CEACAM1;NLRP12
prerank,GO_Biological_Process_2021__antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.6741040926699615,-1.1761200701487642,0.265625,0.9162619241070085,1.0,1/12,0.12%,CXCL2
prerank,GO_Biological_Process_2021__positive regulation of ruffle assembly (GO:1900029),-0.6675849147710541,-1.1760594461571645,0.3090909090909091,0.9155581476810175,1.0,4/11,16.30%,P2RY12;EPS8L2;PLEKHM1;NLGN1
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),0.44364573108678046,1.1758802958870405,0.18181818181818182,0.9658514980162555,1.0,28/92,23.93%,MRPL10;MRPS30;EEF1D;EEFSEC;MRPL15;PTCD3;MRPS9;MRPS2;MRPL37;MRPL58;MRPL52;GFM2;MRPL50;MRPS35;MRPL42;MRPS27;MRPL18;MRPL47;MRPS31;MRPL41;MRPS14;MRPL9;MRPS7;MRPL1;MRPS11;MRPL4;EEF2;MRPL13
prerank,GO_Biological_Process_2021__positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),0.7985630420880157,1.1758686815126385,0.2391304347826087,0.9642948780043847,1.0,1/5,7.27%,LMO3
prerank,GO_Biological_Process_2021__monoacylglycerol metabolic process (GO:0046462),-0.7290427799526866,-1.1758644504283315,0.3064516129032258,0.9154143965216457,1.0,1/8,1.95%,DGAT2L6
prerank,GO_Biological_Process_2021__presynapse organization (GO:0099172),0.6319608684151234,1.1753353164332414,0.20689655172413793,0.9647480954315985,1.0,2/11,4.49%,WNT7A;NLGN3
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.6625302551701256,-1.1752735926024647,0.2898550724637681,0.9173845204920361,1.0,1/13,2.43%,ZFP36
prerank,GO_Biological_Process_2021__positive regulation of production of molecular mediator of immune response (GO:0002702),-0.5997289370375445,-1.1750635918258534,0.24,0.9173464932778508,1.0,6/16,18.80%,WNT5A;TNFRSF14;HLA-E;SCIMP;GPI;PTPRC
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),-0.5552608604585578,-1.1750536991356455,0.20987654320987653,0.9163518550130919,1.0,9/33,14.90%,SERPINA10;TIMP2;SERPINF1;SPOCK3;TIMP1;SERPIND1;SERPINE3;SPINK6;SERPING1
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),-0.5720520740157181,-1.1748973746142382,0.25757575757575757,0.9161200922869245,1.0,7/24,18.20%,OGN;IL12A;IGFBP5;APOD;VIP;APLN;CDKN1A
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),-0.5663480495425223,-1.1745747847678547,0.23943661971830985,0.9167459559369369,1.0,10/27,26.11%,APP;SYP;SHISA8;SHISA9;SLC4A10;GRIK2;CLN3;NSMF;MCTP1;NETO1
prerank,GO_Biological_Process_2021__response to lead ion (GO:0010288),-0.7165022263902452,-1.1745347243584339,0.2542372881355932,0.9158235556894139,1.0,2/5,22.14%,PLSCR1;MAPT
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),-0.4692386638577205,-1.174491999250882,0.19101123595505617,0.9149810208183602,1.0,44/149,23.90%,RPL3;RPL19;RPS27;RPS14;RPL27A;RPL7A;RPL35;NOB1;EMG1;RPL37A;RPL21;RPL27;RPL13A;RPL9;RPS16;RPL24;RPLP1;RPL10A;RPL10;RPLP2;RPL38;RPS7;RPL8;RPS15;RPL5;RPL12;RPL18A;RPS9;MRTO4;PES1;RPL23;RPS6;RPS25;DDX54;RPL7;RPL4;MAPT;WDR46;RPL41;RPL11;EXOSC7;RPL15;RPL36;RPL29
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),0.483499720749911,1.1742945382387115,0.14814814814814814,0.9667739254954694,1.0,2/30,2.10%,LEPR;REEP6
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of NF-kappaB (GO:0007253),0.7093896243797401,1.1742837938733273,0.2564102564102564,0.9652234893657045,1.0,2/7,15.74%,PSMD10;NFKBIB
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),-0.579615743212098,-1.1741930795854036,0.2835820895522388,0.9154992676126993,1.0,2/27,2.43%,PIF1;ZFP36
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),-0.4946661581415941,-1.173694954749431,0.22988505747126436,0.9168985514918416,1.0,11/106,6.49%,FLRT3;NPY;CFAP126;L1CAM;POU4F1;STMN2;LAMB1;SH3GL2;RAB11A;PLP1;APP
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),-0.646895082956491,-1.1736244278619983,0.2753623188405797,0.9162126253226484,1.0,6/17,20.70%,MRAP2;GBP1;PPFIA1;TMBIM1;TGFB1;NUMB
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),0.443789136949338,1.1735468941269067,0.28,0.9660315482809275,1.0,13/60,19.51%,U2AF1;NUDT21;WDR33;CSTF3;PAPOLA;CPSF7;MTPAP;TENT4A;THOC1;THOC3;TENT4B;RPRD1B;CPSF2
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),-0.6230305641853937,-1.1735216175642822,0.25333333333333335,0.9156733627631373,1.0,8/26,19.31%,CALD1;FSCN1;BAIAP2L1;BAIAP2;DMTN;DPYSL3;ADD2;RHOD
prerank,GO_Biological_Process_2021__ribonucleoprotein complex disassembly (GO:0032988),0.7353740360049276,1.173512543128547,0.21052631578947367,0.9645098096263324,1.0,3/7,14.08%,VCP;TFIP11;DYRK3
prerank,GO_Biological_Process_2021__ribosomal large subunit export from nucleus (GO:0000055),0.6972625252492572,1.17349422658787,0.3877551020408163,0.9630377476682352,1.0,1/6,9.59%,XPO1
prerank,GO_Biological_Process_2021__positive regulation of membrane depolarization (GO:1904181),-0.805800017961756,-1.172887136989122,0.25,0.9174540921213298,1.0,2/5,12.36%,ANK3;MLLT11
prerank,GO_Biological_Process_2021__protein autoprocessing (GO:0016540),-0.6849282386467763,-1.172718713281939,0.3050847457627119,0.9173585618911636,1.0,2/10,17.18%,KLK6;MYRF
prerank,GO_Biological_Process_2021__adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.6804660245214642,1.172383137479704,0.2692307692307692,0.9656742597476087,1.0,5/9,24.73%,ADRA1A;DRD2;ADRB2;ADRB1;RAPGEF2
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.6856002903742073,-1.1723147046758877,0.27692307692307694,0.9181789904953163,1.0,3/8,18.90%,NOS1AP;NOS1;CACNB1
prerank,GO_Biological_Process_2021__nucleobase catabolic process (GO:0046113),-0.7246155437557165,-1.1722603612947722,0.27586206896551724,0.9172933251026599,1.0,4/6,26.76%,CRMP1;DPYSL3;DPYSL2;DPYD
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),-0.6558070016055016,-1.1720523245696943,0.2631578947368421,0.9172175402810954,1.0,5/13,17.20%,ICAM1;WNT5A;CD55;CFH;NOXA1
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),-0.5441661169593199,-1.1720321086686043,0.1875,0.9163061717535022,1.0,3/51,4.09%,ECM2;S100A10;SKAP1
prerank,GO_Biological_Process_2021__osteoblast development (GO:0002076),0.7385603786383432,1.1719928964573743,0.42424242424242425,0.9654075000922325,1.0,2/6,2.59%,LIMD1;MEN1
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),-0.6905715262744299,-1.1718931513191029,0.29577464788732394,0.9159630111230865,1.0,2/14,9.27%,RAMP3;AKAP5
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),-0.4941171968599262,-1.1718045622086821,0.2077922077922078,0.9152372497153569,1.0,13/87,17.72%,GGT5;CXCL2;ZFP36;IL12A;CCL2;WNT5A;PDCD1LG2;TNIP2;DAB2IP;SBNO2;SELP;NOS1;SLC11A1
prerank,GO_Biological_Process_2021__vitamin K metabolic process (GO:0042373),0.722450944246938,1.1714259254878652,0.39285714285714285,0.9662308866383807,1.0,4/6,23.30%,CYP4F3;CYP4F12;UBIAD1;VKORC1L1
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),0.46668370917835506,1.1713732610654486,0.10526315789473684,0.9648100103273936,1.0,12/43,16.99%,ERCC8;EGFR;BRCC3;UBE2N;TRIM28;ERCC6;HMGB1;SPIRE2;HDAC10;EYA2;EYA1;CEBPG
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),-0.5941884410794378,-1.1712738486240233,0.2923076923076923,0.916715076772177,1.0,2/18,1.77%,EFNA1;TGFBR2
prerank,GO_Biological_Process_2021__hair cell differentiation (GO:0035315),0.6692808056329963,1.171033032459695,0.30303030303030304,0.9646345923497084,1.0,3/7,12.97%,ERCC2;ERCC3;USH2A
prerank,GO_Biological_Process_2021__sensory perception of taste (GO:0050909),-0.7097000513963633,-1.170972098236151,0.35294117647058826,0.9170993919027829,1.0,4/6,28.63%,TAS1R1;CD36;ASIC2;ASIC3
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),-0.6267829207526836,-1.1709119047606322,0.23376623376623376,0.9164225703522058,1.0,2/23,1.48%,C3;NR4A3
prerank,GO_Biological_Process_2021__insulin metabolic process (GO:1901142),-0.7806175209641908,-1.1706811791960243,0.24074074074074073,0.9166823116942384,1.0,2/5,9.65%,PCSK2;CEACAM1
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),0.5021660926783545,1.170503841977325,0.25,0.9645261097903037,1.0,3/28,4.38%,MEOX2;ACE2;SGCD
prerank,GO_Biological_Process_2021__negative regulation of B cell apoptotic process (GO:0002903),0.6772834568881779,1.1704896208640079,0.325,0.9629824063903665,1.0,2/6,4.77%,BCL10;FOXP1
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),0.6254204123014196,1.17031376290129,0.3333333333333333,0.9620390553784095,1.0,5/13,21.64%,PPARGC1A;SLC25A18;ETFDH;SLC25A22;SDHB
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),-0.6869139621125204,-1.1703102588058123,0.25,0.9173798604825535,1.0,2/13,1.48%,C3;NR4A3
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),0.5885117614842714,1.1702658588258972,0.2,0.9605924292000384,1.0,3/10,19.77%,VDAC2;BAD;BCL2L11
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),0.46533082881600996,1.170121625305024,0.22727272727272727,0.9596120298009345,1.0,6/29,9.13%,PDK4;ADIPOR1;RUBCNL;AKT2;AKT1;GNB3
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.5867663049290814,1.1699255883276407,0.30303030303030304,0.9586786794819214,1.0,1/12,1.86%,RPP40
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.5133145764468476,-1.1697092313944457,0.2125,0.9191610626666928,1.0,23/74,20.91%,CD24;ACKR4;P2RY10;TRPC3;CAV3;GPR18;LPAR4;S1PR3;ITPR3;LPAR6;JPH3;CD55;GLP1R;CACNA1C;ADCY5;CIB2;CCR10;JPH4;PLCE1;ADCY8;RYR2;TAC4;GPER1
prerank,PanglaoDB_Augmented_2021__Schwann Cells,-0.4988698136684671,-1.1696765759068926,0.14772727272727273,0.9183233199462707,1.0,34/124,21.08%,APLNR;NPY;NRN1;RCAN2;MATN2;BCAS1;ART3;CTHRC1;PLP1;SEMA3B;IGFBP5;THY1;RASL12;GAP43;APOD;GFAP;TCEAL6;MAG;HAPLN2;LMOD1;SHC2;DAB2IP;FGF1;NDRG1;ADCY5;DCLK1;STMN1;CNTN2;TNS2;AQP1;PHYHIP;ITGB4;TCEAL7;TMEM132C
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),0.40615678325162013,1.1693453649549155,0.06666666666666667,0.9589313625506786,1.0,40/90,32.59%,U2AF1;PPARGC1A;SNRPF;SF3B4;HNRNPC;RP9;NOVA1;SMNDC1;SYNCRIP;SNRPN;DHX15;CDK12;CCAR2;MBNL1;PDCD7;USB1;YJU2;MAGOH;SNRNP48;SNRPB;SCAF11;PRPF18;LSM1;KHSRP;SRPK2;SCNM1;DHX16;SNRNP35;PTBP1;MAGOHB;SNRNP40;SRSF2;LSM6;SF3B1;PPIG;SF3B3;PPP2R1A;LUC7L3;HNRNPH3;SFPQ
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),-0.5349507032427654,-1.1691687273363056,0.23809523809523808,0.9196910241611986,1.0,1/46,0.16%,LEF1
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),-0.6992565418855547,-1.1688998594563846,0.3,0.9197938239240341,1.0,4/12,18.41%,APP;LDLR;PFDN6;PFDN1
prerank,GO_Biological_Process_2021__histone H4-K20 methylation (GO:0034770),0.7339522835289833,1.1687428521588044,0.358974358974359,0.9581022024609331,1.0,4/5,26.59%,SMYD5;BEND3;SETD4;KMT5B
prerank,GO_Biological_Process_2021__histone H4-K20 trimethylation (GO:0034773),0.7339522835289833,1.1687428521588044,0.358974358974359,0.9581022024609331,1.0,4/5,26.59%,SMYD5;BEND3;SETD4;KMT5B
prerank,GO_Biological_Process_2021__aromatic compound catabolic process (GO:0019439),0.7271119142563205,1.1686585403610183,0.3448275862068966,0.9567630055641388,1.0,2/6,18.30%,PON2;PON1
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),0.4134095296727734,1.1684835363210575,0.2,0.9557763773723973,1.0,23/104,15.03%,ETV5;PPARGC1A;SOD3;PRDX6;SLC25A24;EIF2S1;HSPA1A;KEAP1;EGFR;BRF2;ANKRD2;AKT1;ADNP2;AKR1C3;ERMP1;RAD52;SESN2;PTPRK;MAPK8;PRDX1;CAT;PRKD1;PRDX3
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),0.4430051834651287,1.1681302516282375,0.1875,0.9555318210352413,1.0,13/61,12.37%,SLC26A7;SLC19A1;SLC25A24;CA2;SLC39A8;SLC4A7;CA12;SLC25A19;SLC4A4;SLC25A41;CA3;CYB5R4;SLCO1C1
prerank,GO_Biological_Process_2021__mRNA cleavage involved in mRNA processing (GO:0098787),0.5585598914662498,1.1680205009779419,0.21621621621621623,0.9542682260816734,1.0,5/13,19.51%,NUDT21;CPSF6;CPSF7;ERN1;CPSF2
prerank,GO_Biological_Process_2021__fluid transport (GO:0042044),-0.7777355520607118,-1.167983970793219,0.2,0.9229573751682768,1.0,2/7,5.69%,PDPN;SLC4A11
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),-0.5760372192153709,-1.1679482080753707,0.2916666666666667,0.9221380642215695,1.0,3/26,8.62%,EFNA1;TIMP2;TIMP1
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),-0.48553475472805363,-1.16790952665154,0.1724137931034483,0.9212733150833118,1.0,37/134,20.67%,COL4A1;ANGPTL2;TAMALIN;COL4A2;CALD1;C1R;COL5A1;COL4A4;PI16;SULF1;SRPX2;IGFBP5;COX7A1;CYP1B1;BGN;SCARA3;ITGA5;LMOD1;SQOR;IGFBP7;ITGBL1;FN1;BMX;AMOTL2;ITGA9;TRIM47;PROCR;C1S;TNS2;COL12A1;AQP1;MMRN2;PXDC1;ROBO4;ITGB4;ADGRF5;ENPP4
prerank,GO_Biological_Process_2021__acylglycerol acyl-chain remodeling (GO:0036155),-0.7633597991572965,-1.167652972592617,0.32727272727272727,0.921572221934039,1.0,1/5,1.95%,DGAT2L6
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),0.41984024794663277,1.1675266529724466,0.21052631578947367,0.9545684430720504,1.0,7/57,8.63%,RGCC;BMP2;NMB;RAB27A;CADPS2;APBB3;MYOM1
prerank,GO_Biological_Process_2021__N-acylethanolamine metabolic process (GO:0070291),0.7211602782364027,1.1670992717584276,0.325,0.9533304475077093,1.0,4/5,27.70%,GDE1;NAPEPLD;GDPD1;NAAA
prerank,GO_Biological_Process_2021__ethanolamine-containing compound metabolic process (GO:0042439),0.7211602782364027,1.1670992717584276,0.325,0.9533304475077093,1.0,4/5,27.70%,GDE1;NAPEPLD;GDPD1;NAAA
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),0.6276036141353862,1.1670605168128245,0.2,0.9519058655967876,1.0,2/17,1.15%,MTHFS;SLC19A1
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),-0.6060963674010996,-1.1668627107783722,0.2676056338028169,0.9244271486357398,1.0,4/18,10.99%,SFTPD;GPNMB;PDCD1LG2;TNFRSF14
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),0.5365750419102006,1.1667475250403958,0.24242424242424243,0.951605175404428,1.0,1/28,0.54%,RNF6
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.5450580676980342,-1.16663531021316,0.24050632911392406,0.9244202998143536,1.0,13/43,19.86%,P2RY6;P2RY12;HTR2B;CHRM1;P2RY10;GPR18;LPAR4;LPAR6;VIP;HRH1;HTR2A;PTH1R;PLCE1
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),-0.7345736593718624,-1.1663958351669799,0.3,0.9245829038194213,1.0,1/7,1.77%,TGFBR2
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.706727127026289,-1.16618539259277,0.2698412698412698,0.9245947018313887,1.0,4/12,8.07%,SCN1B;KCNQ1;NOS1AP;CAV3
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),-0.5588979154225052,-1.1661568890822875,0.2345679012345679,0.9237048216194194,1.0,2/32,2.68%,AMN;ANK3
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),-0.6185029857710265,-1.165879605795147,0.2727272727272727,0.9240177871255871,1.0,5/26,17.19%,PIF1;ANKRD28;CDK2;RPA1;NOP10
prerank,MSigDB_Hallmark_2020__Spermatogenesis,-0.5133214097304313,-1.1658648192935508,0.24050632911392406,0.9230368152272994,1.0,17/85,17.06%,CCNB2;TEKT2;RPL39L;ART3;MEP1B;CLGN;GAPDHS;NEFH;ZC2HC1C;SCG5;SEPTIN4;GSG1;GAD1;PCSK1N;KIF2C;NOS1;CDKN3
prerank,PanglaoDB_Augmented_2021__Melanocytes,-0.4960682863490579,-1.1657623000970776,0.1728395061728395,0.9225822336735943,1.0,29/115,22.44%,COL4A1;ANGPTL2;COL4A2;CALD1;LAMB1;CSPG4;GPNMB;SRPX2;FILIP1L;THBS2;FLG;MMP14;OSMR;EMP1;PRRX1;CCND1;FN1;RHBDF1;AMOTL2;MLANA;TNS2;COL12A1;PXDC1;ANTXR1;CTNS;PTPN21;SYNC;GPC1;PLAT
prerank,GO_Biological_Process_2021__negative regulation of glucose import (GO:0046325),0.6861956701957288,1.1657274639571495,0.3157894736842105,0.9536696211956037,1.0,2/6,28.27%,PID1;APPL2
prerank,GO_Biological_Process_2021__negative regulation of leukocyte proliferation (GO:0070664),0.7379201152348249,1.1653912408761633,0.2903225806451613,0.9532383454073637,1.0,2/6,4.53%,GREM1;TNFAIP3
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,-0.494237973017368,-1.1650005231365141,0.18292682926829268,0.9248590102953621,1.0,19/78,13.14%,ANXA1;NR4A3;MYO1F;HLA-A;KMO;PDPN;TAGAP;SLA;P2RY10;IGSF6;HLA-C;TLR3;HLA-DRA;PDCD1LG2;CLEC12A;HLA-B;CTSS;SCIMP;ADAM19
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),-0.6248877469766577,-1.1649702340836043,0.24242424242424243,0.9239644297313782,1.0,7/17,25.17%,TLR3;STAT1;IRF7;IFIH1;RIPK2;HSPD1;NLRC3
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.6983251343349669,1.164934126053694,0.2702702702702703,0.953301200810374,1.0,6/9,29.56%,SMARCAD1;HDAC2;SIRT2;HDAC9;REST;RCOR1
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),-0.6396034337789497,-1.1648671187105566,0.3235294117647059,0.9234077033481206,1.0,4/14,8.11%,MAOB;DUOX1;PRDX5;PRDX4
prerank,GO_Biological_Process_2021__positive regulation of muscle contraction (GO:0045933),-0.7401149641517248,-1.1641471779664518,0.3088235294117647,0.9256014553233798,1.0,2/6,18.85%,SRF;SPHK1
prerank,GO_Biological_Process_2021__regulation of coagulation (GO:0050818),0.7285473565573013,1.164068640755744,0.4,0.9554601980392318,1.0,1/5,2.18%,HS3ST5
prerank,GO_Biological_Process_2021__internal protein amino acid acetylation (GO:0006475),0.6918265353772356,1.1640352371777765,0.275,0.9541097639889395,1.0,4/7,15.27%,KAT2B;KAT2A;EP300;KAT7
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.5225387008466515,-1.1639277888603103,0.21518987341772153,0.9254537544342061,1.0,14/56,15.40%,EPN1;IFI6;SH3GL2;DOK1;EGF;HAP1;CEACAM1;PTK6;WDR54;RHBDF2;DAB2IP;MVP;TGFA;RHBDF1
prerank,GO_Biological_Process_2021__response to UV-C (GO:0010225),0.7704575751532878,1.1638584003700507,0.2692307692307692,0.953254019002861,1.0,2/6,9.34%,MAP3K4;YY1
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),-0.6502799691068377,-1.1638218708817016,0.2835820895522388,0.9249716189288193,1.0,1/14,0.71%,C3
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.7234884494191022,-1.1635564107541914,0.3389830508474576,0.925215061659181,1.0,1/5,5.06%,IFI35
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,-0.5080546013292624,-1.1635257348633579,0.189873417721519,0.9243445571439263,1.0,11/57,15.25%,CD24;EFNA1;KCNQ1;TJP3;OVOL2;FA2H;C1ORF115;CHRM3;SLC44A3;LGR5;TMC4
prerank,GO_Biological_Process_2021__regulation of cilium movement (GO:0003352),-0.7283449535513375,-1.1628842557198937,0.21428571428571427,0.9262657015319076,1.0,4/7,26.40%,CCDC39;DRC1;DNAAF1;CCDC40
prerank,GO_Biological_Process_2021__response to vitamin D (GO:0033280),-0.7882162381048795,-1.1627818400386276,0.328125,0.9257570189546356,1.0,5/5,21.20%,ALPL;FES;SPP1;SFRP1;CDKN2D
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process (GO:0006085),0.6572359188482462,1.162359377894968,0.325,0.9570210540450629,1.0,4/9,24.40%,ACSS1;MLYCD;DLAT;PDHA1
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),0.5691814895988342,1.1623183090400269,0.2857142857142857,0.9556957688409803,1.0,13/18,32.67%,ZNF706;NCOA3;KAT2A;CNOT2;CNOT1;ESRRB;WDR43;ZC3H13;TAF5L;REST;LOXL2;ELAVL1;PTN
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),-0.6518946813876919,-1.1622601129161607,0.24615384615384617,0.9270990272530533,1.0,2/22,1.77%,APLNR;TGFBR2
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.6496531168321046,-1.162227787813563,0.2463768115942029,0.9262579881794721,1.0,2/14,11.75%,PLAAT4;LPCAT4
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),0.5500138107656558,1.1620011780860418,0.358974358974359,0.9553297149391043,1.0,2/17,1.72%,NGF;SOX8
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),0.5110465488686586,1.1618983367837723,0.24324324324324326,0.9541383406417014,1.0,8/23,18.13%,ABHD17A;LYPLA2;ABHD17B;SIRT6;SIRT5;ABHD17C;HDAC10;LYPLAL1
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.7048067432376237,-1.1616116016871512,0.2835820895522388,0.9281317095126453,1.0,2/13,10.82%,MSX2;GATA1
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),-0.6606044897741241,-1.1615856960290416,0.27419354838709675,0.9271899882559618,1.0,3/10,20.38%,NOD1;RIPK2;ERBIN
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),-0.6403874891088159,-1.1612768978410302,0.3283582089552239,0.9274288780779413,1.0,4/14,15.59%,TMEM204;SULF1;SFRP4;ITGA3
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),-0.5008730725658971,-1.1610778797948604,0.2235294117647059,0.9274005219687844,1.0,17/77,18.23%,CACNA1H;CALD1;MYOF;MYOT;GJC1;CAV3;DYSF;UTS2;SNTB1;MYH11;LMOD1;TNNT1;TPM4;TLN1;NOS1;GLRA1;OXTR
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.5159385672302361,-1.1609680242028064,0.22093023255813954,0.9269312343730348,1.0,13/60,19.52%,ANXA1;CDKN2A;GPNMB;KIF14;CCL2;KLF4;GFI1B;CCND1;PSME1;CDKN1A;LSM11;WEE1;HYAL1
prerank,GO_Biological_Process_2021__negative regulation of monooxygenase activity (GO:0032769),-0.6943222958432973,-1.160771519954959,0.31746031746031744,0.9266740483108262,1.0,1/6,8.07%,CAV3
prerank,GO_Biological_Process_2021__replicative senescence (GO:0090399),-0.7072481861305775,-1.1604324761833675,0.29508196721311475,0.927123309202725,1.0,2/10,12.52%,CDKN2A;ROMO1
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),0.5151931037109203,1.1603304287061793,0.20689655172413793,0.9580709913558372,1.0,3/21,5.82%,SLITRK2;ABHD17A;ABHD17B
prerank,GO_Biological_Process_2021__organic cyclic compound catabolic process (GO:1901361),-0.7417863417237145,-1.159996521205466,0.3,0.9284964910724808,1.0,2/6,14.58%,HSD17B14;CYP3A4
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),-0.6520365522056608,-1.1599134198487946,0.3064516129032258,0.9279365770708135,1.0,1/8,1.77%,TGFBR2
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),-0.5275548451319795,-1.1598948781837513,0.2857142857142857,0.926966688419383,1.0,9/55,9.86%,KCNJ13;KCNJ2;SLC39A14;SLC8A3;SLC24A2;ATP1A1;ATP1B1;SLC9A2;SLC24A1
prerank,GO_Biological_Process_2021__negative regulation of B cell activation (GO:0050869),0.6085502160214196,1.1596939326747822,0.22857142857142856,0.9591817387260462,1.0,5/12,17.38%,TNFAIP3;FOXJ1;SAMSN1;RC3H1;ID2
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.4536607226977309,1.1591061921013157,0.2,0.9599304653876755,1.0,10/41,22.91%,SMARCAD1;SIRT6;MIER3;ELK4;HDAC2;PRDM5;HDAC10;MTA2;MIER2;SIRT2
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.6333406944612233,-1.1590933317036773,0.29850746268656714,0.928616488720759,1.0,1/13,2.43%,ZFP36
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.6333406944612233,-1.1590933317036773,0.29850746268656714,0.928616488720759,1.0,1/13,2.43%,ZFP36
prerank,GO_Biological_Process_2021__positive regulation of receptor binding (GO:1900122),-0.7746924003002197,-1.1587265340049417,0.2982456140350877,0.9294341595681943,1.0,3/5,17.71%,B2M;BDNF;ANXA2
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),0.48084451424656816,1.1585949224346301,0.17857142857142858,0.9601714319508218,1.0,11/19,28.71%,BRCC3;KAT2A;USP3;USP49;USP36;TRRAP;USP22;ENY2;USP15;USP7;UIMC1
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.6026798134273413,-1.1585478502661108,0.23529411764705882,0.9280469090488278,1.0,6/26,16.37%,RPS27A;TLR3;IRF7;UBC;BIRC3;FADD
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.6026798134273413,-1.1585478502661108,0.23529411764705882,0.9280469090488278,1.0,6/26,16.37%,RPS27A;TLR3;IRF7;UBC;BIRC3;FADD
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),0.7386714206815499,1.1583522242681297,0.3939393939393939,0.9597387725064641,1.0,2/6,4.53%,NR1D1;TNFAIP3
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),-0.6721290905363301,-1.1581225198472216,0.2786885245901639,0.9289442564675418,1.0,1/12,0.21%,ANXA1
prerank,GO_Biological_Process_2021__cellular response to superoxide (GO:0071451),0.7129930584044251,1.1573611541885078,0.3076923076923077,0.9615959127544716,1.0,2/7,12.69%,SOD3;PRDX1
prerank,GO_Biological_Process_2021__GDP-mannose metabolic process (GO:0019673),-0.7063391110342454,-1.1571440672110143,0.3448275862068966,0.9325693467809528,1.0,1/6,5.42%,GMPPB
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),0.631223036731586,1.1567635645766432,0.275,0.9623153421956019,1.0,5/10,24.42%,NT5C1A;ADSS2;AK4;AK3;NT5E
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane potential (GO:0086036),-0.730977305800198,-1.1566265265466396,0.3548387096774194,0.9338222590082152,1.0,1/6,7.82%,PLN
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),0.6711736520022851,1.1565390297283251,0.3783783783783784,0.9617557984058812,1.0,2/6,15.57%,HSPA1A;CPNE1
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),0.513466370310769,1.156384438601555,0.32142857142857145,0.960821803632838,1.0,4/21,8.12%,PDE3A;SOX9;PDE7B;ADCY1
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),0.5527880551174139,1.1563240044268885,0.22580645161290322,0.959598545935776,1.0,9/32,13.45%,NGF;ASCL1;BRINP3;BMP2;BEND6;KCTD11;ZC4H2;BRINP2;HEYL
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),-0.5645758464264955,-1.156042494060769,0.32,0.9355611367796748,1.0,4/26,9.65%,GBP1;CD160;THY1;CEACAM1
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),-0.6259652569449768,-1.1560285843090796,0.27692307692307694,0.9346296317840997,1.0,5/18,18.51%,SYT4;SYT1;RIMS2;CPNE9;SYT2
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),0.400495975224394,1.1560207740517363,0.11764705882352941,0.9592124078904064,1.0,11/71,13.89%,EPHA6;NCSTN;EFNA2;EFNB2;GIT1;YES1;AP2B1;EFNA5;ARHGEF28;WASL;NCK2
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),-0.5649843867541422,-1.1558275327849343,0.20833333333333334,0.9346211639176959,1.0,6/26,19.68%,CENPV;CENPH;MIS18A;CENPN;CENPU;CENPP
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),-0.5962674317935168,-1.1556282555360937,0.26153846153846155,0.9345315329300027,1.0,1/20,0.43%,THBS1
prerank,GO_Biological_Process_2021__regulation of glial cell differentiation (GO:0045685),-0.762132481273088,-1.1555558424724686,0.3090909090909091,0.9338564116798828,1.0,1/5,8.27%,OPALIN
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),-0.5330117582218045,-1.1555329470336402,0.2597402597402597,0.9330207174174403,1.0,6/26,13.03%,THBS1;TLR2;TLR3;HLA-B;SYK;SCIMP
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),-0.6825612744908909,-1.1555098423540007,0.2878787878787879,0.9321418506234719,1.0,1/11,11.75%,LPCAT4
prerank,GO_Biological_Process_2021__cobalamin metabolic process (GO:0009235),-0.6130975795486802,-1.1553594187652978,0.3709677419354839,0.9308473103438696,1.0,1/15,1.40%,AMN
prerank,GO_Biological_Process_2021__tetrapyrrole metabolic process (GO:0033013),-0.6130975795486802,-1.1553594187652978,0.3709677419354839,0.9308473103438696,1.0,1/15,1.40%,AMN
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),-0.6747834416989615,-1.1553443453168848,0.296875,0.9299377103233091,1.0,1/12,1.73%,MET
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),0.6113621293249358,1.1549026323334277,0.3,0.9617605989758986,1.0,6/14,19.49%,ERI1;INTS7;INTS8;INTS6L;TOE1;INTS14
prerank,PanglaoDB_Augmented_2021__Basal Cells,-0.5140542963307236,-1.1548309270071833,0.25609756097560976,0.9316085189239844,1.0,23/67,20.67%,A4GALT;TYMP;MYOF;ITGA2;SLC16A3;EPS8L2;SRPX2;DUOXA1;RARRES1;FBXO32;ADIRF;EMP1;CD9;ITGA3;LTBR;ANXA2;PLP2;CAPN1;SPHK1;LAMA3;RHOD;ITGB4;HEBP2
prerank,GO_Biological_Process_2021__positive regulation of activated T cell proliferation (GO:0042104),-0.6878292437522099,-1.1547131679337292,0.35714285714285715,0.9312187670754137,1.0,6/10,16.37%,CD24;IL27RA;IGF1;HHLA2;IL18;FADD
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),0.5652403481476227,1.1546955158558199,0.3548387096774194,0.9610607784749797,1.0,3/10,21.73%,ACVR1C;ACVR2A;TGFBR1
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),-0.5848712671952343,-1.1545577675539047,0.2876712328767123,0.9309370504601977,1.0,3/25,5.84%,P2RY6;P2RY12;HTR2B
prerank,GO_Biological_Process_2021__copper ion transport (GO:0006825),-0.6792532960693448,-1.1542785674046172,0.3181818181818182,0.9315216156396747,1.0,4/10,24.22%,STEAP3;ATOX1;STEAP2;STEAP4
prerank,GO_Biological_Process_2021__axon choice point recognition (GO:0016198),-0.7151763747082435,-1.1538390025151786,0.42592592592592593,0.9327111733665855,1.0,2/5,9.11%,APP;GAP43
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),0.48387297022124615,1.1538094584343292,0.25,0.9629139944660916,1.0,5/27,12.88%,RAB33B;COG6;COPB2;VTI1A;GOLGA5
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",-0.5377253251571464,-1.1531982263387395,0.3375,0.9347264480333001,1.0,2/52,1.06%,LEF1;CDKN2A
prerank,GO_Biological_Process_2021__defense response to tumor cell (GO:0002357),-0.7504154633792441,-1.153055234957852,0.2962962962962963,0.9342998763216689,1.0,3/6,21.97%,KLF4;DLEC1;SPI1
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),-0.5654533706160524,-1.1529578059953467,0.3013698630136986,0.9337586744538713,1.0,6/26,22.90%,TOMM7;ARIH2;PINK1;BAP1;MICALL2;UBL5
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),0.6528273754257555,1.152749098083129,0.2972972972972973,0.9632746900045159,1.0,9/10,34.63%,SESN2;SESN3;RPTOR;SESN1;MTOR;LARS1;KLHL22;UBR1;UBR2
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),0.6528273754257555,1.152749098083129,0.2972972972972973,0.9632746900045159,1.0,9/10,34.63%,SESN2;SESN3;RPTOR;SESN1;MTOR;LARS1;KLHL22;UBR1;UBR2
prerank,GO_Biological_Process_2021__replication fork protection (GO:0048478),-0.7193647698814012,-1.1526301566131631,0.27692307692307694,0.9342572883784404,1.0,2/8,11.58%,BLM;DONSON
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),-0.5365189217429597,-1.15252621099883,0.22784810126582278,0.9336374567218658,1.0,1/46,0.03%,ENPP2
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,-0.5024038564426649,-1.1524391006030617,0.21839080459770116,0.9331075175620769,1.0,21/92,15.61%,ENPP2;APLNR;P2RY12;RAMP3;MAOB;GRIN2A;PLP1;GRIA3;GALNT15;OPALIN;GFAP;TCEAL6;CHI3L1;IGSF21;CA10;RNASE1;TGFA;SERPING1;RASSF4;SYNPR;BAALC
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),0.6850678773308259,1.1523627952945519,0.3125,0.9632787373572574,1.0,2/8,14.48%,BMP2;HDAC2
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),-0.620645358203715,-1.1520387717487757,0.29411764705882354,0.933923829468984,1.0,2/14,6.49%,C3;APP
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),0.5751652458880558,1.1519705107584393,0.34285714285714286,0.9635507460825316,1.0,9/15,27.22%,INTS7;INTS8;INTS11;MEPCE;INTS4;MTREX;INTS6;ZCCHC8;INTS9
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),-0.7058640957070415,-1.1519677084762951,0.328125,0.9332532570917391,1.0,2/9,9.23%,KCNQ1;EGF
prerank,GO_Biological_Process_2021__interleukin-23-mediated signaling pathway (GO:0038155),-0.7630671407812084,-1.1518154804205976,0.3442622950819672,0.9329285010029235,1.0,1/6,5.27%,STAT4
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),0.533214194183521,1.151707442945409,0.25925925925925924,0.9631427201230732,1.0,4/18,12.15%,ABCD2;RAB27A;ABCD1;ADGRB1
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),-0.4860276299423695,-1.1516691259084335,0.17045454545454544,0.9325514942874057,1.0,19/120,11.87%,LEF1;ANXA1;THBS1;GBP1;ZFP36;SFTPD;GPNMB;IL12A;NLRC5;ISG15;ADCY7;APOD;CEACAM1;KLF4;PDCD1LG2;NLRP12;ZFPM1;HERC5;SIGIRR
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),-0.5775306789565556,-1.1516220403735022,0.28205128205128205,0.9317610858335201,1.0,9/31,18.85%,TLR2;SFTPD;IL15;PLSCR1;DYSF;SYK;SLC11A1;PTPRC;SPHK1
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),0.40466115992640145,1.1515105380524775,0.15384615384615385,0.9623249052562706,1.0,12/85,11.08%,U2AF1;PPARGC1A;RIDA;NUDT16L1;HSPA1A;SNRPF;SF3B4;SF3A1;NUDT21;CSTF3;HSF1;CPSF6
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),-0.717911411955887,-1.1512629014523594,0.3,0.9323808659219404,1.0,1/7,1.48%,NR4A3
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),-0.4842171122364971,-1.1511616443345642,0.22580645161290322,0.9318736989804653,1.0,26/143,14.46%,THBS1;SP100;ISM1;APLNR;COL4A2;SPARC;SERPINF1;GPNMB;CD160;HK2;SULF1;WARS1;THBS2;ANGPTL3;WNT5A;CYP1B1;BRCA1;CEACAM1;KLF4;CHI3L1;STAT1;BTG1;EMP2;SFRP2;DAB2IP;FGF1
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),-0.5786076289631187,-1.1510589695961773,0.3333333333333333,0.9312445998098983,1.0,7/21,18.15%,PDPN;PROX1;CCDC39;CHI3L1;FGF1;ITGA3;FGF7
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),0.4079865942641208,1.1510421784155518,0.3,0.9622893205795688,1.0,24/91,19.41%,RANBP17;NXT2;NUP62CL;INTS13;PLK1;PPP1R10;AKT1;ARL2BP;IPO5;IPO8;NUP214;NXT1;RANBP6;MORC3;NUP188;HNRNPU;TAF8;NUP85;TAF3;TOR1B;IPO11;MDM2;PIKFYVE;NOL8
prerank,GO_Biological_Process_2021__positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.6660567738106099,1.1507632544240591,0.39473684210526316,0.9602340104914951,1.0,2/7,5.40%,SOX8;SOX9
prerank,GO_Biological_Process_2021__regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.6660567738106099,1.1507632544240591,0.39473684210526316,0.9602340104914951,1.0,2/7,5.40%,SOX8;SOX9
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),-0.5562301131140261,-1.1507185523027432,0.25675675675675674,0.9318805327795521,1.0,10/29,25.59%,SEPTIN5;CPLX1;RIMS2;CPLX2;KCNMB4;GPER1;PNKD;STX1B;MCTP1;RIMS1
prerank,GO_Biological_Process_2021__protection from non-homologous end joining at telomere (GO:0031848),0.6721486753274685,1.1502664873900104,0.3333333333333333,0.9603242914925244,1.0,4/7,23.81%,TFIP11;DCLRE1B;DCLRE1C;DCLRE1A
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.6795636841780482,-1.1501097766969317,0.27419354838709675,0.93372494850639,1.0,6/10,30.78%,DAB2IP;MMRN2;NIBAN2;EMILIN1;CNMD;CADM4
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),-0.5612157551303776,-1.1499698586506903,0.3188405797101449,0.9333848875704535,1.0,3/17,13.37%,MYO1F;MYO15A;MYO1E
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),-0.6171246060321914,-1.1499150077997766,0.3055555555555556,0.9326605986769887,1.0,4/16,16.98%,MET;ITGA3;STMN1;DLC1
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,-0.49892278405607876,-1.1498781436128758,0.1282051282051282,0.9318766364505322,1.0,26/104,17.78%,RIMBP2;CDH22;STMN2;SNCB;ZDHHC22;MYT1;ATRNL1;SLITRK1;SYT4;LRRTM1;SYP;GAP43;SLC18A2;HPCA;CPLX2;PRKCG;JPH3;SCN2A;KCNB2;CALY;STMN4;GDAP1L1;GAD2;CNTN2;KCNC1;GABRG2
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),0.4089884759829498,1.1498143151242952,0.1875,0.960822242278529,1.0,24/115,19.29%,FAM47E;CHRAC1;SMARCAD1;HMGN4;KAT2B;SOX9;KDM5A;HP1BP3;RBBP4;KAT2A;BRWD1;HMG20A;BAZ1A;HDAC2;SMARCA2;HDAC10;DR1;PADI4;HMGN3;TADA2B;MTA2;HMGN1;EHMT1;CDAN1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.7075829978198661,-1.149705933626735,0.31343283582089554,0.9316792340189184,1.0,2/8,9.29%,LRRC55;ATP1B1
prerank,GO_Biological_Process_2021__polyphosphate metabolic process (GO:0006797),0.7052738494962605,1.149544845826808,0.37142857142857144,0.9604225766267355,1.0,3/6,16.64%,MINPP1;BNIPL;PRUNE1
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),0.5877180998151483,1.1493965674113253,0.32,0.9593936883336918,1.0,2/10,4.47%,BMP2;GREM1
prerank,GO_Biological_Process_2021__cellular response to purine-containing compound (GO:0071415),-0.6785732450745738,-1.1493044316623677,0.31746031746031744,0.932354373840061,1.0,1/9,0.68%,P2RY6
prerank,GO_Biological_Process_2021__negative regulation of reproductive process (GO:2000242),-0.6750082590743738,-1.149269877584718,0.2676056338028169,0.9314947495872336,1.0,5/12,15.51%,DUSP1;SULF1;TIMP1;WEE2;IGF1
prerank,GO_Biological_Process_2021__regulation of keratinocyte apoptotic process (GO:1902172),-0.7668870319940451,-1.1489886806264815,0.1836734693877551,0.9319249922199727,1.0,2/5,15.36%,ZFP36;SFRP4
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),-0.6898579791424619,-1.1489107039877582,0.3230769230769231,0.9313892757115277,1.0,4/7,24.87%,TNFRSF1A;TGFB1;CHADL;EMILIN1
prerank,GO_Biological_Process_2021__regulation of fibrinolysis (GO:0051917),-0.7125861331499692,-1.148772607337978,0.31343283582089554,0.9308546637732031,1.0,1/7,0.43%,THBS1
prerank,GO_Biological_Process_2021__purine-containing compound metabolic process (GO:0072521),0.6899745139668634,1.148748016910793,0.32653061224489793,0.9603375237319942,1.0,3/6,23.21%,OARD1;FHIT;MACROD2
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.7130299755466619,-1.1486339531327685,0.29508196721311475,0.9304426229630541,1.0,2/9,9.03%,PARP14;PARP9
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),-0.5125178294400017,-1.148479294918552,0.225,0.9300054274731534,1.0,12/62,9.95%,GRIN2D;GRIN2A;SLC8A3;PLK2;SLC24A2;APP;CCL2;AKAP5;HAP1;SYT1;SLC24A1;RIMS2
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),-0.5662937365730365,-1.1484523373239766,0.2647058823529412,0.9291794939934223,1.0,5/24,14.84%,SOCS3;ST18;ST3GAL6;STAT1;SBNO2
prerank,GO_Biological_Process_2021__positive regulation of lipid localization (GO:1905954),-0.7463689951461467,-1.1484407952972298,0.296875,0.9282860588566643,1.0,1/7,0.71%,C3
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),-0.5914902280947167,-1.1483105461274892,0.2898550724637681,0.9278178571207369,1.0,3/19,14.80%,APP;WDR54;LRPAP1
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),-0.5640440492853896,-1.148083169429193,0.273972602739726,0.927894429401808,1.0,5/32,10.13%,FAT2;PTP4A3;ANLN;CYP1B1;STAT1
prerank,GO_Biological_Process_2021__regulation of cilium beat frequency (GO:0003356),-0.734379430260524,-1.1479826678764504,0.2463768115942029,0.927324109253978,1.0,1/6,5.70%,CCDC39
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),-0.6726187398058318,-1.147898471440322,0.37254901960784315,0.9266515835017916,1.0,2/7,8.07%,MLIP;CAV3
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.7052478430933016,1.1478030137087885,0.2558139534883721,0.9627383770738038,1.0,1/7,2.82%,SRI
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),0.5894703386558913,1.1477187741643398,0.2857142857142857,0.9615284285509549,1.0,2/15,11.11%,FLT3;CSF1R
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),-0.6003961813608971,-1.1474264936268308,0.2727272727272727,0.9278048031995122,1.0,9/25,23.46%,C1R;C1RL;GRIN2A;MMP14;PGK1;FADD;RIPK2;PLAT;CASP8
prerank,GO_Biological_Process_2021__negative regulation of complement activation (GO:0045916),-0.7127040302407549,-1.1470359253503948,0.3559322033898305,0.9285430256270092,1.0,5/9,25.89%,CD55;SERPING1;SUSD4;A2M;CR1L
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),-0.6203698134095683,-1.1467936885487282,0.3088235294117647,0.9286356443813875,1.0,2/15,3.96%,ABCA5;ABCA8
prerank,GO_Biological_Process_2021__detection of bacterium (GO:0016045),-0.6543342001596757,-1.1467280153383412,0.3064516129032258,0.9279731017025151,1.0,3/9,11.94%,HLA-A;NOD1;HLA-B
prerank,GO_Biological_Process_2021__regulation of blood-brain barrier permeability (GO:1905603),-0.7347842334200541,-1.1466694019709287,0.36507936507936506,0.9272604839724524,1.0,2/7,5.05%,TJP3;SH3GL2
prerank,GO_Biological_Process_2021__negative regulation of telomerase activity (GO:0051974),-0.7019227650187012,-1.1465764606024265,0.37735849056603776,0.9267119888314211,1.0,1/9,0.56%,PIF1
prerank,GO_Biological_Process_2021__axon development (GO:0061564),-0.49960938209540406,-1.14652548844705,0.27710843373493976,0.9260192045719746,1.0,13/71,9.32%,CCK;L1CAM;POU4F1;ANK3;SHTN1;S100A6;PLP1;SLITRK1;APP;MAP1B;BAIAP2;GAP43;NEFH
prerank,GO_Biological_Process_2021__box C/D snoRNP assembly (GO:0000492),0.6616350774265073,1.1464978664472674,0.3333333333333333,0.9644661873980855,1.0,4/7,24.02%,NUFIP1;ZNHIT3;RUVBL1;ZNHIT6
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),-0.6096606207548052,-1.1464503931617351,0.3492063492063492,0.9253705477152504,1.0,3/15,11.87%,SYP;SYNGR2;STX19
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),-0.5452516013115916,-1.1464089393171306,0.3698630136986301,0.9246122401819754,1.0,6/38,17.71%,STAT4;IL12A;LMNB1;TCP1;CA1;ANXA2
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),0.524448392533781,1.1462856479699604,0.3333333333333333,0.9636004138737752,1.0,4/24,8.06%,SOX8;SOX9;ANKRD2;RANBP3L
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),-0.6305297080556485,-1.146040730044594,0.3333333333333333,0.9252965536245732,1.0,5/11,26.51%,WNT5A;TGFB1;CD74;CUEDC2;TGFB3
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),0.5576919352705145,1.145600064658639,0.2857142857142857,0.9644504045843029,1.0,6/14,15.54%,EFNB2;GREM1;AKT1;ROBO1;GPLD1;EPHB4
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),-0.5144663802073969,-1.145568824381444,0.2894736842105263,0.9262946682272274,1.0,13/58,19.39%,PROX1;BAIAP2L1;CDC42EP1;BAIAP2;VIL1;SYNPO2L;PFN2;LMOD1;CDC42EP3;FES;CDK5;MYLK3;WDR1
prerank,MSigDB_Hallmark_2020__Hypoxia,-0.46652356130311257,-1.145347631107725,0.14772727272727273,0.926380206151805,1.0,53/162,24.60%,CP;EFNA1;DUSP1;ALDOB;FOSL2;COL5A1;ZFP36;KDELR3;HK2;LDHA;MAFF;PRDX5;ATF3;VLDLR;GAPDHS;GLRX;BGN;P4HA2;LXN;FOS;BTG1;PDK3;FBP1;PDK1;TPD52;PIM1;MYH9;NDRG1;GALK1;PGK1;GPI;IER3;ANXA2;CDKN1A;GPC3;LDHC;PFKFB3;IRS2;PFKL;F3;ANKZF1;CDKN1C;GPC1;ETS1;KLF6;HSPA5;CAVIN1;BHLHE40;ENO2;DDIT4;GYS1;NFIL3;PAM
prerank,MSigDB_Hallmark_2020__Protein Secretion,0.4308663454779481,1.145316956954467,0.3076923076923077,0.964070227066145,1.0,18/90,15.43%,BET1;TMX1;ABCA1;ARFIP1;EGFR;AP3S1;SEC22B;STX7;AP2B1;RAB22A;ERGIC3;COPB2;AP3B1;DOP1A;RPS6KA3;RAB9A;ARCN1;VAMP3
prerank,GO_Biological_Process_2021__negative regulation of peptide hormone secretion (GO:0090278),-0.6795071763097413,-1.1450983865842073,0.3150684931506849,0.9264995767349121,1.0,2/12,9.58%,KCNB1;BMP8A
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),0.5387008568038898,1.145080855930785,0.3142857142857143,0.9636710769329311,1.0,4/16,6.95%,KAT2B;RIOK2;METTL18;RIOK1
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),-0.6084381068722926,-1.1449046997522567,0.25675675675675674,0.9263214603269702,1.0,10/29,22.19%,KCNB1;IL12A;RAB11FIP1;RAB11FIP5;BMP8A;RHBDF2;RHBDF1;CD200;SFRP1;RSAD2
prerank,GO_Biological_Process_2021__mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615),-0.7852223259379764,-1.1447726185786224,0.3137254901960784,0.9259400818748227,1.0,1/5,5.55%,ATP23
prerank,GO_Biological_Process_2021__glycosylceramide biosynthetic process (GO:0046476),-0.7320230389979994,-1.1446911081450917,0.29411764705882354,0.9253730061735992,1.0,3/7,10.72%,B3GALT2;UGT8;FA2H
prerank,GO_Biological_Process_2021__glutamine metabolic process (GO:0006541),0.6491650135270395,1.144626108837214,0.3225806451612903,0.963594161824984,1.0,4/8,22.25%,GLUD1;GLS;GLUL;CAD
prerank,GO_Biological_Process_2021__regulation of pH (GO:0006885),0.6573394142222955,1.14459039786942,0.3488372093023256,0.962275207355647,1.0,1/8,3.00%,PDK4
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),-0.5647965851952371,-1.1445751898681764,0.25,0.9250102818232445,1.0,3/28,8.18%,MX1;MYOF;DYSF
prerank,GO_Biological_Process_2021__lipid transport across blood-brain barrier (GO:1990379),-0.724682938457724,-1.144412563433547,0.3484848484848485,0.9245975339668883,1.0,2/5,26.74%,MFSD2A;CD36
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),-0.6351887572035386,-1.144368178316776,0.3220338983050847,0.9238560578269874,1.0,1/15,0.76%,SIX3
prerank,GO_Biological_Process_2021__negative regulation of myoblast differentiation (GO:0045662),0.6403614623904812,1.144185490333548,0.42857142857142855,0.962400642033117,1.0,3/10,6.70%,SOX8;SOX9;ANKRD2
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.5699259069416661,1.144091457362564,0.2972972972972973,0.9613270461744683,1.0,3/14,18.06%,GNL3L;MUL1;PIAS4
prerank,GO_Biological_Process_2021__synaptic vesicle docking (GO:0016081),-0.7033315429114031,-1.1438461700503821,0.32727272727272727,0.9249394734072133,1.0,2/6,22.13%,UNC13C;STX1B
prerank,PanglaoDB_Augmented_2021__B Cells Memory,-0.5265449099143122,-1.1435671155207718,0.24358974358974358,0.9252701613285634,1.0,13/54,15.30%,RASGRP2;TAGAP;TMC8;P2RY10;GPR18;RCSD1;ARHGAP9;WAS;ACAP1;CTSS;IL7;SP140;ZBTB32
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",0.6953148452682726,1.1434957805617998,0.3404255319148936,0.9617527294197706,1.0,1/6,2.18%,HS3ST5
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,-0.4765946474345692,-1.1434168734627952,0.2261904761904762,0.9250104511661612,1.0,42/121,18.91%,GRIN2D;SPINK8;TAGLN3;CDH22;CCK;STMN2;KCNB1;SNCB;GRIN2A;SLC32A1;SLITRK1;SYT4;LRRTM1;GRIA3;ELAVL4;SRRM4;GRIA1;NRGN;GAP43;GFAP;TCEAL6;IGSF21;HPCA;RIT2;CA10;CPLX2;TCEAL2;PCP4;KCNB2;CALY;C11ORF87;STMN4;GRIN2B;GAD2;SYNPR;CNTN2;KCNC1;GABRG2;TCEAL5;OXTR;RAB3C;GABRA1
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),-0.6027344507866819,-1.1432661958591381,0.3013698630136986,0.9247512599051825,1.0,3/19,9.29%,SCN1B;KCNQ1;ATP1B1
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),-0.572571602263796,-1.1432039593806178,0.26865671641791045,0.9241898982035393,1.0,4/21,10.81%,TMSB10;PFN4;VIL1;PFN2
prerank,GO_Biological_Process_2021__positive regulation of macrophage proliferation (GO:0120041),0.6771432071405051,1.1430215401302186,0.325,0.9624759541950065,1.0,3/5,29.73%,CSF1R;PTK2;MAPK1
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),-0.7081026393400844,-1.1430104268782018,0.27419354838709675,0.9240748352649986,1.0,3/8,23.13%,CDK2;AQP1;KCNC2
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),-0.6508585982599269,-1.1428556557867664,0.3387096774193548,0.9239348278001016,1.0,3/11,8.67%,LEF1;TGFBR2;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta production (GO:0071636),-0.7687597030986716,-1.1426657379686636,0.23333333333333334,0.9237783331657555,1.0,1/6,0.43%,THBS1
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),-0.5458540039655392,-1.1422540196028794,0.2631578947368421,0.9247108428096975,1.0,4/39,9.40%,ZFP36;IFITM3;HEXIM1;POLR2I
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),0.4267754519122614,1.142237844843642,0.2631578947368421,0.9639528873573078,1.0,13/71,12.88%,LEPR;SLC6A13;SLC19A1;AGER;SLC24A3;SLC15A2;SLC4A4;ABCC2;ATP1A2;SLCO1C1;SLC5A6;ATP8A1;SLC6A1
prerank,GO_Biological_Process_2021__oxidative RNA demethylation (GO:0035513),0.7182160415271783,1.141822246884105,0.38461538461538464,0.9640749572853046,1.0,4/5,27.35%,ALKBH3;JMJD6;ALKBH1;FTO
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),-0.454159555878252,-1.1418135589344003,0.2222222222222222,0.9255829366740181,1.0,22/118,19.88%,ARHGAP4;TAGAP;ARHGAP15;ARHGEF3;TRIP10;PLEKHG2;ARHGEF17;ARHGAP9;ARHGAP39;DEPDC1B;ARHGDIG;ARHGEF18;RHOF;FOXM1;OBSCN;VAV1;DLC1;A2M;RHOD;RELN;PLCE1;ARHGAP18
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,-0.4956366898361376,-1.141678474725084,0.2375,0.9252079661588103,1.0,30/98,22.62%,GBP2;COL4A1;COL4A2;C1R;MATN2;COBLL1;SULF1;SRPX2;IGFBP5;BGN;SCARA3;OSMR;FN1;IL17RE;FGF1;AMOTL2;FRAS1;C1S;TNS2;LAMA3;RHOD;COL12A1;PXDC1;ADGRF5;F3;PTPN21;FMO2;SVEP1;PCSK6;SLCO2A1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),-0.5251305788048325,-1.1416317378921146,0.25925925925925924,0.9244413047275665,1.0,10/52,14.22%,THBS1;HPN;SPARC;B2M;SULF1;CEACAM1;STAT1;ATP5IF1;SFRP2;DAB2IP
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),-0.5866651563678712,-1.141349952098634,0.3287671232876712,0.9246854703720996,1.0,5/23,18.04%,NPY;GLRA2;HCRTR2;MCHR2;GLRA1
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,-0.4629225684485466,-1.1413329173154152,0.18181818181818182,0.9238458440819362,1.0,45/160,20.54%,ENPP2;CDH22;BCAS1;ST18;SNCB;ZDHHC9;PLP1;EFNB3;ANLN;NKX6-2;KLK6;VLDLR;OPALIN;NINJ2;MOG;GFAP;TCEAL6;MOBP;IGSF21;MAG;HAPLN2;FA2H;HPCA;CA10;CPLX2;TMEM163;FAM163B;CREB5;STMN4;ADCY5;SYNPR;ARRDC2;TMEM151A;PLLP;RGS7BP;MYRF;CNTN2;TCEAL5;MCAM;ADAMTS4;PHYHIP;ADCY8;SLC25A29;FASN;ITGB4
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),0.562049790730485,1.1413265213799977,0.25,0.9643156638790713,1.0,1/16,0.13%,LEPR
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),-0.5834850095900288,-1.1412474292381787,0.3880597014925373,0.923240974645275,1.0,1/17,5.54%,WNT8B
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),0.35361463764405543,1.141171140871139,0.2,0.9634268859129516,1.0,53/258,17.18%,POLD3;CHRNA4;FANCF;APEX2;ERCC8;DNA2;MEN1;PRIMPOL;LIG4;UBE2T;KPNA2;RFWD3;PMS1;RFC3;SMARCAL1;BRCC3;UBE2N;TRIM28;ERCC6;VCP;PRMT6;COMMD1;WDR33;CSNK1E;MSH2;SLC30A9;ERCC2;RAD52;XRCC2;ATR;TDP2;DCLRE1B;MAPK8;HUS1;ERCC3;RAD9B;MGME1;POLK;ASF1A;EXD2;MSH3;GTF2H5;HERC2;ATRIP;ALKBH3;BACH1;RAD51B;TENT4A;EYA1;GTF2H2;GTF2H2C;ERCC6L2;APTX
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.6504569760723343,-1.1411048713303125,0.2631578947368421,0.9229450170675021,1.0,2/10,8.07%,MLIP;CAV3
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),-0.5972583738185839,-1.1410787310012127,0.32432432432432434,0.9222259101794662,1.0,10/24,24.73%,MET;WAS;ARHGEF18;TMEFF2;STMN1;DLC1;PPFIA1;RHPN2;PHLDB2;ARHGAP6
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),-0.6094898448048893,-1.1405945431988227,0.28169014084507044,0.9231516807457636,1.0,10/21,24.73%,MET;WAS;ARHGEF18;TMEFF2;STMN1;DLC1;PPFIA1;RHPN2;PHLDB2;ARHGAP6
prerank,GO_Biological_Process_2021__regulation of dopamine uptake involved in synaptic transmission (GO:0051584),0.7198850914528752,1.140583337365941,0.3137254901960784,0.9640435491220327,1.0,1/5,11.06%,DRD2
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),-0.44166252545879564,-1.1405670177120513,0.18947368421052632,0.9223840331977076,1.0,29/304,10.49%,ENPP2;LEF1;ANXA1;THBS1;ARHGAP4;TMSB10;LAMB1;PDPN;GPNMB;NEXN;KIF14;SULF1;PODXL;CEMIP;SEMA3B;BST2;IGFBP5;THY1;PODN;ANGPTL3;MMP14;LDB2;CYP1B1;EGF;VIL1;CEACAM1;IGSF10;SST;CLIC4
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),-0.6809357802773157,-1.1404250820416693,0.3230769230769231,0.9220652303312619,1.0,5/9,14.65%,HLA-A;CEACAM1;HLA-B;HLA-E;HLA-F
prerank,GO_Biological_Process_2021__positive regulation of chromatin binding (GO:0035563),-0.650250466466579,-1.1402152338875378,0.2962962962962963,0.9221691218867176,1.0,5/8,33.22%,PARP9;DDX11;DTX3L;KDM4D;HMBOX1
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),0.5867800595276884,1.139984391139441,0.3333333333333333,0.9649940999013248,1.0,3/17,4.49%,WNT7A;CEL;NLGN3
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),-0.6309493930209256,-1.1399763766337583,0.3387096774193548,0.9222728095333304,1.0,5/17,18.51%,SYT4;SYT1;RIMS2;CPNE9;SYT2
prerank,GO_Biological_Process_2021__stabilization of membrane potential (GO:0030322),-0.7357144514389078,-1.1398289704986395,0.35294117647058826,0.9219550533651825,1.0,3/6,17.94%,KCNK1;KCNK10;KCNK12
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,-0.5095532789403929,-1.139733075554289,0.275,0.9214811406056431,1.0,15/61,19.35%,COL4A1;COL4A2;MYOF;SRPX2;MMP14;MYH11;OSMR;EMP1;RHBDF1;ITGA3;AMOTL2;SPHK1;LAMA3;RHOD;COL12A1
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),-0.5072196382794663,-1.1394799018363697,0.23809523809523808,0.9218489875888087,1.0,7/61,9.99%,KIF14;CENPV;PLK2;RAB11A;DCDC1;SVIL;PLK3
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),0.5317947892230627,1.1394044536506376,0.3,0.9652320790038001,1.0,2/20,6.14%,PRDX6;SF3B4
prerank,GO_Biological_Process_2021__proton-transporting ATP synthase complex assembly (GO:0043461),-0.7134918319440349,-1.1393101344415086,0.38181818181818183,0.9215902253221663,1.0,1/6,5.55%,ATP23
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),-0.7773876221081537,-1.139169827712394,0.26666666666666666,0.921249694914316,1.0,1/5,18.88%,BOK
prerank,GO_Biological_Process_2021__cardiocyte differentiation (GO:0035051),0.6053704968554555,1.1390821405335056,0.4,0.9647015143147601,1.0,1/8,2.60%,BMP2
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),-0.6324268538234039,-1.1390653022227857,0.38461538461538464,0.9207947583788888,1.0,4/12,9.29%,KCNJ2;ATP1A1;PLN;ATP1B1
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),-0.7185682577623926,-1.1390166115541736,0.35185185185185186,0.9200861578664329,1.0,1/6,6.83%,SCX
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.41916696624048744,1.1389912568471463,0.11764705882352941,0.9634843782230643,1.0,31/68,25.79%,CEBPA;PSMD10;TRIB3;CBFA2T3;PLK1;HSPA1A;KEAP1;BAG2;VCP;CSNK1E;RNF14;RCHY1;TRIB2;PYHIN1;COP1;RNF217;ZYG11B;MDM2;SUMO2;PTK2;NUB1;SMAD7;DDA1;SIRT2;FBXW7;DNAJB2;HSPBP1;ANKIB1;HECTD1;AXIN1;PTEN
prerank,GO_Biological_Process_2021__regulation of guanyl-nucleotide exchange factor activity (GO:1905097),-0.7508340297333125,-1.138916309034377,0.36538461538461536,0.9195594103466842,1.0,1/5,1.73%,MET
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),-0.5747367891899521,-1.1384870326505008,0.35714285714285715,0.9205826069965807,1.0,2/36,0.67%,LEF1;SP100
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),-0.7017438909186088,-1.1384337701031384,0.328125,0.9199172154282302,1.0,2/8,11.49%,TGFBR2;ZFPM1
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via STAT (GO:1904892),-0.6573273392507888,-1.1383059121040984,0.2898550724637681,0.9195557546922266,1.0,4/10,21.86%,EGF;MGAT5;PTPRC;HES1
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),0.6101752341109546,1.1382465550712126,0.29411764705882354,0.9642142998509315,1.0,3/10,18.40%,PCBP4;NOVA1;PCBP3
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),-0.6309775795974653,-1.1381017021978497,0.3484848484848485,0.9195218548931693,1.0,4/13,9.29%,KCNJ2;ATP1A1;PLN;ATP1B1
prerank,GO_Biological_Process_2021__regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.6397253794106557,-1.137948724196264,0.29577464788732394,0.919079842006853,1.0,2/11,9.07%,APP;SYP
prerank,GO_Biological_Process_2021__negative regulation of interleukin-17 production (GO:0032700),-0.7440218997022241,-1.1364374232123278,0.3448275862068966,0.9248369963147738,1.0,1/5,6.15%,IL12A
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),-0.4905092871645928,-1.1360364249894934,0.18681318681318682,0.9256291613989853,1.0,12/111,13.58%,MX1;AMN;SPARC;SFTPD;RAMP3;COLEC12;VLDLR;LDLR;AP1S1;SYK;M6PR;CD9
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",0.4518846383103919,1.135808857501374,0.09523809523809523,0.9710976108180766,1.0,2/32,5.49%,POLD3;RFC3
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),-0.6358329038689793,-1.1357462720500202,0.3384615384615385,0.9261837382479842,1.0,1/15,0.30%,CCBE1
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),-0.4971734828941309,-1.1356265990245937,0.2682926829268293,0.9257532656979771,1.0,23/79,14.65%,C3;B2M;HLA-A;ICAM1;SFTPD;IRF1;CD160;COLEC12;IL15;NPDC1;ADCY7;PLSCR1;HLA-C;HLA-DRA;CD99;HERC5;IRF7;HLA-B;SYK;PILRA;HLA-E;BIRC3;HLA-F
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),-0.6156347727179887,-1.1355648184222409,0.32786885245901637,0.9252098843760491,1.0,5/17,15.39%,TYMP;SLC8A3;APP;DLGAP3;NPTX2
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),-0.6002922233128953,-1.1355274294815005,0.2647058823529412,0.9244484075720335,1.0,5/18,15.94%,RPL3;RPL24;RPL10;RPL5;MRPL20
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),-0.6223833989629809,-1.1354778441220958,0.32051282051282054,0.923801916615169,1.0,1/16,0.78%,BLM
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),-0.5042887376892469,-1.1350552728489003,0.2702702702702703,0.9249793441749746,1.0,14/53,22.77%,TLR2;IFI35;IL15;APP;WNT5A;TLR3;NLRP12;OSMR;IL18;TNFRSF1A;NMI;ABCC1;NUPR1;ETS1
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),0.6310106629231839,1.134989618801041,0.38235294117647056,0.9723038595105121,1.0,3/9,14.61%,WDR91;PPP2R5A;PIK3R1
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.45489654836174637,1.1349661325033562,0.2222222222222222,0.9711023426926668,1.0,13/60,17.53%,ATP6V0D2;PDK4;ATP6V1A;AKT2;ATP6V1G1;AP3S1;AKT1;PIK3CA;GPLD1;PIK3R1;GRB14;PIK3C2A;IDE
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),-0.5623046475540201,-1.1349278135527032,0.2972972972972973,0.9247301421142174,1.0,4/26,15.88%,NPY;PROX1;DRAXIN;GRID2
prerank,GO_Biological_Process_2021__cellular response to muramyl dipeptide (GO:0071225),-0.6806477585485557,-1.13474825067397,0.36065573770491804,0.9245461002118336,1.0,2/8,19.78%,NOD1;RIPK2
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),-0.46790692293506264,-1.1346228071919642,0.23595505617977527,0.9241039319050289,1.0,30/168,20.19%,S100A10;RFTN1;PKP2;MRAP2;FYB1;ANK3;RAMP3;TESC;KCNB1;ZDHHC22;RAB11A;LRRC4;THY1;CAV3;ABCA12;ATP1B1;FYB2;EMP2;KCNB2;PLEKHF1;NLGN1;SCN3B;PDZK1;AGRN;TNFRSF1A;RAB3C;TSPAN32;FLOT1;ANK1;KCNIP4
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),-0.5528056647267002,-1.1341329496177268,0.27631578947368424,0.9253330471518671,1.0,9/31,27.27%,EFNA1;HAP1;IGF1;RTN1;RTN2;TMED10;RTN4;GSAP;SP1
prerank,GO_Biological_Process_2021__histone arginine methylation (GO:0034969),0.6560797485636536,1.13402523534348,0.3409090909090909,0.9731444448057461,1.0,2/7,8.09%,PRDM4;PRMT6
prerank,GO_Biological_Process_2021__negative regulation of receptor binding (GO:1900121),-0.768744894486997,-1.1339801664194264,0.26666666666666666,0.9252053907915508,1.0,1/5,2.39%,B2M
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),-0.4796265121783829,-1.1339753587340675,0.2619047619047619,0.9243530904566181,1.0,11/101,10.72%,GGT5;ALOX12;ACOT1;LDHA;SLC16A3;AKR1C1;GLYAT;ANGPTL3;PDHX;ACOT4;FA2H
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",-0.6868414627736228,-1.13358839473824,0.3230769230769231,0.9249347163879535,1.0,1/6,5.81%,RAB11A
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),0.39103199691640567,1.1335450718914042,0.13043478260869565,0.9732705639442252,1.0,23/74,21.10%,SDHAF4;SAMM50;COX18;NDUFB1;DMAC2;NDUFAF3;SMIM20;NDUFAF4;NDUFAF2;LYRM7;NDUFA8;NDUFV3;COX19;TIMMDC1;NDUFS1;UQCC1;FASTKD3;NDUFV1;NDUFB4;NDUFAF7;NDUFAF5;IMMP2L;CHCHD4
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.7033698136728257,1.1333833144210035,0.3235294117647059,0.972520475739953,1.0,3/6,20.78%,TNFAIP3;TIRAP;TLR1
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),-0.7041481493076067,-1.1333218463751353,0.3181818181818182,0.9241028846818822,1.0,1/7,1.30%,MX1
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),-0.7041481493076067,-1.1333218463751353,0.3181818181818182,0.9241028846818822,1.0,1/7,1.30%,MX1
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),-0.5878132642284288,-1.1330212784785252,0.2777777777777778,0.9245707563145498,1.0,2/20,5.51%,IHO1;HROB
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),-0.6519317250095935,-1.1329420168348134,0.36231884057971014,0.924051770300059,1.0,2/12,5.84%,NOS1AP;HTR2B
prerank,GO_Biological_Process_2021__galactosylceramide biosynthetic process (GO:0006682),-0.737387583194591,-1.1327714975111995,0.28125,0.9229687508403166,1.0,3/6,10.72%,B3GALT2;UGT8;FA2H
prerank,GO_Biological_Process_2021__galactolipid biosynthetic process (GO:0019375),-0.737387583194591,-1.1327714975111995,0.28125,0.9229687508403166,1.0,3/6,10.72%,B3GALT2;UGT8;FA2H
prerank,GO_Biological_Process_2021__axoneme assembly (GO:0035082),-0.5743038489575744,-1.1321602589856379,0.36363636363636365,0.9246828587395285,1.0,7/24,16.58%,RSPH4A;CCDC39;SPAG17;CFAP74;SPAG1;DRC1;LRGUK
prerank,GO_Biological_Process_2021__regulation of miRNA metabolic process (GO:2000628),0.6545711207989372,1.1321009861432594,0.35714285714285715,0.9752903472057699,1.0,4/5,25.69%,NFKB1;RC3H1;RC3H2;RELA
prerank,GO_Biological_Process_2021__oligodendrocyte development (GO:0014003),-0.6383384016248094,-1.1319132223257635,0.34782608695652173,0.9247167407244969,1.0,6/15,24.79%,CNTNAP1;PLP1;EIF2B2;MYRF;PRDM8;SOX10
prerank,GO_Biological_Process_2021__SNARE complex assembly (GO:0035493),0.6614532230080941,1.131895629861312,0.3448275862068966,0.9748500413695598,1.0,2/8,15.43%,STXBP6;VAMP3
prerank,GO_Biological_Process_2021__negative regulation of bone mineralization (GO:0030502),0.6049286369194797,1.131878004448235,0.3103448275862069,0.9735195063338298,1.0,2/8,12.12%,GREM1;ECM1
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858),-0.7551411584472256,-1.1316031947385916,0.3448275862068966,0.9251574385729052,1.0,2/5,9.65%,IL12A;CEACAM1
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),-0.5826147293320277,-1.1315180188043341,0.32,0.924656784492241,1.0,4/24,10.81%,VIL1;SYNPO2L;WAS;PFN2
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),-0.4761887009342308,-1.1311305806138063,0.25287356321839083,0.925470964983226,1.0,16/123,14.22%,CD24;RASGRP1;APIP;DUSP1;VRK2;TRIM5;CAV3;EGF;CEACAM1;RIT2;SYK;WDR54;FN1;THPO;MINK1;DAB2IP
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),-0.7200263734847073,-1.1310911060723148,0.3283582089552239,0.9247641189467667,1.0,1/7,0.43%,THBS1
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),-0.698104710039142,-1.131067609882819,0.3620689655172414,0.9239552834391793,1.0,2/7,8.21%,OGN;OMD
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,-0.5152771163181954,-1.1307454569222735,0.25925925925925924,0.9242834559590876,1.0,11/54,10.45%,CXCL2;IL1R1;C3;TYMP;NRN1;PPP1R14C;SFTPD;SIGLEC1;DUOXA1;KLF4;CLDN18
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),-0.5101741244152108,-1.130734795114668,0.26582278481012656,0.923444864419062,1.0,12/66,13.66%,RFTN1;TLR2;RPS27A;SFTPD;COLEC12;TLR3;SCARA3;TNIP2;CTSS;SCIMP;UBC;BIRC3
prerank,GO_Biological_Process_2021__sphingosine-1-phosphate receptor signaling pathway (GO:0003376),0.6916392432553209,1.1306878945461112,0.37209302325581395,0.9764890141079371,1.0,2/5,7.94%,S1PR1;AKT1
prerank,GO_Biological_Process_2021__positive regulation of lyase activity (GO:0051349),-0.6538754561567109,-1.1306693361856037,0.3283582089552239,0.9227901372399762,1.0,3/9,17.04%,AKAP5;CACNA1C;NOS1
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),-0.4557987548845608,-1.1305820969251734,0.22826086956521738,0.9222870837888084,1.0,35/157,23.59%,LEF1;THBS1;LAMB1;PDPN;GPNMB;DUOX1;PODXL;CEMIP;SEMA3B;ANGPTL3;MMP14;EGF;VIL1;FGF1;PLET1;F10;IGF1;DDRGK1;MGAT5;CCDC25;SEMA3E;SPHK1;RHOD;TGFB1;PIK3CD;SEMA4G;NUMB;FERMT3;GPER1;F3;MYO1C;RDX;PDGFRA;HSPA5;CAVIN1
prerank,GO_Biological_Process_2021__calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.6766463454613086,-1.130566000780618,0.31666666666666665,0.9214764608658058,1.0,3/7,10.45%,CLDN16;CLDN20;CLDN18
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),-0.5610468652735923,-1.130554358735689,0.25,0.9206436492143858,1.0,8/32,24.00%,TOMM7;ARIH2;ATP5IF1;PINK1;BAP1;MICALL2;UBL5;SREBF1
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),-0.46789702797382926,-1.130545119364446,0.19318181818181818,0.919796607012897,1.0,43/135,22.97%,THBS1;SPARC;APP;SYT4;F8;TIMP1;ABCA12;RAB11FIP1;GTPBP2;EGF;RAB11FIP5;SYT1;F5;CPLX1;RIMS2;SYNGR2;TAGLN2;CPLX2;CD9;FN1;MYH9;SERPING1;IGF1;TLN1;CD63;ABCC4;SELP;CDK5;SRGN;SYT2;A2M;F13A1;WDR1;TGFB1;FERMT3;SYT5;STEAP2;SYNGR3;SYT13;VCL;TF;RAB27B;SELENOP
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),-0.6167894332033721,-1.1302650854101466,0.273972602739726,0.9202054064709299,1.0,2/18,3.37%,TRIM22;TRIM5
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",0.41964315507616845,1.1298672978493356,0.2857142857142857,0.977942734070947,1.0,25/66,28.51%,MTERF1;SNRPF;NUDT21;UBTF;WDR33;CSTF3;ERCC2;PAPOLA;POLR1F;ERCC3;CPSF7;GTF2H5;GTF2H2;CPSF2;GTF2H3;CCNH;CSTF1;SSU72;SNRPB;CLP1;SCAF8;POLR1B;POLR2A;CSTF2T;POLR1A
prerank,GO_Biological_Process_2021__cellular response to estrogen stimulus (GO:0071391),0.6055451101176244,1.1296766295241258,0.29411764705882354,0.9771924024044039,1.0,4/13,8.18%,SERPINB9;TRIM24;NCOA4;AR
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),-0.5757458217404483,-1.1295856636785524,0.26153846153846155,0.9222920983098339,1.0,3/27,9.31%,ANXA1;DUOX1;VIL1
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),0.42260569056573594,1.1295462448054876,0.18181818181818182,0.9763285746624483,1.0,2/59,0.74%,G0S2;NGF
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),-0.6579543684922617,-1.1295462360297437,0.2962962962962963,0.9215876161639928,1.0,2/7,17.18%,TENM4;MYRF
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),-0.6013945784238287,-1.129350496587161,0.323943661971831,0.9216553472351124,1.0,4/20,12.41%,SP100;GPNMB;WARS1;EMP2
prerank,GO_Biological_Process_2021__negative regulation of glycoprotein biosynthetic process (GO:0010561),-0.6589756907908644,-1.1292940723035774,0.296875,0.921094234769682,1.0,2/9,17.76%,ITM2A;ACOT8
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process in the vacuole (GO:1904352),-0.7490167289665508,-1.1288991642078146,0.36764705882352944,0.9218767986828654,1.0,2/5,20.94%,LDLR;LRP2
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),0.47027806192955685,1.1288412201654454,0.2962962962962963,0.9771798193797111,1.0,6/27,24.89%,ZNF207;SLAIN2;TUBG1;TPX2;TUBGCP3;CLASP2
prerank,PanglaoDB_Augmented_2021__Mller Cells,-0.48307486681396505,-1.128709392028873,0.23529411764705882,0.9218499393470128,1.0,20/127,9.90%,COL4A1;APLNR;ANGPTL2;COL4A2;SPARC;TLR2;COL5A1;RCAN2;CD44;KCNJ2;PLP1;IGFBP5;THY1;THBS2;RASL12;LDB2;DBI;EDIL3;BGN;SCARA3
prerank,GO_Biological_Process_2021__neutral lipid catabolic process (GO:0046461),0.7679603821441724,1.128586215391803,0.32432432432432434,0.9766643347397768,1.0,3/5,16.34%,LYPLA2;MGLL;ABHD6
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),0.6192609018824473,1.1280710163405303,0.3235294117647059,0.9768602875330638,1.0,6/7,37.46%,AGO3;DDX3X;DHX36;AGO2;DHX9;AGO4
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),0.6102331802905542,1.1279418560095873,0.38235294117647056,0.975925147346211,1.0,6/13,22.94%,BMP2;SPRY1;HEYL;HEY2;TGFBR1;RBPJ
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),0.4870730601793416,1.12782983681619,0.2903225806451613,0.9750883114596661,1.0,4/20,10.39%,CFAP53;STIL;FOXJ1;ODAD3
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),-0.6251162995267031,-1.1276561954061421,0.3968253968253968,0.9256240908236936,1.0,3/14,14.46%,KLF4;ITGA5;FGF1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.6158769361789233,1.1274946572399906,0.4090909090909091,0.9749990338224263,1.0,1/11,1.19%,UQCRHL
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),-0.6051464127499485,-1.1270840045388977,0.26229508196721313,0.9272380461256287,1.0,3/13,17.18%,RIMS2;TENM4;MYRF
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),-0.4851656968665168,-1.126976200645941,0.3048780487804878,0.9267447573876388,1.0,12/70,18.20%,LEF1;SP100;IFIT1;TMC8;PLN;ZFPM1;IFIT2;LRPAP1;TFAP4;CTSZ;PRKCD;CDKN1A
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),-0.5831278681964802,-1.1268283769779044,0.3333333333333333,0.926494655747032,1.0,6/23,17.31%,ANK3;GLRX;ATP1B1;ABCB1;CTSS;PDZK1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),0.7082874238099365,1.1266187187188739,0.4,0.9767036288438162,1.0,2/5,23.83%,RBPJ;NFE2L2
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,-0.5239852447626248,-1.1262640285667382,0.29850746268656714,0.9279315413053942,1.0,10/35,12.79%,CXCL2;MYO1F;TLR2;TYMP;GPNMB;SIGLEC1;IGSF6;CLEC12A;PILRA;CTSS
prerank,GO_Biological_Process_2021__mature B cell differentiation involved in immune response (GO:0002313),-0.7184859913615212,-1.126123445831781,0.3620689655172414,0.9277276084426034,1.0,2/7,9.71%,GPR183;LFNG
prerank,GO_Biological_Process_2021__negative regulation of lipid catabolic process (GO:0050995),0.599020945139009,1.126061439682015,0.36666666666666664,0.9770315349283255,1.0,4/9,14.51%,PDE3B;PLIN5;AKT1;GPLD1
prerank,GO_Biological_Process_2021__protein localization to axon (GO:0099612),-0.7876370934798236,-1.1260450908155335,0.3157894736842105,0.927220105062994,1.0,2/5,4.56%,ANK3;CNTNAP1
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",-0.6867101594987854,-1.1260366780266915,0.3870967741935484,0.9264098728593109,1.0,1/7,5.81%,RAB11A
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),-0.5767119258272909,-1.1256495646172424,0.2676056338028169,0.9272036400533045,1.0,5/23,14.22%,THBS1;SP100;PFN2;SVBP;DAB2IP
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),-0.5755172429323956,-1.1254722624477065,0.3382352941176471,0.9270477629962162,1.0,2/23,7.73%,THBS1;ATP1A1
prerank,GO_Biological_Process_2021__protein kinase C signaling (GO:0070528),-0.7390044297970533,-1.125097271630456,0.359375,0.9277773606921186,1.0,2/6,19.63%,HTR2B;FLOT1
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,-0.4929289619596795,-1.1250658208914517,0.2804878048780488,0.927085964422948,1.0,17/80,15.58%,CACNA1H;RIMBP2;STMN2;TMEM74B;SYT4;LRRTM1;SLC18A2;SYT1;PLPPR1;CPLX1;CPLX2;SHC2;FAM163B;CALY;ADCY5;F10;PCSK1N
prerank,GO_Biological_Process_2021__regulation of skeletal muscle satellite cell proliferation (GO:0014842),0.6468678337196068,1.1248113822235657,0.3333333333333333,0.9801746254482573,1.0,1/6,14.33%,CFLAR
prerank,GO_Biological_Process_2021__endosomal vesicle fusion (GO:0034058),0.6486736697636692,1.1243649889662761,0.3548387096774194,0.980268754166954,1.0,4/8,17.14%,VPS39;TGFBRAP1;VPS8;VPS11
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),0.4337347735926814,1.1241527341686115,0.23809523809523808,0.9796605587178524,1.0,10/63,10.51%,RITA1;BEND6;POFUT1;KAT2B;MAML3;ENHO;EGFR;LLGL1;AKT1;RFNG
prerank,GO_Biological_Process_2021__myeloid dendritic cell activation (GO:0001773),-0.7083409174470938,-1.1240899716617425,0.40298507462686567,0.9302555968831325,1.0,1/5,1.77%,TGFBR2
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),-0.601691291800149,-1.1240052463142851,0.373134328358209,0.9296870880387368,1.0,7/15,27.31%,ANGPTL3;IL18;MTLN;PNPLA8;GCKR;XBP1;SCARB1
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),-0.6428015474971551,-1.1240031040355922,0.2923076923076923,0.9288411171682817,1.0,2/12,9.75%,ABCA12;ABCB1
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.474743040426637,1.123913325666617,0.3333333333333333,0.9793193323591473,1.0,4/23,9.70%,SLC26A7;SLC19A1;SLC25A18;ABCC2
prerank,GO_Biological_Process_2021__quaternary ammonium group transport (GO:0015697),-0.6666786760341308,-1.1238190037648716,0.38596491228070173,0.928908742201564,1.0,4/7,24.92%,SLC25A45;SLC22A4;SLC25A29;SLC22A1
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),0.404725832148371,1.1238060926989797,0.3333333333333333,0.9755275351807255,1.0,15/82,15.18%,PSMD10;BCL10;TAB3;PSMA1;NRAS;MUC20;PSMD11;CUL1;PSMB5;BTRC;PRKACB;PSMD14;PSMD12;NFKB1;EP300
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.404725832148371,1.1238060926989797,0.3333333333333333,0.9755275351807255,1.0,15/82,15.18%,PSMD10;BCL10;TAB3;PSMA1;NRAS;MUC20;PSMD11;CUL1;PSMB5;BTRC;PRKACB;PSMD14;PSMD12;NFKB1;EP300
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.404725832148371,1.1238060926989797,0.3333333333333333,0.9755275351807255,1.0,15/82,15.18%,PSMD10;BCL10;TAB3;PSMA1;NRAS;MUC20;PSMD11;CUL1;PSMB5;BTRC;PRKACB;PSMD14;PSMD12;NFKB1;EP300
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),-0.5838351225082588,-1.1235895261649647,0.3611111111111111,0.92910751895057,1.0,9/20,25.59%,SYT4;SYT1;RIMS2;SYT2;SYT5;SYT13;DOC2B;SYT12;RIMS1
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),-0.6610296242860036,-1.123559842668083,0.38596491228070173,0.9284032734132038,1.0,3/9,24.86%,DCTN1;CLMN;SYNE3
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),0.5506147487605584,1.1234159463301756,0.4,0.9755331019060847,1.0,3/18,9.42%,WNT7A;NLGN3;NRXN1
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),-0.6198926998323999,-1.1233634265346153,0.34782608695652173,0.9283400779494456,1.0,4/17,13.20%,SLC4A11;YBX3;RCSD1;SCN2A
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),-0.507180564481955,-1.1230665299619869,0.2839506172839506,0.9289007728056871,1.0,5/54,11.66%,THBS1;NR4A3;GATA1;ZFPM1;PRKCQ
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,-0.5180427995183756,-1.1230640028314578,0.2839506172839506,0.9280601554881593,1.0,18/54,19.49%,IL1R1;SOCS3;IL13RA1;TLR2;CD44;IRF1;IL4R;IFNGR2;STAT1;OSMR;CD9;PIM1;IL7;LTBR;IL3RA;TNFRSF1A;A2M;TGFB1
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),-0.6537873928758342,-1.1230295068882552,0.34782608695652173,0.9273133145903315,1.0,1/11,4.17%,KCNB1
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),-0.5814574144789736,-1.122709941414201,0.27941176470588236,0.9278042933005144,1.0,2/24,7.78%,STMN2;MAP1B
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,-0.4604572239063148,-1.1226611016529475,0.22727272727272727,0.9271587930907123,1.0,16/110,10.12%,KCNT2;RIMBP2;CHGB;PCSK2;STMN2;NEFM;SULF1;SYT4;THY1;GNRHR;GRIA3;GRIA1;ZNF385D;GAP43;ZNF536;SST
prerank,GO_Biological_Process_2021__glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),0.7223890779153066,1.1225414207260735,0.34210526315789475,0.9742549068196692,1.0,1/5,7.23%,DCXR
prerank,GO_Biological_Process_2021__glucuronate catabolic process (GO:0006064),0.7223890779153066,1.1225414207260735,0.34210526315789475,0.9742549068196692,1.0,1/5,7.23%,DCXR
prerank,GO_Biological_Process_2021__xylulose 5-phosphate biosynthetic process (GO:1901159),0.7223890779153066,1.1225414207260735,0.34210526315789475,0.9742549068196692,1.0,1/5,7.23%,DCXR
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",-0.7222962066286779,-1.1222590293911654,0.3770491803278688,0.9280783085892542,1.0,3/7,12.99%,HLA-A;IRF1;HLA-E
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),-0.5894671092098237,-1.12221080934668,0.30303030303030304,0.9274567096662429,1.0,4/20,16.23%,PLK2;SLC24A2;SLC24A1;ACHE
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.5996757114336182,1.121716124278699,0.30303030303030304,0.9759112643428439,1.0,4/14,13.61%,ABCD1;EHHADH;SCP2;ACOX1
prerank,GO_Biological_Process_2021__negative regulation of cytosolic calcium ion concentration (GO:0051481),0.7304439185247338,1.1216889926935747,0.35714285714285715,0.9746437375166722,1.0,2/5,11.06%,ATP1A2;DRD2
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via serine (GO:0018242),0.5696315173341725,1.121504222055931,0.34210526315789475,0.9738842671056602,1.0,5/9,21.93%,GALNT3;MGAT5B;GALNT1;POGLUT1;GALNT2
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),0.4405651842469746,1.121503738138204,0.23333333333333334,0.9725483490437868,1.0,5/24,16.44%,MCU;MFF;RALA;MUL1;MIEF2
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),-0.44075230905324886,-1.1212687242999293,0.1958762886597938,0.9303944022058906,1.0,46/345,15.66%,LEF1;PRAME;ANXA1;IFI6;THBS1;APIP;HPN;DHCR24;POU4F1;RPS27A;NAA38;CD44;PDPN;ALOX12;KIF14;PRDX5;PLK2;HTR2B;SCX;CCL2;RPS6KA1;IFIT3;WNT5A;PIM3;KLF4;NUAK2;PLK3;MAG;ITGA5;GATA1;UNC5B;PRKCG;RPS3A;UBC;BIRC3;PTRH2;RPL10;PIM1;RNF213;THOC6;VIP;PINK1;IL7;BCL2L2;IGF1;BDNF
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),0.5998758668425994,1.1212485832149113,0.2647058823529412,0.9721479277046192,1.0,2/14,11.11%,ARFIP2;CSF1R
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),0.4240064874254749,1.1209956911906351,0.29411764705882354,0.971674156955003,1.0,13/73,12.88%,LEPR;SLC6A13;SLC19A1;AGER;SLC24A3;SLC15A2;SLC4A4;ABCC2;ATP1A2;SLCO1C1;SLC5A6;ATP8A1;SLC6A1
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),-0.5278475646518871,-1.1206443922001503,0.3116883116883117,0.9322488156066897,1.0,12/41,21.96%,EFNA1;LAMB1;KIF14;ATRNL1;ITGA8;TMEFF2;FN1;RADIL;ANTXR1;MICALL2;FERMT3;LAMA5
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.665551087935956,-1.1205999645404647,0.43283582089552236,0.9315563835003011,1.0,3/10,25.92%,STAT6;GHR;STAT3
prerank,GO_Biological_Process_2021__regulation of lysosomal protein catabolic process (GO:1905165),-0.7218890270888421,-1.1204766403018382,0.3972602739726027,0.931315444746158,1.0,4/6,25.47%,LDLR;LRP2;MGAT3;LAPTM4B
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),-0.5268836399809138,-1.1198781446717239,0.2619047619047619,0.9330572503421385,1.0,2/48,0.33%,CD24;RASGRP1
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),0.46048408086830284,1.1196774331635173,0.19047619047619047,0.9748445000928033,1.0,8/35,10.43%,ASCL1;CPAMD8;FREM2;ZDHHC16;ADAMTS18;SMG9;PBX1;ATF6
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.4595510100679568,-1.1196617154552897,0.21739130434782608,0.9331124676504486,1.0,30/126,17.52%,FLRT3;CDH22;TGFBR2;L1CAM;FAT2;CLDN16;ICAM1;MYOT;CDH6;NEXN;CDH23;SLITRK1;LRRC4;CLDN20;CEACAM1;CDH12;IL1RAPL1;IGSF21;TENM4;CLDN18;MAG;CDH9;CDH7;CDH19;PCDHB5;GRID2;MMP24;NLGN1;SELP;CNTN2
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),0.4430644085466435,1.1192449592662073,0.21739130434782608,0.974888036029577,1.0,16/39,25.55%,PPARGC1A;MFF;PRMT6;CSNK2A2;MUL1;EP300;MIEF2;USP36;GOLPH3;FZD5;FBXW7;PID1;MARCHF5;MYO19;INF2;STOX1
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell apoptotic process (GO:0034391),-0.7353603626953373,-1.1190862327209823,0.34615384615384615,0.9344004842394166,1.0,2/6,6.15%,CDKN2A;IL12A
prerank,GO_Biological_Process_2021__transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),0.6608577130893455,1.1188425285440389,0.358974358974359,0.9750797347068941,1.0,3/6,26.71%,RAE1;PCID2;LDB1
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),0.5005007669824946,1.1188295463058893,0.34782608695652173,0.973790115517984,1.0,4/18,14.61%,OCLN;AKT2;AKT1;PIK3R1
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),0.5083018478472645,1.1188255283700907,0.1935483870967742,0.9724670311218999,1.0,4/16,6.84%,SLC30A4;SLC39A10;SLC39A8;SLC30A6
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta clearance (GO:1900222),-0.7786988815868343,-1.1185290438241386,0.3389830508474576,0.9357013831271642,1.0,2/5,14.80%,SRF;LRPAP1
prerank,GO_Biological_Process_2021__galactosylceramide metabolic process (GO:0006681),-0.7112421320686939,-1.1178534043774737,0.34375,0.9377444187085984,1.0,3/8,10.72%,B3GALT2;UGT8;FA2H
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),0.5314257053500767,1.1178388525761545,0.2727272727272727,0.9745810455570115,1.0,9/13,39.73%,DESI2;SENP6;ATG7;UBA3;UBA1;NAE1;UBA6;DESI1;SAE1
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),0.5408212567034674,1.1171916890333085,0.23684210526315788,0.9753989013079739,1.0,2/12,5.40%,PDK4;SOX9
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),0.3935007298947025,1.1170986105598963,0.3125,0.9743551575057106,1.0,14/55,16.01%,CCT7;ZPR1;PLK1;HCLS1;TESK1;TRIM28;AKT1;IPO5;CCT3;SESN2;EIF2AK3;PIK3R1;KAT7;PYHIN1
prerank,PanglaoDB_Augmented_2021__NK Cells,-0.5160794942456699,-1.1170474532062524,0.3026315789473684,0.9398824420921096,1.0,9/46,8.92%,MYO1F;CD5;ITGA2;TAGAP;SPON2;SLA;GPR171;P2RY10;ARHGAP9
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),0.6973688817311334,1.117023391813005,0.40425531914893614,0.9732590799754978,1.0,2/5,19.46%,TMEM33;RAB3GAP1
prerank,GO_Biological_Process_2021__protein K6-linked ubiquitination (GO:0085020),0.6547983789642553,1.116286631444256,0.40476190476190477,0.9744242500199557,1.0,2/8,3.16%,RNF6;UBE2T
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),-0.49775805684426844,-1.1162459907335978,0.2875,0.9426232636414825,1.0,12/60,13.36%,SCN1B;SLC6A15;KCNK1;SLC8A3;SLC4A11;SLC24A2;SCN9A;ATP1B1;SLC24A1;SLC5A4;SCN2A;SCN1A
prerank,GO_Biological_Process_2021__sequestering of BMP from receptor via BMP binding (GO:0038098),0.6870504311426432,1.1160363906267883,0.29411764705882354,0.9740094409983955,1.0,2/6,4.47%,BMP2;GREM1
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),0.46980319552380617,1.1158901510425874,0.2,0.9731379822222156,1.0,15/43,23.28%,H2BC18;H2BC21;SOX9;ANP32B;RBBP4;H1-2;ASF1A;PADI4;NOC2L;CDAN1;BAHD1;H2BC5;KAT6B;DAXX;SART3
prerank,GO_Biological_Process_2021__oogenesis (GO:0048477),-0.7046451564396794,-1.1158860093734209,0.40350877192982454,0.9433059870040573,1.0,1/10,3.22%,IHO1
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),0.6437599205073686,1.1158066457513458,0.425,0.9720494335702344,1.0,1/7,4.53%,TNFAIP3
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),-0.6485562588426235,-1.1157263571841167,0.36923076923076925,0.9430942871500478,1.0,4/12,16.71%,TIMP1;EMP2;DMTN;CD63
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),-0.49685956392060326,-1.1156349326775223,0.2702702702702703,0.9426409620501605,1.0,11/53,14.03%,CDH22;PKP2;CDH6;CNTNAP1;FSCN1;GJC1;CDH12;CDH9;CD9;CDH7;CDH19
prerank,GO_Biological_Process_2021__negative regulation of protein processing (GO:0010955),-0.6540345045085914,-1.1155497405063737,0.36764705882352944,0.9422186736235035,1.0,1/11,0.43%,THBS1
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,-0.5031682139934035,-1.1152904407677657,0.2891566265060241,0.9423331290094592,1.0,8/72,9.39%,PIF1;BLM;ERCC6L;HK2;CENPH;ATAD5;ALPL;DEPDC1B
prerank,GO_Biological_Process_2021__sno(s)RNA 3'-end processing (GO:0031126),0.5784977300622911,1.1150244656473265,0.3548387096774194,0.9731369253657144,1.0,7/11,28.06%,EXOSC6;TENT4B;DKC1;FBL;FBLL1;EXOSC5;LARP7
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),-0.5192591258061598,-1.1150110302179332,0.3188405797101449,0.9424624641711123,1.0,5/33,13.37%,MYO1F;MYO15A;SYT4;HAP1;MYO1E
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),0.427460058120137,1.1145101644593203,0.3333333333333333,0.9736926281115522,1.0,9/50,14.66%,NR1D1;SOCS6;ADAMTS9;TRIM24;VCP;UBE2G1;STT3B;ATE1;FBXO27
prerank,GO_Biological_Process_2021__regulation of non-motile cilium assembly (GO:1902855),-0.7089468247866032,-1.1145076031720218,0.36666666666666664,0.9437143736051383,1.0,3/6,23.96%,HAP1;CEP135;SEPTIN9
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),-0.6039832123168392,-1.1145050260761102,0.3194444444444444,0.9428936051124964,1.0,3/20,16.30%,TJP3;ARHGEF18;NLGN1
prerank,GO_Biological_Process_2021__regulation of chloride transport (GO:2001225),-0.7427145606726973,-1.1144248961408927,0.4126984126984127,0.9424278434165475,1.0,4/5,24.74%,ABCB1;GABRE;ATP8B1;GRM5
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter secretion (GO:0001956),-0.7024449887588917,-1.1144239180180313,0.3508771929824561,0.9415946560541001,1.0,3/6,22.13%,NLGN1;GPER1;STX1B
prerank,GO_Biological_Process_2021__TRAIL-activated apoptotic signaling pathway (GO:0036462),-0.7461511649941877,-1.114261185833552,0.3448275862068966,0.9413636533474141,1.0,5/6,24.88%,FADD;SPI1;TNFRSF10A;CASP8;ZDHHC3
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),0.5351957256808675,1.1141784195592634,0.3076923076923077,0.9731540867727406,1.0,4/13,16.29%,KBTBD7;ALS2;ARHGAP24;ARHGAP44
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),-0.4722047740221611,-1.1141383112223007,0.29069767441860467,0.9410955517581353,1.0,19/85,17.15%,FLRT3;CDH22;PKP2;POU4F1;CDH6;FSCN1;SLITRK1;GJC1;CDH12;CDH9;CDH7;FN1;CDH19;PCDHB5;BDNF;ACHE;NLGN1;TLN1;CDK5
prerank,GO_Biological_Process_2021__postsynapse organization (GO:0099173),0.5928956771274121,1.1139177107157985,0.35,0.9727624914314018,1.0,1/8,0.52%,WNT7A
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),-0.7553938760038521,-1.1133101841177069,0.3333333333333333,0.9433838527059645,1.0,2/5,22.77%,PML;ETS1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte migration (GO:0002686),0.6955206419328317,1.1129821821671293,0.391304347826087,0.9745516184427547,1.0,1/5,0.93%,CD200R1
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),-0.494489778523585,-1.112936283188615,0.27906976744186046,0.9440055897009223,1.0,10/70,14.46%,CD24;RASGRP1;DUSP1;HTR2B;CAV3;EGF;PAQR3;DIRAS1;DAB2IP;FGF1
prerank,GO_Biological_Process_2021__pyrimidine nucleobase catabolic process (GO:0006208),-0.674792831063001,-1.1129152619237863,0.4098360655737705,0.9432420395334525,1.0,4/7,26.76%,CRMP1;DPYSL3;DPYSL2;DPYD
prerank,GO_Biological_Process_2021__negative regulation of response to cytokine stimulus (GO:0060761),-0.6949992775923236,-1.1129139162571595,0.3283582089552239,0.9424050900751266,1.0,4/8,25.29%,KLF4;SIGIRR;PTPRC;SH2B3
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),-0.655947871064809,-1.1128669406324427,0.4032258064516129,0.9417264694388657,1.0,1/13,1.48%,NR4A3
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),0.4357004474612899,1.1127591395867253,0.18518518518518517,0.9740685052105726,1.0,14/34,22.32%,TVP23B;MTTP;ABCA1;TMEM167A;RAB8B;MON1A;TANGO6;RAB8A;RCN3;PREB;SEL1L;MIA2;GOLPH3;COPG2
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),0.41345459821628344,1.1125729953886128,0.16666666666666666,0.9734055225671712,1.0,14/60,16.65%,LIMD1;NUP42;NUP37;NUP54;IPO8;AAAS;NUP214;NDC1;RAE1;POLR2C;NUP188;NUP85;NUP205;NUP210
prerank,GO_Biological_Process_2021__DNA ligation involved in DNA repair (GO:0051103),0.6923263300053352,1.1125664404231999,0.3611111111111111,0.9721111003297147,1.0,1/5,3.02%,LIG4
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.6116904530755634,-1.1123703986911913,0.323943661971831,0.942877286994771,1.0,3/16,11.49%,TLR3;CEACAM1;ZFPM1
prerank,GO_Biological_Process_2021__alcohol catabolic process (GO:0046164),0.6045756286553152,1.1120978044295635,0.38461538461538464,0.9725003921418924,1.0,2/8,9.64%,CEL;CYP46A1
prerank,GO_Biological_Process_2021__cation homeostasis (GO:0055080),-0.6488805648813247,-1.112038991985588,0.2982456140350877,0.9434594433084648,1.0,1/7,5.69%,SLC4A11
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),-0.47433694927579845,-1.1120200770905975,0.30864197530864196,0.9426997515824007,1.0,15/82,15.63%,CD24;ACKR4;CDH23;TRPC3;PLN;CAV3;WNT5A;S1PR3;ITPR3;HCRTR2;CD55;GLP1R;CACNA1C;ADCY5;CIB2
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),-0.500447178222313,-1.1117555110096804,0.32926829268292684,0.9429238004202651,1.0,9/54,14.84%,ANXA1;IL1R1;IRF1;LRRC19;WNT5A;HERC5;USP18;BIRC3;SBNO2
prerank,GO_Biological_Process_2021__N-terminal peptidyl-methionine acetylation (GO:0017196),0.6376422368762628,1.1115359201125532,0.4838709677419355,0.9733397393945229,1.0,3/5,28.32%,NAA30;NAA15;NAA25
prerank,GO_Biological_Process_2021__G protein-coupled serotonin receptor signaling pathway (GO:0098664),-0.7481043817839073,-1.1115017545993788,0.3389830508474576,0.9429243784716641,1.0,4/6,24.18%,HTR2B;HTR1E;HTR2A;HTR2C
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),-0.6804589258018623,-1.1114588561955385,0.3157894736842105,0.9422414612086906,1.0,4/7,24.53%,EMP2;EMP1;EMP3;P2RX7
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),-0.4397590814133505,-1.1111767470002256,0.28421052631578947,0.9425321262887375,1.0,36/211,17.18%,GRIN2D;ZIC4;C3;COL4A1;SIX3;TAGLN3;TGFBR2;PROX1;CIC;SH3GL2;GRIN2A;SLC8A3;UGT8;LSR;KLK6;ZIC1;NNAT;MOG;APOD;HAP1;HAPLN2;GRIK1;EIF2B2;CA10;SH3GL3;PAX8;B3GNT5;SPINK6;ZFHX2;THOC6;GRIN2B;DCLK1;MFSD2A;PCDH18;CDK5;MYRF
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,-0.49095511950832277,-1.1111389014682396,0.2823529411764706,0.9418878376677304,1.0,11/53,18.72%,TJP3;PSCA;IL4R;ANO9;SYNGR2;PTK6;RHBDF2;TMC4;PRKCD;TMCO4;CAPN1
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,-0.4469135437761031,-1.1109425488013396,0.27380952380952384,0.9419041441894661,1.0,30/151,20.34%,RASGRP1;PGR;MYOF;CD44;TJP3;OVOL2;PODXL;THSD4;SEMA3B;ANXA9;SVIL;KLF4;KAZN;FOS;HR;SLC7A2;RAPGEFL1;PAPSS2;CCND1;BLVRB;SH3BP5;PRSS23;TMPRSS3;DLC1;PDZK1;TTC39A;RHOD;SYBU;LRIG1;FASN
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),-0.5903093993931986,-1.1107115585996712,0.4153846153846154,0.9419944537763042,1.0,5/17,16.30%,P2RY12;EPS8L2;PFN2;PLEKHM1;NLGN1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.6410650105836068,-1.1105784058441182,0.390625,0.9416925811373632,1.0,3/15,15.51%,NR4A3;TRPC3;IGF1
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),-0.530635277661001,-1.1104274495451896,0.3150684931506849,0.941332116625066,1.0,6/39,11.23%,PSRC1;KIF14;RAB11A;CENPE;CCNB1;NUF2
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),-0.5080641284170989,-1.1103848115093762,0.33766233766233766,0.9406547845353507,1.0,10/43,14.90%,SERPINA10;TIMP2;SERPINF1;SPOCK3;PSMB9;TIMP1;SERPIND1;SERPINE3;BIRC3;SERPING1
prerank,PanglaoDB_Augmented_2021__Satellite Cells,-0.46244186514037183,-1.1102435928721688,0.2967032967032967,0.9402958600630066,1.0,15/113,15.67%,COL4A1;COL4A2;MET;BARX2;LAMB1;CSPG4;SRPX2;IGFBP5;ARHGEF17;SCARA3;LMOD1;NUAK1;DAB2IP;RHBDF1;AMOTL2
prerank,GO_Biological_Process_2021__regulation of protein glycosylation (GO:0060049),-0.679565059052444,-1.1101315810829975,0.3684210526315789,0.9400628670174918,1.0,1/8,9.68%,SLC51B
prerank,GO_Biological_Process_2021__positive regulation of sequestering of triglyceride (GO:0010890),0.6216961786596794,1.1096585442619555,0.4166666666666667,0.9783754353894821,1.0,1/6,5.57%,PLIN5
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),0.4348109526212613,1.109483579731598,0.2857142857142857,0.9776031658287048,1.0,10/47,13.12%,ZNF207;MSRB1;WASHC5;CATIP;MID1IP1;DIAPH3;TTC17;SPIRE2;CASQ1;WASL
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),-0.5344438869232573,-1.1091669520041256,0.3380281690140845,0.9427539260707086,1.0,4/30,9.29%,KCNJ13;KCNJ2;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__neuronal ion channel clustering (GO:0045161),-0.6497217106583552,-1.1090858824828294,0.39655172413793105,0.942232234619671,1.0,3/8,21.32%,CNTN2;AGRN;CNTNAP2
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),-0.5510704216617112,-1.1086099192054248,0.3181818181818182,0.9434537572870292,1.0,3/22,13.68%,SLC6A15;SLC38A1;SLC43A2
prerank,GO_Biological_Process_2021__inhibitory postsynaptic potential (GO:0060080),0.6849183125046503,1.1085121393428246,0.3409090909090909,0.9798881791768526,1.0,2/6,4.49%,CHRNA4;NLGN3
prerank,GO_Biological_Process_2021__negative regulation of lipoprotein lipase activity (GO:0051005),-0.7141104328518957,-1.108476388086298,0.42105263157894735,0.9432335137578036,1.0,1/5,8.02%,ANGPTL3
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,-0.4825249059566841,-1.1082693578613292,0.32954545454545453,0.9431017181453153,1.0,11/69,10.12%,ENPP2;ANGPTL2;ALDOB;ABCA8;PROX1;GRIN2A;THY1;GRIA3;SLC51B;BGN;SST
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,-0.4654582737350036,-1.1082482597564056,0.3023255813953488,0.9423542389312028,1.0,24/116,18.71%,NPY;RIMBP2;TAGLN3;CDH22;CHGB;STMN2;TTLL7;SYT4;LRRTM1;ELAVL4;MAP1B;PLD1;GAP43;SLC18A2;PLD2;CPLX2;SYNPR;CRMP1;DPYSL3;DCLK1;RGS7BP;CNTN2;TCEAL5;RAB3C
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),-0.7164828107573241,-1.1079050731216296,0.36666666666666664,0.9419318323290258,1.0,3/7,23.13%,CDK2;AQP1;KCNC2
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),-0.7164828107573241,-1.1079050731216296,0.36666666666666664,0.9419318323290258,1.0,3/7,23.13%,CDK2;AQP1;KCNC2
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),-0.573925919013771,-1.107773147199076,0.3013698630136986,0.941713865833311,1.0,8/23,19.39%,STMN2;KIF14;VIL1;STMN4;DSTN;KIF2C;STMN1;WDR1
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),-0.6339935572479741,-1.1075231940021861,0.3484848484848485,0.9418470067256403,1.0,3/12,12.79%,LMO2;GATA1;CTSS
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),-0.5766723266567292,-1.1071532652146705,0.3684210526315789,0.9425712596954113,1.0,4/22,9.68%,ANK3;KCNB1;CEMIP;SLC51B
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),0.5313162910166193,1.1071506495975896,0.3125,0.9832081651743239,1.0,1/12,0.67%,RGCC
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),0.5181681743897862,1.1068909335678114,0.391304347826087,0.9829882452277724,1.0,1/14,2.60%,BMP2
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),-0.578519250217332,-1.1066146999609452,0.35294117647058826,0.9441257982469503,1.0,4/18,17.04%,PLN;CAV3;VIP;NOS1
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),-0.4772879157933588,-1.1065270548871586,0.31645569620253167,0.9436078842472838,1.0,10/63,11.84%,OTOS;KCNQ1;CLRN1;CDH23;EPS8L2;CEMIP;MYO3A;NDUFB9;COL11A2;PIEZO2
prerank,GO_Biological_Process_2021__positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),0.6395900961572233,1.1062010621258367,0.3157894736842105,0.9835923533728369,1.0,5/6,35.56%,UBQLN1;NFE2L2;UBQLN2;BCAP31;SGTA
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),0.4716481536000107,1.1061654417688593,0.28,0.9824428739642421,1.0,3/24,5.17%,ACE2;TRIB3;OCLN
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),0.4735925960117508,1.1061414985184395,0.2631578947368421,0.9812428492965005,1.0,11/41,16.99%,ERCC8;EGFR;BRCC3;UBE2N;TRIM28;ERCC6;RAD52;KAT7;EYA2;EYA1;CEBPG
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),0.5766465663973039,1.1061118042784583,0.35294117647058826,0.9800638008604293,1.0,3/13,5.54%,RGCC;SERPINF2;RUNX1
prerank,GO_Biological_Process_2021__stress granule disassembly (GO:0035617),0.7364716837093037,1.1059422394664753,0.45,0.9794754814898425,1.0,3/5,24.37%,VCP;DYRK3;ZFAND1
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),0.6541275485487171,1.1057255092134308,0.4117647058823529,0.9789598364989383,1.0,1/9,3.95%,DUSP6
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),0.49188890172602884,1.105643513212831,0.25,0.977983755592665,1.0,12/18,34.25%,RIDA;YTHDF2;ROCK2;FTO;CELF1;GIGYF2;METTL14;METTL3;YTHDF3;ROCK1;MEX3D;LIN28B
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),-0.5463055556020731,-1.10561042197357,0.30985915492957744,0.9466734122559078,1.0,8/24,18.15%,PDPN;PROX1;CCDC39;CHI3L1;BASP1;FGF1;ITGA3;FGF7
prerank,GO_Biological_Process_2021__positive regulation of deacetylase activity (GO:0090045),0.6140093841367038,1.1054046662801766,0.3684210526315789,0.9774181869636799,1.0,2/6,14.50%,MAPK8;PRKD1
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),-0.628684742887273,-1.1052816621380528,0.36619718309859156,0.9470490559918966,1.0,3/12,14.47%,MYOF;DYSF;MYH9
prerank,GO_Biological_Process_2021__glycerol ether metabolic process (GO:0006662),0.696385354787993,1.1051359981319946,0.4,0.9770843810141678,1.0,1/5,2.08%,AGMO
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),-0.5206139460086707,-1.105087708162726,0.2631578947368421,0.9469806404488822,1.0,7/58,6.72%,LEF1;HPN;EFNA1;TGFBR2;PDPN;OVOL2;ZNF750
prerank,GO_Biological_Process_2021__negative regulation of ATPase activity (GO:0032780),-0.6691389795358822,-1.1047689013674358,0.38333333333333336,0.9474134738100769,1.0,3/12,11.65%,IFIT1;PLN;ATP5IF1
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),0.4431528490549649,1.1047511776448546,0.3333333333333333,0.9769106673283233,1.0,2/44,2.90%,G0S2;BCL10
prerank,GO_Biological_Process_2021__positive regulation of adenylate cyclase activity (GO:0045762),-0.688272275981362,-1.1044534582481131,0.35185185185185186,0.947656892244777,1.0,2/6,14.71%,AKAP5;CACNA1C
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),-0.5366618914938519,-1.104342495992803,0.2876712328767123,0.9473198703645815,1.0,5/33,14.22%,TIMP2;TIMP1;NELL1;PRKCG;DAB2IP
prerank,GO_Biological_Process_2021__detection of virus (GO:0009597),-0.7408408539590249,-1.1042782057184994,0.3684210526315789,0.9467443749762445,1.0,2/5,14.76%,TLR3;IFIH1
prerank,GO_Biological_Process_2021__negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.5448651983111337,1.1042107470121367,0.43478260869565216,0.9775148228713735,1.0,5/14,20.97%,PSMD10;AKT1;OPA1;TRIAP1;HGF
prerank,GO_Biological_Process_2021__negative regulation of leukocyte chemotaxis (GO:0002689),-0.6787564721094537,-1.104040587608938,0.34285714285714286,0.9468574603022643,1.0,1/7,1.53%,DUSP1
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),-0.4962423514559036,-1.1039071016454904,0.2988505747126437,0.9465219924972472,1.0,14/63,23.36%,ANXA1;SFTPD;CHRM1;IL15;CALY;ANXA2;SLC11A1;BOK;GPC3;FLOT1;CAMK1D;SYNGR3;DOC2B;IL15RA
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),-0.5123444859403775,-1.103858827673966,0.33783783783783783,0.9458836335351671,1.0,12/56,19.88%,RHOBTB2;FSCN1;BST2;RND2;BAIAP2;RHOF;DMTN;DLC1;PRKCD;RHOBTB1;RHOD;ARHGAP18
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,-0.4692974622970982,-1.1038418406853174,0.30337078651685395,0.9451236421360719,1.0,36/96,23.96%,MET;A4GALT;ICAM1;GRAMD2A;COL4A4;PDPN;THSD4;SEMA3B;AKAP5;SCARA3;CLDN18;OSMR;EMP2;DAB2IP;SLC44A3;RHBDF1;ITGA3;AMOTL2;RADIL;NOTCH3;SEMA3E;LAMA3;RHOD;COL12A1;PXDC1;ANTXR1;ITGB4;F3;PTPN21;LAMA5;PTPRF;GPC1;SLCO2A1;COL4A3;KIAA1217;WWTR1
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),-0.6671949403314855,-1.1038053586810916,0.3548387096774194,0.9444875734721813,1.0,3/9,20.30%,TGFBR2;SFRP2;RYR2
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),0.4753565793284991,1.1037206562884623,0.19047619047619047,0.9774998125893885,1.0,15/34,31.08%,MIOS;WDR24;PIK3CA;SLC38A9;GOLPH3;RPTOR;LAMTOR3;RHEB;MLST8;WDR59;SIK3;PIP4P1;RICTOR;LARS1;KLHL22
prerank,GO_Biological_Process_2021__isoleucine metabolic process (GO:0006549),0.6442256045254501,1.1036303075291067,0.40476190476190477,0.9764450949372628,1.0,3/5,30.45%,ACADSB;SDSL;HSD17B10
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial membrane potential (GO:0010917),-0.7183882918222322,-1.1035005457709062,0.3728813559322034,0.9447822769570535,1.0,3/6,25.73%,HEBP2;MAPT;ARL6IP5
prerank,GO_Biological_Process_2021__regulation of growth hormone secretion (GO:0060123),0.6894175435585109,1.103430679581729,0.3409090909090909,0.9757275065586891,1.0,3/5,22.96%,DRD2;CHD7;SELENOT
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.5721007948789683,-1.1033435913947525,0.4166666666666667,0.9445652275145822,1.0,6/23,16.12%,DUSP1;CENPE;CCNB1;ANAPC11;HECW2;ANAPC15
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.6214630652163552,-1.1033023386989207,0.38961038961038963,0.9438880980137446,1.0,5/13,23.51%,POU4F1;IGF1;DDRGK1;TGFB1;NIBAN2
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),-0.5711377505570338,-1.1031878215459667,0.3150684931506849,0.9434349645645319,1.0,9/22,23.83%,STAT4;IL15;CCL2;STAT1;PTK6;NMI;STAT6;STAT2;GHR
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),-0.6000091388212705,-1.1030473139460617,0.39705882352941174,0.9430759733134161,1.0,4/19,8.07%,PKP2;CTNNA3;PLN;CAV3
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),-0.6957307029140896,-1.1030021860145807,0.42857142857142855,0.9424592519246804,1.0,3/6,13.44%,P4HA2;P4HA3;P4HTM
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),-0.4666900473040951,-1.102893714332707,0.35294117647058826,0.9420013213999988,1.0,8/104,9.23%,CD24;THBS1;CDKN2A;APP;NLRC5;SRPX2;LDB2;EGF
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),0.4940576893416835,1.1028701315368672,0.3103448275862069,0.9765058412915167,1.0,4/18,12.10%,FLT3;ARMC6;CSF1R;PRRC2C
prerank,GO_Biological_Process_2021__negative regulation of neuroinflammatory response (GO:0150079),0.6163539618278666,1.1023520016961643,0.42105263157894735,0.9771592852147071,1.0,2/9,1.19%,CD200R1;NR1D1
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),0.44647722301790915,1.1022188998098865,0.45454545454545453,0.9763208268191942,1.0,1/38,0.01%,CPA1
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),0.48484026864508073,1.102200985464948,0.3055555555555556,0.9751693571483511,1.0,3/19,19.24%,ATF5;CHMP2B;VPS4B
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.6076375582969357,-1.1021915686390658,0.38028169014084506,0.9442306524853695,1.0,5/13,24.74%,DMTN;SELP;PTPRC;RYR2;GRM5
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),-0.6282656964567386,-1.1021036213276574,0.42028985507246375,0.9437719950791998,1.0,3/15,5.84%,P2RY6;P2RY12;HTR2B
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),0.5484353314832147,1.1018382014878296,0.3870967741935484,0.975087549020583,1.0,4/12,13.61%,ABCD1;ELOVL2;SCP2;ACOX1
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),0.5264460914069623,1.1018194173463327,0.3125,0.9738532964742523,1.0,6/13,23.93%,PPARGC1A;VCP;AK4;SPHK2;PARP1;PID1
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),-0.4935753850647221,-1.1017778789335222,0.33766233766233766,0.9443010635732044,1.0,5/50,9.89%,THBS1;SNCB;TRPC3;PLSCR1;ITPR3
prerank,GO_Biological_Process_2021__regulation of mast cell activation (GO:0033003),-0.7400816499201543,-1.101331296875504,0.41379310344827586,0.9452508323722799,1.0,1/5,7.99%,PLSCR1
prerank,GO_Biological_Process_2021__negative regulation of bone resorption (GO:0045779),0.6870396189072656,1.1012234402429397,0.46511627906976744,0.9746280468502692,1.0,1/5,4.53%,TNFAIP3
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),-0.611546789139733,-1.10118301093326,0.3442622950819672,0.9449923872334792,1.0,2/12,11.58%,BLM;DONSON
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),0.5119956998268267,1.1011754701981997,0.3076923076923077,0.9735717407335841,1.0,4/22,6.97%,PDK4;TRIB3;ADIPOR1;MID1IP1
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),-0.5973896272867459,-1.1011733967821002,0.2878787878787879,0.9442564269487912,1.0,4/20,8.07%,CACNA1H;KCNQ1;PLN;CAV3
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),-0.514668566560574,-1.1011509009283493,0.3150684931506849,0.9435644774773412,1.0,1/37,0.16%,LEF1
prerank,GO_Biological_Process_2021__R-loop disassembly (GO:0062176),0.7337692174096813,1.1010784416977477,0.4594594594594595,0.9725529310914407,1.0,2/5,13.36%,PRIMPOL;DDX21
prerank,GO_Biological_Process_2021__negative regulation of membrane potential (GO:0045837),-0.6872130889474231,-1.1006142592378643,0.3333333333333333,0.9448606141601329,1.0,3/7,25.73%,HEBP2;MAPT;ARL6IP5
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.658327921310097,-1.1004199902283063,0.4307692307692308,0.9448310692936153,1.0,1/10,0.89%,HPN
prerank,GO_Biological_Process_2021__cyclooxygenase pathway (GO:0019371),0.6175524035807527,1.1003742393743414,0.4,0.9736912539301192,1.0,2/7,9.06%,AKR1C3;PTGIS
prerank,GO_Biological_Process_2021__homologous chromosome segregation (GO:0045143),-0.5976765305345638,-1.1003117573991308,0.40540540540540543,0.9444389875274944,1.0,3/13,5.28%,IHO1;MEIOB;RNF212B
prerank,GO_Biological_Process_2021__positive regulation of mesenchymal cell proliferation (GO:0002053),-0.6883758450235834,-1.0997998133651117,0.4067796610169492,0.9456742798586822,1.0,2/7,10.13%,TGFBR2;STAT1
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),0.4340215262394932,1.0994764508799564,0.21428571428571427,0.9754513837965628,1.0,7/41,14.65%,NR1D1;REEP6;TTL;CSNK1E;EFNA5;STXBP4;PARD6G
prerank,GO_Biological_Process_2021__regulation of epithelial cell apoptotic process (GO:1904035),-0.6506040536893956,-1.0991823121362616,0.4444444444444444,0.9470352469981017,1.0,1/8,2.43%,ZFP36
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),-0.4915352344625223,-1.098628744109055,0.2597402597402597,0.9484506556750847,1.0,12/61,13.36%,SCN1B;SLC6A15;KCNK1;SLC8A3;SLC24A2;SCN9A;ATP1A1;ATP1B1;SLC9A2;SLC24A1;SCN2A;SCN1A
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),-0.596525270893269,-1.0985895009868085,0.3333333333333333,0.9478017661517018,1.0,4/13,9.29%,KCNQ1;KCNJ2;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),-0.6897348706541385,-1.098471075109783,0.43859649122807015,0.947373437042226,1.0,2/7,14.53%,TOMM7;PINK1
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),-0.49581887622125176,-1.0984132048087605,0.30952380952380953,0.9467902051919721,1.0,11/50,15.40%,ANXA1;SEPTIN5;HAP1;SYT1;CPLX1;RIMS2;SCG5;SEPTIN4;CPLX2;RHBDF2;RHBDF1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.5406484239412411,-1.098144965142243,0.4,0.9469854092277331,1.0,7/21,19.78%,CEMIP;APP;EGF;CHI3L1;SPHK1;TGFB1;RIPK2
prerank,GO_Biological_Process_2021__inner ear auditory receptor cell differentiation (GO:0042491),0.6295433510577806,1.0979554342975688,0.40476190476190477,0.9792867462639621,1.0,1/6,6.62%,SLC4A7
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.6916605222230151,-1.0976590660411596,0.43548387096774194,0.9480559578116412,1.0,2/7,19.63%,ITGA5;PRKCB
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),-0.5634020358679462,-1.097630857235156,0.3384615384615385,0.9474524518780055,1.0,3/15,13.37%,MYO1F;MYO15A;MYO1E
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),-0.604829194855338,-1.0975994004210556,0.4126984126984127,0.9468358558955344,1.0,2/11,15.55%,APP;ATOX1
prerank,GO_Biological_Process_2021__vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),0.7008198280859735,1.0974090036330948,0.275,0.9800140518780144,1.0,1/5,7.55%,SEC22B
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),0.5103803169775523,1.0973890276482408,0.3333333333333333,0.9788379466808583,1.0,7/33,14.37%,OTUD3;TRIB3;THEM4;AKT1;DRD2;MUL1;MAGI2
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),0.472001280661858,1.0970464649634262,0.2692307692307692,0.9788388461278242,1.0,4/20,12.25%,WDR91;SNF8;PTPN23;PIK3C3
prerank,GO_Biological_Process_2021__fructose metabolic process (GO:0006000),-0.748450481977488,-1.0969952343279321,0.41509433962264153,0.9484251117168522,1.0,2/5,13.19%,ALDOB;FBP1
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),0.38261428736245884,1.0969039868930692,0.21052631578947367,0.9781155325875747,1.0,9/54,13.65%,FGF6;GALNT3;SPRED1;GTF2F2;TIAL1;SHOC2;SPRED2;FLRT2;POLR2C
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.5544951604560618,1.0968839260459537,0.32558139534883723,0.9769462968016612,1.0,1/9,3.52%,DERL2
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.5768581071254547,-1.0965654240229605,0.3582089552238806,0.9493853060413453,1.0,6/16,22.19%,TLR2;IFI35;TLR3;SLC15A4;FLOT1;RSAD2
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.47552039232362636,1.0962876911128026,0.23809523809523808,0.9774311706905375,1.0,3/23,6.36%,SLIT1;NLGN3;ALCAM
prerank,MSigDB_Hallmark_2020__DNA Repair,0.36507550610394834,1.0962776344686274,0.14285714285714285,0.976214218221773,1.0,25/134,13.67%,POLD3;ERCC8;AK1;SNAPC5;RFC3;HCLS1;BRF2;SMAD5;NUDT21;ZNF707;ELOA;CSTF3;ERCC2;RAD52;AAAS;GTF2A2;DGUOK;RRM2B;MPC2;RALA;ERCC3;VPS37B;RAE1;POLR2C;TAF12
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),0.5844423663192527,1.096253853882955,0.34146341463414637,0.9750518033964191,1.0,1/10,3.05%,DUSP19
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),0.4986551549458619,1.0960936369567365,0.4117647058823529,0.9743892178873026,1.0,4/25,10.09%,SLC26A7;SLC19A1;SLC26A3;VDAC2
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte activation (GO:0051250),0.5202751082381686,1.0959368354159273,0.34285714285714286,0.973642734383058,1.0,4/14,11.67%,FGL1;TNFAIP3;FOXJ1;SAMSN1
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),0.6210491693077985,1.0959347033496802,0.3953488372093023,0.9724195651187576,1.0,1/7,3.46%,SPRED1
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),0.505537473656334,1.095921829925747,0.3548387096774194,0.9712677454156174,1.0,6/16,29.08%,HSF1;ATR;MDM2;MAP3K20;WRN;KDM1A
prerank,GO_Biological_Process_2021__response to hepatocyte growth factor (GO:0035728),0.6119113083537951,1.0959187465769773,0.3684210526315789,0.9688876189518577,1.0,5/7,37.76%,HGF;SIRT2;APPL2;NRP1;LGMN
prerank,GO_Biological_Process_2021__cellular response to hepatocyte growth factor stimulus (GO:0035729),0.6119113083537951,1.0959187465769773,0.3684210526315789,0.9688876189518577,1.0,5/7,37.76%,HGF;SIRT2;APPL2;NRP1;LGMN
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome organization (GO:0034723),0.7168856949466307,1.0958603427329696,0.4,0.9665703326281004,1.0,2/5,13.92%,RBBP4;ASF1A
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome assembly (GO:0006335),0.7168856949466307,1.0958603427329696,0.4,0.9665703326281004,1.0,2/5,13.92%,RBBP4;ASF1A
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),-0.5315585053715721,-1.0957925126504684,0.3466666666666667,0.9513776595461065,1.0,2/38,2.39%,C3;B2M
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),-0.4596215177876162,-1.095762323551448,0.28735632183908044,0.9507176876800522,1.0,7/99,11.01%,ENPP2;UGT8;B4GALNT1;ABCA12;PDXDC1;FA2H;SGPP2
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.4974830056394925,1.0957614087329444,0.2903225806451613,0.9656195868660147,1.0,3/17,4.77%,BCL10;SLC39A10;FOXP1
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),0.6578242087059242,1.0955543292820649,0.36363636363636365,0.9652641960622605,1.0,3/6,30.42%,ITCH;TANK;OTUD4
prerank,GO_Biological_Process_2021__T cell homeostasis (GO:0043029),0.6213395655739049,1.095085575912554,0.4117647058823529,0.9656203886286888,1.0,2/7,7.94%,ZC3H8;AKT1
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.46814852176966176,-1.0948836572251734,0.30337078651685395,0.953225140234574,1.0,10/103,6.95%,RASGRP1;P2RY6;GPR183;ICAM1;RAMP3;CD44;GPNMB;HTR2B;APP;CCL2
prerank,GO_Biological_Process_2021__positive regulation of macrophage cytokine production (GO:0060907),-0.6795808793106097,-1.0945293452758111,0.4107142857142857,0.9537432204601322,1.0,2/6,19.76%,WNT5A;CD74
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),0.5548436802851012,1.0945289156825024,0.3888888888888889,0.9660939989875026,1.0,8/18,35.38%,PRKRA;DROSHA;TENT4B;KHSRP;TUT4;LIN28B;AGO2;TUT7
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),0.4798123006574748,1.0945156874038626,0.25,0.964946009468023,1.0,6/25,13.85%,ABCD2;MACIR;IL17D;ABCD1;SIRPA;TICAM1
prerank,GO_Biological_Process_2021__cellular response to cholesterol (GO:0071397),0.5949311976316342,1.093722244142898,0.34615384615384615,0.9663633581446418,1.0,3/9,14.51%,GRAMD1B;GRAMD1C;GPLD1
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),0.601611316248703,1.0933105181523979,0.4,0.966329161246694,1.0,9/15,27.22%,INTS7;INTS8;INTS6L;TOE1;INTS14;INTS11;INTS4;INTS6;INTS9
prerank,GO_Biological_Process_2021__positive regulation of astrocyte differentiation (GO:0048711),0.6826770192248623,1.0929254349684163,0.4090909090909091,0.9664800340193461,1.0,3/7,17.38%,BMP2;SERPINE2;ID2
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),-0.4442758851866168,-1.0925257640590094,0.25773195876288657,0.9606035777171438,1.0,20/170,14.46%,CD24;RASGRP1;P2RY6;GPR183;ICAM1;TRIM5;RAMP3;CD44;GPNMB;HTR2B;APP;CCL2;EGF;CHI3L1;RIT2;SCIMP;THPO;DIRAS1;DAB2IP;FGF1
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),-0.6333981629754273,-1.0922801149567525,0.36619718309859156,0.9607504985712891,1.0,2/15,5.84%,NOS1AP;HTR2B
prerank,GO_Biological_Process_2021__positive regulation of megakaryocyte differentiation (GO:0045654),-0.6980383215799096,-1.092277762174738,0.41935483870967744,0.9599595303915067,1.0,2/8,13.83%,TESC;THPO
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),0.48407038253866363,1.0920584345688522,0.23076923076923078,0.9680749961516908,1.0,7/24,19.98%,NR1D1;PGM2;AGL;PYGM;UGP2;PPP1R3C;PYGB
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),-0.611239013962124,-1.091823289083833,0.417910447761194,0.9606940315403479,1.0,1/15,1.98%,FABP3
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,-0.46608024318159297,-1.091087205670876,0.3333333333333333,0.9627476206734829,1.0,27/105,18.12%,CDH22;STMN2;SNCB;SH3GL2;SLC32A1;SLITRK1;GAP43;ZNF536;GFAP;TCEAL6;SYN2;SST;IGSF21;HPCA;CA10;GADD45B;GAD1;C11ORF87;STMN4;VIP;GAD2;SYNPR;RGS7BP;CNTN2;KCNC1;GABRG2;TCEAL5
prerank,GO_Biological_Process_2021__store-operated calcium entry (GO:0002115),0.6149952204334761,1.090848191682549,0.3611111111111111,0.9706389957323942,1.0,2/6,21.23%,STIM2;STIM1
prerank,GO_Biological_Process_2021__tubulin complex assembly (GO:0007021),-0.6939327383024694,-1.0908160519027101,0.3114754098360656,0.9630179175472314,1.0,2/6,24.33%,TCP1;TBCE
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),-0.6048542535918231,-1.0905399898452637,0.34782608695652173,0.9634690956040844,1.0,5/16,14.76%,RFTN1;IFIT1;COLEC12;TLR3;IFIH1
prerank,GO_Biological_Process_2021__lipoprotein catabolic process (GO:0042159),0.5815645900651389,1.0904795100395686,0.3170731707317073,0.9706164564273445,1.0,3/10,5.82%,ABHD17A;LYPLA2;ABHD17B
prerank,GO_Biological_Process_2021__DNA strand elongation involved in DNA replication (GO:0006271),0.5371330140486759,1.090430337972688,0.36,0.9695229907891487,1.0,2/17,5.49%,POLD3;RFC3
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),-0.6114431476397781,-1.0902969107503924,0.38596491228070173,0.9635780751070496,1.0,2/11,9.03%,PARP14;PARP9
prerank,GO_Biological_Process_2021__pyroptosis (GO:0070269),-0.6153743578176656,-1.0902540220079946,0.3939393939393939,0.9629349079561231,1.0,1/11,0.76%,APIP
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),-0.6435860856649914,-1.0895422311287146,0.4444444444444444,0.9648112020729134,1.0,3/8,24.78%,MAPRE2;FGF7;EPB41L4B
prerank,GO_Biological_Process_2021__nitric oxide biosynthetic process (GO:0006809),-0.6389278308323303,-1.0892781460582304,0.45588235294117646,0.9650717300721724,1.0,4/11,17.04%,ARG2;CYP1B1;GCHFR;NOS1
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),-0.5456696627468222,-1.0890214559782405,0.3283582089552239,0.9652207015851939,1.0,4/29,19.92%,NR4A3;PLEKHM1;MYH9;PIK3CD
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.564467023104901,-1.0885660101811243,0.3698630136986301,0.9663548667497958,1.0,7/24,21.89%,NLRC5;ISG15;WNT5A;USP18;FADD;CDC37;STAT2
prerank,GO_Biological_Process_2021__cellular response to interleukin-9 (GO:0071355),-0.713895158743793,-1.0883465633205491,0.36666666666666664,0.96560379133053,1.0,1/6,10.13%,STAT1
prerank,GO_Biological_Process_2021__interleukin-9-mediated signaling pathway (GO:0038113),-0.713895158743793,-1.0883465633205491,0.36666666666666664,0.96560379133053,1.0,1/6,10.13%,STAT1
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),0.4464744675512524,1.0881474297775315,0.3,0.9752680465781627,1.0,10/35,27.82%,ATF5;EFNA5;MARK2;MAP6;MEMO1;KLHL42;PRKAA1;CLASP2;BICD2;TRAF3IP1
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),0.42590061441573857,1.0876951381709887,0.2692307692307692,0.9757073151247473,1.0,13/46,16.99%,ERCC8;SPRED1;EGFR;BRCC3;UBE2N;TRIM28;ERCC6;ATR;SPRED2;EYA2;FXR2;EYA1;CEBPG
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),-0.6313286363403483,-1.087552572950998,0.38333333333333336,0.9678355400799525,1.0,1/8,1.77%,TGFBR2
prerank,MSigDB_Hallmark_2020__Angiogenesis,-0.5284619759763346,-1.0870306975255994,0.3561643835616438,0.9687632430176005,1.0,9/24,29.19%,APP;TIMP1;LRPAP1;SPP1;SLCO2A1;PGLYRP1;CCND2;JAG2;KCNJ8
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),0.632121926530276,1.0867606190960415,0.42424242424242425,0.9775626753065946,1.0,1/7,0.13%,LEPR
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),-0.48568159671649735,-1.0867587739006817,0.32432432432432434,0.9689360979583727,1.0,10/46,22.08%,KCNQ1;NOS1AP;KCNJ2;CAV3;GNG2;KCNAB3;CD63;KCNMB4;KCNIP4;AKAP6
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),0.5607437505450367,1.0866490596367089,0.34375,0.9765992784163863,1.0,3/10,10.32%,BMP2;SALL1;FOXJ1
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),0.39866879546382655,1.086285260922757,0.2777777777777778,0.9765696180271632,1.0,20/62,22.06%,ELOC;GTF2F2;EAF2;ELOA;ERCC2;ERCC3;POLR2C;ELP2;GTF2H5;IWS1;ELP4;GTF2H2;CDK12;PCID2;MLLT3;CCNT2;CCNT1;NELFA;CTDP1;GTF2H3
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),0.6215376562407625,1.0861037486598422,0.40540540540540543,0.9758589587224192,1.0,4/7,33.90%,SLC25A46;TMCC1;SPAST;DNM1L
prerank,GO_Biological_Process_2021__regulation of histone H4-K16 acetylation (GO:2000618),-0.7278793022553867,-1.0857760408313348,0.36507936507936506,0.9719606749210995,1.0,1/5,9.24%,BRCA1
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),-0.4770646170183629,-1.0854746603845995,0.38666666666666666,0.9722410268479673,1.0,9/58,14.84%,CXCL2;TLR2;ZFP36;CCL2;WNT5A;PDCD1LG2;TNIP2;DAB2IP;SBNO2
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),-0.5809598564527477,-1.0853956815154044,0.38961038961038963,0.9716729234984427,1.0,2/17,3.96%,ABCA5;ABCA8
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),0.4207289163629646,1.0853769694279123,0.35714285714285715,0.9770082514257978,1.0,5/38,5.62%,DNA2;RIDA;NUDT16L1;ZPR1;HSPA1A
prerank,GO_Biological_Process_2021__response to corticosteroid (GO:0031960),0.6914815638516958,1.0853548808098314,0.38095238095238093,0.9758513712545824,1.0,2/5,21.80%,AKR1C3;PDCD7
prerank,PanglaoDB_Augmented_2021__Salivary Mucous Cells,-0.5474164694954798,-1.0853401070600714,0.39436619718309857,0.9710781946102812,1.0,6/19,12.41%,THBS1;ZNF750;DUOXA1;MYH11;ADIRF;EMP2
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.48499681019947044,1.0853022833412198,0.3333333333333333,0.9749124671915422,1.0,9/21,27.64%,ERCC6;KAT7;THOC1;CDK12;HMGN1;CCNT2;CCNT1;SCAF8;CDK13
prerank,GO_Biological_Process_2021__nose development (GO:0043584),-0.6910865764083454,-1.085122881238026,0.4166666666666667,0.9710901428035899,1.0,1/6,3.97%,PROX1
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),0.4960036059611624,1.0850016271702354,0.4090909090909091,0.9747031982281413,1.0,10/24,27.06%,KAT2B;KAT2A;EP300;KAT7;PHF20L1;KAT6B;TRRAP;RUVBL1;NAA50;ATAT1
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.6065442099946455,1.0847977629135246,0.45161290322580644,0.9744449051041092,1.0,2/8,13.85%,IL17D;TICAM1
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),-0.4982024751348159,-1.0847344386234183,0.3448275862068966,0.9717004049425668,1.0,9/64,11.61%,ANXA1;SIX3;OVOL3;PROX1;OVOL2;AKR1C1;VIL1;BASP1;TAGLN2
prerank,GO_Biological_Process_2021__glycerol metabolic process (GO:0006071),0.5808739488331152,1.084690217658786,0.41025641025641024,0.9735605921012223,1.0,2/9,3.21%,GK;COQ3
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),-0.4750098420978779,-1.0845076525652981,0.3488372093023256,0.9716912107728596,1.0,18/73,17.32%,ECM2;L1CAM;CD44;ITGA2;SIGLEC1;THY1;ANGPTL3;THBS3;ITGA8;EMP2;ZYX;ITGBL1;FN1;ITGA3;ITGA11;CD63;DLC1;PPFIA1
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,-0.4725501044825528,-1.0844788994502241,0.3372093023255814,0.9710091453702799,1.0,20/93,22.42%,COL4A1;COL4A2;LAMB1;CSPG4;TEAD2;ARHGEF17;SCARA3;NUAK1;DAB2IP;RHBDF1;AMOTL2;MCAM;LARP6;BOK;SEZ6L2;COL12A1;ANTXR1;PTPN21;PTPRF;GPC1
prerank,PanglaoDB_Augmented_2021__Clara Cells,0.4726831923006511,1.0844490193962644,0.4090909090909091,0.9732878369638074,1.0,7/36,6.65%,LEPR;TFCP2L1;ALDH1A1;EHF;MUC20;CAPN13;TRIM29
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),-0.5264842771591189,-1.0844464930021,0.3918918918918919,0.9703624937961778,1.0,9/50,16.57%,EFNA1;STMN2;THY1;EFNB3;MAG;PAQR3;CRMP1;NLGN1;DPYSL3
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),0.40349233846760146,1.0843888428350792,0.25,0.9724235124851952,1.0,13/39,17.45%,PI4K2A;WASHC5;EXOC8;ZFYVE16;RAB22A;PHETA1;WASL;ALS2;CHMP2B;DNAJC13;RNF26;VPS11;EPS15
prerank,GO_Biological_Process_2021__positive regulation of bone resorption (GO:0045780),-0.6703087684823905,-1.084221539818768,0.421875,0.9703749757241062,1.0,3/7,20.60%,SYK;PLEKHM1;SPP1
prerank,GO_Biological_Process_2021__positive regulation of non-motile cilium assembly (GO:1902857),-0.716815111151973,-1.0842122566282222,0.4576271186440678,0.9696271496143126,1.0,3/5,23.96%,HAP1;CEP135;SEPTIN9
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),0.5764597677665865,1.0840444814790238,0.32142857142857145,0.9724321153818194,1.0,3/12,7.04%,AIFM2;SELENON;ABCD1
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.5743648958515943,1.0839877460949696,0.40625,0.9714560305443846,1.0,8/17,31.42%,ARFIP1;ARFIP2;ABI2;WASF3;GMFG;CTNNA2;NCKAP1;BRK1
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),0.4769963514795558,1.0839534870901568,0.4,0.9704003409991542,1.0,7/17,15.54%,EFNB2;ID1;GREM1;AKT1;ROBO1;GPLD1;EPHB4
prerank,GO_Biological_Process_2021__negative regulation of interferon-beta production (GO:0032688),0.636602446040961,1.0838112269015903,0.4,0.9696418813658527,1.0,2/7,12.62%,YY1;SIRPA
prerank,GO_Biological_Process_2021__response to leptin (GO:0044321),0.6366857414015198,1.0837864604774674,0.34210526315789475,0.9685582061203952,1.0,2/8,1.19%,LEPR;NR1D1
prerank,GO_Biological_Process_2021__rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),0.6781409333313914,1.0833322060638633,0.35,0.9686203945370299,1.0,2/6,21.44%,XPO1;ABCE1
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),-0.49354224614003184,-1.0833016292759492,0.3670886075949367,0.9721792862394354,1.0,2/52,3.37%,TRIM22;TRIM5
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),0.31892144023824737,1.082861753933631,0.0,0.9688618738324247,1.0,92/341,22.35%,SPSB4;RNF6;RNF25;FBXO45;NUP42;KLHL8;BCL10;UBE2T;SPSB2;RFWD3;ELOC;MSL2;MKRN3;NUP37;TRIM24;PLK1;KEAP1;CUL1;DCUN1D2;NUP54;UBE2N;TRIM28;PEX13;RNF103-CHMP3;DCUN1D1;VCP;BTRC;COMMD1;LMO7;FBXL3;RNF14;TSPAN17;UBE2G1;FBXO9;AAAS;NUP214;UBE2D1;DERL1;RCHY1;NDC1;DTX4;ZNF451;MUL1;PEX2;RAE1;CUL2;TRIM7;TMEM129;DCUN1D5;FBXO10;NUP188;RNF26;KIAA1586;CBLL1;FBXL17;NUP85;KLHL24;HERC2;NUP205;VHL;UBE2E3;NUP210;EYA1;UFM1;VPS11;CNOT4;PIAS4;MKRN1;CDC34;RNF34;PEX12;MDM2;EIPR1;KLHL20;TRIM52;RNF182;ABCB11;NEDD4L;H2BC5;SHPRH;MIB1;RNF20;NUP153;FBH1;SUMO2;MARCHF3;UBE2A;NUB1;NUP50;RLIM;URM1;UBE2Z
prerank,GO_Biological_Process_2021__nitric oxide metabolic process (GO:0046209),-0.6286591202855372,-1.0826973363133399,0.42857142857142855,0.9735784420429405,1.0,4/12,17.04%,ARG2;CYP1B1;GCHFR;NOS1
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),0.37984610318847567,1.0825334042658723,0.29411764705882354,0.9690213087736449,1.0,34/155,16.55%,PTCD2;ATAD3C;GDAP1;PLD6;TFB2M;AIFM2;PPARGC1A;AFG1L;SAMM50;TRAK2;TFB1M;ALAS1;MTERF1;RAB5IF;MFF;POLG2;CHCHD3;TMEM11;GABPB1;ESRRA;TOMM22;OPA1;DNM3;MGME1;SIRT5;MUL1;THG1L;PRDX3;MTFR1;TMEM70;TIMM23;NRF1;MIEF2;MTX2
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),-0.5193179813543667,-1.0825162072293943,0.3888888888888889,0.9734994491878783,1.0,3/41,8.67%,LEF1;HTR2B;WNT5A
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),0.3263000095880682,1.082452978718427,0.1111111111111111,0.9680900242129186,1.0,36/206,15.16%,LIMD1;AMER2;BMP2;PSMD10;BICC1;PSMA1;GREM1;GSKIP;GPC5;CCDC88C;PSMD11;SOX9;EGFR;PSMB5;CAPRIN2;VCP;BTRC;RNF146;GID8;PPM1A;CSNK1E;STK4;SCEL;ZNF703;KLHL12;PSMD14;INVS;ZEB2;CSNK1G3;PSMD12;LGR4;TMEM170B;DVL2;KANK1;NFKB1;GNAQ
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),0.49327111261516915,1.0821589311302244,0.28,0.9677948810749561,1.0,6/22,11.44%,EGFR;AKT1;AKR1C3;MT1E;HSF1;MAPK8
prerank,GO_Biological_Process_2021__protein deneddylation (GO:0000338),0.6251935237474495,1.0814594333351808,0.37142857142857144,0.9685557084491212,1.0,4/10,17.09%,COPS8;COPS2;COPS7A;COPS7B
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.4638993658737602,-1.0810832245203885,0.36904761904761907,0.9780016601995327,1.0,14/66,23.81%,TLR2;IRF1;ISG15;TLR3;STAT1;IRF7;IFIH1;FLOT1;RIPK2;DDX41;STAT6;HSPD1;NFKB2;CGAS
prerank,GO_Biological_Process_2021__pyrimidine nucleobase metabolic process (GO:0006206),-0.6131557974884618,-1.0808769037957147,0.4057971014492754,0.9779328571321464,1.0,5/10,31.05%,CRMP1;DPYSL3;DPYSL2;DPYD;CTPS1
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),-0.6386521267774208,-1.0807188757349826,0.42028985507246375,0.9777482901765834,1.0,1/12,0.92%,APLNR
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),-0.5878710767325361,-1.0807034691401598,0.4090909090909091,0.9770191672993321,1.0,3/15,10.25%,SFTPD;GPNMB;PDCD1LG2
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),-0.49375631450469637,-1.0805840032662448,0.3924050632911392,0.9766587019276193,1.0,2/32,3.96%,AGPAT4;ABCA8
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle recycling (GO:1903421),-0.689558204334067,-1.0805505597972929,0.3387096774193548,0.9759724335254942,1.0,1/5,17.15%,CDK5
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),-0.5529619912735488,-1.080549853272934,0.391304347826087,0.9751921531840326,1.0,3/21,9.21%,THBS1;TLR2;APOD
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),-0.4505926024063106,-1.0805397513721116,0.3595505617977528,0.9744606514336055,1.0,31/112,22.49%,P2RY6;BLM;NR4A3;KCNQ1;P2RY12;POU4F1;RAMP3;IGFBP5;CCL2;ATP1A1;CYP1B1;BRCA1;GABRB2;GNG2;ADCY5;DMTN;HRH1;CIB2;IL18;FES;GABRG2;TGFB1;AQP1;ADCY8;SPP1;GPER1;SFRP1;INSIG1;H2AZ1;AKAP6;TFPI
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.5714066910570921,1.0804044169370293,0.32432432432432434,0.9707579028297644,1.0,2/8,15.32%,RUNX1;RC3H1
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),-0.6824837461619054,-1.0803970700382055,0.42857142857142855,0.9742119391530039,1.0,1/7,4.51%,ST18
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),0.3383105611013012,1.0799943559365508,0.2,0.9709465239937877,1.0,103/312,25.74%,SPSB4;RNF6;FBXO45;ERCC8;KLHL8;PSMD10;FEM1C;KBTBD7;SPSB2;RNF150;PSMA1;TNFAIP3;ELOC;WDR91;PSMD11;PLK1;KEAP1;FBXL14;PSMB5;ANAPC1;VCP;BTRC;RNF146;GID8;VPS37A;RNF14;UBE2G1;FBXO8;PSMD14;UBE2D1;PTPN23;FEM1B;RCHY1;RNF114;VPS37B;PSMD12;UBAP1L;RNF11;ATE1;KCTD17;FBXO10;UBE4A;NDFIP1;RC3H1;FBXL17;TRIM3;UBE3B;CDC26;FBXO21;SPOP;COP1;RMND5A;CNOT4;KCTD21;CDC34;UBE3D;RNF217;RNF34;VPS4B;MDM2;KLHL20;UBQLN4;RC3H2;KLHL42;NEDD4L;KCTD5;MIB1;UBL7;RNF20;UBXN2B;RNF130;RNF166;BUB3;UBE2A;NUB1;TRIP12;TRIM9;RLIM;PSMD1;SIRT2;ITCH;FBXL7;PSMF1;UBQLN1;FEM1A;NFE2L2;FBXW7;RNF13;UBE3C;ANKIB1;PSMC2;SPOPL;UBE2L5;ARRB1;KCTD13;PCNP;RNF168;KLHL15;UBR3;KBTBD6;RBCK1;ANKRD9;CLOCK
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),-0.6146319758124358,-1.0799909160833332,0.38666666666666666,0.9751090758938479,1.0,1/14,0.71%,C3
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),-0.6024985944203161,-1.0798362110102686,0.37681159420289856,0.9747654292551428,1.0,2/14,4.65%,SKAP1;KIF14
prerank,GO_Biological_Process_2021__mitochondrial tRNA modification (GO:0070900),0.6621299480090578,1.0795114272915978,0.4444444444444444,0.971620005110894,1.0,6/8,32.11%,TRIT1;MTO1;TRMT5;RPUSD4;HSD17B10;TRMT61B
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),0.4890374121062456,1.0794279268214992,0.34615384615384615,0.9706437972303813,1.0,5/19,24.78%,PPP1R1B;STYXL1;PPP4R4;PPP1R8;MASTL
prerank,GO_Biological_Process_2021__ovarian follicle development (GO:0001541),-0.6555399258418677,-1.0789909113629652,0.3918918918918919,0.977217070865388,1.0,4/10,31.07%,EIF2B2;EIF2B4;EIF2B5;INHA
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),-0.5012845133714101,-1.0788930529801146,0.34177215189873417,0.9767708617440272,1.0,2/45,2.39%,CP;B2M
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleolus (GO:1904749),0.6655201004842981,1.0783253786435028,0.3939393939393939,0.9729460353141081,1.0,3/6,28.51%,GLUL;MCRS1;POLR1A
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),0.5579131613651238,1.0782412214861878,0.34375,0.9720350473948204,1.0,4/15,12.62%,CD200R1;TNFAIP3;FOXJ1;SIRPA
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.5831676954810453,-1.078079240013741,0.410958904109589,0.9790885978948849,1.0,3/20,9.37%,P2RY6;ATP1B1;HAP1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to synapse (GO:1902474),0.6989553304741432,1.0780371750985183,0.42857142857142855,0.9716414276051984,1.0,1/5,0.52%,WNT7A
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),-0.47661095274319343,-1.0778524200477895,0.3950617283950617,0.979107399021128,1.0,15/70,17.15%,CCK;POU4F1;ANK3;SHTN1;S100A6;SLITRK1;APP;MAP1B;BAIAP2;NEFH;MINK1;SLITRK5;SLITRK4;MFSD2A;CDK5
prerank,GO_Biological_Process_2021__lung development (GO:0030324),-0.5452424903582811,-1.0776244099401653,0.323943661971831,0.979092443820055,1.0,7/23,18.15%,PDPN;PROX1;CCDC39;CHI3L1;FGF1;ITGA3;FGF7
prerank,GO_Biological_Process_2021__kynurenine metabolic process (GO:0070189),-0.6613135123974732,-1.0773431052049065,0.40350877192982454,0.9793201470785583,1.0,1/8,3.79%,KMO
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),-0.5686300640989985,-1.0772672634621019,0.352112676056338,0.9787662888825256,1.0,8/19,20.30%,GRIN2D;GRIN2A;ITPR3;JPH3;CACNA1C;GRIN2B;JPH4;RYR2
prerank,GO_Biological_Process_2021__plasma membrane raft assembly (GO:0044854),-0.7333041982696873,-1.0770347442127406,0.45454545454545453,0.9790275343127424,1.0,3/5,19.63%,CAV3;EMP2;FLOT1
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",0.68510729221085,1.077023156713775,0.43333333333333335,0.973451882228527,1.0,1/6,3.63%,ARFIP1
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),0.42387173148853957,1.0767558497774938,0.30434782608695654,0.9731860179621374,1.0,15/61,17.61%,MTHFS;SLC19A1;AOX1;CD320;TPK1;FLAD1;SLC25A19;CUBN;SLC5A6;MTHFD2L;DHFR;PANK2;SLC46A1;SLC19A2;DHFR2
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),-0.5645644822605969,-1.0766547664065003,0.3939393939393939,0.9795976534654948,1.0,1/18,1.06%,CDKN2A
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),-0.6050334432808411,-1.076073290535906,0.40298507462686567,0.9808924450695213,1.0,2/10,13.15%,C12ORF57;IFT122
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),0.5619339643528554,1.0758340096678762,0.35714285714285715,0.9752470758251602,1.0,3/8,20.32%,COMMD1;WNK3;NEDD4L
prerank,GO_Biological_Process_2021__dendritic cell migration (GO:0036336),-0.660593871932112,-1.0756853660977568,0.4098360655737705,0.9815742906149898,1.0,1/7,1.68%,GPR183
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),0.3874539412363702,1.0753810800163919,0.27586206896551724,0.9754764834235952,1.0,12/48,15.65%,GAL3ST2;GANC;ADAMTS9;ST8SIA5;ENGASE;MAN1A2;GAL3ST4;STT3B;PRKCSH;GANAB;FBXO27;ADAMTS13
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.5088416243698068,-1.0753601899134024,0.3875,0.9818928372454961,1.0,14/37,28.55%,NLRC5;ISG15;PARP14;SIGIRR;USP18;SLIT3;CCDC3;PTPRC;STAT2;SH2B3;SLIT2;RFFL;GSTP1;OAS3
prerank,GO_Biological_Process_2021__telomere maintenance via recombination (GO:0000722),0.5767634575721594,1.075178095277653,0.4594594594594595,0.9749530849745462,1.0,2/9,8.68%,TPRKB;SMC6
prerank,GO_Biological_Process_2021__G-quadruplex DNA unwinding (GO:0044806),-0.6601362833405879,-1.0750837244263998,0.3968253968253968,0.9820768307371631,1.0,1/7,0.78%,BLM
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),-0.4418682168449006,-1.0749134570609709,0.3103448275862069,0.9818520154817109,1.0,58/229,19.43%,GRIN2D;NPY;RIMBP2;SNCB;GRIN2A;CHRNA5;SLC32A1;HTR2B;PLP1;CHRM1;GRIA3;SYN3;RPS6KA1;GRIA1;NRGN;AKAP5;SLC18A2;HAP1;SYT1;CBLN2;CPLX1;SYN2;UTS2;SST;GLRA2;GRIK1;CHRM3;UNC13C;RIT2;GABRB2;GABRD;APBA2;HCRTR2;GAD1;MINK1;PCDHB5;GRIN2B;GAD2;NPTX2;HRH1;GRID2;NLGN1;GABRE;CDK5;PDLIM4;GRM7;GABRG2;HTR1E;TBC1D24;GLRA1;CHRM5;HTR2A;CACNB1;GABRA1;SNCG;GRIK2;SLC12A7;KCNMB4
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte mediated immunity (GO:0002886),-0.6416971983927046,-1.0748725368112797,0.4375,0.9812795906191383,1.0,2/7,16.30%,SYK;FES
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),-0.4819348790967543,-1.0746364855059156,0.3493975903614458,0.9812162375171313,1.0,21/73,19.36%,ANK3;NEFL;GRIN2A;APP;GRIA3;GRIA1;HPCA;SHISA8;CTSS;KCNG1;JPH3;MINK1;SHISA9;GRIN2B;NLGN1;NOS1;FGF12;CAPN1;CACNB1;JPH4;RELN
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),-0.5675748506018441,-1.074419262765362,0.42857142857142855,0.9811262606766246,1.0,5/23,16.97%,STMN2;MAP1B;STMN4;MAPRE2;STMN1
prerank,GO_Biological_Process_2021__negative regulation of amyloid fibril formation (GO:1905907),-0.6679439620325422,-1.074402602645458,0.4925373134328358,0.9804289321985574,1.0,3/9,18.41%,LDLR;PFDN6;PFDN1
prerank,GO_Biological_Process_2021__dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.4811076867079935,1.0743913598454307,0.37142857142857144,0.9758057863184404,1.0,4/16,22.08%,ALG6;ALG3;ALG13;ALG2
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),0.5037476926493388,1.074370483986368,0.4411764705882353,0.9747243467355738,1.0,5/12,20.79%,NUDT21;CPSF6;CPSF7;FARSB;PKD2
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),-0.5108682708021358,-1.0741556697256536,0.3375,0.9805865287809965,1.0,14/37,20.43%,TIMP2;CD44;SCUBE3;MMP19;MMP14;TIMP1;CTSS;KIF9;ADAMTS4;CAPN1;A2M;CAPNS1;FLOT1;TLL1
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.4952864331150575,-1.0740346157818732,0.2948717948717949,0.9801440081930761,1.0,9/62,17.39%,IFI6;THBS1;ICAM1;BRCA1;GATA1;UNC5B;IGF1;FADD;TMBIM1
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),0.38983732934866483,1.0739001761126028,0.25,0.974937342004896,1.0,17/96,16.34%,CD247;PPARGC1A;MITF;TCAP;OCLN;SOX9;LPXN;NUP54;LLGL1;MDN1;KMT2A;NDC1;WASL;CAPZA1;PICALM;VAMP3;NUP205
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),-0.5387029889415492,-1.073774943674888,0.3442622950819672,0.980314900705212,1.0,6/24,21.97%,CDKN2A;SRF;PRKCD;CDKN1A;PML;SPI1
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,-0.5128016083266981,-1.0736518862516606,0.3875,0.9799731137831262,1.0,14/44,20.54%,ANXA1;PGR;EPS8L2;OVOL2;WNT5A;BTG1;CD9;SLC44A3;TMC4;PTH1R;RHOD;CEBPD;CD74;ITGB4
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),-0.505901867490023,-1.073580019705502,0.36585365853658536,0.979478929813878,1.0,11/40,20.74%,ANXA1;GPR183;IL12A;IL15;PDCD1LG2;HLA-E;IL7;IL18;PTPRC;CD74;IRS2
prerank,GO_Biological_Process_2021__galactose catabolic process (GO:0019388),0.6441162656126012,1.0735720440066645,0.4864864864864865,0.9747356403284413,1.0,2/6,8.57%,PGM2;GALT
prerank,PanglaoDB_Augmented_2021__Principal Cells,0.38038763032068834,1.0734064593411925,0.3888888888888889,0.9740093123294078,1.0,9/61,8.16%,ACE2;TMEM229A;KCNE1;EHF;ARHGEF16;CAPN13;MYO5B;TRIM29;PLEKHA6
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,-0.4566023776454242,-1.073393997164445,0.3333333333333333,0.9795303474197118,1.0,20/98,16.94%,COL4A1;ANGPTL2;COL4A2;CALD1;LAMB1;SULF1;IGFBP5;THY1;MAP1B;ZIC1;NNAT;RASL12;BGN;SCARA3;LMOD1;PRRX1;SLIT3;AMOTL2;DPYSL3;PCDH18
prerank,GO_Biological_Process_2021__cranial nerve development (GO:0021545),-0.7264893329278914,-1.0731987760542094,0.40816326530612246,0.9794621831364632,1.0,1/5,2.19%,POU4F1
prerank,GO_Biological_Process_2021__regulation of nitrogen compound metabolic process (GO:0051171),-0.6875986398877931,-1.0730295039051265,0.4393939393939394,0.9793344228197891,1.0,2/6,16.90%,LDLR;MFSD2A
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),-0.6272296634282506,-1.0726697644806689,0.3620689655172414,0.979796799104759,1.0,1/13,6.49%,APP
prerank,GO_Biological_Process_2021__positive regulation of T cell apoptotic process (GO:0070234),0.6479908682519719,1.0726586067092312,0.46153846153846156,0.9752554723785021,1.0,2/6,14.95%,ZC3H8;IDO1
prerank,GO_Biological_Process_2021__negative regulation of response to interferon-gamma (GO:0060331),-0.6553437929329099,-1.0723753867399433,0.46774193548387094,0.9793825211165417,1.0,1/6,7.76%,PARP14
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),-0.6553437929329099,-1.0723753867399433,0.46774193548387094,0.9793825211165417,1.0,1/6,7.76%,PARP14
prerank,GO_Biological_Process_2021__regulation of leukocyte degranulation (GO:0043300),-0.6695764562723949,-1.072242985714955,0.4772727272727273,0.9791097410830707,1.0,2/6,16.30%,SYK;FES
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),-0.6128391474347098,-1.0719653732612922,0.4444444444444444,0.9794122583357936,1.0,3/11,6.95%,THBS1;CD160;CCL2
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),0.47508723669192177,1.0716561115177359,0.36666666666666664,0.9773083456910531,1.0,4/22,13.85%,NR1D1;TNFAIP3;LGR4;TICAM1
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),-0.636878565736605,-1.0714991880786329,0.410958904109589,0.9802953228106466,1.0,1/10,9.99%,PLK3
prerank,GO_Biological_Process_2021__positive regulation of interleukin-4 production (GO:0032753),-0.6068433344480664,-1.0713765876195342,0.45901639344262296,0.9799762873876809,1.0,3/10,12.99%,PRKCQ;SYK;HLA-E
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.47018959892509143,-1.0712052354876644,0.3291139240506329,0.9798225558173528,1.0,12/61,15.12%,GGT5;RAMP3;PLK2;ADCY7;SYK;GIPR;RHBDF2;MYH9;VIP;GLP1R;GNG2;ADCY5
prerank,PanglaoDB_Augmented_2021__Ionocytes,-0.49262186005699327,-1.0711926880702012,0.32894736842105265,0.9791025801449318,1.0,7/59,9.29%,C1ORF87;FMO6P;MROH9;CYP4X1;SPAG17;FUT2;ATP1B1
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.5522370946940038,1.0708275853164575,0.3333333333333333,0.9790234487581089,1.0,2/13,9.06%,PPP1R15B;NCK1
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),-0.5166472991779016,-1.0706931957899526,0.379746835443038,0.9802529841783192,1.0,8/28,17.96%,ACOT1;ACSM5;GLYAT;DBI;ACOT4;ACOT2;ACOT8;OXSM
prerank,PanglaoDB_Augmented_2021__Hepatocytes,0.37636897468076214,1.0703882594348904,0.3333333333333333,0.9793724932302514,1.0,8/94,3.15%,LEPR;G0S2;FGL1;GOLT1A;CEBPA;PHLDA1;MTTP;PLIN1
prerank,GO_Biological_Process_2021__ubiquinone biosynthetic process (GO:0006744),0.5587252375135844,1.0702191161419998,0.38461538461538464,0.9777137740842252,1.0,6/13,23.74%,COQ3;COQ2;COQ9;PDSS2;UBIAD1;COQ6
prerank,GO_Biological_Process_2021__quinone biosynthetic process (GO:1901663),0.5587252375135844,1.0702191161419998,0.38461538461538464,0.9777137740842252,1.0,6/13,23.74%,COQ3;COQ2;COQ9;PDSS2;UBIAD1;COQ6
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),-0.4465330316964089,-1.070151618095527,0.34523809523809523,0.9815133967705313,1.0,27/115,19.13%,FLRT3;L1CAM;POU4F1;ANK3;MYOT;SNCB;SLC8A3;SLITRK1;APP;LRRC4;ARHGAP39;CBLN2;DCTN1;UNC13C;PCDHB5;BDNF;DOK7;ACHE;NLGN1;CDK5;PPFIA1;CNTN2;AGRN;SEMA3E;CACNB1;SNCG;C1QB
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),-0.4505748936272048,-1.0701171746238214,0.3333333333333333,0.9808463599178981,1.0,25/114,20.94%,KCNV1;KCNJ13;KCNJ2;KCNK1;SLC8A3;SLC4A11;SCN9A;SLC18A2;ATP1B1;PIEZO2;SLC5A4;KCNG1;SCN2A;SCN1A;SLC22A4;KCNB2;KCNAB3;SCN3B;KCNC1;KCNMB4;AQP1;SLC29A4;SLC25A29;KCND3;LRP2
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.5482307826665057,-1.070073137704677,0.3466666666666667,0.9802197618293984,1.0,6/22,14.22%,HPN;EFNA1;OVOL2;ZNF750;SFRP2;DAB2IP
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,-0.4367717707052281,-1.0699935818453927,0.36470588235294116,0.9796925604292727,1.0,42/143,18.91%,CDH22;STMN2;SNCB;ZDHHC22;SLC32A1;SLC24A2;PLP1;SLITRK1;SYT4;LRRTM1;GRIA3;ELAVL4;SRRM4;SYP;GAP43;TCEAL6;ITPR3;CPLX1;IGSF21;HPCA;RIT2;CA10;CPLX2;SHISA8;TCEAL2;PCP4;GAD1;CALY;C11ORF87;STMN4;GDAP1L1;GAD2;SYNPR;GRID2;CNTN2;KCNC1;GABRG2;TCEAL5;SYT2;RAB3C;PDE5A;GABRA1
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,-0.4494639881083925,-1.069595652292268,0.3793103448275862,0.9802282957148317,1.0,33/123,19.37%,B3GALT2;PCSK2;STMN2;NEFM;PROX1;ZDHHC22;SLC24A2;SLITRK1;SYT4;SRRM4;GRIA1;SYP;ZNF536;TCEAL6;CA10;GRM6;SCN2A;SCN1A;C11ORF87;STMN4;GDAP1L1;GAD2;SYNPR;SCN3B;LRTM1;CNTN2;KCNC1;GABRG2;TCEAL5;RAB3C;CNTNAP5;GABRA1;SV2B
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.694025476486856,-1.0687374468309383,0.4339622641509434,0.9825058101757288,1.0,4/7,25.08%,IL12A;DAB2IP;PIK3CB;DCN
prerank,GO_Biological_Process_2021__positive regulation of cholesterol storage (GO:0010886),-0.6985937612068391,-1.0685270875354993,0.43478260869565216,0.9825344785622839,1.0,4/5,30.15%,MSR1;EHD1;SCARB1;SREBF2
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),-0.6085555042227838,-1.0684307720789377,0.38235294117647056,0.9821706423342794,1.0,4/8,28.55%,IRF7;IFIH1;TRIM25;OAS3
prerank,GO_Biological_Process_2021__mRNA 3'-splice site recognition (GO:0000389),0.7074287995655567,1.068395099335714,0.43243243243243246,0.982577017806901,1.0,1/5,6.48%,SF3A1
prerank,GO_Biological_Process_2021__heart development (GO:0007507),-0.44163116846165956,-1.0683659865281148,0.39080459770114945,0.9817289395051114,1.0,23/106,19.86%,FLRT3;APLNR;PKP2;TGFBR2;POU4F1;MMP21;HTR2B;SYNPO2L;SMYD4;ZFPM1;SRF;IFT122;FN1;CACNA1C;DLC1;PDLIM4;APLN;CDKN1A;TSC2;FGF12;GPC3;TGFB1;PLCE1
prerank,GO_Biological_Process_2021__intermembrane lipid transfer (GO:0120009),0.6753739633003437,1.0682348906565342,0.5,0.9818641012353793,1.0,2/6,21.24%,PLEKHA3;TTPA
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),-0.6055899084923665,-1.06815065070494,0.4262295081967213,0.9817973286096424,1.0,4/18,15.36%,ZFP36;MAFF;ABCA12;SFRP4
prerank,GO_Biological_Process_2021__water transport (GO:0006833),-0.6950125153076858,-1.0681382690173993,0.47540983606557374,0.98108904135348,1.0,1/6,3.84%,PDPN
prerank,GO_Biological_Process_2021__regulation of protein deacetylation (GO:0090311),0.6570680896191994,1.068093572453842,0.4375,0.9810111181063135,1.0,4/8,19.43%,SPRED1;SPRED2;EP300;CCAR2
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,-0.44126848205655644,-1.0680430451995961,0.29545454545454547,0.9806752843059839,1.0,25/142,16.35%,PGR;ZFP36;MYOF;BTG3;CD44;TJP3;OVOL2;SEMA3B;ANXA9;LSR;KLF4;GINS2;FOS;HR;RAPGEFL1;PAPSS2;EMP2;CCND1;BLVRB;ST6GALNAC2;CD9;PCP4;SNX10;PRSS23;TMPRSS3
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),0.48839500181187007,1.0680403922309265,0.3448275862068966,0.9800500104203169,1.0,5/19,19.84%,MSL2;KMT2A;KAT7;KANSL2;MCRS1
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,-0.5029635000684051,-1.0679500695175395,0.3246753246753247,0.9802100415919691,1.0,8/39,8.92%,MYO1F;CD5;CD44;TAGAP;SLA;GPR171;P2RY10;ARHGAP9
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),0.5934135176881823,1.0679313863255948,0.3333333333333333,0.9793739014561386,1.0,2/10,6.55%,ZPR1;SOX12
prerank,GO_Biological_Process_2021__regulation of complement-dependent cytotoxicity (GO:1903659),-0.6970951816862304,-1.0679095176863793,0.47058823529411764,0.9795892618166838,1.0,2/5,14.16%,CD55;CFH
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.4852512382754871,-1.0675841062779703,0.43209876543209874,0.9798932423468776,1.0,13/82,15.54%,CD24;RASGRP1;PSRC1;PROX1;HTR2B;CEMIP;WNT5A;EGF;CCND1;DIRAS1;DAB2IP;FGF1;MTCP1
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),-0.6059419150989493,-1.0675095088497732,0.4375,0.9794751843866375,1.0,5/17,25.65%,HAP1;IGF1;RTN1;RTN2;RTN4
prerank,GO_Biological_Process_2021__cellular modified amino acid biosynthetic process (GO:0042398),0.48238843477212584,1.0674829307745304,0.375,0.9796251700331837,1.0,2/18,7.92%,MTHFS;PTDSS1
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),0.555613510250397,1.0672303100838798,0.4117647058823529,0.9792489096306034,1.0,1/12,2.60%,BMP2
prerank,GO_Biological_Process_2021__ATP synthesis coupled electron transport (GO:0042773),0.6392402350983766,1.067139896491957,0.38095238095238093,0.9783725323431853,1.0,5/6,34.74%,NDUFV3;NDUFV1;NDUFB6;NDUFA12;COA6
prerank,GO_Biological_Process_2021__regulation of cellular extravasation (GO:0002691),-0.6869443534139941,-1.0669475582255705,0.43103448275862066,0.9805192840141722,1.0,2/7,7.01%,ICAM1;THY1
prerank,PanglaoDB_Augmented_2021__Thymocytes,-0.524750000128051,-1.0666388109115112,0.35064935064935066,0.9808607891182411,1.0,9/32,10.33%,MYO1F;CD5;TAGAP;SLA;TMC8;P2RY10;ARHGAP9;WAS;CD99
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),0.4101382864938986,1.0663622641633574,0.2777777777777778,0.9799063784243252,1.0,6/46,6.89%,SOX8;PPARGC1A;CEBPA;ATF5;BBS9;AKT2
prerank,GO_Biological_Process_2021__regulation of mitochondrial gene expression (GO:0062125),0.6095027536226069,1.0662320009063622,0.4642857142857143,0.9791562167617216,1.0,5/8,32.87%,NSUN3;METTL4;ALKBH1;TSFM;MTRES1
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),-0.45308668849813016,-1.0661743812654987,0.4125,0.9816427900479264,1.0,14/89,18.16%,GGT5;OGN;CSPG4;OMD;BGN;ST3GAL6;PAPSS2;GSTM5;B3GNT2;CHST15;CHSY3;CHST6;GGTA1;GSS
prerank,GO_Biological_Process_2021__dendrite arborization (GO:0140059),0.6467979860053512,1.066172800277859,0.4318181818181818,0.9781581460124906,1.0,5/6,33.94%,TAOK2;SEMA3A;PTN;NRP1;CHRNA7
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),-0.5896990773922206,-1.0659964049805986,0.4225352112676056,0.9814579750478459,1.0,2/17,15.66%,MMP14;BDNF
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.43151451334488583,-1.0659136534275326,0.34782608695652173,0.9810014672001517,1.0,20/158,14.22%,RASGRP1;P2RY6;APIP;GPR183;GBP1;ICAM1;RAMP3;CD44;GPNMB;PSCA;HTR2B;APP;CCL2;CEACAM1;CHI3L1;SYK;SCIMP;FN1;THPO;DAB2IP
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,-0.5030108779544765,-1.065682977535798,0.32432432432432434,0.9811603740808982,1.0,1/35,0.16%,LEF1
prerank,GO_Biological_Process_2021__regulation of collagen fibril organization (GO:1904026),-0.6701690758268781,-1.0656338621464005,0.4642857142857143,0.9805690155841552,1.0,3/6,24.87%,AEBP1;CHADL;EMILIN1
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),-0.5129700549480999,-1.0654479197039761,0.34285714285714286,0.9805664917785746,1.0,6/32,12.08%,BAIAP2L1;CDC42EP1;BAIAP2;PFN2;LMOD1;CDC42EP3
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),0.5356579186955519,1.0654204487213559,0.36363636363636365,0.9792661992316639,1.0,5/16,26.46%,SNF8;MDM2;NEDD4L;CHMP6;FAF1
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),0.5191692979834547,1.0654177656891837,0.4411764705882353,0.9781768896568659,1.0,5/15,17.86%,STN1;TFIP11;DCLRE1B;POT1;DCLRE1C
prerank,GO_Biological_Process_2021__mammary gland epithelial cell differentiation (GO:0060644),0.6583173376628766,1.0653583784936498,0.4482758620689655,0.9772611018979178,1.0,5/7,17.38%,AKT2;AKT1;ERBB4;ZNF703;ID2
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),-0.569418479687746,-1.065321956719094,0.421875,0.9802347263882036,1.0,5/14,23.09%,A4GALT;B4GALNT1;B3GALT4;ST6GALNAC3;ST8SIA3
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),0.439881409874894,1.0652647506005926,0.4090909090909091,0.9764716498683649,1.0,11/32,20.44%,GLRB;VCP;DRD2;DERL1;KYNU;TRPV1;DHFR;KAT7;RHBDD1;RCN3;SEL1L
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),0.5369524541872165,1.0651785728576244,0.3793103448275862,0.9755909207709499,1.0,5/13,12.45%,TMEM100;SOX9;FOXJ1;VEZF1;BAD
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),-0.5928567711282277,-1.0651401297012093,0.5076923076923077,0.9800582894614566,1.0,5/13,23.62%,SULF1;WNT5A;DEAF1;PDGFRA;KIAA1217
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.5578857299610397,-1.0649446081192353,0.39705882352941174,0.980004594895842,1.0,2/23,2.90%,TLR2;RPS27A
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to mitochondrion (GO:1903747),-0.682294395172338,-1.0648965439550875,0.43859649122807015,0.9794357035260162,1.0,4/7,24.00%,ATP5IF1;PINK1;MAPT;SREBF1
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),0.5137228370100584,1.0648930178358322,0.3333333333333333,0.9751770549093728,1.0,4/16,16.60%,MCU;TIRAP;MPP1;MDK
prerank,GO_Biological_Process_2021__regulation of protein localization to cilium (GO:1903564),0.656299591646617,1.0647480450233389,0.3541666666666667,0.9745474442420128,1.0,2/5,20.51%,CCDC88A;LZTFL1
prerank,GO_Biological_Process_2021__positive regulation of macrophage activation (GO:0043032),-0.6392610305191446,-1.0643231312895516,0.45614035087719296,0.9807727568286013,1.0,3/8,12.64%,THBS1;WNT5A;TNIP2
prerank,GO_Biological_Process_2021__myeloid cell activation involved in immune response (GO:0002275),-0.6070481682128749,-1.0640516509736737,0.4603174603174603,0.9810787843871526,1.0,4/11,14.84%,IFI35;DYSF;SYK;SBNO2
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),0.465852150674695,1.0638940843861115,0.36363636363636365,0.9761918870853366,1.0,5/24,13.72%,DUSP19;MAP3K4;SASH1;TAOK3;DVL2
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.4640186770571777,-1.0638424865800051,0.379746835443038,0.9810116227453447,1.0,12/62,15.12%,GGT5;RAMP3;PLK2;ADCY7;SYK;GIPR;RHBDF2;MYH9;VIP;GLP1R;GNG2;ADCY5
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),-0.5827738551684565,-1.0635077926645569,0.4603174603174603,0.9816637545912954,1.0,4/14,12.21%,HPN;ZIC1;MYO3A;PAX8
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta clearance (GO:1900223),-0.7045844156809097,-1.0634633130095759,0.44776119402985076,0.9810444342924899,1.0,1/5,14.80%,LRPAP1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),-0.525689107427996,-1.0631678807819296,0.3611111111111111,0.9813749698059528,1.0,3/30,4.59%,KCNQ1;NOS1AP;KCNJ2
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.4058827425594185,1.0631109496526374,0.35,0.977400207661124,1.0,18/51,19.68%,PNLDC1;CNOT9;PDE12;EXOSC1;DCP1B;EXOSC6;CNOT2;DIS3;EDC3;LSM7;LSM5;RC3H1;CNOT6L;CNOT4;CNOT1;PATL1;CNOT8;RC3H2
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),-0.5694625034091931,-1.0630839574931312,0.3939393939393939,0.9809233852397109,1.0,3/15,6.95%,THBS1;CD160;CCL2
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),-0.4356999949150315,-1.0628472851407318,0.3181818181818182,0.9810806609545227,1.0,31/123,22.23%,MYO1F;RHOBTB2;CLRN1;PROX1;GAS2L3;POF1B;MYO15A;RND2;BAIAP2L1;BAIAP2;SVIL;VIL1;WAS;LMOD1;EMP2;NLRP5;MYO1E;RHOF;DSTN;DMTN;ELMO1;TPM4;DPYSL3;RHOBTB1;CORO7;RHOD;FHOD3;PPP1R9A;SHROOM4;TLE6;MYO1C
prerank,GO_Biological_Process_2021__protein side chain deglutamylation (GO:0035610),0.6348108872308034,1.0625670359513502,0.4473684210526316,0.9779425149663903,1.0,2/5,19.28%,AGBL1;AGBL2
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),-0.6266538991916106,-1.061979193453418,0.32786885245901637,0.9835022253774359,1.0,3/11,9.29%,ANK3;GLRX;ATP1B1
prerank,GO_Biological_Process_2021__megakaryocyte development (GO:0035855),-0.7266080192607183,-1.0616005379604114,0.44642857142857145,0.9842134199756036,1.0,3/5,25.29%,THPO;ZNF385A;SH2B3
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),-0.7262875706193849,-1.0612322344910186,0.5147058823529411,0.9849363107307308,1.0,1/5,7.91%,YBX3
prerank,GO_Biological_Process_2021__alanine transport (GO:0032328),0.5907285926471777,1.0611777335957349,0.42424242424242425,0.9810412376132286,1.0,2/7,23.57%,SLC36A4;SLC1A4
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),-0.4641546912830443,-1.0611774943509913,0.40789473684210525,0.984483738726539,1.0,8/56,10.60%,TLR2;IFI35;IL15;APP;PLSCR1;WNT5A;TLR3;NLRP12
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),0.33710362951015804,1.061095837424592,0.2857142857142857,0.9801777034607978,1.0,80/278,23.13%,NR1D1;INTS13;PPARGC1A;NR2E1;RARB;ZC3H8;ELOC;TRIM24;SNAPC5;KAT2B;MAML3;SNRPF;COPS2;NUDT21;ESRRG;RORB;GTF2F2;EAF2;ERCC6;ELOA;AR;WDR33;NR3C1;NRBF2;CSTF3;ERCC2;NOTCH2;PAPOLA;INTS7;GTF2A2;SOX5;ESRRA;ERCC3;INTS8;CPSF7;DDX21;POLR2C;TAF12;TAF4;SNAPC3;ELP2;TAF2;NFKB1;GTF2H5;SNAPC1;TAF8;POU2F1;HDAC10;NR2F1;IWS1;NR1D2;NR3C2;ELP4;GTF2H2;TAF3;CDK12;PCID2;RPRD1B;THRB;MED23;INTS14;CPSF2;ESRRB;RNGTT;MLLT3;INTS11;MED4;CCNT2;GTF2B;CCNT1;RBMX;NELFA;CTDP1;GTF2H3;ESR2;NR2F6;RBPJ;PARP1;TRIP11;ZBTB1
prerank,GO_Biological_Process_2021__glutamine family amino acid catabolic process (GO:0009065),0.5707629425287095,1.0609267790930115,0.45454545454545453,0.9796235742540003,1.0,8/10,23.46%,DAO;GLUD1;GLS;GLUL;DDAH1;ALDH4A1;PRODH;ARG1
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,-0.43629972185065946,-1.060607523922063,0.3176470588235294,0.9858112024267633,1.0,39/133,20.21%,TAGLN3;DHCR24;STMN2;NEFM;SH3GL2;PLP1;SLITRK1;CLGN;SCN9A;SYT4;LRRTM1;ELAVL4;MAP1B;GAP43;NEFH;ZNF536;TCEAL6;PIEZO2;CA10;TCEAL2;SCN2A;SYNM;C11ORF87;STMN4;GDAP1L1;SYNPR;CRMP1;DCLK1;SCN3B;RGS7BP;CNTN2;KCNC1;TCEAL5;RAB3C;SNCG;ADD2;VWA5A;ADCY8;SULT4A1
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),0.5561020603330762,1.0605979067700535,0.4,0.9792856704133652,1.0,2/12,10.13%,NCSTN;APEH
prerank,PanglaoDB_Augmented_2021__Microglia,-0.47312531583698636,-1.0605712524618682,0.40963855421686746,0.9852375705588541,1.0,14/59,11.33%,P2RY13;P2RY6;MYO1F;GPR183;P2RY12;TAGAP;SIGLEC1;SLA;GPR34;COLEC12;IGSF6;HLA-DRA;FOS;CLEC12A
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),-0.5787828983298939,-1.0602758689574547,0.43548387096774194,0.9856136317903944,1.0,4/12,26.24%,PPP3CC;HRH1;PLCE1;NFATC2
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),0.5780709809526559,1.0602520594028981,0.42857142857142855,0.9791785986348686,1.0,3/9,9.32%,ARFIP1;WASHC5;ARFIP2
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),-0.647085572348471,-1.0599622885316458,0.3548387096774194,0.9860463933002989,1.0,1/7,2.42%,COL5A1
prerank,GO_Biological_Process_2021__positive regulation of Golgi to plasma membrane protein transport (GO:0042998),0.6140938037877848,1.059921713335311,0.4411764705882353,0.9789951643185474,1.0,2/5,16.43%,ATP2C1;ACSL3
prerank,GO_Biological_Process_2021__regulation of astrocyte differentiation (GO:0048710),0.6509454513431,1.0597014289510651,0.4722222222222222,0.978597893615979,1.0,4/8,20.03%,BMP2;SERPINE2;ID2;HES5
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),-0.5564765419120535,-1.0595243154878202,0.39436619718309857,0.9867264771282309,1.0,1/30,0.21%,ANXA1
prerank,GO_Biological_Process_2021__fatty acid alpha-oxidation (GO:0001561),0.5937530024542022,1.0591217713536374,0.40540540540540543,0.9795314245805236,1.0,3/6,17.79%,PEX13;PHYH;SLC25A17
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),0.5001750169281003,1.0591177334930342,0.2916666666666667,0.9784626010185455,1.0,8/19,18.10%,ABCB10;ALAS1;HMBS;COX10;SUCLA2;FECH;FLVCR1;SLC25A38
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),0.5314533050022661,1.059113947035425,0.4074074074074074,0.9773656698514843,1.0,1/12,1.60%,NCSTN
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),-0.5617509433937982,-1.0590809185616608,0.39436619718309857,0.9873864745323359,1.0,2/20,3.46%,L1CAM;SHTN1
prerank,GO_Biological_Process_2021__histone H3-K36 methylation (GO:0010452),0.631963163618739,1.0585443074153598,0.45714285714285713,0.9784040892134245,1.0,3/5,29.66%,SETD3;SETD5;SETD2
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),-0.4327214661156629,-1.057885532541598,0.4125,0.9906802143645371,1.0,14/118,17.10%,GBP2;TRAM1L1;GBP1;RAB11A;APP;ISG15;FSIP2;PAQR3;IFT122;SNX10;OBSCN;DDRGK1;RPA1;MICALL1
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),0.6109774911366294,1.0578713035425666,0.4482758620689655,0.9784370443801409,1.0,6/7,38.87%,GABPA;MAPK1;ATF4;PRKN;LRRK2;ABL1
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),0.6109774911366294,1.0578713035425666,0.4482758620689655,0.9784370443801409,1.0,6/7,38.87%,GABPA;MAPK1;ATF4;PRKN;LRRK2;ABL1
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),-0.5365167632861474,-1.057589957905893,0.45454545454545453,0.9909809775078198,1.0,8/18,32.71%,SEMA3B;SEMA3E;SEMA4G;SEMA4C;SEMA6D;SEMA3C;SEMA3D;SEMA5A
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.5074318450389498,-1.0575667522374113,0.43037974683544306,0.9903177281127566,1.0,4/46,9.40%,BLM;HELB;POLQ;POLR2I
prerank,GO_Biological_Process_2021__regulation of lymphocyte proliferation (GO:0050670),-0.6194132826173107,-1.0574764329309203,0.4090909090909091,0.9898645127271062,1.0,1/8,6.15%,IL12A
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),0.49288262525453286,1.0574708611347337,0.4166666666666667,0.9785293865219755,1.0,5/20,19.08%,TEX15;DNMT3B;METTL4;EHMT1;BEND3
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),0.42723992535201527,1.0573844477826349,0.3333333333333333,0.9776963346555002,1.0,14/64,15.60%,RANBP17;NXT2;NUP62CL;PPP1R10;AKT1;IPO5;IPO8;TSPAN17;NUP214;RALA;NXT1;RANBP6;NUP188;NUP85
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),-0.6498218407536185,-1.057361674361606,0.42105263157894735,0.989532242362431,1.0,1/7,8.67%,WNT5A
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),-0.5953059085574642,-1.0571680973864452,0.3888888888888889,0.9894850928654841,1.0,4/14,9.78%,CD44;SKAP1;THY1;KLF4
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),-0.5207189374339167,-1.057034509352666,0.4473684210526316,0.9892041671680971,1.0,1/30,0.43%,THBS1
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis of virus by host cell (GO:0019065),-0.6928191012313307,-1.057008978037051,0.4262295081967213,0.9885384202072185,1.0,1/6,4.80%,SIGLEC1
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),0.5365078044425802,1.0567212757643243,0.37142857142857144,0.9784256013780256,1.0,4/15,16.60%,GIT1;AJAP1;CASK;MDK
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),0.378153875358875,1.056426029883856,0.4117647058823529,0.9784268484408866,1.0,17/64,17.32%,NUP42;NUP37;CBFA2T3;GIT1;NUP54;SLC4A4;AAAS;NUP214;NDC1;RAE1;ZBTB20;NUP188;EP300;NUP85;NUP205;NUP210;JMJD8
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),-0.5218552949671342,-1.0562431891326383,0.4342105263157895,0.9904295118902976,1.0,1/31,0.21%,ANXA1
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),-0.47197925461606455,-1.0562231843748124,0.35064935064935066,0.9897449263956319,1.0,20/61,21.96%,FYB1;ITGA2;ISG15;THY1;ANGPTL3;CEACAM1;FYB2;ITGA5;SYK;ZYX;ITGBL1;FN1;MYH9;ITGA11;LAMA3;ERBIN;ITGB4;FERMT3;CDH17;LAMA5
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),-0.6175000325049351,-1.0559581722743776,0.3968253968253968,0.9897734094976436,1.0,3/12,7.91%,ZFP36;ELAVL4;YBX3
prerank,GO_Biological_Process_2021__pre-mRNA cleavage required for polyadenylation (GO:0098789),0.5307346191488312,1.0558517659009112,0.3235294117647059,0.979108333503948,1.0,4/12,19.51%,NUDT21;CPSF6;CPSF7;CPSF2
prerank,GO_Biological_Process_2021__positive regulation of MHC class II biosynthetic process (GO:0045348),-0.7201508465239541,-1.0555445919871544,0.42592592592592593,0.9904378035527255,1.0,1/5,2.24%,CIITA
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),-0.4534689192281748,-1.0555272810934935,0.4418604651162791,0.9897736212657975,1.0,12/97,16.30%,EFNA1;DUSP1;TESC;KIF14;IL12A;PODXL;FUT2;ARHGDIG;NUAK1;MINK1;IL18;FES
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),0.6157518513846104,1.0555158079988403,0.4473684210526316,0.9789880225760389,1.0,5/8,29.41%,SMG1;RPTOR;NPRL3;MLST8;MTOR
prerank,GO_Biological_Process_2021__response to indole-3-methanol (GO:0071680),-0.6965106113398442,-1.055504945575771,0.509090909090909,0.9883916860750169,1.0,1/5,9.24%,BRCA1
prerank,GO_Biological_Process_2021__cellular response to indole-3-methanol (GO:0071681),-0.6965106113398442,-1.055504945575771,0.509090909090909,0.9883916860750169,1.0,1/5,9.24%,BRCA1
prerank,"GO_Biological_Process_2021__regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)",-0.7199799344353225,-1.0554154539503526,0.46,0.9879941809036508,1.0,2/5,10.67%,PLEKHA4;RSPO3
prerank,GO_Biological_Process_2021__cell migration involved in heart development (GO:0060973),-0.6811814989287821,-1.055059247478177,0.4909090909090909,0.9884629592810081,1.0,1/5,0.90%,FLRT3
prerank,GO_Biological_Process_2021__B cell chemotaxis (GO:0035754),0.6811352405324388,1.0550249516604464,0.5,0.9792752178991713,1.0,2/5,7.12%,CXCL13;CYP7B1
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),-0.5653875854079976,-1.05497342476332,0.4647887323943662,0.9880409187649133,1.0,9/16,18.80%,HLA-A;IL12A;CEACAM1;HLA-DRA;HLA-B;HLA-E;HLA-F;FADD;PTPRC
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),-0.5107438867676833,-1.0549229953420665,0.4266666666666667,0.9874566470355057,1.0,8/37,19.78%,TLR2;IRF1;ISG15;TLR3;IRF7;IFIH1;FLOT1;RIPK2
prerank,GO_Biological_Process_2021__galactose metabolic process (GO:0006012),0.602863940020232,1.0548717730901915,0.48148148148148145,0.978642736442883,1.0,3/9,15.12%,PGM2;GALT;GALK2
prerank,GO_Biological_Process_2021__ornithine metabolic process (GO:0006591),-0.6301566795828926,-1.054757253792012,0.4264705882352941,0.98728008793671,1.0,1/7,4.45%,ARG2
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),0.5022152467573829,1.0546445651323832,0.37142857142857144,0.9784932406687201,1.0,3/14,9.13%,PDK4;ADIPOR1;GNB3
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),-0.4459413138284857,-1.0545708015636568,0.3333333333333333,0.987260153463766,1.0,6/100,7.01%,RASGRP1;S100A10;RASGRP2;DOCK8;CCL2;THY1
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),-0.556008171695772,-1.0543864682916002,0.38571428571428573,0.9872277488489228,1.0,1/21,2.44%,STMN2
prerank,GO_Biological_Process_2021__positive regulation of lipase activity (GO:0060193),0.6260124380644656,1.0543200911775605,0.45161290322580644,0.9782989764362826,1.0,3/8,25.87%,PLIN5;RHOC;PDPK1
prerank,GO_Biological_Process_2021__positive regulation of lipid transport (GO:0032370),-0.6536987938040517,-1.0542790382063436,0.524390243902439,0.9868831309676454,1.0,3/8,20.60%,ABCA12;DBI;SPP1
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),-0.6570112667047734,-1.0540129711698234,0.48333333333333334,0.9870694746384915,1.0,1/6,15.00%,GRIN2B
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),-0.500948038414173,-1.0539267100459992,0.379746835443038,0.9865633485758929,1.0,7/36,16.43%,ALDOB;SLC39A14;GAPDHS;FBP1;CHST15;PGK1;GPI
prerank,GO_Biological_Process_2021__regulation of dendritic cell differentiation (GO:2001198),0.5843165441831926,1.0539006997030778,0.43243243243243246,0.9785556316203302,1.0,2/7,8.15%,AGER;HMGB1
prerank,GO_Biological_Process_2021__attachment of GPI anchor to protein (GO:0016255),0.684812469599193,1.0538889388744286,0.35135135135135137,0.9774917387689616,1.0,3/5,24.01%,PGAP1;PIGU;PIGT
prerank,GO_Biological_Process_2021__negative regulation of ceramide biosynthetic process (GO:1900060),-0.6416975269877518,-1.0538655572423405,0.4716981132075472,0.986070433957341,1.0,2/5,18.85%,ORMDL2;SPHK1
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),0.48298565088792034,1.053765359635221,0.3333333333333333,0.976804771216523,1.0,5/18,17.69%,TEX15;SMYD5;APOBEC3F;ZNF91;PIWIL4
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),-0.5404162306611983,-1.0537442044418694,0.4090909090909091,0.9856903296944955,1.0,9/23,21.97%,IFI35;NLRC5;PLSCR1;WNT5A;HLA-E;FADD;SLC15A4;NMI;SPI1
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),-0.4372332247625189,-1.0536818101383103,0.4431818181818182,0.9851427884563732,1.0,26/145,17.89%,FLRT3;NPY;L1CAM;POU4F1;STMN2;SHTN1;LAMB1;CNTNAP1;SH3GL2;RAB11A;PLP1;APP;NEFH;SVBP;NYAP1;MINK1;DAB2IP;STMN4;BDNF;NLGN1;DCLK1;STMN1;MICALL1;CDK5;GRM7;TBC1D24
prerank,GO_Biological_Process_2021__plasma membrane phospholipid scrambling (GO:0017121),-0.6915404031461033,-1.0535467872100306,0.4375,0.9849007164271165,1.0,3/6,24.53%,PLSCR1;ANO7;P2RX7
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),-0.5594489062824453,-1.0533777455518232,0.4189189189189189,0.9840513466025815,1.0,8/19,24.53%,APP;GAPDHS;IGF1;PRXL2C;PFKFB3;PFKFB2;PFKFB4;P2RX7
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),-0.5594489062824453,-1.0533777455518232,0.4189189189189189,0.9840513466025815,1.0,8/19,24.53%,APP;GAPDHS;IGF1;PRXL2C;PFKFB3;PFKFB2;PFKFB4;P2RX7
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),-0.5222358728293208,-1.0533529199911829,0.4383561643835616,0.9834135675119919,1.0,1/40,0.21%,ANXA1
prerank,PanglaoDB_Augmented_2021__Ductal Cells,-0.4927637184344738,-1.0530696118382459,0.37037037037037035,0.9836446250468625,1.0,6/45,6.95%,CXCL2;S100A10;C3;EFNA1;EPS8L2;CCL2
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),0.45689309222029245,1.0530488660654291,0.34782608695652173,0.9779751975566084,1.0,4/23,10.97%,OTUD3;TNFAIP3;OTUB2;USP27X
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),0.5056392376017775,1.0525990073607847,0.32142857142857145,0.9778722720679603,1.0,3/17,8.97%,KPNA2;NUP54;IPO5
prerank,GO_Biological_Process_2021__cell junction maintenance (GO:0034331),-0.642861284205354,-1.052371682577824,0.43333333333333335,0.9853930475542426,1.0,2/8,10.11%,CBLN2;DCTN1
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),-0.5186333786864662,-1.0522711320539213,0.3835616438356164,0.9850342457534436,1.0,6/26,24.35%,SHTN1;IGSF10;DAB2IP;KIF20B;NSMF;CX3CL1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.6067150892136185,-1.051984200117448,0.3787878787878788,0.9853192749771326,1.0,4/9,25.08%,IL12A;DAB2IP;PIK3CB;DCN
prerank,GO_Biological_Process_2021__sensory perception of smell (GO:0007608),-0.6306759990860111,-1.0517676810295276,0.45454545454545453,0.9853071941906446,1.0,2/9,10.08%,OR51M1;OR51I2
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.457333060882106,-1.0517376491713117,0.38961038961038963,0.984658946776543,1.0,11/78,15.98%,HLA-A;SH3GL2;MFSD6;CENPE;HLA-DRA;DCTN1;AP1S1;CTSS;HLA-E;HLA-F;KIF2C
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,-0.49004380807856796,-1.0516763234748425,0.4225352112676056,0.9841844657932046,1.0,17/42,19.58%,P2RY13;MYO1F;TLR2;TYMP;SIGLEC1;IGSF6;HLA-DRA;CLEC12A;IRF7;PILRA;CTSS;SLC11A1;MSR1;CD4;C1QB;PTAFR;CLEC5A
prerank,GO_Biological_Process_2021__lymphocyte migration (GO:0072676),-0.6801934454228127,-1.05161280107885,0.46153846153846156,0.9836983445036734,1.0,2/6,6.95%,MSMP;CCL2
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),-0.42639200418945916,-1.0515938604455497,0.375,0.9830095557004996,1.0,34/195,21.26%,KLF2;CCBE1;P2RY6;C3;TLR2;SLC39A14;SULF1;KLK6;HAP1;DEPDC1B;RIMS2;ITGA5;RSPO3;EMP2;SCIMP;DAB2IP;FGF1;IL7;GLI1;DMTN;IGF1;BDNF;RSPO4;NLGN1;CD63;MGAT5;PTPRC;RELN;PRKCB;CD74;AGPAT2;GPER1;SFRP1;F3
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),-0.4341083297071563,-1.051373562547486,0.3522727272727273,0.9830299998948407,1.0,17/86,20.08%,FLRT3;APLNR;PKP2;TGFBR2;POU4F1;SMYD4;ZFPM1;SRF;FN1;CACNA1C;PDLIM4;CDKN1A;TSC2;FGF12;TGFB1;PLCE1;CRB2
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),-0.6781828897660104,-1.0513143078069298,0.45454545454545453,0.9825765571154133,1.0,3/6,10.99%,DOCK8;APP;TNFRSF14
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),0.469552650236479,1.0512243997691546,0.375,0.9811446420106377,1.0,6/23,14.01%,GAL3ST2;GK;ALG6;GAL3ST4;RRM2B;ALG11
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),-0.5680879993670996,-1.0510445867297267,0.42424242424242425,0.9828432673788903,1.0,4/15,16.35%,KCNJ2;ATP1A1;ATP1B1;TMPRSS3
prerank,GO_Biological_Process_2021__unsaturated fatty acid biosynthetic process (GO:0006636),-0.6680951504270893,-1.0509017349146863,0.4918032786885246,0.9826118426754239,1.0,1/7,3.91%,ALOX12
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),-0.5965890503813142,-1.0507025730100945,0.41935483870967744,0.9825342686295607,1.0,2/9,11.49%,EFNA1;ZFPM1
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),0.4158652390167842,1.0506124350461385,0.45161290322580644,0.9817992625673884,1.0,4/33,5.95%,PDE3B;CBFA2T3;GIT1;EGFR
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.6100279637774111,-1.0504060980181065,0.3968253968253968,0.9829108760086455,1.0,1/11,9.68%,SLC51B
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),0.554410730074321,1.0504027027031149,0.37037037037037035,0.9813348574962193,1.0,1/12,2.08%,AGMO
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),0.5430852032469077,1.0503867441947776,0.4473684210526316,0.9803058417290321,1.0,4/9,19.23%,ALDH1A1;ADH5;ACSS1;ALDH2
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,-0.4410350907974704,-1.0500576460564333,0.3466666666666667,0.9833911722939619,1.0,14/70,21.51%,SH3GL2;APP;ARHGEF17;SST;SCG5;HSD17B14;PCP4;ZFHX2;CRMP1;TMEM151A;SEZ6L2;SPP1;LRP2;PRR36
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),0.4765754631488082,1.0496788819978136,0.3548387096774194,0.9814498981849841,1.0,8/22,12.30%,SLC26A7;CA2;SLC39A8;SLC4A7;CA12;SLC4A4;CA3;CYB5R4
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),-0.6245041960008483,-1.0495421527046451,0.4528301886792453,0.984434466352242,1.0,4/9,25.68%,SYT1;KCNMB4;RYR2;CALM3
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),0.5696838488831121,1.0495131892015332,0.425,0.9809576906561055,1.0,1/10,1.72%,SOX8
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),0.37310663286551743,1.0489853883268725,0.3888888888888889,0.9812677126236555,1.0,12/56,16.90%,GNL3L;PLK1;TESK1;AKT1;TMEM35A;SESN2;TRAPPC12;EIF2AK3;CENPQ;KAT7;PYHIN1;CCDC88A
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.5367763130980059,1.0487131380573744,0.4444444444444444,0.9810731771091555,1.0,5/15,19.77%,USP13;NCK1;PIK3R1;ERN1;BCL2L11
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),-0.6352702132398587,-1.048683448940204,0.49019607843137253,0.9864926091682548,1.0,1/6,7.63%,DENND3
prerank,GO_Biological_Process_2021__mitochondrial tRNA processing (GO:0090646),0.6129637457081886,1.048530216099491,0.45,0.9805385744740476,1.0,4/7,34.84%,TRIT1;ELAC2;HSD17B10;TRMT10A
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),-0.5103854547812802,-1.048512333016088,0.410958904109589,0.9863390796992838,1.0,14/43,29.14%,THY1;PIM3;KLF4;NLRP12;PTK6;HHIP;ALOX5;MCTP1;SH2B3;SLIT2;AQP11;SPINK5;CDK6;KLF7
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),0.507734808870373,1.0483402245189195,0.3157894736842105,0.9801086489185847,1.0,4/16,24.03%,NAF1;POT1;PARP1;ERCC4
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.5037246326814071,-1.0481002150638854,0.43478260869565216,0.9870783871936183,1.0,9/31,18.01%,SOCS3;IL12A;IL15;PARP14;PARP9;PTK6;IGF1;IL18;TNFRSF1A
prerank,GO_Biological_Process_2021__elastic fiber assembly (GO:0048251),-0.6415379688930802,-1.0480343170764441,0.45901639344262296,0.9865458751676547,1.0,2/6,24.87%,MYH11;EMILIN1
prerank,GO_Biological_Process_2021__protein import into mitochondrial matrix (GO:0030150),0.5017678113487428,1.0480001921053592,0.36666666666666664,0.9802114412855496,1.0,1/16,1.18%,GRPEL2
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",0.39178916570591815,1.0478804324745155,0.4117647058823529,0.9793696417087057,1.0,20/64,22.06%,ELOC;GTF2F2;EAF2;ELOA;ERCC2;ERCC3;POLR2C;ELP2;GTF2H5;IWS1;ELP4;GTF2H2;CDK12;PCID2;MLLT3;CCNT2;CCNT1;NELFA;CTDP1;GTF2H3
prerank,"GO_Biological_Process_2021__regulation of complement activation, classical pathway (GO:0030450)",-0.6928732832911102,-1.047776611118708,0.5161290322580645,0.9859651053308486,1.0,3/6,25.89%,CD55;SUSD4;CR1L
prerank,"GO_Biological_Process_2021__negative regulation of complement activation, classical pathway (GO:0045959)",-0.6928732832911102,-1.047776611118708,0.5161290322580645,0.9859651053308486,1.0,3/6,25.89%,CD55;SUSD4;CR1L
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,-0.4523011633590641,-1.0475923240362432,0.40476190476190477,0.9858795701183358,1.0,25/97,19.81%,APLNR;L1CAM;STMN2;RCAN2;RAMP3;MAOB;PLP1;IGFBP5;THY1;RASL12;APOD;SLC18A2;ZNF536;GFAP;IGSF21;SHC2;ADCY5;DCLK1;RGS7BP;CCDC3;CNTN2;TCEAL5;AQP1;PHYHIP;CRTAC1
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),-0.6363832578112271,-1.0475615746712041,0.4492753623188406,0.9852763647762647,1.0,1/9,0.21%,ANXA1
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),0.6176253621239082,1.0474925086908833,0.42105263157894735,0.9796056700034463,1.0,3/7,18.86%,KDM5A;PRKD1;SPHK2
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial cell proliferation (GO:1905563),-0.7191407481823714,-1.0474500538860456,0.55,0.9849236100305205,1.0,1/5,6.95%,CCL2
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),-0.5794164580225423,-1.0473646547701443,0.45714285714285713,0.9844375409793655,1.0,3/14,8.07%,PKP2;KCNQ1;CAV3
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),0.5235656430493894,1.047175685896229,0.4666666666666667,0.9783847861128127,1.0,1/11,2.15%,RAP2C
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),0.5235656430493894,1.047175685896229,0.4666666666666667,0.9783847861128127,1.0,1/11,2.15%,RAP2C
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),-0.4475264216496519,-1.0469999003457582,0.35294117647058826,0.9850584615232084,1.0,15/89,17.96%,ST6GAL1;PLAAT4;ACOT1;ACSM5;GLYAT;ABCA12;DBI;ACOT4;NIT1;MTHFD2;AEBP1;ORMDL2;ACOT2;ACOT8;OXSM
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),-0.5220789063915314,-1.0469981401811366,0.4583333333333333,0.9843543276721555,1.0,7/29,21.27%,ALDOB;APOD;FBP1;CHST15;GALK1;IRS2;PMM1
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),-0.5271376725459223,-1.0468704822098163,0.4166666666666667,0.9841246487609553,1.0,5/31,17.19%,PIF1;ANKRD28;CDK2;RPA1;NOP10
prerank,GO_Biological_Process_2021__cellular response to bacterial lipopeptide (GO:0071221),-0.7352174778383568,-1.0464886785909735,0.45,0.984738388110035,1.0,1/5,1.93%,TLR2
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),0.5489125443493179,1.0464723182204032,0.42857142857142855,0.9790765660803522,1.0,4/11,23.98%,AR;RNF14;DAXX;PLPP1
prerank,GO_Biological_Process_2021__maintenance of gastrointestinal epithelium (GO:0030277),0.6134109761495183,1.0460761305624868,0.4418604651162791,0.9793559205981095,1.0,1/6,5.40%,SOX9
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),-0.5915359746072943,-1.0458814761283597,0.4696969696969697,0.9860967491606972,1.0,1/13,0.33%,RASGRP1
prerank,GO_Biological_Process_2021__negative regulation of IRE1-mediated unfolded protein response (GO:1903895),-0.6872177584547782,-1.045644796753363,0.5,0.9860904092785595,1.0,2/5,23.59%,DDRGK1;HSPA5
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),-0.5619996296835477,-1.0453230396561979,0.47058823529411764,0.9866166814436256,1.0,3/21,8.71%,ZFP36;PLAAT4;ABCA12
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),0.4631805864706127,1.0452415303706297,0.4,0.9806608983604752,1.0,2/24,6.09%,RAB33B;ARL5A
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),-0.6320802261086431,-1.0452118963098227,0.4482758620689655,0.9861987160480621,1.0,2/8,18.52%,RAB11A;LIMK2
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,-0.44834565561503986,-1.0448909910742137,0.43037974683544306,0.9865065850458631,1.0,25/95,19.16%,P2RY13;TGFBR2;LMO2;TLR2;CD44;SIGLEC1;MAFF;GPR171;THY1;DYSF;ABCB1;CLEC12A;ARID3A;HLA-E;GFI1B;RNASE1;SERPING1;BAALC;FES;IL3RA;SELP;PROCR;PTPRC;C1QB;F13A1
prerank,GO_Biological_Process_2021__regulation of cellular response to oxidative stress (GO:1900407),0.55066188212359,1.0448557105514997,0.3125,0.9806596990198181,1.0,3/9,14.59%,AIFM2;ABCD1;DHFR
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),-0.48032761546482833,-1.0448151742445668,0.4342105263157895,0.9860047477403405,1.0,12/47,19.92%,LEF1;GPR183;TGFBR2;IL15;MYH9;SBNO2;SNX10;CDK2;CDKN1A;CD4;PML;PIK3CD
prerank,GO_Biological_Process_2021__cellular hyperosmotic response (GO:0071474),-0.7176388128884186,-1.0444517803942466,0.41379310344827586,0.986499398503052,1.0,3/5,19.51%,YBX3;RCSD1;AQP1
prerank,GO_Biological_Process_2021__retinoic acid receptor signaling pathway (GO:0048384),0.5170278984450781,1.0444500807343444,0.38095238095238093,0.9808779347653078,1.0,1/9,4.18%,RARB
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),0.4405807821485887,1.0439559046044307,0.3870967741935484,0.9814318034682379,1.0,7/24,9.17%,SOX8;SOX9;LHFPL2;NCOA4;AKR1C3;AR;MSH2
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.4860582257894604,-1.0438971766149328,0.38028169014084506,0.9874999152270849,1.0,9/37,18.01%,SOCS3;IL12A;IL15;PARP14;PARP9;PTK6;IGF1;IL18;TNFRSF1A
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),-0.5001729013611815,-1.0433908751895873,0.4430379746835443,0.9883905266467673,1.0,6/33,16.43%,ALDOB;SLC39A14;GAPDHS;FBP1;PGK1;GPI
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),-0.4716967923456051,-1.043121275613738,0.39759036144578314,0.9885873322152463,1.0,19/60,21.04%,P2RY12;RCAN2;ACKR4;HTR2B;ATP1B1;CHRM3;PPP3CC;LAT2;NUDT4;CACNA1C;DMTN;SELP;CCR10;PTPRC;SPHK1;PLCE1;RYR2;RCAN3;PPP1R9A
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,-0.5385114605502167,-1.0427051859224556,0.3972602739726027,0.9893615578978041,1.0,3/22,10.12%,LMO2;PCSK2;SST
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.621503820881371,1.0426750445926485,0.47058823529411764,0.9841303075044953,1.0,3/9,16.25%,ACADM;ETFDH;ACADS
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle contraction (GO:0045986),0.6332524855319985,1.0425941851952223,0.47368421052631576,0.983221323417449,1.0,2/5,30.25%,ADRB2;DOCK5
prerank,GO_Biological_Process_2021__surfactant homeostasis (GO:0043129),-0.6366639367755276,-1.0424770707921898,0.43478260869565216,0.9887193700081234,1.0,1/6,3.36%,SFTPD
prerank,GO_Biological_Process_2021__chemical homeostasis within a tissue (GO:0048875),-0.6366639367755276,-1.0424770707921898,0.43478260869565216,0.9887193700081234,1.0,1/6,3.36%,SFTPD
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),-0.4855034763543936,-1.042292759558903,0.38461538461538464,0.9885550888535697,1.0,7/45,12.20%,ANXA1;TLR2;NOD1;TLR3;KLF4;CHI3L1;SYK
prerank,GO_Biological_Process_2021__nucleoside salvage (GO:0043174),-0.5838815480751658,-1.042254398085491,0.5084745762711864,0.9880190059435343,1.0,1/10,2.35%,TYMP
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.47742333494279304,-1.0415194251366537,0.4625,0.9898822085929416,1.0,3/43,3.84%,S100A10;GBP1;PDPN
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),0.5230759718812602,1.041422125127469,0.48484848484848486,0.985562544693194,1.0,5/11,7.04%,ABCD2;PPARGC1A;PLIN5;AKT2;ABCD1
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell proliferation (GO:0046640),-0.6772700258401144,-1.0413408245213935,0.4827586206896552,0.9897294349953616,1.0,3/6,12.20%,IRF1;TNFRSF14;SYK
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),0.561582483667424,1.0410313349076106,0.40540540540540543,0.9859344263695059,1.0,5/11,21.11%,GTF2A2;TAF12;BDP1;DR1;GTF2B
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.3987166037280217,1.040993339302745,0.2916666666666667,0.9850264282155751,1.0,9/78,7.43%,PIP5K1B;EPOR;FLT3;PDGFD;SOX9;EGFR;HCLS1;PDGFC;DIPK2A
prerank,GO_Biological_Process_2021__regulation of receptor binding (GO:1900120),-0.6928650937940696,-1.0404011478384774,0.5423728813559322,0.9921456372937794,1.0,4/7,22.11%,B2M;GREM2;BDNF;PTPRF
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),0.4965171248372037,1.040365386734129,0.32,0.9856449205807006,1.0,6/21,11.44%,EGFR;AKT1;AKR1C3;MT1E;HSF1;MAPK8
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),-0.4531969279738041,-1.04035784872436,0.4050632911392405,0.991584593121491,1.0,5/86,5.65%,APIP;BLM;B2M;KCNJ2;POLQ
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),-0.521217440166753,-1.039952965426592,0.4027777777777778,0.9921604091406955,1.0,2/24,0.67%,THBS1;SP100
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),0.5598824870071782,1.039849352400564,0.43902439024390244,0.9858124681025104,1.0,3/10,16.14%,CSGALNACT1;GALT;UGP2
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),0.3813766610786143,1.0394031986883225,0.4,0.9860376132459097,1.0,7/40,14.61%,ZPR1;ANP32B;HCLS1;TRIM28;IPO5;CPSF6;PIK3R1
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),-0.5534016342221622,-1.0393014492124981,0.4225352112676056,0.9934882637713883,1.0,9/21,24.53%,APP;GAPDHS;EGF;IGF1;PRXL2C;PFKFB3;PFKFB2;PFKFB4;P2RX7
prerank,GO_Biological_Process_2021__negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),-0.6401622395136258,-1.03916737965112,0.47058823529411764,0.9931961472823911,1.0,5/7,29.13%,PIK3IP1;DAB2IP;TSC2;NLRC3;NOP53
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,-0.4451464442131353,-1.038953983160659,0.3684210526315789,0.9932564727407345,1.0,19/94,17.73%,TAGLN3;STMN2;CAMK2N2;SNCB;SLC32A1;GNG3;SLITRK1;EFNB3;ARHGAP39;GAP43;NYAP1;HPCA;PRKCG;JPH3;GAD1;C11ORF87;TMEM151A;CNTN2;KCNC1
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),0.5214666880030833,1.0387839003063115,0.4074074074074074,0.986522797099347,1.0,6/17,23.38%,SRI;DRD2;GPR35;GSTM2;PKD2;UBQLN1
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),0.600856440986563,1.0387759487002033,0.45,0.9855033357112053,1.0,3/8,14.10%,DCUN1D2;DCUN1D1;DCUN1D5
prerank,GO_Biological_Process_2021__regulation of hormone secretion (GO:0046883),-0.7284179626748273,-1.0385056554742242,0.5,0.9940798944790115,1.0,1/5,0.21%,ANXA1
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.5784744466655884,-1.0384626561950836,0.47619047619047616,0.99351390490201,1.0,4/14,10.57%,P2RY10;GPR18;LPAR4;LPAR6
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),-0.46919944810837466,-1.037955452468508,0.4625,0.9944550594506205,1.0,11/72,20.05%,THBS1;EFNA1;RPS4X;PLD1;RPL5;PRKCD;TNFRSF1A;RBM3;LARP6;SAMD4A;EIF4A3
prerank,GO_Biological_Process_2021__positive regulation of isomerase activity (GO:0010912),-0.6592528048430133,-1.0377113387867052,0.4528301886792453,0.994526224885111,1.0,1/6,7.99%,PLSCR1
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),0.6372390994592185,1.0376791197389594,0.46808510638297873,0.9874756319839819,1.0,4/6,33.73%,SENP2;SENP5;SENP6;SENP1
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),0.5766912211516362,1.037503407168767,0.42424242424242425,0.9868324285905873,1.0,3/12,5.54%,RGCC;SERPINF2;RUNX1
prerank,GO_Biological_Process_2021__aromatic compound biosynthetic process (GO:0019438),0.6064260189970556,1.0373652672579046,0.5,0.9861905879162463,1.0,1/6,6.93%,TPK1
prerank,PanglaoDB_Augmented_2021__Trichocytes,-0.521708423250155,-1.0368934784120905,0.47368421052631576,0.9967852433829129,1.0,11/30,20.54%,GPR87;EPS8L2;BAIAP2L1;ABCA12;HR;KPNA7;ITGA3;DMKN;LAMA3;RHOD;ITGB4
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),-0.5691181503842606,-1.0366126652794125,0.45714285714285713,0.996985374478676,1.0,1/16,0.16%,LEF1
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),0.34771587193911574,1.036317296918088,0.46153846153846156,0.9882278788304217,1.0,38/103,29.41%,ATP6V0D2;ATP6V1A;EXOC8;ATP6V1G1;AKT1;PRKAB1;SESN2;MAPK8;CASP3;RUFY4;PIK3CA;QSOX1;GPSM1;SESN3;ERN1;SNX5;SLC38A9;SMG1;EXOC7;PRKAA1;USP36;RPTOR;LAMTOR3;UBQLN1;EPM2A;ATP6V0A2;PAFAH1B2;RHEB;SESN1;MAP3K7;VPS26B;MLST8;PRKAB2;UBQLN2;PRKACA;SIRT1;VPS26A;MTOR
prerank,GO_Biological_Process_2021__regulation of transposition (GO:0010528),0.503981674118774,1.0359168526015676,0.40476190476190477,0.9884775675299798,1.0,3/13,10.29%,TEX15;SMYD5;APOBEC3F
prerank,GO_Biological_Process_2021__regulation of germinal center formation (GO:0002634),0.7012816231587948,1.0356493031509693,0.5625,0.9882382772411684,1.0,3/5,15.32%,TNFAIP3;FOXJ1;RC3H1
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),0.48052832989625605,1.0355070242603206,0.4074074074074074,0.9876263639348706,1.0,2/17,10.84%,QRICH2;PARVA
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",-0.631435473105384,-1.0346399093658467,0.5079365079365079,1.0,1.0,2/6,13.75%,TGFBR2;CD55
prerank,GO_Biological_Process_2021__reelin-mediated signaling pathway (GO:0038026),-0.7185156948012041,-1.0346226231884266,0.5555555555555556,1.0,1.0,2/5,19.36%,VLDLR;RELN
prerank,GO_Biological_Process_2021__positive regulation of acute inflammatory response (GO:0002675),-0.6697789493570103,-1.0344056668313453,0.4925373134328358,1.0,1.0,3/5,29.92%,OSMR;ADAM8;PARK7
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transport (GO:0051926),-0.601033009305843,-1.034344754817905,0.42424242424242425,1.0,1.0,3/10,17.04%,PLN;CAV3;NOS1
prerank,GO_Biological_Process_2021__protein-DNA covalent cross-linking repair (GO:0106300),0.609653582178949,1.0343222458905912,0.4186046511627907,0.990155313015896,1.0,1/6,7.99%,VCP
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),-0.6254651148952668,-1.034220916389534,0.49206349206349204,1.0,1.0,1/7,1.30%,MX1
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response (GO:0002821),-0.6567262004682134,-1.0340855108959268,0.44776119402985076,1.0,1.0,2/6,16.37%,SKAP1;FADD
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),0.5742994224424607,1.03403630066563,0.5142857142857142,0.990029579199519,1.0,1/8,12.20%,EIF2AK3
prerank,GO_Biological_Process_2021__regulation of long-chain fatty acid import across plasma membrane (GO:0010746),-0.6791075884439662,-1.0337674451326946,0.515625,1.0,1.0,2/6,10.23%,THBS1;ACSL5
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),-0.590544661928981,-1.0337136196598833,0.47692307692307695,1.0,1.0,5/12,23.51%,SCX;TENM4;NLRP5;TLE6;NIBAN2
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),-0.4538701099330842,-1.0336987827448043,0.379746835443038,1.0,1.0,8/53,10.60%,TLR2;PTP4A3;IFI35;APP;NOD1;LRRC19;TLR3;NLRP12
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),0.4685245099592987,1.0335639353395967,0.42857142857142855,0.9904048127939188,1.0,5/19,12.63%,CEL;NLGN3;NRXN1;GPHN;NLGN4Y
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),-0.5034551143314229,-1.0332460138816584,0.4235294117647059,1.0,1.0,3/38,1.44%,SP100;BLM;RECQL4
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),-0.4496174061606532,-1.0331625206690256,0.4177215189873418,1.0,1.0,10/58,17.96%,ACOT1;SULT1C3;TPST1;ACSM5;GLYAT;DBI;ACOT4;ACOT2;ACOT8;OXSM
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),0.47685342776611717,1.0331531209275742,0.3333333333333333,0.9895254789748741,1.0,4/18,19.08%,TEX15;DNMT3B;EHMT1;BEND3
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),0.47685342776611717,1.0331531209275742,0.3333333333333333,0.9895254789748741,1.0,4/18,19.08%,TEX15;DNMT3B;EHMT1;BEND3
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),0.460814995975274,1.0330760366171514,0.391304347826087,0.9886308486554983,1.0,4/32,10.41%,FAM47E;PLK1;MSH2;ATR
prerank,GO_Biological_Process_2021__chloride ion homeostasis (GO:0055064),0.48921436700832976,1.0327845750045046,0.42424242424242425,0.9873879800337124,1.0,4/9,20.52%,CA12;SLC12A9;SLC12A8;SLC12A2
prerank,GO_Biological_Process_2021__monovalent inorganic anion homeostasis (GO:0055083),0.48921436700832976,1.0327845750045046,0.42424242424242425,0.9873879800337124,1.0,4/9,20.52%,CA12;SLC12A9;SLC12A8;SLC12A2
prerank,GO_Biological_Process_2021__positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568),0.6534002977862337,1.032768432174669,0.5121951219512195,0.9863988749827753,1.0,1/5,2.52%,MYORG
prerank,GO_Biological_Process_2021__regulation of T cell differentiation in thymus (GO:0033081),0.5395225241928258,1.0327446193299465,0.3793103448275862,0.9854970424816047,1.0,4/9,17.68%,ZC3H8;FOXJ1;TOX;CAMK4
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),-0.531924695485759,-1.0325440348967114,0.44594594594594594,1.0,1.0,5/25,18.20%,KIF14;GLI1;DDRGK1;PSME1;CDKN1A
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),0.5076223796257601,1.0324865379253059,0.4642857142857143,0.9851929220899455,1.0,1/17,0.31%,ACE2
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),-0.5662690001676638,-1.0321313285344,0.4307692307692308,1.0,1.0,8/16,23.64%,THBS1;WNT5A;TNIP2;CD200;SPHK1;CD74;MYO18A;HSPD1
prerank,GO_Biological_Process_2021__negative regulation of plasminogen activation (GO:0010757),-0.7250950883778534,-1.0320997649811272,0.46153846153846156,1.0,1.0,1/5,0.43%,THBS1
prerank,GO_Biological_Process_2021__hexose catabolic process (GO:0019320),0.6231211343046287,1.0319119653205262,0.5,0.9861507150461684,1.0,2/6,8.57%,PGM2;GALT
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),-0.5014805266176127,-1.0313893459023555,0.4788732394366197,1.0,1.0,6/33,17.71%,C3;B2M;EGF;SFRP4;CD63;ANXA2
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),-0.5986106607611983,-1.0307769824179898,0.4153846153846154,1.0,1.0,1/8,2.30%,ABCA5
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),-0.5723862167907383,-1.0304206936658111,0.45454545454545453,1.0,1.0,4/13,21.26%,PLSCR1;SIGIRR;MYLK3;F3
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),-0.6112657354003042,-1.03030975429244,0.5396825396825397,1.0,1.0,2/13,8.70%,C3;LDLR
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.6116974474005763,-1.030287825740723,0.44776119402985076,1.0,1.0,1/8,1.77%,TGFBR2
prerank,GO_Biological_Process_2021__negative regulation of protein targeting to membrane (GO:0090315),0.6736959927164302,1.0299365791031596,0.5348837209302325,0.9914243801355243,1.0,1/5,2.53%,KCNE1
prerank,GO_Biological_Process_2021__genitalia development (GO:0048806),-0.6902440606583746,-1.0298107357667932,0.5192307692307693,1.0,1.0,1/5,8.67%,WNT5A
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell development (GO:0072015),-0.6746708909543572,-1.029750610629297,0.4838709677419355,1.0,1.0,2/6,13.37%,PODXL;MYO1E
prerank,GO_Biological_Process_2021__regulation of response to wounding (GO:1903034),-0.6833114051216113,-1.0296663184074821,0.5192307692307693,1.0,1.0,3/5,23.75%,VIL1;STK24;ALOX5
prerank,GO_Biological_Process_2021__mast cell mediated immunity (GO:0002448),-0.6896392494455358,-1.0296603640547815,0.578125,1.0,1.0,1/6,1.48%,NR4A3
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),-0.5298074182710532,-1.0296111059902195,0.4246575342465753,1.0,1.0,5/25,13.75%,TRIM5;IRF1;HERC5;BIRC3;CD55
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),0.5167425937778887,1.0295810571877544,0.46153846153846156,0.9914120332859968,1.0,4/13,18.51%,AKT2;AKT1;GPLD1;PPM1K
prerank,GO_Biological_Process_2021__regulation of epidermis development (GO:0045682),-0.656227112767365,-1.029445184916609,0.4827586206896552,1.0,1.0,1/7,5.23%,MAFF
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),-0.5744756967650869,-1.0294434293994503,0.45714285714285713,1.0,1.0,1/13,2.43%,ZFP36
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),0.4513895094498226,1.0293275550756877,0.41935483870967744,0.9911877990660264,1.0,11/18,31.41%,CWC27;PPIL2;PPIE;PPWD1;PPIL6;PPIC;PPIH;FKBP4;PPIL3;PPID;PPIG
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,-0.43869816074606255,-1.0291587791046295,0.3888888888888889,1.0,1.0,35/122,22.62%,C3;C1R;MATN2;MAOB;SLC16A3;SEMA3B;SCX;IGFBP5;ARHGEF17;RASL12;CDC42EP1;BGN;FAM20C;GATA1;LMOD1;SHC2;CD55;DAB2IP;SERPING1;F10;RHBDF1;AMOTL2;C1S;BOK;PTH1R;TNS2;GPRC5C;AQP1;PXDC1;PFKFB3;VASN;PTPN21;LAMA5;TF;SLCO2A1
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),-0.6198835390541974,-1.029154162714534,0.43548387096774194,1.0,1.0,2/10,0.43%,ANXA1;THBS1
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process from pyruvate (GO:0006086),-0.6860365803380786,-1.029043857730201,0.5081967213114754,1.0,1.0,1/5,9.27%,PDHX
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),0.509043060192301,1.028913346439961,0.36,0.9913027391600984,1.0,7/17,24.13%,PTPN23;DNAJC13;RAB21;VPS11;MAP2K2;EZR;SNX3
prerank,GO_Biological_Process_2021__tyrosine metabolic process (GO:0006570),0.5708076575326463,1.028902455822197,0.4838709677419355,0.9903177771985718,1.0,2/7,12.34%,TYR;DCT
prerank,PanglaoDB_Augmented_2021__Delta Cells,-0.44167500040212143,-1.0288372246196815,0.3793103448275862,1.0,1.0,28/100,18.71%,KCNT2;RIMBP2;CDH22;CHGB;PCSK2;STMN2;RCAN2;PROX1;MAOB;SYT4;LRRTM1;GRIA3;ELAVL4;ATP1B1;PLPPR1;SST;IGSF21;UNC5B;CPLX2;SHC2;KCNB2;GAD2;NPTX2;GPC5-AS1;RGS7BP;GABRG2;TCEAL5;RAB3C
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.5366316223774117,1.0287896457218109,0.4,0.9895179420740023,1.0,5/13,29.91%,PCBP4;RBMX;SAP18;SRSF9;PTBP1
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),0.4235393713576965,1.0286588473226042,0.3103448275862069,0.9888323139749564,1.0,11/31,31.63%,SESN2;DYRK3;SESN3;KPTN;SESN1;ITFG2;SIK3;PIP4P1;LARS1;KLHL22;SZT2
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),0.5350204829803107,1.0284530999514974,0.4782608695652174,0.9884151391293711,1.0,4/12,14.51%,INSIG2;GRAMD1B;GRAMD1C;GPLD1
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.5827306800521468,-1.0284406658317002,0.4411764705882353,1.0,1.0,1/15,2.43%,ZFP36
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.5264314597955866,1.0284079169726188,0.43243243243243246,0.9875214633809003,1.0,2/8,7.99%,PPARGC1A;VCP
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.5229240170667072,1.0283061638297648,0.4411764705882353,0.9867278093432545,1.0,5/20,15.18%,BMP2;CARF;SMAD5;SESN2;EP300
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),-0.5354310807789856,-1.0281705215025978,0.5362318840579711,1.0,1.0,3/18,9.29%,KCNJ2;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),-0.5460546526001376,-1.0278123144819662,0.4626865671641791,1.0,1.0,7/18,22.56%,THY1;PTK6;SH3BP5;MVP;SNX6;PTPRC;ZFYVE28
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),-0.49565135361997525,-1.0276532827249656,0.4625,1.0,1.0,1/38,0.16%,LEF1
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),0.3865691818692444,1.027184562364409,0.36363636363636365,0.9892003852778422,1.0,24/57,30.89%,MIOS;FBXO9;WDR24;PIK3CA;DYRK3;SLC38A9;TBCK;PRKAA1;GOLPH3;TBC1D7;RPTOR;ARAF;LAMTOR3;EPM2A;NPRL2;RHEB;NPRL3;MINAR1;ITFG2;MLST8;WDR59;SIRT1;RICTOR;LARS1
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),-0.5882260003334709,-1.026898235294871,0.45454545454545453,1.0,1.0,4/14,27.48%,RAMP3;ANXA2;OPTN;ECE1
prerank,GO_Biological_Process_2021__negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.5780327313433218,1.0263602915114531,0.5,0.9895021359521401,1.0,3/8,20.79%,SRI;GSTM2;PKD2
prerank,GO_Biological_Process_2021__negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.5780327313433218,1.0263602915114531,0.5,0.9895021359521401,1.0,3/8,20.79%,SRI;GSTM2;PKD2
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),-0.5260172614368626,-1.0262209139580676,0.4383561643835616,1.0,1.0,2/16,1.98%,NR4A3;FABP3
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),-0.538580723681337,-1.025994938104932,0.4264705882352941,1.0,1.0,4/21,10.40%,TYMP;KIF14;NKX6-2;TENM4
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),-0.46305024729770206,-1.0258945548155967,0.4411764705882353,1.0,1.0,4/34,10.81%,ALDOB;PLSCR1;ATP1B1;PFN2
prerank,GO_Biological_Process_2021__tryptophan catabolic process (GO:0006569),-0.6201070188326367,-1.0256446063091178,0.43333333333333335,1.0,1.0,1/9,3.79%,KMO
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),0.47657514503789783,1.025270455136717,0.42105263157894735,0.9916150481904873,1.0,3/19,9.04%,BBS10;HSPA1A;TMEM35A
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),0.5672363444131885,1.0248645625427255,0.3783783783783784,0.9918259289182452,1.0,3/9,13.72%,ZSWIM6;ZSWIM5;TUBB2B
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),0.41641040136275403,1.0248095967392203,0.35,0.9909630467879184,1.0,10/37,14.66%,PI4K2A;WASHC5;EXOC8;RAB27A;RAB22A;PHETA1;ALS2;CHMP2B;DNAJC13;RNF26
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.5729851518863839,-1.0245675182209761,0.463768115942029,1.0,1.0,2/16,5.65%,HELB;POLQ
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),0.4786902792288399,1.0244656757634,0.45161290322580644,0.9907424853065127,1.0,5/17,20.52%,PDK4;CYP4F12;SLC12A9;SLC12A8;SLC12A2
prerank,GO_Biological_Process_2021__heme biosynthetic process (GO:0006783),0.493773338224751,1.0244619142789309,0.4230769230769231,0.9897433670346543,1.0,4/17,5.07%,ABCB10;ALAS1;HMBS;COX10
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.3547948882725296,1.0241598932518672,0.47619047619047616,0.9896078818507872,1.0,17/83,15.50%,FBXO48;PSMD10;PSMA1;PSMD11;CUL1;FBXL14;DMAC2;PSMB5;BTRC;FBXL3;FBXO9;PSMD14;FBXO38;PSMD12;CUL2;FBXO27;FBXL17
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),-0.5788904309161441,-1.0240948030021393,0.4461538461538462,1.0,1.0,1/13,1.53%,DUSP1
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.6161637241223976,1.024092024927219,0.4864864864864865,0.9887091376075029,1.0,4/9,18.46%,FUT9;ZDHHC21;MDK;NFAT5
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),0.44771820825747166,1.0238671880483134,0.4482758620689655,0.9883530898883967,1.0,2/24,8.53%,KDM1B;KDM5A
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),-0.41400591610988996,-1.0235621339969796,0.45054945054945056,1.0,1.0,15/114,16.30%,CD24;PRAME;CASZ1;RPS6KA1;KLK6;KLF4;YWHAH;SRF;LTBP4;EMP2;ZFHX2;RUNX2;BDNF;NLGN1;FES
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),0.3403747853970617,1.0232443845332126,0.3333333333333333,0.9894801657399057,1.0,40/134,23.98%,LCMT2;GAL3ST2;ELOVL4;ALAS1;LPIN3;ELOVL6;ESD;ELOVL2;CSNK2A1;CHPT1;SGMS2;GPHN;CSNK2A2;GAL3ST4;PLA2G4C;ASL;HACD2;VAPA;VAPB;PRKD1;PCTP;DMD;CEPT1;PPM1L;SLC25A15;GSTM2;MOCS2;SPHK2;PCSK5;PLPP3;GOLPH3;GSTA4;SGMS1;ST3GAL2;CERS6;CHKA;DEGS1;ARG1;CDO1;PLPP1
prerank,GO_Biological_Process_2021__positive regulation of receptor recycling (GO:0001921),-0.6448921090624748,-1.02303417434097,0.4838709677419355,1.0,1.0,2/9,17.71%,RAMP3;ANXA2
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),0.39143866215147094,1.0229711611818813,0.3157894736842105,0.9891932585543204,1.0,14/43,23.89%,HSPA1A;HSF1;STT3B;DERL1;ERN1;RHBDD1;ERP44;DNAJB5;TOR1B;TM7SF3;DNAJC4;DAXX;HSPA13;DNAJB2
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),0.529604295916057,1.0229353531096081,0.5454545454545454,0.9882709370441779,1.0,2/11,21.88%,ADRB2;FYCO1
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),-0.5123152939282032,-1.02280933331583,0.43209876543209874,1.0,1.0,2/28,0.76%,C3;SIX3
prerank,GO_Biological_Process_2021__nucleobase-containing compound biosynthetic process (GO:0034654),-0.5303905741237975,-1.0226320953682613,0.4918032786885246,1.0,1.0,2/16,3.08%,TYMS;GMPR
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),0.5096903196674141,1.0224718631782816,0.5,0.988496883882898,1.0,8/17,23.34%,CRPPA;TMTC4;FKRP;POMT2;TMTC3;DPM1;FKTN;TMTC2
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),0.37450090878714387,1.0222234011166247,0.4,0.9882808368195832,1.0,21/97,17.09%,POLD3;ERCC8;LIG4;RFC3;COPS8;COPS2;ERCC6;COMMD1;SLC30A9;ERCC2;HUS1;COPS7A;ERCC3;POLR2C;POLK;GTF2H5;EP300;GTF2H2;AQR;GTF2H2C;COPS7B
prerank,GO_Biological_Process_2021__lens fiber cell development (GO:0070307),0.5696825342454674,1.0221647351640544,0.4594594594594595,0.987348459150207,1.0,1/7,0.52%,WNT7A
prerank,GO_Biological_Process_2021__ammonium transmembrane transport (GO:0072488),-0.6555388504934796,-1.0221556216696692,0.5396825396825397,1.0,1.0,4/6,32.12%,SLC12A7;RHD;SLC12A4;RHCG
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.3127776107777117,1.0219035014336082,0.3333333333333333,0.9870651615218256,1.0,55/309,15.57%,FGF6;ATP6V0D2;VEGFD;NGF;EPHA6;NCSTN;FLT3;VEGFC;EFNA2;EFNB2;CASS4;GALNT3;PDK4;SPRED1;ATP6V1A;MUC20;PDGFD;GIT1;EGFR;PDGFC;FRK;AKT2;ATP6V1G1;GTF2F2;YES1;AP3S1;AKT1;ERBB4;NCK1;EFS;SHC4;AP2B1;PTPRG;CNKSR1;TIAL1;CSF1R;EFNA5;ARHGEF28;SHOC2;SPRED2;EIF2AK3;FLRT2;CASP3;PIK3CA;WASL;POLR2C;NCK2;SHC3;PRKD1;GPLD1;PIK3R1;ZFYVE27;ABI1;EPHB4;GRB14
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),-0.5315465993748314,-1.0218206817290574,0.4444444444444444,1.0,1.0,3/23,9.29%,SCN1B;KCNQ1;ATP1B1
prerank,GO_Biological_Process_2021__ganglioside metabolic process (GO:0001573),-0.5527560285511847,-1.0217301700894512,0.5423728813559322,1.0,1.0,5/16,24.31%,B4GALNT1;B3GALT4;ST6GALNAC3;ST8SIA3;NEU4
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.5829273307636832,-1.021694784731848,0.46153846153846156,1.0,1.0,3/14,13.66%,NLRC5;ISG15;USP18
prerank,GO_Biological_Process_2021__regulation of natural killer cell activation (GO:0032814),-0.6262148720614602,-1.0216516947818612,0.47368421052631576,1.0,1.0,2/7,12.24%,IL12A;PRDM1
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),0.40636804751334976,1.02157740417743,0.42857142857142855,0.9870162910497134,1.0,22/90,16.72%,NUP42;NUP37;KAT2B;NUP54;TRIM28;VCPKMT;AAAS;NUP214;SIRT5;NDC1;ZNF451;RAE1;CTH;NUP188;KIAA1586;EP300;HDAC10;NUP85;NUP205;P3H4;NUP210;EYA1
prerank,GO_Biological_Process_2021__protein hexamerization (GO:0034214),0.6449603569165464,1.0213067620433676,0.4411764705882353,0.9868026124521426,1.0,5/7,34.65%,LETM1;LRRC8D;YME1L1;SPAST;LRRC8A
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of mitotic cell cycle (GO:0007091),0.6180245604285461,1.0212220134370291,0.475,0.9851422398164494,1.0,1/6,7.56%,ANAPC1
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of cell cycle (GO:0044784),0.6180245604285461,1.0212220134370291,0.475,0.9851422398164494,1.0,1/6,7.56%,ANAPC1
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",-0.5330552268142772,-1.020549215551637,0.4307692307692308,1.0,1.0,7/21,14.85%,COL5A1;CD44;PDPN;CEACAM1;ITGA5;TMEFF2;PLET1
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),-0.4333366503555814,-1.0203650868047294,0.4235294117647059,1.0,1.0,24/100,20.07%,ENPP2;TMSB10;NEXN;KIF14;DUOX1;SPOCK3;LDB2;EGF;WAS;CEACAM1;SST;MINK1;FGF1;AMOTL2;FES;SPINT2;CCDC25;FGF7;FGF22;TGFB1;DOCK10;ARHGAP18;DAPK3;ROBO4
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),0.4332561496581736,1.0202424374039802,0.3684210526315789,0.9871780121930845,1.0,11/28,25.74%,ERCC6;ATR;INTS7;HUS1;ATRIP;HINFP;CLSPN;RAD1;USP28;MAP3K20;CLOCK
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),-0.5271369678776868,-1.0197755193181115,0.5223880597014925,1.0,1.0,1/19,1.77%,TGFBR2
prerank,"GO_Biological_Process_2021__positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)",-0.6535151988736179,-1.0197135331222957,0.5076923076923077,1.0,1.0,2/5,12.99%,HLA-A;HLA-E
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),0.427169593125052,1.0194254170302874,0.36363636363636365,0.9886074632179787,1.0,3/19,11.00%,SOX8;SOX9;LIN7C
prerank,GO_Biological_Process_2021__protein localization to kinetochore (GO:0034501),0.5310249811868889,1.019185232785294,0.40625,0.9883522396701893,1.0,2/11,5.56%,CHAMP1;RCC2
prerank,GO_Biological_Process_2021__positive regulation of cell killing (GO:0031343),-0.5750737830442652,-1.018928685609807,0.4727272727272727,1.0,1.0,3/8,17.20%,WNT5A;SYK;NOXA1
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",0.37390315962388365,1.0187792764282302,0.4090909090909091,0.9884526744037756,1.0,24/79,29.66%,VPS50;PHETA1;VTI1A;TBC1D5;WASHC2C;RHOBTB3;RAB9A;VAMP3;RIC1;SNX5;TBC1D23;PIKFYVE;SNX2;VPS29;SNX3;RAB7B;SNX1;SURF4;VPS54;VPS26B;VTI1B;WASHC2A;VPS26A;RGP1
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),0.5273147981961155,1.0186928676822626,0.41025641025641024,0.9866762885146252,1.0,1/14,1.65%,FHDC1
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),0.5273147981961155,1.0186928676822626,0.41025641025641024,0.9866762885146252,1.0,1/14,1.65%,FHDC1
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),-0.6238867649791081,-1.0181386221699689,0.4745762711864407,1.0,1.0,1/7,3.11%,NOS1AP
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",0.3200535254889492,1.0179502017285125,0.375,0.9875952053029629,1.0,109/254,34.16%,U2AF1;SNRPF;SF3B4;SF3A1;NUDT21;GTF2F2;HNRNPC;WDR33;NOVA1;CWC27;SMNDC1;CSTF3;RAVER2;LSM8;RBM41;PAPOLA;TFIP11;SNRPB2;SPEN;CPSF7;RBM17;LSM7;POLR2C;SRSF8;LSM5;SYNCRIP;HNRNPU;SNRNP27;AQR;SNRPN;DHX15;CLNS1A;ZMAT2;PSPC1;PPIE;CPSF2;PPWD1;CRNKL1;GEMIN4;RAVER1;RBM15;USP49;PDCD7;RBMX;SUGP1;PLRG1;SART3;HNRNPD;PPIH;RBM19;WDR77;PRPF40B;CSTF1;MTREX;MAGOH;SNRNP48;SNRPB;SCAF11;ZCCHC8;COIL;CLP1;PRCC;POLR2A;HNRNPH1;SRPK2;SCNM1;CDK13;DDX1;SRSF9;CSTF2T;DHX16;SNRNP35;CTNNBL1;PCF11;PPIL3;PTBP1;MAGOHB;SNRNP40;SRSF2;LSM6;SF3B1;POLR2E;STRAP;SART1;HNRNPL;IK;CCAR1;RBM15B;ELAVL1;SF3B3;RBM22;TRA2A;DDX5;HNRNPH3;SFPQ;METTL14;PRMT5;POLR2K;HNRNPR;METTL3;RALY;PABPC1;BCAS2;CDC5L;SF1;EFTUD2;BUD31;POLR2D;RSRC1
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),-0.5508398834688427,-1.017407029872743,0.42857142857142855,1.0,1.0,4/17,22.29%,PSRC1;DCTN1;ANKRD53;FSD1
prerank,GO_Biological_Process_2021__C-terminal protein lipidation (GO:0006501),0.5766871295880641,1.0172786875566078,0.42105263157894735,0.9885803083348688,1.0,3/5,32.98%,GPLD1;ATG7;ATG12
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),-0.4457065855016836,-1.0172322739725097,0.4523809523809524,1.0,1.0,13/81,14.84%,ANXA1;IL1R1;P2RY12;TRIM5;IRF1;PDE6B;LRRC19;WNT5A;HERC5;USP18;BIRC3;CD55;SBNO2
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),-0.5104515252122275,-1.0172259760648936,0.4927536231884058,1.0,1.0,8/29,25.63%,POLE3;RPA3;CDK2;POLE4;RPA1;CDC7;MCM5;POLE2
prerank,GO_Biological_Process_2021__ESCRT III complex disassembly (GO:1904903),0.52905141225808,1.0172152194356134,0.4,0.9867700260678814,1.0,3/9,19.24%,VTA1;CHMP2B;VPS4B
prerank,GO_Biological_Process_2021__ESCRT complex disassembly (GO:1904896),0.52905141225808,1.0172152194356134,0.4,0.9867700260678814,1.0,3/9,19.24%,VTA1;CHMP2B;VPS4B
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),-0.5486902089383792,-1.0172097584172186,0.4927536231884058,1.0,1.0,3/17,13.15%,COL5A1;C12ORF57;IFT122
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell to AV node cell signaling (GO:0086026),-0.7062264644437608,-1.016992577067067,0.5517241379310345,1.0,1.0,3/5,17.02%,KCNQ1;GJC1;SCN3B
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),-0.42589235401266334,-1.0167631833929456,0.4175824175824176,1.0,1.0,8/136,8.92%,RASGRP1;S100A10;RASGRP2;ARHGAP15;DOCK8;CCL2;THY1;ARHGAP9
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),-0.525252602470405,-1.0166948946077232,0.5074626865671642,1.0,1.0,7/21,20.70%,MRAP2;GBP1;DMTN;PPFIA1;TMBIM1;TGFB1;NUMB
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),-0.509938660214624,-1.01659752894464,0.4307692307692308,1.0,1.0,6/19,28.04%,GMPPB;GFPT2;PMM1;UAP1;UAP1L1;GNPNAT1
prerank,GO_Biological_Process_2021__positive regulation of RNA binding (GO:1905216),0.6090941252959191,1.0165087230321572,0.5128205128205128,0.9882006214021775,1.0,1/5,4.93%,EIF3E
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),0.6100727413282369,1.0164409873161393,0.44,0.9873789651907694,1.0,3/6,25.23%,VCP;SART3;TANK
prerank,PanglaoDB_Augmented_2021__Airway Goblet Cells,-0.5152080863058022,-1.0164085930170705,0.5428571428571428,1.0,1.0,11/31,18.18%,TJP3;PSCA;POF1B;OVOL2;FUT2;CEACAM1;KPNA7;CAPN8;TMC4;LIPH;CXCL17
prerank,GO_Biological_Process_2021__establishment of protein localization to chromosome (GO:0070199),0.545516522706917,1.016336500475349,0.4074074074074074,0.9866807782841214,1.0,2/10,15.93%,NIPBL;POT1
prerank,MSigDB_Hallmark_2020__Myc Targets V2,0.42518018332395,1.0159357236941648,0.5238095238095238,0.9870117786005544,1.0,5/50,6.01%,SLC19A1;TFB2M;IMP4;PLK1;RCL1
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),-0.4739143208812908,-1.0159008125459281,0.40540540540540543,1.0,1.0,10/44,18.51%,L1CAM;SHTN1;SYT4;SYT1;RIMS2;CPNE9;BDNF;PPIB;AGRN;SYT2
prerank,GO_Biological_Process_2021__peptide antigen assembly with MHC protein complex (GO:0002501),-0.6696390722682747,-1.0158429174099581,0.4745762711864407,1.0,1.0,3/5,29.34%,HLA-DRA;HLA-DRB1;HLA-DMA
prerank,GO_Biological_Process_2021__response to testosterone (GO:0033574),0.6168972563072677,1.0157162223991638,0.45714285714285713,0.9857147670914485,1.0,2/5,8.18%,NCOA4;AR
prerank,GO_Biological_Process_2021__cellular response to testosterone stimulus (GO:0071394),0.6168972563072677,1.0157162223991638,0.45714285714285713,0.9857147670914485,1.0,2/5,8.18%,NCOA4;AR
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),-0.4413191025760057,-1.015509370219743,0.4691358024691358,1.0,1.0,13/84,14.46%,THBS1;APLNR;HK2;ANGPTL3;WNT5A;CYP1B1;BRCA1;KLF4;CHI3L1;ITGA5;BTG1;SFRP2;FGF1
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),-0.49775533077174305,-1.01547864102352,0.4583333333333333,1.0,1.0,5/24,19.68%,CENPH;MIS18A;CENPN;CENPU;CENPP
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),-0.49775533077174305,-1.01547864102352,0.4583333333333333,1.0,1.0,5/24,19.68%,CENPH;MIS18A;CENPN;CENPU;CENPP
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),-0.5212169007046487,-1.0153744862472587,0.4473684210526316,1.0,1.0,3/25,8.07%,NOS1AP;HTR2B;CAV3
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),0.495199579784879,1.0153698481335804,0.45454545454545453,0.9857491044453489,1.0,6/15,21.60%,NIPBL;GLI3;BMPR1B;PCSK5;MBNL1;MYH3
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),0.46535328804474385,1.0153132044352706,0.34615384615384615,0.9849212864901747,1.0,2/17,5.03%,BMP2;TCAP
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine metabolic process (GO:0030309),-0.633854406582842,-1.014935381946615,0.578125,1.0,1.0,2/8,13.30%,B3GALT2;B3GNT2
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.633854406582842,-1.014935381946615,0.578125,1.0,1.0,2/8,13.30%,B3GALT2;B3GNT2
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),0.42203141876940165,1.0146927011462992,0.5,0.9858848593242892,1.0,4/26,14.61%,OCLN;AKT2;AKT1;PIK3R1
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),-0.5331619895087227,-1.0144981265686668,0.47058823529411764,1.0,1.0,2/17,2.39%,SIX3;B2M
prerank,GO_Biological_Process_2021__regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),-0.6687222403971296,-1.0144430007402758,0.5192307692307693,1.0,1.0,1/5,7.99%,PLSCR1
prerank,GO_Biological_Process_2021__positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),-0.6687222403971296,-1.0144430007402758,0.5192307692307693,1.0,1.0,1/5,7.99%,PLSCR1
prerank,GO_Biological_Process_2021__regulation of mitochondrial translation (GO:0070129),0.45330399590662285,1.0135031154835292,0.4230769230769231,0.9886210690071819,1.0,8/20,27.38%,FASTKD2;MRPS27;NSUN3;FASTKD3;RPUSD4;MALSU1;ALKBH1;TSFM
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",0.3766400168366175,1.0132666678984978,0.4,0.9882092044257524,1.0,14/79,21.84%,PRDX6;RBM23;SF3B4;PCBP4;NOVA1;RBFOX1;NSRP1;HNRNPU;FXR2;QKI;JMJD6;RBM15;MBNL1;RBMX
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),-0.5519650541048313,-1.0131488816341097,0.4927536231884058,1.0,1.0,1/22,0.56%,PIF1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.5688365620625319,-1.0128466650967953,0.515625,1.0,1.0,2/15,6.15%,CCBE1;IL12A
prerank,GO_Biological_Process_2021__positive regulation of dendrite development (GO:1900006),-0.5850231111385733,-1.0120329648760698,0.5,1.0,1.0,4/9,26.16%,VLDLR;DAB2IP;ALK;PACSIN1
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),-0.4534596741467918,-1.0119077634333382,0.449438202247191,1.0,1.0,13/90,19.08%,PIF1;BLM;RECQL4;HELB;POLE3;BRCA1;DONSON;RPA3;CDK2;RPA1;POLD1;SET;CDC7
prerank,GO_Biological_Process_2021__regulation of glycoprotein biosynthetic process (GO:0010559),-0.6479799390560609,-1.0118472136621914,0.5409836065573771,1.0,1.0,3/8,15.51%,GATA1;NECAB1;IGF1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),-0.6504808289696429,-1.0116437987727018,0.4716981132075472,1.0,1.0,2/6,28.44%,NFATC2;ENG
prerank,GO_Biological_Process_2021__cGMP metabolic process (GO:0046068),-0.6704360697181306,-1.0115060465178687,0.578125,1.0,1.0,2/6,15.82%,GUCY1A1;GUCY2C
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),-0.4646273896086871,-1.0111448848819422,0.4805194805194805,1.0,1.0,6/42,14.71%,KCNB1;ITPR3;PAX8;GIPR;GLP1R;CACNA1C
prerank,GO_Biological_Process_2021__hemidesmosome assembly (GO:0031581),-0.6361488531785405,-1.0109767038281317,0.5,1.0,1.0,4/7,27.61%,LAMA3;PLEC;ITGB4;DST
prerank,GO_Biological_Process_2021__receptor recycling (GO:0001881),0.564641657976636,1.0109613171351082,0.38461538461538464,0.993674788450908,1.0,1/8,12.00%,PHETA1
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),-0.39047954207226365,-1.0109213273795639,0.42,1.0,1.0,80/413,22.26%,LEF1;PRAME;THBS1;HPN;IL13RA1;TGFBR2;TLR2;ZFP36;SFTPD;RAMP3;PDPN;PROX1;KIF14;RPS4X;HTR2B;COLEC12;IL12A;IL15;SCX;COPS9;TRPC3;RPS6KA1;MMP14;TIMP1;WNT5A;EGF;S1PR3;TENM4;PTK6;SRF;OSMR;EMP2;ROMO1;SFRP2;CCND1;FN1;THPO;NAMPT;FGF1;VIP;IL7;TGFA;FOXM1;GLI1;IGF1;CDK2;DDRGK1;RPS9;MFSD2A;MYRF;NOXA1;PRKCD;SLC11A1;TAF9B;FGF7;CAPN1;RPL23;SPHK1;RPS6;CDC7;FGF22;ECHDC3;RHOD;CAPNS1;TGFB1;HYAL1;FLOT1;RIPK2;RYR2;FASN;IRS2;GPER1;SFRP1;CAMK1D;AXIN2;HES1;AKAP6;MAPT;KIF20B;NUPR1
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),0.3970674322242883,1.0108622231387532,0.5,0.9929638736924149,1.0,4/25,5.54%,WNT7A;BMP2;SOX9;RUNX1
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),-0.46802101676244867,-1.010829303082069,0.3918918918918919,1.0,1.0,3/42,7.94%,A4GALT;UGT8;B4GALNT1
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),0.41281545709825485,1.0108057826511687,0.4230769230769231,0.99208028100965,1.0,9/46,17.61%,MTHFS;SLC19A1;ME2;PHYH;MTHFD2L;DHFR;SLC46A1;FH;DHFR2
prerank,GO_Biological_Process_2021__negative regulation of amino acid transport (GO:0051956),-0.6671745572313432,-1.0108024233015243,0.5636363636363636,1.0,1.0,3/5,25.73%,SLC43A2;GRM7;ARL6IP5
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),0.5098520446000907,1.0106162938905685,0.42424242424242425,0.9916532575598765,1.0,5/12,27.02%,S1PR1;TGFBR1;RBPJ;BMP7;HEY1
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.4765043924663618,-1.010594405733807,0.45,1.0,1.0,10/44,23.46%,TOMM7;ARIH2;YWHAH;PPP3CC;PINK1;BAP1;NMT1;MICALL2;UBL5;CASP8
prerank,MSigDB_Hallmark_2020__Apical Surface,-0.4936986040326758,-1.0105859480856958,0.49295774647887325,1.0,1.0,4/35,9.24%,CD160;APP;THY1;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),-0.4490590903085279,-1.0104660457398713,0.47058823529411764,1.0,1.0,16/72,19.92%,THBS1;APLNR;HK2;ANGPTL3;WNT5A;CYP1B1;BRCA1;CHI3L1;BTG1;SFRP2;FGF1;SPHK1;AQP1;HYAL1;PRKCB;PIK3CD
prerank,GO_Biological_Process_2021__negative regulation of cell size (GO:0045792),-0.6633582164262855,-1.010462814042806,0.5272727272727272,1.0,1.0,3/5,26.71%,CAV3;RDX;DEPTOR
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),0.3190991382793144,1.0104463357107623,0.3333333333333333,0.9912538015735194,1.0,72/293,22.33%,ATP6V0D2;TBC1D4;TVP23B;MTTP;ABCA1;TMED5;ARFIP1;ATP6V1A;SCFD2;TXNIP;TBC1D12;RAB23;ARL5A;ATP6V1G1;RABL3;BLZF1;TMEM167A;STX7;CEP290;ARFIP2;RAB1B;C17ORF75;RAB8B;DNAJC27;RAB22A;CMTM6;COPB2;AP3B1;CALCRL;RAB28;NDC1;LRP1B;TBC1D5;RAB26;SCFD1;TBC1D8B;CHMP2B;MON1A;RAB21;UNC119B;SNX27;NAPB;SEC31B;ARCN1;SEC23IP;HERC2;RIC1;SCAMP4;GOLGA7;TANGO6;RAB31;TBCK;RAB8A;RCN3;TBC1D22B;BBS2;PREB;TMED3;SEL1L;RAB18;EVI5L;SCAMP2;MIA2;TMED2;ERP29;GOLPH3;RUNDC1;TLK1;SNX17;RABL2A;COPG2;VPS29
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),-0.48050805858865125,-1.010244766199441,0.45,1.0,1.0,2/47,7.69%,CCNB2;CCNB1
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),-0.48050805858865125,-1.010244766199441,0.45,1.0,1.0,2/47,7.69%,CCNB2;CCNB1
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),-0.4558181151038464,-1.0101372459393447,0.49382716049382713,1.0,1.0,4/46,13.58%,MX1;RAMP3;SYK;CD9
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),0.4832446713406984,1.00971722609474,0.4411764705882353,0.9922837019786034,1.0,6/14,24.80%,ACACB;PMVK;ACSS1;MLYCD;NUDT7;TDO2
prerank,GO_Biological_Process_2021__negative regulation of nitrogen compound metabolic process (GO:0051172),-0.6661996857525881,-1.009143679024363,0.49122807017543857,1.0,1.0,3/7,25.83%,LDLR;TGFB1;ACMSD
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),-0.4651007215194045,-1.00898789414843,0.41333333333333333,1.0,1.0,3/52,4.59%,APIP;B2M;KCNJ2
prerank,GO_Biological_Process_2021__cell differentiation in hindbrain (GO:0021533),-0.6297223256382538,-1.0088570738998723,0.576271186440678,1.0,1.0,2/7,15.88%,PROX1;GRID2
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.5448916523173744,1.008852101172011,0.45714285714285713,0.9939251334708689,1.0,3/12,9.87%,GNL3L;CCT7;CCT3
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),-0.5384047523059581,-1.008758361481975,0.5652173913043478,1.0,1.0,3/16,7.72%,MET;PROX1;LSR
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),-0.5465289783949324,-1.0086941925332318,0.5076923076923077,1.0,1.0,2/14,10.08%,OR51M1;OR51I2
prerank,GO_Biological_Process_2021__negative regulation of macrophage cytokine production (GO:0010936),-0.6699439217413247,-1.0082334629579528,0.4838709677419355,1.0,1.0,4/5,32.95%,TGFB1;CUEDC2;TGFB3;TGFB2
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),-0.44871625198316156,-1.0081145391525765,0.4675324675324675,1.0,1.0,19/81,22.00%,THBS1;RASGRP2;SYT4;TRPC3;WNT5A;SYT1;ITPR3;CLIC4;HPCA;NEUROD2;CPNE9;DMTN;NLGN1;SYT2;KCNMB4;ADCY8;RYR2;SYT5;SYT13
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),-0.4673826472414071,-1.0080412599773474,0.4935064935064935,1.0,1.0,10/41,19.98%,FAT2;CENPV;HTR2B;SEMA3B;PDXDC1;AMOTL2;RADIL;SEMA3E;GPC3;SEMA4G
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.5086459660092314,1.008009591800132,0.4666666666666667,0.9950569999785236,1.0,3/10,24.11%,GREM1;MAP2K2;RNF13
prerank,PanglaoDB_Augmented_2021__Cholangiocytes,-0.4760267547322165,-1.0078677988680593,0.4864864864864865,1.0,1.0,6/41,8.80%,CD24;EFNA1;TJP3;EPS8L2;OVOL2;ALPL
prerank,GO_Biological_Process_2021__RNA polymerase II preinitiation complex assembly (GO:0051123),0.5816901114191919,1.0077050357728927,0.4594594594594595,0.9949885757605151,1.0,4/8,21.11%,GTF2A2;TAF12;DR1;GTF2B
prerank,GO_Biological_Process_2021__mitotic DNA replication (GO:1902969),0.5929499682960218,1.0074667959722654,0.45161290322580644,0.994840491675314,1.0,2/8,25.02%,MCM6;GINS3
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),0.584257276959762,1.007305605717295,0.52,0.9944004058603588,1.0,1/6,2.62%,ABCA1
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),0.41084561390282004,1.0068493502733409,0.375,0.9949831990304424,1.0,3/47,0.72%,ACE2;WNT7A;SLITRK2
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),-0.6039392716533833,-1.0068137125721892,0.4426229508196721,1.0,1.0,2/7,18.96%,FGF1;PTH1R
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),0.41100014997242623,1.0065581755674338,0.38461538461538464,0.9946764325318274,1.0,5/31,13.42%,REEP6;GAS1;AAAS;NUP214;SCFD1
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),0.46020702771909167,1.0065410670289399,0.3103448275862069,0.9937476477350945,1.0,4/17,15.06%,NGF;CASP3;MAGI2;ZFYVE27
prerank,GO_Biological_Process_2021__regulation of protein targeting (GO:1903533),-0.6775614423502978,-1.0062942682868783,0.5692307692307692,1.0,1.0,3/5,24.00%,ATP5IF1;PINK1;SREBF1
prerank,GO_Biological_Process_2021__positive regulation of neuron projection arborization (GO:0150012),-0.5953110079193814,-1.0061456960347372,0.47368421052631576,1.0,1.0,1/8,8.67%,WNT5A
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),-0.5941058612594141,-1.006098006832152,0.4696969696969697,1.0,1.0,1/10,11.25%,HR
prerank,GO_Biological_Process_2021__positive regulation of leukocyte activation (GO:0002696),-0.6190847096231881,-1.0059031755788335,0.46551724137931033,1.0,1.0,3/10,12.64%,THBS1;WNT5A;TNIP2
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 acetylation (GO:2000617),-0.651398413900313,-1.0057586485119234,0.5357142857142857,1.0,1.0,1/5,9.24%,BRCA1
prerank,GO_Biological_Process_2021__negative regulation of myotube differentiation (GO:0010832),-0.6612426023160245,-1.0057092799609582,0.515625,1.0,1.0,3/8,29.52%,BDNF;XBP1;HDAC5
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),0.4073490242226223,1.0055926097886547,0.3793103448275862,0.9953087100884107,1.0,1/28,0.54%,RNF6
prerank,GO_Biological_Process_2021__establishment of monopolar cell polarity (GO:0061162),-0.6406671005489732,-1.005585614305953,0.55,1.0,1.0,1/5,5.71%,FSCN1
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),-0.4403420654663339,-1.005491619237425,0.4931506849315068,1.0,1.0,9/60,16.03%,CXCL2;ZFP36;CCL2;WNT5A;PDCD1LG2;TNIP2;DAB2IP;SBNO2;IL18
prerank,GO_Biological_Process_2021__glutamine family amino acid biosynthetic process (GO:0009084),0.5845657966007554,1.0053956488052966,0.42857142857142855,0.9949231932456399,1.0,3/6,16.77%,GLUD1;GLS;GLUL
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),0.4233084314558395,1.005348406206798,0.42857142857142855,0.9941157511018562,1.0,6/31,13.30%,SNRPF;NUDT21;WDR33;CSTF3;PAPOLA;CPSF7
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),-0.5846577364155193,-1.0051198329475748,0.5342465753424658,1.0,1.0,6/14,19.90%,CHRM3;SRF;KCNB2;SPHK1;PLCE1;DAPK3
prerank,GO_Biological_Process_2021__peptidyl-arginine modification (GO:0018195),-0.6107463837265672,-1.0051169051457631,0.5072463768115942,1.0,1.0,1/10,4.50%,ART3
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.530484350869579,-1.0051057969729176,0.4647887323943662,1.0,1.0,4/24,9.78%,ANXA1;THBS1;SRPX2;KLF4
prerank,GO_Biological_Process_2021__endoplasmic reticulum localization (GO:0051643),-0.6507787586502322,-1.0050010976379233,0.5571428571428572,1.0,1.0,1/6,3.40%,GRAMD2A
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),0.34131592604620475,1.004774727244895,0.4,0.9948669734633225,1.0,33/105,30.11%,WDR91;SNF8;VPS50;PTPN23;PHETA1;PIK3C3;VTI1A;TBC1D5;WASHC2C;RHOBTB3;RAB9A;VAMP3;RIC1;SNX5;EPS15;TBC1D23;PIKFYVE;KLHL20;SNX2;VPS29;SORT1;MON2;BECN1;SNX1;VPS54;VPS26B;VTI1B;WASHC2A;AP2A1;SNX16;VPS26A;RGP1;STX8
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),0.4181329227709972,1.0047478897176774,0.3548387096774194,0.9939820528423058,1.0,1/21,2.24%,PPARGC1A
prerank,GO_Biological_Process_2021__regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127),-0.640475224231869,-1.0046348866179442,0.5,1.0,1.0,2/6,11.73%,TLR3;IRF7
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),-0.5183762752048688,-1.0043280586759473,0.5,1.0,1.0,5/20,16.97%,STMN2;KIF14;STMN4;KIF2C;STMN1
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),0.5482068570409375,1.0043205681016234,0.4594594594594595,0.9941392912340049,1.0,1/8,0.13%,LEPR
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),-0.4694720022556533,-1.004085215421678,0.47560975609756095,1.0,1.0,20/63,22.26%,HPN;NR4A3;B2M;ZFP36;LAMB1;FUT2;SGPP2;SFRP2;DAB2IP;FGF1;TGFA;IGF1;NR4A1;FGF7;TGFB1;HYAL1;SFRP1;DEAF1;CDKN1C;NUPR1
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),0.5449098157767542,1.0040580678276867,0.5161290322580645,0.9939804464080247,1.0,8/14,19.12%,BMP2;SOX9;KAT2A;TRPS1;SOX5;TAPT1;MDK;BMPR1B
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),-0.5873037049967248,-1.003891661200694,0.5,1.0,1.0,4/10,24.46%,SCX;TENM4;CRB2;PHLDB2
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),-0.5344648342916155,-1.003851489289151,0.5344827586206896,1.0,1.0,6/17,26.51%,OVOL2;TGFB1;VEPH1;WWTR1;NODAL;TGFB3
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),-0.5076620646919208,-1.0037560671098176,0.5068493150684932,1.0,1.0,8/28,18.85%,RASGRP1;DUSP1;GADD45A;GADD45B;MINK1;DAB2IP;RELL1;SPHK1
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),-0.588990599931486,-1.0036801775696378,0.5263157894736842,1.0,1.0,4/11,25.92%,IL15;CD4;IL15RA;STAT3
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),-0.588990599931486,-1.0036801775696378,0.5263157894736842,1.0,1.0,4/11,25.92%,IL15;CD4;IL15RA;STAT3
prerank,GO_Biological_Process_2021__T cell apoptotic process (GO:0070231),0.6098510224140388,1.0035396664578011,0.525,0.9943871327444604,1.0,2/5,17.63%,AKT1;GLI3
prerank,GO_Biological_Process_2021__negative regulation of protein K63-linked ubiquitination (GO:1900045),0.5672958214329853,1.0035394948780116,0.5641025641025641,0.9934272996047457,1.0,2/7,22.07%,OTUB2;TRIP12
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),-0.4752291554166979,-1.0035219385864906,0.5,1.0,1.0,4/27,10.11%,MET;PSRC1;CAV3;DCTN1
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),0.5822222119722,1.0034277142178183,0.45714285714285713,0.9928760189670361,1.0,2/7,29.75%,CPEB3;CPEB4
prerank,GO_Biological_Process_2021__indolalkylamine catabolic process (GO:0046218),-0.6211802065801226,-1.0033522461088864,0.55,1.0,1.0,1/8,3.79%,KMO
prerank,GO_Biological_Process_2021__tryptophan metabolic process (GO:0006568),-0.6211802065801226,-1.0033522461088864,0.55,1.0,1.0,1/8,3.79%,KMO
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),-0.5002608713687746,-1.0033276720136683,0.43661971830985913,1.0,1.0,5/35,10.49%,CLIC1;SLC4A11;ANO9;BEST1;CLIC4
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),-0.5161139083771463,-1.0033227075096103,0.5131578947368421,1.0,1.0,4/32,8.93%,AWAT1;ALOX12;CYP4Z1;CYP1B1
prerank,GO_Biological_Process_2021__midbrain dopaminergic neuron differentiation (GO:1904948),-0.6204732321520141,-1.00298027039469,0.515625,1.0,1.0,1/7,8.67%,WNT5A
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),-0.4791819919479264,-1.0028941591442495,0.5428571428571428,1.0,1.0,8/37,14.20%,ST6GAL1;GCNT1;CHST4;GALNT15;B3GNT5;B3GNT2;ST6GALNAC2;GALNT10
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",0.427509691992532,1.002505998759301,0.47058823529411764,0.9944359886620325,1.0,11/51,18.86%,KAT2B;ERCC6;SERTAD2;KAT2A;POLR1F;H1-2;DDX21;ASF1A;EP300;ATAD2B;SPHK2
prerank,GO_Biological_Process_2021__pyrimidine-containing compound salvage (GO:0008655),-0.5917518865268856,-1.0024328685246382,0.5423728813559322,1.0,1.0,1/9,2.35%,TYMP
prerank,GO_Biological_Process_2021__pyrimidine nucleoside salvage (GO:0043097),-0.5917518865268856,-1.0024328685246382,0.5423728813559322,1.0,1.0,1/9,2.35%,TYMP
prerank,GO_Biological_Process_2021__vasoconstriction (GO:0042310),-0.6593730453868797,-1.0018503836197516,0.5342465753424658,1.0,1.0,1/7,5.84%,HTR2B
prerank,GO_Biological_Process_2021__forebrain neuron development (GO:0021884),-0.6335393224654998,-1.0017480891652824,0.5483870967741935,1.0,1.0,1/6,8.67%,WNT5A
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),0.4974649270795268,1.0015193595359662,0.45454545454545453,0.9964381564178537,1.0,4/11,19.46%,RALB;PIP4K2B;PIP4K2C;RAB3GAP1
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),0.43060899964895316,1.0012675868182686,0.3793103448275862,0.996173365130662,1.0,7/31,16.79%,UBTF;ERCC2;POLR1F;ERCC3;GTF2H5;RRN3;GTF2H2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte degranulation (GO:0043302),-0.572198572558469,-1.001125866113458,0.5172413793103449,1.0,1.0,4/8,28.43%,SYK;HLA-F;GAB2;STX4
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),0.410614684762902,1.0009469798080821,0.45454545454545453,0.9960528414249243,1.0,4/39,4.49%,WNT7A;SLITRK2;LIG4;NLGN3
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),0.42179302463967566,1.0006269567921984,0.35714285714285715,0.9961153392771692,1.0,7/33,16.79%,UBTF;ERCC2;POLR1F;ERCC3;GTF2H5;RRN3;GTF2H2
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),0.5082776848524299,1.0005901724767952,0.47058823529411764,0.9952385545727561,1.0,6/11,23.08%,HNRNPU;YTHDF2;ESRRB;HES5;ZFP36L2;JAG1
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),0.4814810116341695,1.000576584672013,0.4666666666666667,0.9943113238029144,1.0,5/16,15.18%,KAT2B;MAML3;PBX1;HEYL;EP300
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),0.5813483454601536,1.0001532699530247,0.42424242424242425,0.9946487069643218,1.0,5/9,40.19%,RIOX2;RIOX1;KDM4B;KDM7A;KDM4C
prerank,GO_Biological_Process_2021__motile cilium assembly (GO:0044458),-0.6095691913572251,-1.000146995827865,0.5625,1.0,1.0,4/8,26.40%,CCDC39;BBOF1;DNAAF1;CCDC40
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),0.2675095285859764,1.0,1.0,0.9934763786454078,1.0,354/1616,18.75%,MEOX2;ZNF300;POU6F2;WNT7A;RGCC;ASCL1;ZNF697;ETV5;ZNF287;POU3F1;DACH1;ZNF202;ZNF615;TFCP2L1;NR1D1;ZNF415;RITA1;ZFP3;SOX8;KCTD1;MED21;POU3F4;ZNF783;PPARGC1A;CEBPA;IRF2BP1;SOX21;MEN1;BMP2;ZNF358;PRDM6;ZNF212;ZNF441;NR2E1;PSMD10;RTRAF;KDM1B;ANXA4;TRIB3;EHF;ZNF426;MITF;ZNF658;ZSCAN20;ZNF107;ZBTB43;HSF5;LMO1;ID1;ATF5;ZSCAN25;LPIN3;CARF;RARB;SERPINF2;GREM1;ZNF525;ZNF778;ZNF624;ZNF24;FOXP1;ZXDA;LCORL;ELOC;POU3F2;ZBTB37;ZNF319;ZNF555;KMT5A;KAT2B;SOX9;BCLAF3;PLK1;ZFP2;MAML3;RUNX1;OTX1;SMARCAL1;EGFR;THAP11;HES6;HCLS1;RNF2;CDK8;GRHL1;ZNF556;SMYD2;SMAD5;ZNF613;ZNF304;SOX12;ZBTB9;ZNF616;ESRRG;FRK;ANKRD2;MTF1;RORB;KLF16;ZNF384;ZBTB40;PRDM4;EAF2;TRIM28;ZNF639;DPF1;ZNF684;ZNF707;DNMT3B;ZNF74;ZNF577;ELOA;EED;ZNF320;NCOA3;TSHZ1;CAPRIN2;NUFIP1;THAP1;SLC2A4RG;ZSCAN23;ZNF408;ZNF268;ZFHX4;HMGB1;AR;ZNF883;ZNF211;SIRT6;PBX1;ZBTB18;ZNF782;NRIP1;ZBTB33;LMO7;ZNF484;PPM1A;NR3C1;MIER3;SALL1;NCK1;ZNF543;ZBTB6;RNF14;ETV1;YY1;ELK4;ZNF696;ZNF595;ZNF587;PHF14;SLC30A9;ZNF133;PHF10;ZNF12;SNF8;NFYC;ZIC2;TENM2;ZNF510;ZNF852;HSF1;JDP2;ZNF786;LCOR;ZNF214;FOXJ1;ATF6;NIPBL;HSF2;EBF4;ZGLP1;ZNF561;FOXJ3;KAT2A;KMT2A;ZNF518A;TIAL1;SSBP3;GABPB1;ZBTB39;HLF;ZXDC;ZNF181;CSF1R;ZNF875;ZNF155;BRWD1;TRPS1;FOXJ2;UBE2D1;KCNIP3;TOX;SOX5;ZNF25;ESRRA;ZNF496;VEZF1;HEXIM2;ZNF530;ZNF792;ARID3B;KLF12;SALL3;ZSCAN22;EMX2;ZXDB;FIZ1;ZNF33A;ZNF677;ZNF669;ZNF793;CNOT2;ZNF347;PATZ1;ZNF774;ARX;ZNF397;ZNF254;ZNF451;ZNF761;SPEN;BRWD3;ZEB2;ACVR2A;PEX2;ZNF121;ETS2;WASL;ZNF283;ZNF382;ZNF527;MLLT10;ZNF665;ZNF507;HEYL;DVL2;ZBTB2;BAZ1A;NCK2;ZNF189;RPS6KA3;SAP130;RNASEL;ZNF276;E2F4;AEBP2;ZNF429;ZNF425;LHX2;ELP2;ZBTB20;HDAC2;PRKD1;ZNF764;PRDM5;PIK3R1;CPEB3;NFKB1;GTF2H5;HTATSF1;ZNF322;MCPH1;HNRNPU;SMARCA2;ZNF354B;EP300;ZNF264;KAT7;POU2F1;PURG;ZNF324B;ZHX2;HDAC10;NR2F1;ZFX;MYNN;MED30;ZNF526;PLAGL2;ZNF534;ZNF471;ZNF43;NCOA2;BACH1;ZNF14;PLAGL1;NRF1;ZNF91;ZNF34;OLIG1;NR1D2;ZNF470;MGA;NR3C2;DR1;VHL;ELP4;ZNF416;ZNF879;ZNF230;ZNF582;ZNF521;ZNF18;NKRF;GTF2H2;AKIRIN2;WWOX;GTF2H2C;MXD3;ZNF865;ZNF41;IRF2BPL;CEBPG;ZNF75A;DCAF1;ZNF558;TAF3;ID2;IKZF3;PBX2;ZNF324;GLI3;ZFP82;ATAD2B;BRD7;ELP3;TADA1;AGO3;PURA;CDK12;BATF2;PIAS4;TET3;CREG1;TRIAP1;ZNF248;ZNF805;ZBTB10;ZHX3;TADA2B;SETD3;NFAT5;PHF20L1;CNOT1;ZNF236;SP3;MTA2;NOC2L;ZNF251;ZBTB34;HEY2;RPRD1B;ZNF611
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",0.27572074056669593,1.0,1.0,0.9934763786454078,1.0,369/1648,18.97%,MEOX2;ZNF300;POU6F2;WNT7A;RNF6;ASCL1;ZNF697;ETV5;ZNF287;POU3F1;DACH1;ZNF202;ZNF615;TFCP2L1;NR1D1;LIMD1;CCNE1;FAM47E;ZNF415;ZFP3;ZNF117;SOX8;KCTD1;MED21;POU3F4;ZNF783;PPARGC1A;CEBPA;IRF2BP1;SOX21;MEN1;BMP2;ZNF358;ZNF212;ZNF195;ZNF441;NR2E1;BCL10;ANXA4;TRIB3;EHF;ZNF426;MITF;ZNF658;ZSCAN20;ZNF107;ZBTB43;HSF5;ID1;ATF5;ZSCAN25;CARF;ZC3H8;SCML2;ZNF525;ZNF778;ZNF624;ZNF24;FOXP1;ZXDA;LCORL;ELOC;USP13;POU3F2;ZBTB37;ZNF319;POFUT1;ZNF555;KMT5A;CBFA2T3;SLC39A8;SOX9;ZFP2;RUNX1;MTERF3;OTX1;SMARCAL1;RBM23;MSANTD1;EGFR;THAP11;HES6;ZNF706;HCLS1;BRF2;TENM1;POLR3F;GRHL1;ZNF556;SMAD5;PHC1;APBB3;ZNF613;ZNF680;ZNF304;SOX12;ZBTB9;ZNF616;ESRRG;ZNF676;ANKRD2;MTF1;RORB;KLF16;ZNF384;ZBTB40;TRIM28;ZNF639;DPF1;ZNF502;ERCC6;ZNF684;ZNF707;ZNF74;ZNF577;ELOA;EED;ZNF320;TSHZ1;AKT1;BTRC;THAP1;SLC2A4RG;ZSCAN23;PRMT6;ZNF408;ZNF268;ZFHX4;HMGB1;AR;ZNF883;ZNF211;PBX1;ZBTB18;KDM5A;ZNF782;ZBTB33;ZNF484;PPM1A;ERBB4;NR3C1;ZNF492;FBXO5;SALL1;GLI4;ZNF543;ZBTB6;RNF14;ETV1;CEP290;YY1;ELK4;ZNF696;ZNF595;ZNF587;PHF14;ZNF133;PHF10;ZNF12;SNF8;NFYC;ZIC2;YAF2;HP1BP3;ZNF510;ZNF852;HSF1;JDP2;ZNF786;LCOR;ZNF214;FOXJ1;ZNF703;ATF6;NIPBL;HSF2;EBF4;ZGLP1;ZNF561;PTPRK;FOXJ3;KAT2A;KMT2A;ZNF518A;TIAL1;ZBTB39;TRIM16;HLF;ZXDC;ZNF181;ZNF875;ZNF155;BRWD1;TRPS1;FOXJ2;MAGED1;TOX;SOX5;ZNF25;ESRRA;ZNF496;VEZF1;HEXIM2;ZNF530;ZNF792;ARID3B;KLF12;SALL3;ZSCAN22;ZNF341;EMX2;ZXDB;ZNF33A;ZNF677;ZNF669;ZNF280D;ZNF793;CNOT2;ZNF347;PATZ1;ZNF774;TGFBRAP1;ARX;ZNF397;APBB2;ZNF254;ZNF761;SPEN;BRWD3;ZEB2;ZNF121;ETS2;ZNF283;ZNF382;ZNF527;ZNF665;HEYL;DAP;BRPF1;ZNF736;DVL2;ZBTB2;ZNF519;HMG20A;BAZ1A;ZNF189;RPS6KA3;KARS1;ZNF276;E2F4;AEBP2;ZNF429;ZNF425;LHX2;ELP2;ZBTB20;HDAC2;TNFSF4;ZNF764;PRDM5;DHFR;NFKB1;HTATSF1;ZNF322;GPBP1L1;PICALM;SMARCA2;ZNF138;ZNF354B;EP300;ZNF264;KAT7;POU2F1;PURG;ZNF324B;ZHX2;HDAC10;NR2F1;NUP85;ZFX;MYNN;MED30;CDK18;ZNF526;PLAGL2;ZNF534;ZNF471;ZNF43;NCOA2;PYHIN1;CHD7;BACH1;ZNF14;PLAGL1;NRF1;ZNF91;PLCB1;ZNF34;OLIG1;NR1D2;ZNF470;MGA;NR3C2;VHL;ELP4;ZNF416;ZNF879;ZNF230;ZNF582;ZNHIT3;ZNF521;ZNF18;NKRF;GTF2H2;GTF2H2C;MXD3;ZNF865;ZNF41;FOXN2;IRF2BPL;CEBPG;ZNF75A;PHC3;ZNF558;SCMH1;LANCL2;THOC1;ID2;SNX5;IKZF3;PBX2;ZNF324;GLI3;CAMK4;ZFP82;BRD7;ELP3;TADA1;PURA;BATF2;PCID2;PIAS4;METTL4;CREG1;NLK;ZNF248;ZNF805;ZBTB10;ZHX3;EFEMP1;TADA2B;SETD3;NFAT5;PHF20L1;ZNF236;SP3;ZNF251;VSX1;ZBTB34;HEY2;PSPC1;MAP2K2;ZNF611;ZNF737;EHMT1;ZNF770;PPIE;CSRNP3;ZNF224
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.5046190685798597,0.9998985326108185,0.3548387096774194,0.9928399656603422,1.0,3/13,7.04%,ABCD2;MACIR;ABCD1
prerank,MSigDB_Hallmark_2020__Pperoxisome,0.36263329295923485,0.9992689280183071,0.4666666666666667,0.9936702990713207,1.0,21/90,14.34%,ABCD2;CEL;PEX11A;BCL10;ALDH1A1;ISOC1;ABCD1;PEX13;SLC25A19;MSH2;EHHADH;ABCD3;ERCC3;PRDX1;PEX2;ECH1;CACNA1B;CAT;SCP2;ACOX1;HSD17B11
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),-0.39823263049483587,-0.9991118357753304,0.5444444444444444,1.0,1.0,43/188,23.90%,RPL3;RPL19;RPS27;RPS14;RPL27A;RPL7A;RPL35;NOB1;EMG1;RPL37A;RPL21;RPL27;RPL13A;RPL9;RPS16;RPL24;RPLP1;RPL10A;RPL10;RPLP2;RPL38;RPS7;RPL8;RPS15;RPL5;RPL12;RPL18A;RPS9;MRTO4;PES1;RPL23;RPS6;RPS25;DDX54;RPL7;RPL4;WDR46;RPL41;RPL11;EXOSC7;RPL15;RPL36;RPL29
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),-0.4864644632013621,-0.9988384365766461,0.4307692307692308,1.0,1.0,5/31,10.45%,CLDN16;POF1B;LSR;CLDN20;CLDN18
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.5699408376737626,-0.9986406066867362,0.4918032786885246,1.0,1.0,5/12,20.95%,RSPO3;RNF213;SFRP4;GPC3;SFRP1
prerank,GO_Biological_Process_2021__cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),-0.6573872134567625,-0.9984581413644832,0.5454545454545454,1.0,1.0,1/5,5.05%,SH3GL2
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),-0.5755382864974868,-0.9984572818997594,0.5245901639344263,1.0,1.0,3/9,24.78%,MAPRE2;FGF7;EPB41L4B
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),-0.4804159979409103,-0.998360690607341,0.4647887323943662,1.0,1.0,12/42,21.22%,ICAM1;GRIN2A;APP;NOD1;IGF1;SNX6;CDK5;RPL23;CACNB1;RIPK2;GPER1;ABCC1
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.5741148617957099,-0.9982364639544553,0.5217391304347826,1.0,1.0,2/11,21.36%,SLC51B;INSIG1
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),0.4560363614613644,0.9981334250734635,0.32,0.9959243172731288,1.0,5/13,32.62%,TNFSF4;NECTIN2;KMT5B;TP53BP1;RIF1
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),-0.45814347222326623,-0.9979530349613751,0.4125,1.0,1.0,7/64,9.70%,L1CAM;MYOT;TJP3;SNCB;SLC8A3;APP;CBLN2
prerank,PanglaoDB_Augmented_2021__Gamma Delta T Cells,-0.505953513766664,-0.9978534656093507,0.5142857142857142,1.0,1.0,4/20,7.69%,TYMS;SPON2;P2RY10;CCNB1
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.5294154906042949,-0.9977839313654882,0.6,1.0,1.0,10/23,28.10%,KLF4;FOS;SRF;APLN;TGFB1;SPI1;ETS1;STAT3;GNL3;JUN
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),-0.4192885416143215,-0.9976365766050187,0.48148148148148145,1.0,1.0,13/95,13.09%,RASGRP1;CDKN2A;RASGRP2;SHTN1;PLK2;USP50;PLD1;RALGDS;PLD2;RAPGEF5;RIT2;SHC2;ARHGEF18
prerank,GO_Biological_Process_2021__sensory perception of pain (GO:0019233),0.4941803648176333,0.9975208216697647,0.3548387096774194,0.9966077448913822,1.0,2/11,3.41%,CHRNA4;KCNA2
prerank,GO_Biological_Process_2021__negative regulation of transporter activity (GO:0032410),0.6058855908404321,0.9974437791861968,0.5952380952380952,0.9958673164712045,1.0,1/6,15.18%,NDFIP1
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.3948245409471275,0.9973700771043656,0.4117647058823529,0.9951282943728125,1.0,1/24,0.74%,NGF
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),-0.4652848105793932,-0.9972682381412379,0.48148148148148145,1.0,1.0,2/50,7.69%,CCNB2;CCNB1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),-0.5236554260801882,-0.9972361199271884,0.484375,1.0,1.0,1/18,0.56%,PIF1
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),0.5547567957504578,0.9971271923570357,0.42857142857142855,0.9948811707853312,1.0,2/8,10.01%,POMK;FGGY
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),-0.5700596147984653,-0.9970649721466697,0.5211267605633803,1.0,1.0,5/13,27.29%,IGFBP5;IGF1;CCN4;SLIT2;SERPINE1
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),-0.5063865651431746,-0.9968267879464501,0.4931506849315068,1.0,1.0,4/25,6.95%,THBS1;ICAM1;CD160;CCL2
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),-0.5997979334402848,-0.9967377491940529,0.49206349206349204,1.0,1.0,3/8,11.36%,APOLD1;CEACAM1;BTG1
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),-0.5290552805005125,-0.9965498307293682,0.46875,1.0,1.0,2/20,3.11%,C3;NOS1AP
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),0.6037679964895533,0.9963129532590507,0.5135135135135135,0.9960401316802565,1.0,2/5,24.73%,CXCL12;RAPGEF2
prerank,GO_Biological_Process_2021__chromatin assembly or disassembly (GO:0006333),0.5580641341423558,0.9962958856622197,0.5405405405405406,0.9951097952065338,1.0,4/10,19.29%,RBBP4;MTA2;NOC2L;CDAN1
prerank,GO_Biological_Process_2021__double-strand break repair via break-induced replication (GO:0000727),-0.631011289385109,-0.9961091088921369,0.5645161290322581,1.0,1.0,3/9,23.90%,GINS2;CDC7;MCM5
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),0.5086059777771311,0.9959130541236861,0.4642857142857143,0.9953138810891987,1.0,7/14,31.00%,ERI1;MTPAP;TENT4B;LSM1;XRN1;TENT2;TUT4
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),0.35489516241827435,0.9954616187075703,0.4,0.9947059953151622,1.0,9/57,15.17%,CD247;MYO10;YES1;NCK1;WIPF2;PIK3CA;WASL;PIK3R1;ABI1
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.35489516241827435,0.9954616187075703,0.4,0.9947059953151622,1.0,9/57,15.17%,CD247;MYO10;YES1;NCK1;WIPF2;PIK3CA;WASL;PIK3R1;ABI1
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),0.49168671557529137,0.9948779367731312,0.5483870967741935,0.9950382318549345,1.0,3/16,8.05%,C1D;MPHOSPH6;RPF1
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,0.3502711127374357,0.9948686193039746,0.4375,0.9941132239223937,1.0,21/137,8.40%,G0S2;WNT7A;PTCD2;NGF;ETV5;TMEM100;GALNT3;BMP2;SPON1;DUSP6;SNAP91;TNFAIP3;CA2;SOX9;AKT2;USP12;MTMR10;ZNF639;ZNF277;STRN;WDR33
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),-0.4695204376702006,-0.9946588243607046,0.4805194805194805,1.0,1.0,4/37,9.29%,KCNQ1;NOS1AP;KCNJ2;ATP1B1
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),-0.42182157644721585,-0.9945711813421451,0.4634146341463415,1.0,1.0,27/91,22.97%,THBS1;SPARC;APP;F8;TIMP1;GTPBP2;EGF;F5;TAGLN2;CD9;FN1;SERPING1;IGF1;TLN1;CD63;ABCC4;SELP;SRGN;A2M;F13A1;WDR1;TGFB1;FERMT3;VCL;TF;RAB27B;SELENOP
prerank,PanglaoDB_Augmented_2021__Erythroblasts,-0.4449595595783702,-0.9943982990139982,0.42528735632183906,1.0,1.0,14/65,15.69%,LMO2;CD44;ADGRE5;GAB3;TMC8;TUBB1;LMNB1;ADCY7;GATA1;IL27RA;GFI1B;PIM1;PRSS57;PTPN7
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),-0.428430295703528,-0.994072166388753,0.4878048780487805,1.0,1.0,18/76,23.64%,PCSK2;MMEL1;TESC;PHEX;NNAT;MMP14;CTSS;ADAM19;AEBP1;SRGN;TSPAN32;APH1A;CPXM2;F3;PCSK6;CLN3;CCS;HSPD1
prerank,GO_Biological_Process_2021__negative regulation of chemokine production (GO:0032682),-0.6183020143049616,-0.9939832467135613,0.5,1.0,1.0,3/8,11.87%,APOD;KLF4;SIGIRR
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",0.3302880818286633,0.9935692738451629,0.4444444444444444,0.9972124740506624,1.0,49/191,24.90%,TFB2M;ELOC;MTERF1;TRIM24;BRF2;COPS2;GTF2F2;EAF2;ERCC6;ELOA;UBTF;THAP1;ERCC2;HSF1;RO60;GTF2A2;SOX5;ERCC3;DDX21;POLR2C;TAF12;TAF4;SNAPC3;TAF2;NFKB1;GTF2H5;NFKBIB;IWS1;GTF2H2;TAF3;THRB;RNGTT;MLLT3;MED4;CCNT2;GTF2B;CCNT1;RBMX;NELFA;CTDP1;GTF2H3;GTF3C3;PARP1;TRIP11;EPC1;NAT14;TCEA1;TAF13;CCNH
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),-0.5819169047931757,-0.9933937448131259,0.5076923076923077,1.0,1.0,3/9,12.96%,ARIH2;WNT5A;SFRP2
prerank,GO_Biological_Process_2021__regulation of delayed rectifier potassium channel activity (GO:1902259),-0.5980781480326995,-0.993339966604768,0.5757575757575758,1.0,1.0,3/9,12.80%,ANK3;NOS1AP;KCNG1
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,0.33061483825505433,0.9929548429709016,0.4666666666666667,0.9975414150228383,1.0,59/179,25.48%,PDK4;ALAS1;MRPS30;COX10;NDUFB1;MRPL15;ATP6V1G1;ACADM;OAT;GLUD1;CS;SUCLA2;PHYH;VDAC2;TOMM22;ETFDH;LRPPRC;OPA1;ATP5PB;MPC1;ECH1;NDUFA8;COX11;PRDX3;ATP5MC2;ACADSB;UQCRC2;SLC25A5;CPT1A;ATP5MC1;MTX2;NQO2;NNT;FH;NDUFS1;ATP5F1A;BDH2;COX7A2L;SLC25A3;NDUFV1;NDUFB4;DECR1;SDHB;MRPS11;MTRF1;DLAT;UQCRB;MFN2;ATP5F1C;NDUFS3;GOT2;TIMM13;PMPCA;SLC25A20;PDHA1;FDX1;OGDH;IDH1;NDUFS4
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),-0.5990190387351244,-0.9929090075715397,0.5535714285714286,1.0,1.0,1/8,1.07%,EFNA1
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),0.41714054516893,0.9928914159480265,0.391304347826087,0.9967701003476076,1.0,4/31,10.33%,RGCC;BMP2;AKT1;ZNF703
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),0.3083149377993418,0.9922263987100995,0.36363636363636365,0.9977247882191085,1.0,27/207,11.43%,LEPR;FGF6;VEGFD;AGER;VEGFC;MEN1;BMP2;PPP1R15B;CCDC88C;OCLN;SOX9;P2RY1;EGFR;FBLN1;TESK1;RALB;AKT2;AKT1;ERBB4;STK4;ANKRD54;SESN2;TWF1;CDK2AP1;CSF1R;PPP2R5A;EFNA5
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),-0.41928800503306507,-0.9921733800347149,0.5,1.0,1.0,11/119,7.89%,FLRT3;NPY;L1CAM;POU4F1;STMN2;LAMB1;SH3GL2;RAB11A;PLP1;APP;SRRM4
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),-0.4711649462195821,-0.9920089652827114,0.5194805194805194,1.0,1.0,6/37,17.64%,ATG9A;SPATA18;MAP1LC3A;PINK1;GABARAPL1;WDR45
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),-0.47128383827880305,-0.9919860670393895,0.47435897435897434,1.0,1.0,2/42,4.81%,CP;SLC39A14
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,0.47560075733612617,0.9918616375511128,0.35714285714285715,0.9978864104880365,1.0,3/19,3.47%,ACE2;ANXA4;EHF
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter transport (GO:0051590),-0.6597756836358374,-0.9917231400800164,0.5666666666666667,1.0,1.0,2/5,22.13%,GPER1;STX1B
prerank,GO_Biological_Process_2021__positive regulation of B cell receptor signaling pathway (GO:0050861),0.6363891247687734,0.991680002680019,0.47058823529411764,0.9974739559632961,1.0,2/6,4.77%,SLC39A10;FOXP1
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),0.36444993106293005,0.991374591514573,0.4444444444444444,0.9971387053726605,1.0,10/75,9.75%,NR1D1;ADIPOR1;ELOVL6;ACACB;RUBCNL;MID1IP1;PMVK;CHD9;GNB3;NFYC
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),-0.5295371037993357,-0.9913210033436367,0.5,1.0,1.0,1/17,4.18%,SUN3
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),-0.48911189588778037,-0.9911870900240506,0.5443037974683544,1.0,1.0,2/32,7.31%,CP;TRPC3
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),0.41757288714589547,0.9910667059757686,0.46875,0.9973386023490971,1.0,7/21,16.68%,KMT5A;PLK1;NCAPH2;CSNK2A1;CSNK2A2;MCPH1;TENT4A
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),0.2798670887108418,0.991041814270457,1.0,0.9964446545396933,1.0,67/263,23.53%,TBC1D4;ABHD17A;TMED5;ARFIP1;ID1;SCFD2;OCLN;TBC1D12;COX18;RAB23;EGFR;ARL5A;RABL3;SEPTIN11;STX7;ARFIP2;RAB1B;C17ORF75;DNAJC27;RAB22A;FOXJ1;NIPBL;PTPRK;ANK2;COPB2;AP3B1;TRAPPC8;RAB28;TBC1D5;SCFD1;TBC1D8B;RAB21;SNX27;NAPB;SEC31B;ARCN1;SEC23IP;HERC2;RIC1;DMD;RAB31;HEY2;PIGU;TBCK;PRRT1;TBC1D22B;ITSN1;SEPTIN6;BBS2;TMED3;GJA1;RAB18;EVI5L;TMED2;AMOT;ERP29;RUNDC1;TLK1;SNX17;RABL2A;VPS29;TM9SF3;MFN2;WDR11;LAMTOR3;ARL5B;SAR1B
prerank,GO_Biological_Process_2021__regulation of MDA-5 signaling pathway (GO:0039533),-0.6532795478678222,-0.9909407799460523,0.5555555555555556,1.0,1.0,1/6,10.23%,DDX60
prerank,GO_Biological_Process_2021__renal filtration (GO:0097205),-0.5930002479416323,-0.9909167921048943,0.5416666666666666,1.0,1.0,4/8,18.28%,SULF1;MYO1E;ITGA3;MCAM
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.5518779173378341,-0.9906486031686877,0.4861111111111111,1.0,1.0,4/14,17.15%,BAIAP2L1;BAIAP2;FES;CDK5
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),-0.5357009837027847,-0.9905688530316633,0.4583333333333333,1.0,1.0,5/12,33.29%,LAMA3;AHI1;LAMA5;ZDHHC7;CELSR1
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),0.4850704124188942,0.9902422787922713,0.4375,0.9980548491533869,1.0,6/21,13.47%,S1PR1;SOX9;FBXO5;SGMS2;ECM1;ANKH
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),-0.4587637504719755,-0.9900839743214407,0.5324675324675324,1.0,1.0,9/56,9.82%,B2M;ANK3;KCNJ13;KCNJ2;CHRM1;SYT4;ATP1A1;SYT1;YWHAH
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),-0.571516890013726,-0.9898287704786433,0.40298507462686567,1.0,1.0,3/16,12.41%,NLRC5;LDB2;EMP2
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),0.3703157082650371,0.9897451740663882,0.4,0.9986213728208047,1.0,9/64,13.64%,CDKL1;TBC1D12;TBC1D19;STIL;RAB1B;ODAD3;TRAPPC12;TBC1D5;ALMS1
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),0.5447263948851951,0.9897128715588446,0.4838709677419355,0.9978428419842041,1.0,1/10,7.43%,NOL11
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),-0.4952037996279259,-0.9896134312519158,0.5194805194805194,1.0,1.0,4/29,10.56%,ANK3;CLDN16;LETM2;FAM20A
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),0.498337152393516,0.9891810870752564,0.4523809523809524,0.9985731846091748,1.0,4/11,29.99%,FBXO5;SLC30A10;SIRT1;ZKSCAN3
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),-0.48396561911259056,-0.9890514324943211,0.5,1.0,1.0,12/37,22.98%,SKAP1;IFI35;IL15;PLSCR1;HLA-DRA;FADD;PTPRC;SLC15A4;CD74;NMI;RSAD2;HLA-DRB1
prerank,GO_Biological_Process_2021__neuron projection arborization (GO:0140058),-0.6402120969354983,-0.9889379787172323,0.5932203389830508,1.0,1.0,2/6,20.94%,NLGN1;LRP2
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),0.46888609680753296,0.988925320443671,0.43333333333333335,0.9983150283609229,1.0,3/18,9.87%,NAF1;CCT7;CCT3
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),0.4637549835151265,0.9888333843808838,0.4666666666666667,0.9977286110637322,1.0,3/15,8.15%,AGER;JAM2;HMGB1
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),-0.4844117010144603,-0.9884453648098157,0.4782608695652174,1.0,1.0,4/28,10.45%,CLDN16;POF1B;CLDN20;CLDN18
prerank,PanglaoDB_Augmented_2021__Paneth Cells,-0.5285876965115945,-0.9884319703813463,0.5769230769230769,1.0,1.0,8/18,21.02%,IL4R;CEACAM1;ACSL5;FBP1;GUCY2C;RIPK2;WNT3;CDH17
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),-0.48676928972746075,-0.9883511309935847,0.48,1.0,1.0,7/22,16.03%,TLR2;APP;WNT5A;TLR3;SIGIRR;IL7;IL18
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),0.4334525094494295,0.9880205251104012,0.358974358974359,0.9990886324022562,1.0,7/27,13.12%,MSRB1;WASHC5;CATIP;DIAPH3;TTC17;SPIRE2;WASL
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),-0.5195502323478742,-0.9878226972850164,0.5074626865671642,1.0,1.0,4/13,24.27%,SHTN1;DAB2IP;KIF20B;NSMF
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),0.4883269552733686,0.9877516913546194,0.32142857142857145,0.9987549938983248,1.0,4/15,18.86%,ASAH2B;QDPR;DHFR;SPHK2
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),0.3087520070513868,0.9875140046054457,0.42857142857142855,0.9985354523507134,1.0,21/194,9.37%,LEPR;FGF6;VEGFD;EPHA6;DSCAM;AGER;FLT3;VEGFC;BMP2;BCL10;SOX9;P2RY1;EGFR;TESK1;RALB;AKT2;AKT1;AR;ERBB4;SLC4A4;STK4
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),0.3106301894618699,0.9874192011445652,0.3333333333333333,0.9978502264625659,1.0,62/339,16.54%,POU6F2;RNF6;LIMD1;ZNF117;PPARGC1A;CEBPA;SOX21;BMP2;ZNF212;ZNF195;MITF;ATF5;USP13;POFUT1;SLC39A8;HES6;HCLS1;COPS2;APBB3;ZNF680;SOX12;ESRRG;ZNF676;RORB;ZNF502;ZNF74;THAP1;SLC2A4RG;ZNF268;NR3C1;ZNF492;GLI4;RNF14;NFYC;YAF2;HP1BP3;ZNF703;ZNF875;MAGED1;ESRRA;ZNF341;ZNF33A;ZNF280D;PATZ1;TGFBRAP1;APBB2;ZNF736;DVL2;ZNF519;HMG20A;GPBP1L1;SMARCA2;ZNF138;EP300;KAT7;HDAC10;NCOA2;CHD7;BACH1;NR1D2;VHL;ZNHIT3
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase III promoter (GO:0006384),0.617781357774827,0.9871900550144469,0.5641025641025641,0.9978458798389365,1.0,3/5,34.98%,BDP1;POLR3H;CRCP
prerank,GO_Biological_Process_2021__aromatic amino acid family metabolic process (GO:0009072),0.5325944940706989,0.9871888327526845,0.5,0.9969362300566721,1.0,3/7,20.68%,QDPR;KYNU;ASRGL1
prerank,GO_Biological_Process_2021__polyphosphate catabolic process (GO:0006798),0.6468859567229561,0.9871589533383172,0.5121951219512195,0.9961036330834003,1.0,2/5,16.64%,BNIPL;PRUNE1
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),-0.6280709989997078,-0.9871038028280882,0.5833333333333334,1.0,1.0,1/6,1.30%,MX1
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),0.5717185588809576,0.9871033926841545,0.5,0.9952976734023836,1.0,4/9,34.52%,UBXN2B;PARD6A;CEP72;GSK3B
prerank,GO_Biological_Process_2021__regulation of protein K63-linked ubiquitination (GO:1900044),0.5266708651934838,0.9869908520074568,0.42105263157894735,0.9947189013684493,1.0,1/7,12.26%,SASH1
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),-0.45772242651009754,-0.9866088299001864,0.5301204819277109,1.0,1.0,7/47,16.43%,ALDOB;SLC39A14;GAPDHS;APOD;FBP1;PGK1;GPI
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),0.3763156445229439,0.9865787278347906,0.4074074074074074,0.99510580919833,1.0,6/61,3.91%,NGF;ASCL1;BRINP3;MOSMO;BMP2;BEND6
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type peptidase activity (GO:1905247),-0.6024820105564692,-0.9865216698278159,0.5178571428571429,1.0,1.0,1/7,1.07%,EFNA1
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),0.3836577413411878,0.9864453761799291,0.44,0.9944656989225621,1.0,4/24,8.97%,ZPR1;HCLS1;TRIM28;IPO5
prerank,GO_Biological_Process_2021__pyrimidine nucleoside biosynthetic process (GO:0046134),-0.5449768941213301,-0.9863900199308087,0.4696969696969697,1.0,1.0,1/12,2.35%,TYMP
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),-0.4119402281129526,-0.986286137075544,0.5376344086021505,1.0,1.0,20/143,17.82%,APLNR;PGR;POU4F1;SH3GL2;OVOL2;APP;PARP14;LDLR;PARP9;KLF4;SFRP2;WDR54;PTRH2;PINK1;LRPAP1;IGF1;DDRGK1;CCDC3;MSR1;APLN
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),0.3329556012228051,0.9861962112659385,0.625,0.9941143671168485,1.0,16/96,12.21%,CARD18;MEN1;BMP2;GNL3L;TRIB3;PLK1;BAG2;STYX;RALB;CAPRIN2;AKT1;CSNK1E;STK4;TFIP11;MAPK8;DERL1
prerank,GO_Biological_Process_2021__pyridine-containing compound metabolic process (GO:0072524),0.6188732269710827,0.9861122328748997,0.5238095238095238,0.9935013287359302,1.0,1/5,4.72%,AOX1
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),-0.4039378676000208,-0.9860543235866822,0.4782608695652174,1.0,1.0,50/178,19.43%,NPY;SNCB;GRIN2A;CHRNA5;HTR2B;PLP1;CHRM1;GRIA3;RPS6KA1;GRIA1;NRGN;AKAP5;SLC18A2;HAP1;SYT1;CPLX1;SYN2;UTS2;SST;GLRA2;GRIK1;CHRM3;UNC13C;RIT2;GABRB2;GABRD;APBA2;HCRTR2;GAD1;MINK1;PCDHB5;GRIN2B;GAD2;NPTX2;HRH1;NLGN1;GABRE;CDK5;GRM7;GABRG2;HTR1E;GLRA1;CHRM5;HTR2A;CACNB1;GABRA1;SNCG;GRIK2;SLC12A7;KCNMB4
prerank,GO_Biological_Process_2021__regulation of T cell mediated immunity (GO:0002709),0.5916694767069277,0.9860024939188999,0.45,0.9928394892678977,1.0,2/5,8.15%,AGER;HMGB1
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),-0.45695045956762664,-0.9858595619303993,0.44047619047619047,1.0,1.0,5/54,12.52%,ANXA1;PRDX5;CYP1B1;FOS;ROMO1
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),-0.4829827105743668,-0.9855741461778842,0.4805194805194805,1.0,1.0,4/29,10.13%,KCNQ1;DUOX1;IGFBP5;STAT1
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),-0.38797585942251905,-0.9855689024035467,0.4946236559139785,1.0,1.0,42/211,20.11%,SCN1B;EFNA1;CCK;L1CAM;POU4F1;ANK3;SHTN1;S100A6;NEXN;GFRA2;SLITRK1;SEMA3B;APP;EFNB3;DOK1;MAP1B;VLDLR;WNT5A;BAIAP2;NEFH;UNC5B;PRKCQ;DOK6;DRAXIN;SLITRK5;SLIT3;SLITRK4;BDNF;RAP1GAP;CDK5;LRTM1;CNTN2;NOTCH3;ANOS1;SEMA3E;LAMA3;RELN;PIK3CB;PIK3CD;SEMA4G;ROBO4;LAMA1
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),-0.4770609264092,-0.9853853041036934,0.5185185185185185,1.0,1.0,5/30,12.21%,PROX1;SULF1;STAT1;ITGA8;PAX8
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,-0.45937354667698915,-0.9846719214808628,0.45569620253164556,1.0,1.0,11/41,21.22%,IPCEF1;PRDX4;GLRX;JUNB;SBNO2;ATOX1;FES;TXNRD2;NDUFA6;CDKN2D;ABCC1
prerank,GO_Biological_Process_2021__regulation of chemokine (C-C motif) ligand 5 production (GO:0071649),0.6262944715159231,0.9842537780612781,0.5581395348837209,0.99649349747849,1.0,2/5,13.02%,SIRPA;MUL1
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),0.6319251492681265,0.9839120354640685,0.5555555555555556,0.9964281439544015,1.0,1/5,13.68%,MARK2
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),0.5563544860945765,0.9837082415990592,0.5675675675675675,0.9960766238723813,1.0,3/9,21.18%,NDC1;NUP205;NUP153
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),-0.5171606437092798,-0.9834922186072118,0.4927536231884058,1.0,1.0,3/19,9.95%,ANK3;SYT1;RIMS2
prerank,GO_Biological_Process_2021__negative regulation of activin receptor signaling pathway (GO:0032926),0.5778315192597885,0.9834307119349643,0.46875,0.9960242067249686,1.0,4/7,34.58%,MAGI2;LEMD3;FSTL3;ACVR1
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),-0.4086896047044409,-0.9833269113603107,0.5487804878048781,1.0,1.0,21/124,17.15%,FLRT3;CCK;POU4F1;ANK3;SHTN1;S100A6;CNTNAP1;SLITRK1;APP;MAP1B;BAIAP2;NEFH;NYAP1;MINK1;DAB2IP;SLITRK5;SLITRK4;BDNF;NLGN1;DCLK1;CDK5
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),-0.5546292021099509,-0.9832700177902869,0.5555555555555556,1.0,1.0,1/18,0.67%,SP100
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),0.45382239155267,0.9831696229717417,0.6,0.9956612730922311,1.0,8/31,16.80%,SLC6A13;SLC19A1;SLC47A1;ATP1A2;SLC5A6;SLC46A1;GLUL;SLC22A2
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),-0.47138091027285167,-0.9830087117096338,0.4605263157894737,1.0,1.0,6/31,19.68%,CENPH;MIS18A;CENPN;CENPU;CABIN1;CENPP
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.5000487385379688,-0.9829797375919042,0.5142857142857142,1.0,1.0,4/16,17.04%,APP;EGF;TGFA;SNX6
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.4221570598502076,0.9828389699788503,0.4482758620689655,0.9957707015521653,1.0,6/27,8.69%,CSPG5;CHST11;NDNF;CHST7;CSGALNACT1;BCAN
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),-0.5632727968972236,-0.9827638704429507,0.5517241379310345,1.0,1.0,3/10,17.04%,AKAP5;CACNA1C;NOS1
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.5452199855766354,-0.9826532925116159,0.532258064516129,1.0,1.0,2/12,8.67%,NR4A3;WNT5A
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),-0.4661801028482002,-0.9826506443261172,0.5466666666666666,1.0,1.0,4/34,10.05%,ABO;B3GALT2;FUT2;ST3GAL6
prerank,GO_Biological_Process_2021__protein retention in Golgi apparatus (GO:0045053),0.6762468051108558,0.9825314433766386,0.6153846153846154,0.99555748273947,1.0,1/5,21.74%,GOLPH3
prerank,GO_Biological_Process_2021__negative regulation of viral release from host cell (GO:1902187),-0.541572469030295,-0.9822542772268685,0.5128205128205128,1.0,1.0,1/12,3.37%,TRIM5
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.625781203828016,-0.9821213213876048,0.5588235294117647,1.0,1.0,2/7,6.16%,SKAP1;PODXL
prerank,GO_Biological_Process_2021__flavin-containing compound metabolic process (GO:0042726),0.5873258699406836,0.9820947419003173,0.5555555555555556,0.9947855896826542,1.0,1/5,7.25%,FLAD1
prerank,GO_Biological_Process_2021__riboflavin metabolic process (GO:0006771),0.5873258699406836,0.9820947419003173,0.5555555555555556,0.9947855896826542,1.0,1/5,7.25%,FLAD1
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),0.4882540071988851,0.9820301146614228,0.46153846153846156,0.994066759356975,1.0,7/11,30.38%,ATL2;VAPB;STX18;VCPIP1;MOSPD3;BNIP1;STEEP1
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),-0.5423348575436809,-0.9817525267559236,0.5362318840579711,1.0,1.0,9/19,25.92%,STAT4;CCL2;STAT1;THPO;NMI;STAT6;STAT2;GHR;STAT3
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),0.38283075566537633,0.9816811378051699,0.3333333333333333,0.9940288577408758,1.0,3/38,3.51%,DGKB;PLD6;DGKE
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),-0.4337186901839519,-0.9816223843384636,0.4430379746835443,1.0,1.0,2/67,0.78%,ANXA1;BLM
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.5241730482557384,0.9815487866078024,0.45714285714285713,0.9935712756153806,1.0,7/12,35.21%,PLXNA3;SEMA3A;PLXNA2;PLXNB2;PLXNB3;NRP1;PLXNA1
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),0.30290508782333414,0.981480700689579,0.5714285714285714,0.9928308325736416,1.0,20/164,11.43%,LEPR;FGF6;VEGFD;AGER;VEGFC;BMP2;SOX9;P2RY1;EGFR;TESK1;RALB;AKT2;UBE2N;AKT1;ERBB4;STK4;CDK2AP1;CSF1R;PPP2R5A;EFNA5
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.40736610569282944,-0.9814785771961514,0.4777777777777778,1.0,1.0,27/127,21.44%,GBP2;GBP1;ZFP36;ST18;CCL2;YBX3;PSMB6;PSMB9;BRCA1;CHI3L1;STAT1;TNFRSF14;MAP3K14;BIRC3;PSMC3;DAB2IP;LTBR;PSMA8;TNFRSF1A;PSME1;HYAL1;ERBIN;PSMA7;GPER1;SFRP1;GSDME;EIF5A
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated immunity (GO:0002710),-0.6044638995383205,-0.9814458674846172,0.5223880597014925,1.0,1.0,3/7,18.80%,CEACAM1;HLA-F;PTPRC
prerank,GO_Biological_Process_2021__response to manganese ion (GO:0010042),0.5771931004302565,0.9813941535626247,0.5,0.9921903165332756,1.0,2/5,36.65%,PRKN;LRRK2
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),0.40313078896947485,0.9812437759582016,0.4444444444444444,0.9917110164500662,1.0,8/26,23.63%,ABCB10;HSPA1A;HSF1;ERN1;RHBDD1;TM7SF3;DAXX;HSPA13
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.40614868378089986,0.981156953879975,0.4090909090909091,0.9910972729947477,1.0,6/53,6.34%,EPOR;FLT3;PDGFD;SOX9;HCLS1;PDGFC
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),-0.4694627171677157,-0.9811481228322525,0.5287356321839081,1.0,1.0,3/44,1.44%,SP100;BLM;RECQL4
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),-0.5553402826812317,-0.9811209719850394,0.5063291139240507,1.0,1.0,4/13,31.07%,EIF2B2;EIF2B4;EIF2B5;INHA
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.4433132240104357,-0.9810828685483682,0.5064935064935064,1.0,1.0,6/52,10.29%,L1CAM;FAT2;MYOT;NEXN;CEACAM1;IGSF21
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.42430686333664125,-0.9809006823940253,0.5180722891566265,1.0,1.0,12/71,17.75%,P2RY12;CLRN1;EPS8L2;FSCN1;ANLN;CDC42EP1;CDC42EP3;PLPPR5;PLEKHM1;NLGN1;DPYSL3;AGRN
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),-0.5829060021167684,-0.980898986212122,0.4838709677419355,1.0,1.0,1/10,5.55%,ATP23
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle contraction (GO:0045987),-0.6054749162692232,-0.98078346384333,0.589041095890411,1.0,1.0,3/7,20.91%,SRF;SPHK1;GPER1
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),0.36492988717914226,0.9806725805100214,0.3888888888888889,0.9916521699664101,1.0,7/49,13.59%,LEPR;TAB3;AKT1;EIF4E;PIK3CA;QSOX1;DAP
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),-0.43180134387720975,-0.9806659936738653,0.48148148148148145,1.0,1.0,3/53,8.67%,LEF1;WNT8B;WNT5A
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),-0.40141478120052887,-0.9805244975063879,0.5113636363636364,1.0,1.0,22/111,21.09%,GBP2;IL1R1;GBP1;RPS27A;ST18;NOD1;CCL2;PSMB6;PSMB9;TNIP2;UBC;PSMC3;DAB2IP;MYLK3;PSMA8;PSME1;IL1RAP;HYAL1;RIPK2;PSMA7;SFRP1;RBX1
prerank,GO_Biological_Process_2021__pentose-phosphate shunt (GO:0006098),0.49030017459098163,0.9805096130239509,0.4666666666666667,0.9911500958903836,1.0,1/11,3.34%,PGM2
prerank,GO_Biological_Process_2021__regulation of Golgi to plasma membrane protein transport (GO:0042996),0.5576766967348039,0.980502441919322,0.48148148148148145,0.9902808979958548,1.0,2/7,16.43%,ATP2C1;ACSL3
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),0.4933166486387847,0.9804527263580692,0.5416666666666666,0.9895848584903311,1.0,8/21,23.34%,CRPPA;TMTC4;FKRP;POMT2;TMTC3;DPM1;FKTN;TMTC2
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.5160628638598046,-0.9803742923479359,0.6216216216216216,1.0,1.0,6/26,16.19%,CTSC;CAV3;ATP5IF1;PSMC3;DAB2IP;DDRGK1
prerank,PanglaoDB_Augmented_2021__Goblet Cells,0.454733482109454,0.9800253154405117,0.4074074074074074,0.9897839977474807,1.0,4/27,6.75%,ACE2;EHF;CAPN13;SLC26A3
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),0.6259385464648172,0.9796717839944329,0.5227272727272727,0.9898726679242564,1.0,1/5,7.27%,LMO3
prerank,GO_Biological_Process_2021__regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.48970002816577807,0.9796694371360031,0.4358974358974359,0.9889832944580172,1.0,3/14,16.08%,HSPA1A;MUL1;SLC25A5
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),-0.4507825210805894,-0.979183722716562,0.4868421052631579,1.0,1.0,13/37,20.95%,S100A6;WNT5A;FN1;DAB2IP;B4GALT7;IGF1;CDKN1A;SPHK1;AQP1;FTH1;CD74;EMD;SFRP1
prerank,GO_Biological_Process_2021__positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.6123766332328555,-0.9791111817279757,0.49206349206349204,1.0,1.0,3/7,7.01%,CD44;SKAP1;THY1
prerank,GO_Biological_Process_2021__microtubule-based transport (GO:0099111),-0.562723546802235,-0.9789398507745264,0.5217391304347826,1.0,1.0,1/11,6.48%,SPAG17
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),-0.41817521412501657,-0.9786689112694994,0.5227272727272727,1.0,1.0,15/70,21.20%,TYMS;CDKN2A;PLK2;PLK3;CRLF3;CCND1;CCNE2;CDK2;MAX;CDKN3;CDK5;CDKN1A;CDC7;BCAT1;CDKN2D
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.49541235589480004,0.9784738930141036,0.5151515151515151,0.9912219384933613,1.0,3/15,9.87%,NAF1;CCT7;CCT3
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,-0.41121421318088097,-0.9782751001533153,0.475,1.0,1.0,23/96,20.99%,STMN2;NEFL;NEFM;ZDHHC22;SH3GL2;PLP1;LRRTM1;MAP1B;GJC1;SRRM4;GRIA1;GAP43;GDAP1L1;CRMP1;GRID2;DCLK1;SCN3B;CNTN2;TCEAL5;RAB3C;SULT4A1;PNMA2;TCEAL7
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),-0.5233506318328245,-0.9782124135570741,0.47619047619047616,1.0,1.0,8/19,27.67%,HTR2B;ITPR3;HTR2A;PTPRC;RYR2;HTR2C;ITPR1;ERO1A
prerank,GO_Biological_Process_2021__positive regulation of endocytic recycling (GO:2001137),-0.628242056055199,-0.9781256972428091,0.5294117647058824,1.0,1.0,1/7,9.27%,AKAP5
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),0.4938452782609961,0.9780916983080133,0.6,0.9914677016291515,1.0,4/11,15.31%,TTL;AGBL1;GPLD1;ICMT
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),0.48613539836290404,0.9774746131567654,0.41935483870967744,0.9923103683758295,1.0,5/15,13.10%,CEL;NLGN3;NRXN1;NLGN4Y;NCAM2
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),0.4907193356766526,0.9772790107138442,0.475,0.9918482897470383,1.0,3/14,15.70%,NT5C1A;VCP;NUDT15
prerank,GO_Biological_Process_2021__adenosine to inosine editing (GO:0006382),0.6177798097827458,0.977080421548461,0.5,0.9913140244140284,1.0,1/6,2.97%,ADAT2
prerank,"GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",0.6347612227352606,0.9766229422141561,0.5116279069767442,0.9917655129509176,1.0,2/5,24.87%,SEC61A1;SEC61A2
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),0.5157679173720551,0.9763697899314493,0.4666666666666667,0.9915602488000911,1.0,5/11,36.01%,ARHGAP35;MYCBP2;PTEN;SPTBN4;B4GALT6
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),0.3588906997636278,0.9760850027647485,0.4,0.9916344862399601,1.0,18/69,18.94%,POLD3;ERCC8;RFC3;COPS8;COPS2;ERCC6;ERCC2;COPS7A;ERCC3;POLR2C;POLK;GTF2H5;EP300;GTF2H2;AQR;COPS7B;HMGN1;PPIE
prerank,GO_Biological_Process_2021__acylglycerol catabolic process (GO:0046464),-0.5081367081640346,-0.9760414765550618,0.5333333333333333,1.0,1.0,4/20,15.77%,FABP3;LIPI;LIPE;LIPH
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),0.4629278734308444,0.9760217152413204,0.5,0.9909204335926933,1.0,3/16,5.54%,RGCC;BMP2;RUNX1
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),-0.3846686081980493,-0.9758220172458482,0.4838709677419355,1.0,1.0,29/215,16.30%,CXCL2;P2RY6;NR4A3;TLR2;KCNQ1;P2RY12;POU4F1;ZFP36;RAMP3;TESC;PRDX5;WNT8B;IGFBP5;CCL2;WNT5A;PDCD1LG2;GLRA2;PTK6;FOS;PDK3;ROMO1;TNIP2;DAB2IP;GNG2;SBNO2;DMTN;CIB2;CDK2;FES
prerank,GO_Biological_Process_2021__positive regulation of DNA-directed DNA polymerase activity (GO:1900264),0.5492296522591504,0.9753199993088328,0.4838709677419355,0.9908517799386705,1.0,2/8,7.07%,RFC3;POLG2
prerank,GO_Biological_Process_2021__regulation of DNA-directed DNA polymerase activity (GO:1900262),0.5492296522591504,0.9753199993088328,0.4838709677419355,0.9908517799386705,1.0,2/8,7.07%,RFC3;POLG2
prerank,GO_Biological_Process_2021__estrogen metabolic process (GO:0008210),-0.5581126116633092,-0.975242328297647,0.5285714285714286,1.0,1.0,6/12,26.49%,CYP1B1;HSD17B14;CYP3A4;HSD17B7;CYP3A5;CYP2D6
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),0.3754332275176514,0.9750311197399272,0.34615384615384615,0.9907087061264324,1.0,10/48,16.05%,GNL3L;TNFAIP3;HSPA1A;BAG2;AKT1;FBXO5;ADGRB1;PRMT3;MARCHF7;PRR7
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),0.4437381568948765,0.9747954855472839,0.5,0.9905779688710801,1.0,4/16,9.56%,SLC30A4;SLC39A8;SLC30A6;SLC30A9
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),0.3247168061243568,0.9747847120274695,0.38461538461538464,0.9897231611177408,1.0,16/186,9.36%,SPSB4;NR1D1;FBXO45;ERCC8;PSMD10;FEM1C;KBTBD7;SPSB2;SOCS6;PSMA1;PSMD11;PSMB5;VCP;BTRC;GID8;UBE2G1
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),-0.3865387132262812,-0.9747662086213228,0.4943820224719101,1.0,1.0,43/161,23.90%,RPL3;RPL19;RPS27;RPS14;RPL27A;RPL7A;RPL35;NOB1;EMG1;RPL37A;RPL21;RPL27;RPL13A;RPL9;RPS16;RPL24;RPLP1;RPL10A;RPL10;RPLP2;RPL38;RPS7;RPL8;RPS15;RPL5;RPL12;RPL18A;RPS9;MRTO4;PES1;RPL23;RPS6;RPS25;DDX54;RPL7;RPL4;WDR46;RPL41;RPL11;EXOSC7;RPL15;RPL36;RPL29
prerank,GO_Biological_Process_2021__negative regulation of nervous system process (GO:0031645),0.59787773400096,0.9747001867118753,0.5555555555555556,0.9890387230731902,1.0,2/5,12.20%,JAM2;EIF2AK3
prerank,GO_Biological_Process_2021__response to acidic pH (GO:0010447),-0.6024147245345409,-0.9746755336442218,0.47540983606557374,1.0,1.0,2/9,12.79%,RAB11FIP5;CTSS
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),0.3985043200515326,0.9745375638537468,0.4444444444444444,0.9886567555882628,1.0,4/48,6.78%,GRPEL2;GDAP1;SAMM50;MFF
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),-0.5006788748421338,-0.9743526208392345,0.45588235294117646,1.0,1.0,3/20,15.34%,SP100;APOD;DMTN
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.5222682708205405,-0.9743452229172969,0.4925373134328358,1.0,1.0,5/19,25.65%,HAP1;IGF1;RTN1;RTN2;RTN4
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),-0.46097465595493314,-0.9733280622107575,0.49333333333333335,1.0,1.0,16/47,21.04%,P2RY12;RCAN2;ACKR4;HTR2B;CHRM3;GUCY1A1;LAT2;NUDT4;HRH1;NOS1;CCR10;SPHK1;PLCE1;RYR2;RCAN3;PPP1R9A
prerank,GO_Biological_Process_2021__sodium-independent organic anion transport (GO:0043252),-0.5774785378376031,-0.9727755495378194,0.546875,1.0,1.0,3/8,22.62%,SLCO3A1;SLCO1A2;SLCO2A1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),-0.6282767431806737,-0.9725597889884745,0.5972222222222222,1.0,1.0,1/5,14.53%,PINK1
prerank,GO_Biological_Process_2021__cilium-dependent cell motility (GO:0060285),-0.5139621384786787,-0.9724397417795282,0.5671641791044776,1.0,1.0,5/20,17.37%,TEKT2;CCDC39;DRC1;DNAH3;DNAH2
prerank,GO_Biological_Process_2021__regulation of dopamine receptor signaling pathway (GO:0060159),0.5827503335077695,0.9722053308293414,0.5675675675675675,0.9934163988317998,1.0,1/6,11.06%,DRD2
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),-0.6030594191876735,-0.9719436868422636,0.5714285714285714,1.0,1.0,1/6,1.07%,EFNA1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),-0.5262564927592595,-0.9719359802369409,0.56,1.0,1.0,1/13,1.48%,NR4A3
prerank,GO_Biological_Process_2021__embryonic digestive tract morphogenesis (GO:0048557),0.5941618115122962,0.9718534426409314,0.5952380952380952,0.9934281936531225,1.0,3/5,17.38%,NIPBL;RBPMS2;ID2
prerank,GO_Biological_Process_2021__negative regulation of purine nucleotide metabolic process (GO:1900543),0.5344507523825939,0.9713358632920456,0.525,0.9929714096098999,1.0,2/8,5.79%,CBFA2T3;GIT1
prerank,GO_Biological_Process_2021__negative regulation of glycolytic process (GO:0045820),0.5344507523825939,0.9713358632920456,0.525,0.9929714096098999,1.0,2/8,5.79%,CBFA2T3;GIT1
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),0.5786072358151002,0.9712336716977038,0.525,0.9923237200892137,1.0,1/6,6.36%,ALCAM
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.5270775302452761,-0.9709572758063882,0.4507042253521127,1.0,1.0,1/15,1.48%,NR4A3
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.4202290798936555,-0.9708579785186988,0.5125,1.0,1.0,14/103,16.97%,ERCC6L;WDR62;RPS27;PLK2;CENPH;CENPE;ZWILCH;CCNB1;NUF2;CENPN;SPC24;CENPU;KIF2C;STMN1
prerank,GO_Biological_Process_2021__protein localization to basolateral plasma membrane (GO:1903361),0.5566762275225701,0.9708245692471253,0.5365853658536586,0.992444315649143,1.0,1/6,11.00%,LIN7C
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),-0.5401117711389334,-0.9705378123942403,0.5606060606060606,1.0,1.0,4/16,25.36%,CTSC;ATP5IF1;RDX;PTTG1IP
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,-0.3911947551763541,-0.9703616959136943,0.5301204819277109,1.0,1.0,34/155,18.26%,FLRT3;TAGLN3;STMN2;NEFL;NEFM;SNCB;ELAVL2;ZDHHC22;SH3GL2;ATRNL1;SLITRK1;SYT4;EFNB3;MAP1B;GAP43;EDIL3;SYT1;ZNF536;PLPPR5;TMEM163;INSYN2A;STMN4;SLITRK5;GDAP1L1;CIB2;CRMP1;GRID2;ACHE;NLGN1;CNR1;DCLK1;CNTN2;KCNC1;KCNH7
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),0.5233455318554044,0.9702849884680923,0.5142857142857142,0.9921464212213633,1.0,3/12,16.60%,MCU;TIRAP;MDK
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),0.5233455318554044,0.9702849884680923,0.5142857142857142,0.9921464212213633,1.0,3/12,16.60%,MCU;TIRAP;MDK
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),-0.46732275076599794,-0.9698013117258858,0.5443037974683544,1.0,1.0,5/31,7.01%,ANK3;CD44;SKAP1;PODXL;THY1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 production (GO:0032692),0.47184968630338026,0.9696942255688963,0.47058823529411764,0.9929961110285325,1.0,3/14,5.79%,CARD18;TNFAIP3;GIT1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),0.30820915162617396,0.9696904270999572,0.6666666666666666,0.992124297059236,1.0,24/143,13.25%,BRINP3;INTS13;PSMD10;PSMA1;ANGEL2;PSMD11;PLK1;CUL1;TTL;PSMB5;ANAPC1;GAS1;BTRC;THAP1;ZNF268;FBXO5;ERCC2;HSF1;PSMD14;UBE2D1;EIF4E;ERCC3;PSMD12;BRINP2
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",-0.4869040562386906,-0.9695815054237928,0.515625,1.0,1.0,8/16,25.97%,GRIK1;UNC13C;GRID2;GRIK2;SLC17A7;CDH8;GRIK4;NAPA
prerank,GO_Biological_Process_2021__steroid catabolic process (GO:0006706),-0.5840876992242042,-0.9690767644807136,0.5423728813559322,1.0,1.0,4/8,20.60%,YWHAH;HSD17B14;CYP3A4;SPP1
prerank,GO_Biological_Process_2021__glycosylceramide catabolic process (GO:0046477),0.6071030769279534,0.9685830523074304,0.5384615384615384,0.9941659204518881,1.0,2/5,33.34%,GALC;GBA2
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),-0.39367543209417105,-0.9685462892139367,0.532608695652174,1.0,1.0,25/175,18.88%,IFI6;MX1;DHCR24;TGFBR2;TLR2;IRF1;HK2;APP;PLSCR1;GADD45A;PLK3;SEPTIN4;CSRNP1;BCL2L14;SCN2A;IFIT2;ELMO1;FADD;DLC1;CDK5;TCHP;IER3;PRKCD;TSC2;BOK
prerank,GO_Biological_Process_2021__purine-containing compound salvage (GO:0043101),-0.5575226771078008,-0.9685055217538885,0.5614035087719298,1.0,1.0,1/11,3.08%,GMPR
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),0.3610067811435407,0.9683052812035029,0.5555555555555556,0.9942484965376641,1.0,10/57,10.43%,POU6F2;REEP6;RDH10;TYR;CRYGS;EYS;OAT;CRYBB2;ZIC2;ATF6
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),-0.4716349484190465,-0.9681551038944672,0.5512820512820513,1.0,1.0,3/30,7.78%,FLRT3;SH3GL2;MAP1B
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),-0.5032310362772637,-0.9680990429230528,0.5454545454545454,1.0,1.0,2/21,5.71%,CLRN1;FSCN1
prerank,GO_Biological_Process_2021__regulation of mast cell degranulation (GO:0043304),-0.5492479129941721,-0.9679489207570462,0.58,1.0,1.0,4/8,28.26%,SYK;FES;GAB2;ADGRE2
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.5020168940384052,-0.9679130786559329,0.5571428571428572,1.0,1.0,9/25,25.29%,SOCS3;CYP1B1;EGF;CRLF3;PTPRC;OCIAD2;HES1;GHR;SH2B3
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),-0.4745594240475095,-0.9674562589075707,0.4819277108433735,1.0,1.0,6/33,14.63%,EPN1;SH3GL2;EGF;DAB2IP;MVP;TGFA
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),-0.5838707441763022,-0.967416635731934,0.4915254237288136,1.0,1.0,3/7,35.67%,PTPRO;PTPRB;DUSP10
prerank,GO_Biological_Process_2021__histidine catabolic process (GO:0006548),0.5863043223165416,0.9672718527595865,0.4888888888888889,0.9953416278404054,1.0,1/5,2.37%,CARNMT1
prerank,GO_Biological_Process_2021__histidine metabolic process (GO:0006547),0.5863043223165416,0.9672718527595865,0.4888888888888889,0.9953416278404054,1.0,1/5,2.37%,CARNMT1
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),-0.372841037817278,-0.9671893720793003,0.5353535353535354,1.0,1.0,67/320,24.05%,RPL3;RPL19;RPS27A;TESC;RPS27;RPS14;RPS4X;RPL27A;RPL7A;RPL35;SCX;WARS1;ELAVL4;RPL37A;RPL21;POLR2I;RPL27;RPL13A;RPL9;RPS13;RPS16;PAX8;RPL24;RPS3A;RPLP1;RPL10A;RPS18;RPL10;RPS11;RPS8;RPLP2;THOC6;RPL38;RPS7;RPL8;RPS15;RPL5;MRPL23;RPS21;RPL12;DHX38;RPS23;RPL18A;RPS9;GLE1;COPS5;RBM3;RPL23;RPS6;RPS25;TSPAN32;EEF1A2;DDX54;EIF4A3;NXF5;RPL7;RPL4;ANGPT2;RPL41;RBMS1;RPS20;RPL11;RPL15;HSPD1;RPL36;RPL29;POLR2J
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.5582931705050336,-0.967020969709108,0.5466666666666666,1.0,1.0,1/9,7.98%,VLDLR
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.5582931705050336,-0.967020969709108,0.5466666666666666,1.0,1.0,1/9,7.98%,VLDLR
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),-0.5667580818496767,-0.9670134411761359,0.5555555555555556,1.0,1.0,1/9,3.47%,IFIT1
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),0.41042997690585703,0.9669743251916669,0.6086956521739131,0.9953278210948195,1.0,6/28,17.22%,FLT3;RABL3;MSH2;SLC25A5;CEBPG;DCAF1
prerank,GO_Biological_Process_2021__regulation of glutamate receptor signaling pathway (GO:1900449),-0.6291088994913053,-0.966968005577814,0.5735294117647058,1.0,1.0,5/6,34.25%,CX3CL1;NECAB2;FRRS1L;FYN;SHANK3
prerank,GO_Biological_Process_2021__regulation of translational termination (GO:0006449),-0.6187634494673461,-0.9669336201401036,0.5901639344262295,1.0,1.0,2/8,17.40%,OGFOD1;GLE1
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.5838344805027136,-0.9668990014996122,0.546875,1.0,1.0,1/9,2.30%,ABCA5
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),0.42220120503154873,0.9668924572027887,0.5416666666666666,0.9945892404385964,1.0,9/38,17.54%,UQCRHL;SDHAF4;PPARGC1A;COX10;LYRM7;ETFDH;MTFR1;UQCRC2;NDUFS1
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,-0.4828833975173133,-0.9666970632328538,0.547945205479452,1.0,1.0,10/33,18.89%,L1CAM;THY1;VLDLR;MYH9;GLI1;CRMP1;ACHE;RTN1;PML;DPYSL2
prerank,GO_Biological_Process_2021__extracellular transport (GO:0006858),-0.5712367930744082,-0.9664148848401096,0.5384615384615384,1.0,1.0,1/10,6.48%,SPAG17
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),-0.42802884407224934,-0.9662753474338325,0.5,1.0,1.0,3/48,8.02%,TLCD2;FABP3;ANGPTL3
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.6612117367234391,-0.9662239475313058,0.5901639344262295,1.0,1.0,1/6,9.78%,KLF4
prerank,GO_Biological_Process_2021__negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.6612117367234391,-0.9662239475313058,0.5901639344262295,1.0,1.0,1/6,9.78%,KLF4
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.4364911658573767,-0.9660465425182093,0.4533333333333333,1.0,1.0,8/52,14.22%,TLR2;RPS27A;PRDX4;TLR3;MAP3K14;UBC;BIRC3;DAB2IP
prerank,GO_Biological_Process_2021__endothelial cell chemotaxis (GO:0035767),0.5834988161088454,0.9657059790170855,0.5238095238095238,0.9967486110266969,1.0,1/6,4.26%,CXCL13
prerank,GO_Biological_Process_2021__regulation of hemoglobin biosynthetic process (GO:0046984),0.5318519559141918,0.9653603153417654,0.5405405405405406,0.9967929198122318,1.0,2/7,6.59%,ABCB10;SLC25A37
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.3546179039066046,0.9653029869386336,0.5217391304347826,0.9960905456799968,1.0,10/77,14.37%,WNT7A;PSMD10;PSMA1;PSMD11;PSMB5;AP2B1;PSMD14;PSMD12;DVL2;MAGI2
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),-0.4619069196697094,-0.9647578521029982,0.5625,1.0,1.0,6/32,16.98%,MET;FBP1;DAB2IP;ITGA3;STMN1;DLC1
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),0.49196920520567905,0.9646186035753885,0.52,0.9972602042597296,1.0,1/13,2.62%,ABCA1
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.5262766522614648,0.9645412878908154,0.5,0.9965704755877082,1.0,2/13,5.54%,OCLN;RUNX1
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.3195806584791669,0.9645395308255952,0.7142857142857143,0.9957046454612202,1.0,48/231,23.57%,U2AF1;SNRPF;SF3B4;SF3A1;NUDT21;GTF2F2;HNRNPC;WDR33;NOVA1;CWC27;SMNDC1;CSTF3;RAVER2;LSM8;RBM41;PAPOLA;TFIP11;SNRPB2;SPEN;CPSF7;RBM17;LSM7;POLR2C;SRSF8;LSM5;SYNCRIP;HNRNPU;SNRNP27;AQR;SNRPN;DHX15;ZMAT2;PSPC1;PPIE;CPSF2;PPWD1;CRNKL1;RAVER1;RBM15;USP49;PDCD7;RBMX;SUGP1;PLRG1;SART3;HNRNPD;PPIH;RBM19
prerank,GO_Biological_Process_2021__ureteric bud morphogenesis (GO:0060675),0.5501963578069868,0.9645199299385198,0.5555555555555556,0.9948993671901126,1.0,2/6,9.00%,BMP2;SALL1
prerank,GO_Biological_Process_2021__lysosomal lumen acidification (GO:0007042),-0.5999180244635968,-0.9644812062797143,0.5714285714285714,1.0,1.0,1/6,23.26%,CLN3
prerank,PanglaoDB_Augmented_2021__Podocytes,-0.39884424972939864,-0.9642290409850363,0.6111111111111112,1.0,1.0,33/163,22.14%,COL4A1;ANGPTL2;COL4A2;MET;CALD1;LAMB1;COL4A4;SULF1;PODXL;THSD4;ARHGEF17;SCARA3;MYO1E;NUAK1;DAB2IP;RHBDF1;ITGA3;AMOTL2;RHPN1;SEMA3E;PTH1R;TNS2;LAMA3;COL12A1;PLCE1;TDRD5;CRB2;ANTXR1;PTPRO;PTPN21;CDKN1C;PTPRF;MAPT
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),0.5046774834214187,0.9642200474636183,0.5333333333333333,0.9948860517900258,1.0,8/14,37.02%,SEC31B;SEC24A;SEC23B;MIA3;SEC31A;SEC24B;RAB1A;SCAP
prerank,GO_Biological_Process_2021__antibacterial humoral response (GO:0019731),-0.5818241421842738,-0.9641874363129039,0.5714285714285714,1.0,1.0,3/9,12.99%,HLA-A;SFTPD;HLA-E
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.422044433902789,-0.9641536012492189,0.6,1.0,1.0,16/82,22.36%,THBS1;TGFBR2;RPS27A;ASPN;ADAMTSL2;LTBP4;EID2;UBC;ITGA3;SNX6;LDLRAD4;TGFB1;VASN;CDKN1C;VEPH1;PMEPA1
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),-0.43179748129001394,-0.9633521789675972,0.527027027027027,1.0,1.0,5/46,12.95%,UGT8;FUT2;B4GALNT1;ST3GAL6;B3GNT5
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.49728255161589274,-0.9627800251813312,0.5974025974025974,1.0,1.0,3/27,11.58%,BLM;BRCA1;DONSON
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),0.4060957051338275,0.9627232761073187,0.4666666666666667,0.9980912296680364,1.0,6/24,9.17%,SOX8;SOX9;NCOA4;AKR1C3;AR;MSH2
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),-0.3876144573716503,-0.9626185241227923,0.6145833333333334,1.0,1.0,46/238,22.26%,THBS1;CCNB2;CDKN2A;DHCR24;DUSP1;POU4F1;IRF1;PROX1;IL12A;CCNB1;PIM3;BRCA1;GADD45A;PTK6;TSPYL2;CRLF3;CCND1;JUNB;GADD45B;BIRC3;DAB2IP;FOXM1;TFAP4;BAP1;GMNC;NR4A1;CDKN3;CDK5;PES1;SRA1;CDKN1A;TSC2;PML;RPL23;PTPRC;RASSF1;TGFB1;NUDT6;DAPK3;FBXL22;GPER1;SFRP1;CDKN2D;GADD45GIP1;KIF20B;NUPR1
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),-0.3982643236447855,-0.9624601449099659,0.5411764705882353,1.0,1.0,23/103,21.22%,AMN;SLC6A15;SLC25A45;RAMP3;PDPN;SLC38A4;SLC18A2;SLC3A1;SLC7A14;SLC7A2;SLC38A1;SLC22A4;SLC43A2;MYH9;ARRDC2;SLC35F3;SLC11A1;SLC15A4;AQP1;SLC29A4;SLC25A29;LRP2;ABCC1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",0.3443796202072845,0.9624410942378019,0.4,0.9978867088319824,1.0,34/147,16.79%,NR1D1;TFB2M;PPARGC1A;NR2E1;TFB1M;RARB;KAT2B;MAML3;BRF2;ESRRG;RORB;GTF2F2;UBTF;AR;NR3C1;NRBF2;ERCC2;NOTCH2;POLR1F;GTF2A2;ESRRA;ERCC3;POLR2C;TAF12;TAF4;TAF2;GTF2H5;TAF8;RRN3;HDAC10;NR2F1;NR1D2;NR3C2;GTF2H2
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),0.29737481322200265,0.9619038910419281,0.6363636363636364,0.9984945939702148,1.0,8/189,5.46%,CPA1;CPO;LVRN;NCSTN;ADAMTS9;KLKB1;ADAMTS3;CAPN13
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),-0.4464904302488474,-0.9617381267116211,0.4935064935064935,1.0,1.0,12/43,18.20%,THBS1;TGFBR2;AKR1C1;CYP1B1;BRCA1;GADD45A;PDK3;ROMO1;PINK1;FOXM1;NOXA1;CDKN1A
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.4289604749555015,-0.9616550401757331,0.5454545454545454,1.0,1.0,3/64,5.11%,THBS1;SKOR1;SULF1
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),-0.5038704885336853,-0.9616077559095485,0.6049382716049383,1.0,1.0,5/23,16.03%,WNT5A;FGF1;PINK1;IGF1;IL18
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),-0.4972814843454947,-0.9614899756582996,0.5875,1.0,1.0,5/22,18.00%,RPS27A;RPA3;UBC;RPA1;POLD1
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),0.3831145089429556,0.9613615841006807,0.375,0.9991837392101988,1.0,3/37,3.51%,DGKB;PLD6;DGKE
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),0.3668999427234076,0.9613478488363996,0.36666666666666664,0.9984031260571702,1.0,8/40,21.25%,GRPEL2;AKT2;PEX2;TIMM23;PEX12;PEX6;CHCHD4;SEC61A1
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),0.5553691099091054,0.9612931124313987,0.5714285714285714,0.9968224808270272,1.0,3/6,29.66%,IWS1;NSUN2;SETD2
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),0.5553691099091054,0.9612931124313987,0.5714285714285714,0.9968224808270272,1.0,3/6,29.66%,IWS1;NSUN2;SETD2
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),-0.5269934880700171,-0.9608023357540945,0.5833333333333334,1.0,1.0,4/13,23.09%,B4GALNT1;B3GALT4;ST6GALNAC3;ST8SIA3
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),-0.4497380421704185,-0.9607417507090071,0.5797101449275363,1.0,1.0,5/32,19.68%,CENPH;MIS18A;CENPN;CENPU;CENPP
prerank,GO_Biological_Process_2021__negative regulation of chromosome organization (GO:2001251),0.5506906168771544,0.9606756986082884,0.4482758620689655,0.997627873858978,1.0,3/7,24.03%,WAPL;ESPL1;ERCC4
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.5215992876037212,-0.9606398617383378,0.5,1.0,1.0,1/18,1.07%,EFNA1
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),-0.5074939805557543,-0.9605270678412052,0.5875,1.0,1.0,9/27,21.22%,ICAM1;RAMP3;GRIN2A;APP;IGF1;SNX6;CDK5;CACNB1;ABCC1
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),0.42908791020083664,0.9604109840567204,0.5357142857142857,0.9974484000388614,1.0,3/17,7.04%,ABCD2;PLIN5;ABCD1
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,-0.41203809491687704,-0.9603923896987743,0.5824175824175825,1.0,1.0,24/92,26.95%,COL4A1;COL4A2;LAMB1;WNT5A;SCARA3;CCND1;NUAK1;FN1;DAB2IP;RHBDF1;AMOTL2;LARP6;COL12A1;ANTXR1;PTPN21;PTPRF;ABCG2;WWTR1;CD276;LAPTM4B;SH3D19;SLIT2;SMARCA1;MYO1B
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),0.38294836465662857,0.9603220406245946,0.4583333333333333,0.9968130114688809,1.0,4/25,8.97%,ZPR1;HCLS1;TRIM28;IPO5
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,-0.396435698162528,-0.9602193482547048,0.5568181818181818,1.0,1.0,29/146,18.12%,RIMBP2;TAGLN3;CCK;STMN2;NEFM;MFSD6;GFRA2;ATRNL1;SYT4;LRRTM1;CASZ1;ELAVL4;MAP1B;GAP43;ZNF536;SLC7A14;CA10;CPLX2;JPH3;STMN4;VIP;GDAP1L1;CRMP1;DCLK1;RGS7BP;CNTN2;KCNC1;DMKN;TCEAL5
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),-0.4631679172025254,-0.9598173741191559,0.5217391304347826,1.0,1.0,2/32,6.49%,TRAM1L1;APP
prerank,GO_Biological_Process_2021__late endosome to Golgi transport (GO:0034499),0.5919954924697549,0.9596051038029438,0.5833333333333334,0.997931912496404,1.0,3/5,33.70%,SNX3;RAB7B;SNX12
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),0.37505074257862886,0.9595899237570833,0.5333333333333333,0.9971570642522037,1.0,13/45,16.87%,MSRB1;WASHC5;CATIP;VILL;DIAPH3;TTC17;SPIRE2;TWF1;MICAL2;WASL;MICAL1;ABI1;ABI2
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.5670932360750177,-0.9594933141209522,0.5454545454545454,1.0,1.0,1/11,9.17%,ANAPC11
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.5670932360750177,-0.9594933141209522,0.5454545454545454,1.0,1.0,1/11,9.17%,ANAPC11
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),-0.5670932360750177,-0.9594933141209522,0.5454545454545454,1.0,1.0,1/11,9.17%,ANAPC11
prerank,GO_Biological_Process_2021__cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.5882809124353303,0.959430654950286,0.5652173913043478,0.9966169038339632,1.0,2/5,13.85%,AKT1;TICAM1
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),-0.45457987549028045,-0.9593459549930182,0.6,1.0,1.0,9/40,20.95%,BLM;ADCY7;BRCA1;GLRA2;GNG2;ADCY5;GLRA1;ADCY8;SFRP1
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),0.4096755359951102,0.9593419056522601,0.5,0.9959610897452396,1.0,7/18,30.65%,EIF3M;DENR;EIF2S3;EIF2D;EIF2B3;EIF5;EIF4A2
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),-0.4880022109453359,-0.9593222806942386,0.5375,1.0,1.0,2/26,5.70%,NPY;CCDC39
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),0.4775068892034627,0.9586301688215169,0.5,0.9968788730119066,1.0,1/12,0.74%,NGF
prerank,GO_Biological_Process_2021__DNA catabolic process (GO:0006308),0.5513582474998157,0.9585437425419818,0.5806451612903226,0.99614249087442,1.0,4/9,22.78%,DNASE1L2;DFFB;FBH1;DNASE1L1
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.30427735625901814,0.9585127427513587,0.6,0.9953375992255666,1.0,39/291,14.21%,SPSB4;FBXO48;FBXO45;ERCC8;PSMD10;FEM1C;KBTBD7;SPSB2;DERL2;PSMA1;PSMD11;PLK1;CUL1;FBXL14;DMAC2;TMUB2;PSMB5;ANAPC1;RNF103-CHMP3;AUP1;VCP;BTRC;ECPAS;GID8;FBXL3;FBXO5;UBE2G1;FBXO9;STT3B;PSMD14;UBE2D1;FBXO38;FEM1B;DERL1;PSMD12;CUL2;TMEM129;ERLIN1;KCTD17
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),-0.5637079997360106,-0.9581121870220692,0.5652173913043478,1.0,1.0,4/11,19.63%,IFIT1;COLEC12;IFIH1;FLOT1
prerank,GO_Biological_Process_2021__parallel actin filament bundle assembly (GO:0030046),-0.6693932595810015,-0.958065514579027,0.5892857142857143,1.0,1.0,1/5,5.71%,FSCN1
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),-0.5189068261302185,-0.9578889429748465,0.5277777777777778,1.0,1.0,5/21,23.46%,YBX3;BIRC3;CDC37;FLOT1;CASP8
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),-0.5033980363507674,-0.9578529460067942,0.5833333333333334,1.0,1.0,1/24,2.44%,STMN2
prerank,GO_Biological_Process_2021__regulation of DNA-templated transcription in response to stress (GO:0043620),-0.5857319494183628,-0.9575661392719365,0.5625,1.0,1.0,1/7,7.55%,RPS6KA1
prerank,GO_Biological_Process_2021__polyamine biosynthetic process (GO:0006596),0.5692778776373447,0.957529597021804,0.5,0.9966950521139439,1.0,5/6,33.84%,SAT1;SMOX;SRM;SMS;AMD1
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),-0.5120641948776018,-0.9568256659815183,0.5538461538461539,1.0,1.0,4/16,14.05%,PKD2L2;CAV3;PIEZO2;LHFPL5
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),0.4980420949513699,0.9564211396256662,0.43333333333333335,0.9989440202602209,1.0,2/13,5.54%,LEPR;RUNX1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.5788576494152096,-0.9562671117624011,0.5774647887323944,1.0,1.0,4/10,23.63%,CD44;TAF9B;CD74;ZNF385A
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.5788576494152096,-0.9562671117624011,0.5774647887323944,1.0,1.0,4/10,23.63%,CD44;TAF9B;CD74;ZNF385A
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),-0.5572583413673757,-0.9560336326504364,0.6,1.0,1.0,3/11,16.53%,PLAAT4;SFRP4;PRKCH
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),-0.47435588490307373,-0.9559334384378001,0.5571428571428572,1.0,1.0,2/30,4.43%,IFI6;HK2
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),0.30387209050750075,0.9554942552350312,0.5454545454545454,1.0,1.0,39/197,19.97%,TTC29;FHDC1;MACIR;SPAG16;CEP19;BBS9;CATIP;SSX2IP;RAB23;CEP20;EXOC8;TEKT5;EXOC6;DZIP1;CEP290;TTC17;INTU;RAB8B;CNGA4;FOXJ1;PARVA;PCM1;PTPN23;TTC8;IQCB1;SCLT1;NEK1;UNC119B;RAB3IP;TCTN3;EXOC5;UBXN10;SNAP29;TMEM237;RAB8A;MKKS;SEPTIN6;BBS2;EXOC7
prerank,GO_Biological_Process_2021__regulation of carbohydrate biosynthetic process (GO:0043255),-0.5610408887731515,-0.9554805383269365,0.5245901639344263,1.0,1.0,1/9,13.19%,FBP1
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.5916600744110805,-0.9552554262257303,0.5714285714285714,1.0,1.0,1/8,9.21%,APOD
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),-0.5568007174866999,-0.9552508512176086,0.532258064516129,1.0,1.0,1/10,3.92%,ITPKC
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),-0.5170855747645922,-0.9550434343255069,0.5753424657534246,1.0,1.0,5/16,22.98%,HLA-DRA;DDX60;PTPRC;MYO18A;HLA-DRB1
prerank,GO_Biological_Process_2021__regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.5562148023460275,0.954990319089979,0.5135135135135135,1.0,1.0,2/8,2.60%,MYORG;BMP2
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.5345807560599836,-0.9546312997622722,0.5555555555555556,1.0,1.0,6/13,23.83%,CYP1B1;CRLF3;MGAT5;OCIAD2;HES1;GHR
prerank,GO_Biological_Process_2021__resolution of meiotic recombination intermediates (GO:0000712),0.5319815771475305,0.9545448734825859,0.45714285714285713,1.0,1.0,1/12,0.52%,MSH4
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),0.37170599505288554,0.9539472779127453,0.5,1.0,1.0,12/59,23.28%,H2BC18;H2BC21;SOX9;ANP32B;H1-2;ASF1A;PADI4;H2BC5;KAT6B;ACTR6;DAXX;SART3
prerank,GO_Biological_Process_2021__regulation of cyclase activity (GO:0031279),0.5708802186729761,0.9535798561176418,0.6,1.0,1.0,1/5,11.44%,MAPK8
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),-0.49578040767322074,-0.9534751517570927,0.5072463768115942,1.0,1.0,3/20,9.23%,THBS1;APP;EGF
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.42738267939751734,0.9529557955316765,0.42424242424242425,1.0,1.0,2/14,4.53%,NR1D1;TNFAIP3
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),-0.5292042923318718,-0.9529050030995327,0.5652173913043478,1.0,1.0,4/15,26.94%,OGFOD1;GLE1;CLN3;HDAC6
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),0.3587646767557054,0.9525276806123895,0.41379310344827586,1.0,1.0,10/56,12.50%,ERCC8;LIG4;SMARCAL1;BRCC3;UBE2N;ERCC6;HMGB1;PSMD14;DCLRE1B;CYREN
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),-0.42973903421115367,-0.9523406843979915,0.5287356321839081,1.0,1.0,10/63,14.03%,CDH22;PKP2;CDH6;TJP3;FSCN1;GJC1;CDH12;CDH9;CDH7;CDH19
prerank,GO_Biological_Process_2021__monoacylglycerol catabolic process (GO:0052651),0.5755241618577256,0.9522544053479619,0.5681818181818182,1.0,1.0,4/5,29.67%,MGLL;ABHD6;ABHD12B;ABHD12
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),-0.4293788193536436,-0.952169362401323,0.5844155844155844,1.0,1.0,10/72,15.00%,GRIN2D;GRIN2A;SLC8A3;SLC24A2;TRPC3;MCUB;SLC24A1;SLC24A5;CACNA1C;GRIN2B
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",0.4658072687728897,0.9519583939529713,0.52,1.0,1.0,3/14,19.94%,ATR;POT1;TPP1
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),0.5917617145056167,0.9519445665978644,0.6176470588235294,1.0,1.0,4/6,38.51%,TENT4B;TUT4;LIN28B;DIS3L2
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),0.4625439359759897,0.9518123761027346,0.5862068965517241,1.0,1.0,5/30,14.90%,PEX11A;EPS8;HP1BP3;RAB22A;PICALM
prerank,GO_Biological_Process_2021__positive regulation of peptidase activity (GO:0010952),0.42347690848164066,0.9517287973018412,0.47368421052631576,1.0,1.0,5/17,18.96%,NCSTN;VCP;MAPK12;RCN3;CLDN4
prerank,GO_Biological_Process_2021__regulation of MHC class II biosynthetic process (GO:0045346),-0.6271347103695177,-0.9512804851591282,0.6206896551724138,1.0,1.0,1/7,2.24%,CIITA
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.43465204257797246,0.9512064800158093,0.5625,1.0,1.0,6/18,18.24%,SRI;ATP1A2;CASQ1;ANK2;DMD;GSTM2
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.49471635482136334,0.9511472996026807,0.5,1.0,1.0,1/11,0.09%,MEOX2
prerank,GO_Biological_Process_2021__regulation of biosynthetic process (GO:0009889),0.5338043102404879,0.9510536210035239,0.5,1.0,1.0,3/7,19.38%,MID1IP1;SPHK2;PIKFYVE
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),0.47894399921402186,0.951052263358037,0.53125,0.9995874743586802,1.0,2/18,2.97%,ACE2;ADRA1A
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),0.4805019750999645,0.9505030796092884,0.5,1.0,1.0,5/12,16.60%,GUCA1B;PPEF1;NMT2;METAP1;CAMKMT
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),-0.5128876654184087,-0.9502805200565789,0.6027397260273972,1.0,1.0,6/14,23.74%,ADCY7;GUCY1A1;ADCY5;GUCY2C;ADCY8;ADCY3
prerank,GO_Biological_Process_2021__Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.5709694760546796,-0.9501583771801407,0.6212121212121212,1.0,1.0,3/7,28.15%,WNT5A;WNT3;WNT9B
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),0.5458895776100517,0.9496819028180977,0.5428571428571428,1.0,1.0,2/6,22.07%,OTUB2;TRIP12
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.47856771569683754,-0.9495760978971236,0.5194805194805194,1.0,1.0,10/29,16.89%,CDH22;CDH6;CDH23;CDH12;CDH9;CDH7;CDH19;PCDHB5;NLGN1;SELP
prerank,GO_Biological_Process_2021__regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),-0.6336175992276047,-0.949493913550192,0.6206896551724138,1.0,1.0,1/6,7.69%,ELAVL4
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),0.3500768556204342,0.9494774080990398,0.43478260869565216,1.0,1.0,4/46,8.15%,SLC6A13;EFNB2;EIF2S1;AKR1C3
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.45311647793561,0.9494336171336444,0.5185185185185185,1.0,1.0,4/19,12.20%,HSPA1A;NCK1;OPA1;EIF2AK3
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,0.324697059079062,0.9493325086901434,0.5909090909090909,1.0,1.0,12/73,11.58%,SPSB4;MEX3A;CSPG5;EFNA2;SNAP91;POU3F2;KLHL23;RHBDL3;CNTFR;PPM1E;DRD2;BTBD17
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),-0.46093810592641427,-0.9492291081666526,0.547945205479452,1.0,1.0,7/27,16.03%,TLR2;APP;WNT5A;TLR3;SYK;IL7;IL18
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),-0.49090583524992837,-0.9490486503864819,0.5882352941176471,1.0,1.0,8/20,19.76%,S100A6;WNT5A;FN1;IGF1;CDKN1A;SPHK1;AQP1;CD74
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),0.4163301797119814,0.9482681153502138,0.5833333333333334,1.0,1.0,3/20,10.15%,SNX18;GULP1;SPIRE2
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),0.42063121843908263,0.9481970277136611,0.5416666666666666,1.0,1.0,9/27,16.43%,ABCD2;ACACB;MID1IP1;ABCD1;CPT2;ABCD3;SPX;CPT1A;ACSL3
prerank,GO_Biological_Process_2021__scaRNA localization to Cajal body (GO:0090666),-0.6018691757715509,-0.9481308394082542,0.6140350877192983,1.0,1.0,2/5,23.91%,TCP1;WRAP53
prerank,GO_Biological_Process_2021__RNA localization to Cajal body (GO:0090670),-0.6018691757715509,-0.9481308394082542,0.6140350877192983,1.0,1.0,2/5,23.91%,TCP1;WRAP53
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),-0.3946558104893843,-0.9478571164919141,0.6111111111111112,1.0,1.0,9/135,6.72%,PRAME;SIX3;HPN;EFNA1;PKP2;ABCA5;COL5A1;OVOL2;ZNF750
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),0.36704321593215594,0.9478320349350168,0.56,1.0,1.0,10/42,18.07%,RIDA;PDE12;NUDT16L1;HSPA1A;NBDY;LSM5;RC3H1;ERN1;AGO3;YTHDF2
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),0.45793546993670253,0.947646966352035,0.5238095238095238,1.0,1.0,9/29,20.03%,ASCL1;HES6;AKT1;NOTCH2;HEYL;PRUNE1;YTHDF2;HEY2;HES5
prerank,GO_Biological_Process_2021__cellular protein complex disassembly (GO:0043624),0.5741485056862454,0.9475637274149517,0.65,1.0,1.0,3/6,21.44%,APEH;VPS4B;ABCE1
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),-0.3795650378992386,-0.9474951165891085,0.6914893617021277,1.0,1.0,34/189,19.63%,PRAME;THBS1;HIC1;SULF1;IL12A;IGFBP5;NOTUM;MMP14;APOD;EGF;NLRP12;PTK6;PRKCQ;SIGIRR;SFRP2;IFT122;HHIP;DAB2IP;LRPAP1;SFRP4;BDNF;CBY1;EGFL7;TMBIM1;PRKCD;APLN;NOTCH3;TSC2;PTPRC;TNS2;GPC3;PIK3CB;MMRN2;PRKCB
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),0.3123318463191993,0.9471930797376873,0.5714285714285714,1.0,1.0,14/119,8.77%,EPHA6;FLT3;NAF1;TRIB3;GREM1;PLK1;RFC3;EGFR;DCUN1D2;POLG2;MAP3K4;UBE2N;DCUN1D1;ERBB4
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),0.47407438594111556,0.9471136192617845,0.48484848484848486,1.0,1.0,5/14,20.45%,PLIN5;AUP1;PLA2G4C;RAB3GAP1;RAB18
prerank,GO_Biological_Process_2021__dopamine transport (GO:0015872),-0.6118956302110464,-0.9469521571104308,0.5660377358490566,1.0,1.0,3/5,24.92%,SLC18A2;SLC29A4;SLC22A1
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),-0.4786887654810752,-0.9467241324236376,0.5373134328358209,1.0,1.0,2/20,5.35%,PDPN;DUOX1
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),0.44087444154516675,0.9466834934580289,0.4827586206896552,1.0,1.0,11/24,27.63%,NUDT16L1;EXOSC6;DIS3;TENT4B;EXOSC8;POP1;EXOSC5;MTREX;ZCCHC8;DIS3L;XRN1
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),0.5292914567183395,0.9466583795841134,0.5333333333333333,0.9996143795719131,1.0,4/11,19.67%,AAAS;NUP214;UHMK1;PTPN14
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),-0.467720794028713,-0.9463625165090074,0.6428571428571429,1.0,1.0,6/29,19.36%,EFNA1;EGF;TGFA;BDNF;DOK7;RELN
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),0.45704703205850966,0.9462252552486762,0.5625,0.999993515790811,1.0,3/13,10.76%,ABCA1;RELCH;STARD4
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),0.36882102300317277,0.9462023356361332,0.43478260869565216,0.9992533538370244,1.0,7/42,7.25%,AGER;CARD18;TNFAIP3;FOXP1;GIT1;STMP1;TMEM106A
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",0.5433042559686835,0.946180782062539,0.525,0.9984353882449849,1.0,4/7,12.19%,AGER;TWSG1;TARM1;SH3RF1
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198),0.6110404270584451,0.9460234602029954,0.6511627906976745,0.9979572073909674,1.0,3/5,22.94%,HEYL;HEY2;RBPJ
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),0.4118321379210795,0.9456064905727223,0.6153846153846154,0.9973410886862393,1.0,2/17,5.03%,MYBPC1;TCAP
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),0.4118321379210795,0.9456064905727223,0.6153846153846154,0.9973410886862393,1.0,2/17,5.03%,MYBPC1;TCAP
prerank,GO_Biological_Process_2021__axon regeneration (GO:0031103),-0.6219387548826603,-0.9455920385418467,0.6896551724137931,1.0,1.0,2/7,9.21%,GAP43;APOD
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),0.4126607940656731,0.9455623962886374,0.5,0.9965949287353022,1.0,6/26,16.82%,UBE2T;ANAPC13;ANAPC1;RNF26;UBE2E3;CDC26
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),-0.43803018598881505,-0.9454943760353872,0.5769230769230769,1.0,1.0,11/44,16.11%,RASGRP1;ARHGEF3;RASGEF1A;P2RY10;GPR18;LPAR4;SYNPO2L;LPAR6;IGF1;MAPRE2;VAV1
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),-0.42187670799290033,-0.9454761297225918,0.5952380952380952,1.0,1.0,10/64,11.65%,THBS1;SPARC;PROX1;SULF1;HTR2B;FUT2;WNT5A;EGF;STAT1;ATP5IF1
prerank,GO_Biological_Process_2021__intestinal absorption (GO:0050892),0.53316919674901,0.945336328718935,0.5384615384615384,0.9964796464570324,1.0,1/7,0.43%,SLC2A5
prerank,GO_Biological_Process_2021__regulation of positive chemotaxis (GO:0050926),-0.6227105462719454,-0.9451980849164975,0.6440677966101694,1.0,1.0,3/5,31.53%,F3;ANGPT2;NTRK3
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.4271299123053006,0.9449917083722873,0.5172413793103449,0.9965555387674082,1.0,6/24,18.48%,CNOT9;FOXP1;CNOT2;HEYL;VPS11;CNOT1
prerank,GO_Biological_Process_2021__T cell activation involved in immune response (GO:0002286),-0.5755382411466791,-0.9448401129483778,0.6,1.0,1.0,3/7,19.76%,ICAM1;SLC11A1;CD74
prerank,GO_Biological_Process_2021__cardiac myofibril assembly (GO:0055003),-0.5058502064891208,-0.9446794042935631,0.5694444444444444,1.0,1.0,4/12,23.36%,PROX1;MYLK3;FHOD3;PDGFRA
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),0.47300081427375257,0.9445123296147968,0.53125,0.996979283795341,1.0,4/18,6.34%,RAP2C;GREM1;PDGFD;PDGFC
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),0.5049226711632853,0.9444148279549521,0.6333333333333333,0.9963592569148193,1.0,2/11,13.45%,FOXP1;HEYL
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),0.3994943088832239,0.9443927938236479,0.5,0.9956057722654448,1.0,3/29,4.49%,WNT7A;CEL;NLGN3
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),0.32077478795687825,0.9443248684259944,0.8333333333333334,0.9949319095726974,1.0,91/274,30.17%,U2AF1;PPARGC1A;SNRPF;SF3B4;SF3A1;NUDT21;GTF2F2;HNRNPC;WDR33;NOVA1;CWC27;SMNDC1;CSTF3;ERCC2;RAVER2;LSM8;RBM41;PAPOLA;CPSF6;TFIP11;ERCC3;SNRPB2;SPEN;CPSF7;RBM17;LSM7;POLR2C;SRSF8;LSM5;SYNCRIP;GTF2H5;HNRNPU;SNRNP27;ERN1;GTF2H2;AQR;SNRPN;THOC1;DHX15;ZMAT2;THOC3;PSPC1;RPRD1B;PPIE;CPSF2;PPWD1;RNGTT;CRNKL1;RAVER1;RBM15;USP49;PDCD7;RBMX;GTF2H3;SUGP1;PLRG1;SART3;HNRNPD;PPIH;RBM19;CMTR2;PRPF40B;CCNH;CSTF1;MTREX;MAGOH;SNRNP48;SNRPB;SCAF11;ZCCHC8;PRPF18;CLP1;PRCC;POLR2A;HNRNPH1;RPRD2;SRSF9;CSTF2T;DHX16;SNRNP35;KIN;PRKACA;CELF1;CTNNBL1;PCF11;PPIL3;PTBP1;MAGOHB;SNRNP40;SRSF2;LSM6
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.531002152211561,-0.9440275035795939,0.5970149253731343,1.0,1.0,1/11,3.67%,KDELR3
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),0.3595256693269081,0.9439773011306527,0.4090909090909091,0.9951653970239769,1.0,14/54,21.42%,MITF;METTL18;PCBP4;NOVA1;RBM12B;CLK4;RC3H1;YTHDF2;METTL4;PCBP3;RC3H2;RRP1B;USP36;MBNL1
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),-0.3651554344172178,-0.9439576524010399,0.6770833333333334,1.0,1.0,56/311,19.76%,LEF1;PRAME;THBS1;IL13RA1;NR4A3;TGFBR2;LAMB1;PROX1;S100A6;KIF14;RPS4X;HTR2B;IL15;BST2;SCX;COPS9;TIMP1;WNT5A;EGF;S1PR3;STAT1;OSMR;EMP2;ROMO1;SFRP2;FN1;THPO;NAMPT;PIM1;SOX15;FGF1;VIP;IL7;TGFA;FOXM1;GLI1;IGF1;CDK2;IL18;DDRGK1;PRKCH;RPS9;FGF7;CDKN1A;CAPN1;RPL23;PTPRC;SPHK1;RPS6;CDC7;FGF22;CAPNS1;TGFB1;AQP1;HYAL1;CD74
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),0.48191996325745745,0.9438896407375171,0.6176470588235294,0.9945377195098187,1.0,1/11,4.85%,USP13
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,0.3296654356313342,0.9435617041529892,0.47058823529411764,0.9945142418217655,1.0,9/84,6.66%,ACE2;TFCP2L1;PPARGC1A;EHF;MUC20;LARP1B;MYO5B;ESRRG;FRK
prerank,GO_Biological_Process_2021__postsynaptic density protein 95 clustering (GO:0097119),-0.6016513000799684,-0.943516448786879,0.559322033898305,1.0,1.0,2/5,16.30%,LRRC4;NLGN1
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),0.3963465606763137,0.9434651625338457,0.5357142857142857,0.993943931483469,1.0,6/32,10.23%,BMP2;ADAMTS9;SGCD;TCAP;SMAD5;NOTCH2
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.5217761751609161,-0.9433314535229437,0.5151515151515151,1.0,1.0,2/12,6.66%,IFITM3;BST2
prerank,GO_Biological_Process_2021__positive regulation of hormone secretion (GO:0046887),0.5777854773873938,0.9430823811204302,0.6410256410256411,0.9940547968516052,1.0,1/7,4.21%,NMB
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.4970129958953917,-0.942922381692477,0.5942028985507246,1.0,1.0,1/23,0.56%,PIF1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.46315984148002376,0.942043287686712,0.5,0.9956808408991937,1.0,2/12,7.94%,FGL1;AKT1
prerank,GO_Biological_Process_2021__negative regulation by host of viral transcription (GO:0043922),-0.5549082728292664,-0.9416956222615422,0.5789473684210527,1.0,1.0,3/10,15.27%,POU2F3;PSMC3;TFAP4
prerank,GO_Biological_Process_2021__vitamin transport (GO:0051180),-0.4945408277296929,-0.9416296821833356,0.5466666666666666,1.0,1.0,3/20,4.34%,AMN;PDPN;GC
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),0.5747543400834575,0.9414102187018806,0.6216216216216216,0.9964358311893686,1.0,4/7,33.14%,NFIB;RYK;SMO;NRP1
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.44506419624131544,-0.941257845721904,0.5625,1.0,1.0,7/59,9.07%,C3;MRAP2;RAMP3;SLC39A14;PDE6B;KLK6;SYP
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),0.5328951159755408,0.941104505974757,0.5769230769230769,0.996477642274279,1.0,5/10,23.13%,PTPN23;RAB21;VPS11;EIPR1;EZR
prerank,GO_Biological_Process_2021__carnitine transport (GO:0015879),-0.618993205118403,-0.9409450788437481,0.6078431372549019,1.0,1.0,3/5,20.31%,SLC22A4;PDZK1;SLC25A29
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),-0.5840981020081102,-0.9409113057396968,0.6176470588235294,1.0,1.0,5/8,40.49%,RAB27B;HSPB1;MAP1A;MAPK8IP3;KIF5B
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),-0.5840981020081102,-0.9409113057396968,0.6176470588235294,1.0,1.0,5/8,40.49%,RAB27B;HSPB1;MAP1A;MAPK8IP3;KIF5B
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),-0.5840981020081102,-0.9409113057396968,0.6176470588235294,1.0,1.0,5/8,40.49%,RAB27B;HSPB1;MAP1A;MAPK8IP3;KIF5B
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.49910954129812934,0.9408132424535665,0.5384615384615384,0.9962859690894353,1.0,3/9,14.51%,AKT2;AKT1;GPLD1
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),-0.4716548779631799,-0.9406844034236499,0.5,1.0,1.0,6/27,16.38%,PTP4A3;CYP1B1;STAT1;EMP2;MYH9;NR4A1
prerank,GO_Biological_Process_2021__positive regulation of hemoglobin biosynthetic process (GO:0046985),0.5336559038028905,0.9403560351242051,0.5853658536585366,0.9965943775704496,1.0,2/6,6.59%,ABCB10;SLC25A37
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),0.34922573420807523,0.9398635692368215,0.5,0.9970687366342318,1.0,14/100,11.11%,NGF;EPHA6;FLT3;CASS4;GUCA1B;EGFR;FRK;YES1;ERBB4;EFS;SHC4;PTPRG;CNKSR1;CSF1R
prerank,"GO_Biological_Process_2021__synaptic transmission, GABAergic (GO:0051932)",0.5067025561162326,0.9396767578699642,0.4,0.9967439959188631,1.0,2/11,2.65%,GABRA4;GABRG1
prerank,GO_Biological_Process_2021__polyol transport (GO:0015791),-0.6109386788995096,-0.9395099770808514,0.6101694915254238,1.0,1.0,4/5,35.73%,AQP1;AQP11;SLC26A6;SLC5A11
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),0.5654507396252255,0.9394126978357502,0.6571428571428571,0.9965416513363532,1.0,2/6,10.07%,MYOM1;PRKACB
prerank,GO_Biological_Process_2021__icosanoid transport (GO:0071715),-0.5582900527093693,-0.9392922826761915,0.5217391304347826,1.0,1.0,4/9,22.62%,SLCO3A1;ABCC4;ABCC1;SLCO2A1
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),0.4372685777505255,0.9391368478684318,0.5333333333333333,0.9965167532436963,1.0,8/22,15.21%,GDAP1;PEX11A;WASHC5;MFF;OPA1;DNM3;MUL1;MTFR1
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),-0.39143018282379916,-0.9390258635902773,0.5542168674698795,1.0,1.0,12/90,15.12%,GGT5;RAMP3;PLK2;ADCY7;SYK;GIPR;RHBDF2;MYH9;VIP;GLP1R;GNG2;ADCY5
prerank,GO_Biological_Process_2021__catecholamine catabolic process (GO:0042424),-0.6239807466277395,-0.9388789156563231,0.65,1.0,1.0,1/5,5.04%,MAOB
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.5669432204999637,-0.9387580934726218,0.5942028985507246,1.0,1.0,1/11,5.63%,ATF3
prerank,GO_Biological_Process_2021__chromatin maintenance (GO:0070827),0.5621255244944146,0.9384718930531961,0.5294117647058824,0.997697525620917,1.0,2/5,29.25%,HDAC2;SIRT1
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),0.3531058316279414,0.9375881631935382,0.5,0.999097416409044,1.0,9/77,13.72%,WNT7A;PSMD10;PSMA1;PSMD11;PSMB5;AP2B1;PSMD14;PSMD12;DVL2
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),-0.39636142891566584,-0.9375498922134892,0.6395348837209303,1.0,1.0,33/134,20.76%,RFTN1;FYB1;HLA-A;SKAP1;INPP5D;THY1;PSMB6;PSMB9;MOG;WAS;HLA-DRA;FYB2;NFKBID;EIF2B2;PRKCQ;SYK;BTN3A1;PSMC3;LAT2;BMX;HHLA2;PSMA8;PSME1;CD4;THEMIS;PTPRC;PIK3CB;PRKCB;SH2B2;RIPK2;PIK3CD;PSMA7;BLNK
prerank,GO_Biological_Process_2021__carboxylic acid catabolic process (GO:0046395),-0.5226300228060179,-0.9373472007588056,0.6197183098591549,1.0,1.0,2/11,17.76%,ACOT4;ACOT8
prerank,GO_Biological_Process_2021__establishment of protein localization to chromatin (GO:0071169),0.564957985718243,0.9372544807252555,0.5333333333333333,0.9991698902872204,1.0,1/6,10.47%,NIPBL
prerank,GO_Biological_Process_2021__positive regulation of phospholipid transport (GO:2001140),-0.6011888593247501,-0.9372356695404159,0.6571428571428571,1.0,1.0,1/7,9.15%,DBI
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.43177414441417394,0.937115871785464,0.5294117647058824,0.9987788222385714,1.0,2/15,5.79%,CBFA2T3;GIT1
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),-0.46751797089778535,-0.9367185798915814,0.6056338028169014,1.0,1.0,10/29,25.59%,SEPTIN5;SYT4;SYT1;RIMS2;SYT2;SYT5;SYT13;RAB15;SYT12;RIMS1
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),0.3512805387574415,0.9365118034044444,0.45,0.9995019101821665,1.0,12/64,16.28%,NGF;SOX8;LIG4;CAPRIN2;TIAM2;ROBO1;DRD2;DCT;SPEN;CAPRIN1;FAIM;MAP6
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),0.32503309860994467,0.9364358549830291,0.5833333333333334,0.9988027573433875,1.0,14/76,14.16%,TBC1D4;ARHGEF16;CXCL13;TBC1D12;TAX1BP3;TIAM2;FOXJ1;MTSS2;ARHGEF26;SYDE2;TBC1D5;GARNL3;ARHGAP24;TBC1D8B
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.4253392312184847,-0.936311415168666,0.5921052631578947,1.0,1.0,12/61,18.16%,B2M;HLA-A;MFSD6;PSMB6;PSMB9;HLA-C;HLA-B;HLA-E;PSMC3;HLA-F;PSMA8;PSME1
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),0.4409664673656646,0.9362144831873345,0.5,0.9985780425055195,1.0,4/21,15.67%,LLPH;CAPRIN2;CPEB3;CAPRIN1
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex III assembly (GO:0034551),0.5561428456455554,0.936075891459085,0.5454545454545454,0.9971736284571678,1.0,2/8,17.87%,LYRM7;UQCC1
prerank,GO_Biological_Process_2021__respiratory chain complex III assembly (GO:0017062),0.5561428456455554,0.936075891459085,0.5454545454545454,0.9971736284571678,1.0,2/8,17.87%,LYRM7;UQCC1
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),0.5159181733321268,0.9357759201445283,0.6153846153846154,0.9970935188444626,1.0,3/9,13.12%,CD200R1;AKT1;WASL
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,-0.3977331146412295,-0.9357408343743906,0.5842696629213483,1.0,1.0,7/93,7.79%,COL4A1;COL4A2;CALD1;LAMB1;THY1;MAP1B;GJC1
prerank,GO_Biological_Process_2021__positive regulation of mRNA binding (GO:1902416),0.5901398318880735,0.9352946854497259,0.6486486486486487,0.9976169778348403,1.0,1/6,4.93%,EIF3E
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),-0.4811394749586022,-0.9352923125923349,0.5571428571428572,1.0,1.0,3/24,11.07%,TYMS;GLRX;NUDT13
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated protein folding (GO:1903644),0.591465169532684,0.9350723511916277,0.55,0.9973721983094942,1.0,3/5,35.56%,DNAJB2;PDCL3;SGTA
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),-0.3996577630726747,-0.9348775553852092,0.6046511627906976,1.0,1.0,22/106,22.42%,LEF1;SEMA3B;APP;EFNB3;MAP1B;ARHGEF17;ARHGAP39;GFAP;SCARA3;KAZN;NYAP1;NUAK1;DAB2IP;AMOTL2;LARP6;SEZ6L2;PHYHIP;ANTXR1;PTPN21;PTPRF;ABCG2;GPC1
prerank,GO_Biological_Process_2021__ethanol oxidation (GO:0006069),0.549718155096914,0.9348473807360262,0.6363636363636364,0.997324984192178,1.0,4/7,19.23%,ALDH1A1;ADH5;ACSS1;ALDH2
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),-0.45447942678690767,-0.934665734828321,0.6428571428571429,1.0,1.0,9/32,19.36%,EFNA1;APP;THY1;PTK6;SH3BP5;MVP;DOK7;PTPRC;RELN
prerank,GO_Biological_Process_2021__glycosylceramide metabolic process (GO:0006677),-0.6021257553194705,-0.93464785703005,0.6451612903225806,1.0,1.0,1/5,22.01%,ST6GALNAC3
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.5303760869900288,0.934366165338478,0.45454545454545453,0.9977813227200508,1.0,4/10,23.54%,CSGALNACT1;DSE;B3GAT2;XYLT1
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),0.4936273744207498,0.934326255311518,0.53125,0.9970558021294426,1.0,2/11,5.54%,IL17D;RUNX1
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,-0.3806599231455258,-0.9342982261637846,0.6867469879518072,1.0,1.0,10/185,8.89%,PIF1;CCNB2;ARHGAP4;ARHGEF3;FSCN1;PLEKHG2;CENPE;LMNB1;ANLN;CDC42EP1
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),-0.38139599893173504,-0.9338144725635271,0.6144578313253012,1.0,1.0,15/127,16.97%,ERCC6L;WDR62;RPS27;PLK2;RAB11A;CENPH;CENPE;ZWILCH;CCNB1;NUF2;CENPN;SPC24;CENPU;KIF2C;STMN1
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),0.29844595742196456,0.9337011726292849,0.6153846153846154,0.9979377987350174,1.0,18/129,13.72%,LIMD1;AMER2;BMP2;PSMD10;BICC1;PSMA1;GREM1;CCDC88C;PSMD11;SOX9;PSMB5;STK4;KLHL12;PSMD14;INVS;PSMD12;TMEM170B;DVL2
prerank,GO_Biological_Process_2021__positive regulation of type 2 immune response (GO:0002830),-0.5181661560620465,-0.9336240181620102,0.6,1.0,1.0,4/8,27.22%,IL18;CD74;RSAD2;RARA
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),0.26947241062334515,0.9333247942582379,0.75,0.9980322265572047,1.0,112/445,22.51%,SPSB4;RNF6;RNF25;FBXO45;ERCC8;KLHL8;IRF2BP1;PSMD10;BCL10;UBE2T;SPSB2;PSMA1;RFWD3;ELOC;MSL2;MKRN3;TRIM24;PSMD11;PLK1;KEAP1;CUL1;FBXL14;PHC1;PSMB5;UBE2N;PEX13;RNF103-CHMP3;VCP;BTRC;FBXO30;COMMD1;RNF146;BLMH;LMO7;FBXL3;RNF14;TSPAN17;UBE2G1;FBXO9;FBXO15;KLHL12;PSMD14;UBE2D1;SH3RF1;DERL1;SASH1;RCHY1;RNF114;DTX4;RNF141;MUL1;PEX2;PSMD12;CUL2;TRIM7;TMEM129;RNF11;MARCHF7;FBXO10;FBXO27;RNF26;UBE4A;RC3H1;CBLL1;FBXL17;KLHL24;HERC2;PPIL2;VHL;UBE2E3;TRIM3;UBE3B;RNF208;FBXO21;VPS11;SPOP;RMND5A;CNOT4;MKRN1;CDC34;UBE3D;RNF217;RNF34;PEX12;MDM2;EIPR1;KLHL20;TRIM52;RC3H2;KLHL42;RNF182;ABCB11;NEDD4L;H2BC5;LNPEP;SHPRH;MIB1;RNF20;RNF166;FBH1;USP22;MARCHF3;FBXO28;UBE2A;NUB1;TRIP12;DDA1;RLIM;PELI2;UBE2Z;PSMD1;CAND1
prerank,GO_Biological_Process_2021__organic acid catabolic process (GO:0016054),0.42753435916191895,0.9332635954684023,0.5588235294117647,0.9974719007455619,1.0,5/8,24.63%,CTH;ADO;TST;PON1;TXN2
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),-0.4759106290257459,-0.933092503407693,0.5616438356164384,1.0,1.0,6/26,17.31%,ANK3;KCNB1;CEMIP;SLC51B;DMTN;PDZK1
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),-0.4645339280257231,-0.9328964390870901,0.5217391304347826,1.0,1.0,5/29,10.49%,B2M;THY1;EFNB3;YWHAH;MAG
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,-0.42786419395665926,-0.9328457648211325,0.5662650602409639,1.0,1.0,22/53,20.91%,MYO1F;ALOX12;PROX1;TAGAP;SPON2;PDE6B;ARHGAP9;SYP;WAS;PLK3;GATA1;CLEC12A;PILRA;CD9;ACHE;SELP;SLC11A1;F13A1;TSPAN32;TGFB1;PSTPIP1;FERMT3
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),-0.5325245364660723,-0.9327903630662812,0.5833333333333334,1.0,1.0,4/10,24.70%,IFT122;RYR2;HES1;TBX20
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),-0.5147500508436388,-0.9326141623683788,0.5970149253731343,1.0,1.0,1/18,0.92%,APLNR
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),-0.4798014494236782,-0.9325412694833906,0.5416666666666666,1.0,1.0,2/18,10.66%,SUV39H1;EEF1AKMT2
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),0.5217453229217575,0.932521467318568,0.5384615384615384,0.998536765759679,1.0,5/10,31.42%,ABI2;WHAMM;WASF3;NCKAP1;BRK1
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.32392623074510435,0.9324979875387597,0.7692307692307693,0.9978244373030518,1.0,29/99,25.85%,PHC1;UBE2N;PRMT6;MIER3;KAT2A;HDAC2;PRDM5;EP300;HDAC10;EYA2;EYA1;PADI4;PHF20L1;MTA2;USP3;EHMT1;KAT6B;USP36;TRRAP;USP22;UBE2A;RUVBL1;MIER2;ENY2;SIRT2;RPS6KA4;NAA50;PRMT1;BAZ1B
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),-0.5183561656460779,-0.9324408688960036,0.6229508196721312,1.0,1.0,2/15,7.31%,P2RY12;TRPC3
prerank,GO_Biological_Process_2021__negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),-0.6474876290588735,-0.9324346873420462,0.6612903225806451,1.0,1.0,2/6,28.41%,FOXM1;GSTP1
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),-0.4175567081149973,-0.9323323267131333,0.6588235294117647,1.0,1.0,14/70,20.91%,MRAP2;GBP1;RAMP3;MMP14;AKAP5;ITGA3;PRKCH;CDK5;PPFIA1;TMBIM1;TGFB1;STAC2;NUMB;GPER1
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),-0.5721104650533453,-0.9321175218239618,0.625,1.0,1.0,1/10,2.35%,TYMP
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),-0.3590789155962887,-0.9318884470137944,0.696969696969697,1.0,1.0,61/545,16.37%,LEF1;PRAME;ANXA1;IFI6;THBS1;APIP;HPN;DHCR24;RPS27A;NAA38;CD44;PDPN;KIF14;ARHGEF3;PRDX5;PLK2;HTR2B;TP53I3;PLEKHG2;SCX;RPS6KA1;STEAP3;ARHGEF17;IFIT3;WNT5A;PIM3;CYP1B1;GADD45A;NUAK2;PLK3;STAT1;GATA1;SEPTIN4;PAX8;MLLT11;TFPT;BCL2L14;RPS3A;SFRP2;ARHGEF18;UBC;GADD45B;BIRC3;IFIT2;RPL10;PIM1;DAB2IP;THOC6;VIP;PINK1;IL7;NDRG1;BCL2L2;TFAP4;SFRP4;IGF1;OBSCN;GRID2;VAV1;DDRGK1;FADD
prerank,GO_Biological_Process_2021__chromatin organization involved in negative regulation of transcription (GO:0097549),-0.6030086180129148,-0.9318686333691555,0.6101694915254238,1.0,1.0,1/6,8.05%,POLE3
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.4976932170780719,0.9316576928804345,0.56,0.9990614581413917,1.0,6/15,32.59%,AKT1;UBQLN1;NFE2L2;MAPK7;SIRT1;SFPQ
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),-0.4469695650925408,-0.9313850236429446,0.5571428571428572,1.0,1.0,2/35,3.92%,AGPAT4;ITPKC
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),-0.48679681952439635,-0.9311621043327847,0.5223880597014925,1.0,1.0,1/16,3.46%,SHTN1
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),0.3770817207713228,0.9310502828970538,0.5238095238095238,0.9997309934129964,1.0,11/29,16.93%,ZDHHC16;ZDHHC14;ZDHHC11;ZDHHC13;ZDHHC18;ZDHHC21;ZDHHC20;ZDHHC5;GLUL;GOLGA7;ZDHHC11B
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),-0.43711390793529903,-0.9310289112117783,0.5897435897435898,1.0,1.0,8/56,14.46%,BLM;PLK2;RAB11A;HTR2B;PLK3;NLRP5;SFRP2;FGF1
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),-0.5268137530042161,-0.9307261874103856,0.6153846153846154,1.0,1.0,2/15,10.40%,OPALIN;TENM4
prerank,MSigDB_Hallmark_2020__Androgen Response,-0.40629975493472686,-0.9305876532536562,0.6582278481012658,1.0,1.0,21/92,24.62%,DHCR24;B2M;DBI;MAK;SRF;GUCY1A1;CENPN;CCND1;TPD52;HSD17B14;NDRG1;ABCC4;INSIG1;PTPN21;UAP1;PMEPA1;SELENOP;IDI1;ARID5B;STEAP4;HMGCS1
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),-0.41621962562266857,-0.9304787437763871,0.5616438356164384,1.0,1.0,9/41,20.31%,SLC6A15;SLC17A5;SLC16A3;SLC38A1;SLC16A11;SLC16A4;SLC16A14;SLC15A4;SLC25A29
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),0.3801351031182188,0.9303751931028169,0.4583333333333333,1.0,1.0,7/27,9.17%,SOX8;SOX9;NCOA4;AKR1C3;AR;SALL1;MSH2
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.43254355568968933,-0.9303643086848893,0.6172839506172839,1.0,1.0,13/56,22.36%,TGFBR2;RPS27A;ASPN;ADAMTSL2;EID2;UBC;SNX6;LDLRAD4;LTBP1;TGFB1;VASN;VEPH1;PMEPA1
prerank,GO_Biological_Process_2021__dendritic cell differentiation (GO:0097028),-0.5478831576794522,-0.9301686042974814,0.6349206349206349,1.0,1.0,1/8,1.77%,TGFBR2
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),0.5025626936671198,0.9300927210068735,0.4857142857142857,1.0,1.0,4/12,18.82%,LIMD1;EDC3;RC3H1;PATL1
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),0.4822103974231518,0.9299499965126089,0.5925925925925926,1.0,1.0,2/11,5.17%,PDE3A;OCLN
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),-0.4065005933103767,-0.929518724429181,0.627906976744186,1.0,1.0,27/84,24.62%,ANXA1;SFTPD;GPNMB;HTR2B;IL15;ISG15;LRRC19;MOG;NLRP12;IRF7;HLA-B;BTN3A1;IFIH1;HHLA2;SRGN;SLC11A1;PTPRC;FLOT1;PIK3CD;AGPAT2;BCL6;HLA-DRB1;CASP8;ALOX5;EIF2AK2;CD276;IGF2BP2
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.5508810503478255,-0.9294962339364367,0.5633802816901409,1.0,1.0,3/10,17.73%,IL18;PRKCH;MSR1
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),0.3596485948220073,0.9293283862233616,0.6,1.0,1.0,3/27,11.88%,NCOA4;ZFYVE16;MFSD1
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),0.4889077971589701,0.9292915005088614,0.47058823529411764,1.0,1.0,2/12,11.87%,GLUD1;IREB2
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.42015688868343587,0.9291614353501297,0.6296296296296297,0.9997861737796381,1.0,4/19,7.94%,RGCC;PSMD10;EGFR;AKT1
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),-0.41898950359969644,-0.929129255982576,0.6,1.0,1.0,10/49,17.54%,RPL3;RPL7A;RPL24;RPL10A;RPL10;RPL26L1;RPL5;MRPL20;MRTO4;PES1
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),0.42543987588715754,0.9290521565535943,0.5483870967741935,0.9992726117982189,1.0,5/20,8.69%,CSPG5;CHST11;CHST7;CSGALNACT1;BCAN
prerank,GO_Biological_Process_2021__t-circle formation (GO:0090656),-0.562877554929714,-0.9289043297126418,0.6285714285714286,1.0,1.0,1/9,0.78%,BLM
prerank,GO_Biological_Process_2021__telomere maintenance via telomere trimming (GO:0090737),-0.562877554929714,-0.9289043297126418,0.6285714285714286,1.0,1.0,1/9,0.78%,BLM
prerank,GO_Biological_Process_2021__formation of extrachromosomal circular DNA (GO:0001325),-0.562877554929714,-0.9289043297126418,0.6285714285714286,1.0,1.0,1/9,0.78%,BLM
prerank,GO_Biological_Process_2021__negative regulation of defense response to virus (GO:0050687),0.5165878968100633,0.9287920712192922,0.5238095238095238,0.9990840471057865,1.0,4/9,27.82%,MUL1;RNF26;ITCH;TRAF3IP1
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),-0.46547675205458683,-0.9287178194061603,0.6447368421052632,1.0,1.0,3/35,11.58%,BLM;BRCA1;DONSON
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),0.43124576251692426,0.9286308942504484,0.6176470588235294,0.9987014272162605,1.0,5/16,20.79%,NUDT21;CPSF6;CPSF7;FARSB;PKD2
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),0.4741675344310122,0.9283983018130852,0.5833333333333334,0.9985136145571084,1.0,6/12,27.02%,SALL1;HEYL;HEY2;MDM4;HECTD1;HEY1
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),-0.40501941314877504,-0.927989108966453,0.5894736842105263,1.0,1.0,16/89,17.72%,TGFBR2;KIF14;ADCY7;WNT5A;TLR3;CHI3L1;EMP2;MINK1;FGF1;PINK1;ADCY5;STRADB;IGF1;IL18;PRKCD;SLC11A1
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),0.39731988957453274,0.9279501263938557,0.43478260869565216,0.9988219961412635,1.0,7/25,17.13%,DCHS1;FAT4;STK4;CASP3;DVL2;AMOTL1;MOB1B
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),0.43002250364086825,0.9277117065660854,0.5517241379310345,0.9978658531844605,1.0,9/19,30.45%,ACADSB;DBT;BCKDHB;HIBCH;HIBADH;ECHS1;ALDH6A1;IVD;HSD17B10
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),0.43002250364086825,0.9277117065660854,0.5517241379310345,0.9978658531844605,1.0,9/19,30.45%,ACADSB;DBT;BCKDHB;HIBCH;HIBADH;ECHS1;ALDH6A1;IVD;HSD17B10
prerank,GO_Biological_Process_2021__positive regulation of rRNA processing (GO:2000234),0.505793875618257,0.927504368042125,0.5588235294117647,0.9976470305477444,1.0,2/10,6.95%,RIOK2;RIOK1
prerank,GO_Biological_Process_2021__regulation of glucokinase activity (GO:0033131),0.5568379558864747,0.9271235081653122,0.59375,0.9977079573947787,1.0,2/5,14.51%,BAD;DUSP12
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),0.4718603345425077,0.9265049919083892,0.5476190476190477,0.9985419109641461,1.0,6/10,31.70%,HSPA1A;SACS;DNAJB2;SNCAIP;DNAJA4;HSPA2
prerank,GO_Biological_Process_2021__positive regulation of vasculogenesis (GO:2001214),0.5130502537189849,0.9264301679504027,0.625,0.9979260869388308,1.0,1/8,1.76%,TMEM100
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),-0.44980907878274823,-0.926376933271255,0.6419753086419753,1.0,1.0,5/40,16.37%,CCBE1;CTSC;ATP5IF1;PINK1;FADD
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),0.5046248194840117,0.9263541461497424,0.55,0.9974720469005021,1.0,7/10,38.40%,MKKS;BBS2;PTEN;CTNNA2;SPEF2;PAFAH1B1;FBXW11
prerank,"GO_Biological_Process_2021__synaptic transmission, cholinergic (GO:0007271)",0.47299186655553105,0.9262787406615703,0.5641025641025641,0.9968687475425438,1.0,2/12,7.89%,CHRNA4;CHRNB4
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),0.34577132763057244,0.9262432110406208,0.5833333333333334,0.9961486532428049,1.0,19/107,12.97%,WNT7A;ASCL1;FUT9;POU3F2;RUNX1;TENM1;FZD8;RORB;ERCC6;ADNP2;PBX1;ERCC2;TENM2;TDP2;TENM3;EMX2;ERCC3;CASP3;USH2A
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),-0.43700106015916645,-0.9260512411428453,0.5853658536585366,1.0,1.0,9/38,19.33%,RPS27;RPS14;NOB1;EMG1;RPS16;RPS7;RPS15;RPS6;RPS25
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.4257161341360688,0.9260130717144316,0.5806451612903226,0.9959216892090522,1.0,4/16,7.94%,RGCC;PSMD10;EGFR;AKT1
prerank,GO_Biological_Process_2021__amino-acid betaine metabolic process (GO:0006577),-0.5892986763473227,-0.9256652795603922,0.5789473684210527,1.0,1.0,1/6,5.64%,BHMT
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.45784341045587007,-0.9256472508671328,0.5945945945945946,1.0,1.0,1/29,0.44%,S100A10
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),0.48235693012399583,0.9256323498130855,0.5357142857142857,0.9961439444809449,1.0,3/24,7.16%,INSC;PLK1;LLGL1
prerank,GO_Biological_Process_2021__striated muscle cell development (GO:0055002),-0.6186772692020649,-0.9256237906286238,0.6181818181818182,1.0,1.0,1/6,11.95%,LMOD1
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),0.4347245610090266,0.9256192852874202,0.5,0.9954154359508541,1.0,5/19,24.89%,SLAIN2;TUBG1;TPX2;TUBGCP3;CLASP2
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,-0.36495110627722155,-0.9254802627944189,0.6666666666666666,1.0,1.0,46/186,26.70%,CFAP126;PPP1R14C;ANO2;TESC;IMPDH1;CLGN;SCN9A;EFNB3;PDE4A;ARHGAP39;CARNS1;PFN2;NYAP1;HPCA;CIBAR2;SLC16A11;WDR54;KIF9;ZBBX;CCDC184;FGF12;LARP6;SEZ6L2;SYBU;RARG;PRR36;PDE1C;PTPRF;GPC1;CCDC28B;DUSP8;VSTM2L;CFAP52;CNTN4;MORN5;EPB41L4B;LRRIQ1;CERS5;CLSTN2;FLRT1;MAPK8IP1;STOM;CALB2;KLHDC9;NRSN2;RETREG1
prerank,GO_Biological_Process_2021__lipoxygenase pathway (GO:0019372),-0.5739166134234697,-0.925329932475034,0.6060606060606061,1.0,1.0,1/8,3.91%,ALOX12
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),-0.43692427482138685,-0.92523542886708,0.6,1.0,1.0,4/34,9.37%,ANXA1;WDR62;GCM2;HAP1
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),0.3708001994822384,0.9251581889443939,0.6666666666666666,0.9958724894048279,1.0,16/60,19.93%,PPP1R15B;EIF3E;MIF4GD;NCK1;MTIF2;EIF4EBP2;EIF2AK4;EIF2AK3;UHMK1;EIF3H;C8ORF88;NCK2;PAIP1;YTHDF2;EIF4EBP1;CDC123
prerank,GO_Biological_Process_2021__phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.5718389093604122,-0.925089763711587,0.6349206349206349,1.0,1.0,1/7,11.75%,LPCAT4
prerank,GO_Biological_Process_2021__negative regulation of actin filament depolymerization (GO:0030835),-0.6123863765182573,-0.9249392835035812,0.6268656716417911,1.0,1.0,1/5,9.31%,VIL1
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),0.4771862892231609,0.9248484225725334,0.5588235294117647,0.9957850603401585,1.0,4/12,23.34%,CPSF6;IWS1;NUP153;NSUN2
prerank,GO_Biological_Process_2021__molybdopterin cofactor biosynthetic process (GO:0032324),0.6012425966860439,0.924847190178657,0.6190476190476191,0.9950052756413799,1.0,2/6,18.37%,GPHN;MOCS2
prerank,GO_Biological_Process_2021__TORC2 signaling (GO:0038203),-0.6246122813067048,-0.9247517791045307,0.6153846153846154,1.0,1.0,1/6,14.53%,PINK1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),0.5251034984941105,0.9247186866277846,0.5652173913043478,0.9945354277319906,1.0,1/8,10.09%,VDAC2
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.5246844569259304,-0.9245387214543959,0.5606060606060606,1.0,1.0,2/11,16.95%,ARPC5L;ARPC3
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),-0.5745847912704476,-0.9244807990565975,0.65625,1.0,1.0,2/10,15.22%,NUAK1;FOXM1
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),0.3302589584282383,0.9242861580807684,0.5,0.9947683613035508,1.0,19/112,16.65%,NUP42;AIFM2;NUP37;HSPA1A;BAG2;ABCD1;NUP54;HSF1;AAAS;ATR;NUP214;NDC1;RAE1;DYRK3;NUP188;EP300;NUP85;NUP205;NUP210
prerank,GO_Biological_Process_2021__nuclear DNA replication (GO:0033260),-0.5793204217522636,-0.9240899394507167,0.6388888888888888,1.0,1.0,2/9,23.90%,DONSON;MCM5
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),0.4860386568437631,0.9226484198074547,0.5806451612903226,0.9977112652401574,1.0,5/13,20.12%,CCNE1;HNRNPU;KAT7;PDCD2;GJA1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),-0.4001928302874044,-0.9222036517520054,0.6329113924050633,1.0,1.0,11/65,19.08%,KIF14;CENPV;CCNB1;PLSCR1;SVIL;EGF;SOX15;TGFA;IGF1;NUDT16;CDC7
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte proliferation (GO:0010838),0.5388111472489067,0.9215161630237091,0.5555555555555556,0.9998849010122333,1.0,3/6,16.60%,NOTCH2;STXBP4;MDK
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),0.4887449803681613,0.9213736993442522,0.6176470588235294,0.9995082224516177,1.0,3/13,11.06%,DAO;MOXD1;DRD2
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),-0.4157796250131548,-0.9210954456090096,0.6133333333333333,1.0,1.0,11/34,27.78%,LZTS1;VLDLR;DAB2IP;HECW2;MFSD2A;BCL11A;CAMK1D;ALK;NSMF;PACSIN1;CSMD3
prerank,GO_Biological_Process_2021__IMP metabolic process (GO:0046040),0.5334079997834622,0.9210048683668841,0.54,0.9995774952589994,1.0,2/8,14.03%,NT5C1A;ADSS2
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),0.4228668513155882,0.9209535153977394,0.52,0.9988731776676788,1.0,2/11,12.28%,ZNF502;VAPA
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),0.3833208937364421,0.9209383590337943,0.5294117647058824,0.9981381940754983,1.0,4/42,4.49%,WNT7A;SLITRK2;SLIT1;NLGN3
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),-0.46028356060672654,-0.9208613371571325,0.6060606060606061,1.0,1.0,6/23,18.90%,ANK3;DCTN1;UNC13C;DOK7;AGRN;CACNB1
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),-0.4429790108690215,-0.9203735819430482,0.6060606060606061,1.0,1.0,7/35,20.04%,RHOBTB2;RND2;RHOF;NLGN1;RHOBTB1;RHOD;FHOD3
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),0.3594471127433817,0.9200185105991082,0.6538461538461539,0.9997952464507712,1.0,8/42,13.47%,BMP2;S1PR1;GREM1;SGMS2;GPM6B;ECM1;ACVR2A;ANKH
prerank,GO_Biological_Process_2021__pyrimidine nucleoside catabolic process (GO:0046135),-0.5721341318149364,-0.9199172506385516,0.65625,1.0,1.0,1/9,2.35%,TYMP
prerank,GO_Biological_Process_2021__positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.5338194601257931,-0.9198844650355913,0.6307692307692307,1.0,1.0,3/11,21.15%,SLC51B;IGF1;SOAT1
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),0.45513817470636697,0.9195445318668596,0.4666666666666667,1.0,1.0,5/14,29.91%,PCBP4;RBMX;SAP18;SRSF9;PTBP1
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),0.3636072519397037,0.9189258822203407,0.5909090909090909,1.0,1.0,11/35,16.77%,ZDHHC16;ZDHHC14;KAT2B;ZDHHC13;ZDHHC18;KAT2A;ZDHHC21;ZDHHC20;ZDHHC5;EP300;GLUL
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),0.39790126525002467,0.9186270464390387,0.5263157894736842,1.0,1.0,8/28,21.16%,RAB27A;VPS37A;SNF8;VTA1;VPS37B;CHMP2B;VPS4B;CHMP6
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),0.3421235129526471,0.918539596286426,0.56,1.0,1.0,26/72,25.06%,DAO;CARNMT1;ALDH7A1;GLUD1;GLS;BLMH;QDPR;KYNU;PIPOX;IDO1;ACADSB;GLUL;DBT;DDO;SDSL;BCKDHB;HIBCH;DDAH1;ALDH4A1;PRODH;GOT2;ARG1;HIBADH;FAH;TDO2;OGDH
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),0.2861501703825913,0.9184252423167912,0.75,0.9998538211392094,1.0,48/337,14.50%,DGKB;LMTK3;CDKL1;LIMD1;CCNE1;BMP2;GK;PDK4;PASK;DGKE;PIK3R4;PLK1;COPS8;CDK8;COPS2;MAPK10;ACVR1C;FRK;POMK;AKT1;CSNK2A1;TP53RK;CSNK1E;PRKAB1;STK4;FGGY;PRKACB;MAPK6;EIF2AK4;MAPK8;MAP4K5;STK38L;PRKG1;STK17B;EIF2AK3;MAP4K2;TRIB2;TAOK2;ACVR2A;PIK3CA;TAOK3;MARK2;WNK3;RNASEL;DYRK3;MORC3;NEK1;PRKD1
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),-0.4070532467879179,-0.9183130029298718,0.6309523809523809,1.0,1.0,14/77,25.08%,TRIM22;TRIM5;PLK2;PLK3;PINK1;PLEKHF1;TSC2;PIK3CB;TRIM65;TRIML2;KAT5;SUPT5H;OPTN;DCN
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),0.32490800904239786,0.9182194783028705,0.7368421052631579,0.9996485627893859,1.0,16/95,14.76%,PSMD10;BCL10;TAB3;PSMA1;PSMD11;CUL1;MAPK10;PSMB5;BTRC;PSMD14;MAPK8;PIK3CA;PSMD12;PIK3R1;NFKB1;MAP2K4
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),-0.4799891963214728,-0.9179749953308375,0.6,1.0,1.0,7/18,20.47%,SYNPO2L;TNNT1;OBSCN;MYLK3;WDR1;FHOD3;MYOZ2
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),-0.3625491610645359,-0.9177948275928699,0.6483516483516484,1.0,1.0,44/179,23.90%,RPL3;RPL19;RPS27;RPS14;RPL27A;RPL7A;RPL35;NOB1;EMG1;RPL37A;RPL21;RPL27;RPL13A;RPL9;RPS16;RPL24;RPLP1;RPL10A;RPL10;RPLP2;RPL38;RPL26L1;RPS7;RPL8;RPS15;RPL5;RPL12;RPL18A;RPS9;MRTO4;PES1;RPL23;RPS6;RPS25;DDX54;RPL7;RPL4;WDR46;RPL41;RPL11;EXOSC7;RPL15;RPL36;RPL29
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),-0.5549833200911445,-0.917499953672899,0.6166666666666667,1.0,1.0,2/8,19.46%,LRRC19;OCIAD2
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),-0.4314570589909613,-0.9170438409330799,0.6081081081081081,1.0,1.0,10/38,23.74%,IMPDH1;ADCY7;PAPSS2;GUCY1A1;ADCY5;GUCY2C;ADCY8;AK5;DCAKD;ADCY3
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),-0.41186148046154036,-0.9169555297342297,0.625,1.0,1.0,1/66,0.16%,LEF1
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406),-0.5870237457601906,-0.9168361929425748,0.578125,1.0,1.0,1/5,20.82%,DPM3
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via tryptophan (GO:0018317),-0.5870237457601906,-0.9168361929425748,0.578125,1.0,1.0,1/5,20.82%,DPM3
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),-0.44598057355988807,-0.9164534192209703,0.5822784810126582,1.0,1.0,3/38,6.49%,B2M;RPS27A;APP
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),0.41073582517568896,0.9164198950416046,0.5714285714285714,1.0,1.0,9/15,34.15%,UHMK1;YTHDF2;CDC123;RPS6KB1;MTOR;RPS6KB2;DDX3X;YTHDF3;POLR2D
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),0.3597595640265752,0.9162643885000137,0.6206896551724138,1.0,1.0,17/58,24.89%,ZNF207;SGO2;PLK1;NSL1;EPS8;AAAS;CEP192;TUBG1;TOGARAM1;ESPL1;TPX2;CTDP1;MAP9;PIBF1;KIFC2;SMC3;CLASP2
prerank,GO_Biological_Process_2021__regulation of B cell activation (GO:0050864),0.4185118331044902,0.9160975595651353,0.6666666666666666,1.0,1.0,5/13,17.49%,TNFAIP3;FOXJ1;SAMSN1;TNFSF4;IKZF3
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell membrane repolarization (GO:0099625),-0.5705114544249896,-0.9160356840579971,0.6557377049180327,1.0,1.0,1/7,2.03%,KCNQ1
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.47525455053794086,-0.9160026076008053,0.6447368421052632,1.0,1.0,1/23,0.21%,ANXA1
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),-0.4083332664635234,-0.9156324424990004,0.6190476190476191,1.0,1.0,11/69,10.97%,CLDN16;KCNJ2;SLC8A3;HTR2B;LETM2;SLC24A2;GCM2;ATP1A1;ATP1B1;SLC24A1;SLC24A5
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),-0.4755234188820824,-0.915522255070157,0.6285714285714286,1.0,1.0,7/27,19.92%,CD160;HTR2B;NYAP1;IGF1;HTR2A;PIK3CB;PIK3CD
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),0.3918258309597047,0.9154845618354308,0.6410256410256411,1.0,1.0,5/25,7.64%,DACH1;MEN1;GNL3L;STN1;HNRNPC
prerank,GO_Biological_Process_2021__iron import into cell (GO:0033212),-0.6012739842595463,-0.9154308945893146,0.6557377049180327,1.0,1.0,1/5,4.81%,SLC39A14
prerank,GO_Biological_Process_2021__serine family amino acid metabolic process (GO:0009069),0.4694279879318937,0.9153749525585732,0.6956521739130435,1.0,1.0,5/15,15.88%,DAO;CTH;PSPH;SRR;SEPSECS
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),-0.5063337146753991,-0.915278150230621,0.6417910447761194,1.0,1.0,2/15,17.64%,ATG9A;WDR45
prerank,GO_Biological_Process_2021__glomerular filtration (GO:0003094),-0.5598851382534213,-0.9152438192993974,0.6712328767123288,1.0,1.0,3/7,18.28%,SULF1;MYO1E;MCAM
prerank,GO_Biological_Process_2021__glyceraldehyde-3-phosphate metabolic process (GO:0019682),-0.5862638269410352,-0.9152126266411411,0.6825396825396826,1.0,1.0,1/7,1.98%,ALDOB
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),-0.4293322423659083,-0.9148984970686946,0.6172839506172839,1.0,1.0,4/40,11.66%,PIF1;KLF4;TCP1;PRKCQ
prerank,GO_Biological_Process_2021__delamination (GO:0060232),-0.5759720040508424,-0.9148921897214755,0.6111111111111112,1.0,1.0,2/5,21.97%,ABCA12;SPI1
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.4488065954727348,-0.9148527370417993,0.6103896103896104,1.0,1.0,1/27,0.21%,ANXA1
prerank,GO_Biological_Process_2021__vitamin D metabolic process (GO:0042359),-0.5337608266623446,-0.9147141103094335,0.6229508196721312,1.0,1.0,3/8,20.94%,GC;CYP3A4;LRP2
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.5168922860006423,0.9145240180823835,0.6176470588235294,1.0,1.0,3/10,16.39%,HSPA1A;NCK1;VHL
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),0.4662790183737631,0.9143702141663873,0.5,1.0,1.0,6/16,23.40%,EP400;ING3;SPHK2;TRRAP;RUVBL1;EPC1
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),0.44103664076174914,0.9142525758120803,0.5384615384615384,1.0,1.0,3/14,8.24%,SOX8;SOX9;SIRT6
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),-0.4034192845443442,-0.9142135373412676,0.6455696202531646,1.0,1.0,14/72,19.90%,RHOBTB2;FSCN1;BST2;RND2;BAIAP2;RHOF;DMTN;DLC1;PRKCD;RHOBTB1;SEMA3E;RHOD;ARHGAP18;DAPK3
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),0.4224910305956272,0.9141602082769664,0.4838709677419355,1.0,1.0,3/17,8.41%,MYORG;SELENON;ZBTB18
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),-0.5351412496175993,-0.9141359986672349,0.5588235294117647,1.0,1.0,1/8,1.53%,DUSP1
prerank,GO_Biological_Process_2021__mRNA 3'-end processing by stem-loop binding and cleavage (GO:0006398),-0.6154988503611037,-0.9140845781392518,0.6451612903225806,1.0,1.0,2/5,18.55%,ZNF473;LSM11
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),-0.3993790673213249,-0.9139731266125842,0.5882352941176471,1.0,1.0,14/92,19.88%,RHOBTB2;NEXN;FSCN1;BST2;RND2;BAIAP2;CLIC4;RHOF;DMTN;DLC1;PRKCD;RHOBTB1;RHOD;ARHGAP18
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),-0.43718228217010957,-0.9137827448457787,0.6052631578947368,1.0,1.0,5/33,17.64%,ATG9A;MAP1LC3A;PINK1;GABARAPL1;WDR45
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),-0.4924717298084115,-0.9135197182684972,0.5909090909090909,1.0,1.0,2/17,4.41%,B3GALT2;NDST4
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),-0.5972968413992139,-0.9135018101810429,0.6984126984126984,1.0,1.0,5/7,39.70%,ITGA3;FYN;IGF1R;PICK1;PRNP
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),0.34016780942606756,0.9134835101159716,0.65,1.0,1.0,5/49,8.52%,TMEM100;BMP2;SOX9;SMAD5;ZFYVE16
prerank,GO_Biological_Process_2021__negative regulation of T cell migration (GO:2000405),0.5844049900349548,0.913460706002646,0.6756756756756757,1.0,1.0,1/5,0.93%,CD200R1
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.40506745175928605,0.9131319801984852,0.6896551724137931,1.0,1.0,10/26,24.71%,BMP2;TWSG1;GDF11;ACVR2A;GDF10;GDF9;TGFBR1;BMP7;HFE;SMAD4
prerank,GO_Biological_Process_2021__beta-catenin destruction complex assembly (GO:1904885),0.5842749093581645,0.9130366563952357,0.6078431372549019,1.0,1.0,2/5,34.52%,AXIN1;GSK3B
prerank,GO_Biological_Process_2021__medium-chain fatty acid catabolic process (GO:0051793),0.5360062109386312,0.9130214532278134,0.6666666666666666,1.0,1.0,2/5,8.72%,ACADM;ABHD1
prerank,GO_Biological_Process_2021__taurine metabolic process (GO:0019530),0.5620107088671977,0.9128469035085817,0.5918367346938775,1.0,1.0,1/5,6.99%,CSAD
prerank,GO_Biological_Process_2021__protein localization to condensed chromosome (GO:1903083),0.48675330296674724,0.9122104503171646,0.5555555555555556,1.0,1.0,1/9,1.46%,CHAMP1
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),-0.4726190715534787,-0.9122077603632176,0.6521739130434783,1.0,1.0,2/25,4.49%,ICAM1;TJP3
prerank,GO_Biological_Process_2021__natural killer cell differentiation (GO:0001779),0.5070584667095175,0.9121980158359886,0.59375,1.0,1.0,4/8,15.27%,RABL3;PBX1;TOX;KAT7
prerank,GO_Biological_Process_2021__maintenance of DNA repeat elements (GO:0043570),0.5261351991198358,0.9120900586785413,0.6086956521739131,1.0,1.0,2/6,14.11%,MSH2;MSH3
prerank,PanglaoDB_Augmented_2021__Mast Cells,-0.37329171487360513,-0.9119102706365463,0.6105263157894737,1.0,1.0,18/164,8.59%,ENPP2;IL1R1;APLNR;DUSP1;SPARC;A4GALT;C1R;RAMP3;KDELR3;ABCA8;SLA;MAOB;GPR34;HS3ST3A1;CCL2;PODN;RASL12;LDB2
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),-0.4288896982762733,-0.9115027530826669,0.5606060606060606,1.0,1.0,4/35,10.45%,CLDN16;POF1B;CLDN20;CLDN18
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),0.30512114910128524,0.9114366031690784,0.7,1.0,1.0,14/85,13.52%,WNT7A;AGER;MEN1;DUSP19;SERPINF2;EGFR;HMGB1;TIRAP;MARVELD3;SH3RF1;MAP4K2;SIRPA;TAOK2;TAOK3
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.39019483154821266,0.9112896205313685,0.625,1.0,1.0,5/26,8.69%,CSPG5;CHST11;CHST7;CSGALNACT1;BCAN
prerank,GO_Biological_Process_2021__phosphatidylinositol acyl-chain remodeling (GO:0036149),0.5223182721016196,0.9111898706528508,0.55,1.0,1.0,5/9,38.40%,PLA2G4C;PLBD1;LPGAT1;LCLAT1;PLA2G5
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),-0.526783272914237,-0.9109452690562942,0.6376811594202898,1.0,1.0,1/12,3.15%,NEFL
prerank,GO_Biological_Process_2021__sulfur amino acid biosynthetic process (GO:0000097),0.5354879770155586,0.9108001651276192,0.7,1.0,1.0,2/7,23.94%,CTH;CDO1
prerank,GO_Biological_Process_2021__basement membrane assembly (GO:0070831),-0.5443405931047993,-0.910776283269189,0.6166666666666667,1.0,1.0,1/7,3.55%,LAMB1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),-0.4666995981152684,-0.9107375957789956,0.6716417910447762,1.0,1.0,3/23,12.47%,CCL2;TRPC3;GRM6
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),-0.4335672535024988,-0.9106894056528706,0.5866666666666667,1.0,1.0,3/31,10.11%,NEFL;HAP1;DCTN1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),0.4556796158741073,0.910636384797361,0.5454545454545454,1.0,1.0,4/11,29.73%,DNAJC13;MAP2K2;USP7;MAPK1
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),-0.5179800678095448,-0.9106197692814664,0.6307692307692307,1.0,1.0,1/14,3.92%,ITPKC
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),-0.5544304736021155,-0.9105012355210039,0.6515151515151515,1.0,1.0,1/7,7.82%,PLN
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),-0.4012176794654272,-0.9103714022243622,0.6352941176470588,1.0,1.0,11/88,9.68%,FABP3;ABCA6;ABCA5;SLC51A;ABCA8;AKR1C1;SLCO3A1;LDLR;ABCA12;CEACAM1;SLC51B
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),0.3266227828851946,0.9099295687690793,0.45454545454545453,1.0,1.0,33/107,25.42%,PIK3R4;MTERF3;RUBCNL;VCP;CSNK2A1;PGAM5;VPS37A;PRKAB1;SNF8;CSNK2A2;VTA1;VPS39;TOMM22;PIK3C3;VPS37B;TBC1D5;CHMP2B;HDAC10;PIP4K2B;SNAP29;VPS4B;PRKAA1;CHMP6;LIX1L;EI24;MFN2;DYNLL2;UBQLN1;VPS16;TMEM74;BECN1;VIPAS39;VPS41
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),0.44318063785216144,0.9098191436203794,0.5789473684210527,1.0,1.0,2/13,13.12%,SNAP91;WASL
prerank,GO_Biological_Process_2021__positive regulation of 3'-UTR-mediated mRNA stabilization (GO:1905870),-0.6336299178560986,-0.9095679402615753,0.7142857142857143,1.0,1.0,1/5,7.69%,ELAVL4
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,-0.3760193372975903,-0.9094299325485414,0.6470588235294118,1.0,1.0,10/95,9.52%,SIX3;TAGLN3;SNCB;ZDHHC22;RND2;EFNB3;MAP1B;GAP43;NEFH;ZNF536
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),0.5251784271109139,0.909170385902564,0.55,1.0,1.0,1/7,1.63%,AGER
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),0.29111003638792105,0.9087203846187946,1.0,1.0,1.0,27/231,11.93%,OTUD3;PSMD10;KDM1B;CDC25A;PSMA1;TNFAIP3;USP13;INO80D;PSMD11;KAT2B;KEAP1;COPS8;USP38;COPS2;BRCC3;USP40;PSMB5;USP12;VCP;AR;YY1;OTUB2;KAT2A;USP27X;PSMD14;UBE2D1;COPS7A
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),0.3824083385679376,0.908717455430267,0.5714285714285714,1.0,1.0,2/33,3.51%,DGKB;DGKE
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),0.41965903215174394,0.908603389503638,0.5555555555555556,1.0,1.0,1/21,0.67%,RGCC
prerank,GO_Biological_Process_2021__heart process (GO:0003015),-0.5470489745252217,-0.9085943327990854,0.609375,1.0,1.0,1/10,3.49%,RAMP3
prerank,GO_Biological_Process_2021__negative regulation of interleukin-10 production (GO:0032693),0.5343069289220503,0.9084889214851409,0.6666666666666666,1.0,1.0,2/8,12.56%,AGER;TRIB2
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),-0.44967842506718897,-0.908355084982989,0.6233766233766234,1.0,1.0,4/32,8.70%,ABCA5;ABCA8;AKR1C1;LDLR
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,-0.35408829998029545,-0.9081145747783704,0.6341463414634146,1.0,1.0,37/144,20.21%,TAGLN3;POU4F1;STMN2;NEFL;NEFM;SNCB;ZDHHC22;SH3GL2;SLITRK1;SYT4;LRRTM1;GAP43;DCTN1;NELL1;NYAP1;HPCA;CA10;TCEAL2;PLPPR5;TMEM163;JPH3;LHFPL5;CALY;C11ORF87;STMN4;NARF;GDAP1L1;CRMP1;CNTN2;KCNC1;CCDC184;TCEAL5;FGF12;SNCG;SYT16;SLC29A4;SULT4A1
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),0.3958942188732723,0.9080522789646125,0.6785714285714286,1.0,1.0,6/23,18.70%,MOSMO;VCP;BTRC;GLI3;KCTD21;HERC4
prerank,GO_Biological_Process_2021__SMAD protein complex assembly (GO:0007183),-0.5851074932004738,-0.9073290446543766,0.6507936507936508,1.0,1.0,2/6,19.49%,EID2;TGFB1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.47893753906327563,0.9073090262058724,0.6060606060606061,1.0,1.0,2/11,5.07%,AFG1L;COX10
prerank,GO_Biological_Process_2021__heparin metabolic process (GO:0030202),0.611379229716804,0.9071844474782479,0.6486486486486487,1.0,1.0,1/5,5.24%,CSGALNACT1
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),0.35770231314137246,0.9071798027564744,0.5357142857142857,1.0,1.0,7/41,9.17%,POLD3;PRIMPOL;RFC3;UBE2N;VCP;WDR33;MSH2
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),-0.5551901150617927,-0.9069079368393475,0.711864406779661,1.0,1.0,2/9,12.21%,ZIC1;PAX8
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),-0.4949108475343887,-0.9068732218345896,0.6666666666666666,1.0,1.0,6/14,25.59%,CPLX1;CPLX2;KCNMB4;FLOT1;MCTP1;RIMS1
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),-0.5523428943429883,-0.9065927165056197,0.6617647058823529,1.0,1.0,1/9,2.55%,PLAAT4
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),-0.4345348599446283,-0.9065732326263573,0.6025641025641025,1.0,1.0,2/33,1.44%,BLM;RECQL4
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle assembly (GO:0034379),0.5095310652699381,0.9065261657031133,0.6,1.0,1.0,1/8,2.56%,MTTP
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),-0.3507675890752008,-0.9064841703500532,0.7938144329896907,1.0,1.0,43/373,17.31%,CD24;ARHGAP4;BLM;POU4F1;GBP1;VRK2;TAGAP;ARHGAP15;ARHGEF3;TRIP10;PLEKHG2;ARHGEF17;WNT5A;ARHGAP9;ARHGAP39;BRCA1;AKAP5;DEPDC1B;CEACAM1;ARHGDIG;PLK3;NLRP12;RIT2;PRDM1;RPA3;ARHGEF18;WDR54;NUAK1;BIRC3;MINK1;DAB2IP;FGF1;RPL5;RHOF;TAF10;OBSCN;CDK2;VAV1;NLGN1;DLC1;RPA1;CDK5;IER3
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),-0.40705547099900313,-0.9064538222722706,0.6547619047619048,1.0,1.0,11/77,12.52%,THBS1;HPN;TGFBR2;RAMP3;AKR1C1;CCNB1;EGF;GADD45A;KLF4;PAX8;ROMO1
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),-0.46565650129490055,-0.9063855343481099,0.6233766233766234,1.0,1.0,5/25,18.85%,ARG2;CYP1B1;GCHFR;NOS1;SPHK1
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),-0.3986623176876154,-0.9060641527927868,0.7023809523809523,1.0,1.0,16/84,17.52%,ARHGAP4;SULF1;BST2;IGFBP5;SPOCK3;THY1;PODN;CYP1B1;WAS;CLIC4;SFRP2;TMEFF2;DPYSL3;DLC1;LDLRAD4;SPINT2
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),0.45767727187161505,0.9060168107543446,0.4883720930232558,1.0,1.0,3/12,26.41%,SNX2;SNX1;SURF4
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.4383375327118336,0.9058983853935796,0.5625,1.0,1.0,2/14,12.12%,HSPA1A;OPA1
prerank,GO_Biological_Process_2021__myelination (GO:0042552),-0.4299245577320546,-0.9057508400939615,0.6329113924050633,1.0,1.0,9/43,17.18%,BCAS1;CNTNAP1;SLC8A3;PLP1;KLK6;EIF2B2;SCN2A;PLLP;MYRF
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),-0.4058406947111943,-0.9056098898556109,0.6666666666666666,1.0,1.0,17/83,18.85%,SEPTIN5;RAB11A;USP6;PLD1;HAP1;SYT1;CPLX1;RIMS2;RIT2;SEPTIN4;CPLX2;SYK;FES;TSC2;RAB3C;PTPRC;SPHK1
prerank,GO_Biological_Process_2021__glutamine transport (GO:0006868),-0.5844531156720911,-0.9054683594321146,0.5740740740740741,1.0,1.0,1/5,12.10%,SLC38A1
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),-0.44536963531943946,-0.9054396921191391,0.6216216216216216,1.0,1.0,1/29,1.07%,EFNA1
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),0.38916046182178315,0.9053615076820066,0.6538461538461539,1.0,1.0,6/28,21.10%,GRPEL2;PEX2;TIMM23;PEX12;PEX6;CHCHD4
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),0.4988500995609828,0.9050675567290923,0.5,1.0,1.0,2/10,8.01%,PLK1;BTRC
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,-0.38107053963064125,-0.9048867411199721,0.6625,1.0,1.0,34/101,23.72%,CDH22;STMN2;GRIN2A;SLITRK1;SRRM4;GRIA1;GAP43;TCEAL6;HPCA;RIT2;CA10;CPLX2;SCN2A;SCN1A;C11ORF87;STMN4;GRIN2B;GAD2;SYNPR;SCN3B;CNTN2;KCNC1;GABRG2;DIRAS2;CNTNAP5;GABRA1;TMEM130;OPCML;SLC1A6;ST8SIA3;KCNC2;SLC17A7;CELF4;PTPN5
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),0.4562477520735836,0.9047399909959379,0.575,1.0,1.0,1/11,1.69%,NIPAL1
prerank,GO_Biological_Process_2021__response to interleukin-6 (GO:0070741),-0.551231937768293,-0.9046571487989318,0.6153846153846154,1.0,1.0,3/8,14.84%,ST3GAL6;CHI3L1;SBNO2
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),0.29835241474702995,0.9046504983077618,0.7272727272727273,1.0,1.0,20/97,20.44%,TMX1;TRIB3;PPP1R15B;EIF2S1;GORASP2;TMEM33;VCP;NCK1;ATF6;EIF2AK3;DERL1;PIK3R1;ERN1;UFM1;TMTC3;RHBDD1;ERP44;RCN3;BCL2L11;SEL1L
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),-0.41178178444297264,-0.9046096015683868,0.6538461538461539,1.0,1.0,10/62,17.32%,S100A10;MET;SYNPO2L;WAS;PFN2;ARHGEF18;TMEFF2;STMN1;DLC1;PPFIA1
prerank,GO_Biological_Process_2021__phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),0.5508808143214368,0.9042021873291708,0.5384615384615384,1.0,1.0,5/8,27.64%,GTF2H5;CDK12;GTF2H3;CCNH;CDK13
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),-0.5764663296238894,-0.9040880899016948,0.6551724137931034,1.0,1.0,3/9,23.07%,MAP1LC3A;GABARAPL1;GABARAPL2
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),-0.5764663296238894,-0.9040880899016948,0.6551724137931034,1.0,1.0,3/9,23.07%,MAP1LC3A;GABARAPL1;GABARAPL2
prerank,GO_Biological_Process_2021__mammary gland duct morphogenesis (GO:0060603),0.5723800943318298,0.9039391729053263,0.5517241379310345,1.0,1.0,1/5,11.11%,CSF1R
prerank,GO_Biological_Process_2021__response to dsRNA (GO:0043331),-0.5663445625801531,-0.9038659588526142,0.55,1.0,1.0,2/7,9.56%,RFTN1;TLR3
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in immune response (GO:0002719),-0.5413826927685041,-0.9035572393170078,0.6515151515151515,1.0,1.0,4/9,26.51%,HLA-F;TGFB1;CUEDC2;TGFB3
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,-0.4308611430444479,-0.90312517585461,0.6296296296296297,1.0,1.0,8/45,15.67%,MSX2;OVOL2;BAIAP2L1;ABCA12;EMP2;CCND1;RHBDF1;AMOTL2
prerank,GO_Biological_Process_2021__acylglycerol biosynthetic process (GO:0046463),0.4322758895713091,0.902873049980691,0.5666666666666667,1.0,1.0,4/17,8.44%,AGMO;GK;LPIN3;MOGAT1
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),-0.4105244897963722,-0.9028388034737522,0.6375,1.0,1.0,3/40,6.36%,L1CAM;SHTN1;SLITRK1
prerank,GO_Biological_Process_2021__membrane repolarization during ventricular cardiac muscle cell action potential (GO:0098915),-0.6183427940309194,-0.9027977434808793,0.6851851851851852,1.0,1.0,1/5,2.03%,KCNQ1
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.44045467261863724,-0.9024987106970168,0.6410256410256411,1.0,1.0,7/35,17.04%,EPN1;SH3GL2;EGF;DAB2IP;MVP;TGFA;SNX6
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),0.5163789949053675,0.9021008138124571,0.6410256410256411,1.0,1.0,5/11,27.39%,SESN2;SESN3;KPTN;SESN1;ITFG2
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),-0.43742549116521146,-0.9020093934513865,0.6455696202531646,1.0,1.0,2/40,0.43%,CCBE1;THBS1
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),-0.5724130850767342,-0.9015010144806754,0.6774193548387096,1.0,1.0,1/7,2.43%,ZFP36
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),-0.47961264044006086,-0.9014835346603696,0.6410256410256411,1.0,1.0,8/24,21.22%,ICAM1;GRIN2A;APP;IGF1;SNX6;CDK5;CACNB1;ABCC1
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),-0.5242577300616518,-0.9014047063836611,0.625,1.0,1.0,1/13,1.79%,PGR
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),-0.47820801703458526,-0.9010777128476193,0.5970149253731343,1.0,1.0,5/17,20.11%,CYP1B1;C12ORF57;IFT122;CACNA1C;LAMA1
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),-0.4827591625956986,-0.9010707365628903,0.6027397260273972,1.0,1.0,2/15,3.49%,POU4F1;RAMP3
prerank,GO_Biological_Process_2021__negative regulation of coagulation (GO:0050819),0.5378966311503387,0.9007530054520761,0.5714285714285714,1.0,1.0,1/6,2.18%,HS3ST5
prerank,GO_Biological_Process_2021__multi-ciliated epithelial cell differentiation (GO:1903251),0.5594955556098572,0.9007462946359632,0.5555555555555556,1.0,1.0,2/5,14.20%,CEP152;E2F4
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),-0.5071715872404658,-0.9006576090437971,0.6716417910447762,1.0,1.0,4/15,18.89%,TYMP;CRMP1;DPYSL3;DPYSL2
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),0.5088127999325918,0.9003246463463837,0.5517241379310345,1.0,1.0,1/7,4.47%,SERPINB9
prerank,GO_Biological_Process_2021__late nucleophagy (GO:0044805),-0.6045742373006415,-0.9002844559774702,0.6896551724137931,1.0,1.0,1/6,10.52%,ATG9A
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),-0.4259872951204542,-0.9002713964427318,0.6666666666666666,1.0,1.0,1/30,0.78%,BLM
prerank,GO_Biological_Process_2021__foam cell differentiation (GO:0090077),-0.5978393982489745,-0.8999458575140418,0.6612903225806451,1.0,1.0,3/5,21.15%,STAT1;TGFB1;SOAT1
prerank,GO_Biological_Process_2021__macrophage derived foam cell differentiation (GO:0010742),-0.5978393982489745,-0.8999458575140418,0.6612903225806451,1.0,1.0,3/5,21.15%,STAT1;TGFB1;SOAT1
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),0.5518171543985878,0.899914145535524,0.6363636363636364,1.0,1.0,4/6,37.40%,DCP1A;DDX1;DDX3X;DHX9
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),0.3792368160680441,0.8997192731048802,0.6538461538461539,1.0,1.0,5/36,8.13%,SLC6A13;SLC47A1;SLC25A18;SLC3A2;SFXN2
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),-0.4514860879404823,-0.8995379762654255,0.6710526315789473,1.0,1.0,6/28,22.78%,DUSP1;DUSP16;TNS2;PTPRO;PTPRF;DUSP8
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),-0.5111334211336931,-0.899349040954029,0.5737704918032787,1.0,1.0,1/10,5.64%,BHMT
prerank,GO_Biological_Process_2021__alditol metabolic process (GO:0019400),0.5888189725242008,0.8990415533611051,0.7021276595744681,1.0,1.0,2/5,3.21%,GK;COQ3
prerank,GO_Biological_Process_2021__positive regulation of cholesterol metabolic process (GO:0090205),-0.5918168158860344,-0.8989495049189609,0.6607142857142857,1.0,1.0,1/5,14.46%,FGF1
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),-0.5036548147305826,-0.8988145267296664,0.6666666666666666,1.0,1.0,2/15,5.25%,SIX3;POF1B
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),-0.4285187370174554,-0.8987475967049152,0.6829268292682927,1.0,1.0,5/39,9.23%,GRAMD2A;PLN;CAV3;PLPP4;EGF
prerank,GO_Biological_Process_2021__glycoside catabolic process (GO:0016139),0.5054896607718783,0.8983072258740601,0.5161290322580645,1.0,1.0,2/8,33.34%,ABHD10;GBA2
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",-0.5894353117948462,-0.8981955757791158,0.7021276595744681,1.0,1.0,2/7,14.93%,ZFP36;EDC4
prerank,GO_Biological_Process_2021__regulation of synapse structural plasticity (GO:0051823),-0.6162305472651702,-0.8981670734328825,0.639344262295082,1.0,1.0,2/5,26.19%,FRMPD4;CAMK1
prerank,GO_Biological_Process_2021__mesenchyme development (GO:0060485),0.47499022561917764,0.8977297693026625,0.6206896551724138,1.0,1.0,1/10,2.60%,BMP2
prerank,GO_Biological_Process_2021__vascular associated smooth muscle contraction (GO:0014829),0.5301482423512817,0.8976899814472191,0.5666666666666667,1.0,1.0,2/5,20.83%,PIK3C2A;EDNRB
prerank,GO_Biological_Process_2021__bone development (GO:0060348),-0.4650343306191577,-0.897623245799744,0.647887323943662,1.0,1.0,5/25,18.80%,SULF1;NOTUM;SFRP4;PPIB;PTPRC
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),0.2977024808642859,0.8975888942970297,1.0,1.0,1.0,88/375,20.27%,POU6F2;RNF6;LIMD1;ZNF117;PPARGC1A;CEBPA;SOX21;BMP2;ZNF212;ZNF195;MITF;ATF5;USP13;POFUT1;SLC39A8;HES6;HCLS1;APBB3;METTL18;ZNF680;SOX12;ESRRG;ZNF676;RORB;ZNF502;RABL3;ZNF74;THAP1;SLC2A4RG;ZNF268;NR3C1;ZNF492;FBXO5;GLI4;RNF14;NFYC;YAF2;HP1BP3;ZNF703;ZNF875;MAGED1;ESRRA;ZNF341;ZNF33A;EIF4E;ORC5;ZNF280D;PATZ1;TGFBRAP1;APBB2;ZNF736;DVL2;ZNF519;HMG20A;GPBP1L1;SMARCA2;ZNF138;EP300;KAT7;HDAC10;NCOA2;CHD7;BACH1;METAP1;NR1D2;VHL;ZNHIT3;CCDC88A;FOXN2;ANKRD17;NLK;EFEMP1;SP3;VSX1;PSPC1;ZNF737;PPIE;CNBP;MED23;ZNF253;CCAR2;ZNF460;ESRRB;HINFP;DDX25;RHOXF1;PRDM2;NFXL1
prerank,GO_Biological_Process_2021__inner ear receptor cell stereocilium organization (GO:0060122),-0.5791140518201374,-0.8974328619447499,0.647887323943662,1.0,1.0,4/7,37.87%,USH1C;PLS1;IFT88;PDZD7
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),-0.408850850647057,-0.8970774644128304,0.6075949367088608,1.0,1.0,15/58,19.29%,CLIC1;ANO2;ANO9;BEST1;CLIC4;GLRA2;GABRB2;GABRD;SLC26A8;GABRE;GABRG2;GLRA1;SLC4A10;GABRA1;SLC12A7
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),0.43424502483183924,0.8969781254842598,0.5555555555555556,1.0,1.0,8/19,21.87%,TFB2M;TFB1M;ZCCHC4;METTL15;NSUN3;FBL;MRM3;FBLL1
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),-0.39566796381513036,-0.8965599593857055,0.6627906976744186,1.0,1.0,20/86,22.14%,HPN;L1CAM;SHTN1;SYT4;RPS6KA1;MMP14;SYT1;RIMS2;SFRP2;CPNE9;IGF1;BDNF;MFSD2A;TAF9B;SYT2;SPHK1;HYAL1;SFRP1;AKAP6;MAPT
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.48911841816951873,-0.8965265417802672,0.6133333333333333,1.0,1.0,5/15,31.78%,PARP9;WRAP53;DTX3L;SHLD1;KDM4D
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),0.3137409350140184,0.8964206564322212,0.9166666666666666,1.0,1.0,21/113,14.74%,PSMD10;PSMA1;GSKIP;GPC5;PSMD11;EGFR;PSMB5;CAPRIN2;VCP;RNF146;GID8;PPM1A;CSNK1E;SCEL;PSMD14;ZEB2;CSNK1G3;PSMD12;LGR4;KANK1;NFKB1
prerank,GO_Biological_Process_2021__positive regulation of cellular extravasation (GO:0002693),-0.5125648065540908,-0.8962650934531673,0.6818181818181818,1.0,1.0,3/10,10.33%,ICAM1;THY1;CD99
prerank,GO_Biological_Process_2021__response to vitamin (GO:0033273),-0.6108631380728069,-0.8961236928513786,0.7121212121212122,1.0,1.0,3/5,21.20%,ALPL;SPP1;CDKN2D
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,0.3027080765566304,0.8961030534678122,0.75,1.0,1.0,32/128,15.44%,SLITRK2;DAO;AMER2;ADGRA1;GABRG1;KCNA2;NTSR2;ADGRB3;P2RY1;EGFR;MAPK10;TRPM3;CHL1;GRIA2;SLC4A4;NRXN1;CADM2;ATP1A2;RBFOX1;GPM6B;BTBD17;SLCO1C1;SLC6A1;ZEB2;GRM3;KCNJ10;PMP2;FAIM2;MAGI2;ELAVL3;GDF10;GPR37L1
prerank,PanglaoDB_Augmented_2021__Eosinophils,0.39326588911860794,0.8959061016775733,0.68,1.0,1.0,4/34,6.12%,C1ORF162;NR1D1;EPX;HCLS1
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),-0.4842656763808683,-0.895894780175183,0.631578947368421,1.0,1.0,1/15,1.77%,TGFBR2
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),-0.501870436226517,-0.8954691577631256,0.6875,1.0,1.0,1/11,9.67%,C12ORF57
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),-0.4419720108384315,-0.8951877350376705,0.6493506493506493,1.0,1.0,4/41,8.93%,AWAT1;ALOX12;CYP4Z1;CYP1B1
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),0.5181386615060979,0.8951091683164085,0.6052631578947368,1.0,1.0,5/9,35.21%,PLXNA3;PLXNA2;PLXNB2;PLXNB3;PLXNA1
prerank,GO_Biological_Process_2021__urea cycle (GO:0000050),-0.5588480926573711,-0.895011365465676,0.6363636363636364,1.0,1.0,1/7,4.45%,ARG2
prerank,GO_Biological_Process_2021__regulation of proton transport (GO:0010155),0.5200617833891169,0.8949477084094565,0.5897435897435898,1.0,1.0,3/7,30.80%,SPHK2;SLC30A5;ATPSCKMT
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),-0.45357094335642606,-0.8947939776895528,0.6142857142857143,1.0,1.0,3/26,9.03%,ART3;PARP14;PARP9
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),-0.46660031322752693,-0.8946302631270144,0.618421052631579,1.0,1.0,7/23,19.95%,ADCY7;GIPR;GLP1R;LGR5;ADCY5;RXFP1;ADCY8
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),-0.4179313172715797,-0.8944470763534048,0.6619718309859155,1.0,1.0,2/37,4.83%,PIF1;HELB
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),0.3709742210215773,0.8942946669890175,0.6666666666666666,1.0,1.0,4/43,4.64%,HS3ST5;SDC4;SDC3;GPC5
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),-0.4960818807413272,-0.89419250725988,0.6451612903225806,1.0,1.0,1/12,5.71%,FSCN1
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),0.41956930641114154,0.8931412094393916,0.6296296296296297,1.0,1.0,1/13,0.72%,SLITRK2
prerank,GO_Biological_Process_2021__pseudouridine synthesis (GO:0001522),0.4662089487442094,0.8929439924380839,0.5806451612903226,1.0,1.0,2/13,8.29%,PUS10;PUS7L
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),0.28829516173927405,0.8927040162557662,0.8666666666666667,1.0,1.0,30/153,17.62%,DGKB;PIP5K1B;PLD6;PI4K2A;DGKE;LPIN3;PIK3R4;CPNE3;ABHD5;PTDSS1;CSNK2A1;CHPT1;CSNK2A2;PLA2G4C;SACM1L;PIK3C3;PLEKHA3;PIK3CA;RAB4A;PIK3R1;DGKH;CPNE1;PIP4K2B;FIG4;GNPAT;PCTP;PIK3C2A;PIP4K2C;PTPN13;CEPT1
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by miRNA (GO:0060965),-0.5753737473897862,-0.8926398218387303,0.6885245901639344,1.0,1.0,2/7,19.49%,DND1;TGFB1
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),-0.37241072441952505,-0.8926182673534188,0.71875,1.0,1.0,13/170,11.48%,TLCD2;A4GALT;ANK3;ATP8B4;GOLGA8O;MYOF;SUN3;USP50;CAV3;DYSF;SYP;SYNGR2;GOLGA8B
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),-0.5474600159257136,-0.8924600344724624,0.7014925373134329,1.0,1.0,2/11,14.80%,WDR54;LRPAP1
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),-0.39848510450476554,-0.8923478183200378,0.6823529411764706,1.0,1.0,10/83,16.04%,KLF2;RASGRP1;PLK2;APP;WNT5A;KLF4;DAB2IP;VIP;IL18;HECW2
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.43218269009594956,-0.8919290270367001,0.6153846153846154,1.0,1.0,2/32,3.92%,SOCS3;ITPKC
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),-0.4250555576076643,-0.8916561524822583,0.6153846153846154,1.0,1.0,3/42,7.91%,CP;SLC39A14;STEAP3
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),-0.5497572156025656,-0.8916252518987923,0.6271186440677966,1.0,1.0,1/8,2.68%,ANK3
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),0.36545088111203544,0.8914689131629728,0.6875,1.0,1.0,8/41,16.11%,WNT7A;WDR91;METTL18;AKT1;SSH1;EIF4E;NFKB1;METAP1
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),0.4117069647331912,0.8913783879711644,0.6296296296296297,1.0,1.0,3/9,32.48%,SLC25A5;FBXO7;PRKN
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),-0.45325328533329134,-0.8911638390433301,0.671875,1.0,1.0,2/26,13.41%,RPS27A;UBC
prerank,GO_Biological_Process_2021__rRNA base methylation (GO:0070475),-0.5842184633696388,-0.8909008215306984,0.6206896551724138,1.0,1.0,1/6,7.54%,EMG1
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),-0.5078790928184204,-0.8908616102985927,0.6338028169014085,1.0,1.0,2/15,13.66%,DDX60;BIRC3
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.402583116327147,-0.8907465823423023,0.7402597402597403,1.0,1.0,11/48,18.20%,CCNB2;BLM;CCNI2;CCNB1;GADD45A;HERC5;CCND1;CCNE2;CDKN3;CDC37;CDKN1A
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),-0.47309863796526885,-0.8905589098380965,0.703125,1.0,1.0,2/13,18.79%,SET;RPL23
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.5474344267278397,-0.8905326883526037,0.6885245901639344,1.0,1.0,1/9,4.51%,ST18
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),-0.4672270065620566,-0.890339484028378,0.6388888888888888,1.0,1.0,6/23,21.26%,PLEKHG2;WAS;PFN2;WDR1;ARHGAP18;COTL1
prerank,GO_Biological_Process_2021__tRNA wobble base modification (GO:0002097),0.45826510188926955,0.8901849442305018,0.5517241379310345,1.0,1.0,5/13,17.92%,ADAT2;DPH3;ELP4;MTO1;ELP3
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.47519423626896157,-0.8900480277429801,0.589041095890411,1.0,1.0,7/18,22.72%,HIC1;HEXIM1;RPS7;RPS15;RPL23;EIF5A;RPS20
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.4557674287913143,-0.8899178431151833,0.6419753086419753,1.0,1.0,6/26,21.22%,RPS27A;RPA3;UBC;RPA1;RBX1;CETN2
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),-0.49198489864993245,-0.8898324097664941,0.6338028169014085,1.0,1.0,1/13,1.53%,DUSP1
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),-0.3828590898223701,-0.8898280428973094,0.691358024691358,1.0,1.0,13/55,21.20%,CDKN2A;PLK2;PLK3;CRLF3;CCND1;CCNE2;CDK2;MAX;CDKN3;CDKN1A;CDC7;BCAT1;CDKN2D
prerank,GO_Biological_Process_2021__intracellular pH elevation (GO:0051454),0.5463230522934641,0.8896679372259227,0.5757575757575758,1.0,1.0,1/6,6.75%,SLC26A3
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),0.3591590205861701,0.8895880931350381,0.6111111111111112,1.0,1.0,4/49,2.62%,ATP11C;PRELID2;MTTP;ABCA1
prerank,GO_Biological_Process_2021__cerebral cortex cell migration (GO:0021795),0.5227764389812446,0.8895227453952255,0.6521739130434783,1.0,1.0,1/5,7.60%,PEX13
prerank,GO_Biological_Process_2021__regulation of T cell mediated immune response to tumor cell (GO:0002840),0.5061713914793942,0.8894905127352994,0.5777777777777777,1.0,1.0,2/5,12.10%,HMGB1;FBXO38
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity (GO:0097202),-0.5319169486770866,-0.8892589111391264,0.5652173913043478,1.0,1.0,4/12,23.46%,GRIN2A;FADD;RIPK2;CASP8
prerank,GO_Biological_Process_2021__negative regulation of activated T cell proliferation (GO:0046007),-0.5450354948283569,-0.8886481110413395,0.65,1.0,1.0,1/7,10.25%,PDCD1LG2
prerank,GO_Biological_Process_2021__regulation of store-operated calcium entry (GO:2001256),-0.5420986875276813,-0.8886156713998496,0.6885245901639344,1.0,1.0,1/9,3.40%,GRAMD2A
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.44427701106174383,-0.8884832340472042,0.6376811594202898,1.0,1.0,6/31,12.52%,THBS1;TGFBR2;AKR1C1;GADD45A;SYK;ROMO1
prerank,PanglaoDB_Augmented_2021__Neuroblasts,0.31572926131387147,0.8884664290402152,0.8095238095238095,1.0,1.0,21/111,14.40%,POU6F2;SPSB4;ASCL1;CSPG5;EFNA2;SNAP91;POU3F2;EGFR;TSHZ1;PBX1;ERBB4;RHBDL3;CNTFR;PPM1E;BTBD17;SALL3;CACNA1B;MARK2;TUBB2B;SLC35F1;ELAVL3
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),-0.528713762109484,-0.8884532153826155,0.6515151515151515,1.0,1.0,4/10,23.46%,IL15;CD4;HLA-DRB1;CASP8
prerank,GO_Biological_Process_2021__phospholipid efflux (GO:0033700),0.5216230297329901,0.8883248882252659,0.675,1.0,1.0,1/6,2.62%,ABCA1
prerank,GO_Biological_Process_2021__positive regulation of melanin biosynthetic process (GO:0048023),0.5249560081400869,0.8882100807644615,0.6428571428571429,1.0,1.0,1/6,12.99%,ZEB2
prerank,GO_Biological_Process_2021__positive regulation of secondary metabolite biosynthetic process (GO:1900378),0.5249560081400869,0.8882100807644615,0.6428571428571429,1.0,1.0,1/6,12.99%,ZEB2
prerank,GO_Biological_Process_2021__toll-like receptor 9 signaling pathway (GO:0034162),0.4581011417902654,0.8879240342337197,0.6,1.0,1.0,2/11,12.25%,PIK3R4;PIK3C3
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),0.30407213461016547,0.8878049773700966,0.8181818181818182,1.0,1.0,7/70,9.06%,CD200R1;PPARGC1A;PDE12;HSPA1A;AKT1;ADNP2;NCK1
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),-0.4539479127434836,-0.8877663897758585,0.6753246753246753,1.0,1.0,5/27,15.51%,MYOF;CAV3;DYSF;MYH11;IGF1
prerank,GO_Biological_Process_2021__neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),-0.5138271765409469,-0.8875950042812115,0.6231884057971014,1.0,1.0,4/9,28.17%,RAB11A;STX1B;GRIP2;STX3
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),-0.3788278669058953,-0.8873253372357948,0.75,1.0,1.0,27/119,20.42%,RFTN1;FYB1;HLA-A;SKAP1;INPP5D;THY1;PSMB6;PSMB9;MOG;WAS;HLA-DRA;FYB2;NFKBID;EIF2B2;PRKCQ;BTN3A1;PSMC3;HHLA2;PSMA8;PSME1;CD4;THEMIS;PTPRC;PIK3CB;RIPK2;PIK3CD;PSMA7
prerank,GO_Biological_Process_2021__choline catabolic process (GO:0042426),-0.5663161050520911,-0.8873123715173002,0.7037037037037037,1.0,1.0,1/6,5.64%,BHMT
prerank,GO_Biological_Process_2021__cellular biogenic amine biosynthetic process (GO:0042401),0.4462922634600909,0.8873096692594102,0.5625,1.0,1.0,5/10,27.56%,MOXD1;SAT1;SMOX;SRM;PNMT
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),0.3328616043728265,0.887278229417723,0.6428571428571429,1.0,1.0,15/63,18.43%,BET1;PEF1;SEC22B;RAB1B;PPP6R1;KLHL12;VAPA;VAPB;CNIH1;SCFD1;SEC31B;SEC23IP;SEC24A;CNIH3;SEC23B
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),0.40726573837158314,0.8871606924407325,0.48,1.0,1.0,6/29,16.79%,UBTF;ERCC2;POLR1F;ERCC3;GTF2H5;GTF2H2
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.43281386149389517,-0.8870319920834839,0.6075949367088608,1.0,1.0,1/31,2.44%,STMN2
prerank,GO_Biological_Process_2021__protein processing involved in protein targeting to mitochondrion (GO:0006627),0.5387924410865035,0.8869647002277546,0.6428571428571429,1.0,1.0,3/5,27.81%,IMMP2L;PMPCA;MIPEP
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),-0.48667261093271363,-0.8867690106801337,0.6857142857142857,1.0,1.0,2/22,5.84%,KLF2;HTR2B
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),0.38315386370571336,0.8867383340867745,0.6666666666666666,1.0,1.0,8/32,16.77%,PLK1;TESK1;AKT1;SESN2;EIF2AK3;KAT7;PYHIN1;GLUL
prerank,GO_Biological_Process_2021__rRNA catabolic process (GO:0016075),0.4278891329559324,0.8867298503906506,0.5294117647058824,1.0,1.0,6/13,27.63%,EXOSC6;DIS3;EXOSC8;EXOSC5;DIS3L;XRN1
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),-0.4432077813050183,-0.8866626178905327,0.7051282051282052,1.0,1.0,6/33,17.72%,ZFP36;ELAVL4;YBX3;VIP;DND1;SLC11A1
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),0.49461273324069743,0.8866499140895597,0.6,1.0,1.0,2/10,5.79%,HSPA1A;GIT1
prerank,GO_Biological_Process_2021__glomerular epithelial cell development (GO:0072310),-0.5544012287300348,-0.8863053320337425,0.6461538461538462,1.0,1.0,2/7,13.37%,PODXL;MYO1E
prerank,GO_Biological_Process_2021__lipid droplet formation (GO:0140042),0.51986149564835,0.8861560144330545,0.6363636363636364,1.0,1.0,2/7,10.57%,AUP1;PLA2G4C
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),-0.5049818277517576,-0.8858036922418361,0.6086956521739131,1.0,1.0,2/10,9.37%,NEFL;HAP1
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.4297149296127126,0.8854120943020187,0.6086956521739131,1.0,1.0,4/16,16.43%,ELOVL6;ELOVL2;HACD2;ACSL3
prerank,GO_Biological_Process_2021__intracellular distribution of mitochondria (GO:0048312),-0.5663897604825778,-0.8853361911532889,0.6551724137931034,1.0,1.0,1/5,22.14%,MAPT
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),0.3926562873150952,0.8850318021816389,0.6,1.0,1.0,6/20,24.70%,CYP7B1;CYP46A1;SCP2;ABCB11;OSBPL3;OSBPL6
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),-0.35359247730962473,-0.8850017849178146,0.7790697674418605,1.0,1.0,39/175,23.91%,SCN1B;EFNA1;L1CAM;NEXN;GFRA2;SEMA3B;EFNB3;DOK1;VLDLR;WNT5A;GAP43;UNC5B;PRKCQ;DOK6;DRAXIN;SLIT3;BDNF;RAP1GAP;LRTM1;CNTN2;NOTCH3;ANOS1;SEMA3E;LAMA3;RELN;PIK3CB;PIK3CD;SEMA4G;ROBO4;LAMA1;IRS2;PTPRO;SH3KBP1;LAMA5;GPC1;VSTM2L;NIBAN2;CNTN4;GAB2
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),0.36743880345972496,0.8849033325863238,0.6363636363636364,1.0,1.0,4/32,5.72%,DNA2;PRIMPOL;RFWD3;SMARCAL1
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),0.4346432936782581,0.8848344804346271,0.6388888888888888,1.0,1.0,4/13,22.78%,IWS1;PCID2;DDX25;ENY2
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),0.31947170734424424,0.8846433645868825,0.8571428571428571,1.0,1.0,16/97,13.24%,GNL3L;PSMD10;BCL10;TNFAIP3;HSPA1A;BAG2;UBE2N;DCUN1D1;AKT1;COMMD1;UBE2D1;ADGRB1;DERL1;SASH1;RCHY1;PRMT3
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,-0.3766773843672588,-0.8845260586257071,0.75,1.0,1.0,23/105,25.40%,FLRT3;IGFBP5;EFNB3;ARHGEF17;GYG2;ATP1B1;SHC2;DAB2IP;SLC44A3;ADCY5;AMOTL2;SLC4A2;NOTCH3;SLC4A10;AQP1;SLC29A4;PTPN21;PTPRF;KIAA1217;HTR2C;EPB41L4B;PCDHB4;CTNND1
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),-0.454382038734551,-0.8844210329246253,0.6891891891891891,1.0,1.0,8/21,33.64%,CAV3;VAV1;RARG;RDX;DEPTOR;PLEK;MSN;VAV2
prerank,GO_Biological_Process_2021__regulation of hair cycle (GO:0042634),0.5259335998191709,0.8841965070517411,0.6666666666666666,1.0,1.0,1/5,10.47%,NIPBL
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),-0.38526603955629934,-0.88413672830403,0.717391304347826,1.0,1.0,6/69,9.24%,BLM;RECQL4;MEIOB;POLQ;ZSWIM7;BRCA1
prerank,GO_Biological_Process_2021__protein K29-linked ubiquitination (GO:0035519),0.5282242555434127,0.8840670819675297,0.5714285714285714,1.0,1.0,1/5,3.16%,UBE2T
prerank,GO_Biological_Process_2021__alpha-amino acid catabolic process (GO:1901606),0.4218516010725747,0.8838983461063562,0.5517241379310345,1.0,1.0,12/24,25.82%,DAO;BLMH;KYNU;IDO1;ACADSB;DDO;ALDH4A1;PRODH;GOT2;FAH;TDO2;THNSL2
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),-0.4158215167494481,-0.8837900040392024,0.6933333333333334,1.0,1.0,7/47,19.90%,SP100;PDPN;EGF;CD9;FES;ARHGAP18;DAPK3
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial translation (GO:0070131),0.4301014516704023,0.883766108491985,0.6764705882352942,1.0,1.0,4/13,23.31%,FASTKD2;MRPS27;FASTKD3;RPUSD4
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.5060536817180277,-0.8836471233129913,0.6428571428571429,1.0,1.0,5/14,25.36%,CD44;TAF9B;CD74;ZNF385A;PTTG1IP
prerank,GO_Biological_Process_2021__depyrimidination (GO:0045008),-0.5330998703705423,-0.8836123599508718,0.6507936507936508,1.0,1.0,2/8,29.05%,OGG1;MBD4
prerank,GO_Biological_Process_2021__positive regulation of vasoconstriction (GO:0045907),-0.5752608714925537,-0.8834990524667701,0.7213114754098361,1.0,1.0,1/7,2.04%,SMTNL1
prerank,GO_Biological_Process_2021__glycerolipid biosynthetic process (GO:0045017),0.4560092273749121,0.8829172195326341,0.5641025641025641,1.0,1.0,2/8,15.57%,CPNE3;CPNE1
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization to mitochondrion (GO:1903748),-0.5851162707660726,-0.8829049183298935,0.6730769230769231,1.0,1.0,1/5,22.14%,MAPT
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),-0.3869746801678815,-0.8827397786835203,0.6794871794871795,1.0,1.0,3/60,7.01%,PRAME;GRIN3A;THY1
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.37142690699954045,-0.8827387528905869,0.7093023255813954,1.0,1.0,18/113,19.78%,TRIM22;TLR2;RPS27A;TRIM5;APP;NOD1;SLCO3A1;WNT5A;PRKCQ;UBC;IL18;DDRGK1;PRKCH;SPHK1;IL1RAP;PRKCB;FLOT1;RIPK2
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),0.35675025281792094,0.8825549602698539,0.7647058823529411,1.0,1.0,5/31,8.97%,ZPR1;RAB23;HCLS1;TRIM28;IPO5
prerank,MSigDB_Hallmark_2020__Notch Signaling,-0.40214627272958553,-0.8822337971383477,0.5846153846153846,1.0,1.0,8/29,21.86%,WNT5A;LFNG;ST3GAL6;CCND1;NOTCH3;APH1A;RBX1;HES1
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),0.2743785766199734,0.8819859013588721,1.0,1.0,1.0,24/223,11.30%,OTUD3;PSMD10;KDM1B;CDC25A;PSMA1;TNFAIP3;USP13;INO80D;PSMD11;KAT2B;KEAP1;USP38;BRCC3;USP40;PSMB5;USP12;VCP;AR;YY1;OTUB2;KAT2A;USP27X;PSMD14;UBE2D1
prerank,GO_Biological_Process_2021__tRNA thio-modification (GO:0034227),-0.5839737573585505,-0.8817972756009713,0.6785714285714286,1.0,1.0,1/5,11.96%,CTU2
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),-0.509825837182368,-0.8817328274209512,0.6805555555555556,1.0,1.0,1/10,2.03%,KCNQ1
prerank,GO_Biological_Process_2021__positive regulation of blood-brain barrier permeability (GO:1905605),-0.6115182413522859,-0.8809454424668387,0.7121212121212122,1.0,1.0,1/5,4.49%,TJP3
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),0.4332552965273391,0.8809172808669983,0.6571428571428571,1.0,1.0,4/12,20.12%,FBLN1;HNRNPU;AGO3;GJA1
prerank,GO_Biological_Process_2021__fructose catabolic process (GO:0006001),-0.596731365849178,-0.8807038051227694,0.6851851851851852,1.0,1.0,1/5,1.98%,ALDOB
prerank,GO_Biological_Process_2021__fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate (GO:0061624),-0.596731365849178,-0.8807038051227694,0.6851851851851852,1.0,1.0,1/5,1.98%,ALDOB
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),-0.3828572327559205,-0.8806959079539771,0.6704545454545454,1.0,1.0,16/78,24.62%,TYMS;IGFBP5;HAP1;RPL13A;PATL2;IGF1;ORMDL2;RTN1;SPHK1;SAMD4A;DAPK3;EIF4A3;SHMT1;RTN2;EIF2AK2;IGF2BP2
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),0.39368036136959556,0.8804522200365372,0.5,1.0,1.0,2/19,8.52%,NCOA4;ZFYVE16
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),-0.421643207133402,-0.8801352266189739,0.6388888888888888,1.0,1.0,8/35,23.09%,A4GALT;B3GNT5;PIGA;PGAP2;PIGC;DPM3;PIGH;ST8SIA3
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),-0.41199006103238484,-0.8800194155469949,0.6842105263157895,1.0,1.0,2/39,3.72%,TRIM5;ARIH2
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),-0.484372283147579,-0.8800006018223644,0.6617647058823529,1.0,1.0,2/15,5.51%,TYMS;HROB
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),-0.40423082204432353,-0.8799741376010822,0.6785714285714286,1.0,1.0,17/56,28.36%,AGPAT4;ACSM5;ACSL5;LIPI;OLAH;CYP21A2;LIPH;OXSM;MVK;ALOX5;SREBF1;PAM;ACSM3;SCD;XBP1;LSS;ACSL1
prerank,GO_Biological_Process_2021__regulation of histone H2B ubiquitination (GO:2001166),0.5051483546401148,0.8797096965597129,0.6097560975609756,1.0,1.0,2/5,20.96%,WDR70;RNF20
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),-0.3667268978780625,-0.8797080355515182,0.7282608695652174,1.0,1.0,30/172,19.86%,HPN;CDKN2A;RASGRP2;PSRC1;TP53TG5;KIF14;TMC8;BST2;RPS6KA1;MMP14;CEACAM1;TSPYL2;BTG1;PRKCQ;LTBP4;CRLF3;SFRP2;FBP1;SLIT3;BAP1;MFSD2A;TCHP;TAF9B;CDKN1A;PML;SPHK1;TGFB1;HYAL1;NUBP1;PLCE1
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),0.45441753131223667,0.8796414200729201,0.5925925925925926,1.0,1.0,3/10,23.13%,DNM3;FGD4;EZR
prerank,GO_Biological_Process_2021__positive regulation of synapse maturation (GO:0090129),-0.5041806626658744,-0.8793468643545589,0.6619718309859155,1.0,1.0,3/8,19.36%,NEUROD2;DAB2IP;RELN
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),-0.45622030839216543,-0.8793396988197498,0.6521739130434783,1.0,1.0,8/20,27.39%,EFNA1;ELN;SLIT3;TGFB1;TBX20;EMILIN1;SLIT2;ROBO2
prerank,GO_Biological_Process_2021__mRNA transcription by RNA polymerase II (GO:0042789),0.4961039218168523,0.8790704676964267,0.6666666666666666,1.0,1.0,4/6,38.74%,ZBTB1;ATF4;TFCP2;MED1
prerank,GO_Biological_Process_2021__sulfation (GO:0051923),-0.5025704903196024,-0.8790226519116444,0.640625,1.0,1.0,2/9,6.79%,SULT1C3;CHST4
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),0.47729968616114626,0.878846166803225,0.6551724137931034,1.0,1.0,1/11,6.30%,RAB27A
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),0.4510315228624118,0.8787146022060127,0.7666666666666667,1.0,1.0,2/14,7.04%,ABCD2;ABCD1
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),0.4850661079716248,0.8785014597348637,0.5952380952380952,1.0,1.0,1/7,10.93%,EIF2AK4
prerank,GO_Biological_Process_2021__L-serine metabolic process (GO:0006563),0.4821378922677734,0.8783017874642218,0.6,1.0,1.0,4/10,22.42%,PSPH;SRR;SERINC5;PHGDH
prerank,GO_Biological_Process_2021__postsynaptic density assembly (GO:0097107),0.592833162715982,0.8780656741538456,0.7368421052631579,1.0,1.0,1/5,9.42%,NRXN1
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),-0.4909185766753237,-0.8780203860644346,0.6567164179104478,1.0,1.0,4/10,10.99%,DOCK8;APP;APOD;TNFRSF14
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),-0.46891435720573776,-0.8778031117175246,0.7162162162162162,1.0,1.0,4/19,17.73%,ABCA5;IL18;PRKCH;MSR1
prerank,GO_Biological_Process_2021__regulation of cell projection organization (GO:0031344),-0.5031051759365311,-0.8776763158502552,0.6911764705882353,1.0,1.0,3/11,26.43%,MFSD2A;MYO9A;ERMN
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),-0.37809234592925517,-0.8776493807155594,0.797752808988764,1.0,1.0,20/124,20.33%,TOMM7;ANK3;ARIH2;KCNB1;CEMIP;ZIC1;AKAP5;SLC51B;YWHAH;PLK3;PPP3CC;PINK1;BAP1;PDZK1;PRKCD;NMT1;OAZ2;TGFB1;MICALL2;EMD
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell surface (GO:2000010),0.46188925781098444,0.8775101694328451,0.6,1.0,1.0,1/11,9.04%,TMEM35A
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),-0.39847437766841615,-0.877468440210068,0.6626506024096386,1.0,1.0,11/63,17.76%,AWAT1;ALOX12;ACOT1;CYP4Z1;CYP1B1;ACSL5;ACOT4;CYP3A4;GLYATL2;ACOT2;ACOT8
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),-0.45342200085868883,-0.8774098796363923,0.72,1.0,1.0,5/25,20.36%,STMN2;PFN2;STMN1;PRKCD;KANK3
prerank,GO_Biological_Process_2021__positive regulation of memory T cell differentiation (GO:0043382),-0.5621406901642791,-0.8771230221874202,0.6607142857142857,1.0,1.0,2/5,22.98%,HLA-DRA;HLA-DRB1
prerank,GO_Biological_Process_2021__regulation of memory T cell differentiation (GO:0043380),-0.5621406901642791,-0.8771230221874202,0.6607142857142857,1.0,1.0,2/5,22.98%,HLA-DRA;HLA-DRB1
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.41380688401987864,0.8767880442069161,0.6666666666666666,1.0,1.0,2/19,8.76%,RPP40;ERI1
prerank,GO_Biological_Process_2021__B cell activation involved in immune response (GO:0002312),-0.5369570973824378,-0.8765945243876055,0.639344262295082,1.0,1.0,1/7,1.68%,GPR183
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.4417946401930989,-0.8765658510593692,0.6714285714285714,1.0,1.0,4/28,12.55%,ST6GAL1;GLYAT;ACOT4;CYP4F22
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.4301595983273219,-0.8765099399842953,0.5909090909090909,1.0,1.0,5/24,21.55%,RPL7A;RPL35;RPL10A;PES1;RPL7
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),0.5006132257821357,0.8763713968312745,0.7741935483870968,1.0,1.0,7/11,22.67%,KMT5A;SMYD2;METTL18;SETD3;EHMT1;CSKMT;SETD4
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),-0.38185747590731445,-0.8763625229864532,0.7341772151898734,1.0,1.0,15/83,21.09%,IL1R1;RPS27A;ST18;NOD1;PSMB6;PSMB9;TNIP2;UBC;PSMC3;PSMA8;PSME1;IL1RAP;RIPK2;PSMA7;RBX1
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),-0.39416270763881783,-0.8757842992134758,0.6744186046511628,1.0,1.0,10/65,21.36%,STMN2;CAV3;LDLR;PFDN6;PFN2;STMN1;PRKCD;PFDN1;KANK3;CHADL
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),-0.5324041992318291,-0.8756569507434725,0.6507936507936508,1.0,1.0,1/7,15.51%,IGF1
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),0.49188942430029614,0.875631054587339,0.5666666666666667,1.0,1.0,1/7,4.47%,SERPINB9
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.4899063536424954,0.875571727238224,0.5806451612903226,1.0,1.0,6/13,19.12%,BMP2;SOX9;SOX5;TAPT1;MDK;BMPR1B
prerank,GO_Biological_Process_2021__DNA packaging (GO:0006323),0.4142395822453545,0.8747665715060973,0.5789473684210527,1.0,1.0,4/14,19.29%,RBBP4;H1-2;NOC2L;CDAN1
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),-0.4109171767104421,-0.8744521913309513,0.654320987654321,1.0,1.0,4/39,10.28%,MAOB;PLP1;YWHAH;BASP1
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.29069525688093817,0.8742279627623283,0.9,1.0,1.0,26/153,15.93%,BET1;GOLT1A;PEF1;TMED5;TMEM115;PGAP1;SEC22B;TRAPPC11;RAB1B;ERGIC3;TRAPPC12;KLHL12;ANK2;COG6;COPB2;ATL2;TRAPPC8;VAPA;VTI1A;VAPB;CNIH1;SCFD1;CAPZA1;ARCN1;DCTN5;SEC24A
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),-0.44345348160383935,-0.8742251715930925,0.6486486486486487,1.0,1.0,3/22,11.42%,TLR2;APP;EIF2B2
prerank,GO_Biological_Process_2021__erythrocyte development (GO:0048821),0.49792506852959845,0.8741634135324747,0.6363636363636364,1.0,1.0,2/9,3.95%,ABCB10;ALAS1
prerank,GO_Biological_Process_2021__cellular response to histamine (GO:0071420),-0.5856907997047366,-0.8735645982083463,0.7121212121212122,1.0,1.0,3/6,17.78%,GABRB2;HRH1;GABRG2
prerank,GO_Biological_Process_2021__medium-chain fatty acid metabolic process (GO:0051791),-0.5142211971139706,-0.8733033611144293,0.6865671641791045,1.0,1.0,4/12,17.96%,CYP4Z1;OLAH;GLYATL2;OXSM
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),0.4866856108597529,0.872595902665751,0.5789473684210527,1.0,1.0,6/9,40.31%,AGO3;CLP1;AGO2;DHX9;AGO4;DICER1
prerank,PanglaoDB_Augmented_2021__Enterocytes,-0.3855419804905768,-0.8725542457361793,0.6823529411764706,1.0,1.0,19/88,15.25%,SLC28A2;ALDOB;L1CAM;NR1I3;SLC51A;ASPN;SPON2;ART3;RBP2;GFRA2;VIL1;CEACAM1;SLC51B;ACSL5;CD55;CA1;CDH19;CYP3A4;TMC4
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),0.488799751580923,0.8724803346810067,0.6571428571428571,1.0,1.0,2/7,10.08%,SRI;ATP1A2
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),-0.3787522286186296,-0.8720642670853561,0.7209302325581395,1.0,1.0,20/105,24.46%,SP100;SPARC;GPNMB;LZTS1;WARS1;CEACAM1;LFNG;EMP2;HECW2;CDK5;TGFB1;CRB2;SFRP1;STAT2;BCL6;MAPT;ETS1;BMPER;NSMF;PHLDB2
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),-0.38392902629308295,-0.8717852624972978,0.7407407407407407,1.0,1.0,3/63,2.43%,RFTN1;TGFBR2;ZFP36
prerank,GO_Biological_Process_2021__C4-dicarboxylate transport (GO:0015740),0.4393072784836483,0.8714999791648874,0.5757575757575758,1.0,1.0,9/13,33.13%,SLC25A18;SLC25A22;SLC25A14;LRRC8D;SLC13A5;SLC25A12;SLC1A2;SLC25A11;SLC25A13
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),-0.413952975348591,-0.8714090402884846,0.7,1.0,1.0,3/34,10.49%,L1CAM;SHTN1;MAG
prerank,"GO_Biological_Process_2021__protein localization to chromosome, centromeric region (GO:0071459)",0.46714701745422227,0.871396668457564,0.7,1.0,1.0,1/13,1.46%,CHAMP1
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),-0.43433089638736766,-0.8713830360361245,0.6933333333333334,1.0,1.0,9/28,23.36%,SYNPO2L;LMOD1;TNNT1;OBSCN;MYLK3;WDR1;FHOD3;MYOZ2;PDGFRA
prerank,GO_Biological_Process_2021__pyrimidine-containing compound biosynthetic process (GO:0072528),0.504917716568997,0.8712817787635996,0.65,1.0,1.0,1/7,6.93%,TPK1
prerank,GO_Biological_Process_2021__atrioventricular valve formation (GO:0003190),0.5471249816617612,0.8711719716601647,0.6904761904761905,1.0,1.0,1/6,1.96%,DCHS1
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.4803927609494582,0.8708960198733344,0.6129032258064516,1.0,1.0,4/8,14.53%,RUNX1;HMGB1;SH3RF1;TNFSF4
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),-0.42479056389145686,-0.8707369059991014,0.676056338028169,1.0,1.0,7/28,20.74%,EGF;WDR54;LRPAP1;SFRP4;CD63;FLOT1;AHI1
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.3989863304169851,-0.8705524966847262,0.7105263157894737,1.0,1.0,11/59,18.16%,B2M;HLA-A;PSMB6;PSMB9;HLA-C;HLA-B;HLA-E;PSMC3;HLA-F;PSMA8;PSME1
prerank,GO_Biological_Process_2021__aromatic amino acid family catabolic process (GO:0009074),-0.4949824794987845,-0.8702889328559672,0.6,1.0,1.0,1/12,3.79%,KMO
prerank,PanglaoDB_Augmented_2021__Noradrenergic Neurons,-0.4475554819778914,-0.8702831020696091,0.68,1.0,1.0,5/23,9.92%,RIMBP2;ALDOB;GC;SLC18A2;PLPPR1
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),0.37497850916440223,0.8699029369179675,0.6285714285714286,1.0,1.0,6/25,16.88%,TNFAIP3;ZDHHC11;APOBEC3F;EIF2AK4;MUL1;IFNLR1
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",-0.44833323106433043,-0.8695625147047212,0.6825396825396826,1.0,1.0,6/21,18.04%,GRIN2D;GRIN2A;INSYN2A;GRIN2B;GRID2;GLRA1
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),0.4321636166925268,0.8692371461121419,0.6410256410256411,1.0,1.0,6/15,24.17%,STIL;PCM1;C2CD3;CEP192;CEP83;PIBF1
prerank,GO_Biological_Process_2021__integrin activation (GO:0033622),-0.5456262094510564,-0.8690953293074871,0.6666666666666666,1.0,1.0,3/7,24.35%,FN1;FERMT3;CX3CL1
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),0.5348825507848778,0.8689665834210925,0.6976744186046512,1.0,1.0,1/6,3.32%,AFG1L
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),0.4823084183635317,0.8689661679777245,0.55,1.0,1.0,3/5,27.74%,ATP8A1;TMEM30A;ATP11B
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),-0.37044823203441973,-0.868796378570534,0.6896551724137931,1.0,1.0,15/103,15.51%,THBS1;TLR2;CIITA;RPS4X;NLRC5;CCL2;ATAD5;PLD1;EGF;KLF4;NLRP12;NAMPT;RPL5;GLI1;IGF1
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),-0.3593776170887224,-0.8687840008889749,0.7872340425531915,1.0,1.0,8/145,8.87%,RASGRP1;S100A10;RASGRP2;DOCK8;CCL2;THY1;USP6;TBC1D9
prerank,GO_Biological_Process_2021__insulin secretion involved in cellular response to glucose stimulus (GO:0035773),-0.5547358466311748,-0.8687181527326877,0.671875,1.0,1.0,2/6,19.17%,RAB11FIP5;PTPRN
prerank,GO_Biological_Process_2021__positive regulation of protein localization to centrosome (GO:1904781),0.5369363784553222,0.8686111139455386,0.6571428571428571,1.0,1.0,2/6,34.52%,PARD6A;GSK3B
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),0.5259083445533445,0.8684383320021178,0.65,1.0,1.0,1/6,16.03%,PDZD8
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),-0.4457693384427463,-0.8683429899821558,0.6388888888888888,1.0,1.0,7/19,19.72%,SLC51A;AKR1C1;CEACAM1;SLC51B;ABCC4;ATP8B1;SLCO1A2
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),-0.4754661542071311,-0.8682942226425616,0.6266666666666667,1.0,1.0,3/14,15.51%,HTR2B;EGF;IGF1
prerank,GO_Biological_Process_2021__rescue of stalled ribosome (GO:0072344),0.5299251555862236,0.8682382118839641,0.6388888888888888,1.0,1.0,2/5,32.87%,NEMF;MTRES1
prerank,GO_Biological_Process_2021__gap junction assembly (GO:0016264),-0.6044388697866196,-0.868235288318818,0.7333333333333333,1.0,1.0,1/5,7.79%,GJC1
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),-0.4616832134886808,-0.8678846579509764,0.6666666666666666,1.0,1.0,4/22,10.25%,SFTPD;GPNMB;CEACAM1;PDCD1LG2
prerank,GO_Biological_Process_2021__heterocycle biosynthetic process (GO:0018130),0.448363062339253,0.8677573707574723,0.6666666666666666,1.0,1.0,4/12,21.99%,GPHN;MOCS2;NOXRED1;LIAS
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),-0.4823790502329954,-0.8676349528303302,0.6774193548387096,1.0,1.0,2/16,5.35%,ALOX12;DUOX1
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),-0.4277504490945116,-0.867457117328447,0.6268656716417911,1.0,1.0,2/30,8.02%,ABCA5;ANGPTL3
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),0.3882459078724322,0.8674435374070931,0.56,1.0,1.0,6/31,13.26%,NGF;CEL;NLGN3;EIF4EBP2;NLGN4Y;CACNA1B
prerank,GO_Biological_Process_2021__modulation by symbiont of host apoptotic process (GO:0052150),0.5106939005279707,0.867323201316599,0.6774193548387096,1.0,1.0,1/6,4.47%,SERPINB9
prerank,GO_Biological_Process_2021__positive regulation of microtubule nucleation (GO:0090063),0.5189716478205687,0.8673188241773698,0.6363636363636364,1.0,1.0,2/7,5.79%,HSPA1A;GIT1
prerank,GO_Biological_Process_2021__negative regulation of excitatory postsynaptic potential (GO:0090394),0.5624288607828543,0.8671896818971082,0.6428571428571429,1.0,1.0,3/5,42.04%,PTEN;LRRK2;NLGN4X
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),-0.40160904145329734,-0.8671861254166193,0.76,1.0,1.0,13/45,23.64%,RASGRP1;GPR183;AKAP17A;TPD52;LAT2;PTPRC;PRKCB;PIK3CD;BLNK;RAG1;KLF6;CASP8;HSPD1
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),0.3449122034534583,0.8670270248940195,0.75,1.0,1.0,12/30,28.54%,HSPA1A;HSF1;ERN1;RHBDD1;DNAJB14;TM7SF3;DNAJC18;DAXX;HSPA13;DNAJB12;BAK1;ATXN3
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),-0.36961253160696567,-0.8668361442294203,0.7582417582417582,1.0,1.0,11/138,9.78%,KLF2;THBS1;FABP3;NOS1AP;RPS4X;ATAD5;DUOXA1;PLD1;LDLR;EGF;KLF4
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.556305888786783,-0.866739695612117,0.7068965517241379,1.0,1.0,1/5,2.68%,ANK3
prerank,GO_Biological_Process_2021__negative regulation of delayed rectifier potassium channel activity (GO:1902260),-0.556305888786783,-0.866739695612117,0.7068965517241379,1.0,1.0,1/5,2.68%,ANK3
prerank,"GO_Biological_Process_2021__phototransduction, visible light (GO:0007603)",-0.5389532516413865,-0.8665421782676301,0.6935483870967742,1.0,1.0,1/7,7.93%,PDE6B
prerank,GO_Biological_Process_2021__positive regulation of histone H4 acetylation (GO:0090240),-0.5583003683170811,-0.8662297906015676,0.7619047619047619,1.0,1.0,1/6,9.24%,BRCA1
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.3936270163444132,0.8662156761205969,0.625,1.0,1.0,8/26,22.88%,CNOT9;RUNX1;CNOT2;UFM1;VPS11;CNOT1;GPAM;LATS1
prerank,GO_Biological_Process_2021__dolichyl diphosphate biosynthetic process (GO:0006489),-0.5440010838161963,-0.8661656354105997,0.7666666666666667,1.0,1.0,3/6,36.35%,DHDDS;DPAGT1;MVD
prerank,GO_Biological_Process_2021__dolichyl diphosphate metabolic process (GO:0046465),-0.5440010838161963,-0.8661656354105997,0.7666666666666667,1.0,1.0,3/6,36.35%,DHDDS;DPAGT1;MVD
prerank,GO_Biological_Process_2021__skeletal myofibril assembly (GO:0014866),-0.5755794816296824,-0.8656644258870928,0.7142857142857143,1.0,1.0,2/5,11.55%,PROX1;MYH11
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),-0.34968529438582774,-0.8652345564835021,0.7849462365591398,1.0,1.0,20/254,9.95%,LEF1;KLF2;HPN;TLR2;POU4F1;ANK3;NOS1AP;RAMP3;TESC;OVOL2;APP;SCX;WARS1;PLSCR1;WNT5A;EGF;BRCA1;TLR3;KLF4;RIMS2
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),0.46260507139935875,0.8651985160608315,0.6052631578947368,1.0,1.0,4/8,27.02%,SOX9;HEY2;ROCK2;HEY1
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,-0.3671527581893847,-0.8651389702027668,0.7692307692307693,1.0,1.0,8/71,9.23%,FMO6P;CLDN16;P2RY14;SPAG17;ZNF750;CYP4Z1;DCDC1;EGF
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.4029267051260905,-0.8650744128866167,0.691358024691358,1.0,1.0,12/43,25.84%,GRIN2A;NOD1;USP50;SYK;NLRP2;GRIN2B;FADD;RIPK2;GPER1;CASP8;ARL6IP5;NODAL
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),0.2813625518908798,0.8650683113538729,0.8461538461538461,1.0,1.0,17/147,11.15%,LIMD1;CXXC4;AMER2;BMP2;PSMD10;BICC1;PSMA1;GREM1;CCDC88C;PSMD11;SOX9;PSMB5;TAX1BP3;STK4;KLHL12;PSMD14;INVS
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),-0.42048912529562466,-0.8649291054397751,0.6052631578947368,1.0,1.0,6/26,21.03%,IFI35;PLSCR1;DDX60;SCIMP;SLC15A4;NMI
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.4341107577901512,-0.8645339801346205,0.7183098591549296,1.0,1.0,5/23,14.76%,RPS27A;NOD1;ALPK1;UBC;IFIH1
prerank,GO_Biological_Process_2021__negative regulation of protein activation cascade (GO:2000258),-0.5695179349112854,-0.8645172884666794,0.734375,1.0,1.0,6/7,22.49%,F8;SERPING1;F10;A2M;F3;TFPI
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),-0.5014987136622103,-0.8643044640812537,0.6229508196721312,1.0,1.0,1/11,2.07%,P2RY12
prerank,GO_Biological_Process_2021__nucleoside metabolic process (GO:0009116),-0.517889950178484,-0.8642731048817536,0.6567164179104478,1.0,1.0,1/10,2.35%,TYMP
prerank,GO_Biological_Process_2021__amino sugar biosynthetic process (GO:0046349),-0.45668516449345037,-0.8640888246705202,0.6190476190476191,1.0,1.0,5/12,32.49%,GFPT2;UAP1;UAP1L1;GNPNAT1;GNPDA1
prerank,GO_Biological_Process_2021__sphingomyelin metabolic process (GO:0006684),-0.4961968515157562,-0.8633759455104463,0.7169811320754716,1.0,1.0,1/10,3.96%,ABCA8
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",0.4048266826807348,0.8633341407988234,0.6818181818181818,1.0,1.0,3/23,5.49%,POLD3;LIG4;RFC3
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),0.3493244563880612,0.8629336915699432,0.7916666666666666,1.0,1.0,4/46,6.04%,WNT7A;ASCL1;LIG4;HES6
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),0.36053393984747056,0.8628852281939224,0.6666666666666666,1.0,1.0,1/21,0.43%,SLC2A5
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.5359978416449808,-0.8625957555597434,0.6984126984126984,1.0,1.0,1/9,1.77%,TGFBR2
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),-0.40757918765439105,-0.8622889626762117,0.6666666666666666,1.0,1.0,12/48,23.46%,IRF1;IFI35;PLSCR1;PARP9;HLA-E;USP18;BIRC3;CDC37;SLC15A4;NMI;ERAP1;CASP8
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),-0.4186954165435671,-0.8622367109818037,0.7435897435897436,1.0,1.0,7/27,20.91%,KCNB1;SLC39A14;RAB11FIP5;PDK3;PTPRN;ADCY8;GPER1
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),-0.36026549711364997,-0.8621533409486352,0.7209302325581395,1.0,1.0,25/119,21.22%,ANXA1;IL1R1;TLR2;IFI35;IL15;APP;LRRC19;WNT5A;TLR3;KLF4;NLRP12;USP18;BIRC3;SBNO2;IL18;CD200;SNX6;PRKCD;TNFRSF1A;CXCL17;SPHK1;MVK;GPER1;NMI;ABCC1
prerank,GO_Biological_Process_2021__regulation of cellular response to osmotic stress (GO:0106049),0.5097254226544599,0.8621097500946175,0.6818181818181818,1.0,1.0,1/5,7.38%,LETM1
prerank,GO_Biological_Process_2021__negative regulation of cell activation (GO:0050866),0.4491776677037728,0.8619936769248372,0.5675675675675675,1.0,1.0,1/9,1.19%,NR1D1
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),-0.39295215508056563,-0.8619132209320887,0.7073170731707317,1.0,1.0,14/55,22.00%,RASGRP2;SYT4;WNT5A;SYT1;CLIC4;HPCA;NEUROD2;CPNE9;DMTN;NLGN1;SYT2;ADCY8;SYT5;SYT13
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),0.4068947143935478,0.8616527731320749,0.6875,1.0,1.0,2/17,3.41%,CHRNA4;KCNA2
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),-0.4167069290339531,-0.8615352233732148,0.6986301369863014,1.0,1.0,4/41,12.55%,ABCA8;ARG2;FA2H;CYP4F22
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),-0.3330170165382603,-0.8615053872827274,0.8686868686868687,1.0,1.0,87/523,19.58%,LEF1;PRAME;THBS1;SIX3;CDKN2A;IL13RA1;NR4A3;TGFBR2;FABP3;BTG3;TESC;PDPN;IRF1;PROX1;GPNMB;ST18;KIF14;IFI35;RPS4X;STAT4;HTR2B;CHRM1;IL15;APP;SCX;COPS9;WARS1;PODN;IFIT3;TIMP1;CYP1B1;ELN;EGF;S1PR3;KLF4;SST;STAT1;P3H2;BTG1;SHCBP1;OSMR;IGFBP7;EMP2;ROMO1;EID2;SFRP2;NUAK1;JUNB;FN1;THPO;NAMPT;DAB2IP;FGF1;VIP;IL7;TGFA;FOXM1;GLI1;TFAP4;SFRP4;BAP1;IGF1;CDK2;SQLE;DDRGK1;FES;RPS9;CD200;DLC1;CDKN3;FGF7;CLMN;CDKN1A;TSC2;CDCA7;CAPN1;PML;RPL23;BOK;RPS6;TNS2;CDC7;FGF22;CAPNS1;TGFB1;NUDT6;FTH1
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,-0.35340572491255534,-0.8614654932057602,0.7654320987654321,1.0,1.0,22/118,15.71%,C1QL1;TAGLN3;STMN2;CSPG4;SNCB;PLP1;LRRTM1;NKX6-2;NNAT;GAP43;ZNF536;GFAP;TCEAL6;IGSF21;HAPLN2;NYAP1;HPCA;CA10;C11ORF87;STMN4;ADCY5;CRMP1
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,0.2902679079367381,0.8613233501796816,0.9444444444444444,1.0,1.0,38/109,20.52%,PCDH19;TSPAN11;ADGRA1;SNAP91;PDGFD;SPRY1;ADGRB3;MAPK10;TMEM47;GRIA2;FAT3;NOVA1;TMEM35A;EFS;PCDH17;CNTFR;MEGF10;ATP1A2;GPM6B;ANK2;EMX2;SLC6A1;FAIM2;SLC35F1;SHC3;PURG;CACNA2D1;NDRG4;MAP6;GLI3;ADGRL3;LRRC4C;CSRNP3;ID4;HES5;GJA1;PTPRZ1;MARK1
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),-0.409776634430062,-0.8612713757450786,0.675,1.0,1.0,8/37,19.90%,DUSP1;CCNB1;EGF;TGFA;IGF1;ANAPC15;AURKAIP1;DAPK3
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),-0.49099323513689974,-0.8610308241328802,0.676923076923077,1.0,1.0,3/14,16.95%,LMOD1;ARPC5L;ARPC3
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),-0.3691173827735798,-0.8610302208620089,0.7471264367816092,1.0,1.0,16/120,19.36%,EFNA1;TGFBR2;KIF14;CENPE;EMP2;MINK1;DAB2IP;STRADB;MTCP1;DOK7;PRKCD;SLC11A1;CDKN1A;CD4;PTPRC;RELN
prerank,PanglaoDB_Augmented_2021__Germ Cells,-0.368587419300346,-0.8608364503326428,0.8181818181818182,1.0,1.0,12/83,14.06%,SPATA12;MAEL;TSKS;GAPDHS;BRCA1;MARCHF11;TSACC;SPATA18;BCL2L14;CREB5;GSG1;DEPDC4
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),0.536050905112363,0.8607708159096039,0.6333333333333333,1.0,1.0,4/7,23.13%,PTPN23;RAB21;VPS11;EZR
prerank,GO_Biological_Process_2021__positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.5190401222633299,-0.8607088091867968,0.7101449275362319,1.0,1.0,4/11,7.96%,C3;MRAP2;SLC39A14;KLK6
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),-0.41796545609723884,-0.860575135957371,0.6571428571428571,1.0,1.0,4/32,11.49%,ZFP36;STAT1;GATA1;ZFPM1
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),0.36468903848007045,0.8603873640553014,0.6923076923076923,1.0,1.0,9/40,22.91%,SIRT6;MIER3;SIRT5;HDAC2;PRDM5;HDAC10;MTA2;MIER2;SIRT2
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),-0.3958202628387621,-0.860336133824163,0.7105263157894737,1.0,1.0,2/44,2.68%,AMN;ANK3
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),-0.43948417312687765,-0.8601488555488636,0.6891891891891891,1.0,1.0,7/23,29.00%,VIP;DND1;SLC11A1;AXIN2;MEIOC;EIF4ENIF1;TAF15
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.40616714340968746,0.8600673054987786,0.6666666666666666,1.0,1.0,3/14,9.42%,CACNG2;NLGN3;NRXN1
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),-0.43187111796962674,-0.8600044413944979,0.6901408450704225,1.0,1.0,5/28,19.09%,RAMP3;SYT1;RIMS2;ANXA2;GRIK2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to endosome (GO:1905668),-0.5401757269357426,-0.8598031404515885,0.6764705882352942,1.0,1.0,4/8,28.38%,EGF;MGAT3;RDX;DTX3L
prerank,GO_Biological_Process_2021__regulation of protein localization to early endosome (GO:1902965),-0.5401757269357426,-0.8598031404515885,0.6764705882352942,1.0,1.0,4/8,28.38%,EGF;MGAT3;RDX;DTX3L
prerank,GO_Biological_Process_2021__positive regulation of protein localization to early endosome (GO:1902966),-0.5401757269357426,-0.8598031404515885,0.6764705882352942,1.0,1.0,4/8,28.38%,EGF;MGAT3;RDX;DTX3L
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),-0.43173554216038407,-0.8597435684589477,0.7307692307692307,1.0,1.0,4/29,15.34%,CLRN1;FSCN1;WAS;DMTN
prerank,GO_Biological_Process_2021__cellular nitrogen compound catabolic process (GO:0044270),-0.5529267286016077,-0.8596710765581035,0.7121212121212122,1.0,1.0,5/7,30.41%,NIT1;CYP3A4;CYP3A5;CYP2D6;PM20D1
prerank,GO_Biological_Process_2021__hydrogen peroxide catabolic process (GO:0042744),-0.5143181234927445,-0.8595972769755472,0.6610169491525424,1.0,1.0,2/8,8.11%,PRDX5;PRDX4
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),0.3197216344564173,0.8593492666836392,0.75,1.0,1.0,18/62,24.25%,ERCC8;UBE2T;RNF146;SH3RF1;RNF141;RNF11;MARCHF7;KLHL24;RNF208;CNOT4;UBE3D;MDM2;TRIM52;UBE2A;ITCH;TRIM68;RNF13;MARCHF5
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),-0.3345316234384346,-0.8592783086981468,0.8315789473684211,1.0,1.0,57/270,21.92%,HPN;OGN;CDKN2A;FABP3;B2M;BTG3;TESC;PDPN;IRF1;PROX1;GPNMB;ST18;IFI35;IL12A;APP;IGFBP5;WARS1;PODN;IFIT3;WNT5A;CYP1B1;APOD;KLF4;SST;P3H2;BTG1;NELL1;IGFBP7;SFRP2;DAB2IP;VIP;B4GALT7;TFAP4;SFRP4;BAP1;CD200;DLC1;CDKN3;CLMN;CDKN1A;TSC2;PML;TNS2;TGFB1;NUDT6;FTH1;EMD;GPER1;SFRP1;NMI;CDKN2D;GSDME;RARG;ADAMTS8;AXIN2;HES1;CDKN1C
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),0.411063602940416,0.8592043041095704,0.6956521739130435,1.0,1.0,8/17,23.06%,TRAK2;MUL1;MARK2;NECTIN2;MSTO1;MARK1;ZBED3;MFN2
prerank,GO_Biological_Process_2021__negative regulation of glial cell proliferation (GO:0060253),-0.5550641313410491,-0.8591020627891632,0.7213114754098361,1.0,1.0,1/5,21.86%,HES1
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),-0.43854459869631446,-0.859050080872962,0.7215189873417721,1.0,1.0,4/24,11.66%,GPNMB;CCL2;THY1;PRKCQ
prerank,GO_Biological_Process_2021__cellular response to UV-B (GO:0071493),-0.5849152914744855,-0.8590137731862687,0.7321428571428571,1.0,1.0,3/5,29.27%,CDKN1A;HYAL1;HYAL2
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),-0.36866029994348914,-0.8589097591217161,0.7816091954022989,1.0,1.0,9/95,10.91%,GGT5;ALOX12;ACOT1;ACSM5;ANGPTL3;ACSL5;ACOT4;FA2H;LIPI
prerank,GO_Biological_Process_2021__protein prenylation (GO:0018342),-0.5191203695341247,-0.8587408932291967,0.7413793103448276,1.0,1.0,1/9,5.60%,AIPL1
prerank,GO_Biological_Process_2021__negative regulation of inclusion body assembly (GO:0090084),0.4602408717265511,0.8586662587076007,0.6744186046511628,1.0,1.0,3/9,23.89%,HSPA1A;SACS;DNAJB2
prerank,GO_Biological_Process_2021__negative regulation of muscle cell apoptotic process (GO:0010656),-0.582283862577451,-0.8584491153624372,0.6875,1.0,1.0,2/6,15.51%,ALOX12;IGF1
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),-0.423448678403956,-0.8583007907431023,0.7236842105263158,1.0,1.0,7/42,16.57%,STMN2;YWHAH;MAG;PAQR3;GRIN2B;CRMP1;DPYSL3
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),-0.45059455332686804,-0.8582756372082744,0.6567164179104478,1.0,1.0,8/20,27.67%,HTR2B;ITPR3;HTR2A;PTPRC;RYR2;HTR2C;ITPR1;ERO1A
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),0.3063833020003456,0.8582713805917304,0.75,1.0,1.0,16/60,23.28%,TRIB3;USP13;WDR91;KEAP1;ABCD1;WDR24;RAB39B;EP300;ABL2;PIP4K2B;PIP4K2C;RAB8A;ABCB11;VPS29;RPTOR;DRAM2
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),0.3238951513331593,0.8579753275583243,0.8,1.0,1.0,19/47,24.06%,CDC25A;EIF2S1;YY1;ATR;PTPRK;EIF2AK4;SMPD1;POLK;EP300;RHBDD1;TRIAP1;GNGT1;NOC2L;USP47;N4BP1;PARP1;ZBTB1;ERCC4;USP28
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),0.4834903215625548,0.8578565506775416,0.696969696969697,1.0,1.0,2/10,4.49%,CEL;NLGN3
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),0.3478429250251038,0.8578130870651888,0.6666666666666666,1.0,1.0,8/56,9.59%,PAK1IP1;NAF1;ZNF658;LTO1;RIOK2;RIOK1;LTV1;XPO1
prerank,GO_Biological_Process_2021__negative regulation of microglial cell activation (GO:1903979),0.5444003382341908,0.8574597256346325,0.7045454545454546,1.0,1.0,1/6,1.19%,NR1D1
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.30635250772061196,0.8574455044288878,0.7894736842105263,1.0,1.0,12/60,14.33%,NGF;ANP32B;VCP;EGLN3;ROBO1;TRADD;EIF2AK3;CRADD;BAD;MUL1;DAP;CFLAR
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.4292787711077607,-0.8572681951754596,0.686046511627907,1.0,1.0,1/29,0.21%,ANXA1
prerank,GO_Biological_Process_2021__double-strand break repair via synthesis-dependent strand annealing (GO:0045003),0.5151422465801666,0.8571411594590086,0.6756756756756757,1.0,1.0,1/5,18.29%,DMC1
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),-0.43825956487655804,-0.8570450326892695,0.7123287671232876,1.0,1.0,1/23,2.26%,SUV39H1
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),-0.4058407537762522,-0.856982010352949,0.6710526315789473,1.0,1.0,4/43,6.48%,TEKT2;RSPH4A;CCDC39;SPAG17
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),-0.405770321579521,-0.8566692756809033,0.7027027027027027,1.0,1.0,4/41,10.81%,S100A10;VIL1;SYNPO2L;PFN2
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),0.3105773202846063,0.8564339485011514,0.6818181818181818,1.0,1.0,6/34,14.45%,SOX8;PEF1;ERBB4;KLHL12;CDH2;TAPT1
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),0.3992063775752728,0.8563910524060598,0.7241379310344828,1.0,1.0,2/19,2.26%,AGMO;ARV1
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.42062669779788653,0.8558305488384459,0.56,1.0,1.0,2/20,2.90%,G0S2;BCL10
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),-0.5175433710999738,-0.8557518670935101,0.7121212121212122,1.0,1.0,6/10,39.70%,ITGA3;FYN;SUPV3L1;IGF1R;PICK1;PRNP
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),0.36711084422682594,0.8555908224654144,0.7,1.0,1.0,4/22,7.94%,RITA1;BEND6;EGFR;AKT1
prerank,"GO_Biological_Process_2021__establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",0.5153030478577467,0.8553203374786807,0.6097560975609756,1.0,1.0,3/6,30.90%,LRPPRC;RHOT1;MAP1S
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),-0.42953300011007606,-0.8543767477024827,0.6585365853658537,1.0,1.0,7/26,29.23%,APP;IGF1;MFSD2A;GHR;OLFM1;SPAAR;LATS2
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),-0.3864775901643389,-0.8543092684192974,0.7790697674418605,1.0,1.0,4/76,5.84%,DHCR24;RAMP3;SNCB;HTR2B
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),-0.46763230906333664,-0.8541402139455743,0.7164179104477612,1.0,1.0,1/18,0.92%,APLNR
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),0.3046440874388465,0.8540840123150901,0.8888888888888888,1.0,1.0,14/75,13.52%,WNT7A;AGER;BMP2;DUSP19;SERPINF2;MID1;MAP3K4;HMGB1;TIRAP;SH3RF1;SASH1;MAP4K2;TAOK2;TAOK3
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),0.2959270695507693,0.8537967850485721,0.72,1.0,1.0,12/56,15.16%,RTRAF;DUSP19;TRIB3;SPRED1;GSKIP;AKT1;PPM1E;PPP2R5A;TRIB2;HNRNPU;PRDX3;GNAQ
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.3565785011000132,0.8537262616370482,0.6774193548387096,1.0,1.0,9/41,18.36%,FLT3;EGFR;TTL;ERBB4;CSF1R;ABI1;ABL2;ABI2;EFEMP1
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),-0.38216717773279235,-0.8532816177548717,0.6582278481012658,1.0,1.0,7/52,14.58%,DHCR24;GC;AKR1C1;CYP1B1;HSD17B14;CYP21A2;CYP3A4
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.47456756699432256,-0.8532675599693399,0.6538461538461539,1.0,1.0,6/21,23.63%,CD44;SFRP2;TAF9B;CD74;CDKN2D;ZNF385A
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),0.39161453349526076,0.8532370978247135,0.7,1.0,1.0,6/27,8.91%,MCU;ADRA1A;SLC35G1;MAIP1;JPH1;CACNB3
prerank,GO_Biological_Process_2021__mRNA cleavage involved in gene silencing by miRNA (GO:0035279),0.49782073825243245,0.8529026203296198,0.6304347826086957,1.0,1.0,3/5,37.46%,AGO3;AGO2;AGO4
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),-0.49579563063319176,-0.8528711343341014,0.7142857142857143,1.0,1.0,4/13,19.95%,APP;AKAP5;RELN;ADCY8
prerank,GO_Biological_Process_2021__mitotic DNA replication initiation (GO:1902975),0.5043588111043167,0.8525964440479288,0.6829268292682927,1.0,1.0,1/5,25.02%,GINS3
prerank,GO_Biological_Process_2021__nuclear cell cycle DNA replication initiation (GO:1902315),0.5043588111043167,0.8525964440479288,0.6829268292682927,1.0,1.0,1/5,25.02%,GINS3
prerank,GO_Biological_Process_2021__negative regulation of histone H4 acetylation (GO:0090241),-0.5630414290139916,-0.8525775930125644,0.7017543859649122,1.0,1.0,2/5,25.66%,SPI1;TAF7
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),0.3409911083673897,0.8522854476744223,0.6818181818181818,1.0,1.0,3/29,7.09%,NAF1;GREM1;MAP3K4
prerank,PanglaoDB_Augmented_2021__T Cells Naive,-0.45602301408454965,-0.8522361585892881,0.704225352112676,1.0,1.0,7/25,9.59%,CD5;TAGAP;SLA;GPR171;P2RY10;ARHGAP9;WAS
prerank,PanglaoDB_Augmented_2021__Follicular Cells,-0.3999625336396296,-0.8521678849970703,0.6666666666666666,1.0,1.0,11/42,18.09%,SERPINA10;ALDOB;BHMT;ANGPTL3;SLC3A1;SLC16A11;ADH4;DIO1;CYP3A4;PDZK1;ITIH2
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.536827900856899,-0.8521580392250191,0.703125,1.0,1.0,3/9,25.66%,BRCA1;SET;TAF7
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),0.33718028306475933,0.8519200061510296,0.6842105263157895,1.0,1.0,17/53,24.20%,PPP1R10;RNF2;PHC1;EED;FBXO5;YAF2;RBBP4;MGA;PHC3;EHMT1;WAPL;ESPL1;BMP7;EPC1;PCGF2;E2F6;FOXO4
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),-0.44204409855804816,-0.8518862700055582,0.6486486486486487,1.0,1.0,2/18,8.55%,GBP1;MMP14
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),-0.38151011890540026,-0.8518286309167984,0.7066666666666667,1.0,1.0,15/50,22.66%,RPE65;PLB1;RDH13;RBP2;AKR1C1;CYP1B1;ADH4;CYP3A4;AGRN;DHRS13;GPC3;LRP2;GPC1;CYP3A5;ALDH8A1
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),-0.4777050585700945,-0.851601166417377,0.7272727272727273,1.0,1.0,2/13,7.31%,SLC39A14;TRPC3
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),-0.4917592060817919,-0.8515456135694994,0.6933333333333334,1.0,1.0,1/12,2.03%,KCNQ1
prerank,GO_Biological_Process_2021__associative learning (GO:0008306),0.44789124473802033,0.8514441296306444,0.725,1.0,1.0,2/8,12.88%,DRD2;SLC6A1
prerank,GO_Biological_Process_2021__NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.48760736120195763,-0.8513641621885467,0.6818181818181818,1.0,1.0,2/11,14.01%,PARP9;NAMPT
prerank,GO_Biological_Process_2021__regulation of stem cell division (GO:2000035),0.4835197837420421,0.8512474058342163,0.6,1.0,1.0,4/7,20.08%,SMYD5;NCOA3;ESRRB;MLLT3
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),0.44109665379940066,0.8508853777187562,0.6842105263157895,1.0,1.0,2/10,12.34%,DRD2;DCT
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.3156619844466155,0.8508772972790779,0.7857142857142857,1.0,1.0,12/58,14.76%,POLD3;DNA2;PDE12;RFC3;DNASE1L2;DCP1B;ERCC2;ERCC3;EDC3;POLK;EXD2;GTF2H5
prerank,GO_Biological_Process_2021__response to misfolded protein (GO:0051788),0.4644127223071645,0.8506930999737087,0.575,1.0,1.0,4/7,28.54%,DNAJB14;DNAJC18;DNAJB12;ATXN3
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),-0.33626351155233936,-0.8503550254493182,0.8181818181818182,1.0,1.0,45/273,19.78%,ENPP2;RASGRP1;C3;APLNR;EFNA1;RAMP3;CD44;CSPG4;GPNMB;CEMIP;IL15;APP;CENPE;SLCO3A1;EGF;BMP8A;CHI3L1;ITGA5;FAM20A;PFN2;GATA1;TNFRSF14;SFRP2;CCND1;THPO;FGF1;PINK1;IGF1;MTCP1;BDNF;DDRGK1;NOS1;FGF7;CDKN1A;LIMK2;CD4;PTPRC;SPHK1;NEK10;FGF22;RELN;TGFB1;FLOT1;CD74;RIPK2
prerank,GO_Biological_Process_2021__positive regulation of T cell receptor signaling pathway (GO:0050862),0.45415117458351917,0.8502891062605182,0.7142857142857143,1.0,1.0,1/11,2.90%,BCL10
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),-0.3311185110227265,-0.8500914895158203,0.8888888888888888,1.0,1.0,63/418,19.58%,PRAME;SP100;BLM;CDKN2A;DUSP1;TLR2;FABP3;PSRC1;BTG3;TESC;PDPN;IRF1;PROX1;GPNMB;TP53TG5;ST18;IFI35;HTR2B;PODXL;APP;BST2;WARS1;PODN;PLSCR1;IFIT3;DYSF;CYP1B1;ARHGDIG;KLF4;SST;APOBEC3H;P3H2;TSPYL2;BTG1;IGFBP7;CRLF3;SFRP2;FBP1;CD9;DAB2IP;MYH9;LRPAP1;FOXM1;TFAP4;SFRP4;SLIT3;BAP1;GMNC;NR4A1;CD200;DLC1;NOS1;CDKN3;TCHP;CLMN;CDKN1A;TSC2;PML;TNS2;TGFB1;HYAL1;NUDT6;FTH1
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),-0.36323149345686767,-0.8499319536588107,0.7439024390243902,1.0,1.0,12/87,18.04%,P2RY6;KCNQ1;P2RY12;IGFBP5;BRCA1;GLRA2;GABRB2;DMTN;HRH1;CIB2;GABRG2;GLRA1
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),0.31067111892764343,0.8498816990667727,0.631578947368421,1.0,1.0,17/53,23.98%,ELOVL4;ELOVL6;ELOVL2;SGMS2;HACD2;VAPA;VAPB;PRKD1;PPM1L;SPHK2;PLPP3;ST8SIA6;SGMS1;ST3GAL2;CERS6;DEGS1;PLPP1
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),-0.4673331933260792,-0.8497351265291919,0.6842105263157895,1.0,1.0,1/10,2.43%,ZFP36
prerank,GO_Biological_Process_2021__cochlea morphogenesis (GO:0090103),-0.5825953058043433,-0.8497149142302547,0.75,1.0,1.0,2/5,9.05%,HPN;MYO3A
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),0.5582703635146693,0.8495533343823787,0.7631578947368421,1.0,1.0,1/5,18.05%,PCID2
prerank,GO_Biological_Process_2021__positive regulation of spindle checkpoint (GO:0090232),0.5582703635146693,0.8495533343823787,0.7631578947368421,1.0,1.0,1/5,18.05%,PCID2
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.3817671265783625,-0.849068788677302,0.7625,1.0,1.0,9/66,15.27%,CDKN2A;DUSP1;SLC8A3;CAV3;HEXIM1;GADD45A;PAQR3;DAB2IP;TFAP4
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),-0.3849496402262936,-0.849036791740885,0.7901234567901234,1.0,1.0,8/55,12.08%,PLEKHG2;BAIAP2L1;CDC42EP1;BAIAP2;VIL1;PFN2;LMOD1;CDC42EP3
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),0.4139821116212464,0.8490328491344321,0.6071428571428571,1.0,1.0,5/18,12.48%,GANC;ST8SIA5;MAN1A2;PRKCSH;GANAB
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.40312029838577945,-0.848763619140926,0.6410256410256411,1.0,1.0,8/34,22.08%,APLNR;CEMIP;THY1;JPH3;NOS1;JPH4;GPER1;AKAP6
prerank,GO_Biological_Process_2021__tRNA 3'-end processing (GO:0042780),0.5277672500562113,0.848610272781211,0.6923076923076923,1.0,1.0,4/6,39.68%,ELAC2;HSD17B10;PTCD1;TRMT10C
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),0.3058623658277753,0.8485857170534079,0.75,1.0,1.0,30/119,17.37%,NR1D1;PPARGC1A;NR2E1;RARB;KAT2B;MAML3;ESRRG;RORB;GTF2F2;AR;NR3C1;NRBF2;ERCC2;NOTCH2;GTF2A2;ESRRA;ERCC3;POLR2C;TAF12;TAF4;TAF2;GTF2H5;TAF8;HDAC10;NR2F1;NR1D2;NR3C2;DR1;GTF2H2;TAF3
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),0.4407103615724227,0.8482396717338216,0.6875,1.0,1.0,3/12,23.07%,UBE2N;POT1;DAXX
prerank,PanglaoDB_Augmented_2021__Luteal Cells,-0.36553402689278425,-0.8481648242861646,0.8333333333333334,1.0,1.0,21/120,22.42%,DHCR24;SLC39A14;ZDHHC9;BHMT;ARHGEF17;GYG2;SCARA3;SLC7A2;DAB2IP;GPT2;F10;SFRP4;RHBDF1;AMOTL2;BOK;BCAT1;ASS1;PGAM1;PTPN21;PTPRF;GPC1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),-0.4781623642599264,-0.8481553995949688,0.6949152542372882,1.0,1.0,1/11,3.98%,PTP4A3
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,-0.3440258579705885,-0.8479877276495367,0.7647058823529411,1.0,1.0,42/179,24.67%,DHCR24;HK2;SLA;LDHA;IGFBP5;WARS1;CTSC;VLDLR;LDLR;GLRX;MLLT11;M6PR;PDK1;MTHFD2;CD9;NAMPT;ARPC5L;SQLE;PGK1;GPI;RPA1;COPS5;CDKN1A;NMT1;BCAT1;SDF2L1;PFKL;INSIG1;RIT1;NUPR1;PNP;CCNF;EIF2S2;IDI1;HSPA5;HSPD1;BHLHE40;PPA1;DDIT4;NFIL3;HMGCS1;PSMA3
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),0.4602886201329081,0.8478888133094896,0.6341463414634146,1.0,1.0,1/11,1.63%,AGER
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),0.3568194287621384,0.8478164245401129,0.8181818181818182,1.0,1.0,6/50,7.15%,PSMD10;ATF5;PSMA1;PSMD11;CUL1;PSMB5
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),0.44358724947078815,0.8476949539480658,0.6176470588235294,1.0,1.0,2/14,1.39%,WNT7A;SLIT1
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),-0.40726452418027115,-0.8475363259544336,0.75,1.0,1.0,4/29,16.04%,LZTS1;YWHAH;IL1RAPL1;HECW2
prerank,GO_Biological_Process_2021__base conversion or substitution editing (GO:0016553),-0.5147873004915159,-0.8473193566046175,0.6714285714285714,1.0,1.0,3/9,18.56%,APOBEC3H;APOBEC2;NUDT16
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),-0.43354187937522737,-0.8471999908188046,0.7205882352941176,1.0,1.0,1/21,2.22%,GRIN3A
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),-0.3978378682160207,-0.846829666322258,0.6666666666666666,1.0,1.0,4/32,16.97%,STMN2;STMN4;MAPRE2;STMN1
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),-0.446654297731759,-0.8467422896081302,0.7352941176470589,1.0,1.0,2/20,11.75%,PLSCR1;LPCAT4
prerank,GO_Biological_Process_2021__spermidine metabolic process (GO:0008216),0.47005261850449,0.8463831003502312,0.6216216216216216,1.0,1.0,3/6,23.76%,HDAC10;SAT1;SRM
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),-0.48858105578989874,-0.8461538315645667,0.7761194029850746,1.0,1.0,4/16,18.90%,NOS1AP;CAV3;NOS1;CACNB1
prerank,GO_Biological_Process_2021__protein localization to non-motile cilium (GO:0097499),-0.5757595000809113,-0.8460003548827727,0.7,1.0,1.0,2/5,24.88%,ARL13A;ZDHHC3
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.36905997288035214,0.8459546974910204,0.68,1.0,1.0,7/21,18.98%,PNLDC1;CNOT9;CNOT2;CNOT6L;CNOT4;CNOT1;CNOT8
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),0.287305308427014,0.8459427065235465,0.8571428571428571,1.0,1.0,34/114,27.35%,FASTKD1;GTF2F2;HNRNPC;NUFIP1;TP53RK;NOVA1;FASTKD2;LSM8;DROSHA;PAPOLA;TFIP11;POLR2C;RNASEL;SYNCRIP;HNRNPU;THOC1;AGO3;PCBP3;DKC1;PPP1R8;RNGTT;NOL9;RBMX;HNRNPD;ADARB1;RBM39;MTREX;LSM1;PAPOLG;CLP1;ALKBH1;POLR2A;HNRNPH1;FTO
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),0.3112873236513194,0.8456361826892764,0.8,1.0,1.0,10/56,15.93%,BET1;PEF1;SEC22B;RAB1B;PPP6R1;KLHL12;CNIH1;SCFD1;SEC23IP;SEC24A
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.3112873236513194,0.8456361826892764,0.8,1.0,1.0,10/56,15.93%,BET1;PEF1;SEC22B;RAB1B;PPP6R1;KLHL12;CNIH1;SCFD1;SEC23IP;SEC24A
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),0.3112873236513194,0.8456361826892764,0.8,1.0,1.0,10/56,15.93%,BET1;PEF1;SEC22B;RAB1B;PPP6R1;KLHL12;CNIH1;SCFD1;SEC23IP;SEC24A
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,-0.4123339526583441,-0.845613849029557,0.6363636363636364,1.0,1.0,5/35,7.42%,EFNA1;MET;PKP2;PROX1;BAIAP2L1
prerank,GO_Biological_Process_2021__response to UV-B (GO:0010224),-0.5251161357304366,-0.845381578959475,0.7358490566037735,1.0,1.0,3/8,19.52%,IL12A;CDKN1A;HYAL1
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),0.35277340760755077,0.8451509555297808,0.78125,1.0,1.0,13/22,31.98%,AKT1;EIF4EBP2;CCDC88A;EIF4EBP1;SMG1;RPTOR;RPS6KB1;NPRL3;MEAK7;MLST8;MTOR;RICTOR;RPS6KB2
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),0.2777135783989824,0.8451217805362843,0.8888888888888888,1.0,1.0,21/146,11.46%,SEM1;RAD54B;DNA2;LIG4;KPNA2;RFWD3;SMARCAD1;SMARCAL1;BRCC3;UBE2N;VCP;HMGB1;SMC6;YY1;RAD52;XRCC2;TDP2;PSMD14;DCLRE1B;MAPK8;HUS1
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),0.41404840545784727,0.8450409309613541,0.7105263157894737,1.0,1.0,3/16,13.07%,PDK4;ZNF304;PIK3CA
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.45670853954715385,-0.8449892321693259,0.6842105263157895,1.0,1.0,5/11,32.49%,GFPT2;UAP1;UAP1L1;GNPNAT1;GNPDA1
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.45670853954715385,-0.8449892321693259,0.6842105263157895,1.0,1.0,5/11,32.49%,GFPT2;UAP1;UAP1L1;GNPNAT1;GNPDA1
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),0.31395827785950386,0.8448269441332474,0.8,1.0,1.0,11/83,10.07%,TBC1D4;TRIB3;PDE3B;LPIN3;KAT2B;AKT2;AKT1;ADCY1;INSIG2;RAB8B;PRKACB
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.39094756636211325,-0.8447707514085052,0.7341772151898734,1.0,1.0,4/50,9.17%,ANXA1;RAB11A;CCNB1;ANAPC11
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),0.37819879285146984,0.8444761515863274,0.631578947368421,1.0,1.0,3/20,15.70%,NT5C1A;FHIT;NUDT15
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),0.46390940511009904,0.8444760086021493,0.7631578947368421,1.0,1.0,2/10,9.59%,LTV1;XPO1
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),-0.38040238184725395,-0.8443988240022412,0.6883116883116883,1.0,1.0,1/61,0.14%,ST6GAL1
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,-0.3452724938043931,-0.8435104125100256,0.8658536585365854,1.0,1.0,17/114,12.46%,TAGLN3;STMN2;IFIT1;S100A6;ZDHHC22;PLP1;SLITRK1;ISG15;RND2;EFNB3;ZIC1;GAP43;ZNF536;GFAP;TLR3;NYAP1;PLPPR5
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),-0.4103841364119384,-0.8434290737975035,0.7297297297297297,1.0,1.0,4/33,4.59%,KCNQ1;ANK3;NOS1AP;KCNJ2
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),0.3875497988111955,0.8434137504412563,0.8214285714285714,1.0,1.0,2/19,14.90%,PRKD1;PICALM
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),-0.3598002933188871,-0.8433636015442836,0.7586206896551724,1.0,1.0,13/136,12.24%,TRIM22;APLNR;TRIM61;TRIM5;PROX1;APP;YBX3;LDLR;ATP1B1;TRIM17;NFKBID;NELL1;PRDM1
prerank,GO_Biological_Process_2021__regulation of microglial cell activation (GO:1903978),0.4914405159427592,0.8431163090055631,0.6585365853658537,1.0,1.0,1/8,1.19%,NR1D1
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),-0.3600065637092919,-0.84277033051934,0.8351648351648352,1.0,1.0,10/120,15.94%,RPL3;RPS27;RPS14;SNRPD2;RPL24;RPL10;RPL38;RPS15;RPL5;MRPL20
prerank,GO_Biological_Process_2021__positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),0.5397873023941353,0.8427470285120152,0.7272727272727273,1.0,1.0,2/5,11.34%,HMGB1;TIRAP
prerank,GO_Biological_Process_2021__skeletal muscle contraction (GO:0003009),-0.5014316104280384,-0.8422317528342886,0.7352941176470589,1.0,1.0,4/10,20.17%,RCSD1;PVALEF;TNNT1;STAC2
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),-0.45292915600172656,-0.8421851669171548,0.6438356164383562,1.0,1.0,3/14,9.65%,CIITA;SLC18A2;CEACAM1
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),0.4460322467691388,0.8420891786677267,0.65625,1.0,1.0,3/9,14.59%,AKT1;QDPR;DHFR
prerank,PanglaoDB_Augmented_2021__Decidual Cells,-0.5259293596674581,-0.842035729086678,0.6825396825396826,1.0,1.0,4/8,7.12%,CD5;SKAP1;GPR171;P2RY10
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),0.3044252932255661,0.8416098209330555,0.9375,1.0,1.0,7/36,15.03%,BCO2;AKT2;ABCD1;AKT1;VCP;BAD;PRDX3
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),-0.4027265891170641,-0.8415724719521558,0.6756756756756757,1.0,1.0,5/33,18.96%,BLM;GADD45A;ADIRF;CDKN1A;RGR
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),0.3443141893071086,0.8409667479409684,0.8181818181818182,1.0,1.0,10/27,24.06%,MCU;GLUD1;DRD2;BAD;SLC30A8;UCN;TM7SF3;CRH;SELENOT;HFE
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),-0.4160971525109464,-0.8409122425038814,0.7058823529411765,1.0,1.0,4/16,13.03%,TLR2;TLR3;SYK;SCIMP
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),0.370634789484013,0.8408741952750921,0.6774193548387096,1.0,1.0,6/22,22.39%,PDE12;CSTF3;TOE1;ERN1;ZC3H12C;POP1
prerank,GO_Biological_Process_2021__tetrahydrofolate interconversion (GO:0035999),-0.5062044694010186,-0.8407261223820506,0.734375,1.0,1.0,1/9,0.73%,TYMS
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),0.2782481030691879,0.8406096710119486,1.0,1.0,1.0,17/147,6.62%,RGCC;NR1D1;AGER;HS3ST5;BMP2;ALDH1A1;SPRED1;ID1;ADIPOR1;TWSG1;SOX9;IL17D;SPRY1;EGFR;ZNF706;RGS2;ACVR1C
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),-0.35278638885262276,-0.8404680254660278,0.7934782608695652,1.0,1.0,20/163,20.05%,THBS1;TYMS;RPS4X;APP;IGFBP5;RPS6KA1;PLD1;RPL13A;PATL2;EIF2B2;OGFOD1;RPL10;RPL5;RBM4B;GLE1;RBM3;LARP6;SAMD4A;DAPK3;EIF4A3
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),-0.5157472331298026,-0.8399780058985341,0.7424242424242424,1.0,1.0,3/10,17.52%,SPOCK3;WAS;SPINT2
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.3320770484158785,0.8397761861424949,0.6363636363636364,1.0,1.0,6/28,15.93%,NUDT16L1;ERCC6;HSF1;TFIP11;CYREN;POT1
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),0.3403111082301348,0.8397656361321446,0.7058823529411765,1.0,1.0,15/49,26.79%,RALB;SESN2;RUFY4;GPSM1;SESN3;PIP4K2B;SLC25A5;PIP4K2C;ADRB2;RAB3GAP1;FYCO1;EPM2A;PAFAH1B2;SESN1;MAP3K7
prerank,GO_Biological_Process_2021__regulation of endodeoxyribonuclease activity (GO:0032071),0.5077043973817983,0.8395621549513067,0.7368421052631579,1.0,1.0,2/7,8.15%,AKT1;HMGB1
prerank,GO_Biological_Process_2021__regulation of hyaluronan biosynthetic process (GO:1900125),-0.5705768376421978,-0.8392083709503438,0.7049180327868853,1.0,1.0,2/5,19.49%,EGF;TGFB1
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),0.2516800752269574,0.8390940418768781,1.0,1.0,1.0,32/231,13.42%,CD247;BET1;PPARGC1A;MEN1;MCU;PEF1;MITF;SAMM50;TSPAN33;TCAP;OCLN;SOX9;CUL1;PYGO2;LPXN;LLGL1;SEC22B;PYGO1;RAB1B;PPP6R1;WDCP;HSF1;MDN1;PDE4DIP;KLHL12;KMT2A;TRADD;OPA1;BAD;WASL;CNIH1;SCFD1
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.44647523982314363,-0.8389636353304305,0.7377049180327869,1.0,1.0,1/14,4.20%,IMPDH1
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),-0.38803137389520315,-0.8389060348679974,0.7901234567901234,1.0,1.0,8/59,10.48%,SIX3;RPE65;CLRN1;CDH23;CRYBA1;BEST1;SLC24A1;ARR3
prerank,GO_Biological_Process_2021__regulation of DNA demethylation (GO:1901535),-0.5632581291890149,-0.8387649747410919,0.7884615384615384,1.0,1.0,1/5,7.94%,STPG4
prerank,GO_Biological_Process_2021__positive regulation of DNA demethylation (GO:1901537),-0.5632581291890149,-0.8387649747410919,0.7884615384615384,1.0,1.0,1/5,7.94%,STPG4
prerank,GO_Biological_Process_2021__diacylglycerol biosynthetic process (GO:0006651),0.5103943631724227,0.8386580969194192,0.6904761904761905,1.0,1.0,3/5,20.76%,MOGAT1;PLA2G15;GPAM
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated calcium channel activity (GO:1901387),0.509231484435084,0.8382408111740866,0.7666666666666667,1.0,1.0,2/7,15.53%,CACNB3;CACNA2D1
prerank,GO_Biological_Process_2021__isoprenoid metabolic process (GO:0006720),0.4271049386813357,0.8382022021471031,0.6111111111111112,1.0,1.0,2/6,17.96%,PHYH;PDSS2
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),-0.39345390396569957,-0.8380308580440157,0.8117647058823529,1.0,1.0,6/51,18.20%,BLM;BRCA1;DONSON;CCND1;CDK2;CDKN1A
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),-0.35025809038855443,-0.8378741168222882,0.8275862068965517,1.0,1.0,10/126,9.78%,ANXA1;TGFBR2;ZFP36;STMN2;CD44;OVOL2;CCL2;WNT5A;VIL1;KLF4
prerank,GO_Biological_Process_2021__histone phosphorylation (GO:0016572),-0.5020481644263048,-0.8378711511516265,0.6875,1.0,1.0,4/9,29.31%,CDK2;PRKCD;MAP3K12;INCENP
prerank,MSigDB_Hallmark_2020__Apical Junction,-0.33444991887760717,-0.8378136050717632,0.8588235294117647,1.0,1.0,18/157,16.15%,FYB1;ICAM1;ITGA2;CDH6;NEXN;FSCN1;THY1;THBS3;BAIAP2;YWHAH;CD99;CLDN18;SYK;ZYX;MYH9;RHOF;ITGA3;ITGA9
prerank,GO_Biological_Process_2021__retinol metabolic process (GO:0042572),-0.4828133650942274,-0.8376140623887013,0.6825396825396826,1.0,1.0,3/11,14.58%,CYP1B1;ADH4;CYP3A4
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),0.32509152768409383,0.8376022729399927,0.75,1.0,1.0,16/44,25.18%,NGF;CSF1R;PIK3C3;PIK3CA;ADAP2;PIK3R1;PLCB1;PIK3C2A;PLCB4;PLCL1;PIK3C2G;PI4KB;EZR;PLCH1;RPS6KB1;IRS1
prerank,GO_Biological_Process_2021__plus-end-directed vesicle transport along microtubule (GO:0072383),0.5358349180469478,0.8375946857417819,0.6976744186046512,1.0,1.0,4/5,39.95%,FYCO1;KIF3B;KIFAP3;KIF13A
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),-0.4671101066064705,-0.8375902913396541,0.7714285714285715,1.0,1.0,7/18,27.29%,TNFRSF14;ROMO1;SELP;SLC11A1;AQP1;OPTN;SERPINE1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),-0.4283168839069469,-0.837589946451824,0.6933333333333334,1.0,1.0,1/23,2.55%,PLAAT4
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.41550849071163176,-0.8375713945208993,0.6621621621621622,1.0,1.0,8/23,23.07%,EFNA1;PRKCG;RPS7;RPL5;PML;RPL23;RPL11;GABARAPL2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),-0.4075045063626795,-0.8375363874647618,0.7037037037037037,1.0,1.0,2/31,6.15%,THBS1;IL12A
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),0.3750393726928584,0.8373408515780989,0.7037037037037037,1.0,1.0,6/26,17.62%,LPIN3;CSNK2A1;CHPT1;CSNK2A2;PCTP;CEPT1
prerank,GO_Biological_Process_2021__T cell migration (GO:0072678),-0.5215173601044643,-0.8371800548256317,0.734375,1.0,1.0,2/8,10.33%,GPR183;CD99
prerank,GO_Biological_Process_2021__bone resorption (GO:0045453),-0.5318327017255944,-0.8367416093223616,0.673469387755102,1.0,1.0,1/6,14.59%,IL7
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),-0.535723560097283,-0.8364706605841922,0.75,1.0,1.0,3/8,27.55%,IGF1;AKAP6;SLC9A1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.535723560097283,-0.8364706605841922,0.75,1.0,1.0,3/8,27.55%,IGF1;AKAP6;SLC9A1
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",-0.4641953803917465,-0.8363293632005862,0.6865671641791045,1.0,1.0,6/15,34.78%,SNRNP200;NCBP2;WBP4;DDX23;SNRPC;PSIP1
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),-0.44438510755482435,-0.8362107301207976,0.7049180327868853,1.0,1.0,3/15,23.95%,WNT5A;MFSD2A;MYO9A
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),-0.44821784011992905,-0.836108493461873,0.7101449275362319,1.0,1.0,10/16,32.55%,DAB2IP;B4GALT7;FTH1;EMD;SFRP1;NLRC3;GSTP1;TRIM32;PARP10;TP53
prerank,GO_Biological_Process_2021__inclusion body assembly (GO:0070841),-0.5610128085217696,-0.8359204619291419,0.7230769230769231,1.0,1.0,3/5,33.45%,MAPT;HDAC6;BAG3
prerank,GO_Biological_Process_2021__negative regulation of immune system process (GO:0002683),0.4438634311484998,0.8358517332051354,0.6785714285714286,1.0,1.0,2/8,5.51%,SOX9;IL17D
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.3764024633177351,0.8357847636087656,0.7777777777777778,1.0,1.0,3/19,7.90%,SRI;SELENON;JPH1
prerank,GO_Biological_Process_2021__positive regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903997),-0.5167876686350411,-0.8357812453678851,0.6792452830188679,1.0,1.0,1/5,15.66%,BDNF
prerank,GO_Biological_Process_2021__G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.3784674498160382,0.8357233409779302,0.7714285714285715,1.0,1.0,1/14,0.79%,RGS10
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),-0.3380620321147191,-0.835179651403949,0.7840909090909091,1.0,1.0,16/129,15.12%,CXCL2;POU4F1;ZFP36;RAMP3;TESC;WNT8B;CCL2;ATP1A1;WNT5A;PDCD1LG2;PTK6;PDK3;TNIP2;DAB2IP;SBNO2;ADCY5
prerank,MSigDB_Hallmark_2020__p53 Pathway,-0.34260915556141824,-0.8351619828508631,0.7741935483870968,1.0,1.0,21/170,14.85%,S100A10;CDKN2A;PLK2;EPS8L2;ATF3;APP;STEAP3;HEXIM1;BAIAP2;GADD45A;KLF4;RALGDS;PLK3;FOS;TSPYL2;BTG1;RHBDF2;PVT1;IRAG2;TGFA;NDRG1
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),-0.4250947937467376,-0.8351577997732589,0.7285714285714285,1.0,1.0,7/25,19.72%,SLC51A;AKR1C1;CEACAM1;SLC51B;ABCC4;ATP8B1;SLCO1A2
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.40334474307650514,-0.8348941866797892,0.7222222222222222,1.0,1.0,8/34,19.78%,CEMIP;APP;EGF;CHI3L1;DMTN;SPHK1;TGFB1;RIPK2
prerank,GO_Biological_Process_2021__protein sulfation (GO:0006477),-0.5551710575343844,-0.8348819402991908,0.7580645161290323,1.0,1.0,2/5,6.79%,TPST1;CHST4
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.4760946609136859,-0.8348355600415596,0.7796610169491526,1.0,1.0,5/15,23.83%,CYP1B1;CRLF3;OCIAD2;HES1;GHR
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),-0.3337926081402822,-0.8344488992948967,0.8842105263157894,1.0,1.0,25/332,9.95%,LEF1;THBS1;HPN;TLR2;POU4F1;ANK3;NOS1AP;RAMP3;TESC;RPS4X;HTR2B;OVOL2;IL15;APP;SCX;WARS1;ELAVL4;PLSCR1;PLD1;WNT5A;EGF;BRCA1;TLR3;KLF4;RIMS2
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),0.2594398604793534,0.8340894362648803,1.0,1.0,1.0,33/202,18.12%,LEPR;ATP6V0D2;TAB3;TRIB3;ATP6V1A;USP13;KEAP1;EXOC8;ATP6V1G1;AKT1;HMGB1;PRKAB1;CSNK2A2;ATF6;MAPK8;WDR24;EIF4E;CASP3;BAD;RAB39B;DAP;TICAM1;PRKD1;TPCN1;EP300;ABL2;PIP4K2B;ERN1;PIK3C2A;PIP4K2C;SNX5;MID2;SLC38A9
prerank,GO_Biological_Process_2021__regulation of immunoglobulin production (GO:0002637),-0.4572534700243446,-0.8339788820421071,0.7333333333333333,1.0,1.0,6/13,29.32%,HLA-E;GPI;PTPRC;XBP1;STX4;CD22
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),-0.44707906355043425,-0.8339530463534306,0.6086956521739131,1.0,1.0,2/12,12.21%,BASP1;PAX8
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),0.3369882115950609,0.8336755145864098,0.875,1.0,1.0,5/41,7.95%,ASCL1;BRINP3;SOX9;RORB;ADNP2
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),0.32967786117128856,0.8332107176898998,0.6,1.0,1.0,8/58,16.39%,NR1D1;MACIR;TNFAIP3;PTGIS;SIRPA;MUL1;RNF26;ENPP3
prerank,GO_Biological_Process_2021__negative regulation of ERAD pathway (GO:1904293),-0.5196157620532083,-0.8330894837139757,0.7017543859649122,1.0,1.0,3/6,28.56%,UBXN1;AQP11;SVIP
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.3064434630813826,0.8328603452224241,0.8666666666666667,1.0,1.0,14/47,19.34%,RGCC;CNOT9;PCBP4;CRADD;CNOT2;E2F4;EP300;CNOT6L;PLAGL1;CNOT4;TRIAP1;CNOT1;CNOT8;MDM2
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),-0.3851285507792984,-0.8326792495791752,0.7407407407407407,1.0,1.0,7/51,16.93%,CTSC;DENND3;VLDLR;SPATA18;CTSS;DAB2IP;CTSZ
prerank,MSigDB_Hallmark_2020__heme Metabolism,0.2591619847885352,0.8324898666111255,1.0,1.0,1.0,30/163,15.14%,EPOR;TRAK2;ADIPOR1;HMBS;TYR;CA2;KAT2B;BSG;GDE1;RCL1;SLC25A37;ARHGEF12;NCOA4;DCUN1D1;GMPS;BTRC;ARL2BP;NR3C1;FBXO9;YPEL5;FBXO34;FOXJ2;VEZF1;CAT;ATG4A;FECH;MINPP1;XPO7;PICALM;MPP1
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),0.48328081718512167,0.8323339574594921,0.7,1.0,1.0,4/8,21.93%,GALNT3;GALNT1;EOGT;GALNT2
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),-0.3697406197629419,-0.8321385334565634,0.7468354430379747,1.0,1.0,11/78,16.57%,SCN1B;STMN2;VLDLR;WNT5A;PTK6;RIT2;PLPPR5;DAB2IP;BDNF;FES;DPYSL3
prerank,GO_Biological_Process_2021__marginal zone B cell differentiation (GO:0002315),-0.5244415144467036,-0.8320322438473519,0.7333333333333333,1.0,1.0,2/6,19.68%,LFNG;DOCK10
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),-0.3993539255223368,-0.83197008032889,0.7361111111111112,1.0,1.0,8/32,21.89%,NLRC5;ISG15;USP18;SERPING1;SUSD4;A2M;NMI;STAT2
prerank,GO_Biological_Process_2021__pyrimidine nucleoside metabolic process (GO:0006213),-0.4838906104262193,-0.8315436546655185,0.7313432835820896,1.0,1.0,1/13,2.35%,TYMP
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),0.40732724243134466,0.8313198864686714,0.7142857142857143,1.0,1.0,5/20,22.05%,PHC1;UBE2N;RNF20;USP22;UBE2A
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),0.32111255726439275,0.8309742256800262,0.6666666666666666,1.0,1.0,4/45,8.52%,TMEM100;BMP2;SMAD5;ZFYVE16
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),0.3061783024847916,0.8302754595679679,0.8125,1.0,1.0,14/112,11.14%,NR1D1;PSMD10;PSMA1;ADIPOR1;PSMD11;ELOVL6;ACACB;RUBCNL;PSMB5;PMVK;CHD9;PRKAB1;NFYC;PSMD14
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),0.3404075971483067,0.8302175568507842,0.7647058823529411,1.0,1.0,5/35,5.54%,WNT7A;SNORC;BMP2;SOX9;RUNX1
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),-0.4580417010678515,-0.8300330279745711,0.7258064516129032,1.0,1.0,4/14,18.85%,ORMDL2;PRKCD;TNFRSF1A;SPHK1
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),-0.34840029556055646,-0.8300257625529975,0.7701149425287356,1.0,1.0,19/99,22.08%,CDKN2A;PSRC1;TP53TG5;BST2;TSPYL2;BTG1;MT1H;CRLF3;SFRP2;FBP1;SLIT3;TCHP;CDKN1A;PML;TGFB1;HYAL1;SFRP1;CDKN2D;BCL6
prerank,GO_Biological_Process_2021__regulation of vascular wound healing (GO:0061043),0.5176393326304601,0.8299676457311086,0.7,1.0,1.0,1/5,4.53%,TNFAIP3
prerank,GO_Biological_Process_2021__regulation of mammary gland epithelial cell proliferation (GO:0033599),0.438625947703002,0.8298002397414528,0.7142857142857143,1.0,1.0,2/8,10.99%,ZNF703;ROBO1
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),-0.44231793361029415,-0.8297293035139639,0.75,1.0,1.0,3/16,11.49%,PKP2;PROX1;ZFPM1
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),-0.5118618021471457,-0.8293782047959809,0.7166666666666667,1.0,1.0,1/9,0.92%,APLNR
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),0.3416650851159638,0.829301845699333,0.65,1.0,1.0,8/51,13.20%,PSMD10;PDK4;PSMA1;PSMD11;PSMB5;PSMD14;SIRT5;PSMD12
prerank,GO_Biological_Process_2021__fibrinolysis (GO:0042730),0.5322803994644177,0.8290762023675642,0.7142857142857143,1.0,1.0,1/6,4.21%,SERPINF2
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),-0.3619005907459104,-0.8289591987122943,0.8131868131868132,1.0,1.0,8/84,12.64%,BLM;RECQL4;MEIOB;POLQ;ZSWIM7;BRCA1;GINS2;RPA3
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),0.45300832767773236,0.8286048929625642,0.75,1.0,1.0,3/10,12.71%,MCU;MAIP1;MICU2
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),-0.48118349549173384,-0.8282926394386072,0.75,1.0,1.0,5/14,25.90%,ATAD5;GLI1;DDRGK1;ZNF16;PAF1
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),0.35254140942046686,0.827957994502624,0.6818181818181818,1.0,1.0,8/31,16.68%,KMT5A;PLK1;NCAPH2;CSNK2A1;CSNK2A2;H1-2;MCPH1;TENT4A
prerank,GO_Biological_Process_2021__tetrahydrofolate metabolic process (GO:0046653),-0.47440839634578835,-0.8278443895220051,0.765625,1.0,1.0,1/11,0.73%,TYMS
prerank,GO_Biological_Process_2021__cellular response to acidic pH (GO:0071468),-0.5179835630608733,-0.8277845183645507,0.7213114754098361,1.0,1.0,1/8,9.48%,RAB11FIP5
prerank,GO_Biological_Process_2021__dicarboxylic acid catabolic process (GO:0043649),0.4283485335160831,0.8276027139219191,0.68,1.0,1.0,2/13,7.65%,MTHFS;GLUD1
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.35196992751025674,0.8274641649822398,0.8571428571428571,1.0,1.0,12/35,24.71%,BMP2;GREM1;TWSG1;GDF11;ACVR2A;GDF10;GDF9;TGFBR1;SMAD7;BMP7;HFE;SMAD4
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),-0.5145439570468993,-0.8274065218733435,0.7049180327868853,1.0,1.0,1/7,10.23%,DDX60
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),-0.329991000211892,-0.8273626497173263,0.8064516129032258,1.0,1.0,12/141,14.53%,ENPP2;SCX;RPS6KA1;VLDLR;WNT5A;VIL1;BASP1;SRF;NLRP5;NEUROD2;DAB2IP;PINK1
prerank,GO_Biological_Process_2021__negative regulation of protein autophosphorylation (GO:0031953),-0.4894938114308427,-0.8272622921837084,0.6949152542372882,1.0,1.0,2/8,14.58%,NLRP12;MVP
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),-0.3737219223722465,-0.8270138426295102,0.8539325842696629,1.0,1.0,14/86,20.91%,ANK3;RAMP3;KCNB1;CEMIP;AKAP5;SLC51B;YWHAH;PPP3CC;ITGA3;PRKCH;PDZK1;NMT1;STAC2;GPER1
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.2744724406522456,0.8268672837519543,1.0,1.0,1.0,18/132,13.64%,HMMR;PSMD10;CDC25A;PSMA1;PSMD11;PLK1;RCC2;CUL1;PSMB5;CEP152;FBXO5;CSNK1E;CEP290;PSMD14;HAUS1;PCM1;PSMD12;ALMS1
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),-0.5194397449085092,-0.8268154723981113,0.7,1.0,1.0,2/8,16.30%,LRRC4;NLGN1
prerank,GO_Biological_Process_2021__arginine catabolic process (GO:0006527),-0.5401939945980859,-0.8267529164613425,0.7424242424242424,1.0,1.0,2/5,17.04%,ARG2;NOS1
prerank,PanglaoDB_Augmented_2021__Tanycytes,-0.3492022220841853,-0.8264114333254435,0.8,1.0,1.0,20/112,17.29%,KCNT2;STMN2;RCAN2;IGFBP5;THY1;EFNB3;MAP1B;RASL12;LDB2;GAP43;EDIL3;LMOD1;SHC2;ADCY5;CRMP1;DPYSL3;DCLK1;PCDH18;RGS7BP;CCDC3
prerank,GO_Biological_Process_2021__regulation of synapse maturation (GO:0090128),-0.48400432338692634,-0.826367512147955,0.78125,1.0,1.0,3/9,19.36%,NEUROD2;DAB2IP;RELN
prerank,GO_Biological_Process_2021__retinal metabolic process (GO:0042574),-0.472380275491007,-0.8263297182463596,0.6825396825396826,1.0,1.0,3/11,8.93%,RDH13;AKR1C1;CYP1B1
prerank,GO_Biological_Process_2021__positive regulation of mast cell degranulation (GO:0043306),-0.5184366740224915,-0.8262401692427521,0.7346938775510204,1.0,1.0,2/6,23.91%,SYK;GAB2
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",-0.5009297596509937,-0.8259210019896459,0.7017543859649122,1.0,1.0,1/7,4.41%,NDST4
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum exit site (GO:0070973),0.47855370789582474,0.8258850864173855,0.6842105263157895,1.0,1.0,3/5,36.65%,MIA3;BCAP31;LRRK2
prerank,GO_Biological_Process_2021__myeloid cell development (GO:0061515),-0.4809681364405527,-0.8257712138428603,0.7540983606557377,1.0,1.0,6/15,17.71%,TLR2;APP;GATA1;THPO;DMTN;ANXA2
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.4851900425564179,-0.8251938572524492,0.746031746031746,1.0,1.0,3/8,20.95%,PLEKHA4;RSPO3;SFRP1
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),0.4098699858185789,0.8250880664553809,0.6216216216216216,1.0,1.0,2/14,8.18%,NCOA4;AR
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),-0.5685889952410383,-0.8250174409242396,0.7301587301587301,1.0,1.0,3/5,37.26%,ULK1;ULK2;FGF13
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.3750689794881553,0.8249600280321816,0.7586206896551724,1.0,1.0,1/23,3.14%,TRIB3
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),0.46194940224217607,0.824845380581397,0.6511627906976745,1.0,1.0,4/8,18.48%,CNOT9;CNOT2;VPS11;CNOT1
prerank,PanglaoDB_Augmented_2021__T Cytotoxic Cells,-0.4404550720121852,-0.824788743393397,0.6527777777777778,1.0,1.0,4/17,7.12%,CD5;TAGAP;GPR171;P2RY10
prerank,GO_Biological_Process_2021__T cell differentiation in thymus (GO:0033077),0.44988772329872906,0.8246805058555031,0.625,1.0,1.0,2/10,7.52%,LIG4;RABL3
prerank,GO_Biological_Process_2021__negative regulation of macrophage activation (GO:0043031),0.47533630390438103,0.8242152712331048,0.7297297297297297,1.0,1.0,1/9,1.19%,NR1D1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),-0.4742488243815816,-0.8241934407689978,0.6891891891891891,1.0,1.0,1/13,7.91%,YBX3
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),-0.39001630463215475,-0.8241466793101553,0.7922077922077922,1.0,1.0,1/42,0.43%,THBS1
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,-0.3500057324106318,-0.8240323746075309,0.8111111111111111,1.0,1.0,20/107,17.45%,COL4A1;COL4A2;GFRA2;PLP1;SEMA3B;IGFBP5;THY1;LRRTM1;EFNB3;MAP1B;EDIL3;SCARA3;LMOD1;NUAK1;DAB2IP;AMOTL2;DPYSL3;DCLK1;PCDH18;TUSC3
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),0.35171603138244173,0.8240166861364436,0.7878787878787878,1.0,1.0,8/28,25.25%,HSPA1A;UGGT1;DNAJB14;DNAJB5;CHCHD4;DNAJC18;HSPA13;DNAJB12
prerank,GO_Biological_Process_2021__detection of visible light (GO:0009584),-0.500882359726817,-0.8239680082904614,0.7846153846153846,1.0,1.0,3/10,12.47%,RPE65;PDE6B;GRM6
prerank,GO_Biological_Process_2021__regulation of actin filament-based movement (GO:1903115),-0.558098679749012,-0.8239382702569488,0.734375,1.0,1.0,2/6,7.82%,PDPN;PLN
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),0.44254218048338,0.823801983139937,0.7317073170731707,1.0,1.0,2/11,11.61%,CEP19;PCM1
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell apoptotic process (GO:0010664),0.5395495675110484,0.8236556549822245,0.7391304347826086,1.0,1.0,3/5,23.26%,PPP1R10;MDK;BMP7
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),-0.4726770641987216,-0.823495547352596,0.711864406779661,1.0,1.0,2/9,9.29%,ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__negative regulation of gluconeogenesis (GO:0045721),0.4850271169903152,0.8233357236038259,0.6097560975609756,1.0,1.0,1/6,15.18%,EP300
prerank,GO_Biological_Process_2021__telencephalon cell migration (GO:0022029),0.5164889646020069,0.8231063717360675,0.6857142857142857,1.0,1.0,1/5,7.60%,PEX13
prerank,GO_Biological_Process_2021__protein localization to nucleolus (GO:1902570),0.47157106755521133,0.8227667411705661,0.6538461538461539,1.0,1.0,2/5,27.97%,NOL8;WRN
prerank,GO_Biological_Process_2021__cellular response to angiotensin (GO:1904385),0.45209611221917195,0.8227154235262361,0.6666666666666666,1.0,1.0,2/7,14.74%,CA2;NFKB1
prerank,MSigDB_Hallmark_2020__Adipogenesis,-0.3404431747554937,-0.8226768753034724,0.8421052631578947,1.0,1.0,3/178,0.72%,ENPP2;C3;COL4A1
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),-0.4364860472285683,-0.8225782364492816,0.6986301369863014,1.0,1.0,1/15,2.43%,ZFP36
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.36969103319051566,-0.8225493482636176,0.7228915662650602,1.0,1.0,3/55,5.90%,THBS1;SP100;TMC8
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287),0.49049181824219235,0.8223890270145358,0.7567567567567568,1.0,1.0,1/7,1.10%,CFAP53
prerank,GO_Biological_Process_2021__positive regulation of oligodendrocyte differentiation (GO:0048714),-0.5379473283457114,-0.8219291160637449,0.7678571428571429,1.0,1.0,1/6,10.40%,TENM4
prerank,GO_Biological_Process_2021__peroxisome proliferator activated receptor signaling pathway (GO:0035357),-0.5338828238042015,-0.8219211426171571,0.711864406779661,1.0,1.0,1/5,12.30%,PDK3
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.3788810670668367,-0.8218384540921403,0.75,1.0,1.0,1/42,0.44%,S100A10
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),-0.42420835690453235,-0.8218033984200735,0.7384615384615385,1.0,1.0,2/21,10.66%,BHMT;EEF1AKMT2
prerank,GO_Biological_Process_2021__mitotic G1/S transition checkpoint signaling (GO:0044819),-0.4773164188110055,-0.8217623393289568,0.7142857142857143,1.0,1.0,3/12,15.78%,PLK3;CCND1;CDK2
prerank,GO_Biological_Process_2021__regulation of B cell differentiation (GO:0045577),-0.4897710862230895,-0.8214541429274526,0.7719298245614035,1.0,1.0,3/11,20.95%,MMP14;SYK;SFRP1
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),-0.477439657136119,-0.8213144934227519,0.71875,1.0,1.0,1/12,8.02%,ANGPTL3
prerank,GO_Biological_Process_2021__glycolipid transport (GO:0046836),0.5279382952986302,0.8207218148340025,0.7297297297297297,1.0,1.0,2/6,18.13%,RFT1;NPC2
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),0.4287511693337292,0.8206131634062858,0.717948717948718,1.0,1.0,3/12,7.56%,PLK1;RIOK2;ANAPC1
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.4094386493085067,-0.8204708794714024,0.6710526315789473,1.0,1.0,1/24,0.73%,TYMS
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),-0.48066744941051043,-0.8204199898441809,0.7407407407407407,1.0,1.0,1/6,18.20%,CDKN1A
prerank,GO_Biological_Process_2021__regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),-0.4940987833719782,-0.820331262558546,0.7037037037037037,1.0,1.0,1/6,15.66%,BDNF
prerank,GO_Biological_Process_2021__establishment of endothelial intestinal barrier (GO:0090557),0.40012511723418775,0.8201190351969198,0.7297297297297297,1.0,1.0,2/10,9.33%,RAP2C;RAB1B
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),0.3243523177862618,0.8197692137762069,0.9444444444444444,1.0,1.0,6/46,9.37%,MEN1;BMP2;TRIB3;RALB;CAPRIN2;STK4
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),0.44211444741256983,0.8196647954840921,0.6923076923076923,1.0,1.0,1/9,2.15%,RAP2C
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.34669069775287437,0.819631039927799,0.6956521739130435,1.0,1.0,3/30,8.77%,NR1D1;TNFAIP3;PPM1A
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),0.31152828297476376,0.819476305206031,0.8,1.0,1.0,7/61,9.13%,NR1D1;BMP2;TRIB3;ANKRD26;LMO3;AKT1;GNB3
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate catabolic process (GO:0009169),0.5191950334365507,0.8190290514896581,0.6923076923076923,1.0,1.0,6/7,32.33%,NT5C1A;PRTFDC1;NT5E;NT5C2;AMPD3;HPRT1
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),-0.3980321817947617,-0.8187700980934558,0.7142857142857143,1.0,1.0,1/24,0.78%,BLM
prerank,GO_Biological_Process_2021__tRNA threonylcarbamoyladenosine metabolic process (GO:0070525),0.5024455693483516,0.8187316252482646,0.7631578947368421,1.0,1.0,3/5,12.22%,TPRKB;TP53RK;TRIT1
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),0.36770424538938956,0.8187107923569976,0.7333333333333333,1.0,1.0,5/16,21.13%,RCC2;GPSM1;RRP1B;LRCH1;TMED2
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),-0.4807888213064533,-0.8187082154177336,0.6944444444444444,1.0,1.0,2/10,17.64%,ATG9A;WDR45
prerank,GO_Biological_Process_2021__regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547),0.528837897616908,0.8178852617865973,0.7674418604651163,1.0,1.0,2/5,15.50%,TSPAN12;ADAMTS12
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),0.28236304596436423,0.8177305639331072,1.0,1.0,1.0,25/222,11.49%,LEPR;G0S2;RGCC;KSR2;SOX8;PPARGC1A;BMP2;ABCA1;ADRA1A;ADIPOR1;SOX9;ELOVL6;PDGFC;ESRRG;NCOA3;SIRT6;FBXO5;PRKAB1;HSF1;FOXJ1;ZNF703;KAT2A;TRIM16;SOX5;CPT2
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),0.43900230797248735,0.8176068128630446,0.75,1.0,1.0,5/17,14.18%,BMP2;TRIB3;AKR1C3;PRMT3;ERLIN1
prerank,GO_Biological_Process_2021__aspartate transmembrane transport (GO:0015810),0.49928218218869425,0.8173670632170364,0.7435897435897436,1.0,1.0,4/6,27.76%,SLC25A18;SLC25A22;LRRC8D;SLC25A12
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),-0.4236305470998696,-0.8173505719875095,0.703125,1.0,1.0,2/16,11.05%,PTP4A3;TCP1
prerank,GO_Biological_Process_2021__branching involved in ureteric bud morphogenesis (GO:0001658),0.43917988347299486,0.8170889265999993,0.6216216216216216,1.0,1.0,2/7,9.00%,BMP2;SALL1
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),0.39037032415117356,0.8170816535975302,0.7931034482758621,1.0,1.0,3/15,6.83%,DNA2;EGFR;STN1
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),-0.34954993323944694,-0.8170713255880706,0.7411764705882353,1.0,1.0,14/86,22.29%,SIX3;IHO1;PLK2;RAB11A;PLK3;NUDT16;DAPK3;GPER1;SFRP1;CETN2;KIF11;KNSTRN;KIF20B;FSD1
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),0.31038016098208554,0.8167925856799862,0.8260869565217391,1.0,1.0,6/42,12.05%,GRPEL2;GDAP1;MFF;AKT1;TOMM22;RALA
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),0.43903128843864286,0.8164674864103947,0.6875,1.0,1.0,6/13,27.02%,NOTCH2;ROBO1;HEYL;HEY2;JAG1;HEY1
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),-0.4193261193486693,-0.8162237005202766,0.717948717948718,1.0,1.0,2/24,9.65%,C3;CEACAM1
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),-0.376856547328126,-0.8158414508120728,0.8148148148148148,1.0,1.0,4/52,10.89%,TLCD2;SLC4A11;ANGPTL3;SLC4A9
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),0.39343826074946586,0.8158294343129261,0.7142857142857143,1.0,1.0,1/13,14.56%,SMG7
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),0.3423739902624918,0.8156448111338556,0.7142857142857143,1.0,1.0,12/34,24.20%,RNF2;PHC1;EED;YAF2;RBBP4;MGA;PHC3;EHMT1;EPC1;PCGF2;E2F6;FOXO4
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),-0.402404945396893,-0.8154323851755668,0.7887323943661971,1.0,1.0,3/40,9.59%,HELB;POLQ;WAS
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),0.4454050482125239,0.8152907101572302,0.7575757575757576,1.0,1.0,2/20,5.44%,INSC;PLK1
prerank,GO_Biological_Process_2021__ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.44868265464435386,-0.8149095936961284,0.7704918032786885,1.0,1.0,1/13,4.20%,IMPDH1
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),-0.32758275138675247,-0.8148472479390537,0.8172043010752689,1.0,1.0,32/209,19.76%,TLCD2;RSPH4A;PKP2;CALD1;ANK3;STAG3;TEAD2;FSCN1;SPAG17;BAIAP2L1;WNT5A;BAIAP2;VIL1;NEFH;WAS;CFAP74;SYCE2;SYCE1;ELOB;TFAP4;DMTN;TEX11;NLGN1;DPYSL3;LRGUK;REC8;PML;IL1RAP;ADD2;RHOD;TGFB1;CD74
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),0.449807125069955,0.8147218391128043,0.6571428571428571,1.0,1.0,2/8,8.06%,SIGMAR1;DISP1
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),0.449807125069955,0.8147218391128043,0.6571428571428571,1.0,1.0,2/8,8.06%,SIGMAR1;DISP1
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),-0.4667082321027778,-0.8144394754753007,0.6666666666666666,1.0,1.0,1/12,9.24%,BRCA1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),0.4454425871604909,0.814403311300461,0.6829268292682927,1.0,1.0,3/11,16.60%,HMGB1;SIRT6;MDK
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,-0.35550035007725794,-0.814330188746611,0.8214285714285714,1.0,1.0,20/67,27.96%,ATF3;SEMA3B;PLSCR1;LDLR;PDK3;CD9;ADH4;SQLE;FDPS;MVK;FASN;HSD17B7;IDI1;ACAT2;NFIL3;HMGCS1;FADS2;SCD;PLAUR;LSS
prerank,GO_Biological_Process_2021__purine nucleobase biosynthetic process (GO:0009113),0.4610234199149738,0.8142423535368524,0.6590909090909091,1.0,1.0,1/6,7.93%,GMPS
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),-0.37035554052789993,-0.8142049353237738,0.8048780487804879,1.0,1.0,12/67,17.15%,DHCR24;GPNMB;SNCB;KIF14;WNT5A;FOS;HLA-F;GRIN2B;GRID2;CD200;CTSZ;CDK5
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),-0.48233746669268596,-0.8141187174819615,0.7377049180327869,1.0,1.0,4/9,34.78%,SREBF1;SEC14L2;SREBF2;RAN
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),-0.4928163305036801,-0.8141144150475956,0.6779661016949152,1.0,1.0,2/10,4.65%,SIX3;KIF14
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell apoptotic process (GO:0010665),0.4658920306799721,0.8139905326662773,0.6666666666666666,1.0,1.0,2/7,16.60%,PPP1R10;MDK
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.3811269220042164,0.8138637001906411,0.696969696969697,1.0,1.0,3/18,10.37%,HS3ST5;CSGALNACT1;EXT2
prerank,GO_Biological_Process_2021__response to hydroperoxide (GO:0033194),-0.4917621837198216,-0.8138557515860448,0.6833333333333333,1.0,1.0,4/6,27.27%,PRKCD;XRCC1;RNF112;SP1
prerank,GO_Biological_Process_2021__rRNA pseudouridine synthesis (GO:0031118),0.42918697061205,0.8135474874797501,0.7096774193548387,1.0,1.0,1/10,2.80%,NAF1
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),0.29166256825984654,0.8130958176153862,0.8620689655172413,1.0,1.0,13/70,19.51%,U2AF1;NUDT21;WDR33;CSTF3;PAPOLA;CPSF6;CPSF7;MTPAP;THOC1;THOC3;TENT4B;RPRD1B;CPSF2
prerank,GO_Biological_Process_2021__regulation of T cell apoptotic process (GO:0070232),-0.5105943214380775,-0.8128954372106729,0.7313432835820896,1.0,1.0,1/6,11.66%,PRKCQ
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),-0.37340251200813285,-0.8125934570679917,0.7974683544303798,1.0,1.0,9/51,20.31%,ANXA1;THSD7B;MINK1;MYH9;DMTN;PDLIM4;FGF7;ANTXR1;MICALL2
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.35158499249540764,-0.8124115064828278,0.8023255813953488,1.0,1.0,15/86,22.36%,SKOR1;TGFBR2;RPS27A;ASPN;ADAMTSL2;EID2;UBC;VWC2;SNX6;LDLRAD4;TGFB1;LRP2;VASN;VEPH1;PMEPA1
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),-0.39518117744711256,-0.8118380862979621,0.7397260273972602,1.0,1.0,7/33,20.95%,TGFBR2;KLF4;NOS1;SPHK1;EMD;LRP2;SFRP1
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),-0.31747667780240074,-0.8115493133596995,0.9368421052631579,1.0,1.0,29/385,13.12%,LEF1;KLF2;SP100;BLM;CIITA;PSRC1;TESC;IRF1;SKAP1;TEAD2;DNAJC2;SCX;CASZ1;RPS6KA1;ZIC1;WNT5A;PARP9;EGF;BRCA1;KLF4;YWHAH;STAT1;GATA1;FOS;IRF7;PAX8;MLLT11;CRLF3;CREB5
prerank,GO_Biological_Process_2021__radial glial cell differentiation (GO:0060019),-0.5195968597299991,-0.811334280364953,0.7,1.0,1.0,2/5,25.92%,HES1;STAT3
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),0.3457160329884287,0.8112723646702433,0.8333333333333334,1.0,1.0,4/23,13.01%,ABCB10;HSPA1A;ANKRD54;ACVR2A
prerank,GO_Biological_Process_2021__one-carbon compound transport (GO:0019755),0.47133143218199136,0.8111797469921129,0.6060606060606061,1.0,1.0,1/6,4.83%,CA2
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),-0.3968367523970032,-0.8111700024957732,0.7972972972972973,1.0,1.0,7/31,16.19%,CD44;SULF1;SCX;CHI3L1;COL11A2;NAMPT;DDRGK1
prerank,PanglaoDB_Augmented_2021__Nuocytes,-0.433030769078985,-0.8106846952956774,0.75,1.0,1.0,4/21,7.12%,CD5;TAGAP;GPR171;P2RY10
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),-0.43397236207393436,-0.810673117823332,0.6666666666666666,1.0,1.0,6/18,15.77%,LIPI;HSD17B14;CYP3A4;GLYATL2;LIPE;LIPH
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),0.33537923536251035,0.8106262945283501,0.8095238095238095,1.0,1.0,13/62,20.37%,LVRN;CARNMT1;APEH;GSTT2;LTA4H;ADAMTS13;DMD;IDE;GSTM2;TPP1;GSR;PCSK5;LNPEP
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),0.33722814957593306,0.8105982736709483,0.8461538461538461,1.0,1.0,4/38,3.02%,SOX8;BMP2;ZNF358;LIG4
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),0.4603565317502053,0.8104446019092267,0.6923076923076923,1.0,1.0,4/8,31.42%,ABI2;WASF3;NCKAP1;BRK1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),-0.44405382004082994,-0.8101842639559194,0.746268656716418,1.0,1.0,5/15,24.70%,PIM1;GLI1;IGF1;AKAP6;TBX20
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),0.465154641144883,0.8097577892677892,0.75,1.0,1.0,5/10,14.90%,COMMD1;TAX1BP3;GPM6B;LEPROTL1;PICALM
prerank,GO_Biological_Process_2021__negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.5219691835806037,-0.809653836957876,0.7808219178082192,1.0,1.0,3/7,33.69%,TGFB1;STAT3;NCOR1
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),-0.49689998061551494,-0.8096201570014033,0.7808219178082192,1.0,1.0,2/10,19.95%,ABCB1;ADCY8
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),-0.45722008120464236,-0.8096003150278496,0.7567567567567568,1.0,1.0,1/16,1.53%,DUSP1
prerank,GO_Biological_Process_2021__negative regulation of osteoclast differentiation (GO:0045671),-0.4847324227075884,-0.8094755928891569,0.75,1.0,1.0,1/11,9.56%,TLR3
prerank,GO_Biological_Process_2021__muscle cell migration (GO:0014812),0.4466456237953438,0.8094378261466939,0.6341463414634146,1.0,1.0,1/7,9.89%,MEGF10
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),0.3779401720853439,0.8086432887988793,0.6923076923076923,1.0,1.0,3/22,8.78%,SLC30A4;ZNF658;MT1E
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),-0.36094424203911285,-0.8081228738258402,0.75,1.0,1.0,16/73,16.90%,SLC6A15;SLC25A45;SLC51A;PDPN;SLC38A4;AKR1C1;CEACAM1;SLC51B;SLC3A1;SLC7A14;SLC7A2;SLC38A1;SLC43A2;SLC26A8;ABCC4;MFSD2A
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),-0.32801202455586703,-0.8079089056917063,0.8876404494382022,1.0,1.0,37/165,23.20%,ALDOB;PLB1;PLAAT4;ITPKC;INPP5D;HK2;HTR2B;ANGPTL3;ALPL;PLPPR1;LPCAT4;PRKCG;PLPPR5;FBP1;NUDT4;PLCH2;DUSP16;PGK1;HDHD2;GPI;CDK5;LIMK2;PTPRC;SPHK1;PIK3CB;TGFB1;PFKFB3;PLCE1;PIK3CD;GFPT2;AGPAT2;PFKL;ALK;PXYLP1;PFKFB2;DUSP8;PFKFB4
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),-0.3572274410664968,-0.8072768606956554,0.7804878048780488,1.0,1.0,7/69,13.41%,TGFBR2;RPS27A;FOS;EID2;ZYX;ARHGEF18;UBC
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),-0.35182832505648914,-0.8068632834925186,0.7926829268292683,1.0,1.0,3/71,6.49%,CP;SLC39A14;APP
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),-0.37652586686712874,-0.8066027142089064,0.7948717948717948,1.0,1.0,4/38,12.21%,PROX1;SULF1;ITGA8;PAX8
prerank,GO_Biological_Process_2021__purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.4561400112236802,-0.8065178001768136,0.7666666666666667,1.0,1.0,1/11,4.20%,IMPDH1
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,-0.33076239302766375,-0.8065129734959166,0.8488372093023255,1.0,1.0,32/142,22.45%,CD44;IFITM3;HK2;MAFF;SCN9A;PLSCR1;IL4R;ABCB1;SYNGR2;GATA1;EMP1;ADAM19;MYO1E;GADD45B;PTRH2;PIM1;NDRG1;DRC1;IL3RA;PRKCH;SELP;CTSZ;ITIH5;GABARAPL1;PRAF2;PTH1R;LRIG1;PLEC;SPP1;CDKN1C;MYO1C;PNP
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),-0.46960153199912164,-0.8063616648470382,0.7619047619047619,1.0,1.0,7/12,26.83%,ALOX12;CEACAM1;CD9;PRKCD;PDGFRA;SH2B3;C1QTNF1
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),-0.45543982239159075,-0.806245350294529,0.7536231884057971,1.0,1.0,1/14,3.11%,NOS1AP
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,-0.3744941354765169,-0.8062079448112283,0.8157894736842105,1.0,1.0,1/51,0.43%,THBS1
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.3502770902823342,-0.8061939936891666,0.8375,1.0,1.0,16/73,18.20%,CCNB2;BLM;CDKN2A;PSRC1;PROX1;CCNI2;CCNB1;HEXIM1;GADD45A;HERC5;CCND1;TFAP4;CCNE2;CDKN3;CDC37;CDKN1A
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),-0.447198466480601,-0.8056963728019515,0.7580645161290323,1.0,1.0,1/13,1.77%,TGFBR2
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.3274401675530571,0.8052585194484206,0.7916666666666666,1.0,1.0,8/52,15.17%,VEGFD;VEGFC;NCK1;PIK3CA;NCK2;PRKD1;PIK3R1;ABI1
prerank,GO_Biological_Process_2021__self proteolysis (GO:0097264),-0.5419825714480431,-0.8050305200478546,0.8,1.0,1.0,3/6,31.50%,CAPN1;CASP8;NLRP1
prerank,GO_Biological_Process_2021__positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),-0.4944646044256794,-0.8047291653181976,0.75,1.0,1.0,3/7,32.55%,PSMC3;PSMC4;TP53
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),0.4164066199680152,0.8044737641973713,0.6923076923076923,1.0,1.0,1/11,1.29%,PDE3A
prerank,GO_Biological_Process_2021__nucleoside triphosphate catabolic process (GO:0009143),0.5045269063272874,0.8043702235955611,0.8,1.0,1.0,2/5,27.71%,ENPP3;DCTPP1
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),-0.4074226581808567,-0.8042228581687861,0.7846153846153846,1.0,1.0,1/22,3.08%,GMPR
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),0.27353672867913154,0.8041629381388076,0.8888888888888888,1.0,1.0,25/133,14.74%,BMP2;PSMD10;PSMA1;TNFAIP3;GSKIP;GPC5;PSMD11;EGFR;PSMB5;CAPRIN2;VCP;CSNK2A1;RNF146;GID8;PPM1A;SALL1;CSNK1E;SCEL;PSMD14;ZEB2;CSNK1G3;PSMD12;LGR4;KANK1;NFKB1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),-0.4354911221705394,-0.8039834337842051,0.8142857142857143,1.0,1.0,4/23,9.29%,KCNQ1;PLN;CAV3;ATP1B1
prerank,GO_Biological_Process_2021__urate metabolic process (GO:0046415),-0.4931466095195002,-0.8038143864949603,0.7230769230769231,1.0,1.0,3/7,24.96%,ABCG2;PNP;GCKR
prerank,GO_Biological_Process_2021__lens fiber cell differentiation (GO:0070306),-0.5054841783517562,-0.8033787583949222,0.7230769230769231,1.0,1.0,1/6,0.76%,SIX3
prerank,GO_Biological_Process_2021__imitative learning (GO:0098596),0.44132907039996183,0.8032600530457374,0.7209302325581395,1.0,1.0,1/5,9.42%,NRXN1
prerank,GO_Biological_Process_2021__vocal learning (GO:0042297),0.44132907039996183,0.8032600530457374,0.7209302325581395,1.0,1.0,1/5,9.42%,NRXN1
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),-0.4298262817432461,-0.8030189464172034,0.8082191780821918,1.0,1.0,7/22,17.15%,SLC32A1;SLC18A2;CPLX1;PLD2;CPLX2;NLGN1;CDK5
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),0.27885289601668906,0.8029280154656548,0.9166666666666666,1.0,1.0,25/81,25.14%,STXBP6;EXOC8;AP1S3;LLGL1;EXOC6;COMMD1;AP1B1;SCFD1;GOLGA7;BLOC1S4;EXOC5;EPS15;MYO5A;FTL;KLHL20;SCAMP2;DNAJC6;ACBD3;ARL3;EXOC6B;SORT1;MON2;RABIF;AP1M1;ARRB1
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),-0.4036946160159405,-0.8029159831939026,0.7272727272727273,1.0,1.0,4/29,6.95%,CLRN1;CDH23;SCN9A;CCL2
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),0.2733241842551847,0.8028238299271072,1.0,1.0,1.0,14/140,8.77%,FGF6;FLT3;OTUD3;CASS4;MYORG;TRIB3;THEM4;EGFR;HCLS1;AKT2;AKT1;STRN;AKR1C3;ERBB4
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),0.3973573634384651,0.8028104749433087,0.7586206896551724,1.0,1.0,8/8,60.28%,RB1;EGR1;SORL1;NAB2;HSP90AB1;HSP90AA1;CLU;C5AR1
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),-0.3420262149529564,-0.802662121250934,0.7752808988764045,1.0,1.0,20/84,22.10%,P2RY12;RAMP3;ADGRE5;ADCY7;AKAP5;S1PR3;GIPR;VIP;GLP1R;LGR5;ADCY5;GPR12;CNR1;RXFP1;HTR1E;PTH1R;ADCY8;GPER1;ADGRG2;PTH2R
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),-0.45377158961452246,-0.8020924205974742,0.78125,1.0,1.0,1/13,3.19%,MSX2
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.34957900524919067,-0.8019551099990353,0.8481012658227848,1.0,1.0,11/64,18.75%,SP100;PLK2;CCNB1;GADD45A;PLK3;ARID3A;NDRG1;FOXM1;TFAP4;CDKN1A;PML
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),0.4049902815182253,0.801769870616443,0.7777777777777778,1.0,1.0,2/14,5.80%,DSCAM;BSG
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.3679553309119843,-0.8016334515033691,0.8095238095238095,1.0,1.0,8/76,13.82%,KLF2;RPS27A;ATF3;PSMB6;PSMB9;ELOB;UBC;PSMC3
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),-0.36429395731555714,-0.8009838899208378,0.8375,1.0,1.0,14/61,18.91%,FLRT3;POU4F1;SLITRK1;LRRC4;WNT5A;GABRB2;PCDHB5;BDNF;GRID2;ACHE;NLGN1;CDK5;GABRG2;GABRA1
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),0.39103358033167074,0.8007480328426558,0.7666666666666667,1.0,1.0,5/14,23.09%,TNFAIP3;RNF26;IFNLR1;ELMOD2;ITCH
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),-0.3635311175525945,-0.8004992897637037,0.8690476190476191,1.0,1.0,11/84,21.44%,THBS1;RPS4X;YBX3;PLD1;RPL5;RPS9;RBM3;LARP6;SAMD4A;EIF4A3;EIF5A
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),0.3566527851902178,0.800054848629461,0.8064516129032258,1.0,1.0,2/26,4.49%,WNT7A;NLGN3
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),-0.4176387303949557,-0.7999102246157604,0.7868852459016393,1.0,1.0,2/23,6.49%,TRAM1L1;APP
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),0.3477762248450916,0.7998001123819083,0.7692307692307693,1.0,1.0,3/25,4.64%,SDC4;SDC3;GPC5
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),-0.40541026443165484,-0.7997949990999904,0.7945205479452054,1.0,1.0,6/31,16.12%,RPS27A;ANLN;ANAPC11;UBE2S;UBC;ANAPC15
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),-0.39229252937588566,-0.7997350851355601,0.7846153846153846,1.0,1.0,3/35,9.61%,RSPH4A;PSRC1;CFAP74
prerank,GO_Biological_Process_2021__cellular response to acetylcholine (GO:1905145),-0.5155945495185197,-0.7992967327527346,0.7761194029850746,1.0,1.0,1/6,11.04%,CHRM3
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),-0.38465347863453336,-0.7988122392608118,0.7945205479452054,1.0,1.0,3/35,10.81%,S100A10;SYNPO2L;PFN2
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),-0.4655324737424869,-0.7986478871971842,0.7391304347826086,1.0,1.0,1/12,1.98%,FABP3
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),0.32433727574866933,0.7985888300047383,0.8333333333333334,1.0,1.0,8/47,10.41%,GNL3L;NAF1;CCT7;STN1;MAP3K4;HNRNPC;CCT3;ATR
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),0.3908892043805588,0.7984994259365337,0.6774193548387096,1.0,1.0,1/16,0.52%,WNT7A
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),-0.41650403873046327,-0.7984889093518486,0.7704918032786885,1.0,1.0,3/25,14.22%,ZFP36;VIL1;DAB2IP
prerank,GO_Biological_Process_2021__polyadenylation-dependent snoRNA 3'-end processing (GO:0071051),0.45362027905297686,0.7984716868981396,0.6578947368421053,1.0,1.0,2/6,25.00%,EXOSC6;EXOSC5
prerank,GO_Biological_Process_2021__negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128),-0.5383664967226633,-0.7982324113990202,0.8,1.0,1.0,1/5,9.56%,TLR3
prerank,GO_Biological_Process_2021__negative regulation of platelet aggregation (GO:0090331),-0.49367190594105737,-0.7981340242009293,0.8135593220338984,1.0,1.0,4/9,17.56%,ALOX12;CEACAM1;CD9;PRKCD
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),-0.47057744794029993,-0.7979745000605122,0.703125,1.0,1.0,1/11,6.88%,IGFBP5
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),-0.4536648471585092,-0.7976202878463458,0.7301587301587301,1.0,1.0,1/13,3.97%,PROX1
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),-0.46590226501325915,-0.7976069216924432,0.7966101694915254,1.0,1.0,4/12,34.78%,SREBF1;SEC14L2;SREBF2;RAN
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.417272507609549,-0.7973169985606061,0.796875,1.0,1.0,4/20,13.20%,RAB11A;ATAD5;CCNB1;CCND1
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),0.26453280818741054,0.7971911515730358,0.8333333333333334,1.0,1.0,29/134,19.65%,FLT3;PASK;RIOK2;EGFR;AKT1;ERBB4;STK4;ATR;EIF2AK4;CSF1R;STK17B;EIF2AK3;TAOK2;UHMK1;TAOK3;MARK2;WNK3;PRKD1;EPHB4;ERN1;TNIK;CAMK4;CDK12;MAP2K2;SLK;PIKFYVE;SMG1;PRKX;MELK
prerank,PanglaoDB_Augmented_2021__T Helper Cells,-0.3674640220774135,-0.797130105755741,0.7777777777777778,1.0,1.0,10/37,18.80%,CD5;TAGAP;GPR171;P2RY10;IL4R;LTBR;CCR10;CD4;THEMIS;PTPRC
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.40096553402857593,-0.7966507758289293,0.7922077922077922,1.0,1.0,6/30,21.11%,NDUFB11;NDUFA2;NDUFB9;NDUFB10;NDUFA6;NDUFA3
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),0.43075853582121354,0.7966159440291132,0.8,1.0,1.0,3/12,13.07%,PDK4;ZNF304;PIK3CA
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),-0.48128417819773683,-0.7962329503188754,0.8028169014084507,1.0,1.0,1/8,24.09%,OLFM1
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),0.47325368559700354,0.7960555220757695,0.7272727272727273,1.0,1.0,3/6,23.17%,CUL1;CAND1;FBXL7
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.3309268930159024,-0.7960294227768122,0.875,1.0,1.0,21/138,20.24%,TRIM22;TRIM5;PLK2;HTR2B;BST2;NOD1;TNIP2;MAP3K14;ALPK1;BIRC3;PINK1;SHISA5;LTBR;FADD;APOL3;TNFRSF1A;CD4;PRKCB;CD74;RIPK2;LGALS1
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),-0.4268772710192305,-0.7958911052765494,0.8028169014084507,1.0,1.0,3/18,16.43%,HK2;RBKS;GPI
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),0.4073134768237546,0.7958529573851021,0.6923076923076923,1.0,1.0,2/12,9.06%,AKR1C3;PTGIS
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.3023875734266552,0.7957600314339116,0.7894736842105263,1.0,1.0,13/65,16.39%,LIMD1;PSMD10;PSMA1;ELOC;PSMD11;PSMB5;EGLN3;PSMD14;PSMD12;CUL2;EP300;BACH1;VHL
prerank,PanglaoDB_Augmented_2021__Immature Neurons,0.2878370042625227,0.7957125188542756,0.9090909090909091,1.0,1.0,20/121,11.42%,FEZF2;ASCL1;AMER2;ADGRA1;FUT9;SNAP91;POU3F2;ADGRB3;GRIA2;FAT3;UNC79;NOVA1;STIM2;NRXN1;CADM2;RBFOX1;ROBO1;GPM6B;ANK2;SOX5
prerank,GO_Biological_Process_2021__histone H3-K4 monomethylation (GO:0097692),0.49950248754435456,0.7957095442958988,0.7391304347826086,1.0,1.0,3/7,22.67%,KMT2A;KMT2C;SETD4
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),0.38416701941956805,0.7955928860685896,0.7647058823529411,1.0,1.0,8/19,25.14%,PPARGC1A;KAT7;BRD7;TADA2B;SPHK2;RPS6KA4;SMAD4;ARRB1
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,-0.3609919435116596,-0.7955649672138354,0.8333333333333334,1.0,1.0,5/70,8.11%,RECQL4;KREMEN2;TEAD2;BAIAP2L1;PRDX4
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),0.4554916916565374,0.7955087142199853,0.7,1.0,1.0,6/11,34.58%,ACVR2A;MAGI2;SMAD7;LEMD3;FSTL3;ACVR1
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),0.36614862416054117,0.7954055865025914,0.78125,1.0,1.0,1/22,1.38%,DSCAM
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),-0.3704496905699103,-0.7952144982131254,0.8108108108108109,1.0,1.0,12/41,19.72%,SLC51A;SLC16A3;AKR1C1;SLCO3A1;CEACAM1;SLC51B;SLC16A11;SLC16A4;ABCC4;SLC16A14;ATP8B1;SLCO1A2
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),0.27798760586863,0.7951285969899464,0.9230769230769231,1.0,1.0,9/73,9.83%,NGF;MEN1;BMP2;TRIB3;RALB;CAPRIN2;HMGB1;STK4;DPH3
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),-0.36713384014340006,-0.7948084831560226,0.7922077922077922,1.0,1.0,7/37,21.42%,DUSP1;CAV3;PAQR3;DAB2IP;PRKCD;PIK3CB;HIPK3
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),0.28206094007724986,0.7946840593935656,0.8571428571428571,1.0,1.0,19/70,23.56%,RAB33B;SPATA4;TMEM33;MFF;PRMT6;PDE4DIP;ZEB2;MUL1;MARK2;EP300;MIEF2;VPS11;MYO5A;PREB;PTK2;GOLPH3;EZR;SAR1B;STX18
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),-0.3245785456313941,-0.7942208226703295,0.9270833333333334,1.0,1.0,36/257,21.11%,TYMS;APLNR;PGR;POU4F1;ZFP36;GPNMB;CENPV;SH3GL2;OVOL2;APP;IGFBP5;PARP14;PARP9;RPL13A;KLF4;PATL2;NLRP12;RPS13;SFRP2;PTRH2;PINK1;IGF1;DDRGK1;CCDC3;SRGN;SLC11A1;MSR1;APLN;NUDT16;SAMD4A;TGFB1;DAPK3;EIF4A3;GPER1;SFRP1;SHMT1
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),0.2925432517974744,0.7940188488808475,1.0,1.0,1.0,7/69,12.24%,RGCC;GNL3L;SDC4;VCP;SNF8;TIRAP;SMPD3
prerank,GO_Biological_Process_2021__ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),-0.5492263971502416,-0.793906254959879,0.8103448275862069,1.0,1.0,1/5,18.43%,MAN1A1
prerank,GO_Biological_Process_2021__mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),-0.5492263971502416,-0.793906254959879,0.8103448275862069,1.0,1.0,1/5,18.43%,MAN1A1
prerank,GO_Biological_Process_2021__protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),-0.5492263971502416,-0.793906254959879,0.8103448275862069,1.0,1.0,1/5,18.43%,MAN1A1
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),0.35587838149275114,0.7934672336268531,0.84,1.0,1.0,10/28,24.46%,CHST11;CSGALNACT1;EXT2;GAL3ST4;B3GAT2;BMPR1B;EXTL3;EXT1;XYLT1;CANT1
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),0.3932267388733861,0.7932611765538479,0.7333333333333333,1.0,1.0,1/13,6.02%,ANP32B
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),0.43085668566274743,0.7929743640210782,0.7368421052631579,1.0,1.0,1/8,10.47%,NIPBL
prerank,GO_Biological_Process_2021__positive regulation of striated muscle contraction (GO:0045989),-0.5352019053370414,-0.7928599509140866,0.8125,1.0,1.0,1/5,2.03%,KCNQ1
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),0.33228075578847976,0.7928027757424547,0.8,1.0,1.0,4/39,7.99%,POLD3;PRIMPOL;RFC3;VCP
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.4389499221877343,0.792797379740545,0.8536585365853658,1.0,1.0,2/7,18.71%,EGFR;MAP2K2
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),-0.3050936424600933,-0.7927958790186048,0.9368421052631579,1.0,1.0,52/354,17.15%,ZIC4;FLRT3;TAGLN3;MET;L1CAM;POU4F1;WDR62;NRSN1;PROX1;SH3GL2;GFRA2;WNT8B;CHRM1;SLITRK1;UGT8;EFNB3;SRRM4;KLK6;VLDLR;ZIC1;LDB2;NRGN;NINJ2;MOG;HAP1;DCTN1;MOBP;HAPLN2;GRIK1;CHRM3;EIF2B2;NELL1;RAPGEF5;RAPGEFL1;SH3GL3;PAX8;B3GNT5;SCN2A;APBA2;FN1;NEUROD2;SPINK6;PCDHB5;THOC6;BDNF;CRMP1;ACHE;NLGN1;NUMBL;PCDHA1;DCLK1;CDK5
prerank,GO_Biological_Process_2021__anterior/posterior axis specification (GO:0009948),0.44803149781891183,0.7927109078793109,0.7948717948717948,1.0,1.0,2/8,22.92%,TASOR;FZD5
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),-0.37719045087061964,-0.7926965766290853,0.6986301369863014,1.0,1.0,7/33,19.06%,MX1;SNCB;SYT1;NLGN1;CDK5;SYT2;SNCG
prerank,GO_Biological_Process_2021__neuron fate commitment (GO:0048663),0.4788735934454377,0.7926459298992312,0.7567567567567568,1.0,1.0,2/9,4.88%,ASCL1;POU3F2
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication initiation (GO:0030174),0.5027621545996824,0.7925376659578867,0.7,1.0,1.0,3/5,27.47%,KAT7;TICRR;WRNIP1
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),0.2736308905686513,0.7922670772515121,1.0,1.0,1.0,18/128,12.62%,MEN1;RTRAF;DUSP19;TRIB3;SPRED1;PPP1R15B;GREM1;GSKIP;OCLN;FBLN1;TESK1;AKT1;NCK1;PPM1E;SAMSN1;SPRED2;TRIB2;SIRPA
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),0.3838557908539723,0.7922634872370669,0.7333333333333333,1.0,1.0,4/18,8.97%,PLK1;BAG2;BTRC;FBXO5
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.36400384384325546,0.7922376306350265,0.7586206896551724,1.0,1.0,5/17,24.78%,PPP1R1B;STYXL1;PPP4R4;ROCK2;MASTL
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.451593920996408,-0.7918214277714536,0.782608695652174,1.0,1.0,6/11,25.73%,CYP1B1;PDK1;PRKCD;STK24;ZNF622;ARL6IP5
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),-0.4426521199009982,-0.7916749816756548,0.7936507936507936,1.0,1.0,2/12,12.20%,ISG15;SYK
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),0.2701703336152375,0.7914296156361016,0.8888888888888888,1.0,1.0,23/163,13.64%,RGCC;HMMR;PSMD10;PSMA1;PSMD11;PLK1;RIOK2;CUL1;PSMB5;ANAPC1;BTRC;CEP152;FBXO5;CSNK1E;CEP290;ERCC2;PSMD14;UBE2D1;HAUS1;PCM1;ERCC3;PSMD12;ALMS1
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),-0.43738249080806135,-0.7913469898347867,0.75,1.0,1.0,2/14,15.55%,APP;ATOX1
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),-0.3436071080649497,-0.7910874150289752,0.8421052631578947,1.0,1.0,14/78,18.80%,CAMK2N2;SLC8A3;THY1;WARS1;CAV3;CEACAM1;GADD45A;PTK6;SH3BP5;DAB2IP;MVP;CDKN1A;TSC2;PTPRC
prerank,"GO_Biological_Process_2021__CD4-positive, alpha-beta T cell activation (GO:0035710)",0.4934505823040525,0.7910539373219395,0.7777777777777778,1.0,1.0,2/5,14.53%,HMGB1;TNFSF4
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.3712449985317134,-0.7910329490696502,0.8285714285714286,1.0,1.0,5/41,18.88%,HIC1;BRCA1;BCL2L2;PML;BOK
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),0.32803511249060135,0.7908977300636828,0.84,1.0,1.0,4/30,8.12%,PDE3A;SOX9;PDE7B;ADCY1
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.4018317704125181,0.7903368673013915,0.7037037037037037,1.0,1.0,1/14,7.43%,NOL11
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),-0.39877095800775897,-0.7896284905362897,0.8088235294117647,1.0,1.0,6/24,20.19%,ANK3;VIP;KCNAB3;CD63;NOS1;KCNIP4
prerank,GO_Biological_Process_2021__regulation of chromatin silencing (GO:0031935),0.40788446832743697,0.7892470883417891,0.7407407407407407,1.0,1.0,3/10,17.77%,H1-2;ASF1A;ATAD2B
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),0.46982363443033687,0.7891955938670772,0.75,1.0,1.0,2/8,7.04%,ABCD2;ABCD1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),-0.5405371771474861,-0.7889928000369453,0.8214285714285714,1.0,1.0,1/5,11.04%,CHRM3
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),0.38579845054609185,0.7888345844322362,0.7142857142857143,1.0,1.0,7/16,15.21%,GDAP1;MFF;SLC25A46;OPA1;DNM3;MUL1;MTFR1
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),0.3044829334382492,0.7887935295672921,0.8181818181818182,1.0,1.0,23/108,19.71%,SRPRB;GDAP1;TRAK2;ZDHHC14;ZDHHC11;AP1S3;MFF;VPS37A;ZDHHC18;TOMM22;VPS37B;TAOK2;ZDHHC21;ZDHHC20;ICMT;TIMM23;RAB3IP;GOLGA7;ZDHHC11B;ZFAND6;PEX12;PIKFYVE;PEX6
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),-0.36424943331108306,-0.788585366698984,0.7954545454545454,1.0,1.0,12/56,23.16%,HPN;RFTN1;RPS6KA1;MMP14;SFRP2;MFSD2A;TAF9B;SPHK1;HYAL1;SFRP1;AKAP6;DNPH1
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),-0.40360099065803,-0.7882109871015908,0.7777777777777778,1.0,1.0,2/24,6.88%,KCNQ1;IGFBP5
prerank,GO_Biological_Process_2021__ribosomal small subunit export from nucleus (GO:0000056),0.5265165794474219,0.7882048215011331,0.8378378378378378,1.0,1.0,2/6,9.59%,LTV1;XPO1
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),0.40834921940584445,0.7875384031344963,0.8636363636363636,1.0,1.0,3/17,7.09%,AGER;BMP2;MAP3K4
prerank,GO_Biological_Process_2021__histone H2A-K119 monoubiquitination (GO:0036353),0.4509194332983676,0.7868503035556769,0.6976744186046512,1.0,1.0,1/8,6.23%,RNF2
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),-0.4273894757954749,-0.7868404686926541,0.7391304347826086,1.0,1.0,6/16,23.26%,KLK6;TMCC2;ADAM19;ACHE;APH1A;CLN3
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.38643662399554624,-0.7863551759981336,0.8441558441558441,1.0,1.0,6/27,17.63%,RPS14;HELB;RPS16;RPS8;RPS21;TSR2
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),0.46192992218568524,0.786132061159527,0.7317073170731707,1.0,1.0,2/9,11.61%,CEP19;PCM1
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,0.28049438225294326,0.7860929032645884,1.0,1.0,1.0,32/129,19.76%,G0S2;REEP6;CEL;PRDX6;ALDH1A1;CA2;OSTC;KMT5A;NCAPH2;ACADM;SUCLA2;PTPRG;EHHADH;CPT2;ETFDH;ECH1;ACOX1;HSD17B11;ACSS1;MGLL;METAP1;CPT1A;ACADS;MAOA;GLUL;FH;EPHX1;BLVRA;BMPR1B;BCKDHB;SLC22A5;HIBCH
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),0.40906467415316583,0.7859987731014152,0.64,1.0,1.0,2/11,9.94%,AKT1;QDPR
prerank,PanglaoDB_Augmented_2021__Myeloid-derived Suppressor Cells,-0.4011352189856857,-0.7857173873919536,0.7464788732394366,1.0,1.0,7/23,12.79%,MYO1F;ICAM1;TAGAP;IGSF6;IL4R;CLEC12A;CTSS
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),-0.32831616370039635,-0.7848229386043701,0.8690476190476191,1.0,1.0,23/101,26.20%,ARHGAP4;RHOBTB2;CNTNAP1;CCL2;THY1;RND2;PLD2;RHOF;DMTN;RHOBTB1;DPYSL2;RHOD;ANK1;PLCE1;SH3KBP1;PAK6;ARHGAP10;SYNE3;PAK5;NEDD9;FGD5;PACSIN1;SH3D19
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),0.2907828693531077,0.7846881647579628,0.8571428571428571,1.0,1.0,12/40,25.42%,ADAMTS9;DNASE1L2;UBE2G1;STT3B;FBXO27;IDE;PPP1R8;DFFB;DNASE1L1;HNRNPD;RAB12;MTREX
prerank,GO_Biological_Process_2021__nucleobase biosynthetic process (GO:0046112),0.44470992679161814,0.7845682216691616,0.6944444444444444,1.0,1.0,1/7,7.93%,GMPS
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),-0.3383156279187909,-0.7844444207041863,0.9047619047619048,1.0,1.0,18/112,19.08%,BLM;RECQL4;RPS27A;HELB;POLE3;PSMB6;PSMB9;GINS2;RPA3;UBC;PSMC3;CDK2;POLE4;RPA1;PSMA8;POLD1;PSME1;CDC7
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.4543731679571782,-0.7842574847887828,0.8333333333333334,1.0,1.0,3/11,13.58%,LDLR;SYK;CD9
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),-0.46261468138153505,-0.7839930814784649,0.8064516129032258,1.0,1.0,3/12,16.35%,ATP1A1;ATP1B1;TMPRSS3
prerank,GO_Biological_Process_2021__carboxylic acid biosynthetic process (GO:0046394),-0.4692115834110061,-0.7837746312845882,0.7575757575757576,1.0,1.0,2/10,20.94%,CARNS1;PAH
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),0.40418432480555594,0.7830622615364177,0.71875,1.0,1.0,3/14,5.54%,RGCC;SERPINF2;RUNX1
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),0.3411822386674851,0.782965472152226,0.8235294117647058,1.0,1.0,6/32,12.65%,RAP2C;PDGFD;PDGFC;TESK1;PPP2R5A;TAOK2
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),-0.43011089923484846,-0.7829619246896464,0.7692307692307693,1.0,1.0,1/18,0.43%,THBS1
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),-0.37961695617790836,-0.7829025553416757,0.8,1.0,1.0,7/33,25.16%,B4GALNT1;FA2H;CYP4F22;B3GALT4;ST6GALNAC3;ST8SIA3;CERS5
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),0.31129188314163775,0.7824601902954808,0.9130434782608695,1.0,1.0,5/27,14.13%,BBS10;CEP290;PCM1;C2CD3;TTC8
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),-0.38149352294745664,-0.7822896081777344,0.7922077922077922,1.0,1.0,5/32,12.20%,TLR2;NOD1;TLR3;CHI3L1;SYK
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),-0.3766640253343709,-0.782238550737595,0.7894736842105263,1.0,1.0,9/35,21.70%,GPR183;MMP14;SYK;TNIP2;IL7;PTPRC;CD74;IRS2;SH3KBP1
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.32877964236019624,0.7819342656353725,0.8181818181818182,1.0,1.0,15/38,25.79%,QRICH2;CSNK2A1;COMMD1;XPO1;CSNK2A2;PYHIN1;UBQLN4;PTK2;NUB1;ARAF;LATS1;FBXW7;HFE;AXIN1;PTEN
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate biosynthetic process (GO:0034036),-0.5092380439613234,-0.7818859158386733,0.7241379310344828,1.0,1.0,1/5,12.07%,PAPSS2
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428),-0.5092380439613234,-0.7818859158386733,0.7241379310344828,1.0,1.0,1/5,12.07%,PAPSS2
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.3421397409632603,-0.7818034441815337,0.8076923076923077,1.0,1.0,12/69,18.16%,RPS27A;CCNB1;PSMB6;PSMB9;ANAPC11;UBE2S;UBC;PSMC3;CDK2;ANAPC15;PSMA8;PSME1
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),-0.35292343575103463,-0.7816785215474684,0.7662337662337663,1.0,1.0,6/44,9.87%,OGN;CD44;CSPG4;CEMIP;OMD;BGN
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.2925048646409825,0.7816760300631974,0.9333333333333333,1.0,1.0,15/56,19.34%,RGCC;CNOT9;RFWD3;PCBP4;CRADD;CNOT2;E2F4;EP300;CNOT6L;PLAGL1;CNOT4;TRIAP1;CNOT1;CNOT8;MDM2
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),-0.4589686933456026,-0.781544836393531,0.7971014492753623,1.0,1.0,5/14,23.67%,BEST1;ABCB1;ABCC1;ABCG2;CXADR
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.39377796578836277,0.781499324798619,0.8857142857142857,1.0,1.0,1/10,5.95%,EGFR
prerank,PanglaoDB_Augmented_2021__Osteocytes,-0.356043711138424,-0.7812070953869983,0.8518518518518519,1.0,1.0,16/80,22.44%,COL4A1;COL4A2;CALD1;PDPN;WNT5A;P3H2;AMOTL2;DPYSL3;PCDH18;PDLIM4;NOTCH3;ANTXR1;GFPT2;SFRP1;PTPN21;PLAT
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),-0.30685562843640996,-0.7811437785092264,0.9690721649484536,1.0,1.0,70/391,21.28%,TRIM22;THBS1;MET;TLR2;P2RY12;NOS1AP;TRIM5;RAMP3;PTP4A3;IFI35;PLK2;HTR2B;APP;BST2;NOD1;LRRC19;WNT5A;HEXIM1;EGF;TLR3;CHI3L1;DDX60;NLRP12;UNC5B;RIT2;SEPTIN4;TNIP2;MAP3K14;ALPK1;BIRC3;FN1;THPO;NEUROD2;DAB2IP;FGF1;PINK1;TGFA;SHISA5;RPS15;F10;IGF1;IL18;LTBR;VAV1;NLGN1;FADD;SELP;APOL3;TNFRSF1A;FGF7;CD4;RPL23;PTPRC;SPHK1;BOK;FGF22;RELN;PIK3CB;TGFB1;PRKCB;CD74;RIPK2;PIK3CD;LGALS1;IRS2;GPER1;LRP2;NMI;F3;GSDME
prerank,GO_Biological_Process_2021__midbody abscission (GO:0061952),0.3935877933368312,0.7809152680027729,0.7586206896551724,1.0,1.0,3/12,21.16%,CHMP2B;VPS4B;CHMP6
prerank,GO_Biological_Process_2021__regulation of B cell apoptotic process (GO:0002902),0.47363292085933206,0.7807449872100002,0.8108108108108109,1.0,1.0,1/6,4.77%,FOXP1
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),0.3218551002950666,0.7806570974571408,0.9285714285714286,1.0,1.0,8/28,21.42%,MEN1;WDR82;SMYD2;KMT2A;PRDM5;SETD3;ASH2L;SMYD3
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),-0.38861921183069875,-0.7805721557963327,0.7285714285714285,1.0,1.0,8/22,22.14%,IFI35;APP;DYSF;SYK;SBNO2;SLC11A1;NMI;MAPT
prerank,GO_Biological_Process_2021__cadmium ion transmembrane transport (GO:0070574),-0.49353452222098765,-0.7805422613218411,0.7971014492753623,1.0,1.0,2/5,17.72%,SLC39A14;SLC11A1
prerank,GO_Biological_Process_2021__cadmium ion transport (GO:0015691),-0.49353452222098765,-0.7805422613218411,0.7971014492753623,1.0,1.0,2/5,17.72%,SLC39A14;SLC11A1
prerank,GO_Biological_Process_2021__regulation of centriole elongation (GO:1903722),0.478910203471813,0.7800912344916797,0.7,1.0,1.0,2/5,19.24%,CEP120;VPS4B
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),0.3897739396516163,0.779786739927889,0.8125,1.0,1.0,1/11,6.78%,MFF
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),0.2985219665425692,0.779286597387462,0.8333333333333334,1.0,1.0,10/44,18.70%,MOSMO;GAS1;VCP;BTRC;INTU;FBXL17;TUBD1;GLI3;KCTD21;HERC4
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),-0.3299695782602931,-0.7792597775208174,0.9024390243902439,1.0,1.0,23/109,20.00%,GGT5;RAMP3;PLK2;ADCY7;KLF4;NLRP12;SYK;GIPR;RHBDF2;MYH9;VIP;GLP1R;GNG2;ADCY5;IGF1;CD200;PRKCD;RXFP1;TNFRSF1A;CXCL17;PTH1R;ADCY8;MVK
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),-0.41784205216316017,-0.7791645049632905,0.7536231884057971,1.0,1.0,3/17,10.53%,PKP2;CTNNA3;ITGA5
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),-0.44037171875702663,-0.779122066790443,0.7285714285714285,1.0,1.0,2/14,8.70%,ABCA8;LDLR
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),0.25507931195238076,0.778950808115643,1.0,1.0,1.0,26/226,12.45%,NGF;NCSTN;AIFM2;PHLDA1;BMP2;BCL10;DUSP6;ARHGEF16;ACVR1C;ARHGEF12;C3ORF38;ZNF268;HMGB1;IP6K2;STK4;TIAM2;ATF6;ARHGEF26;USP27X;MAPK8;TRADD;STK17B;ERCC3;CRADD;CASP3;BAD
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),-0.38672229911003897,-0.778881545447624,0.7866666666666666,1.0,1.0,3/25,9.32%,P2RY12;KIF17;NEFH
prerank,GO_Biological_Process_2021__negative regulation of chromatin silencing (GO:0031936),0.425125162973508,0.7783744286914461,0.8235294117647058,1.0,1.0,3/8,17.77%,H1-2;ASF1A;ATAD2B
prerank,GO_Biological_Process_2021__negative regulation of chromatin organization (GO:1905268),0.425125162973508,0.7783744286914461,0.8235294117647058,1.0,1.0,3/8,17.77%,H1-2;ASF1A;ATAD2B
prerank,GO_Biological_Process_2021__negative regulation of gene silencing (GO:0060969),0.425125162973508,0.7783744286914461,0.8235294117647058,1.0,1.0,3/8,17.77%,H1-2;ASF1A;ATAD2B
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.2785197777838625,0.7783256754794183,0.8461538461538461,1.0,1.0,20/85,18.67%,NGF;BCL10;ANP32B;ACVR1C;VCP;HMGB1;EGLN3;ROBO1;TRADD;EIF2AK3;CRADD;BAD;MUL1;DAP;CFLAR;PRR7;SLC22A2;BCL2L13;MALT1;PDCD2
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),-0.4375250186971972,-0.7780975041338456,0.8059701492537313,1.0,1.0,2/14,5.96%,IFIT1;COLEC12
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,-0.32825298711723155,-0.7780765084982371,0.8461538461538461,1.0,1.0,9/105,14.93%,IFIT1;KDELR3;RPS14;ATF3;CCL2;DCTN1;TSPYL2;MTHFD2;EDC4
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),-0.3522745236827167,-0.7776411750628612,0.7662337662337663,1.0,1.0,8/62,17.04%,ARHGAP15;ARHGAP9;ATP5IF1;DAB2IP;VAV1;CFAP73;RAP1GAP;NOS1
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,-0.39407643797884107,-0.7776185337293143,0.8513513513513513,1.0,1.0,8/32,8.92%,MYO1F;GPR183;CD5;TAGAP;SLA;GPR171;P2RY10;ARHGAP9
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,-0.3365151379376874,-0.777506055023766,0.8076923076923077,1.0,1.0,6/86,5.41%,DHCR24;ABCA6;ABCA5;ABCA8;GC;PRDX5
prerank,GO_Biological_Process_2021__kidney epithelium development (GO:0072073),-0.513961345686785,-0.777408332913463,0.7818181818181819,1.0,1.0,2/5,14.46%,PAX8;FGF1
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),-0.45002990555333106,-0.7773051224872274,0.8,1.0,1.0,5/16,19.49%,CCL2;PLK3;IGF1;TSC2;TGFB1
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),0.3275340336087645,0.7771897514601819,0.875,1.0,1.0,2/21,9.79%,PIK3R4;AP2B1
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.401253471063232,0.7769318935479439,0.7297297297297297,1.0,1.0,5/11,19.77%,TMEM33;ATF6;PIK3R1;ERN1;BCL2L11
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),-0.3435958228344682,-0.7768990467549992,0.8651685393258427,1.0,1.0,16/72,23.75%,KCNB1;NNAT;ABCA12;BMP8A;ITPR3;GIPR;GLP1R;CACNA1C;ADCY5;MYRIP;IRS2;GPER1;SFRP1;DOC2B;KCNC2;ALOX5
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),-0.4767522252637696,-0.7767929706003696,0.7647058823529411,1.0,1.0,3/8,25.36%,RPS7;EIF5A;PTTG1IP
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.3866610746059521,0.7766825543516166,0.7878787878787878,1.0,1.0,8/19,29.25%,AEN;MSH2;EP300;DYRK2;CDIP1;USP28;RPS27L;SIRT1
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),-0.3721455352563658,-0.7764536491922165,0.7662337662337663,1.0,1.0,14/38,30.90%,KIF14;TMC8;RPL13A;LDLRAD4;PMEPA1;HSPA5;NLRC3;HDAC6;SVIP;NOP53;ANKRD27;CRYAB;PARK7;ULK1
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,-0.33188845507593223,-0.7763767000698324,0.9058823529411765,1.0,1.0,11/105,10.12%,FLRT3;RIMBP2;STMN2;RCAN2;PROX1;MAOB;IGFBP5;SYT4;ATP1B1;PLPPR1;SST
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),0.4039654130662303,0.7763285662075099,0.7878787878787878,1.0,1.0,3/8,23.26%,SALL1;PKD2;BMP7
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),-0.3787686640018936,-0.7762971077149654,0.8289473684210527,1.0,1.0,4/35,14.76%,NLRC5;ISG15;HERC5;IFIH1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),-0.3528413211859994,-0.77620438670605,0.8472222222222222,1.0,1.0,7/38,14.76%,TLR2;APP;WNT5A;TLR3;SYK;SCIMP;IFIH1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.41689398182183024,-0.7761722735738034,0.7746478873239436,1.0,1.0,4/20,21.22%,RPS27A;UBC;RBX1;CETN2
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),-0.4576934349069348,-0.7757381409756816,0.8028169014084507,1.0,1.0,1/10,9.24%,BRCA1
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),0.4366009981829345,0.7756113667749004,0.7666666666666667,1.0,1.0,2/11,4.49%,CEL;NLGN3
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),-0.38096550527791295,-0.7755355796865497,0.7945205479452054,1.0,1.0,5/23,19.49%,EFNA1;ELN;SLIT3;TNFRSF1A;TGFB1
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),-0.3219720104562625,-0.7754796066740728,0.9080459770114943,1.0,1.0,16/110,20.96%,SOCS3;MTMR7;ITPKC;INPP5D;VAC14;SBF1;PLEKHA4;BMX;PITPNM2;PIK3CB;PIGA;PGAP2;PIK3CD;PIGC;DPM3;PIGH
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),-0.4620235691216953,-0.7754548216748308,0.8103448275862069,1.0,1.0,2/9,26.24%,PPP3CC;NFATC2
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),-0.4620235691216953,-0.7754548216748308,0.8103448275862069,1.0,1.0,2/9,26.24%,PPP3CC;NFATC2
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),-0.46915583568162694,-0.7754000716539937,0.7580645161290323,1.0,1.0,2/9,19.39%,VIL1;WDR1
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),0.39579684269549353,0.7749558968326951,0.875,1.0,1.0,1/25,0.54%,RNF6
prerank,GO_Biological_Process_2021__synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.46831079401617526,-0.7748279168609825,0.7777777777777778,1.0,1.0,4/10,28.43%,STX19;STX1B;STX3;STX4
prerank,GO_Biological_Process_2021__G protein-coupled receptor internalization (GO:0002031),-0.5101721426250692,-0.7743660045564186,0.8153846153846154,1.0,1.0,1/5,10.48%,ARR3
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),-0.4717444636661091,-0.7740516907922168,0.7384615384615385,1.0,1.0,4/11,25.66%,BRCA1;SET;SPI1;TAF7
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),-0.40911459227906094,-0.7739580813505174,0.7121212121212122,1.0,1.0,2/17,9.24%,BLM;BRCA1
prerank,GO_Biological_Process_2021__piRNA metabolic process (GO:0034587),0.42088142402383905,0.77395733915367,0.7272727272727273,1.0,1.0,2/13,2.75%,PLD6;TEX15
prerank,GO_Biological_Process_2021__protein sialylation (GO:1990743),-0.5013416816413594,-0.773839812049374,0.6964285714285714,1.0,1.0,2/5,23.09%,ST6GALNAC2;ST8SIA3
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),0.27416505777927735,0.7733547370022331,0.9473684210526315,1.0,1.0,10/56,12.13%,ELOVL4;ELOVL6;ASAH2B;ABCD1;ELOVL2;ABHD1;MCAT;ABCD3;HACD2;LTA4H
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),-0.41393941219642344,-0.7732491979347373,0.75,1.0,1.0,1/12,13.15%,IFT122
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),-0.34975306974566334,-0.7730618571636435,0.8048780487804879,1.0,1.0,3/64,6.49%,TRAM1L1;SHTN1;APP
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",0.4467048669226647,0.7730419098436947,0.7714285714285715,1.0,1.0,3/7,25.00%,EXOSC6;EXOSC8;EXOSC5
prerank,GO_Biological_Process_2021__U4 snRNA 3'-end processing (GO:0034475),0.4467048669226647,0.7730419098436947,0.7714285714285715,1.0,1.0,3/7,25.00%,EXOSC6;EXOSC8;EXOSC5
prerank,GO_Biological_Process_2021__ammonium transport (GO:0015696),-0.49270278719483585,-0.7723958860986488,0.8095238095238095,1.0,1.0,2/5,21.82%,AQP1;RHD
prerank,GO_Biological_Process_2021__positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),-0.4971077073900576,-0.7723761387742366,0.7758620689655172,1.0,1.0,5/7,29.38%,AKAP6;CALM3;JPH2;GSTO1;TRDN
prerank,GO_Biological_Process_2021__vesicle localization (GO:0051648),-0.5075343919210836,-0.7723112168624411,0.7454545454545455,1.0,1.0,2/5,18.52%,RAB11A;LIMK2
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),0.2576807458142898,0.772294450095678,1.0,1.0,1.0,21/69,29.09%,ZPR1;HSPA1A;RBM23;RBM12B;CLK4;PIK3R1;ERN1;QKI;METTL4;RRP1B;JMJD6;MBNL1;RBM39;RBM38;POLR2A;DYRK1A;HNRNPH1;SRPK2;LARP7;HNRNPLL;CELF1
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),0.31073463820388086,0.7716826884783815,0.9090909090909091,1.0,1.0,6/26,23.42%,ELOVL6;ELOVL2;HACD2;ACSL3;SCD5;HSD17B12
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),-0.340878683243782,-0.7716747284180144,0.8571428571428571,1.0,1.0,8/78,14.20%,ST6GAL1;GCNT1;CHST4;GALNT15;B3GNT5;B3GNT2;ST6GALNAC2;GALNT10
prerank,GO_Biological_Process_2021__glandular epithelial cell development (GO:0002068),0.46739997859558724,0.7713825952879625,0.7368421052631579,1.0,1.0,1/5,12.77%,CDH2
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),-0.383263048207642,-0.7711721448016845,0.8157894736842105,1.0,1.0,13/26,29.48%,DHCR24;SQLE;FDPS;MVK;INSIG1;HSD17B7;IDI1;ACAT2;HMGCS1;MSMO1;LSS;NSDHL;G6PD
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),-0.4057748522130452,-0.7711489543147269,0.75,1.0,1.0,5/17,15.00%,USP50;PSMB9;NLRP12;BIRC3;GRIN2B
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.3983310293282078,-0.7710268295731764,0.78125,1.0,1.0,3/14,21.55%,RPL35;PES1;RPL7
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.3086030878364105,0.7709855251207042,0.9545454545454546,1.0,1.0,23/64,25.51%,PSMD10;BCL10;DCUN1D2;DCUN1D1;COMMD1;UBE2D1;DERL1;RCHY1;MUL1;DCUN1D5;NDFIP1;PIAS4;MALT1;SMAD7;TBC1D7;DCUN1D4;UBQLN1;SENP2;FBXW7;HSPBP1;MYCBP2;TANK;AXIN1
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),0.30273766394733037,0.7707540011170296,0.8636363636363636,1.0,1.0,11/79,16.39%,NR1D1;MACIR;TNFAIP3;PTGIS;DRD2;AJAP1;SIRPA;MUL1;RNF26;CASK;ENPP3
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),-0.38626821132215405,-0.7707147491985146,0.84,1.0,1.0,13/25,29.48%,DHCR24;SQLE;FDPS;MVK;INSIG1;HSD17B7;IDI1;ACAT2;HMGCS1;MSMO1;LSS;NSDHL;G6PD
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),0.3725812522494556,0.7701492840458485,0.7631578947368421,1.0,1.0,3/12,13.85%,PGAM5;IPMK;TICAM1
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),-0.39330260051514654,-0.770128756412044,0.8026315789473685,1.0,1.0,1/21,5.64%,BHMT
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),-0.5233693011767697,-0.7701283135857805,0.8367346938775511,1.0,1.0,1/5,13.51%,NUAK1
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),0.44534899415998935,0.769849775101782,0.7428571428571429,1.0,1.0,6/8,35.56%,UBQLN1;NFE2L2;USP14;UBQLN2;BCAP31;SGTA
prerank,GO_Biological_Process_2021__positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666),-0.4979331034526459,-0.7693697652010104,0.8088235294117647,1.0,1.0,1/5,13.03%,SCIMP
prerank,GO_Biological_Process_2021__regulation of antifungal innate immune response (GO:1905034),0.49401340634348617,0.7692812840638089,0.7619047619047619,1.0,1.0,1/5,6.33%,FAM3A
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),-0.47001004009335967,-0.7691497162376719,0.7704918032786885,1.0,1.0,2/8,12.41%,PDPN;EMP2
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),0.3930999963616405,0.7688986221629205,0.8709677419354839,1.0,1.0,2/24,5.44%,INSC;PLK1
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.3874287694380334,-0.7686796682697491,0.8260869565217391,1.0,1.0,10/31,28.10%,KLF4;FOS;SRF;APLN;TGFB1;SPI1;ETS1;STAT3;GNL3;JUN
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),0.2786137266700805,0.768593791627532,0.9411764705882353,1.0,1.0,11/87,12.40%,WNT7A;PDE3A;ID1;TWSG1;SOX9;SMAD5;LPXN;NR3C1;PTPRK;SOX5;TGFBRAP1
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),0.33279021097504896,0.7684302279999157,0.9375,1.0,1.0,5/31,12.45%,PSMD10;MFF;AKT1;OPA1;BAD
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.3950408230155723,0.7682284314464742,0.78125,1.0,1.0,2/15,12.02%,SPRED1;SPRED2
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),-0.5332460557611762,-0.7678970888517984,0.8305084745762712,1.0,1.0,1/5,9.75%,ABCB1
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",-0.2956667550446263,-0.7678546768381714,0.99,1.0,1.0,60/735,15.38%,LEF1;PRAME;KLF2;SP100;SIX3;SKOR1;CDKN2A;EFNA1;FOSB;NR4A3;MAEL;POU4F1;CIITA;SUV39H1;ZFP36;HIC1;RPS27A;NR1I3;MSX2;RPS14;IRF1;PROX1;MLIP;CIC;PRDX5;ATF3;ZNF750;NKX6-2;LDB2;WNT5A;ZFP69;HEXIM1;PARP9;BRCA1;ZNF536;GADD45A;KLF4;PLK3;STAT1;BASP1;GATA1;MAFK;ZFPM1;IRF7;PRDM1;EID2;SFRP2;GFI1B;FBP1;CCND1;UBC;RPL10;SOX15;DAB2IP;RUNX2;SBNO2;FOXM1;TFAP4;ZBTB32;BAP1
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),-0.37191186712942315,-0.7677878988437665,0.8641975308641975,1.0,1.0,6/42,16.22%,BLM;ATAD5;EGF;TSPYL2;GLI1;GMNC
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),0.3370145602646353,0.7676245324654206,0.7619047619047619,1.0,1.0,7/27,21.16%,VPS37A;SNF8;VTA1;VPS37B;CHMP2B;VPS4B;CHMP6
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),-0.44453324459980703,-0.7675493565361913,0.8194444444444444,1.0,1.0,5/12,22.98%,IRF7;FES;CD4;CD74;HLA-DRB1
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),-0.3238498549027902,-0.7675405380780266,0.9090909090909091,1.0,1.0,21/100,20.43%,CD44;SULF1;PHEX;NOTUM;MMP14;WNT5A;ALPL;CHI3L1;COL10A1;COL11A2;HAPLN2;COL9A2;PAPSS2;HHIP;IGF1;DDRGK1;PPIB;ADAMTS4;PTH1R;HYAL1;TLL1
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell proliferation (GO:0061469),-0.4824752976707659,-0.7672761111201608,0.7592592592592593,1.0,1.0,5/6,22.26%,NR4A3;SGPP2;NR4A1;PTPRN;NUPR1
prerank,GO_Biological_Process_2021__IMP biosynthetic process (GO:0006188),0.51995868122498,0.7671484949634262,0.6904761904761905,1.0,1.0,1/5,10.18%,ATIC
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),-0.38007848735517447,-0.7671112402617024,0.8533333333333334,1.0,1.0,13/28,29.48%,DHCR24;SQLE;FDPS;MVK;INSIG1;HSD17B7;IDI1;ACAT2;HMGCS1;MSMO1;LSS;NSDHL;G6PD
prerank,GO_Biological_Process_2021__regulation of oxidative phosphorylation (GO:0002082),0.3561091605781628,0.7666055998579846,0.8292682926829268,1.0,1.0,3/14,7.99%,PDE12;ABCD1;VCP
prerank,GO_Biological_Process_2021__cardiac muscle hypertrophy (GO:0003300),-0.4719041830717585,-0.7665811280683034,0.8153846153846154,1.0,1.0,1/7,5.84%,HTR2B
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),0.3774803561087778,0.7665300492620382,0.7741935483870968,1.0,1.0,4/13,29.25%,ADRB2;PKIB;RAPGEF2;SIRT1
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),0.31959830020214736,0.7664926829820414,0.9411764705882353,1.0,1.0,4/53,7.94%,LEPR;TAB3;PLIN5;AKT1
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),-0.3619309719901861,-0.7660873347565532,0.8157894736842105,1.0,1.0,6/29,19.98%,HTR2B;SEMA3B;FN1;RADIL;SEMA3E;SEMA4G
prerank,GO_Biological_Process_2021__negative regulation of lipase activity (GO:0060192),0.4482038716806812,0.7659979675505122,0.725,1.0,1.0,2/7,6.20%,PLIN5;RGS2
prerank,GO_Biological_Process_2021__regulation of superoxide metabolic process (GO:0090322),-0.4857550267571089,-0.7657730070810489,0.7192982456140351,1.0,1.0,1/6,12.20%,SYK
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),-0.4404575864026661,-0.7655849726150564,0.7846153846153846,1.0,1.0,2/12,17.53%,BRCA1;PCGF3
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),0.2980480080944099,0.7653817075075079,0.9090909090909091,1.0,1.0,5/32,8.86%,NCOA4;ADCY1;AKR1C3;AR;NR3C1
prerank,GO_Biological_Process_2021__zinc ion import across plasma membrane (GO:0071578),0.45796770097200495,0.765288788614797,0.8,1.0,1.0,2/5,5.35%,SLC39A10;SLC39A8
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,-0.3446439609014476,-0.7650599714168989,0.9146341463414634,1.0,1.0,5/62,9.38%,CTAGE14P;ART3;GCM2;CTNNA3;SYNPO2L
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),0.24704012115869384,0.7649214110146019,1.0,1.0,1.0,47/351,15.82%,LIMD1;FHDC1;MACIR;SPAG16;CEP19;BBS9;EIF2S1;SSX2IP;RAB23;GORASP2;CEP20;EXOC8;TEKT5;AUP1;EXOC6;DZIP1;VPS37A;STX7;CEP290;RAB1B;INTU;SNF8;RAB8B;CNGA4;VTA1;FOXJ1;PLA2G4C;PARVA;HAUS1;PCM1;PTPN23;PRRC2C;PIK3C3;RUFY4;VPS37B;G3BP1;EDC3;TTC8;E2F4;IQCB1;CHMP2B;SCLT1;NEK1;UNC119B;RC3H1;GOLGA8N;RAB3IP
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),-0.37310800653055953,-0.7648622708296874,0.8214285714285714,1.0,1.0,3/34,4.81%,KCNB1;HK2;SLC39A14
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),0.28153175249712464,0.7644171730299221,0.9473684210526315,1.0,1.0,11/75,15.55%,HMMR;ATF5;PLK1;CEP152;CSNK1E;CEP290;HAUS1;PCM1;ALMS1;DYRK3;CEP192
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),-0.4877646350011956,-0.7642526066487123,0.7580645161290323,1.0,1.0,2/6,27.59%,PTPRF;PTPRD
prerank,GO_Biological_Process_2021__lactation (GO:0007595),-0.48199218140514,-0.7641988193211791,0.8095238095238095,1.0,1.0,3/8,19.83%,APLN;OXTR;FOXB1
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),0.30143352202947343,0.7638685756806504,1.0,1.0,1.0,10/41,21.27%,PDK4;BCO2;ACACB;GNB3;SSH1;PANK2;NPC2;RNF34;ABCB11;PM20D2
prerank,GO_Biological_Process_2021__actin crosslink formation (GO:0051764),-0.4928518924785384,-0.763265542534057,0.8125,1.0,1.0,3/9,9.06%,GAS2L3;BAIAP2L1;BAIAP2
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),-0.31702365662847,-0.7632435692392653,0.8913043478260869,1.0,1.0,12/98,10.97%,CDH23;SLC8A3;HTR2B;SLC24A2;TRPC3;GCM2;PLN;MCUB;CAV3;ATP1B1;SLC24A1;SLC24A5
prerank,GO_Biological_Process_2021__autophagosome-lysosome fusion (GO:0061909),0.41315406365093493,0.7632380906958374,0.7333333333333333,1.0,1.0,3/8,15.64%,RUBCNL;VPS39;PIP4K2B
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),0.31969803171779515,0.7632054912643771,0.8387096774193549,1.0,1.0,7/25,20.02%,ABHD17A;ABHD17B;ABHD17C;ARHGAP44;ABI2;PDLIM5;LZTS3
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),0.29175169974749676,0.7630720538447163,0.84375,1.0,1.0,9/26,28.17%,SNRPF;ERI1;MTPAP;TENT4B;CPSF2;SNRPB;LSM1;XRN1;TENT2
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),0.22746510849632884,0.7630516464642553,1.0,1.0,1.0,49/273,19.97%,FHDC1;MACIR;BBS10;SPAG16;CEP19;BBS9;SSX2IP;PLK1;RAB23;CEP20;EXOC8;TEKT5;EXOC6;DZIP1;CEP152;CSNK1E;CEP290;INTU;RAB8B;CNGA4;FOXJ1;PARVA;HAUS1;PCM1;PTPN23;CEP97;C2CD3;ALMS1;TTC8;E2F4;IQCB1;SCLT1;NEK1;UNC119B;CEP192;RAB3IP;TCTN3;EXOC5;UBXN10;TUBG1;SNAP29;TMEM237;RAB8A;SSNA1;MKKS;TOGARAM1;SEPTIN6;BBS2;EXOC7
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),-0.3896611452795954,-0.7630160489841448,0.8266666666666667,1.0,1.0,4/24,21.22%,RPS27A;UBC;RBX1;CETN2
prerank,GO_Biological_Process_2021__phosphate ion transmembrane transport (GO:0035435),0.35070834169433945,0.7629368198105718,0.8,1.0,1.0,5/12,23.47%,XPR1;SLC20A1;SLC37A1;SLC25A3;SLC25A14
prerank,GO_Biological_Process_2021__phosphate ion transport (GO:0006817),0.35070834169433945,0.7629368198105718,0.8,1.0,1.0,5/12,23.47%,XPR1;SLC20A1;SLC37A1;SLC25A3;SLC25A14
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.47944239623406093,-0.762927688308814,0.821917808219178,1.0,1.0,2/9,21.26%,APOD;F3
prerank,GO_Biological_Process_2021__maintenance of apical/basal cell polarity (GO:0035090),-0.46125150078181526,-0.7624571206507504,0.7692307692307693,1.0,1.0,3/8,20.08%,WDR1;ANK1;CRB2
prerank,GO_Biological_Process_2021__maintenance of epithelial cell apical/basal polarity (GO:0045199),-0.46125150078181526,-0.7624571206507504,0.7692307692307693,1.0,1.0,3/8,20.08%,WDR1;ANK1;CRB2
prerank,GO_Biological_Process_2021__glycosyl compound catabolic process (GO:1901658),0.4451025056947606,0.762345662707778,0.75,1.0,1.0,6/6,55.50%,GBA2;GLA;FUCA2;GBA3;FUCA1;NAGA
prerank,GO_Biological_Process_2021__glycoside metabolic process (GO:0016137),0.4451025056947606,0.762345662707778,0.75,1.0,1.0,6/6,55.50%,GBA2;GLA;FUCA2;GBA3;FUCA1;NAGA
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",-0.39790441591051695,-0.7621210789066248,0.8142857142857143,1.0,1.0,4/23,18.43%,RPS27A;MAN1C1;UBC;MAN1A1
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),-0.3670679221564154,-0.7619942196906454,0.8484848484848485,1.0,1.0,5/25,22.17%,P2RY12;DMTN;RHOD;PTPRO;VCL
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),-0.3694429301906974,-0.7617959737050066,0.8051948051948052,1.0,1.0,8/28,24.74%,APP;RPL10;RBM4B;PRKCD;RBM3;PGAM1;TMED10;GRM5
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.44440715429027833,-0.7617862247639308,0.7605633802816901,1.0,1.0,1/11,2.72%,HIC1
prerank,GO_Biological_Process_2021__aminoglycan metabolic process (GO:0006022),-0.43682975114440453,-0.7611391282295766,0.8181818181818182,1.0,1.0,2/9,19.30%,B4GALT7;CHST9
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),0.4079482780976308,0.7609062946812205,0.7631578947368421,1.0,1.0,4/11,19.12%,AKT2;AKT1;EPM2AIP1;DYRK2
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.3413006498918034,-0.7606453795486384,0.8354430379746836,1.0,1.0,3/62,9.58%,THBS1;SULF1;BMP8A
prerank,GO_Biological_Process_2021__neuron fate specification (GO:0048665),0.522039990494545,0.760468601440972,0.8108108108108109,1.0,1.0,2/5,4.88%,ASCL1;POU3F2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-13 production (GO:0032736),-0.4866039146179907,-0.7603164329590062,0.8113207547169812,1.0,1.0,2/6,16.03%,HLA-E;IL18
prerank,GO_Biological_Process_2021__positive regulation of RNA export from nucleus (GO:0046833),0.5176014680919683,0.7603059802770755,0.8666666666666667,1.0,1.0,1/5,11.08%,CPSF6
prerank,GO_Biological_Process_2021__positive regulation of nucleobase-containing compound transport (GO:0032241),0.5176014680919683,0.7603059802770755,0.8666666666666667,1.0,1.0,1/5,11.08%,CPSF6
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),-0.3929144561773263,-0.7602971014295068,0.875,1.0,1.0,1/25,3.47%,IFIT1
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),-0.34297858374424145,-0.7599215710063224,0.8536585365853658,1.0,1.0,16/70,21.12%,RASGRP1;KIF14;EPS8L2;RASGEF1A;DENND3;ARHGEF18;FBP1;DAB2IP;FOXM1;IGF1;VAV1;DLC1;PLCE1;ERBIN;IRS2;ARFGAP1
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),-0.3905926157851697,-0.7598994596309546,0.8333333333333334,1.0,1.0,5/31,10.40%,TYMP;KIF14;NKX6-2;HES7;TENM4
prerank,GO_Biological_Process_2021__adherens junction maintenance (GO:0034334),0.46980295477937783,0.7596968507650276,0.7692307692307693,1.0,1.0,1/5,23.99%,FERMT2
prerank,GO_Biological_Process_2021__regulation of microtubule motor activity (GO:2000574),-0.48155454681697457,-0.7595132365269969,0.7910447761194029,1.0,1.0,2/6,24.80%,CFAP73;CFAP100
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),-0.35268549083091727,-0.7594470730611593,0.8169014084507042,1.0,1.0,4/41,14.86%,ITPKC;INPP5D;NUDT4;PLCH2
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),0.24783067624656996,0.7590470928424946,1.0,1.0,1.0,28/246,12.45%,NGF;NCSTN;AIFM2;PHLDA1;BMP2;BCL10;DUSP6;ARHGEF16;ACVR1C;ARHGEF12;C3ORF38;ZNF268;HMGB1;IP6K2;PTGIS;STK4;TIAM2;ATF6;ARHGEF26;USP27X;MAPK8;TP53BP2;TRADD;STK17B;ERCC3;CRADD;CASP3;BAD
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),0.40580808707402943,0.7589596994242331,0.8,1.0,1.0,4/12,19.12%,AKT2;AKT1;EPM2AIP1;DYRK2
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),-0.37727407084894937,-0.7586226040824001,0.8783783783783784,1.0,1.0,5/30,16.30%,TESC;STAT1;GATA1;THPO;FES
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),-0.320437732461785,-0.7585646571466824,0.8791208791208791,1.0,1.0,19/118,19.86%,RASGRP2;KIF14;TMC8;ANGPTL7;WNT5A;GFAP;CEACAM1;PRKCQ;RIT2;LTBP4;DAB2IP;PINK1;BAP1;SLITRK4;ALKBH4;TSC2;SPHK1;NUBP1;PLCE1
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),-0.3027308727069914,-0.7585307510962145,0.9555555555555556,1.0,1.0,36/238,19.49%,RASGRP1;MET;ZFP36;RPS27A;NEFL;ZDHHC9;GFRA2;HTR2B;RASGEF1A;CCL2;PSMB6;PSMB9;EGF;RALGDS;PRKCQ;RIT2;SHC2;TNIP2;PAQR3;UBC;PSMC3;MINK1;DAB2IP;FGF1;TGFA;GRIN2B;IGF1;PTPN7;IL18;IL3RA;PSMA8;FGF7;PSME1;FGF22;PIK3CB;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),0.4095043555074759,0.7580449381660032,0.75,1.0,1.0,4/11,22.55%,CCT7;CCT3;DKC1;MEPCE
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),0.4095043555074759,0.7580449381660032,0.75,1.0,1.0,4/11,22.55%,CCT7;CCT3;DKC1;MEPCE
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),-0.3690310966163145,-0.7578553136378536,0.84,1.0,1.0,4/28,11.10%,TESC;WNT8B;WNT5A;PTK6
prerank,GO_Biological_Process_2021__pyrimidine-containing compound metabolic process (GO:0072527),-0.4349263942778184,-0.7578408092447647,0.7014925373134329,1.0,1.0,1/11,2.35%,TYMP
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),-0.30417303119989314,-0.7577062038927644,0.9791666666666666,1.0,1.0,27/277,13.82%,CP;SOCS3;C3;CHGB;SERPINA10;LAMB1;ASB16;RAB11A;APP;IGFBP5;NOTUM;PSMB6;PSMB9;TIMP1;F5;FBXL18;FAM20C;SERPIND1;FBXW12;SPSB1;FBXO32;IGFBP7;FBXW10;ELOB;ASB14;FN1;PSMC3
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),0.40047841254075744,0.7576904640394914,0.7777777777777778,1.0,1.0,4/14,10.08%,AKR1C3;AR;NR3C1;ATP1A2
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial inner membrane (GO:0045039),-0.45662029451141706,-0.7574681989397737,0.7384615384615385,1.0,1.0,3/10,29.16%,ROMO1;TIMM10;TIMM22
prerank,GO_Biological_Process_2021__death-inducing signaling complex assembly (GO:0071550),-0.4860499529069364,-0.7572486619571027,0.8382352941176471,1.0,1.0,3/6,23.46%,FADD;TNFRSF1A;CASP8
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell differentiation (GO:0051150),-0.4840539022144629,-0.756955043952437,0.7910447761194029,1.0,1.0,1/6,11.67%,SRF
prerank,GO_Biological_Process_2021__positive regulation of miRNA metabolic process (GO:2000630),0.4813630408226536,0.7567301604200533,0.8620689655172413,1.0,1.0,2/6,25.69%,NFKB1;RELA
prerank,GO_Biological_Process_2021__eye development (GO:0001654),-0.3656554798810497,-0.7567005470712754,0.8518518518518519,1.0,1.0,2/39,2.42%,SIX3;COL5A1
prerank,GO_Biological_Process_2021__regulation of lipid catabolic process (GO:0050994),0.4055706277552162,0.7566811277999855,0.7368421052631579,1.0,1.0,2/10,7.04%,PDE3B;ABCD1
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.3686031004903306,-0.7565660121208134,0.8333333333333334,1.0,1.0,1/35,0.78%,BLM
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.44314378727407244,-0.7561534809646608,0.8253968253968254,1.0,1.0,3/9,19.20%,GCNT1;SELP;ADD2
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),0.24109966630762578,0.7559715422523976,1.0,1.0,1.0,45/241,19.97%,FHDC1;MACIR;RAP2C;SPAG16;CEP19;S1PR1;BBS9;SSX2IP;RAB23;CEP20;EXOC8;TEKT5;EXOC6;DZIP1;CEP290;ARFIP2;INTU;RAB8B;CNGA4;FOXJ1;PARVA;PCM1;PTPN23;DNM3;TTC8;IQCB1;SCLT1;NEK1;UNC119B;RAB3IP;TCTN3;FGD4;TNIK;CCDC88A;EXOC5;UBXN10;WHAMM;ARHGEF6;SNAP29;TMEM237;RAB8A;MKKS;SEPTIN6;BBS2;EXOC7
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.3020885341119282,0.7559689185980648,0.9047619047619048,1.0,1.0,7/55,13.20%,PSMD10;PSMA1;PSMD11;CUL1;PSMB5;PSMD14;PSMD12
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.3734760099776329,-0.7558562155994375,0.8356164383561644,1.0,1.0,3/24,13.41%,RPS27A;NOD1;UBC
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),0.3844003433547391,0.7558461068836798,0.8372093023255814,1.0,1.0,1/11,1.76%,TMEM100
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),0.397331592673247,0.7556051507399643,0.7647058823529411,1.0,1.0,4/15,16.60%,MCU;XG;TIRAP;MDK
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),0.30274000523161887,0.755605044618188,0.9166666666666666,1.0,1.0,10/38,16.29%,MYO10;TENM1;GPM6A;TENM2;ARAP1;RALA;WASL;PIK3R1;FXR2;ARHGAP44
prerank,PanglaoDB_Augmented_2021__Pinealocytes,-0.33447620255997274,-0.7554170407241122,0.8918918918918919,1.0,1.0,11/64,13.62%,KCNB1;AIPL1;SLC24A2;MYO15A;SRRM4;PDE6B;SLC7A14;XKR4;UNC13C;GRM6;CDH7
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),-0.42210095815733095,-0.7552945956318461,0.8115942028985508,1.0,1.0,5/19,23.46%,BIRC3;CDC37;FLOT1;NUPR1;CASP8
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),-0.4077643813332027,-0.7550416261437167,0.8142857142857143,1.0,1.0,7/18,23.51%,PROX1;MMP14;IGF1;MYLK3;TGFB1;AKAP6;NIBAN2
prerank,GO_Biological_Process_2021__positive regulation of membrane potential (GO:0045838),-0.46693649582344177,-0.7549947814394286,0.782608695652174,1.0,1.0,2/8,9.19%,ANK3;GLRX
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),-0.3533609167035624,-0.7548452188237382,0.8194444444444444,1.0,1.0,4/40,14.86%,ITPKC;INPP5D;NUDT4;PLCH2
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),0.3423044567983985,0.7546385570383901,0.9090909090909091,1.0,1.0,2/22,5.95%,LIMD1;EGFR
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),0.3093588441525818,0.7544381996917392,0.8181818181818182,1.0,1.0,7/46,9.64%,ARV1;ABCA1;CYP7B1;CYP4V2;PMVK;INSIG2;CYP46A1
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),-0.3344439666840977,-0.7543120043223673,0.8648648648648649,1.0,1.0,5/63,16.08%,GOLGA8O;RAB11A;GOLGA8B;HAUS7;MAPRE2
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),-0.4260522787343769,-0.7541988277240743,0.7313432835820896,1.0,1.0,1/8,19.63%,PRKCB
prerank,GO_Biological_Process_2021__chromatin-mediated maintenance of transcription (GO:0048096),0.4020155943872226,0.7540349530096562,0.7878787878787878,1.0,1.0,1/10,8.78%,SERTAD2
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),-0.4476070288835144,-0.7538686685584236,0.8484848484848485,1.0,1.0,4/9,30.21%,SLC29A4;ANTXR1;SLC22A1;RAB40B
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),-0.34275556573876276,-0.7538158628019072,0.9156626506024096,1.0,1.0,4/60,5.81%,RFTN1;ZDHHC22;ZDHHC9;RAB11A
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),0.4109338615527868,0.7536702399934938,0.7222222222222222,1.0,1.0,1/11,2.97%,ADRA1A
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),-0.3947492096052621,-0.7531065508304382,0.821917808219178,1.0,1.0,2/26,8.70%,FABP3;LDLR
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),0.31523573282566747,0.7525294251556355,0.8214285714285714,1.0,1.0,2/22,3.41%,CHRNA4;KCNA2
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),-0.40573280911464593,-0.7523726437332121,0.7681159420289855,1.0,1.0,2/13,13.68%,CAV3;SLC43A2
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),0.26837464023791774,0.7523521146712394,1.0,1.0,1.0,16/95,14.76%,PSMD10;BCL10;TAB3;PSMA1;PSMD11;CUL1;MAPK10;PSMB5;BTRC;PSMD14;MAPK8;PIK3CA;PSMD12;PIK3R1;NFKB1;MAP2K4
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),-0.3273109492823942,-0.7522179281797542,0.9069767441860465,1.0,1.0,9/84,15.64%,SUV39H1;RPS27A;CENPV;CENPH;POLE3;NUF2;UBC;SOX15;FAM50A
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),0.27632956691588684,0.7521971792448309,0.9166666666666666,1.0,1.0,19/58,24.39%,CDC25A;EIF2S1;YY1;ATR;PTPRK;EIF2AK4;SMPD1;POLK;EP300;RHBDD1;TRIAP1;NOC2L;USP47;N4BP1;PARP1;ZBTB1;ERCC4;USP28;MME
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),-0.416057745306899,-0.7521325645879366,0.835820895522388,1.0,1.0,2/18,13.41%,RPS27A;UBC
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),-0.3781278182314831,-0.7519232011569104,0.75,1.0,1.0,1/19,3.97%,PROX1
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),-0.33051731798991507,-0.7517105730156739,0.9259259259259259,1.0,1.0,15/95,18.20%,CCNB2;BLM;SLC8A3;CCNI2;THY1;CCNB1;GADD45A;HERC5;CCND1;DAB2IP;CCNE2;MTCP1;CDKN3;CDC37;CDKN1A
prerank,GO_Biological_Process_2021__limb development (GO:0060173),0.34727965290552687,0.7514561923987562,0.8857142857142857,1.0,1.0,9/22,20.03%,GREM1;KAT2B;SALL1;INTU;KAT2A;CHD7;GLI3;BMPR1B;PCSK5
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.30699872806850165,-0.7513969030449718,0.9655172413793104,1.0,1.0,26/178,20.24%,TRIM22;TRIM5;PLK2;HTR2B;BST2;NOD1;WNT5A;STAT1;NLRP12;TNIP2;MAP3K14;ALPK1;BIRC3;DAB2IP;PINK1;SHISA5;CARD19;LTBR;FADD;APOL3;TNFRSF1A;CD4;PRKCB;CD74;RIPK2;LGALS1
prerank,GO_Biological_Process_2021__negative regulation of heart contraction (GO:0045822),0.4169632781863021,0.7511865870599643,0.7428571428571429,1.0,1.0,3/8,14.71%,SRI;ATP1A2;SPX
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),0.261993467223048,0.7508319724152034,1.0,1.0,1.0,27/134,19.05%,PSMD10;FASTKD1;RIDA;PDE12;PSMA1;PSMD11;HSPA1A;EXOSC1;PSMB5;PCBP4;AKT1;XPO1;EXOSC6;NUP214;PSMD14;DIS3;PSMD12;ZC3H14;HNRNPU;RC3H1;FXR2;PAIP1;PCID2;YTHDF2;CSDC2;FASTKD3;PUM2
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),0.25126738321611786,0.7507391184368075,1.0,1.0,1.0,31/138,18.70%,WNT7A;ASCL1;NDNF;FUT9;POU3F2;EML1;RUNX1;HES6;FZD8;TAFA1;ERCC6;PEX13;ADNP2;GPM6A;EMX2;SH3RF1;CASP3;HEYL;MARK2;TUBB2B;LHX2;LRP12;CEP85L;OLIG1;ACSL3;PRUNE1;ADGRL3;ELP3;YTHDF2;DTNB;HEY2
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),0.33271436465887627,0.7507159965891719,0.84,1.0,1.0,5/30,12.08%,CFAP53;STIL;FOXJ1;ODAD3;PKD1L1
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),-0.40425153329110886,-0.7505183196631544,0.8481012658227848,1.0,1.0,6/20,28.57%,HLA-E;GPI;PTPRC;XBP1;STX4;SHLD1
prerank,GO_Biological_Process_2021__protein deglycosylation (GO:0006517),0.40464364252052,0.750396673955573,0.75,1.0,1.0,1/8,8.48%,ENGASE
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),-0.3153442010157351,-0.7502452887972987,0.90625,1.0,1.0,23/119,25.36%,TRIM22;TRIM5;PLK2;APP;GAPDHS;PLEKHF1;IGF1;PRKCD;PRXL2C;PIK3CB;PFKFB3;IRS2;TRIM65;PFKFB2;MTLN;RDX;PFKFB4;TRIML2;KAT5;P2RX7;OPTN;DCN;PTTG1IP
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.3791971446162296,-0.7501348446295588,0.8133333333333334,1.0,1.0,5/23,21.22%,RPS27A;UBC;COPS5;RBX1;CETN2
prerank,GO_Biological_Process_2021__mesoderm development (GO:0007498),-0.42102612471088596,-0.749844233043641,0.7678571428571429,1.0,1.0,2/10,14.52%,HES7;BMX
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),-0.38163827974923287,-0.7496147903697865,0.8611111111111112,1.0,1.0,3/23,11.84%,SLC39A14;TMC8;MT1H
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),-0.3504770408609946,-0.7493651179002827,0.8354430379746836,1.0,1.0,6/43,14.03%,CDH22;CDH6;CDH12;CDH9;CDH7;CDH19
prerank,GO_Biological_Process_2021__regulation of gap junction assembly (GO:1903596),0.4963925115224446,0.7492230110921392,0.7142857142857143,1.0,1.0,1/5,0.31%,ACE2
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),-0.4533833692638329,-0.7492212246723292,0.8,1.0,1.0,3/10,22.17%,S1PR3;TNFRSF1A;VCL
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),-0.4147345421919132,-0.7490770845789688,0.7910447761194029,1.0,1.0,1/13,5.63%,ATF3
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),-0.3756644860658683,-0.7482580762155163,0.8734177215189873,1.0,1.0,11/37,23.46%,IRF1;TLR3;GADD45A;PIEZO2;MAP3K14;LTBR;FADD;TNFRSF1A;AQP1;TNFRSF10A;CASP8
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),-0.3780626039351651,-0.7477335089708189,0.8375,1.0,1.0,1/20,3.37%,TRIM5
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.4257834256925688,-0.7476473227107538,0.8059701492537313,1.0,1.0,1/12,2.41%,GBP1
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.4257834256925688,-0.7476473227107538,0.8059701492537313,1.0,1.0,1/12,2.41%,GBP1
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),0.37243607829642517,0.7474974699165674,0.8611111111111112,1.0,1.0,8/16,30.37%,LLGL1;FMNL3;FMNL2;ROCK2;LLGL2;RHOQ;DLG1;NCKAP1
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),-0.3344676034143046,-0.74729734702578,0.9047619047619048,1.0,1.0,6/58,14.04%,ZFP36;RPS27A;NOD1;TNIP2;UBC;MINK1
prerank,GO_Biological_Process_2021__gas transport (GO:0015669),-0.49275535702585793,-0.7470717352275762,0.75,1.0,1.0,1/5,1.49%,IPCEF1
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.2814656215824247,0.7463144696642356,0.9444444444444444,1.0,1.0,9/85,7.89%,SLC26A7;CHRNA4;SLC24A3;GLRB;SLC15A2;TRPM3;SLC26A3;SLC25A18;CHRNB4
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.4231445454969967,-0.7462581066576266,0.75,1.0,1.0,3/10,28.41%,CCDC3;RFFL;GSTP1
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),0.22615743216170528,0.7459730982301824,1.0,1.0,1.0,40/152,22.60%,OTUD3;PPARGC1A;ZNF207;USP13;CCT7;HSPA1A;BAG2;RABL3;STK4;CCT3;PRKRA;PARVA;USP27X;ANK2;MFSD1;STXBP4;MUL1;MARCHF7;MORC3;RAB21;PIK3R1;GNAQ;EP300;PYHIN1;VHL;GOLGA7;NLK;P3H1;ATP1B2;PEX6;SUGT1;SEL1L;PLPP3;RASSF2;MDM4;USP36;PER3;SMAD7;ZBED3;SAXO1
prerank,GO_Biological_Process_2021__water homeostasis (GO:0030104),-0.5112886691644358,-0.745869333644957,0.8484848484848485,1.0,1.0,3/5,26.66%,AQP1;CLN3;AQP11
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),0.2635618633923719,0.7455449267814943,1.0,1.0,1.0,41/239,16.04%,POLD3;CHRNA4;DNA2;MEN1;PRIMPOL;TOP3B;LIG4;UBE2T;KPNA2;SMARCAD1;LTO1;RFC3;SMARCAL1;DNASE1L2;STN1;UBE2N;TRIM28;VCP;HMGB1;CSNK1E;MSH2;RAD52;XRCC2;ATR;TOP1MT;DCLRE1B;HUS1;ERCC3;ORC5;RAD9B;DDX21;POLK;ASF1A;EXD2;MSH3;THAP9;NUDT15;POT1;ATRIP;ALKBH3;BACH1
prerank,GO_Biological_Process_2021__smooth muscle cell migration (GO:0014909),0.4694988052653907,0.7451959325659282,0.725,1.0,1.0,1/5,10.84%,PARVA
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),-0.31952785090378605,-0.745135139912389,0.9036144578313253,1.0,1.0,12/108,18.16%,LEF1;PDE6B;PSMB6;PSMB9;WNT5A;SFRP2;PSMC3;GNG2;SFRP4;PRICKLE1;PSMA8;PSME1
prerank,GO_Biological_Process_2021__lipid import into cell (GO:0140354),0.45209712080193476,0.7450837082213714,0.8,1.0,1.0,3/7,24.28%,SPX;ACSL3;RPS6KB1
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.37358098612265833,-0.7449568171355236,0.7671232876712328,1.0,1.0,3/21,12.80%,CAV3;ATP1B1;KCNG1
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),0.2271826087704631,0.7449232368309004,1.0,1.0,1.0,34/302,14.11%,CHRNA4;FANCF;FBXO45;ERCC8;MEN1;UBE2T;ZDHHC16;RFWD3;FOXP1;RFC3;SMARCAL1;ZBTB40;TRIM28;VCP;SMC6;CSNK1E;MSH2;YY1;RAD52;XRCC2;ATR;NIPBL;OARD1;HUS1;ERCC3;RAD9B;MAPK12;TAOK2;STXBP4;TAOK3;POLK;ASF1A;DCUN1D5;MSH3
prerank,GO_Biological_Process_2021__placenta development (GO:0001890),-0.45166528431457553,-0.7446904093574415,0.8656716417910447,1.0,1.0,4/8,33.18%,ADAM19;NODAL;PPARG;PLAC1
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),-0.3777385176342566,-0.7446037144785618,0.810126582278481,1.0,1.0,4/27,14.80%,BRCA1;WDR54;PINK1;LRPAP1
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),-0.31987001575711554,-0.7445071714491418,0.9146341463414634,1.0,1.0,15/75,19.83%,POU4F1;KCNB1;KIF14;CCL2;MAG;UNC5B;PRKCG;PINK1;BDNF;GRID2;SNX6;CDK5;SET;NRBP2;FOXB1
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),0.4076847978877842,0.7443705345391151,0.7727272727272727,1.0,1.0,2/8,14.18%,INSIG2;ERLIN1
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),0.4076847978877842,0.7443705345391151,0.7727272727272727,1.0,1.0,2/8,14.18%,INSIG2;ERLIN1
prerank,GO_Biological_Process_2021__retinoic acid metabolic process (GO:0042573),0.43669830207118776,0.7442567384627701,0.8095238095238095,1.0,1.0,1/8,3.38%,BCO2
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),0.34290217669481704,0.7439903457878368,0.8666666666666667,1.0,1.0,3/22,13.41%,BMP2;PPP2R5A;SMPD1
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),-0.31283332323902346,-0.7439544142647386,0.9222222222222223,1.0,1.0,16/107,17.42%,ARHGAP4;SULF1;BST2;IGFBP5;THY1;PODN;TIMP1;CYP1B1;CLIC4;PFN2;SFRP2;TMEFF2;DAB2IP;DPYSL3;DLC1;LDLRAD4
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),-0.35925474293970594,-0.7437519269333828,0.8734177215189873,1.0,1.0,1/41,0.33%,RASGRP1
prerank,PanglaoDB_Augmented_2021__Astrocytes,-0.303176235894915,-0.7435735419154768,0.8953488372093024,1.0,1.0,27/141,21.08%,SOCS3;STMN2;RCAN2;GRIN2A;PLP1;GRIA3;OPALIN;GAP43;GFAP;TCEAL6;IGSF21;CA10;TCEAL2;SYNM;C11ORF87;FGF1;ADCY5;SYNPR;BAALC;RGS7BP;CNTN2;TCEAL5;PHYHIP;ADCY8;WNT3;TCEAL7;TMEM132C
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.3819432182864865,-0.7433932910899967,0.8787878787878788,1.0,1.0,7/21,18.95%,PLN;CAV3;HPCA;JPH3;NOS1;CACNB1;JPH4
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.3696170577188473,-0.743152243282684,0.8961038961038961,1.0,1.0,3/22,13.41%,RPS27A;NOD1;UBC
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),0.2750770121858619,0.7431267729768177,0.9545454545454546,1.0,1.0,14/46,25.74%,ERCC6;SESN2;ATR;INTS7;HUS1;ATRIP;TRIAP1;HINFP;CLSPN;MDM4;RAD1;USP28;MAP3K20;CLOCK
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated calcium channel activity (GO:1901386),0.408776997549015,0.7425087801101398,0.7560975609756098,1.0,1.0,2/8,16.43%,DRD2;GPR35
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),0.3738501015485178,0.742478698301189,0.7931034482758621,1.0,1.0,4/12,10.02%,ZNF207;CSNK2A1;SMC6;CSNK2A2
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),0.4626197198576819,0.7423372512041284,0.8461538461538461,1.0,1.0,1/9,12.72%,SLC5A6
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),-0.3921784469573062,-0.7422449580345012,0.8611111111111112,1.0,1.0,12/19,27.60%,F8;SERPING1;F10;A2M;F3;PLAT;TFPI;PDGFRA;C1QTNF1;CPB2;SERPINE1;PLAUR
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),0.25513158770061617,0.7420266802777916,1.0,1.0,1.0,33/135,21.18%,BBS10;STXBP6;SAMM50;PSMD11;HSPA1A;RAB5IF;MID1IP1;TTC12;TMEM35A;NCK1;HSF1;DNAJC28;PDE4DIP;CASQ1;POMP;NDC1;SGIP1;NCK2;PICALM;VAMP3;PSMG2;NUP205;PIK3C2A;EPS15;DMD;COX7A2L;DNAJB14;ADRB2;MKKS;IMMP2L;CHCHD4;GTF2B;NUP153
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),-0.44625046267654256,-0.7415165169417262,0.8524590163934426,1.0,1.0,1/9,3.11%,NOS1AP
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),0.3783757376491129,0.7413922197936359,0.8,1.0,1.0,5/14,20.50%,BMP2;SERPINE2;MDK;ID2;PTPRZ1
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),-0.3423579452170521,-0.7413707245150258,0.8918918918918919,1.0,1.0,4/40,6.76%,RPE65;PLB1;RBP2;AKR1C1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.3616153771563469,0.7413550731409726,0.9032258064516129,1.0,1.0,7/19,23.38%,SRI;ATP1A2;DRD2;GPR35;GSTM2;PKD2;UBQLN1
prerank,GO_Biological_Process_2021__response to caffeine (GO:0031000),0.45815022072988887,0.7410905071442508,0.7674418604651163,1.0,1.0,3/6,20.00%,CACNA1S;GSTM2;RYR1
prerank,GO_Biological_Process_2021__cellular response to caffeine (GO:0071313),0.45815022072988887,0.7410905071442508,0.7674418604651163,1.0,1.0,3/6,20.00%,CACNA1S;GSTM2;RYR1
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),0.2541491218977479,0.7409752655330119,1.0,1.0,1.0,28/106,23.28%,H2BC18;PSMD10;PSMA1;H2BC21;PSMD11;SOX9;ANP32B;PSMB5;ERCC2;PSMD14;ERCC3;ORC5;PSMD12;ASF1A;GTF2H5;GTF2H2;PADI4;DMC1;H2BC5;KAT6B;MCM6;GTF2H3;PSMD1;TCF4;PARP1;DAXX;PSMF1;SART3
prerank,"GO_Biological_Process_2021__wound healing, spreading of epidermal cells (GO:0035313)",0.4281244167891867,0.7407032401436711,0.7608695652173914,1.0,1.0,1/6,0.52%,WNT7A
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),0.3334497935951385,0.7406965080637212,0.8,1.0,1.0,4/25,10.93%,AGER;ADCY1;CYP46A1;EIF2AK4
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),-0.3457623155768079,-0.740661866594008,0.8902439024390244,1.0,1.0,4/47,11.50%,ANXA1;STEAP3;RIMS2;SVBP
prerank,GO_Biological_Process_2021__xenobiotic transport across blood-brain barrier (GO:1990962),-0.45407954615673396,-0.7406420350231053,0.7457627118644068,1.0,1.0,4/6,24.92%,ABCB1;ABCC1;ABCG2;SLC22A1
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),-0.37391837844868586,-0.7405929579854804,0.8356164383561644,1.0,1.0,3/36,12.21%,SCX;POLR2I;PAX8
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),0.4486453932851771,0.7400651322064878,0.7142857142857143,1.0,1.0,4/7,40.31%,AGO3;AGO2;AGO4;DICER1
prerank,GO_Biological_Process_2021__negative regulation of histone H3-K9 methylation (GO:0051573),-0.49294667610508963,-0.7399341133331295,0.84375,1.0,1.0,1/6,9.24%,BRCA1
prerank,GO_Biological_Process_2021__chondrocyte development (GO:0002063),-0.47018173854863954,-0.7397729721099099,0.855072463768116,1.0,1.0,1/6,5.11%,SULF1
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.3231522948916409,-0.7395911057586245,0.92,1.0,1.0,14/76,26.65%,SH3GL2;CENPE;HLA-DRA;DCTN1;AP1S1;CTSS;KIF2C;CD74;MARCHF1;KIF11;HLA-DRB1;DYNC1LI2;DCTN6;DCTN2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.305039886736288,0.7394093707991325,1.0,1.0,1.0,7/33,16.79%,POLD3;RFC3;ERCC2;ERCC3;POLK;GTF2H5;GTF2H2
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),0.37172413999575105,0.7389459688146918,0.8333333333333334,1.0,1.0,2/10,10.83%,KAT2B;KAT2A
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),-0.37413422062224805,-0.7388804975991781,0.8767123287671232,1.0,1.0,5/30,22.14%,PLEKHG2;PFN2;ARHGAP18;COTL1;MAPT
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),-0.3696724797014622,-0.7388413685353971,0.8169014084507042,1.0,1.0,7/23,21.43%,SNCB;SYT1;NLGN1;CDK5;SYT2;SNCG;SYT5
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),0.36974626987321246,0.7383028479538787,0.7575757575757576,1.0,1.0,2/13,5.40%,TRIB3;SOX9
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),0.2551298089775341,0.7381947658527755,1.0,1.0,1.0,11/158,5.78%,NR1D1;LIMD1;PDE3A;OTUD3;PSMD10;TRIB3;SPRED1;PDE3B;ADIPOR1;TNFAIP3;THEM4
prerank,MSigDB_Hallmark_2020__E2F Targets,-0.30293145400669735,-0.7381812907163594,0.9456521739130435,1.0,1.0,22/169,18.20%,CCNB2;CDKN2A;SUV39H1;NAA38;CENPE;LMNB1;PRDX4;PMS2;BRCA1;WDR90;DONSON;UBE2S;RPA3;MTHFD2;SPC24;KIF2C;POLE4;STMN1;CDKN3;RPA1;POLD1;CDKN1A
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),0.3203107093241315,0.7380456152226241,0.8148148148148148,1.0,1.0,2/11,12.28%,EIF2AK4;VAPA
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,0.293084763977994,0.7379688154554135,0.9565217391304348,1.0,1.0,4/40,9.42%,EPOR;MSRB1;TOR2A;SHKBP1
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),0.3085216769396807,0.737868799775598,0.9375,1.0,1.0,10/34,24.89%,ZNF207;AAAS;CEP192;TOGARAM1;TPX2;MAP9;PIBF1;KIFC2;SMC3;CLASP2
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),-0.315264744109165,-0.7377725263637207,0.926829268292683,1.0,1.0,13/80,18.90%,SIX3;CCNB1;PSMB6;PSMB9;ANAPC11;UBE2S;PSMC3;TFAP4;ANAPC15;PSMA8;PSME1;CDKN1A;NEK10
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),-0.36226123306303226,-0.7374966158028677,0.8918918918918919,1.0,1.0,8/48,18.99%,PLK2;ANGPTL3;WNT5A;DAB2IP;VIP;HECW2;GPC3;OAZ2
prerank,GO_Biological_Process_2021__mRNA 5'-splice site recognition (GO:0000395),-0.4672257477951454,-0.73626475793413,0.847457627118644,1.0,1.0,2/5,34.78%,SNRPC;PSIP1
prerank,GO_Biological_Process_2021__organic hydroxy compound catabolic process (GO:1901616),-0.44206044950699563,-0.7362394052871987,0.8,1.0,1.0,3/7,17.81%,ADH4;CYP3A4;LDHD
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.39505215739762367,-0.7361636967862966,0.8524590163934426,1.0,1.0,3/17,15.34%,GADD45A;PAQR3;DMTN
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),0.2981711180242696,0.7358428943038027,0.9090909090909091,1.0,1.0,6/35,20.96%,UBE2T;KLHL12;MARCHF7;UBE3D;PEX12;RNF20
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.31704164918076055,-0.7353801040477135,0.8589743589743589,1.0,1.0,7/61,14.22%,CDKN2A;NLRC5;CYP1B1;KLF4;NLRP12;NLRP2;DAB2IP
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),-0.3179276276285145,-0.7343653457518582,0.9195402298850575,1.0,1.0,15/76,24.62%,TYMS;IGFBP5;RPL13A;PATL2;NELL1;DAB2IP;CDK5;SAMD4A;DAPK3;EIF4A3;SHMT1;PLAT;CLN3;EIF2AK2;IGF2BP2
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),0.3612813258363894,0.7343559391595013,0.8709677419354839,1.0,1.0,3/15,21.16%,CHMP2B;VPS4B;CHMP6
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.423638235929187,0.7342808407278731,0.8333333333333334,1.0,1.0,3/9,11.34%,FOXP1;HMGB1;TIRAP
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.32199426647147583,-0.7340912999580516,0.8947368421052632,1.0,1.0,7/74,15.98%,SH3GL2;CENPE;HLA-DRA;DCTN1;AP1S1;CTSS;KIF2C
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),-0.36251175326612356,-0.7339012689155271,0.8591549295774648,1.0,1.0,6/28,19.90%,BAIAP2L1;BAIAP2;FES;CDK5;SEMA3E;DAPK3
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),0.36773955086521487,0.7338643195652661,0.8333333333333334,1.0,1.0,3/14,13.85%,PGAM5;IPMK;TICAM1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),0.3902428211364709,0.7337247121670073,0.7435897435897436,1.0,1.0,2/11,9.87%,CCT7;CCT3
prerank,GO_Biological_Process_2021__positive regulation of activin receptor signaling pathway (GO:0032927),0.43685204953865786,0.7336255837345118,0.7441860465116279,1.0,1.0,1/5,13.01%,ACVR2A
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),0.39526163759975974,0.7335648204621126,0.7631578947368421,1.0,1.0,2/9,11.05%,CASQ1;ANK2
prerank,GO_Biological_Process_2021__acetylcholine receptor signaling pathway (GO:0095500),0.363460742095625,0.7335511430144538,0.8,1.0,1.0,1/15,0.79%,RGS10
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),-0.34954734830995865,-0.733479178813518,0.8902439024390244,1.0,1.0,7/41,19.49%,TGFBR2;TEAD2;ZFPM1;IFT122;RPL10;MFSD2A;TGFB1
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),-0.36489053758301393,-0.7334177547720115,0.9054054054054054,1.0,1.0,2/32,9.37%,NEFL;HAP1
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),-0.3934826243949243,-0.733364344764659,0.8596491228070176,1.0,1.0,1/12,6.68%,SLC25A21
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),-0.3934826243949243,-0.733364344764659,0.8596491228070176,1.0,1.0,1/12,6.68%,SLC25A21
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.30848385872738787,-0.733317965465661,0.9620253164556962,1.0,1.0,12/108,15.36%,SP100;CDKN2A;PROX1;NLRC5;CYP1B1;KLF4;NLRP12;SIGIRR;NLRP2;PIM1;DAB2IP;SFRP4
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.33965692783674417,0.7332091444289834,0.9333333333333333,1.0,1.0,3/14,13.52%,MID1;TAOK2;TAOK3
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),-0.3271251384918322,-0.7329308329854199,0.9259259259259259,1.0,1.0,14/58,22.26%,CDKN2A;DUSP1;BTG3;HEXIM1;TSPYL2;BTG1;TFAP4;GMNC;NR4A1;TGFB1;NUDT6;GPER1;CDKN1C;NUPR1
prerank,GO_Biological_Process_2021__regulation of protein localization to chromatin (GO:1905634),0.4497223062790814,0.732655064172233,0.851063829787234,1.0,1.0,4/6,29.66%,VCP;WAPL;VCPIP1;SETD2
prerank,GO_Biological_Process_2021__lipid oxidation (GO:0034440),0.46114131268939895,0.7326053605121006,0.8,1.0,1.0,2/6,3.98%,PPARGC1A;ADIPOR1
prerank,GO_Biological_Process_2021__excitatory synapse assembly (GO:1904861),0.47052423850008057,0.7321737816386743,0.7837837837837838,1.0,1.0,1/8,0.52%,WNT7A
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),-0.3501556921880241,-0.7317936811916312,0.868421052631579,1.0,1.0,5/29,12.51%,APP;USP50;WNT5A;NLRP12;NLRP2
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),-0.38620718275019084,-0.7317529124176354,0.8260869565217391,1.0,1.0,7/18,24.92%,ABCA8;ABCB1;SLC22A4;SLC29A4;ABCC1;ABCG2;SLC22A1
prerank,GO_Biological_Process_2021__isoprenoid biosynthetic process (GO:0008299),-0.4457826665441733,-0.7317182118611728,0.7794117647058824,1.0,1.0,4/7,31.51%,MVK;IDI1;DHDDS;HMGCR
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),-0.39812649363983843,-0.7316888967713532,0.8428571428571429,1.0,1.0,3/19,15.40%,IL12A;RHBDF2;RHBDF1
prerank,GO_Biological_Process_2021__response to histamine (GO:0034776),-0.4529571715805035,-0.7314826880900354,0.7910447761194029,1.0,1.0,3/8,17.78%,GABRB2;HRH1;GABRG2
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.3079137107892592,0.7312368473540792,0.84,1.0,1.0,10/35,23.99%,BMP2;FBXO5;ACVR2A;PRKD1;ZHX3;BMPR1B;HGF;WNT7B;BMP7;FERMT2
prerank,PanglaoDB_Augmented_2021__Crypt Cells,-0.31962656437372894,-0.7309406320481711,0.9411764705882353,1.0,1.0,7/84,8.46%,APLNR;RIMBP2;KCNQ1;ANK3;MAOB;IGFBP5;RASL12
prerank,GO_Biological_Process_2021__hydrogen sulfide metabolic process (GO:0070813),-0.4996443801388991,-0.7309352845755412,0.85,1.0,1.0,1/5,12.23%,SQOR
prerank,GO_Biological_Process_2021__negative regulation of protein polyubiquitination (GO:1902915),-0.47005425893812575,-0.7309236105559614,0.7903225806451613,1.0,1.0,3/5,41.26%,PARP10;PPIA;GPS2
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),-0.41148374255199877,-0.7308150051563499,0.8181818181818182,1.0,1.0,3/13,21.30%,CHST4;CHST6;MGAT3
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),-0.41849737043523794,-0.7300152283967513,0.8,1.0,1.0,5/13,28.94%,SLC9A2;SLC9A5;SLC9A7;SLC9A1;SLC9A9
prerank,GO_Biological_Process_2021__negative regulation of secretion (GO:0051048),-0.44614952566490684,-0.7295763636494969,0.8253968253968254,1.0,1.0,2/8,19.76%,EGF;CD74
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),0.34484023785900253,0.7294665562790117,0.8571428571428571,1.0,1.0,4/21,9.56%,SLC39A10;SLC39A8;MT1E;SLC30A9
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),-0.3416854309541068,-0.7292876767570794,0.8701298701298701,1.0,1.0,9/31,18.91%,GRIN2D;GRIN2A;INSYN2A;GRIN2B;GRID2;GABRE;GABRG2;GLRA1;GABRA1
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),0.31247793410441993,0.7292547502455652,0.9130434782608695,1.0,1.0,12/39,19.50%,CEBPA;RUNX1;HCLS1;TIRAP;CASP3;DYRK3;PRDX3;SLC25A5;FLVCR1;SNRK;SLC25A38;PRKX
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),-0.4012846591966579,-0.7291406222758055,0.8153846153846154,1.0,1.0,1/13,8.05%,POLE3
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.2942661356210905,-0.7290875307616524,1.0,1.0,1.0,26/184,19.95%,TRIM22;TLR2;RPS27A;TRIM5;BEX1;APP;NOD1;SLCO3A1;WNT5A;PRKCQ;SRF;UBC;NEUROD2;IL18;DDRGK1;PRKCH;PPARGC1B;CD200;COPS5;SPHK1;IL1RAP;RELN;PRKCB;FLOT1;RIPK2;ADCY8
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),-0.45843737696766207,-0.7290789082444731,0.8260869565217391,1.0,1.0,4/6,32.95%,TGFB1;TGFB3;MSN;TGFB2
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),-0.3090912574718246,-0.7288002619681834,0.8705882352941177,1.0,1.0,16/98,19.84%,AMN;ABCA6;ABCA5;RAMP3;ABCA8;ABCA12;SLC18A2;ABCA10;SLC22A4;MYH9;ARRDC2;MFSD2A;SLC35F3;SLC50A1;SLCO1A2;SLC29A4
prerank,GO_Biological_Process_2021__intestinal cholesterol absorption (GO:0030299),-0.4820928804928572,-0.7284648791370993,0.8225806451612904,1.0,1.0,2/6,8.70%,AKR1C1;LDLR
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),-0.41475800349046965,-0.7282815821561401,0.9264705882352942,1.0,1.0,4/15,31.45%,FOLH1;ASS1;NIT2;MTHFD1
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.33902900626086063,-0.7279863883524945,0.9078947368421053,1.0,1.0,1/35,1.79%,PGR
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),0.3821621677703962,0.7279461346460586,0.8947368421052632,1.0,1.0,4/11,19.13%,KMT2A;WNK3;PON1;SGK2
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),-0.4006191161747187,-0.7278064315919176,0.8717948717948718,1.0,1.0,4/21,17.08%,RPS27A;RPA3;UBC;RPA1
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.2730292064409897,0.7276561889935431,0.9473684210526315,1.0,1.0,4/53,5.82%,UQCRHL;AFG1L;COX10;NDUFB1
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),0.3395792475560221,0.7268898320418835,0.8461538461538461,1.0,1.0,2/18,5.10%,TNFSF13B;CD320
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),0.40484925591480087,0.7268495239638904,0.8157894736842105,1.0,1.0,2/10,9.87%,CCT7;CCT3
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),0.3358519358982049,0.7267888842078752,0.9210526315789473,1.0,1.0,4/21,10.08%,ATP6V1A;DMAC2L;UCP3;ATP1A2
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),-0.37986888135724056,-0.7264258099716083,0.8333333333333334,1.0,1.0,3/22,22.14%,MAP1B;AEBP1;MAPT
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),-0.3668073006969391,-0.726237235178768,0.9117647058823529,1.0,1.0,1/20,5.11%,SULF1
prerank,GO_Biological_Process_2021__regulation of lysosomal lumen pH (GO:0035751),-0.4536451780627435,-0.7258306631917659,0.7741935483870968,1.0,1.0,1/8,23.26%,CLN3
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.31256246071202487,-0.7255865627027234,0.9382716049382716,1.0,1.0,15/80,21.20%,CDKN2A;GPNMB;CCL2;PSMB6;PSMB9;KLF4;GFI1B;PSMC3;PSMA8;PSME1;CDKN1A;WEE1;PSMA7;RBX1;CDKN2D
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),-0.4178435102004757,-0.7255623317607655,0.8688524590163934,1.0,1.0,3/14,15.57%,PLK2;BRCA1;CEP76
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.3555168742156096,-0.7252612750956716,0.868421052631579,1.0,1.0,7/23,28.59%,ARG2;IGF1;CX3CL1;NLRC3;RARA;GSTP1;CD274
prerank,GO_Biological_Process_2021__nucleoside diphosphate phosphorylation (GO:0006165),-0.44748923465123314,-0.7252034255348576,0.85,1.0,1.0,1/8,3.30%,CMPK2
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),0.3139040968460086,0.724978905238632,0.8387096774193549,1.0,1.0,6/21,26.71%,GPM6B;EFNA5;SLK;PTK2;ROCK2;LDB1
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),0.3809359354971799,0.7248374615982258,0.8275862068965517,1.0,1.0,5/14,23.08%,NOTCH2;ROBO1;HEYL;HEY2;JAG1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol transport (GO:0032375),0.4497090716774473,0.7246740935659434,0.9024390243902439,1.0,1.0,1/5,14.74%,NFKB1
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),0.3052401783118438,0.7246009854036706,0.875,1.0,1.0,7/31,17.10%,VCP;MRRF;MTIF2;DENR;DYRK3;GFM2;UFM1
prerank,GO_Biological_Process_2021__intestinal lipid absorption (GO:0098856),-0.47660885469736836,-0.724140185226264,0.8548387096774194,1.0,1.0,2/7,8.70%,AKR1C1;LDLR
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),-0.37004451384982445,-0.7238803307467309,0.9102564102564102,1.0,1.0,5/23,20.28%,EFNA1;USP50;GRIN2B;PSME1;APH1A
prerank,GO_Biological_Process_2021__glutathione biosynthetic process (GO:0006750),-0.42834334260918455,-0.7235090323231513,0.8095238095238095,1.0,1.0,3/9,31.15%,GSS;CHAC2;GGCT
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),-0.43778429393268864,-0.7234132130821571,0.8266666666666667,1.0,1.0,1/9,9.24%,BRCA1
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),0.39982405756848316,0.723274926266245,0.8529411764705882,1.0,1.0,2/7,14.33%,ADGRB1;CFLAR
prerank,GO_Biological_Process_2021__nucleotide phosphorylation (GO:0046939),-0.44672071117897505,-0.7229880009563959,0.7761194029850746,1.0,1.0,1/8,3.30%,CMPK2
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C signaling (GO:0090037),0.45814992804928756,0.7229626552247338,0.7894736842105263,1.0,1.0,1/6,2.97%,ADRA1A
prerank,MSigDB_Hallmark_2020__UV Response Dn,-0.30802066250565663,-0.7228077350241736,0.9759036144578314,1.0,1.0,8/132,8.70%,DUSP1;MET;TGFBR2;GCNT1;IGFBP5;MAP1B;VLDLR;LDLR
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),-0.28392441799834317,-0.7227339513212812,1.0,1.0,1.0,26/188,21.22%,CCNB2;CDKN2A;PLK2;CCNI2;CCNB1;ABCB1;PLK3;DCTN1;UBE2S;CRLF3;CCND1;HAUS7;FOXM1;CCNE2;CEP76;CDK2;MAX;CDKN3;CDKN1A;WEE1;CDC7;CEP135;BCAT1;FBXL22;CDKN2D;CETN2
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),-0.3637229187415593,-0.7227070620556661,0.8481012658227848,1.0,1.0,7/27,20.54%,THY1;FN1;DLC1;LAMA3;RHOD;PLEC;ITGB4
prerank,GO_Biological_Process_2021__mRNA pseudouridine synthesis (GO:1990481),0.4224114141882684,0.7220702343112352,0.7241379310344828,1.0,1.0,2/7,29.67%,DKC1;TRUB1
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),0.33221913464365277,0.7217714782201237,0.9333333333333333,1.0,1.0,3/18,14.27%,KPNA2;VPS37B;CHMP2B
prerank,GO_Biological_Process_2021__cardiac muscle cell myoblast differentiation (GO:0060379),0.4555552598742729,0.721763900439959,0.7727272727272727,1.0,1.0,2/5,29.23%,RBPJ;REST
prerank,GO_Biological_Process_2021__purine-containing compound catabolic process (GO:0072523),0.36260768196573057,0.7217586372676947,0.825,1.0,1.0,2/11,15.70%,NT5C1A;NUDT15
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),-0.35117326639518687,-0.7217190900507612,0.8933333333333333,1.0,1.0,6/34,17.63%,RPS14;HELB;NOB1;RPS16;RPS8;TSR2
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),-0.4153942884948142,-0.7216848173035816,0.8309859154929577,1.0,1.0,4/11,23.74%,ADCY7;ADCY5;ADCY8;ADCY3
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),0.2859235796392745,0.7215559756295973,0.92,1.0,1.0,10/57,12.62%,CD200R1;AGER;BCL10;TNFAIP3;IL17D;TMEM106A;HMGB1;FOXJ1;TIRAP;SIRPA
prerank,GO_Biological_Process_2021__maintenance of DNA methylation (GO:0010216),0.4199006598355189,0.7214493363549003,0.7714285714285715,1.0,1.0,4/6,37.78%,USP7;UHRF2;ZNF445;HELLS
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.370910869258526,-0.7209950628750643,0.9014084507042254,1.0,1.0,5/22,14.63%,DOK1;EGF;HAP1;PTK6;TGFA
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.28544197111281927,0.7207916489874516,0.92,1.0,1.0,5/34,15.43%,QRICH2;CSNK2A1;CSNK2A2;EIF3H;FHIT
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),-0.34815953886255335,-0.7204896492937408,0.8157894736842105,1.0,1.0,1/28,0.21%,ANXA1
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),-0.34978241465396637,-0.720469976211573,0.8441558441558441,1.0,1.0,10/28,24.53%,APP;GAPDHS;PINK1;IGF1;PRXL2C;PFKFB3;NUPR1;PFKFB2;PFKFB4;P2RX7
prerank,GO_Biological_Process_2021__protein hydroxylation (GO:0018126),-0.4397729386499436,-0.7203370477461127,0.8787878787878788,1.0,1.0,2/13,12.42%,P3H2;OGFOD1
prerank,GO_Biological_Process_2021__ceramide catabolic process (GO:0046514),0.37492525770381185,0.7201860215579831,0.7647058823529411,1.0,1.0,4/14,29.04%,ASAH2B;NEU3;ACER3;NEU1
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),-0.30981945191357985,-0.7198991481194698,0.8837209302325582,1.0,1.0,12/66,19.52%,FLRT3;ZFP36;CD44;CCL2;POLR2I;SHCBP1;FGF1;NR4A1;FGF7;ANOS1;FGF22;HYAL1
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),0.35237934582840474,0.7198041040508067,0.7619047619047619,1.0,1.0,2/21,3.02%,PDE3A;LIG4
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),-0.41088100876955685,-0.7197874404242546,0.8360655737704918,1.0,1.0,2/10,19.39%,VIL1;WDR1
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),-0.4050111419540818,-0.7197631843850826,0.7910447761194029,1.0,1.0,5/15,22.94%,SVIL;BASP1;MYOZ2;MYL6B;MYL6
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),-0.2960867388852722,-0.719040068634598,0.967741935483871,1.0,1.0,9/92,14.22%,SKAP1;FSCN1;ISG15;WARS1;USP50;SYK;RPA3;PSMC3;DAB2IP
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),-0.3891080757438222,-0.7187177327292621,0.8450704225352113,1.0,1.0,2/14,6.26%,CD44;CEMIP
prerank,GO_Biological_Process_2021__epoxygenase P450 pathway (GO:0019373),-0.4821269235920636,-0.718653484275442,0.8870967741935484,1.0,1.0,1/6,8.93%,CYP1B1
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),-0.30646347725535084,-0.7185250777239035,0.9302325581395349,1.0,1.0,13/72,22.25%,DUSP1;GBP1;PSCA;CAV3;PAQR3;DAB2IP;FOXM1;PRKCD;PTPRC;PIK3CB;GPER1;RPS6KA6;PTPRR
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell migration (GO:0090521),-0.4493851979355692,-0.7182059407572379,0.8135593220338984,1.0,1.0,1/5,7.80%,ANLN
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),-0.4201401741727221,-0.7181429538209254,0.8181818181818182,1.0,1.0,3/10,19.39%,VIL1;DSTN;WDR1
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),-0.38185722158715474,-0.7178635301497237,0.835820895522388,1.0,1.0,4/15,17.71%,GPR183;SBNO2;SNX10;ANXA2
prerank,GO_Biological_Process_2021__regulation of I-kappaB phosphorylation (GO:1903719),0.4353481125243827,0.7176998753297067,0.8536585365853658,1.0,1.0,2/5,12.62%,AKT1;SIRPA
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),0.31954140510074447,0.7175590339691567,0.8333333333333334,1.0,1.0,10/24,30.50%,KAT2B;EP300;GTF2B;NAA50;CLOCK;NAA15;NAT10;SIRT1;NAA35;DSCC1
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),-0.3052390935238083,-0.7174395617966839,0.8441558441558441,1.0,1.0,17/78,20.27%,OGN;CSPG4;CEMIP;HS3ST3A1;OMD;BGN;ST3GAL6;B3GNT2;CHST15;B4GALT7;CHSY3;CHST6;AGRN;GPC3;CHST9;HYAL1;HS6ST1
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),0.2913327819904208,0.7172469793982624,0.9047619047619048,1.0,1.0,10/42,19.92%,SPRED1;CCDC88C;KAT2B;RABL3;SESN2;SPRED2;CCDC88A;CCAR2;FNIP2;FKTN
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),-0.392434151956637,-0.7171520948183164,0.8888888888888888,1.0,1.0,3/17,18.52%,RAB11A;CDK5;LIMK2
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),0.33875519075856686,0.7168650026596137,0.8214285714285714,1.0,1.0,3/13,15.53%,SRI;ANK2;CACNA2D1
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),-0.44106502395402447,-0.7166745142310759,0.859375,1.0,1.0,1/8,6.76%,AKR1C1
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),-0.40438884561716765,-0.7166733520314085,0.8115942028985508,1.0,1.0,5/11,34.56%,KAT5;CAMK1;FAM161A;PARK7;TERF2IP
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),0.27390122400810657,0.7163571537929315,0.9444444444444444,1.0,1.0,4/52,5.82%,UQCRHL;AFG1L;COX10;NDUFB1
prerank,GO_Biological_Process_2021__axonemal dynein complex assembly (GO:0070286),-0.3649987366753094,-0.7163260277357215,0.875,1.0,1.0,11/27,27.63%,CCDC39;SPAG1;ODAD1;DRC1;CFAP73;DNAH17;DNAAF1;CFAP100;CCDC40;ODAD4;DNAI1
prerank,GO_Biological_Process_2021__detection of light stimulus involved in visual perception (GO:0050908),-0.4782192532222189,-0.7162101318786771,0.8269230769230769,1.0,1.0,2/5,12.47%,RPE65;GRM6
prerank,GO_Biological_Process_2021__detection of light stimulus involved in sensory perception (GO:0050962),-0.4782192532222189,-0.7162101318786771,0.8269230769230769,1.0,1.0,2/5,12.47%,RPE65;GRM6
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.42269573966161317,-0.7159968504277153,0.9047619047619048,1.0,1.0,4/11,17.56%,ALOX12;CEACAM1;CD9;PRKCD
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion mediated by integrin (GO:0033629),0.4051816819185685,0.7158238528516084,0.8108108108108109,1.0,1.0,1/7,3.92%,PDE3B
prerank,GO_Biological_Process_2021__nucleoside triphosphate biosynthetic process (GO:0009142),-0.43184749780683396,-0.715794909448089,0.8095238095238095,1.0,1.0,1/8,3.30%,CMPK2
prerank,GO_Biological_Process_2021__thymus development (GO:0048538),-0.463380044048192,-0.7157184542819137,0.8529411764705882,1.0,1.0,2/6,21.86%,FADD;HES1
prerank,GO_Biological_Process_2021__regulation of protein ADP-ribosylation (GO:0010835),-0.466249420445821,-0.7155596361235721,0.8813559322033898,1.0,1.0,3/7,18.44%,WARS1;HPF1;XRCC1
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),0.39708814152184335,0.7155548075601196,0.7894736842105263,1.0,1.0,1/7,4.47%,GREM1
prerank,GO_Biological_Process_2021__purine deoxyribonucleotide catabolic process (GO:0009155),0.47792702670885756,0.7153185927528884,0.875,1.0,1.0,2/5,15.70%,NT5C1A;NUDT15
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),-0.40662952399551305,-0.7153006154888591,0.90625,1.0,1.0,3/15,16.35%,ATP1A1;ATP1B1;TMPRSS3
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell activation (GO:0046636),0.45796297903617444,0.7148940189631853,0.8461538461538461,1.0,1.0,2/6,7.58%,TWSG1;TARM1
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),-0.3222006858524825,-0.7148795732759142,0.9615384615384616,1.0,1.0,9/57,18.20%,B2M;IFIT1;TMC8;ZFPM1;IFIT2;LRPAP1;CTSZ;PRKCD;CDKN1A
prerank,GO_Biological_Process_2021__replication-born double-strand break repair via sister chromatid exchange (GO:1990414),-0.4463001529483064,-0.7144994122379732,0.8333333333333334,1.0,1.0,2/5,18.44%,REC8;XRCC1
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),-0.400893431584593,-0.7143922120862617,0.8533333333333334,1.0,1.0,3/11,25.92%,IL7;IRS2;STAT3
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),-0.400893431584593,-0.7143922120862617,0.8533333333333334,1.0,1.0,3/11,25.92%,IL7;IRS2;STAT3
prerank,GO_Biological_Process_2021__short-chain fatty acid catabolic process (GO:0019626),0.3859822859945623,0.7143904738861369,0.75,1.0,1.0,2/7,27.70%,ACADS;PCCA
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),-0.4277648866686277,-0.71432769793594,0.8382352941176471,1.0,1.0,4/9,23.74%,ADCY7;ADCY5;ADCY8;ADCY3
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell differentiation (GO:0051151),0.4258117473348191,0.7140937907876437,0.7105263157894737,1.0,1.0,2/6,24.20%,RBPMS2;FOXO4
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),-0.3103072783177574,-0.7139803864794465,0.9302325581395349,1.0,1.0,16/79,19.83%,POU4F1;GPNMB;KIF14;CCL2;MAG;UNC5B;PRKCG;PINK1;HLA-F;BDNF;CD200;SNX6;CDK5;SET;NRBP2;FOXB1
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),-0.38169134594228304,-0.7139268737403978,0.9523809523809523,1.0,1.0,7/18,28.59%,APP;SCN2A;CDK5;TRPC5;SIAH1;FAM162A;FAS
prerank,GO_Biological_Process_2021__neurotransmitter reuptake (GO:0098810),-0.43433783585447117,-0.7138596382331514,0.864406779661017,1.0,1.0,2/6,24.92%,SLC29A4;SLC22A1
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),0.29455591751321464,0.7137251087354175,0.9473684210526315,1.0,1.0,6/42,13.30%,CYP7B1;AKR1C3;PMVK;INSIG2;CYP46A1;SCP2
prerank,GO_Biological_Process_2021__regulation of adipose tissue development (GO:1904177),-0.4599642664313861,-0.7137176021947836,0.8769230769230769,1.0,1.0,4/6,37.95%,SPI1;KLF7;PLAAT3;TRPM4
prerank,GO_Biological_Process_2021__regulation of morphogenesis of an epithelium (GO:1905330),0.483486623259609,0.7134816321858289,0.8461538461538461,1.0,1.0,3/5,20.12%,FOXP1;ADAMTS12;GJA1
prerank,GO_Biological_Process_2021__nicotinamide nucleotide biosynthetic process (GO:0019359),0.4022736007872295,0.7133708723222616,0.8409090909090909,1.0,1.0,2/7,16.68%,KYNU;NADSYN1
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.37248281069975286,-0.7132318478491046,0.8133333333333334,1.0,1.0,2/21,5.12%,ZDHHC22;ZDHHC9
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.37248281069975286,-0.7132318478491046,0.8133333333333334,1.0,1.0,2/21,5.12%,ZDHHC22;ZDHHC9
prerank,GO_Biological_Process_2021__erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221),0.44866235401207377,0.7132030013802533,0.8055555555555556,1.0,1.0,2/5,20.68%,QDPR;ASRGL1
prerank,GO_Biological_Process_2021__photoreceptor cell development (GO:0042461),0.395296721243568,0.713193862284249,0.8648648648648649,1.0,1.0,2/9,9.28%,RORB;CEP290
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),-0.3935839149846533,-0.7131504899783137,0.8333333333333334,1.0,1.0,1/14,4.20%,IMPDH1
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),-0.3364794765142437,-0.7131451409122699,0.8873239436619719,1.0,1.0,5/28,22.17%,P2RY12;DMTN;RHOD;PTPRO;VCL
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),-0.4110139728275226,-0.713039866624462,0.8611111111111112,1.0,1.0,2/11,11.49%,PROX1;ZFPM1
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.3849462635821185,-0.7130020100356335,0.8513513513513513,1.0,1.0,6/17,25.53%,FSCN1;CLIC4;CRB2;ERBIN;LRRC7;PATJ
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.39269441430807844,-0.7124712587088778,0.8823529411764706,1.0,1.0,2/19,13.82%,SRF;PSMC3
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),0.2869687628588784,0.7124671966027558,0.8666666666666667,1.0,1.0,2/30,6.68%,NCSTN;NAPSA
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),-0.3513482757558381,-0.7124489566501805,0.9027777777777778,1.0,1.0,1/28,2.43%,ZFP36
prerank,GO_Biological_Process_2021__xenobiotic catabolic process (GO:0042178),0.41891992434988967,0.7120993493528632,0.7906976744186046,1.0,1.0,2/6,22.89%,GSTM2;CRYZ
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.37034977496233346,-0.7120169291083824,0.9014084507042254,1.0,1.0,1/19,2.07%,P2RY12
prerank,GO_Biological_Process_2021__presynaptic active zone organization (GO:1990709),-0.4611048784142938,-0.7116342187903646,0.8620689655172413,1.0,1.0,3/6,37.52%,RAB3A;CAST;PCLO
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),-0.330552862959863,-0.7115464819606506,0.9367088607594937,1.0,1.0,1/41,2.43%,ZFP36
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),0.29030892285968646,0.7115304311783276,0.9259259259259259,1.0,1.0,7/38,12.04%,HS3ST5;SDC4;SDC3;GPC5;B3GALT1;EXT2;HSPG2
prerank,GO_Biological_Process_2021__retinal cone cell development (GO:0046549),-0.46193485806367257,-0.7115245271083991,0.8235294117647058,1.0,1.0,2/5,20.08%,THY1;CRB2
prerank,GO_Biological_Process_2021__retinal cone cell differentiation (GO:0042670),-0.46193485806367257,-0.7115245271083991,0.8235294117647058,1.0,1.0,2/5,20.08%,THY1;CRB2
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),-0.3760574417779267,-0.7114180811730594,0.8405797101449275,1.0,1.0,4/16,23.74%,ADCY7;ADCY5;ADCY8;ADCY3
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),-0.33153964875025954,-0.7109408464183439,0.9058823529411765,1.0,1.0,8/46,17.72%,MYOF;DYSF;WNT5A;SRF;FGF1;MYH9;IGF1;SLC11A1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.3464810020157413,-0.7109095669062505,0.9090909090909091,1.0,1.0,6/26,25.43%,YWHAH;PPP3CC;NMT1;BOK;CASP8;BBC3
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),-0.2903331234322942,-0.710892581681293,1.0,1.0,1.0,21/146,21.62%,TGFBR2;VRK2;PLK2;RPS6KA1;PRKCQ;SBK1;PDK3;PRKCG;PINK1;STK32B;HIPK4;CDK2;PRKCH;CDK5;PRKCD;CDC7;PRKCB;STK32A;RPS6KA6;HIPK3;CAMK1D
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.3271759670432522,0.7107390349931229,0.8260869565217391,1.0,1.0,3/26,4.85%,FLT3;PIK3R4;WDR91
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),-0.36478229232112447,-0.710360624531515,0.8428571428571429,1.0,1.0,5/21,19.95%,RAB11A;ADCY7;ADCY5;AQP1;ADCY8
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),-0.27282700674894655,-0.7103418193225441,1.0,1.0,1.0,52/337,21.58%,C3;TLR2;TIMP2;B2M;ATP8B4;CD44;ADGRE5;IMPDH1;BST2;CTSC;PRDX4;PLD1;HLA-C;TMC6;ARHGAP9;CEACAM1;CHI3L1;MMP25;FRMPD3;CLEC12A;HLA-B;SYK;CTSS;CD55;IRAG2;PSMC3;MVP;RHOF;PYGL;GPI;CD63;CTSZ;HRNR;TMBIM1;PRKCD;ANXA2;SLC11A1;FLG2;CAPN1;PTPRC;SLC15A4;PGRMC1;PTAFR;FTH1;CLEC5A;ENPP4;HEBP2;AGPAT2;PFKL;COTL1;PTGES2;PGAM1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),-0.3947978290452994,-0.7102962795644502,0.8472222222222222,1.0,1.0,2/13,15.73%,ANGPTL7;AEBP1
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),0.35711210485514394,0.7102147047433892,0.7391304347826086,1.0,1.0,4/11,16.12%,AKT1;EIF2AK3;PIK3R1;PLCB1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),0.32487319656249597,0.7096652202223812,0.92,1.0,1.0,10/30,23.69%,COMMD1;TAX1BP3;GPM6B;LEPROTL1;PICALM;NEDD4L;LZTFL1;UBXN2B;LATS1;ROCK2
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),-0.32630940168913225,-0.7095600456931211,0.926829268292683,1.0,1.0,9/59,21.38%,DUSP1;PODXL;CYP1B1;ARHGDIG;DMTN;SPINT2;PTPRC;TGFB1;PTPRO
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.3214489438224743,-0.7095370881237423,0.8974358974358975,1.0,1.0,7/45,16.84%,SHTN1;CNTNAP1;NYAP1;MINK1;DAB2IP;BDNF;DCLK1
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),-0.32982009808550433,-0.7091172872821077,0.8846153846153846,1.0,1.0,1/45,0.78%,BLM
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),-0.3475640029574678,-0.7090119312033047,0.8846153846153846,1.0,1.0,6/22,28.41%,ARG2;IGF1;CX3CL1;NLRC3;RARA;GSTP1
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),-0.3389673016540268,-0.7089040905815434,0.9102564102564102,1.0,1.0,2/42,7.80%,ANK3;ANLN
prerank,GO_Biological_Process_2021__protein polyglutamylation (GO:0018095),-0.41450296719633983,-0.7088851979920594,0.8235294117647058,1.0,1.0,2/10,17.62%,TTLL7;TTLL6
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",0.2852717102311598,0.7084820215341494,1.0,1.0,1.0,7/35,16.79%,POLD3;RFC3;ERCC2;ERCC3;POLK;GTF2H5;GTF2H2
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),-0.3803517924494742,-0.7083243548761534,0.9154929577464789,1.0,1.0,3/18,9.67%,SLC8A3;CAV3;C12ORF57
prerank,GO_Biological_Process_2021__dopamine uptake (GO:0090494),-0.42471604761384096,-0.7082451415607269,0.7678571428571429,1.0,1.0,2/5,24.92%,SLC29A4;SLC22A1
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),-0.33469401888396794,-0.7079850475365872,0.9027777777777778,1.0,1.0,2/40,3.55%,RASGRP1;CD44
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.360242538229528,-0.7078458699011477,0.8666666666666667,1.0,1.0,11/26,29.92%,ICAM1;BRCA1;FADD;TMBIM1;TNFRSF10A;CASP8;HMOX1;RFFL;SERPINE1;FAS;PARK7
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),-0.3138699855088064,-0.7076127667443363,0.9069767441860465,1.0,1.0,19/84,21.26%,HPN;NR4A3;LAMB1;PROX1;HTR2B;WNT5A;EGF;FGF1;VIP;TGFA;IGF1;NR4A1;EGFL7;FGF7;PTPRN;HYAL1;PIK3CD;SFRP1;F3
prerank,GO_Biological_Process_2021__regulation of anion transport (GO:0044070),-0.4734475136113095,-0.7075476985007626,0.8548387096774194,1.0,1.0,3/5,18.72%,ABCB1;PDZK1;ATP8B1
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),-0.3247389399960414,-0.7070482185628887,0.9342105263157895,1.0,1.0,7/63,10.71%,GRIN3A;RAMP3;CDH23;SLC8A3;TRPC3;SLC24A1;NIPAL2
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),0.31969182419013326,0.7066705763712767,0.8636363636363636,1.0,1.0,4/20,12.84%,SLC19A1;DISP1;SLC5A6;PLEKHA3
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),-0.3120808547617984,-0.7066360256880371,0.9156626506024096,1.0,1.0,16/84,20.95%,TLR2;HIC1;SULF1;APP;NOTUM;DEPDC1B;RSPO3;SFRP2;SFRP4;ITGA3;RSPO4;CBY1;TSC2;GPC3;EMD;SFRP1
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,-0.33555313950564447,-0.7065768176046016,0.8795180722891566,1.0,1.0,12/48,20.54%,EPS8L2;OVOL2;BAIAP2L1;LSR;MMP14;RARRES1;BTN3A1;RUNX2;SLC44A3;LAMA3;RHOD;ITGB4
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),0.3479304181174352,0.7065755856057194,0.7948717948717948,1.0,1.0,4/17,15.55%,STIL;PCM1;C2CD3;CEP192
prerank,GO_Biological_Process_2021__negative regulation of centriole replication (GO:0046600),0.4295145202713164,0.706260259624636,0.8222222222222222,1.0,1.0,2/6,10.83%,KAT2B;KAT2A
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),0.25141306364031696,0.7061994793354239,1.0,1.0,1.0,15/63,19.34%,NR1D1;SOCS6;TNFAIP3;VCP;RSPRY1;ATE1;FBXL17;ADAMTS12;CTSV;IDE;RHBDD1;MALT1;ZYG11B;VPS4B;MDM2
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),-0.2761261636091567,-0.7060340923024129,1.0,1.0,1.0,83/835,15.78%,ANXA1;CP;THBS1;SOCS3;C3;B3GALT2;DUSP1;CHGB;SERPINA10;TGFBR2;VRK2;MTMR7;LAMB1;ART3;ASB16;PHEX;PLK2;RAB11A;APP;CHST4;IGFBP5;CCL2;ISG15;MAP3K6;FUT2;PARP14;NOTUM;USP6;PSMB6;PSMB9;SBF1;FLG;TIMP1;PIM3;PARP9;GLRX;F5;NUAK2;ST3GAL6;FBXL18;MAK;FAM20A;FAM20C;PP2D1;CHRM3;SERPIND1;PTK6;FBXW12;SPSB1;HERC5;FBXO32;SYK;PDK3;PRKCG;IGFBP7;OGFOD1;UBE2S;B3GNT5;FBXW10;ELOB;PDK1;B3GNT2;PPP3CC;NUAK1;ST6GALNAC2;ASB14;FN1;PSMC3;GAD1;MINK1;PIM1;BMX;PINK1;B3GALT4;SHISA5;B4GALT7;STRADB;PRSS23;BAP1;DUSP16;PTPN7;LIPE;CDK2
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell proliferation (GO:0046642),0.43541996162350466,0.7058948373597917,0.8157894736842105,1.0,1.0,1/5,4.56%,TWSG1
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),-0.45519404816802916,-0.7055188268635965,0.8571428571428571,1.0,1.0,2/5,25.00%,EXOSC7;EXOSC10
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),-0.45519404816802916,-0.7055188268635965,0.8571428571428571,1.0,1.0,2/5,25.00%,EXOSC7;EXOSC10
prerank,GO_Biological_Process_2021__tRNA surveillance (GO:0106354),-0.45519404816802916,-0.7055188268635965,0.8571428571428571,1.0,1.0,2/5,25.00%,EXOSC7;EXOSC10
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),-0.45519404816802916,-0.7055188268635965,0.8571428571428571,1.0,1.0,2/5,25.00%,EXOSC7;EXOSC10
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.2969879658014668,0.7053425545588795,0.92,1.0,1.0,4/21,14.51%,NR1D1;EFNA5;STXBP4;GPLD1
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),-0.29217616662044404,-0.7053418026980738,0.967391304347826,1.0,1.0,16/145,17.15%,SCN1B;STMN2;WNT5A;IL1RAPL1;MAG;PTK6;RIT2;PLPPR5;PAQR3;DAB2IP;BDNF;CRMP1;FES;DPYSL3;MFSD2A;CDK5
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),-0.4444526671362655,-0.7047279193115394,0.75,1.0,1.0,1/5,7.99%,PLSCR1
prerank,GO_Biological_Process_2021__male meiosis I (GO:0007141),0.35499162929294226,0.7046383817859667,0.8823529411764706,1.0,1.0,2/13,11.24%,FOXJ3;FOXJ2
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),-0.3483904194393785,-0.7043312895458701,0.8378378378378378,1.0,1.0,1/21,2.07%,P2RY12
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.36544811561331875,0.7043202732999172,0.896551724137931,1.0,1.0,4/16,21.53%,MITF;MED30;MED4;SUB1
prerank,GO_Biological_Process_2021__dorsal aorta morphogenesis (GO:0035912),0.4669454264134999,0.7039370935104996,0.8,1.0,1.0,4/5,32.57%,HEY2;RBPJ;HEY1;BMPR1A
prerank,GO_Biological_Process_2021__dorsal aorta development (GO:0035907),0.4669454264134999,0.7039370935104996,0.8,1.0,1.0,4/5,32.57%,HEY2;RBPJ;HEY1;BMPR1A
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),-0.3439469941798435,-0.7036683979985053,0.9333333333333333,1.0,1.0,1/28,2.19%,POU4F1
prerank,GO_Biological_Process_2021__nucleoside triphosphate metabolic process (GO:0009141),-0.3904449366860534,-0.7032681009492744,0.9104477611940298,1.0,1.0,1/13,3.30%,CMPK2
prerank,GO_Biological_Process_2021__angiogenesis involved in wound healing (GO:0060055),0.41956890523932544,0.7030735190582278,0.8571428571428571,1.0,1.0,1/6,3.58%,NDNF
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),-0.3011693871289554,-0.7022566729317624,0.9620253164556962,1.0,1.0,16/86,24.29%,KCNB1;IL12A;ITPR3;GIPR;RHBDF2;GLP1R;CACNA1C;RHBDF1;IGF1;ACHE;TGFB1;RSAD2;MYO18A;KCNC2;ALOX5;TMED10
prerank,GO_Biological_Process_2021__cellular response to pH (GO:0071467),-0.3962168531002825,-0.7021479909826274,0.835820895522388,1.0,1.0,5/13,29.65%,RAB11FIP5;HYAL1;HVCN1;SLC9A1;GPR68
prerank,GO_Biological_Process_2021__positive regulation of DNA ligation (GO:0051106),0.4319095659069271,0.7019435172739735,0.8461538461538461,1.0,1.0,2/5,20.76%,HMGB1;APLF
prerank,GO_Biological_Process_2021__regulation of meiotic nuclear division (GO:0040020),-0.4489164493044463,-0.7018986415741829,0.8813559322033898,1.0,1.0,1/6,10.35%,WEE2
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),-0.2886993923379172,-0.7017551576110396,0.9629629629629629,1.0,1.0,20/93,19.43%,SLC8A3;APP;LRRC4;SYN3;SYT1;CPLX1;RIMS2;GRIK1;CPLX2;GRM6;DLGAP3;NPTX2;BDNF;GRID2;NLGN1;CDK5;GRM7;GRIK2;RELN;KCNMB4
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.38588516172563203,-0.7015339077595948,0.855072463768116,1.0,1.0,4/19,19.49%,LTBP4;EID2;ITGA3;TGFB1
prerank,GO_Biological_Process_2021__hormone transport (GO:0009914),0.4113122686962497,0.7014628550508957,0.7804878048780488,1.0,1.0,1/6,12.37%,SLCO1C1
prerank,GO_Biological_Process_2021__thyroid hormone transport (GO:0070327),0.4113122686962497,0.7014628550508957,0.7804878048780488,1.0,1.0,1/6,12.37%,SLCO1C1
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.27422419669681986,-0.7013854604855112,1.0,1.0,1.0,22/429,10.28%,LEF1;PRAME;TYMS;SIX3;CDKN2A;MAEL;CIITA;SUV39H1;MSX2;IRF1;PROX1;CIC;IGFBP5;NKX6-2;WNT5A;HEXIM1;DBI;BRCA1;RPL13A;KLF4;PATL2;BASP1
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),0.2924126903165516,0.7013681814863597,1.0,1.0,1.0,11/65,13.20%,PSMD10;PSMA1;PSMD11;COPS8;CUL1;PSMB5;AKT1;BTRC;PSMD14;TIRAP;PSMD12
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),-0.2716988888407351,-0.7012955640118372,0.99,1.0,1.0,11/362,4.67%,LEF1;PRAME;SIX3;CDKN2A;MAEL;CIITA;SUV39H1;MSX2;IRF1;PROX1;CIC
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),-0.2745839058375071,-0.7012783577351221,1.0,1.0,1.0,41/531,14.22%,KLF2;SP100;SKOR1;EFNA1;FOSB;NR4A3;POU4F1;CIITA;SUV39H1;ZFP36;HIC1;RPS27A;NR1I3;MSX2;RPS14;PROX1;MLIP;ATF3;ZNF750;LDB2;ZFP69;HEXIM1;PARP9;ZNF536;GADD45A;KLF4;PLK3;STAT1;GATA1;MAFK;ZFPM1;SRF;IRF7;PRDM1;GFI1B;FBP1;CCND1;UBC;RPL10;SOX15;DAB2IP
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),-0.38274274233266375,-0.7011158806547858,0.8805970149253731,1.0,1.0,4/14,23.74%,ADCY7;ADCY5;ADCY8;ADCY3
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),-0.36227162308372735,-0.7008424563937655,0.8769230769230769,1.0,1.0,5/21,18.77%,CYP1B1;ADH4;CYP3A4;IGF1;ALDH3A2
prerank,GO_Biological_Process_2021__cellular response to prostaglandin E stimulus (GO:0071380),-0.47436101724953306,-0.7008380052706363,0.8666666666666667,1.0,1.0,2/5,20.95%,GNG2;SFRP1
prerank,GO_Biological_Process_2021__regulation of aerobic respiration (GO:1903715),0.35076419460670183,0.7007738897551575,0.896551724137931,1.0,1.0,6/13,18.03%,CBFA2T3;ABCD1;VCP;IDE;AK4;COX7A2L
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),-0.3257918342364087,-0.7006742096792261,0.9024390243902439,1.0,1.0,11/49,23.70%,PRDX5;APOD;PLK3;FOS;ROMO1;TXNRD2;PTPRN;HYAL1;MAPT;PDGFRA;STK24
prerank,GO_Biological_Process_2021__negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924),-0.45474501503378817,-0.7005875608502404,0.8524590163934426,1.0,1.0,3/7,25.89%,CD55;SUSD4;CR1L
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),0.3754991422539888,0.7005630655116857,0.7714285714285715,1.0,1.0,3/12,19.50%,THAP1;ERN1;PRKX
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.3653966458629922,-0.7004148614365259,0.8857142857142857,1.0,1.0,2/23,6.02%,RASGRP1;RASGEF1A
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),-0.4258323266805925,-0.7001096763633391,0.859375,1.0,1.0,1/8,4.81%,SLC39A14
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),-0.4175018666509972,-0.7001051660641525,0.8461538461538461,1.0,1.0,5/11,22.55%,APOD;CEACAM1;CCDC3;GPER1;ALK
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),0.29245337505457203,0.7000160565170511,0.9523809523809523,1.0,1.0,12/36,24.20%,RNF2;PHC1;EED;YAF2;RBBP4;MGA;PHC3;EHMT1;EPC1;PCGF2;E2F6;FOXO4
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),-0.2690627829858659,-0.7000049389005553,1.0,1.0,1.0,51/335,21.58%,C3;TLR2;TIMP2;B2M;ATP8B4;CD44;ADGRE5;IMPDH1;BST2;CTSC;PRDX4;PLD1;HLA-C;TMC6;ARHGAP9;CEACAM1;CHI3L1;MMP25;FRMPD3;CLEC12A;HLA-B;CTSS;CD55;IRAG2;PSMC3;MVP;RHOF;PYGL;GPI;CD63;CTSZ;HRNR;TMBIM1;PRKCD;ANXA2;SLC11A1;FLG2;CAPN1;PTPRC;SLC15A4;PGRMC1;PTAFR;FTH1;CLEC5A;ENPP4;HEBP2;AGPAT2;PFKL;COTL1;PTGES2;PGAM1
prerank,GO_Biological_Process_2021__positive regulation of regulatory T cell differentiation (GO:0045591),-0.4320356627824894,-0.6998182439238588,0.8448275862068966,1.0,1.0,3/8,22.98%,HLA-DRA;BCL6;HLA-DRB1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),-0.44928163095772794,-0.6991455811715169,0.8214285714285714,1.0,1.0,3/7,25.71%,ATP1B1;ATP1B3;WNK4
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.3703867243216378,-0.6991071345021793,0.8571428571428571,1.0,1.0,2/21,3.55%,HIC1;CD44
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.3360292210049776,0.6990909969885428,0.9545454545454546,1.0,1.0,4/20,16.43%,ELOVL6;ELOVL2;HACD2;ACSL3
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),-0.37134955579577567,-0.6990129130073264,0.8461538461538461,1.0,1.0,2/17,11.55%,LAMB1;MYH11
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),-0.3045125844369218,-0.6988705295787692,0.9759036144578314,1.0,1.0,18/100,21.20%,CDKN2A;PSRC1;TP53TG5;BST2;MAG;TSPYL2;BTG1;CRLF3;SFRP2;FBP1;SLIT3;TCHP;CDKN1A;PML;TGFB1;HYAL1;SFRP1;CDKN2D
prerank,GO_Biological_Process_2021__histone H3-K4 dimethylation (GO:0044648),0.44480129968357907,0.6987574298856444,0.8541666666666666,1.0,1.0,2/6,22.67%,KMT2A;SETD4
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),-0.26855561569030095,-0.6984660500720788,1.0,1.0,1.0,51/338,21.58%,C3;TLR2;TIMP2;B2M;ATP8B4;CD44;ADGRE5;IMPDH1;BST2;CTSC;PRDX4;PLD1;HLA-C;TMC6;ARHGAP9;CEACAM1;CHI3L1;MMP25;FRMPD3;CLEC12A;HLA-B;CTSS;CD55;IRAG2;PSMC3;MVP;RHOF;PYGL;GPI;CD63;CTSZ;HRNR;TMBIM1;PRKCD;ANXA2;SLC11A1;FLG2;CAPN1;PTPRC;SLC15A4;PGRMC1;PTAFR;FTH1;CLEC5A;ENPP4;HEBP2;AGPAT2;PFKL;COTL1;PTGES2;PGAM1
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),-0.39788131450164055,-0.6983449767610777,0.927536231884058,1.0,1.0,3/12,27.55%,WAS;FHOD1;SLC9A1
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),0.31503248864652245,0.6983306708304478,0.9375,1.0,1.0,1/22,3.89%,TRAK2
prerank,GO_Biological_Process_2021__pinocytosis (GO:0006907),0.40702600559588237,0.6982003387525186,0.8285714285714286,1.0,1.0,3/8,33.38%,SNX5;CARMIL1;MAPKAPK2
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),-0.3510863964329482,-0.6981044321952942,0.918918918918919,1.0,1.0,6/24,23.78%,PDE6B;RBM4B;MTA1;PML;FBXL22;BHLHE40
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),0.40371745752739296,0.6980765168194211,0.9117647058823529,1.0,1.0,2/8,13.07%,AKT1;PIK3CA
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),0.3501097420692116,0.6980570907673896,0.875,1.0,1.0,3/12,25.05%,ASAH2B;SPHK2;ACER3
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),0.3501097420692116,0.6980570907673896,0.875,1.0,1.0,3/12,25.05%,ASAH2B;SPHK2;ACER3
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),-0.3253360374130623,-0.6976837913975296,0.9873417721518988,1.0,1.0,6/62,18.10%,ANK3;SEPTIN5;ANLN;SEPTIN4;STMN1;ALKBH4
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),0.2840437774491988,0.6975230956398482,0.9565217391304348,1.0,1.0,12/35,21.73%,BMP2;TCAP;SOX9;NIPBL;FLRT2;HEYL;EPHB4;CHD7;HEY2;MDM4;PTK2;TGFBR1
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),0.32661364942954796,0.6974014665543666,0.8275862068965517,1.0,1.0,6/19,18.18%,MCU;MAIP1;LETM1;MICU2;PDZD8;MICU3
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),0.2979861037638992,0.6972951641778329,0.9411764705882353,1.0,1.0,10/30,24.90%,GTF2F2;ERCC2;ERCC3;POLR2C;GTF2H5;GTF2H2;RNGTT;GTF2H3;CMTR2;CCNH
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),0.2979861037638992,0.6972951641778329,0.9411764705882353,1.0,1.0,10/30,24.90%,GTF2F2;ERCC2;ERCC3;POLR2C;GTF2H5;GTF2H2;RNGTT;GTF2H3;CMTR2;CCNH
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.2920572860257279,-0.6972499940181272,0.9887640449438202,1.0,1.0,10/98,14.67%,TGFBR2;RPS27A;SCX;BMP8A;FOS;EID2;ZYX;ARHGEF18;UBC;RUNX2
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),0.3920558951179157,0.6972322966611527,0.8974358974358975,1.0,1.0,2/9,22.09%,ZNF703;SMAD7
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),-0.34217271329648946,-0.6968579058511174,0.9428571428571428,1.0,1.0,4/30,15.66%,CAV3;EGF;RAB11FIP5;BDNF
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),-0.32945960845415967,-0.6967464950295549,0.8947368421052632,1.0,1.0,3/31,11.45%,ISG15;WNT5A;NELL1
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),-0.3288646487888333,-0.6966956514425654,0.8809523809523809,1.0,1.0,8/36,28.66%,PARP9;WAS;FOXM1;WRAP53;DDX11;DTX3L;SHLD1;RAD51AP1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),0.34773201910181717,0.6966091482030354,0.8275862068965517,1.0,1.0,1/18,2.24%,PPARGC1A
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),0.30857114938674635,0.6966079726677504,0.96,1.0,1.0,2/25,5.10%,TNFSF13B;CD320
prerank,GO_Biological_Process_2021__response to prostaglandin E (GO:0034695),-0.4483129504309672,-0.6965207638961967,0.8769230769230769,1.0,1.0,2/6,20.95%,GNG2;SFRP1
prerank,GO_Biological_Process_2021__icosanoid biosynthetic process (GO:0046456),0.36594312097987697,0.6963708454739941,0.8421052631578947,1.0,1.0,4/9,30.12%,LTA4H;CYP2C8;MGST2;LTC4S
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),-0.3608043233895343,-0.6963308788303572,0.8428571428571429,1.0,1.0,2/21,5.69%,SULT1C3;TPST1
prerank,GO_Biological_Process_2021__protein polyufmylation (GO:1990564),-0.45737680391549573,-0.6961280568694961,0.8507462686567164,1.0,1.0,1/5,16.19%,DDRGK1
prerank,GO_Biological_Process_2021__protein K69-linked ufmylation (GO:1990592),-0.45737680391549573,-0.6961280568694961,0.8507462686567164,1.0,1.0,1/5,16.19%,DDRGK1
prerank,GO_Biological_Process_2021__protein ufmylation (GO:0071569),-0.45737680391549573,-0.6961280568694961,0.8507462686567164,1.0,1.0,1/5,16.19%,DDRGK1
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.3585783352678935,0.6961259254622867,0.9411764705882353,1.0,1.0,4/15,12.93%,CSPG5;CSGALNACT1;BCAN;DSE
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.3439394781085175,-0.6961154649254367,0.9041095890410958,1.0,1.0,1/32,2.19%,POU4F1
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),-0.4041056589639036,-0.6959561158111441,0.8382352941176471,1.0,1.0,2/10,9.65%,SH3GL2;CEACAM1
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),-0.3051918355036519,-0.6958124971955783,0.9102564102564102,1.0,1.0,10/64,15.51%,B3GALT2;GCNT1;FUT2;ST3GAL6;B3GNT5;B3GNT2;ST6GALNAC2;B3GALT4;B4GALT7;IGF1
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,-0.30068291831262955,-0.695069859433375,0.9767441860465116,1.0,1.0,10/96,9.38%,FABP3;NEXN;ART3;COX7A1;CTNNA3;PLN;VLDLR;CAV3;RASL12;SYNPO2L
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.3726319460803238,-0.6949722484199667,0.8813559322033898,1.0,1.0,1/18,4.20%,IMPDH1
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),-0.3188156779848333,-0.6949721933739819,0.9,1.0,1.0,5/35,15.34%,RPS14;GATA1;ZFPM1;ATP5IF1;DMTN
prerank,GO_Biological_Process_2021__negative regulation of heart rate (GO:0010459),0.4075822223244553,0.6948745967631766,0.7333333333333333,1.0,1.0,1/5,2.82%,SRI
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),-0.37972194387526603,-0.6942724040807878,0.9014084507042254,1.0,1.0,2/15,6.26%,CD44;CEMIP
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),0.25767063761111775,0.6940427290838572,1.0,1.0,1.0,15/106,13.21%,RGCC;LIMD1;PSMD10;NDNF;PSMA1;ELOC;PSMD11;PSMB5;PTGIS;HP1BP3;EGLN3;PSMD14;BAD;PSMD12;CUL2
prerank,GO_Biological_Process_2021__regulation of macrophage migration (GO:1905521),-0.4148929181864754,-0.6934997829099201,0.8615384615384616,1.0,1.0,1/9,2.07%,P2RY12
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),0.2819209202841852,0.6934906683161285,0.96,1.0,1.0,5/34,15.20%,PIK3R4;SESN2;EIF2AK3;PIK3C3;SESN3
prerank,GO_Biological_Process_2021__cell fate commitment involved in formation of primary germ layer (GO:0060795),-0.4507169611922811,-0.6934057034838236,0.9090909090909091,1.0,1.0,3/5,37.77%,PAF1;CTR9;RTF1
prerank,GO_Biological_Process_2021__endodermal cell fate commitment (GO:0001711),-0.4507169611922811,-0.6934057034838236,0.9090909090909091,1.0,1.0,3/5,37.77%,PAF1;CTR9;RTF1
prerank,GO_Biological_Process_2021__positive regulation of ligase activity (GO:0051351),0.4257084692025889,0.6926679009414344,0.8157894736842105,1.0,1.0,1/8,6.97%,MID1IP1
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),0.26574647641043786,0.6926567804367965,1.0,1.0,1.0,11/65,18.89%,HSPA1A;AR;HSF1;TFIP11;WASL;WASHC2C;PRKD1;EP300;CARMIL2;PON1;SACS
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell cytokine production (GO:0002732),-0.4009880019884916,-0.6925900861515084,0.803030303030303,1.0,1.0,1/6,13.03%,SCIMP
prerank,GO_Biological_Process_2021__oligodendrocyte differentiation (GO:0048709),0.3053468771371626,0.69226967025601,0.9230769230769231,1.0,1.0,2/18,5.40%,SOX8;SOX9
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.41032982422852093,-0.6921027825686699,0.8591549295774648,1.0,1.0,3/13,24.29%,HEXIM1;NELFE;SUPT5H
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),0.3526879756245883,0.691823355965168,0.9090909090909091,1.0,1.0,1/12,3.89%,TRAK2
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),0.2437364538805299,0.6917088781300054,1.0,1.0,1.0,4/86,5.95%,EPHA6;FLT3;DUSP19;EGFR
prerank,GO_Biological_Process_2021__negative regulation of leukocyte activation (GO:0002695),-0.4726842648838243,-0.6916366293761126,0.8461538461538461,1.0,1.0,2/6,20.91%,CD200;GPER1
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),0.3368412983732269,0.6915723386918937,0.8947368421052632,1.0,1.0,4/17,25.74%,RNF2;UBE2A;RNF168;CUL4B
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),-0.38176555315370564,-0.6907753236085644,0.8955223880597015,1.0,1.0,1/13,3.30%,CMPK2
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),0.3561901774402792,0.6907056140356456,0.8571428571428571,1.0,1.0,3/12,12.20%,EIF2S1;EIF2AK4;EIF2AK3
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),-0.33723430890655404,-0.6906216735836171,0.8947368421052632,1.0,1.0,1/27,2.26%,SUV39H1
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),-0.37253028969364466,-0.6905638952761314,0.875,1.0,1.0,5/17,20.74%,EGF;SFRP4;CD63;APLN;AHI1
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),0.40850988210859995,0.690233059589926,0.8484848484848485,1.0,1.0,1/7,4.21%,SERPINF2
prerank,GO_Biological_Process_2021__regulation of actin filament length (GO:0030832),-0.4263996173543327,-0.690037600758855,0.8305084745762712,1.0,1.0,1/6,9.59%,WAS
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte differentiation (GO:0002761),0.4001291528726657,0.6899100199269166,0.8717948717948718,1.0,1.0,1/7,4.77%,FOXP1
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),-0.4176108565004372,-0.6898030138719315,0.9130434782608695,1.0,1.0,2/10,16.22%,TSPYL2;GMNC
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),-0.42262962260028825,-0.6897947974696708,0.9107142857142857,1.0,1.0,1/5,18.79%,RPL23
prerank,GO_Biological_Process_2021__leucine metabolic process (GO:0006551),-0.41323844661345865,-0.6896393366681475,0.9038461538461539,1.0,1.0,3/7,34.46%,BCAT1;BCAT2;HMGCLL1
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.3939748686853197,-0.6894584620277969,0.8888888888888888,1.0,1.0,4/13,23.59%,DAB2IP;DDRGK1;COPS5;HSPA5
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256),0.44336199099687523,0.6894104445011509,0.8181818181818182,1.0,1.0,1/6,4.47%,GREM1
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),0.35563804120215337,0.6893877561648839,0.8787878787878788,1.0,1.0,1/8,7.39%,ZNF502
prerank,GO_Biological_Process_2021__C21-steroid hormone metabolic process (GO:0008207),0.38049587978818633,0.6893633558330257,0.8666666666666667,1.0,1.0,7/12,24.58%,STARD3NL;AKR1C3;CYP46A1;AKR1B1;CYP11A1;STARD3;FDX1
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),-0.3707832638719689,-0.6892177331586985,0.9090909090909091,1.0,1.0,3/17,18.85%,SGPP2;GCHFR;SPHK1
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),-0.36503738196574015,-0.689185170234706,0.9154929577464789,1.0,1.0,2/19,5.05%,STMN2;SH3GL2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),0.42378676814456356,0.6885469965731231,0.8181818181818182,1.0,1.0,4/5,42.63%,EPB41L2;EPB41;NUMA1;GNAI1
prerank,GO_Biological_Process_2021__regulation of nuclear cell cycle DNA replication (GO:0033262),-0.4218418090801467,-0.6883963629258838,0.8813559322033898,1.0,1.0,1/7,19.08%,CDC7
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),-0.29627780399602877,-0.6881968630597141,0.9651162790697675,1.0,1.0,21/105,21.26%,THBS1;MET;P2RY12;RAMP3;EGF;CHI3L1;THPO;FGF1;PINK1;TGFA;F10;IL18;VAV1;FGF7;FGF22;PIK3CB;TGFB1;PIK3CD;IRS2;LRP2;F3
prerank,MSigDB_Hallmark_2020__Myc Targets V1,0.2274611170007085,0.6881698091900144,1.0,1.0,1.0,42/185,23.33%,U2AF1;KPNA2;PSMA1;CCT7;EIF2S1;CUL1;SF3A1;AP3S1;TRIM28;HNRNPC;XPO1;CCT3;PSMD14;ERH;EIF4E;SNRPB2;G3BP1;DDX21;LSM7;KARS1;HDAC2;SYNCRIP;HNRNPU;PRDX3;EIF1AX;FAM120A;DHX15;CLNS1A;CNBP;SLC25A3;FBL;MRPL9;MCM6;ABCE1;BUB3;NOP56;CAD;RSL1D1;PSMD1;DUT;GOT2;HNRNPD
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),-0.39367060955582844,-0.6880648389905812,0.8181818181818182,1.0,1.0,2/12,18.85%,SGPP2;SPHK1
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),0.3406304323876943,0.6880203248892157,0.9090909090909091,1.0,1.0,1/20,2.56%,RAB33B
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),-0.3250333555766923,-0.6880188396803861,0.9259259259259259,1.0,1.0,4/41,14.17%,ZFP36;ADIRF;SFRP2;PIM1
prerank,GO_Biological_Process_2021__negative regulation of tubulin deacetylation (GO:1904428),-0.43069255176772936,-0.6878053519740751,0.8125,1.0,1.0,3/5,31.57%,MAPT;BEX4;TPPP
prerank,GO_Biological_Process_2021__cardiolipin acyl-chain remodeling (GO:0035965),0.40293596557833444,0.6877536621833854,0.775,1.0,1.0,6/6,59.72%,LCLAT1;PLA2G5;PLA2G6;PLA2G4A;HADHB;HADHA
prerank,GO_Biological_Process_2021__positive regulation of epidermis development (GO:0045684),-0.44249423658131304,-0.6877435853865355,0.8333333333333334,1.0,1.0,1/5,15.36%,SFRP4
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),-0.4246484707771686,-0.6872904873420518,0.8524590163934426,1.0,1.0,3/8,25.71%,ATP1B1;ATP1B3;WNK4
prerank,GO_Biological_Process_2021__purine nucleotide biosynthetic process (GO:0006164),-0.39115213169396995,-0.6870559284767124,0.8787878787878788,1.0,1.0,4/10,34.54%,ADA;MTHFD1;PRPS1;PRPS2
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),0.3166212790686638,0.6867700705131942,0.8947368421052632,1.0,1.0,1/39,0.31%,ACE2
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),-0.38591844646222473,-0.6866809922264607,0.873015873015873,1.0,1.0,1/12,8.62%,TIMP1
prerank,GO_Biological_Process_2021__regulation of protein lipidation (GO:1903059),-0.42820428326410526,-0.6865673545401005,0.8333333333333334,1.0,1.0,1/5,9.15%,DBI
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),0.34616137819014103,0.6863396272823493,0.8717948717948718,1.0,1.0,3/9,29.25%,SNX5;IRS1;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of NLRP3 inflammasome complex assembly (GO:1900227),-0.42305244621632293,-0.6862246886134803,0.875,1.0,1.0,1/6,7.99%,USP50
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,-0.3142781908401612,-0.6862235980322435,0.961038961038961,1.0,1.0,5/59,9.05%,LEF1;ZDHHC22;RND2;EFNB3;MYO3A
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),-0.40361058120939314,-0.6861728024841667,0.8382352941176471,1.0,1.0,2/11,9.65%,BRCA1;CEACAM1
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),0.2835507080742367,0.6855010275298862,0.8181818181818182,1.0,1.0,6/43,13.20%,PSMD10;PSMA1;PSMD11;PSMB5;PSMD14;PSMD12
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),-0.3088117363519701,-0.6852198085532318,0.9772727272727273,1.0,1.0,8/60,10.97%,SLC8A3;HTR2B;SLC24A2;GCM2;ATP1B1;SLC24A1;FAM20A;SLC24A5
prerank,GO_Biological_Process_2021__positive regulation of protein sumoylation (GO:0033235),0.39561323521691594,0.6851676804483259,0.7894736842105263,1.0,1.0,2/9,18.06%,MUL1;PIAS4
prerank,GO_Biological_Process_2021__endosome to pigment granule transport (GO:0043485),-0.4707265339748775,-0.684393466734044,0.8947368421052632,1.0,1.0,1/5,16.71%,CD63
prerank,GO_Biological_Process_2021__endosome to melanosome transport (GO:0035646),-0.4707265339748775,-0.684393466734044,0.8947368421052632,1.0,1.0,1/5,16.71%,CD63
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),-0.2960420655429623,-0.6839731618415097,1.0,1.0,1.0,12/107,16.57%,SCN1B;STMN2;SLITRK1;WNT5A;IL1RAPL1;PTK6;RIT2;PLPPR5;DAB2IP;BDNF;FES;DPYSL3
prerank,GO_Biological_Process_2021__medium-chain fatty acid biosynthetic process (GO:0051792),-0.44865661614825175,-0.6837909017153234,0.8405797101449275,1.0,1.0,2/6,17.96%,OLAH;OXSM
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),-0.30972583442625384,-0.6833832879344908,0.9342105263157895,1.0,1.0,3/53,8.02%,DHCR24;ABCA5;ANGPTL3
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),0.37325547646230517,0.6830635850006397,0.9302325581395349,1.0,1.0,3/7,23.08%,HEY2;ZFPM2;JAG1
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),-0.4331696039370693,-0.682328514926606,0.8695652173913043,1.0,1.0,1/8,15.36%,SFRP4
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),0.3800695682137522,0.6821483263534897,0.8387096774193549,1.0,1.0,1/11,2.97%,ADRA1A
prerank,GO_Biological_Process_2021__white fat cell differentiation (GO:0050872),-0.4388298744305894,-0.682078299994252,0.859375,1.0,1.0,3/5,32.08%,CTBP2;PPARG;PER2
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),-0.332413983588395,-0.6820336977192129,0.8923076923076924,1.0,1.0,3/29,8.67%,KREMEN2;NOTUM;WNT5A
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,-0.3122824008854961,-0.6820194189306034,0.9583333333333334,1.0,1.0,6/59,8.80%,HPN;ALDOB;GC;BHMT;GLYAT;ALPL
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),-0.30527330473701975,-0.6816285214033612,0.9629629629629629,1.0,1.0,9/57,17.82%,APLNR;PROX1;HTR2B;WNT5A;EGF;VIP;NR4A1;EGFL7;APLN
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),0.3773946347229231,0.6812826885284669,0.8529411764705882,1.0,1.0,3/9,30.06%,CEBPG;ARL8B;VAMP7
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),0.22817328542632173,0.6810471909533804,1.0,1.0,1.0,25/120,20.50%,PTPN4;PPEF1;DUSP6;PPP1R15B;BTRC;PPM1A;NCK1;PTPRG;PTPRK;PPM1E;PPP2R5A;SSH1;PPP1CC;DUSP12;DUSP18;EYA2;ILKAP;EYA1;PPP4R1;PTPN13;PPM1L;RPRD1B;PTPN14;FAM220A;PTPRZ1
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.39149823722086907,-0.6808533695557611,0.8571428571428571,1.0,1.0,1/10,3.55%,CD44
prerank,GO_Biological_Process_2021__positive regulation of tau-protein kinase activity (GO:1902949),0.4023587770803809,0.6806569453806541,0.85,1.0,1.0,5/5,59.77%,EGR1;NAB2;HSP90AB1;HSP90AA1;CLU
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),0.29407683806397505,0.6805995184589123,0.9655172413793104,1.0,1.0,2/23,4.49%,CACNG2;NLGN3
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),0.3907575156264446,0.6804575740305759,0.90625,1.0,1.0,4/7,32.48%,DISP3;NR1H3;NR1H2;PRKN
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),-0.31820096617025856,-0.6798502295743697,0.9342105263157895,1.0,1.0,5/32,12.51%,APP;USP50;WNT5A;NLRP12;NLRP2
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.36165495292297983,-0.679757304358235,0.8769230769230769,1.0,1.0,3/17,13.20%,RAB11A;CCNB1;CCND1
prerank,GO_Biological_Process_2021__purine nucleotide catabolic process (GO:0006195),0.3452829052860552,0.6791920230387012,0.8918918918918919,1.0,1.0,2/11,15.70%,NT5C1A;NUDT15
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),-0.34860838842894865,-0.679177600340939,0.8513513513513513,1.0,1.0,4/33,12.10%,SLC38A4;SLC25A21;ABCB1;SLC38A1
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine morphogenesis (GO:0061003),0.379978745694286,0.6789025736776401,0.9032258064516129,1.0,1.0,2/9,15.67%,CAPRIN2;CAPRIN1
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),-0.31936232729529773,-0.6787098417503735,0.9036144578313253,1.0,1.0,7/38,21.19%,RPS27A;NOD1;UBC;MINK1;RIPK2;SH2D3C;SH2D3A
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),0.28396497146829924,0.678117747308261,0.9565217391304348,1.0,1.0,8/32,15.71%,KAT2B;TESK1;SEC22B;KAT2A;NBDY;CEP97;SCFD1;STYXL1
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),-0.2916500432457649,-0.6780895792952875,0.9761904761904762,1.0,1.0,10/77,19.01%,PSRC1;KIF14;RAB11A;CENPE;CCNB1;NCAPD3;KIF2C;REC8;SET;ANKRD53
prerank,GO_Biological_Process_2021__regulation of mesenchymal stem cell differentiation (GO:2000739),-0.4229520166542333,-0.6777616240271443,0.8983050847457628,1.0,1.0,1/7,5.69%,SLC4A11
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),-0.30174706295129805,-0.6775150485653565,0.9529411764705882,1.0,1.0,8/56,16.07%,RASGRP1;APP;GADD45A;GADD45B;MINK1;DAB2IP;ANKRD6;LTBR
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),-0.26413711634687653,-0.6775084934719114,1.0,1.0,1.0,70/669,17.04%,LEF1;KLF2;NR4A3;MET;LMO2;PGR;TLR2;FOSL2;POU4F1;CIITA;BARX2;PLAG1;RPS27A;NR1I3;IRF1;PROX1;SKAP1;MLIP;ST18;BEX1;MAFF;ATF3;APP;NLRC5;ZNF750;SCX;HELZ2;CASZ1;RPS6KA1;PLSCR1;LDB2;WNT5A;BRCA1;TLR3;WAS;KLF4;STAT1;LAGE3;POU2F3;GATA1;FOS;ZFPM1;SRF;IRF7;PAX8;ADIRF;CSRNP1;TNIP2;CRLF3;SFRP2;UBC;JUNB;PSMC3;NAMPT;SOX15;DAB2IP;FGF1;RUNX2;SBNO2;FOXM1;GLI1;IGF1;IL18;DDRGK1;FADD;NR4A1;MAX;PPARGC1B;MACC1;NOS1
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,0.23685022792619181,0.6774711095901796,1.0,1.0,1.0,23/150,14.05%,ABCD2;PDK4;ALAS1;AOX1;TYR;NDRG2;CA2;HES6;FBLN1;CSAD;DCXR;AKR1C3;ABCC2;ASL;ETFDH;GSTT2;KYNU;ADH5;ETS2;ECH1;CAT;ACOX1;KARS1
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),-0.384634015520611,-0.6771011394559169,0.9342105263157895,1.0,1.0,4/12,20.30%,KCNQ1;SCN3B;APLN;RYR2
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),-0.4210141824641439,-0.6768236754982979,0.859375,1.0,1.0,4/7,30.69%,PIK3CD;MYO1C;PRKD2;HSPB1
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.2877012431879799,0.6767577303778827,0.9523809523809523,1.0,1.0,8/41,12.62%,SPRED1;DUSP6;SPRY1;FBLN1;LMO3;C3ORF33;SPRED2;SIRPA
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),0.3733311385448279,0.6767158956855598,0.8484848484848485,1.0,1.0,1/9,10.43%,ATF6
prerank,GO_Biological_Process_2021__B cell mediated immunity (GO:0019724),0.4350183843451763,0.6764697455261925,0.7619047619047619,1.0,1.0,1/5,9.17%,MSH2
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),-0.3114047834387372,-0.6762335726000908,0.961038961038961,1.0,1.0,13/54,31.19%,RPS27A;UBC;DDRGK1;LGALS8;DYNC1LI2;RETREG1;HDAC6;SQSTM1;PARK7;ATG14;ULK1;ULK2;CFTR
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.2898749438120276,0.6762301736625158,0.9,1.0,1.0,7/29,11.37%,DCHS1;CRB1;FAT4;TENM1;ALCAM;TENM2;TENM3
prerank,GO_Biological_Process_2021__negative regulation of lipid localization (GO:1905953),0.45040373561602054,0.6760266864191717,0.9761904761904762,1.0,1.0,3/5,32.03%,PTPN2;NR1H3;NR1H2
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),-0.3739241139333748,-0.6759734586033255,0.8888888888888888,1.0,1.0,1/12,3.97%,PROX1
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),-0.3389356393353002,-0.6756845290284325,0.9342105263157895,1.0,1.0,6/25,23.78%,PDE6B;RBM4B;MTA1;PML;FBXL22;BHLHE40
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),-0.29642078237252256,-0.6756002001288006,0.9767441860465116,1.0,1.0,9/73,11.84%,SLC39A14;SLC8A3;HTR2B;SLC24A2;GCM2;ATP1B1;SLC24A1;SLC24A5;MT1H
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),-0.3017171824567691,-0.6754286972723917,1.0,1.0,1.0,7/67,15.38%,PHEX;USP6;ST3GAL6;CHRM3;UBE2S;B4GALT7;BAP1
prerank,GO_Biological_Process_2021__mitochondrial respirasome assembly (GO:0097250),-0.43157819606745074,-0.6753115851774407,0.8387096774193549,1.0,1.0,3/6,21.69%,COX7A1;COX7A2;HIGD1B
prerank,GO_Biological_Process_2021__negative regulation of T cell differentiation (GO:0045581),-0.4212285709668696,-0.6752184633684808,0.85,1.0,1.0,1/6,3.95%,IRF1
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),-0.3810735914213551,-0.6750439248596858,0.8405797101449275,1.0,1.0,1/13,5.81%,RAB11A
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),-0.3810735914213551,-0.6750439248596858,0.8405797101449275,1.0,1.0,1/13,5.81%,RAB11A
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.29890596756886134,0.6746370624061376,0.9743589743589743,1.0,1.0,7/17,33.15%,CYTH3;GOLPH3;EZR;FERMT1;CYTH1;CLASP1;CDC42
prerank,GO_Biological_Process_2021__peptidyl-glutamine methylation (GO:0018364),0.3934583859247946,0.6740152416033914,0.8372093023255814,1.0,1.0,2/5,21.87%,FBL;FBLL1
prerank,GO_Biological_Process_2021__catecholamine metabolic process (GO:0006584),0.3509723101281434,0.6738248017073339,0.8787878787878788,1.0,1.0,6/9,32.48%,DRD2;SNCAIP;PNMT;RNF180;DRD4;PRKN
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),0.26796970703350415,0.6737199876547421,0.92,1.0,1.0,4/33,11.61%,PGAP1;TENM1;CEP290;PCM1
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),0.34330479050338697,0.6733141435493889,0.9722222222222222,1.0,1.0,3/10,19.54%,PYGM;UGP2;PPP1R3C
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),-0.32946835024313265,-0.6731950518300878,0.9420289855072463,1.0,1.0,5/22,19.63%,PRKCQ;PRKCD;TSC2;TNS2;PRKCB
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),-0.40314996557739735,-0.6726625552815891,0.9545454545454546,1.0,1.0,3/12,14.53%,HK2;ISG15;PINK1
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),0.2880027059697189,0.6721590440056315,1.0,1.0,1.0,5/25,19.28%,KCNE1;KCNIP3;WNK3;SNTA1;DPP6
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),-0.2949639583131913,-0.6720738056248137,0.9411764705882353,1.0,1.0,6/57,13.20%,PSRC1;PROX1;APP;CCNB1;PTK6;CCND1
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),0.24962130080629488,0.671457513071438,1.0,1.0,1.0,11/35,25.08%,GATC;VARS1;QRSL1;KARS1;YARS2;FARSB;LARS2;FARS2;EPRS1;YARS1;IARS1
prerank,GO_Biological_Process_2021__fatty acid homeostasis (GO:0055089),0.3625160063957444,0.6708553860448317,0.8837209302325582,1.0,1.0,1/8,7.04%,ABCD1
prerank,GO_Biological_Process_2021__regulation of metaphase/anaphase transition of cell cycle (GO:1902099),0.3992538585593155,0.6699352705633594,0.8205128205128205,1.0,1.0,2/6,5.69%,PLK1;RIOK2
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),-0.3299873197833603,-0.6699060607095166,0.9493670886075949,1.0,1.0,6/27,21.22%,ATP8B4;PLSCR1;ABCB1;MFSD2A;ATP8B1;ABCC1
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),0.25977007984374667,0.6698215644870608,1.0,1.0,1.0,6/55,11.61%,TENM1;APBB3;ATP2C1;MYOM1;CEP290;PCM1
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),-0.3298144166421799,-0.6697972541466305,0.9367088607594937,1.0,1.0,3/33,9.65%,PROX1;BRCA1;CEACAM1
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),-0.3067297995027165,-0.6695991238945218,0.975609756097561,1.0,1.0,1/64,0.43%,THBS1
prerank,GO_Biological_Process_2021__succinyl-CoA metabolic process (GO:0006104),-0.44540590506441724,-0.6687942639610283,0.8166666666666667,1.0,1.0,1/5,10.37%,ACOT4
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.3040274544477966,-0.6685797803847183,0.9506172839506173,1.0,1.0,10/58,17.56%,NR4A3;PLPP4;BAIAP2;WAS;PLD2;SYK;ELMO1;VAV1;ARPC3;PRKCD
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),0.3330015715930271,0.6685640341770854,0.8529411764705882,1.0,1.0,1/10,9.13%,GNB3
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),0.2896696494716347,0.6682091780290912,1.0,1.0,1.0,5/29,14.93%,MCU;GLUD1;BAD;GPLD1;SLC30A8
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.23637654516779588,0.6677526784364165,1.0,1.0,1.0,10/74,15.90%,KIF15;TMEM115;SEC22B;RAB1B;ERGIC3;DNAJC28;COPB2;SCFD1;ARCN1;SCYL1
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),0.29750659118779066,0.667504617068215,0.9375,1.0,1.0,11/24,28.17%,WDR33;CSTF3;PAPOLA;MTPAP;TENT4B;CPSF2;SSU72;PAPOLG;CLP1;SCAF8;TENT2
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),0.29750659118779066,0.667504617068215,0.9375,1.0,1.0,11/24,28.17%,WDR33;CSTF3;PAPOLA;MTPAP;TENT4B;CPSF2;SSU72;PAPOLG;CLP1;SCAF8;TENT2
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),0.31325898749044456,0.6674296961430412,1.0,1.0,1.0,3/19,7.38%,MCU;MAIP1;LETM1
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.4036469348332241,-0.6671950201486196,0.8873239436619719,1.0,1.0,2/12,21.49%,HEXIM1;NELFE
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),-0.35076084676490443,-0.6671583591359048,0.873015873015873,1.0,1.0,4/14,22.57%,CMPK2;ENTPD3;AK5;AK7
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),0.22457800711393755,0.6671043844871266,1.0,1.0,1.0,8/90,11.34%,ABCA1;BBS10;GNL3L;RALB;VCP;HSF1;TFIP11;TIRAP
prerank,GO_Biological_Process_2021__meiosis I (GO:0007127),-0.35526790003858477,-0.6666563810923238,0.8783783783783784,1.0,1.0,1/19,3.66%,MEIOB
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070432),0.39928984525339684,0.6657566620399631,0.9333333333333333,1.0,1.0,1/6,5.62%,HSPA1A
prerank,GO_Biological_Process_2021__carnitine metabolic process (GO:0009437),0.3496493567599601,0.6654948409720545,0.8461538461538461,1.0,1.0,3/11,16.21%,ACADM;CPT2;CPT1A
prerank,GO_Biological_Process_2021__attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.4024472767375198,-0.6652335707307571,0.8524590163934426,1.0,1.0,3/9,15.98%,CENPE;NUF2;KIF2C
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),-0.37342440349340905,-0.6647299275842788,0.8955223880597015,1.0,1.0,2/12,9.87%,CSPG4;BGN
prerank,GO_Biological_Process_2021__cellular response to platelet-derived growth factor stimulus (GO:0036120),0.42831103476919374,0.6647270805349594,0.8108108108108109,1.0,1.0,1/5,10.35%,MTSS2
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,-0.29275171862484684,-0.6645178924227672,0.9518072289156626,1.0,1.0,7/88,10.81%,C1QL1;TRAM1L1;EFNB3;MAP1B;B4GALNT1;SCARA3;PFN2
prerank,GO_Biological_Process_2021__N-acetylglucosamine metabolic process (GO:0006044),-0.3750812000326499,-0.6644417836297992,0.9090909090909091,1.0,1.0,3/15,21.30%,CHST4;CHST6;MGAT3
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),0.251143705966193,0.6641047581835345,0.9545454545454546,1.0,1.0,16/56,19.14%,GABRA4;GABRG1;GLRB;ANO5;XPR1;GABRB1;SLC5A6;SLC6A1;SLC26A2;GABRR2;SLC12A9;GABRR1;SLC20A1;SLC12A8;SLC37A1;SLC25A3
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),0.2982932543978933,0.6639255064276028,0.9393939393939394,1.0,1.0,6/24,20.85%,PGAP1;PIGP;GPLD1;PIGU;DPM1;PIGF
prerank,GO_Biological_Process_2021__neuron projection regeneration (GO:0031102),-0.40796358867516347,-0.6635349034082719,0.8709677419354839,1.0,1.0,1/8,9.11%,GAP43
prerank,GO_Biological_Process_2021__dendrite extension (GO:0097484),-0.43166035781435863,-0.6635223296745275,0.8909090909090909,1.0,1.0,1/5,5.05%,SH3GL2
prerank,GO_Biological_Process_2021__positive regulation of trophoblast cell migration (GO:1901165),0.3723614274867122,0.6633874830784612,0.8536585365853658,1.0,1.0,6/6,62.78%,AGO2;SYDE1;SMURF2;VEGFA;ACVR1B;C1QBP
prerank,GO_Biological_Process_2021__peptidyl-lysine deacetylation (GO:0034983),0.3901853265791971,0.6633067679048729,0.8378378378378378,1.0,1.0,4/8,29.25%,HDAC10;SIRT2;HDAC9;SIRT1
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),0.32577008755697456,0.6632820062318464,0.9642857142857143,1.0,1.0,1/18,1.60%,NCSTN
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),-0.3809598965101567,-0.6632275039122986,0.921875,1.0,1.0,1/13,3.91%,ALOX12
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),-0.38197892131995215,-0.6625004542659176,0.9264705882352942,1.0,1.0,1/12,5.81%,RAB11A
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),-0.38197892131995215,-0.6625004542659176,0.9264705882352942,1.0,1.0,1/12,5.81%,RAB11A
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),0.35550942404604235,0.6621569577347383,0.8181818181818182,1.0,1.0,2/9,21.60%,MBNL1;MYH3
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),-0.32248942564378175,-0.6618819848656325,0.8970588235294118,1.0,1.0,2/30,9.24%,APLNR;BRCA1
prerank,GO_Biological_Process_2021__ruffle assembly (GO:0097178),0.4175946547884188,0.661771508102504,0.8333333333333334,1.0,1.0,5/5,58.25%,AIF1L;RAC1;INPP5K;PIP5K1A;ARF6
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),-0.4042962130109238,-0.661731003954554,0.9154929577464789,1.0,1.0,1/10,12.24%,PRDM1
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),-0.3700254266150779,-0.6615769182483023,0.9027777777777778,1.0,1.0,2/11,11.49%,PROX1;ZFPM1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),0.29414737611920083,0.6615016824779884,0.9714285714285714,1.0,1.0,2/17,8.77%,RUNX1;ERBB4
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),0.27507260787467497,0.6612113860340183,0.9285714285714286,1.0,1.0,10/46,17.86%,FANCF;UBE2T;RFWD3;VCP;ATR;DCLRE1B;ATRIP;ERCC6L2;MCM9;DCLRE1C
prerank,GO_Biological_Process_2021__response to UV-A (GO:0070141),-0.4044560531552356,-0.6611943098967227,0.8656716417910447,1.0,1.0,2/7,13.20%,TIMP1;CCND1
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),-0.32085439660872894,-0.6611749444556446,0.9848484848484849,1.0,1.0,1/30,2.12%,MAEL
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.2972860131547629,-0.6607429132064907,0.9772727272727273,1.0,1.0,5/58,9.59%,FSCN1;PODXL;PLD1;GAP43;WAS
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),-0.2656372410044262,-0.6599212069397918,1.0,1.0,1.0,14/122,21.22%,CCNB2;CCNB1;ABCB1;PLK3;DCTN1;HAUS7;FOXM1;CEP76;CDK2;CDKN1A;WEE1;CEP135;FBXL22;CETN2
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),-0.2975733464001263,-0.6591341626201496,0.961038961038961,1.0,1.0,12/57,19.83%,POU4F1;KIF14;CCL2;MAG;UNC5B;PRKCG;PINK1;BDNF;SNX6;SET;NRBP2;FOXB1
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),0.28411869852955596,0.6587750124276197,1.0,1.0,1.0,4/27,13.04%,TENM1;CEP290;PCM1;UHMK1
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.2860132094483315,-0.6587547892285591,0.9880952380952381,1.0,1.0,6/79,14.76%,IRF1;NLRC5;ISG15;HERC5;IRF7;IFIH1
prerank,GO_Biological_Process_2021__activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.3875405065358998,-0.6584023075647075,0.8918918918918919,1.0,1.0,2/12,10.10%,TLR3;CHI3L1
prerank,GO_Biological_Process_2021__nuclear mRNA surveillance (GO:0071028),0.3497415055487452,0.6581510619048094,0.9393939393939394,1.0,1.0,5/10,27.63%,EXOSC6;PCID2;EXOSC8;EXOSC5;XRN1
prerank,GO_Biological_Process_2021__peptidyl-cysteine modification (GO:0018198),0.3863480443822513,0.6577391388091035,0.8936170212765957,1.0,1.0,3/6,21.10%,TMX3;PRDX3;CHCHD4
prerank,GO_Biological_Process_2021__photoreceptor cell differentiation (GO:0046530),-0.4031516903146477,-0.657418484822311,0.8985507246376812,1.0,1.0,3/6,27.26%,STAT3;NKD1;DCX
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),0.2715097777203815,0.6572903273292061,1.0,1.0,1.0,2/34,5.19%,EFNB2;EIF2S1
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),-0.31958810643456137,-0.6572796948217463,0.9466666666666667,1.0,1.0,1/42,0.93%,SKOR1
prerank,GO_Biological_Process_2021__regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449),-0.44107070311517615,-0.6569086869699564,0.9166666666666666,1.0,1.0,1/5,18.80%,PTPRC
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),0.270072423269451,0.6568903156624945,0.96,1.0,1.0,4/30,9.27%,CA2;SLC4A7;SLC26A3;SLC4A4
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),-0.36198632557688126,-0.6564779950946914,0.9315068493150684,1.0,1.0,2/13,28.57%,SLC15A4;SHLD1
prerank,GO_Biological_Process_2021__negative regulation of trophoblast cell migration (GO:1901164),-0.42181507026336595,-0.6560891892325299,0.8615384615384616,1.0,1.0,1/5,8.62%,TIMP1
prerank,GO_Biological_Process_2021__positive regulation of histone ubiquitination (GO:0033184),0.3598391483862903,0.6560412590243038,0.868421052631579,1.0,1.0,3/5,34.29%,RNF20;KDM1A;RNF40
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),-0.2647892245746783,-0.6559826615674127,1.0,1.0,1.0,14/121,21.22%,CCNB2;CCNB1;ABCB1;PLK3;DCTN1;HAUS7;FOXM1;CEP76;CDK2;CDKN1A;WEE1;CEP135;FBXL22;CETN2
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),-0.38256588514107515,-0.6558859197659359,0.9545454545454546,1.0,1.0,4/12,23.91%,USP50;PML;ETS1;WRAP53
prerank,GO_Biological_Process_2021__negative regulation by host of viral process (GO:0044793),0.40525829155956183,0.6556293473202276,0.8421052631578947,1.0,1.0,2/5,12.28%,EIF2AK4;VAPA
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),0.3274961535814152,0.6552466804294687,1.0,1.0,1.0,2/22,2.62%,ATP11C;ABCA1
prerank,GO_Biological_Process_2021__regulation of long-term synaptic depression (GO:1900452),-0.3944305188483921,-0.655148794669852,0.8787878787878788,1.0,1.0,4/7,22.14%,KCNB1;GRID2;ADCY8;MAPT
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",-0.25189424640462466,-0.6550132161069373,1.0,1.0,1.0,74/886,15.27%,LEF1;KLF2;SP100;BLM;NR4A3;MET;LMO2;PGR;TLR2;FOSL2;POU4F1;CIITA;BARX2;PLAG1;RPS27A;NR1I3;PSRC1;TESC;IRF1;PROX1;SKAP1;MLIP;ST18;BEX1;MAFF;TEAD2;ATF3;DNAJC2;APP;NLRC5;ZNF750;SCX;HELZ2;CASZ1;RPS6KA1;PLSCR1;ZIC1;LDB2;WNT5A;PARP9;EGF;BRCA1;TLR3;WAS;KLF4;YWHAH;STAT1;LAGE3;POU2F3;GATA1;FOS;ZFPM1;SRF;IRF7;PAX8;MLLT11;ADIRF;CSRNP1;TNIP2;CRLF3;SFRP2;CREB5;UBC;JUNB;PSMC3;NAMPT;SOX15;DAB2IP;FGF1;RUNX2;SBNO2;FOXM1;GLI1;TFAP4
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),0.38028134841546296,0.6549884713006797,0.8444444444444444,1.0,1.0,3/7,25.17%,RBPJ;CCM2;STARD13
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),-0.3575118959918965,-0.6546188264739351,0.9393939393939394,1.0,1.0,2/15,14.53%,SVBP;PINK1
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),0.38956893296319783,0.6545518503853092,0.8235294117647058,1.0,1.0,4/7,21.54%,PIK3C3;PIK3CA;PIK3C2A;PIK3C2G
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),-0.3580343164703714,-0.6542785024408333,0.918918918918919,1.0,1.0,5/14,19.90%,PVALEF;KCNB2;TNNT1;PLCE1;DAPK3
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),0.33541236070589087,0.6542432283522719,0.9722222222222222,1.0,1.0,4/11,22.15%,TESK1;CEP97;EVI5L;TBC1D7
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),-0.4086959805007221,-0.6533853610024939,0.90625,1.0,1.0,1/8,8.67%,WNT5A
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),-0.33553062371894166,-0.6533740666973417,0.9402985074626866,1.0,1.0,7/28,23.26%,GBP1;MMP14;CDK5;PDZK1;GPC3;GPC1;CLN3
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",-0.3793105394694095,-0.6533035247161857,0.9027777777777778,1.0,1.0,5/11,24.88%,SYN3;HAP1;NLGN1;CLN3;ZDHHC3
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),-0.3234303121275988,-0.6532223892442661,0.9761904761904762,1.0,1.0,4/37,18.41%,LDLR;PFDN6;PRKCG;PFDN1
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),-0.3382776659012933,-0.6529781647619672,0.8939393939393939,1.0,1.0,5/18,26.38%,PARP9;NAMPT;QPRT;NNMT;NMNAT3
prerank,GO_Biological_Process_2021__L-phenylalanine metabolic process (GO:0006558),0.3981331298954139,0.6529557132754408,0.8333333333333334,1.0,1.0,3/7,24.15%,QDPR;ASRGL1;FAH
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),-0.2552694119084515,-0.652715965937313,1.0,1.0,1.0,46/776,9.95%,LEF1;TRIM22;HPN;APLNR;SKOR1;PGR;TLR2;POU4F1;ANK3;PLAG1;HIC1;ZNF114;SPIN2A;TRIM61;NOS1AP;SFTPD;TRIM5;RAMP3;TESC;PROX1;PTP4A3;ELAVL2;SH3GL2;MYT1;TEAD2;OVOL2;APP;SCX;WARS1;CASZ1;PARP14;SRRM4;YBX3;NKX6-2;PLSCR1;LRRC19;WNT5A;PARP9;MOG;EGF;BRCA1;ATP1B1;ZNF536;TLR3;KLF4;RIMS2
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),0.29001572709235945,0.6526329637457066,0.9032258064516129,1.0,1.0,3/24,14.66%,TNFAIP3;MUL1;RNF26
prerank,GO_Biological_Process_2021__N-acetylneuraminate catabolic process (GO:0019262),0.3600043526453608,0.6525969847916958,0.8536585365853658,1.0,1.0,4/6,36.05%,GNPDA2;NAGK;RENBP;NPL
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),-0.28006349571900396,-0.6525939117039325,0.9886363636363636,1.0,1.0,4/81,10.19%,TYMS;IGFBP5;RPL13A;PATL2
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),0.3599331396644472,0.6524440294953876,0.8888888888888888,1.0,1.0,2/10,13.92%,RBBP4;ASF1A
prerank,GO_Biological_Process_2021__cellular amino acid biosynthetic process (GO:0008652),-0.3937680882915451,-0.6521743673497054,0.9137931034482759,1.0,1.0,4/6,20.94%,GAD1;GAD2;BCAT1;PAH
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),-0.3200636078208111,-0.6521724681953298,0.9420289855072463,1.0,1.0,5/23,19.63%,PRKCQ;PRKCD;TSC2;TNS2;PRKCB
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),-0.4087128012349356,-0.651439911560539,0.8307692307692308,1.0,1.0,1/7,8.67%,WNT5A
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),-0.4087128012349356,-0.651439911560539,0.8307692307692308,1.0,1.0,1/7,8.67%,WNT5A
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.358391375780991,-0.6514387661438157,0.9264705882352942,1.0,1.0,2/16,6.48%,CCDC39;SPAG17
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),0.30559888729537943,0.6512532201270607,0.9259259259259259,1.0,1.0,4/15,17.45%,SGIP1;PICALM;PIK3C2A;EPS15
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),0.2618699954349825,0.6512424335138546,0.9545454545454546,1.0,1.0,2/34,6.49%,BBS10;METTL18
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),-0.3400533463543914,-0.6511324333047119,0.9342105263157895,1.0,1.0,3/23,17.75%,THY1;NLGN1;AGRN
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),0.28216000270675445,0.6505887105058301,1.0,1.0,1.0,7/24,21.73%,BMP2;HES6;HEYL;HEY2;PCSK5;HES5;TGFBR1
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.4068039288459855,-0.6505232254592032,0.8870967741935484,1.0,1.0,1/7,7.59%,DUOXA1
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),-0.25567512373556966,-0.6504095578983784,1.0,1.0,1.0,20/285,14.33%,PRAME;TRIM22;RPS27A;TRIM5;ARIH2;PSMB6;PSMB9;ANAPC11;BRCA1;FBXL18;HERC6;FBXW12;SPSB1;HERC5;FBXO32;UBE2S;FBXW10;UBC;PSMC3;RNF213
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),-0.28449730361741504,-0.6501556232503114,0.9615384615384616,1.0,1.0,17/75,25.12%,MET;VAC14;NLRC5;LDB2;TSPYL2;EMP2;CD4;CD74;PLCE1;IRS2;CDKN1C;MAPT;ALK;HLA-DRB1;PDGFRA;ZNF622;ZNF16
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.2630121114698698,0.6498217600829759,1.0,1.0,1.0,7/48,13.24%,GNL3L;TNFAIP3;HSPA1A;BAG2;AKT1;ADGRB1;PRMT3
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),0.371452166048356,0.6491804451250552,0.8888888888888888,1.0,1.0,2/7,23.26%,LIN7C;BMP7
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex disassembly (GO:0043242),-0.41205610659024233,-0.6490661942580848,0.9206349206349206,1.0,1.0,2/7,26.94%,PHF23;HDAC6
prerank,"GO_Biological_Process_2021__exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",0.37100145018387215,0.6489922683391842,0.8857142857142857,1.0,1.0,2/8,21.53%,ERI1;EXOSC8
prerank,GO_Biological_Process_2021__exonucleolytic trimming involved in rRNA processing (GO:0000459),0.37100145018387215,0.6489922683391842,0.8857142857142857,1.0,1.0,2/8,21.53%,ERI1;EXOSC8
prerank,GO_Biological_Process_2021__neurotransmitter biosynthetic process (GO:0042136),-0.39847514815569174,-0.6486007539408899,0.9285714285714286,1.0,1.0,3/8,20.94%,ACHE;NOS1;PAH
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),0.26064214559736504,0.6485127914232071,1.0,1.0,1.0,13/55,18.79%,ZDHHC16;ZDHHC14;PIGP;ZDHHC13;ZDHHC18;PIK3C3;ZDHHC21;ZDHHC20;GPLD1;ZDHHC5;GLUL;PIGU;DPM1
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.34922157943514903,-0.6485000314477278,0.9473684210526315,1.0,1.0,1/14,3.55%,CD44
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),-0.423618988868702,-0.6482878890504763,0.9402985074626866,1.0,1.0,2/7,20.95%,BTG1;SFRP1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),-0.2987587510746183,-0.6482656344467861,0.9746835443037974,1.0,1.0,10/35,25.84%,PODXL;CEACAM1;MINK1;SPINT2;TGFB1;FERMT3;PTPRR;RNASE10;ADA;NODAL
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),-0.30966778652308696,-0.6479430844872879,0.9605263157894737,1.0,1.0,10/37,22.08%,BTG3;PLK2;ZWILCH;WEE2;BTG1;WEE1;AURKAIP1;TGFB1;CDKN1C;BCL6
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),0.23066284265084927,0.6478025622634357,1.0,1.0,1.0,24/111,19.68%,PSMD10;PSMA1;PSMD11;HSPA1A;EXOSC1;PSMB5;PCBP4;AKT1;XPO1;EXOSC6;NUP214;PSMD14;DIS3;PSMD12;ZC3H14;RC3H1;FXR2;PCID2;YTHDF2;CSDC2;CNOT1;CNOT8;PUM2;RC3H2
prerank,GO_Biological_Process_2021__regulation of leukocyte tethering or rolling (GO:1903236),0.40547303120310324,0.6476635023985869,0.85,1.0,1.0,1/5,4.28%,FUT9
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),0.32323355578745383,0.6475862466005601,0.8974358974358975,1.0,1.0,6/15,25.79%,AJAP1;SERPINE2;CASK;SLC12A2;CLASP2;PTEN
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),-0.32498591362478246,-0.6474755100730784,0.9436619718309859,1.0,1.0,1/22,3.30%,CMPK2
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),-0.356478159636786,-0.6470244827119528,0.8970588235294118,1.0,1.0,2/13,9.87%,CSPG4;BGN
prerank,GO_Biological_Process_2021__negative regulation of protein import into nucleus (GO:0042308),-0.3928161820963936,-0.6469356190125435,0.9230769230769231,1.0,1.0,1/7,9.21%,APOD
prerank,GO_Biological_Process_2021__negative regulation of protein import (GO:1904590),-0.3928161820963936,-0.6469356190125435,0.9230769230769231,1.0,1.0,1/7,9.21%,APOD
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),-0.37055862131634026,-0.6466809308630702,0.8615384615384616,1.0,1.0,2/11,9.87%,CSPG4;BGN
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.2921682981097802,-0.6465527645063331,0.9459459459459459,1.0,1.0,8/38,19.36%,CCL2;SYT1;GRIK1;GRM6;NLGN1;CDK5;GRM7;RELN
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),-0.35484999219974234,-0.6458851318276259,0.9393939393939394,1.0,1.0,5/16,26.51%,APLN;OXTR;FOXB1;WNT3;TGFB3
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),-0.3315488380986171,-0.6456232698534065,0.926829268292683,1.0,1.0,6/25,22.26%,LZTS1;PINK1;TSC2;NRBP2;PHF23;NUPR1
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),-0.3691781577553528,-0.6454456216501454,0.9508196721311475,1.0,1.0,3/14,19.49%,RPS13;NUDT16;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),-0.43857495792819345,-0.6454187677473429,0.9393939393939394,1.0,1.0,2/6,20.95%,BTG1;SFRP1
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),0.3147577889741665,0.6454135359138656,0.9705882352941176,1.0,1.0,4/15,17.68%,KAT2A;EIF2AK4;CPEB3;CAMK4
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),0.2755802645005881,0.6452205216092918,1.0,1.0,1.0,1/28,1.39%,SLIT1
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.35085497327355203,-0.6448223984716374,0.9538461538461539,1.0,1.0,2/18,8.78%,CDKN2A;HEXIM1
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),-0.36364763737599093,-0.644313075145603,0.922077922077922,1.0,1.0,2/12,28.57%,TGFB1;SHLD1
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.26945131844614983,-0.6437505957795439,0.9767441860465116,1.0,1.0,12/89,18.16%,ST18;PSMB6;PSMB9;STAT1;TNFRSF14;MAP3K14;BIRC3;PSMC3;LTBR;PSMA8;TNFRSF1A;PSME1
prerank,GO_Biological_Process_2021__positive regulation of DNA-dependent DNA replication (GO:2000105),-0.38244418955640147,-0.6436335287293298,0.9344262295081968,1.0,1.0,2/9,24.89%,CDC7;STOML2
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),-0.3956744474806563,-0.6436296211572717,0.9433962264150944,1.0,1.0,2/8,14.22%,PIK3IP1;DAB2IP
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),-0.38307551595749606,-0.6434403955431549,0.85,1.0,1.0,2/9,19.84%,OAZ2;SLC29A4
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),0.2488070716895167,0.643205060088982,1.0,1.0,1.0,4/54,8.15%,PDK4;RALB;GAS2L1;AKR1C3
prerank,GO_Biological_Process_2021__negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),-0.355311543212786,-0.6431029829360709,0.9523809523809523,1.0,1.0,1/10,10.74%,APOBEC3H
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),-0.31423571344498064,-0.642907172905299,0.9642857142857143,1.0,1.0,1/31,1.53%,DUSP1
prerank,GO_Biological_Process_2021__negative regulation of RIG-I signaling pathway (GO:0039536),0.3723614274867122,0.6428740017424472,0.9117647058823529,1.0,1.0,6/6,62.78%,GPATCH3;UFD1;SEC14L1;NPLOC4;DHX58;C1QBP
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),-0.2898580003732439,-0.6427918591938964,0.987012987012987,1.0,1.0,7/46,23.26%,WNT8B;MAP1LC3A;GABARAPL1;RPL23;LIX1;GABARAPL2;CLN3
prerank,GO_Biological_Process_2021__deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087),0.3882429454433088,0.6421807190240398,0.7954545454545454,1.0,1.0,2/5,13.52%,DCP1B;EDC3
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.34846405022622845,-0.6421606372952431,0.8333333333333334,1.0,1.0,4/14,25.92%,CD55;IL18;HLA-DRB1;STAT3
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),-0.3651349647251142,-0.6416671555090755,0.8947368421052632,1.0,1.0,3/9,23.46%,FADD;TGFB1;CASP8
prerank,GO_Biological_Process_2021__drug catabolic process (GO:0042737),-0.3905680982804075,-0.6415549584885729,0.9230769230769231,1.0,1.0,5/10,28.25%,CYP3A4;NOS1;CYP3A5;CYP2D6;CYP2E1
prerank,GO_Biological_Process_2021__regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.3704035228041242,-0.6414186880558465,0.9117647058823529,1.0,1.0,4/9,26.74%,USP50;EIF2AK2;NLRC3;CD36
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),-0.25612594437808955,-0.6413665990493185,1.0,1.0,1.0,20/182,16.53%,LEF1;TGFBR2;ZFP36;PDPN;RPS6KA1;CEACAM1;BTG1;NELL1;SRF;PAX8;ADIRF;SFRP2;NEUROD2;PCP4;VWC2;RUNX2;IGF1;IL18;FES;PRKCH
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),-0.3586727550751819,-0.6413404434805069,0.8933333333333333,1.0,1.0,2/13,17.15%,NLGN1;CDK5
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),-0.3165805518036824,-0.6412721742323187,0.987012987012987,1.0,1.0,3/27,13.41%,RPS27A;TNIP2;UBC
prerank,GO_Biological_Process_2021__cognition (GO:0050890),0.27810483216835985,0.6408492789623899,0.896551724137931,1.0,1.0,7/37,16.02%,CHRNA4;RP9;DGCR2;NIPBL;TTC8;CHMP2B;CHD7
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),-0.2820436450750953,-0.6408338672804825,0.9746835443037974,1.0,1.0,11/57,25.23%,SKOR1;SULF1;VWC2;SFRP4;ITGA3;CRB2;LRP2;PCSK6;BMPER;TBX20;VWC2L
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),0.3743199741767564,0.6407336971766076,0.8974358974358975,1.0,1.0,2/7,8.68%,RCC2;SMC6
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.34727701260230803,-0.6404055006930477,0.9076923076923077,1.0,1.0,6/16,25.17%,IFI35;NLRP12;NMI;SPI1;HDAC7;NLRC3
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),-0.3577848706367767,-0.6403487748324378,0.9242424242424242,1.0,1.0,2/14,15.51%,SOX15;IGF1
prerank,GO_Biological_Process_2021__prostanoid biosynthetic process (GO:0046457),0.32271113364978854,0.6401283769130696,0.9090909090909091,1.0,1.0,1/8,9.06%,PTGIS
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),0.38796418406702504,0.6400747882191307,0.926829268292683,1.0,1.0,1/6,23.51%,ADARB1
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),-0.2787163954481293,-0.6395185256484809,0.9866666666666667,1.0,1.0,2/48,7.78%,CCK;MAP1B
prerank,GO_Biological_Process_2021__regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.3999860536098453,-0.6394059077808013,0.8793103448275862,1.0,1.0,1/8,7.69%,CCNB1
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.34470694538263386,-0.6384362976331894,0.9142857142857143,1.0,1.0,6/19,27.55%,IGF1;MYOZ2;AKAP6;EFHB;HOMER3;SLC9A1
prerank,GO_Biological_Process_2021__vacuole organization (GO:0007033),0.3633276793508552,0.6382115913744539,0.8947368421052632,1.0,1.0,1/6,17.14%,VPS11
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),-0.2828198984836835,-0.6378347527357401,0.9764705882352941,1.0,1.0,5/65,12.55%,A4GALT;ABCA8;FA2H;SGPP2;CYP4F22
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.34396786807402585,-0.6378296403487707,0.927536231884058,1.0,1.0,5/19,25.43%,YWHAH;PPP3CC;NMT1;CASP8;BBC3
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.34396786807402585,-0.6378296403487707,0.927536231884058,1.0,1.0,5/19,25.43%,YWHAH;PPP3CC;NMT1;CASP8;BBC3
prerank,GO_Biological_Process_2021__DNA deamination (GO:0045006),0.3530604475467974,0.6374316039009963,0.9411764705882353,1.0,1.0,2/7,10.91%,APOBEC3F;EXOSC6
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),-0.3101455546448668,-0.6370056611576417,0.987012987012987,1.0,1.0,7/39,18.00%,RPS27A;HROB;ISG15;RPA3;UBC;RPA1;POLD1
prerank,GO_Biological_Process_2021__cellular response to fatty acid (GO:0071398),-0.38048534431480535,-0.6364708524341003,0.9682539682539683,1.0,1.0,2/7,12.30%,AKR1C1;PDK3
prerank,GO_Biological_Process_2021__porphyrin-containing compound catabolic process (GO:0006787),-0.3791990359646683,-0.6354417200596344,0.8904109589041096,1.0,1.0,4/8,25.75%,BLVRB;ABCC1;ABCG2;HMOX1
prerank,GO_Biological_Process_2021__heme catabolic process (GO:0042167),-0.3791990359646683,-0.6354417200596344,0.8904109589041096,1.0,1.0,4/8,25.75%,BLVRB;ABCC1;ABCG2;HMOX1
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid metabolic process (GO:0009448),0.3880263474276391,0.6353072497875262,0.9024390243902439,1.0,1.0,1/5,3.42%,ALDH1A1
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),-0.36007411877784057,-0.6352897499554474,0.8909090909090909,1.0,1.0,1/9,14.47%,MYH9
prerank,GO_Biological_Process_2021__tRNA wobble uridine modification (GO:0002098),0.31498301880176316,0.6352014106991074,0.9032258064516129,1.0,1.0,6/13,26.12%,DPH3;ELP4;MTO1;ELP3;URM1;ALKBH8
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),-0.29464414209293144,-0.6351402171651932,0.9746835443037974,1.0,1.0,10/52,22.52%,TLR2;NNAT;IGF1;ACHE;MYRIP;TGFB1;IRS2;GPER1;MYO18A;DOC2B
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),0.2672808067833334,0.6349513939180723,0.9523809523809523,1.0,1.0,7/31,23.37%,GLRB;IPO5;SESN2;CPEB3;SLC38A9;RPTOR;LAMTOR3
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),0.23134912011475503,0.6347206288504758,1.0,1.0,1.0,7/47,15.29%,ELOVL4;CYP7B1;MCAT;CYP46A1;ABCD3;SCP2;SRR
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),-0.2838637459669499,-0.634408826527864,0.9529411764705882,1.0,1.0,5/53,17.56%,TGFBR2;SBK1;HIPK4;CDK5;PRKCD
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),-0.35466486674395936,-0.6340570465532382,0.9016393442622951,1.0,1.0,1/11,10.74%,APOBEC3H
prerank,GO_Biological_Process_2021__UV protection (GO:0009650),-0.4031792235267754,-0.6337997747618804,0.890625,1.0,1.0,1/6,9.90%,SCARA3
prerank,GO_Biological_Process_2021__desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.3975077420253772,-0.6331952096476753,0.9076923076923077,1.0,1.0,3/8,25.58%,ARR3;GRK2;ADM
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),-0.4064412162715574,-0.6331080283982242,0.8823529411764706,1.0,1.0,1/7,9.59%,WAS
prerank,GO_Biological_Process_2021__translocation of molecules into host (GO:0044417),-0.38887863380419374,-0.6330998072422905,0.8928571428571429,1.0,1.0,1/6,14.46%,THOC6
prerank,GO_Biological_Process_2021__viral mRNA export from host cell nucleus (GO:0046784),-0.38887863380419374,-0.6330998072422905,0.8928571428571429,1.0,1.0,1/6,14.46%,THOC6
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),-0.3475492484484565,-0.6329858745028605,0.9482758620689655,1.0,1.0,1/10,10.11%,DCTN1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron death (GO:1903203),-0.4197302178831293,-0.6322410150823261,0.9354838709677419,1.0,1.0,1/5,14.53%,PINK1
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),0.2170787698095341,0.6321337218950362,1.0,1.0,1.0,9/135,7.99%,FLT3;OSGIN1;AIFM2;TRIM24;SOX9;ANP32B;GAS1;AKT1;VCP
prerank,GO_Biological_Process_2021__negative regulation of mitotic nuclear division (GO:0045839),0.3657810688206027,0.6321309338770734,0.9,1.0,1.0,1/7,8.97%,FBXO5
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),-0.2839840491772744,-0.6317741511972967,0.9880952380952381,1.0,1.0,12/89,20.05%,THBS1;RPS4X;PLD1;KLF4;RPL5;FADD;RBM3;LARP6;SAMD4A;AURKAIP1;TGFB1;EIF4A3
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.2865093780917566,-0.6315987855829192,0.9893617021276596,1.0,1.0,13/59,21.19%,RAMP3;CD44;APP;PFN2;SFRP2;PINK1;MTCP1;BDNF;NOS1;TGFB1;RIPK2;SH2D3C;SH2D3A
prerank,GO_Biological_Process_2021__regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),0.3677007452723904,0.6311946549237981,0.9230769230769231,1.0,1.0,1/8,3.00%,PDK4
prerank,GO_Biological_Process_2021__regulation of acyl-CoA biosynthetic process (GO:0050812),0.3677007452723904,0.6311946549237981,0.9230769230769231,1.0,1.0,1/8,3.00%,PDK4
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),0.32188824981498326,0.6302311221914031,0.8,1.0,1.0,3/8,25.14%,KAT7;IWS1;ARRB1
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),0.3241604153098233,0.6298826975994198,0.8571428571428571,1.0,1.0,4/8,21.27%,NOTCH2;ANK2;HEY2;MDM4
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),-0.30212972204365823,-0.6297995328763355,0.9868421052631579,1.0,1.0,3/35,14.76%,KMO;FOLH1;GPT2
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),-0.30682791761123457,-0.6296704710939138,0.961038961038961,1.0,1.0,3/31,10.91%,FABP3;CAV3;LIPI
prerank,GO_Biological_Process_2021__regulation of acute inflammatory response (GO:0002673),0.38347216636622394,0.629320993853682,0.8709677419354839,1.0,1.0,1/7,5.11%,KLKB1
prerank,GO_Biological_Process_2021__ribose phosphate biosynthetic process (GO:0046390),-0.3967444509503005,-0.6292432795113904,0.9322033898305084,1.0,1.0,3/6,34.54%,G6PD;PRPS1;PRPS2
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),0.2659841340235462,0.6289910778132671,1.0,1.0,1.0,4/30,13.01%,BMP2;FBXO5;GPM6B;ACVR2A
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),-0.3420532826349557,-0.6289551305790302,0.8939393939393939,1.0,1.0,1/11,9.03%,PARP9
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),0.26844728352080766,0.6289106940127347,1.0,1.0,1.0,8/36,17.31%,PLK1;AKT1;BTRC;BAD;SERPINE2;HDAC2;SPOP;CAMK2N1
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.3628366585700302,-0.6288283880187943,0.8823529411764706,1.0,1.0,4/10,31.19%,ADCY8;HLA-DRB1;STX4;CFTR
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),-0.3398348635568068,-0.628637282216121,0.9322033898305084,1.0,1.0,3/13,24.86%,DCTN1;CLMN;SYNE3
prerank,GO_Biological_Process_2021__negative regulation of nuclear division (GO:0051784),0.34459074582015864,0.6284600746537721,0.926829268292683,1.0,1.0,1/9,8.97%,FBXO5
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),-0.34434338571466905,-0.6281874846158506,0.9538461538461539,1.0,1.0,2/19,10.13%,PARP9;STAT1
prerank,GO_Biological_Process_2021__positive regulation of nuclear cell cycle DNA replication (GO:0010571),-0.42244553915018834,-0.6270094793345232,0.9615384615384616,1.0,1.0,1/6,19.08%,CDC7
prerank,GO_Biological_Process_2021__purine nucleobase metabolic process (GO:0006144),0.34367504964015816,0.6269968797229001,0.9761904761904762,1.0,1.0,1/8,7.93%,GMPS
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),-0.2920950173012298,-0.6264449729954289,0.972972972972973,1.0,1.0,15/59,25.25%,SYNPO2L;LMOD1;ZYX;MYH9;TNNT1;OBSCN;MYLK3;ALKBH4;WDR1;FHOD3;MYOZ2;MYO18A;EPB41L4A;EPB41L4B;SORBS1
prerank,GO_Biological_Process_2021__methylguanosine-cap decapping (GO:0110156),-0.37625104788178654,-0.6263622410891225,0.9104477611940298,1.0,1.0,2/10,14.93%,PATL2;EDC4
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),-0.291517099014213,-0.6262448845949695,0.9868421052631579,1.0,1.0,8/54,20.42%,RPS27A;PSMB6;PSMB9;UBC;PSMC3;PSMA8;PSME1;PSMA7
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),-0.2787209835908234,-0.6262079077508117,1.0,1.0,1.0,13/74,22.26%,CDKN2A;SH3GL2;WARS1;PAQR3;FBP1;DAB2IP;CDKN1A;TGFB1;IRS2;CDKN2D;CDKN1C;MAPT;NUPR1
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,-0.2823983507320943,-0.6257381804317653,0.9746835443037974,1.0,1.0,20/94,24.78%,C1QL1;FLRT3;EFNB3;ATP1B1;SLC7A2;SHC2;DAB2IP;SLC44A3;SEZ6L2;CKMT1B;ASS1;PRR36;HES1;ONECUT1;PTPRF;NKAIN1;KIAA1217;CXADR;CD276;EPB41L4B
prerank,GO_Biological_Process_2021__cell differentiation in spinal cord (GO:0021515),-0.3928521253079369,-0.6252860484690137,0.9454545454545454,1.0,1.0,1/7,12.97%,DRAXIN
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),0.29906173916285594,0.6248409640891063,0.972972972972973,1.0,1.0,1/17,6.23%,RNF2
prerank,GO_Biological_Process_2021__histone H3-K27 demethylation (GO:0071557),-0.4140145376034384,-0.6248073339935267,0.9491525423728814,1.0,1.0,1/5,30.38%,KDM6B
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),-0.2547083105542966,-0.6246773593613067,1.0,1.0,1.0,23/156,21.62%,TGFBR2;VRK2;PLK2;RPS6KA1;PRKCQ;SBK1;PDK3;PRKCG;PINK1;STK32B;HIPK4;CDK2;PRKCH;CDK5;HPF1;PRKCD;CDC7;PRKCB;GALNT16;STK32A;RPS6KA6;HIPK3;CAMK1D
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),-0.3175067508939696,-0.6246170040301074,0.95,1.0,1.0,1/18,6.68%,SLC25A21
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),0.35178854619902383,0.6244789032565323,0.9629629629629629,1.0,1.0,2/9,19.12%,HOMER2;DYRK2
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.35178854619902383,0.6244789032565323,0.9629629629629629,1.0,1.0,2/9,19.12%,HOMER2;DYRK2
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),-0.35365181836723236,-0.6241242836554958,0.9705882352941176,1.0,1.0,2/14,12.64%,ICAM1;TNIP2
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),-0.35056600860619824,-0.6238672011020685,0.90625,1.0,1.0,3/11,26.51%,TGFB1;NODAL;TGFB3
prerank,GO_Biological_Process_2021__endothelium development (GO:0003158),-0.4191683059462016,-0.6237651662706083,0.9333333333333333,1.0,1.0,3/6,30.38%,EDF1;PECAM1;KDM6B
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),-0.35781796522258297,-0.6237521499231342,0.9264705882352942,1.0,1.0,3/13,23.54%,BRCA1;RAI2;CELF4
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),0.3294862060237916,0.6237196400104789,0.95,1.0,1.0,6/6,67.06%,SMAD4;BMPR1A;CDH3;HIF1A;SMAD3;TGFB2
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transport (GO:0034767),-0.38828637743186023,-0.6237122825156018,0.95,1.0,1.0,2/6,24.53%,PDZK1;P2RX7
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),-0.2613403071380393,-0.6233324070977447,0.9770114942528736,1.0,1.0,13/90,19.86%,CAMK2N2;CENPE;THY1;WARS1;CAV3;CEACAM1;TSPYL2;CDKN1A;TSC2;CD4;PTPRC;RELN;PLCE1
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),0.29025041962625137,0.622725817642824,0.9714285714285714,1.0,1.0,12/29,29.25%,SESN2;SESN3;PRKAA1;KPTN;TBC1D7;EPM2A;NPRL2;SESN1;NPRL3;MINAR1;ITFG2;SIRT1
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),-0.26716598506584827,-0.6226882242320798,1.0,1.0,1.0,8/95,14.89%,MTMR7;MTMR11;INPP5D;VAC14;SBF1;PLEKHA4;BMX;PITPNM2
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.30418554737860626,-0.6223898197881432,0.9861111111111112,1.0,1.0,5/21,18.52%,PFN2;RAP1GAP;TCHP;PRKCD;LIMK2
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.3398834465542721,-0.6223692626260993,0.9253731343283582,1.0,1.0,4/18,20.42%,PSMB6;PSMB9;PSMA8;PSMA7
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),0.260244356466606,0.6223635809596544,1.0,1.0,1.0,5/24,14.93%,SLC30A4;SLC4A7;SLC4A4;WNK3;SLC30A8
prerank,GO_Biological_Process_2021__aromatic amino acid transport (GO:0015801),0.3688912999430979,0.6223310144782567,0.8536585365853658,1.0,1.0,2/5,19.20%,SLC3A2;SLC36A4
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),-0.2737957455612017,-0.6222134776719713,1.0,1.0,1.0,15/77,21.19%,RAMP3;CD44;APP;PFN2;PAQR3;SFRP2;PINK1;DMTN;MTCP1;BDNF;NOS1;TGFB1;RIPK2;SH2D3C;SH2D3A
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),0.34954945833755185,0.6221379315795299,0.8888888888888888,1.0,1.0,7/7,65.06%,UBR5;UBE3A;SRC;NEDD4;YAP1;WBP2;TRERF1
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),0.23508566641431183,0.6220570791371854,1.0,1.0,1.0,14/88,16.33%,PLK1;CEP152;CSNK1E;CEP290;HAUS1;PCM1;CEP97;C2CD3;ALMS1;IQCB1;SCLT1;CEP192;RAB3IP;TCTN3
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.36048909284937575,-0.6211611593891413,0.9193548387096774,1.0,1.0,3/10,23.75%,SELP;ETS1;ALOX5
prerank,GO_Biological_Process_2021__inner dynein arm assembly (GO:0036159),-0.3758839849568668,-0.6202508861631758,0.9130434782608695,1.0,1.0,5/11,26.40%,CCDC39;CFAP73;DNAAF1;CFAP100;CCDC40
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.24411018404698134,0.6199877690514258,1.0,1.0,1.0,3/28,13.68%,CRB1;LIN7C;MARK2
prerank,GO_Biological_Process_2021__regulation of leukocyte cell-cell adhesion (GO:1903037),-0.41183321969517755,-0.6198717520400727,0.9692307692307692,1.0,1.0,1/8,4.09%,SKAP1
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),0.27704796178550556,0.6197497532631924,1.0,1.0,1.0,2/21,5.40%,SOX8;SOX9
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,-0.25574009125584724,-0.6195634629327926,1.0,1.0,1.0,22/165,22.37%,CCNB2;SUV39H1;POLQ;CENPE;LMNB1;EGF;GINS2;SLC38A1;UBE2S;CCND1;SQLE;KIF2C;STMN1;CDKN3;PML;CDC7;TGFB1;CBX1;KIF11;H2AZ1;KIF20B;JPT1
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),-0.35513023590511306,-0.6193418452494355,0.921875,1.0,1.0,5/12,34.56%,KAT5;CAMK1;FAM161A;DIP2B;TERF2IP
prerank,GO_Biological_Process_2021__arginine metabolic process (GO:0006525),0.344251007236103,0.6191253845054652,0.9210526315789473,1.0,1.0,1/7,5.35%,SLC39A8
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),-0.3279376790862968,-0.6190531803486667,0.9444444444444444,1.0,1.0,3/15,25.25%,ANGPTL3;EEF1A2;SORBS1
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),-0.3065225343888197,-0.6190433358590749,0.9736842105263158,1.0,1.0,1/26,4.80%,SIGLEC1
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),-0.33628146058944164,-0.6189492950226028,0.9508196721311475,1.0,1.0,6/16,24.92%,SLC22A4;PDZK1;SLC25A26;SLC29A4;SLC25A29;SLC22A1
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),-0.3364929991207746,-0.6181634419007567,0.9523809523809523,1.0,1.0,2/12,18.63%,BRCA1;SET
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),-0.3463010331172196,-0.6180871441633735,0.9142857142857143,1.0,1.0,1/14,3.95%,IRF1
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.34077356517972884,-0.6177620470976665,0.9538461538461539,1.0,1.0,3/12,19.49%,CCL2;IL18;TGFB1
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),0.23037650705002316,0.6171506033816623,1.0,1.0,1.0,12/39,26.48%,CARS2;VARS1;KARS1;YARS2;NARS2;FARSB;LARS2;FARS2;EPRS1;YARS1;IARS1;AARS2
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),0.2850714893881307,0.6167509951557046,0.967741935483871,1.0,1.0,4/19,11.06%,SRI;CACNB4;CACNB3;DRD2
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),0.30753204284384794,0.6166328508638016,1.0,1.0,1.0,4/10,28.73%,DENR;EIF2S3;EIF2D;EIF5
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.3252903474089345,-0.6164983043921253,0.9692307692307692,1.0,1.0,2/20,8.78%,CDKN2A;HEXIM1
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide-induced cell death (GO:1903205),0.31767999142610903,0.6162269328481284,0.8529411764705882,1.0,1.0,2/9,23.83%,GPR37L1;NFE2L2
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.3112500719130037,-0.6161295703622107,0.9487179487179487,1.0,1.0,6/25,22.39%,LTBP4;EID2;SFRP4;ITGA3;TGFB1;PCSK6
prerank,GO_Biological_Process_2021__regulation of mitophagy (GO:1901524),-0.41247485921494165,-0.6160837028139139,0.927536231884058,1.0,1.0,1/5,18.40%,TSC2
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.33289268171472536,0.6160041065571782,0.9142857142857143,1.0,1.0,1/10,5.40%,SOX9
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),0.2513388892015459,0.6159118987664515,1.0,1.0,1.0,11/29,28.33%,DNASE1L2;NUDT9;NUDT15;ENTPD1;PPP1R8;DFFB;DNASE1L1;HNRNPD;MTREX;ENTPD4;ENTPD6
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),-0.3662407917529002,-0.6157630432745794,0.9285714285714286,1.0,1.0,1/9,6.95%,CCL2
prerank,GO_Biological_Process_2021__positive regulation of execution phase of apoptosis (GO:1900119),0.34000685621454346,0.6149603139011873,0.8571428571428571,1.0,1.0,2/7,11.53%,PTGIS;TP53BP2
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.2866822405715927,-0.6147654198946487,0.9753086419753086,1.0,1.0,9/38,27.60%,SEPTIN4;PINK1;BCL2L2;BOK;GSDME;NUPR1;BBC3;SIAH1;PLAUR
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.34508778856306255,-0.6146132916103776,0.9180327868852459,1.0,1.0,2/13,15.25%,PIM1;GLI1
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),0.2606093368141137,0.6142130127699986,0.9583333333333334,1.0,1.0,4/42,9.08%,GPC5;RALB;VCP;CSNK1E
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),0.2752791055355918,0.6140188990631562,1.0,1.0,1.0,6/23,25.25%,HSPA1A;DNAJB14;DNAJB5;DNAJC18;HSPA13;DNAJB12
prerank,GO_Biological_Process_2021__outer dynein arm assembly (GO:0036158),-0.339183398325112,-0.6140165916116112,0.9090909090909091,1.0,1.0,5/15,27.63%,ODAD1;DNAH17;DNAAF1;ODAD4;DNAI1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),-0.41683539177971246,-0.613818463565634,0.9193548387096774,1.0,1.0,5/5,58.33%,MTMR1;MTMR3;MTMR4;MTMR2;MTMR9
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),-0.36403746366021966,-0.6130847081884627,0.9393939393939394,1.0,1.0,1/9,15.62%,SEC11C
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),-0.33603098216686694,-0.6129005225335925,0.971830985915493,1.0,1.0,2/16,14.71%,AKAP5;CACNA1C
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),-0.3573216237913964,-0.6126990002586636,0.9516129032258065,1.0,1.0,1/10,8.02%,ANGPTL3
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),-0.28158208098112747,-0.6124415892212418,1.0,1.0,1.0,4/50,10.49%,SLITRK1;THY1;EFNB3;MAG
prerank,GO_Biological_Process_2021__regulation of skeletal muscle tissue development (GO:0048641),-0.3996318990940912,-0.6119276012518448,0.9047619047619048,1.0,1.0,2/5,19.63%,TGFB1;FLOT1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),0.3290384462302301,0.611498848018184,0.8918918918918919,1.0,1.0,1/10,5.95%,EGFR
prerank,GO_Biological_Process_2021__tachykinin receptor signaling pathway (GO:0007217),-0.37992545319918036,-0.6113695718704167,0.9180327868852459,1.0,1.0,5/6,37.20%,TAC4;GRK2;TAC1;TACR1;GRK5
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.3085744991617107,-0.6111867852869088,0.9615384615384616,1.0,1.0,8/31,26.34%,SEPTIN4;RPS7;BOK;GSDME;EIF5A;NUPR1;BBC3;SIAH1
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),0.3371280107614234,0.611130674143144,0.9705882352941176,1.0,1.0,1/7,18.70%,HEY2
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),0.2787331861777845,0.6110930306177047,0.96,1.0,1.0,6/29,18.63%,PPARGC1A;KMT2A;IWS1;BRD7;TADA2B;NOC2L
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),0.3356440098886085,0.6110134726927573,0.8974358974358975,1.0,1.0,1/10,3.58%,NDNF
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),-0.31437987315279037,-0.6109724509035136,0.9104477611940298,1.0,1.0,3/23,17.02%,P3H2;OGFOD1;PPIB
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),0.34739433650070517,0.6108251598592919,0.8490566037735849,1.0,1.0,1/6,8.01%,BTRC
prerank,GO_Biological_Process_2021__creatine metabolic process (GO:0006600),0.35715291211963673,0.610791210103865,0.926829268292683,1.0,1.0,2/6,26.40%,CKB;GAMT
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),-0.29561848502118404,-0.6107491199684234,1.0,1.0,1.0,7/30,21.55%,IFT122;PRICKLE1;DLC1;TSC2;TGFB1;LRP2;DEAF1
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),-0.31612298721328486,-0.610549667448457,0.9696969696969697,1.0,1.0,2/23,10.66%,SUV39H1;EEF1AKMT2
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.2478257215473955,0.61045693799882,1.0,1.0,1.0,8/62,11.14%,PSMD10;LMO1;PSMA1;PSMD11;RUNX1;PSMB5;KMT2A;PSMD14
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),0.23827764128621914,0.6102869896922418,1.0,1.0,1.0,13/50,20.21%,NDUFB1;DMAC2;NDUFAF3;NDUFAF4;NDUFAF2;NDUFA8;NDUFV3;TIMMDC1;NDUFS1;NDUFV1;NDUFB4;NDUFAF7;NDUFAF5
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),0.23827764128621914,0.6102869896922418,1.0,1.0,1.0,13/50,20.21%,NDUFB1;DMAC2;NDUFAF3;NDUFAF4;NDUFAF2;NDUFA8;NDUFV3;TIMMDC1;NDUFS1;NDUFV1;NDUFB4;NDUFAF7;NDUFAF5
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),0.2696593422156547,0.6098260698659732,1.0,1.0,1.0,5/27,14.61%,EGFR;CPNE3;ERBB4;PIK3CA;PIK3R1
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.3365196284744532,-0.6095708507467354,0.967741935483871,1.0,1.0,4/14,26.51%,APLN;CDKN1A;GPER1;TGFB3
prerank,PanglaoDB_Augmented_2021__Transient Cells,0.20164598371510037,0.6094691087765655,1.0,1.0,1.0,11/103,13.41%,SDC4;HID1;ARHGEF16;MYO5B;CADPS2;TMEM54;PLEKHA6;PPP1R26;WASL;LGR4;SMPD1
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),0.2986958636158411,0.6094067717446082,0.9354838709677419,1.0,1.0,3/13,14.51%,PLIN5;ABHD5;GPLD1
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),0.26105523518615315,0.6090415310115977,1.0,1.0,1.0,8/58,11.14%,PSMD10;LMO1;PSMA1;PSMD11;RUNX1;PSMB5;KMT2A;PSMD14
prerank,PanglaoDB_Augmented_2021__Sebocytes,-0.29121381662398094,-0.6086091004150602,0.9733333333333334,1.0,1.0,9/39,16.07%,TJP3;PLEKHG6;KLF4;FBP1;ST6GALNAC2;TGFA;HRH1;IL18;LTBR
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),-0.28109212365926384,-0.6085438649664306,0.9487179487179487,1.0,1.0,1/36,5.89%,SNRPD2
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),-0.3546766093113717,-0.6084560730319346,0.9104477611940298,1.0,1.0,3/11,18.39%,FN1;CD200;LTBP1
prerank,GO_Biological_Process_2021__aspartate family amino acid biosynthetic process (GO:0009067),-0.3907233675462717,-0.6082779289347389,0.9516129032258065,1.0,1.0,1/6,31.45%,MTHFD1
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.30380699479357487,0.6077756064949077,0.9629629629629629,1.0,1.0,1/10,14.51%,GPLD1
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.31814929096394323,0.607696071476071,0.9411764705882353,1.0,1.0,4/9,29.25%,PRKAA1;KLF15;SETD5;SIRT1
prerank,GO_Biological_Process_2021__hematopoietic stem cell differentiation (GO:0060218),-0.3852235795982441,-0.6072307601747494,0.9152542372881356,1.0,1.0,4/6,32.55%,SFRP1;MEOX1;LMBR1L;TP53
prerank,GO_Biological_Process_2021__regulation of focal adhesion disassembly (GO:0120182),-0.4098772322572921,-0.6070690761629945,0.9411764705882353,1.0,1.0,1/6,16.08%,MAPRE2
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion disassembly (GO:0120183),-0.4098772322572921,-0.6070690761629945,0.9411764705882353,1.0,1.0,1/6,16.08%,MAPRE2
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),-0.27498482587613765,-0.6070487490265598,0.9868421052631579,1.0,1.0,12/59,20.74%,CD160;HTR2B;NYAP1;PLCH2;PITPNM2;IGF1;HTR2A;PTAFR;PIK3CB;PLCE1;PIK3CD;IRS2
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.27378367982782414,-0.6068321627110876,1.0,1.0,1.0,16/58,21.83%,RAMP3;ADGRE5;ADCY7;S1PR3;VIP;GLP1R;GNG2;LGR5;ADCY5;GPR12;CNR1;RXFP1;PTH1R;ADCY8;GPER1;ADGRG2
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin protein ligase activity (GO:1904667),-0.3590702593074469,-0.6061665870571016,0.9047619047619048,1.0,1.0,4/8,22.87%,RPS7;RPL5;RPL23;RPL11
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),-0.3125574713667405,-0.6059742525909367,0.9142857142857143,1.0,1.0,5/24,17.75%,FSCN1;PLPPR5;NLGN1;DPYSL3;AGRN
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),0.2750704415762937,0.6059514946285173,0.96875,1.0,1.0,5/19,20.31%,EIF2S1;PRRC2C;G3BP1;YTHDF2;UBAP2L
prerank,GO_Biological_Process_2021__nucleoside diphosphate catabolic process (GO:0009134),-0.3405983049477388,-0.605914918134618,0.8596491228070176,1.0,1.0,3/8,31.94%,ENTPD3;ENTPD2;ENTPD7
prerank,GO_Biological_Process_2021__regulation of neutrophil extravasation (GO:2000389),-0.4077012154408247,-0.6056147412770371,0.9322033898305084,1.0,1.0,1/5,10.33%,CD99
prerank,GO_Biological_Process_2021__positive regulation of neutrophil extravasation (GO:2000391),-0.4077012154408247,-0.6056147412770371,0.9322033898305084,1.0,1.0,1/5,10.33%,CD99
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),-0.308830087637779,-0.6055637626167796,0.9285714285714286,1.0,1.0,10/25,28.94%,SLC9A2;SLC4A9;SLC4A2;SLC4A10;SLC9A5;CLN3;SLC9A7;SLC9A1;SLC4A3;SLC9A9
prerank,GO_Biological_Process_2021__aflatoxin metabolic process (GO:0046222),-0.3545546458854606,-0.6055329115067188,0.9491525423728814,1.0,1.0,2/8,22.61%,CYP3A4;CYP3A5
prerank,GO_Biological_Process_2021__organic heteropentacyclic compound metabolic process (GO:1901376),-0.3545546458854606,-0.6055329115067188,0.9491525423728814,1.0,1.0,2/8,22.61%,CYP3A4;CYP3A5
prerank,GO_Biological_Process_2021__mycotoxin metabolic process (GO:0043385),-0.3545546458854606,-0.6055329115067188,0.9491525423728814,1.0,1.0,2/8,22.61%,CYP3A4;CYP3A5
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),-0.3227547633105734,-0.605322469134795,0.9473684210526315,1.0,1.0,1/19,3.55%,LAMB1
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),0.24385910682225137,0.6052180269999615,1.0,1.0,1.0,8/74,7.15%,PSMD10;LMO1;PSMA1;PSMD11;RUNX1;NUDT21;SMYD5;PSMB5
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),0.2189263823863142,0.6050727599631285,1.0,1.0,1.0,5/57,13.65%,KPNA2;PDE12;GTF2F2;VAPB;POLR2C
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),0.24842709698193502,0.6047749884558499,1.0,1.0,1.0,6/38,13.30%,CYP7B1;AKR1C3;PMVK;INSIG2;CYP46A1;SCP2
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),0.33091188196501703,0.6047505817737006,0.9545454545454546,1.0,1.0,2/6,14.24%,SASH1;MARCHF7
prerank,GO_Biological_Process_2021__negative regulation of cell volume (GO:0045794),-0.4044367966803584,-0.6047170430187594,0.9642857142857143,1.0,1.0,3/5,37.05%,P2RX7;SHANK3;ANO6
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),0.27315470928698093,0.6046519953681249,1.0,1.0,1.0,2/20,10.37%,HS3ST5;EXT2
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),-0.3863372735280518,-0.6045413139385698,0.9649122807017544,1.0,1.0,1/6,11.08%,NFKBID
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),0.3315115113904544,0.6045039314556552,0.9090909090909091,1.0,1.0,3/9,27.16%,ABL2;PDP2;PDP1
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),-0.28895169149662475,-0.6034761454473142,0.972972972972973,1.0,1.0,10/42,19.29%,ANO2;ANO9;GLRA2;GABRB2;GABRD;GABRE;GABRG2;GLRA1;GABRA1;SLC12A7
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),0.33319973073049614,0.6030605245896055,0.95,1.0,1.0,1/7,6.12%,HCLS1
prerank,GO_Biological_Process_2021__androgen metabolic process (GO:0008209),-0.3551380580863175,-0.6029782468696628,0.9365079365079365,1.0,1.0,3/10,22.37%,CYP3A4;SPP1;HSD17B7
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, GABAergic (GO:0032230)",0.3894599426720418,0.6027345004524078,0.9393939393939394,1.0,1.0,1/5,2.97%,ADRA1A
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),-0.28079568542786104,-0.6023101399830225,0.9743589743589743,1.0,1.0,8/67,18.99%,PLK2;WNT5A;PLK3;DAB2IP;VIP;HECW2;GPC3;OAZ2
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),0.31556000746556656,0.6022328087494767,0.8285714285714286,1.0,1.0,4/11,33.94%,PICALM;ROCK2;ROCK1;CHRNA7
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.2693805084976838,0.601548707805855,1.0,1.0,1.0,11/26,28.06%,EAF2;HNRNPU;CDK12;ZMYND11;RECQL5;NELFA;WDR43;RNF168;LDB1;CDK13;LARP7
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",0.3761953535331747,0.6015119331899769,0.896551724137931,1.0,1.0,7/8,35.96%,FERMT2;CLASP2;PTEN;FERMT1;MTOR;CLASP1;RREB1
prerank,GO_Biological_Process_2021__bone cell development (GO:0098751),-0.37054464319346797,-0.6012144934687188,0.873015873015873,1.0,1.0,4/8,25.29%,THPO;ANXA2;ZNF385A;SH2B3
prerank,GO_Biological_Process_2021__regulation of adherens junction organization (GO:1903391),0.38470887679942745,0.6008288182410947,0.9166666666666666,1.0,1.0,2/5,24.81%,PTPN23;ADD1
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),0.28252655747950634,0.6007793460596449,0.9393939393939394,1.0,1.0,3/18,14.33%,SGCD;ZBTB18;CFLAR
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),-0.3511963727339744,-0.6007217060871751,0.95,1.0,1.0,3/11,22.97%,SLC38A1;SLC29A4;SLC1A6
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),0.36120672200850357,0.6006304566585768,0.9210526315789473,1.0,1.0,5/5,63.89%,PTPN2;HIP1;PTPN12;HIP1R;LRP1
prerank,GO_Biological_Process_2021__secretion (GO:0046903),-0.3461813408032231,-0.5997719880783156,0.9714285714285714,1.0,1.0,3/10,14.50%,TPD52;SLC22A4;VIP
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),-0.28091174963103194,-0.5995503148858364,0.9886363636363636,1.0,1.0,9/49,23.07%,PRKCG;PSMC3;DAB2IP;PINK1;RHBDF1;DDRGK1;PSME1;NUPR1;GABARAPL2
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),-0.2985147479826229,-0.5993689784230293,1.0,1.0,1.0,2/29,5.65%,HELB;POLQ
prerank,GO_Biological_Process_2021__negative regulation of lyase activity (GO:0051350),-0.3491613336035495,-0.5993266707708463,0.9452054794520548,1.0,1.0,1/11,9.27%,AKAP5
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),0.2571498912998799,0.5992395349931527,0.9696969696969697,1.0,1.0,3/22,10.40%,CHST11;CSGALNACT1;GAL3ST4
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),-0.320925902322456,-0.5991886014102795,0.9452054794520548,1.0,1.0,2/18,17.62%,TTLL7;TTLL6
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.27298877318278136,0.5989773972162169,1.0,1.0,1.0,8/18,25.74%,ERCC2;ERCC3;GTF2H5;GTF2H2;GTF2H3;PARP1;ERCC4;CUL4B
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.27298877318278136,0.5989773972162169,1.0,1.0,1.0,8/18,25.74%,ERCC2;ERCC3;GTF2H5;GTF2H2;GTF2H3;PARP1;ERCC4;CUL4B
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),-0.3541811756511039,-0.5989401910585589,0.9508196721311475,1.0,1.0,4/10,39.22%,STK24;RTN4RL1;CERS2;INPP5F
prerank,GO_Biological_Process_2021__positive regulation of deoxyribonuclease activity (GO:0032077),0.35688395253022787,0.5989235538826737,0.9459459459459459,1.0,1.0,1/5,7.94%,AKT1
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell differentiation (GO:0046637),-0.3809491053221902,-0.5988380379741367,0.9354838709677419,1.0,1.0,2/5,22.45%,PRDM1;PNP
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),-0.31229367897126226,-0.5987651810633122,0.972972972972973,1.0,1.0,1/17,3.90%,KREMEN2
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),0.2703821540517316,0.5986053676419099,0.9565217391304348,1.0,1.0,3/23,7.70%,GREM1;NLGN3;NCOA3
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),0.2827110419257575,0.5985460889413,1.0,1.0,1.0,4/19,12.75%,RCC2;PTPRK;TAOK2;THSD1
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),0.30286316698556087,0.5979713036928724,1.0,1.0,1.0,6/15,32.36%,EPS15;KLHL20;SORT1;MON2;AP2A1;RAB14
prerank,GO_Biological_Process_2021__negative regulation of cellular response to hypoxia (GO:1900038),0.38640395964077356,0.5968363903878174,0.9117647058823529,1.0,1.0,1/5,21.13%,DDAH1
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),-0.29988409474484157,-0.5964902206704926,0.9666666666666667,1.0,1.0,2/23,7.72%,TJP3;LSR
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),0.3049225159525982,0.5956582301574612,0.9230769230769231,1.0,1.0,15/15,69.53%,SIK3;PIP4P1;LARS1;KLHL22;GPR137B;RRAGA;PIH1D1;RRAGD;LAMTOR5;CLEC16A;RRAGB;SEH1L;TELO2;GPR137;GPR137C
prerank,GO_Biological_Process_2021__cellular response to zinc ion (GO:0071294),-0.3230408974810721,-0.5948998350791997,0.9436619718309859,1.0,1.0,3/14,18.04%,GLRA2;MT1H;GLRA1
prerank,GO_Biological_Process_2021__eye photoreceptor cell development (GO:0042462),-0.35273124179261867,-0.5945951591586145,0.9333333333333333,1.0,1.0,1/11,7.01%,THY1
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),0.36152872690458093,0.5945710237790343,0.9459459459459459,1.0,1.0,6/6,63.86%,OGT;MTF2;MACROH2A1;PHF1;SUPT6H;PHF19
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),-0.27716527603870755,-0.5945431589110369,0.9722222222222222,1.0,1.0,2/32,10.11%,PSRC1;DCTN1
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),-0.382596015434688,-0.5931173053717378,0.9666666666666667,1.0,1.0,3/6,26.28%,SLIT3;SH2B3;SLIT2
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),-0.29825954862275955,-0.5927875937011836,1.0,1.0,1.0,7/27,21.55%,IFT122;PRICKLE1;DLC1;TSC2;TGFB1;LRP2;DEAF1
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),-0.29825954862275955,-0.5927875937011836,1.0,1.0,1.0,7/27,21.55%,IFT122;PRICKLE1;DLC1;TSC2;TGFB1;LRP2;DEAF1
prerank,GO_Biological_Process_2021__establishment of centrosome localization (GO:0051660),0.37563735014181915,0.5926691235952782,0.9512195121951219,1.0,1.0,2/5,29.68%,EZR;DLG1
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),0.25422816378902935,0.5926295572306506,0.9629629629629629,1.0,1.0,8/26,33.88%,SF3A1;KHDC4;LUC7L;SRSF9;CELF1;CELF2;LUC7L3;SF1
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),-0.3491448772432999,-0.5921304713904167,0.9402985074626866,1.0,1.0,6/9,32.20%,ADCY5;ADCY8;ADCY3;ADCY2;CFTR;AHR
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),-0.3491448772432999,-0.5921304713904167,0.9402985074626866,1.0,1.0,6/9,32.20%,ADCY5;ADCY8;ADCY3;ADCY2;CFTR;AHR
prerank,GO_Biological_Process_2021__oxidative DNA demethylation (GO:0035511),-0.3657056848078224,-0.591105485848195,0.90625,1.0,1.0,1/5,16.19%,ALKBH2
prerank,GO_Biological_Process_2021__negative regulation of cyclase activity (GO:0031280),-0.35584195334070307,-0.5906295617358203,0.9583333333333334,1.0,1.0,1/9,9.27%,AKAP5
prerank,GO_Biological_Process_2021__negative regulation of adenylate cyclase activity (GO:0007194),-0.35584195334070307,-0.5906295617358203,0.9583333333333334,1.0,1.0,1/9,9.27%,AKAP5
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),0.2908224958969018,0.5905034568413612,1.0,1.0,1.0,4/11,31.87%,CDK12;CDK13;SUPT16H;CDC73
prerank,GO_Biological_Process_2021__mitochondrial RNA processing (GO:0000963),0.3500050622658702,0.5895868005685546,0.8888888888888888,1.0,1.0,7/7,65.01%,ELAC2;TRMT10A;TRMT10C;PNPT1;TBRG4;TRMT10B;SUPV3L1
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),-0.27095835976810106,-0.5891249414438823,0.9875,1.0,1.0,8/46,20.42%,BHMT;PSMB6;PSMB9;PSMC3;PSMA8;PSME1;OAZ2;PSMA7
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),0.30156295354461843,0.5888342557609793,0.9333333333333333,1.0,1.0,4/10,26.02%,SPIRE2;CARMIL2;PLS3;CARMIL1
prerank,GO_Biological_Process_2021__regulation of translational elongation (GO:0006448),0.3868038860667063,0.5884257948237721,0.8888888888888888,1.0,1.0,1/5,8.49%,EIF5A2
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),-0.28286046660490183,-0.5879765089858411,1.0,1.0,1.0,9/32,29.92%,PRKCG;DDRGK1;UBXN1;RPL11;GABARAPL2;AQP11;GIPC1;NOP53;PARK7
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),-0.34569370547398426,-0.5879018586441486,0.9344262295081968,1.0,1.0,3/8,30.58%,SLC2A3;GSTO1;CYB5R3
prerank,GO_Biological_Process_2021__positive regulation of IRE1-mediated unfolded protein response (GO:1903896),0.3685783844468671,0.5877642854332205,0.9473684210526315,1.0,1.0,1/6,6.45%,TMEM33
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),-0.3098495335298467,-0.5872270491756815,0.9516129032258065,1.0,1.0,2/22,7.69%,APP;CCNB1
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),-0.2930404816747635,-0.5872249630271569,0.9861111111111112,1.0,1.0,3/20,11.10%,DOK1;HAP1;PTK6
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),0.24907716220241063,0.5872167215306889,1.0,1.0,1.0,1/24,6.23%,RNF2
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),-0.3104570852326763,-0.5863734528990381,0.9552238805970149,1.0,1.0,2/16,9.31%,SVIL;VIL1
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),-0.3104570852326763,-0.5863734528990381,0.9552238805970149,1.0,1.0,2/16,9.31%,SVIL;VIL1
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.3305243079180893,-0.5862455153109497,0.9682539682539683,1.0,1.0,3/10,19.20%,GCNT1;SELP;ADD2
prerank,GO_Biological_Process_2021__membrane fusion involved in viral entry into host cell (GO:0039663),-0.36404502209434686,-0.5861931996184825,0.9583333333333334,1.0,1.0,4/7,36.24%,CD4;HYAL2;PPIA;GAS6
prerank,GO_Biological_Process_2021__fusion of virus membrane with host plasma membrane (GO:0019064),-0.36404502209434686,-0.5861931996184825,0.9583333333333334,1.0,1.0,4/7,36.24%,CD4;HYAL2;PPIA;GAS6
prerank,GO_Biological_Process_2021__macropinocytosis (GO:0044351),0.3561123766135158,0.5859988123833836,0.8823529411764706,1.0,1.0,6/6,64.40%,CARMIL1;MAPKAPK2;SNX33;MAPKAPK3;RAB34;DOCK2
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.25275369124137664,0.5857363602422906,1.0,1.0,1.0,2/24,12.12%,HSPA1A;OPA1
prerank,GO_Biological_Process_2021__positive regulation of triglyceride biosynthetic process (GO:0010867),-0.3373499817205762,-0.5855488045199575,1.0,1.0,1.0,4/10,27.31%,LDLR;MFSD2A;SREBF1;SCARB1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),-0.27404169667637396,-0.5852889057307205,0.9876543209876543,1.0,1.0,6/47,20.91%,RAMP3;AKAP5;ITGA3;PRKCH;STAC2;GPER1
prerank,GO_Biological_Process_2021__activation of Janus kinase activity (GO:0042976),-0.3605749204600869,-0.5843353811654393,0.9090909090909091,1.0,1.0,1/5,23.83%,GHR
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),0.33749890532597104,0.5828685052651128,0.9393939393939394,1.0,1.0,2/8,20.32%,COMMD1;NEDD4L
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),-0.29194989996924775,-0.5826786386678323,0.9855072463768116,1.0,1.0,3/21,12.20%,ISG15;PDCD1LG2;SYK
prerank,GO_Biological_Process_2021__exogenous drug catabolic process (GO:0042738),-0.35060950958772386,-0.5822175694076777,0.9846153846153847,1.0,1.0,4/9,28.25%,CYP3A4;NOS1;CYP2D6;CYP2E1
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),-0.29325634226903863,-0.5813395953661187,0.9444444444444444,1.0,1.0,2/18,22.26%,CDK5;NUPR1
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),-0.25381074869203096,-0.581274539826248,1.0,1.0,1.0,11/63,22.26%,TGFBR2;ARIH2;WNT5A;ZFPM1;SFRP2;RUNX2;PTPRC;TGFB1;GLRX5;SFRP1;ETV6
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),0.25384074438825543,0.5810513859233567,1.0,1.0,1.0,11/37,21.63%,SOX9;EGFR;AKT1;PIK3CA;NCK2;SHC3;PIK3R1;PIK3C2A;EFEMP1;BRAF;PTK2
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),-0.30902366062949915,-0.5808129581388733,0.9545454545454546,1.0,1.0,1/12,18.63%,SET
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),-0.30902366062949915,-0.5808129581388733,0.9545454545454546,1.0,1.0,1/12,18.63%,SET
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),-0.298565141857886,-0.5802473522808569,0.9863013698630136,1.0,1.0,2/22,12.64%,ICAM1;TNIP2
prerank,GO_Biological_Process_2021__detection of muscle stretch (GO:0035995),-0.35671088435270587,-0.579967077630133,0.9193548387096774,1.0,1.0,1/6,8.07%,CAV3
prerank,GO_Biological_Process_2021__monocyte activation (GO:0042117),-0.3696327046439871,-0.5797993500898107,0.9516129032258065,1.0,1.0,1/8,8.18%,DYSF
prerank,GO_Biological_Process_2021__methionine metabolic process (GO:0006555),0.31446795585704157,0.5797949417198878,0.8918918918918919,1.0,1.0,7/7,68.56%,ADI1;SMS;MTR;MTRR;MTHFR;MSRA;MTHFD1
prerank,GO_Biological_Process_2021__contact inhibition (GO:0060242),0.3324727916983041,0.5794815797718782,0.9743589743589743,1.0,1.0,6/6,66.76%,SMO;PTPRJ;CDHR2;YAP1;FAP;PAK1
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.3145774307180125,-0.5791394278790425,0.971830985915493,1.0,1.0,1/12,9.59%,WAS
prerank,GO_Biological_Process_2021__deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),-0.384460866010873,-0.579045833320528,0.9230769230769231,1.0,1.0,1/7,10.19%,PATL2
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),-0.32631346712442794,-0.5788757692232749,0.9393939393939394,1.0,1.0,2/11,26.16%,MICALL1;PACSIN1
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),0.29820003570230924,0.5783237343243831,0.9655172413793104,1.0,1.0,6/14,36.27%,PANK2;NUDT7;SLC25A16;PPCS;PANK1;PANK4
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.2914703631744935,0.5780317367216667,0.9696969696969697,1.0,1.0,4/13,18.24%,ATP1A2;ANK2;DMD;GSTM2
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),-0.28075638896956034,-0.5778039408570216,0.9736842105263158,1.0,1.0,1/35,2.43%,ZFP36
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),0.30592325381123536,0.5772515860267985,0.9666666666666667,1.0,1.0,5/12,21.63%,TCAP;CDH2;PIK3CA;DMD;PTK2
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),-0.24856558657807465,-0.5768892671890987,1.0,1.0,1.0,12/86,19.63%,WARS1;DCTN1;FRMPD4;SYK;NEUROD2;CALY;DAB2IP;GPC3;RELN;TGFB1;HYAL1;FLOT1
prerank,GO_Biological_Process_2021__body fluid secretion (GO:0007589),-0.33873140870838847,-0.5764591713518149,0.9428571428571428,1.0,1.0,5/12,19.83%,SLC22A4;VIP;APLN;OXTR;FOXB1
prerank,GO_Biological_Process_2021__regulation of flagellated sperm motility (GO:1901317),-0.3857691511566397,-0.5751446526504779,0.9473684210526315,1.0,1.0,2/5,23.28%,TAC4;RNASE10
prerank,GO_Biological_Process_2021__positive regulation of flagellated sperm motility (GO:1902093),-0.3857691511566397,-0.5751446526504779,0.9473684210526315,1.0,1.0,2/5,23.28%,TAC4;RNASE10
prerank,GO_Biological_Process_2021__positive regulation of cilium movement (GO:0003353),-0.3857691511566397,-0.5751446526504779,0.9473684210526315,1.0,1.0,2/5,23.28%,TAC4;RNASE10
prerank,GO_Biological_Process_2021__positive regulation of cilium-dependent cell motility (GO:2000155),-0.3857691511566397,-0.5751446526504779,0.9473684210526315,1.0,1.0,2/5,23.28%,TAC4;RNASE10
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),-0.2411771305199745,-0.5751252863527767,1.0,1.0,1.0,14/128,16.25%,DUSP1;MTMR7;SBF1;ALPL;PLPP4;PLPPR1;PP2D1;SGPP2;PLPPR5;FBP1;PPP3CC;DUSP16;PTPN7;HDHD2
prerank,GO_Biological_Process_2021__carbohydrate derivative transport (GO:1901264),-0.31260160045575497,-0.5749554408228863,0.961038961038961,1.0,1.0,4/16,23.26%,VLDLR;MFSD2A;SLC15A4;CLN3
prerank,GO_Biological_Process_2021__regulation of homophilic cell adhesion (GO:1903385),0.3869136755940687,0.5746878150828776,0.8918918918918919,1.0,1.0,3/5,11.91%,PTPRG;TENM3;PTPN23
prerank,GO_Biological_Process_2021__establishment of planar polarity (GO:0001736),-0.37327258921791956,-0.5745026124416904,0.9523809523809523,1.0,1.0,6/6,62.69%,CELSR1;BRSK1;BRSK2;VANGL2;NPHP1;FUZ
prerank,GO_Biological_Process_2021__glycine metabolic process (GO:0006544),-0.35241364521507224,-0.5743524185489922,0.971830985915493,1.0,1.0,1/9,6.85%,GLYAT
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell proliferation (GO:1902033),-0.3739280904230675,-0.5739224934648806,0.9375,1.0,1.0,2/5,24.07%,THPO;EIF2AK2
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),-0.3083430625940188,-0.5739015043670621,1.0,1.0,1.0,4/17,30.15%,FGF1;SREBF1;SEC14L2;SREBF2
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",0.26663760167803285,0.5736103585244282,1.0,1.0,1.0,2/25,9.55%,SF3B4;SMNDC1
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.23106165479858168,0.5731824918995866,1.0,1.0,1.0,17/47,32.49%,NOVA1;RBFOX1;NSRP1;HNRNPU;FXR2;RBM15;MBNL1;RBMX;MAGOH;SAP18;CELF1;REST;PTBP1;HNRNPL;RBM15B;CELF2;DDX5
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),-0.24281967878465488,-0.5731783848459946,1.0,1.0,1.0,17/139,18.79%,BLM;POU4F1;HEXIM1;BRCA1;PLK3;PRDM1;RPA3;NUAK1;RPS15;RPL5;TAF10;CDK2;RPA1;CDK5;TAF9B;PML;RPL23
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),-0.25302127605213937,-0.5729828471412602,1.0,1.0,1.0,2/72,5.65%,BLM;POLQ
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),0.2712888688248871,0.5726293325467292,0.9615384615384616,1.0,1.0,5/13,30.50%,NIPBL;NAA50;POGZ;PDS5B;DSCC1
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),0.35958771604359147,0.5723292419619732,0.9354838709677419,1.0,1.0,3/7,36.62%,SNAP29;STX17;VAMP8
prerank,GO_Biological_Process_2021__cellular response to nutrient (GO:0031670),-0.3845779939112671,-0.5721829177857111,0.9649122807017544,1.0,1.0,2/5,35.44%,XBP1;CDKN2B
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),-0.2578703196479926,-0.5716671904361853,1.0,1.0,1.0,6/52,16.02%,SUV39H1;SLC8A3;SCN2A;PINK1;NDRG1;PGK1
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.3056691691468039,-0.5715172910204974,0.9722222222222222,1.0,1.0,6/18,27.60%,MLLT11;PINK1;GPER1;BBC3;FAM162A;PLAUR
prerank,GO_Biological_Process_2021__negative regulation of osteoblast proliferation (GO:0033689),0.34669155572889276,0.5713852477824182,0.925,1.0,1.0,1/7,4.47%,GREM1
prerank,GO_Biological_Process_2021__negative regulation of response to reactive oxygen species (GO:1901032),0.3216389734499925,0.5710575208920369,0.90625,1.0,1.0,2/8,23.83%,GPR37L1;NFE2L2
prerank,GO_Biological_Process_2021__negative regulation of chemokine-mediated signaling pathway (GO:0070100),-0.3843727779632572,-0.5710400991781864,0.9636363636363636,1.0,1.0,3/5,26.28%,SLIT3;SH2B3;SLIT2
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070424),-0.3664839670056851,-0.5710254078430365,0.9672131147540983,1.0,1.0,2/5,19.21%,BIRC3;SLC15A4
prerank,GO_Biological_Process_2021__2-oxoglutarate metabolic process (GO:0006103),0.27233948951956616,0.5705285316471961,0.9761904761904762,1.0,1.0,4/11,25.41%,PHYH;GOT2;OGDH;IDH1
prerank,GO_Biological_Process_2021__positive regulation of secretion (GO:0051047),0.3879970438559144,0.5704154091832546,0.9696969696969697,1.0,1.0,3/5,20.15%,GPLD1;ACSL3;ABCB11
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),-0.2820393192959099,-0.568652634798178,0.9852941176470589,1.0,1.0,4/26,24.77%,PLK2;CEP76;CCNF;CHMP2A
prerank,GO_Biological_Process_2021__serine transport (GO:0032329),0.3250630679000112,0.568550810000164,0.8974358974358975,1.0,1.0,3/6,24.27%,SFXN2;SLC1A4;SFXN1
prerank,GO_Biological_Process_2021__regulation of histamine secretion by mast cell (GO:1903593),-0.37828455466525807,-0.5674761933304355,0.9206349206349206,1.0,1.0,1/5,17.04%,SNX6
prerank,GO_Biological_Process_2021__positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987),-0.3953619475722601,-0.5674623905641035,0.9310344827586207,1.0,1.0,1/5,7.69%,CCNB1
prerank,GO_Biological_Process_2021__sarcoplasmic reticulum calcium ion transport (GO:0070296),0.35198182723978994,0.5674505428251444,0.918918918918919,1.0,1.0,2/6,20.00%,ANK2;RYR1
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),-0.2667197043951585,-0.5674107134587462,1.0,1.0,1.0,5/32,19.63%,PRKCQ;PRKCD;TSC2;TNS2;PRKCB
prerank,GO_Biological_Process_2021__chromatin silencing at telomere (GO:0006348),0.3348533576616277,0.5673022853702266,1.0,1.0,1.0,4/6,32.62%,SIRT2;DPY30;EZH2;RIF1
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),-0.3130639791310061,-0.5671904259877769,1.0,1.0,1.0,1/12,9.24%,BRCA1
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),-0.22139563571908702,-0.5659282392849245,1.0,1.0,1.0,52/408,19.92%,TGFBR2;TLR2;VRK2;PLK2;APP;CCL2;MAP3K6;RPS6KA1;PRDX4;PIM3;MYO3A;TLR3;NUAK2;MAK;FAM20A;FAM20C;PTK6;PRKCQ;SBK1;SYK;PDK3;PRKCG;PDK1;NUAK1;MINK1;PIM1;DAB2IP;BMX;PINK1;STK32B;STRADB;HIPK4;LIPE;CDK2;FES;PRKCH;COQ8B;DCLK1;CDK5;MYLK3;PRKCD;GLYCTK;LIMK2;NEK10;CDC7;RELN;TGFB1;PRKCB;NRBP2;AATK;DAPK3;PIK3CD
prerank,GO_Biological_Process_2021__positive regulation of histone phosphorylation (GO:0033129),0.3369609232638187,0.5652707496514914,0.8974358974358975,1.0,1.0,5/5,66.31%,RPS6KA4;FMR1;MAPK3;RPS6KA5;CDK9
prerank,GO_Biological_Process_2021__negative regulation of skeletal muscle cell differentiation (GO:2001015),-0.37649321725045554,-0.5650191184392146,0.9821428571428571,1.0,1.0,5/5,62.37%,SIX4;AKIRIN1;MSTN;EPHB1;MYOCD
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),-0.3620529172974242,-0.5647671877353208,0.9298245614035088,1.0,1.0,1/7,23.26%,CLN3
prerank,GO_Biological_Process_2021__cellular response to copper ion (GO:0071280),0.30486597831029144,0.5638831842409743,0.9333333333333333,1.0,1.0,2/13,10.05%,MT1E;HSF1
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),0.2969782223512192,0.5634409843655006,0.8974358974358975,1.0,1.0,1/10,10.05%,HSF1
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),-0.2658256657752731,-0.5634188092707195,0.9864864864864865,1.0,1.0,2/36,10.66%,BHMT;EEF1AKMT2
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),0.28835785626287275,0.562950342694202,1.0,1.0,1.0,2/16,10.05%,MT1E;HSF1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.32665687041057956,-0.5628359859287831,0.9710144927536232,1.0,1.0,6/16,27.68%,ATP1B1;CACNA1C;RYR2;CALM3;SLC9A1;GSTO1
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),-0.2641381827212508,-0.562794141392787,1.0,1.0,1.0,4/42,16.66%,ABCA12;FA2H;CYP4F22;ORMDL2
prerank,GO_Biological_Process_2021__long-chain fatty acid biosynthetic process (GO:0042759),-0.2950658736127578,-0.5625907050734013,0.9710144927536232,1.0,1.0,1/20,3.91%,ALOX12
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),0.2903455619995336,0.5624381228545301,0.967741935483871,1.0,1.0,4/13,29.43%,SNAPC3;RPAP2;NIFK;SPIN1
prerank,GO_Biological_Process_2021__steroid hormone biosynthetic process (GO:0120178),0.27546203193435936,0.5622794272076904,0.9666666666666667,1.0,1.0,7/17,24.58%,STARD3NL;HSD17B11;HSD17B6;AKR1B1;CYP11A1;STARD3;FDX1
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),-0.27620003372666646,-0.5622771437322245,0.9868421052631579,1.0,1.0,4/27,20.36%,CAV3;PFN2;PRKCD;KANK3
prerank,GO_Biological_Process_2021__muscle tissue development (GO:0060537),0.3174245794047156,0.5608707267486213,0.90625,1.0,1.0,3/9,26.78%,POGLUT1;SMO;NF1
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),0.3054523400429914,0.5603095445290837,0.972972972972973,1.0,1.0,2/10,11.53%,PTGIS;TP53BP2
prerank,GO_Biological_Process_2021__leucine catabolic process (GO:0006552),0.35548117026249265,0.5591339444958819,0.8695652173913043,1.0,1.0,2/5,31.16%,IVD;HMGCL
prerank,GO_Biological_Process_2021__monoubiquitinated protein deubiquitination (GO:0035520),-0.37247998915527025,-0.5590381681028284,0.953125,1.0,1.0,1/6,15.38%,BAP1
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),-0.2618188010075073,-0.5590155398473703,1.0,1.0,1.0,8/53,21.12%,RIT2;CALY;LRPAP1;TSC2;SPHK1;GPC3;FLOT1;ARFGAP1
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),0.3086427586414144,0.5590023287259036,0.9459459459459459,1.0,1.0,2/8,29.25%,PKIB;SIRT1
prerank,GO_Biological_Process_2021__succinate transport (GO:0015744),0.3358918332087705,0.5587582816082801,1.0,1.0,1.0,4/6,32.24%,SLC25A14;SLC13A5;SLC13A3;SLC25A11
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),-0.3184140572892486,-0.5583868322171862,0.9402985074626866,1.0,1.0,5/16,23.67%,MYH11;MYLK3;FHOD3;PDGFRA;CXADR
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.2125123756683623,0.5582532388090612,1.0,1.0,1.0,8/44,19.66%,TNFAIP3;HSPA1A;TRADD;SPATA2;CFLAR;CPNE1;CLIP3;SPPL2A
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),0.23180971164819925,0.5579712748190582,1.0,1.0,1.0,7/29,24.68%,NAF1;HNRNPU;PAIP1;DKC1;ZCCHC17;NSUN2;TRDMT1
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),0.26416541141348876,0.5578506014694283,1.0,1.0,1.0,7/23,19.20%,SLC47A1;SLC25A18;SLC3A2;SLC22A2;SLC25A22;SLC25A38;SLC36A4
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),-0.31287042583381297,-0.5572923720762828,0.9733333333333334,1.0,1.0,3/13,25.92%,STAT6;GHR;STAT3
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),0.23111021218961,0.5572411470735128,1.0,1.0,1.0,5/47,13.33%,SRPRB;DNAJB11;SERP1;VAPB;SSR1
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),0.3055583679254833,0.5562118192251089,0.9736842105263158,1.0,1.0,7/7,69.45%,YWHAZ;CDC42;COPG1;PDCD10;ARHGAP21;STK25;RIPOR1
prerank,GO_Biological_Process_2021__rRNA 3'-end processing (GO:0031125),-0.33036308172961454,-0.5560130342244274,0.9523809523809523,1.0,1.0,3/9,25.00%,RPS21;EXOSC7;EXOSC10
prerank,GO_Biological_Process_2021__protein localization to ciliary transition zone (GO:1904491),0.3263818586758455,0.5560012006719751,0.9523809523809523,1.0,1.0,5/5,67.37%,SPATA7;TCTN2;TCTN1;NPHP4;TMEM107
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),-0.25749084599791244,-0.5557187125844235,0.9882352941176471,1.0,1.0,2/39,13.79%,SUN3;IRAG2
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),-0.2988061191534215,-0.5555026711919984,0.9701492537313433,1.0,1.0,4/15,23.74%,ADCY7;ADCY5;ADCY8;ADCY3
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),-0.3449322126660346,-0.5553088632021603,0.9516129032258065,1.0,1.0,1/8,16.19%,DDRGK1
prerank,GO_Biological_Process_2021__epithelial structure maintenance (GO:0010669),-0.3694276367736364,-0.5549924136513406,0.9827586206896551,1.0,1.0,3/7,28.65%,CXADR;MUC6;MUC4
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),-0.306618580876541,-0.5547979251937436,0.9452054794520548,1.0,1.0,4/12,31.01%,DDRGK1;RETREG1;ULK1;ULK2
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),0.2531586813492874,0.554735115398307,1.0,1.0,1.0,2/25,5.63%,TRIB3;ANKRD26
prerank,GO_Biological_Process_2021__regulation of lymphocyte activation (GO:0051249),0.31441288565817743,0.5546992643092448,0.90625,1.0,1.0,2/5,17.49%,KAT2A;IKZF3
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),0.25970661578468607,0.5545783157394402,1.0,1.0,1.0,5/20,21.99%,GPHN;SCP2;MOCS2;NOXRED1;LIAS
prerank,GO_Biological_Process_2021__carnitine biosynthetic process (GO:0045329),-0.3661024707375615,-0.5537208278154961,0.9365079365079365,1.0,1.0,2/5,21.11%,TMLHE;SHMT1
prerank,GO_Biological_Process_2021__amino-acid betaine biosynthetic process (GO:0006578),-0.3661024707375615,-0.5537208278154961,0.9365079365079365,1.0,1.0,2/5,21.11%,TMLHE;SHMT1
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),-0.2659358726018349,-0.5535126352032497,0.9871794871794872,1.0,1.0,5/40,18.78%,APP;PARP9;RPL10;RBM4B;RBM3
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),0.262155604549247,0.5533678097244954,1.0,1.0,1.0,2/21,9.33%,TBC1D12;RAB1B
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),-0.24453621159182853,-0.553208243491271,1.0,1.0,1.0,10/81,19.61%,PLK2;WNT5A;GFAP;PRKCG;DAB2IP;VIP;HECW2;GPC3;OAZ2;EEF1A2
prerank,GO_Biological_Process_2021__negative regulation of blood pressure (GO:0045776),-0.33018600237028184,-0.5525785693637513,0.9411764705882353,1.0,1.0,2/8,17.82%,NOS1;APLN
prerank,GO_Biological_Process_2021__negative regulation of autophagosome maturation (GO:1901097),-0.3642942801162321,-0.550873596763388,0.890625,1.0,1.0,1/5,21.69%,PHF23
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),0.25392645187052054,0.5504872296544737,1.0,1.0,1.0,3/14,14.45%,ANK2;VAPA;TAPT1
prerank,GO_Biological_Process_2021__digestive tract morphogenesis (GO:0048546),0.3240745082177935,0.5504040734207821,0.9428571428571428,1.0,1.0,3/8,17.38%,NIPBL;RBPMS2;ID2
prerank,GO_Biological_Process_2021__depurination (GO:0045007),-0.3499062214959383,-0.5502267855241083,0.8852459016393442,1.0,1.0,2/8,24.83%,OGG1;TINF2
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),-0.234280351828729,-0.5499295713087289,1.0,1.0,1.0,19/112,23.09%,B3GALT2;FUT2;ST3GAL6;MAN1C1;B3GNT5;B3GNT2;ST6GALNAC2;GALNT10;B3GALT4;B4GALT7;MGAT5;TUSC3;GFPT2;DPM3;PMM1;MGAT3;TMEM258;ALG1L2;ST8SIA3
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.2928504057444464,-0.5498248569992468,1.0,1.0,1.0,7/17,35.31%,BCL2L2;BOK;FAS;ITGAV;BCL2L1;MCL1;MOAP1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),0.2612416447235164,0.547647684871752,1.0,1.0,1.0,13/13,73.89%,PARP1;ERCC4;TERF1;PINX1;ERCC1;TERF2;TNKS;TNKS2;SMG6;ATM;TERF2IP;NBN;SLX4
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),-0.3344039837146838,-0.5471996800426161,0.9682539682539683,1.0,1.0,1/8,11.49%,ZFPM1
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),-0.2649242431499375,-0.5467481318946665,1.0,1.0,1.0,5/38,17.04%,SLC39A14;ATP5IF1;GCHFR;DAB2IP;NOS1
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),0.23485315317388542,0.5464878122775672,1.0,1.0,1.0,3/30,17.60%,TRAK2;LRPPRC;TMEM201
prerank,GO_Biological_Process_2021__modulation by symbiont of host autophagy (GO:0075071),-0.36419014473347877,-0.5458313433196142,0.9827586206896551,1.0,1.0,3/5,38.56%,ULK1;ULK2;IRGM
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),0.26654185858360113,0.5453380497933676,0.9333333333333333,1.0,1.0,3/13,21.88%,ADRB2;UBQLN4;FYCO1
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),0.3210637115377236,0.5453367598846934,1.0,1.0,1.0,1/10,5.03%,TCAP
prerank,GO_Biological_Process_2021__positive regulation of histone exchange (GO:1900051),0.2701707895151108,0.5451440489439245,0.9487179487179487,1.0,1.0,4/9,33.61%,POT1;DAXX;TERF1;ATRX
prerank,GO_Biological_Process_2021__regulation of histone exchange (GO:1900049),0.2701707895151108,0.5451440489439245,0.9487179487179487,1.0,1.0,4/9,33.61%,POT1;DAXX;TERF1;ATRX
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),-0.26630194612290503,-0.5450331420132459,0.9552238805970149,1.0,1.0,1/18,11.17%,RPS13
prerank,GO_Biological_Process_2021__negative regulation of oxidoreductase activity (GO:0051354),-0.3477926495846581,-0.5446513407627216,0.9629629629629629,1.0,1.0,2/6,37.83%,HDAC6;MT3
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),0.3090007087172218,0.5443032681026037,0.975609756097561,1.0,1.0,7/7,69.11%,ATG2B;ATG7;RB1CC1;ATG2A;ATG13;ULK2;ULK1
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),0.3090007087172218,0.5443032681026037,0.975609756097561,1.0,1.0,7/7,69.11%,ATG2B;ATG7;RB1CC1;ATG2A;ATG13;ULK2;ULK1
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),0.26324377868216603,0.5439606501518517,1.0,1.0,1.0,3/15,19.84%,KAT7;KANSL2;MCRS1
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),0.26324377868216603,0.5439606501518517,1.0,1.0,1.0,3/15,19.84%,KAT7;KANSL2;MCRS1
prerank,GO_Biological_Process_2021__RIG-I signaling pathway (GO:0039529),-0.36380752049214016,-0.5434875712877176,0.9821428571428571,1.0,1.0,3/5,34.53%,TRIM25;OAS3;CLPB
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),-0.31002786834751944,-0.5430900677743646,0.9714285714285714,1.0,1.0,3/12,22.26%,PINK1;PHF23;NUPR1
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),0.23431762628617453,0.5425197053751655,1.0,1.0,1.0,2/25,9.69%,ERCC6;ERCC2
prerank,GO_Biological_Process_2021__cellular response to prostaglandin stimulus (GO:0071379),0.3109175814380414,0.5417590030741009,0.9487179487179487,1.0,1.0,2/6,14.53%,AKR1C3;TNFSF4
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),-0.3441824313613753,-0.5413412174811459,0.971830985915493,1.0,1.0,4/9,31.02%,PRKCB;ZDHHC3;CD36;PPARG
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),-0.324336949606781,-0.541032428476663,0.96,1.0,1.0,2/9,15.08%,COPS9;RPL5
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),-0.28836104297658993,-0.5408622842336008,1.0,1.0,1.0,5/17,30.23%,FAR2;FASN;SCD;DGAT1;CBR4
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),-0.29077965519061405,-0.5396510421139069,0.9736842105263158,1.0,1.0,3/16,27.57%,GLI1;SFRP1;TXNDC15
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.3068470706495341,-0.5392184994293048,0.9736842105263158,1.0,1.0,5/14,29.84%,SFRP2;CDKN2D;TRIM32;RPS3;DDIAS
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma production (GO:0032689),0.2661541105728794,0.5381475983671233,1.0,1.0,1.0,3/15,14.58%,HMGB1;TNFSF4;HAVCR2
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),0.28852243824562085,0.5379898371968138,0.9487179487179487,1.0,1.0,3/11,16.39%,HAVCR2;RC3H1;ENPP3
prerank,GO_Biological_Process_2021__nuclear RNA surveillance (GO:0071027),0.29008235497275986,0.5376373117607786,1.0,1.0,1.0,4/9,27.63%,EXOSC6;EXOSC8;EXOSC5;XRN1
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),-0.3108445597414607,-0.5375076289779991,1.0,1.0,1.0,1/16,3.95%,ASPN
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),0.2590886075949366,0.5371745874546425,1.0,1.0,1.0,11/11,74.11%,PAPOLA;CDC73;DHX36;ZC3H3;ZFP36L1;NCBP1;LEO1;AHCYL1;BARD1;NCBP2;PAF1
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),0.2945881638232169,0.5367970953810813,0.9714285714285714,1.0,1.0,8/8,70.55%,BECN1;PRKN;AMBRA1;PHB2;MAP1LC3B;ATG13;ATG14;SQSTM1
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),0.2316646937315972,0.5367929760925931,1.0,1.0,1.0,5/27,20.85%,PGAP1;PIGP;PIGU;DPM1;PIGF
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),-0.3086401160261651,-0.5360974424869913,1.0,1.0,1.0,1/11,9.24%,BRCA1
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),0.251289115061428,0.535233654330382,0.96875,1.0,1.0,2/10,17.38%,HSF1;ID2
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),-0.28437228591766817,-0.5351608323795568,0.9696969696969697,1.0,1.0,3/15,20.96%,PIGA;PIGC;PIGH
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.2595555522644955,0.5349259002349904,0.9743589743589743,1.0,1.0,4/13,19.69%,HOMER2;GRM1;GRM3;GRM8
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),-0.34471343808946386,-0.5341449005841722,0.9552238805970149,1.0,1.0,1/7,21.15%,ARL13A
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),0.23376266129988718,0.5340684966844668,1.0,1.0,1.0,7/19,34.08%,ABL2;PDPK1;GNA13;ARF4;PLCG1;ESR1;FGFR2
prerank,GO_Biological_Process_2021__mitochondrial RNA 3'-end processing (GO:0000965),0.3499696294796517,0.5336987111594184,0.9736842105263158,1.0,1.0,5/5,65.01%,HSD17B10;TRMT10C;PNPT1;TRNT1;SUPV3L1
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),0.2579266377508529,0.5332469874860358,1.0,1.0,1.0,2/22,12.77%,MAPK12;CDH2
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),-0.2468807112930404,-0.5331622534131669,0.9841269841269841,1.0,1.0,2/36,13.15%,KIF17;IFT122
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),0.3433168484236642,0.5330013422267461,0.9361702127659575,1.0,1.0,1/5,23.06%,MFN2
prerank,GO_Biological_Process_2021__nucleosome positioning (GO:0016584),-0.31263105008340125,-0.5328636531790845,0.9545454545454546,1.0,1.0,2/9,25.90%,H1-4;PAF1
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),0.23945018035272317,0.532782440682819,1.0,1.0,1.0,4/21,17.68%,RUNX1;KAT2A;MDK;CAMK4
prerank,GO_Biological_Process_2021__polyamine metabolic process (GO:0006595),0.2804982986445464,0.5326222177137443,0.9310344827586207,1.0,1.0,4/10,23.76%,HDAC10;SAT1;SMOX;SRM
prerank,GO_Biological_Process_2021__tRNA transcription (GO:0009304),0.27190806459778255,0.5324497849610084,1.0,1.0,1.0,8/8,72.82%,GTF3C3;GTF3C4;GTF3C5;GTF3C2;GTF3C1;BRF1;POLR2L;GTF3C6
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),-0.3546220241386306,-0.5324455950427083,0.96875,1.0,1.0,2/6,19.49%,SOX15;TGFB1
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),-0.31621229866472134,-0.532368984750776,0.9622641509433962,1.0,1.0,1/8,22.17%,VCL
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),-0.2564170873715223,-0.5317445826924705,1.0,1.0,1.0,2/29,15.25%,CC2D2A;GLI1
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),0.25926416435904215,0.531716411638205,1.0,1.0,1.0,4/28,13.70%,MTERF1;BRF2;TAF12;TAF4
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte apoptotic process (GO:0070229),-0.3383425617491292,-0.5316776635778611,0.9552238805970149,1.0,1.0,3/6,22.08%,PRKCQ;IRS2;BCL6
prerank,GO_Biological_Process_2021__leukotriene transport (GO:0071716),-0.3411135966658816,-0.5315843982174687,1.0,1.0,1.0,2/7,21.22%,ABCC4;ABCC1
prerank,GO_Biological_Process_2021__regulation of oxidoreductase activity (GO:0051341),0.30702868899625524,0.530412787711253,0.9583333333333334,1.0,1.0,1/8,15.58%,ABL2
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),0.30948907903817413,0.5292370843869842,0.9722222222222222,1.0,1.0,3/9,24.28%,SPX;ACSL3;RPS6KB1
prerank,GO_Biological_Process_2021__histone-serine phosphorylation (GO:0035404),0.30385705608422764,0.528263834707478,0.9743589743589743,1.0,1.0,5/5,69.62%,RPS6KA4;VRK1;HMGA2;RPS6KA5;MST1
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),0.23800505981744188,0.5274952628558851,1.0,1.0,1.0,3/15,21.23%,ACSS1;SCD5;MLYCD
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.3594485123771062,0.5269395431376369,0.9705882352941176,1.0,1.0,2/6,17.68%,TICAM1;CAMK4
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle priming (GO:0010807),-0.3262216271422509,-0.526034312468872,0.9354838709677419,1.0,1.0,2/5,25.97%,STX1B;NAPA
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),0.2530938765248931,0.5256924467158319,0.9411764705882353,1.0,1.0,5/12,24.89%,LLGL1;ESPL1;ZBED3;LLGL2;CLASP2
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),-0.28164519208468414,-0.5244170054967887,1.0,1.0,1.0,6/23,23.51%,POU4F1;EGF;IGF1;TGFB1;HES1;NIBAN2
prerank,GO_Biological_Process_2021__immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.3051962111198441,-0.5242071202995514,0.9552238805970149,1.0,1.0,2/10,24.95%,SH2B2;FPR3
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),-0.23032255091573964,-0.5237710784421818,1.0,1.0,1.0,3/51,10.11%,RAB11A;PLK3;DCTN1
prerank,GO_Biological_Process_2021__toll-like receptor 4 signaling pathway (GO:0034142),-0.29657681663006874,-0.5234701528469032,0.9545454545454546,1.0,1.0,3/11,27.92%,SCIMP;NMI;CD14
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),-0.2526554445145236,-0.523012376072565,1.0,1.0,1.0,9/48,23.83%,IL15;PTK6;SYK;BMX;FES;RELN;AATK;PDGFRA;GHR
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.28189798273023,-0.5226514335942694,0.9863013698630136,1.0,1.0,4/14,22.87%,RPS7;RPL5;RPL23;RPL11
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),-0.2910537028955467,-0.5223559181983445,1.0,1.0,1.0,4/16,21.62%,CD200;RELN;ADCY8;CAMK1D
prerank,GO_Biological_Process_2021__late endosome to lysosome transport (GO:1902774),-0.35966152161829595,-0.5213780483439492,0.9565217391304348,1.0,1.0,1/5,14.28%,PLEKHM1
prerank,GO_Biological_Process_2021__positive regulation of ceramide biosynthetic process (GO:2000304),-0.3187087684735765,-0.5210193653917256,0.9841269841269841,1.0,1.0,2/9,18.01%,PRKCD;TNFRSF1A
prerank,GO_Biological_Process_2021__positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.3187087684735765,-0.5210193653917256,0.9841269841269841,1.0,1.0,2/9,18.01%,PRKCD;TNFRSF1A
prerank,GO_Biological_Process_2021__snRNA modification (GO:0040031),0.3196894332020407,0.5198070388984314,0.972972972972973,1.0,1.0,3/6,22.55%,METTL4;DKC1;MEPCE
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),-0.2423364615657706,-0.5193525819168169,1.0,1.0,1.0,1/42,5.89%,SNRPD2
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),0.2360210696920583,0.5187688768677204,1.0,1.0,1.0,17/17,76.42%,GTF3C3;NIFK;SPIN1;TCOF1;GTF3C4;TAF1B;SIRT7;MARS1;GTF3C5;GTF3C2;GTF3C1;BRF1;GTF3A;POLR1G;POLR1E;GTF3C6;CAVIN1
prerank,GO_Biological_Process_2021__regulation of chromatin assembly or disassembly (GO:0001672),0.3146038977474056,0.5186871501541682,0.9777777777777777,1.0,1.0,6/6,68.55%,TLK1;MAP1S;TLK2;SPTY2D1;PADI2;PARP10
prerank,GO_Biological_Process_2021__inositol metabolic process (GO:0006020),0.3143667105396376,0.5186522674964006,1.0,1.0,1.0,7/7,68.57%,ISYNA1;PPIP5K2;IPPK;IMPA2;PPIP5K1;ITPK1;IMPA1
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),-0.3089196506223243,-0.5186017975238053,0.9857142857142858,1.0,1.0,2/7,25.40%,MMP24;CTNND1
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),0.30012705268575973,0.5175967493161941,0.9411764705882353,1.0,1.0,1/10,9.42%,NRXN1
prerank,GO_Biological_Process_2021__tRNA aminoacylation for mitochondrial protein translation (GO:0070127),-0.32868664902553474,-0.5153767514539155,1.0,1.0,1.0,2/7,23.02%,GARS1;DARS2
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 9 signaling pathway (GO:0034165),-0.3385165745253934,-0.5147404374771576,1.0,1.0,1.0,3/5,25.65%,SLC15A4;RSAD2;RTN4
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell development (GO:0097084),-0.3235348089067687,-0.5140909475401619,0.9661016949152542,1.0,1.0,2/6,28.44%,HES1;ENG
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),0.23190498790146843,0.5137657191015588,1.0,1.0,1.0,11/20,32.33%,NT5C1A;PDE9A;PRTFDC1;MLYCD;NUDT7;NT5E;ENTPD4;FITM2;NT5C2;AMPD3;HPRT1
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),-0.2772124457469011,-0.5132696645609347,0.9855072463768116,1.0,1.0,1/16,9.24%,BRCA1
prerank,GO_Biological_Process_2021__negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.27683272579991913,0.5129715048237431,1.0,1.0,1.0,9/9,72.33%,GPATCH3;UFD1;TKFC;SEC14L1;NPLOC4;RIOK3;DHX58;C1QBP;TSPAN6
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),0.23464597353219596,0.5125588057117987,1.0,1.0,1.0,4/27,17.38%,MEGF10;MAPK12;CDH2;ID2
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),-0.27201894814680355,-0.5112113137556614,0.9682539682539683,1.0,1.0,3/16,23.27%,CCL2;APLN;COL4A3
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.2503020497131104,-0.5108803456828689,1.0,1.0,1.0,1/23,10.24%,IL1RAPL1
prerank,GO_Biological_Process_2021__membrane invagination (GO:0010324),-0.32086198343924466,-0.5108362686749848,0.9818181818181818,1.0,1.0,2/6,32.60%,CHMP2A;FCHO2
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),-0.3110511668102126,-0.5103411554439321,0.9846153846153847,1.0,1.0,1/8,23.26%,CLN3
prerank,GO_Biological_Process_2021__regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.30784314196199436,-0.5103283387453244,0.9655172413793104,1.0,1.0,2/9,15.39%,DLGAP3;NPTX2
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.20922530669355105,0.5095970610629997,1.0,1.0,1.0,6/27,24.06%,STYX;EIF3H;FHIT;CCAR2;N4BP1;HFE
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.30330860260445297,0.5089159885852587,0.9714285714285714,1.0,1.0,2/8,20.32%,ATP1A2;NEDD4L
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",-0.2859565160112136,-0.5084778360686626,0.9852941176470589,1.0,1.0,3/15,29.05%,OGG1;TINF2;MBD4
prerank,GO_Biological_Process_2021__negative regulation of mRNA polyadenylation (GO:1900364),0.272267940763673,0.5077555890786679,0.96875,1.0,1.0,3/8,21.78%,ZC3H14;RNF20;CCNT1
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),-0.2936133415102056,-0.5069470931619617,1.0,1.0,1.0,1/13,11.66%,PRKCQ
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),0.18784766858879348,0.5068886535958991,1.0,1.0,1.0,5/52,12.51%,RAB23;RAB1B;TRAPPC8;PIK3C3;RUFY4
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),-0.25045845312720993,-0.5061398923821374,1.0,1.0,1.0,6/27,26.51%,ISG15;NELL1;TGFB1;ALOX5;P2RX7;TGFB3
prerank,GO_Biological_Process_2021__negative regulation of execution phase of apoptosis (GO:1900118),0.30847115456169605,0.5047673837349262,0.9555555555555556,1.0,1.0,2/6,25.94%,RNF34;FZD3
prerank,GO_Biological_Process_2021__COPI-coated vesicle budding (GO:0035964),-0.3380439568037578,-0.504742884185422,0.9836065573770492,1.0,1.0,2/6,28.34%,TMED10;ARFGAP3
prerank,GO_Biological_Process_2021__COPI coating of Golgi vesicle (GO:0048205),-0.3380439568037578,-0.504742884185422,0.9836065573770492,1.0,1.0,2/6,28.34%,TMED10;ARFGAP3
prerank,GO_Biological_Process_2021__Golgi transport vesicle coating (GO:0048200),-0.3380439568037578,-0.504742884185422,0.9836065573770492,1.0,1.0,2/6,28.34%,TMED10;ARFGAP3
prerank,GO_Biological_Process_2021__negative regulation of axon regeneration (GO:0048681),-0.32067830928878766,-0.5042482070873763,0.9636363636363636,1.0,1.0,6/6,67.95%,RTN4RL1;CERS2;INPP5F;PTPRS;RTN4R;EPHA4
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),0.2896874800155369,0.5038668686221608,1.0,1.0,1.0,4/10,33.70%,NDFIP1;SNX3;TERF1;SNX12
prerank,GO_Biological_Process_2021__glycine transport (GO:0015816),0.3497420689817202,0.5034247345746423,0.9722222222222222,1.0,1.0,1/5,18.10%,SLC25A38
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.2382368392502714,-0.5027922904529232,1.0,1.0,1.0,14/54,30.69%,YBX3;SFRP2;PINK1;BCL2L2;CREB3;CDKN2D;PTTG1IP;XBP1;PLAUR;SYVN1;TRIM32;DDIAS;PARK7;HSPB1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),0.29921538850923823,0.5018132065961461,0.9230769230769231,1.0,1.0,6/6,70.09%,FBXW7;PRKN;NONO;HIF1A;MCL1;PARK7
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),-0.2939780615392705,-0.5016033876281454,0.9705882352941176,1.0,1.0,2/10,25.25%,ECHDC3;SORBS1
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),-0.28396374499974686,-0.5003214065041693,0.972972972972973,1.0,1.0,12/12,71.63%,PARP2;PARK7;MT3;HDAC1;HLCS;HELLS;SIRT7;UFL1;SIRT1;CHD1;SETD5;MBD2
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.3103174468230483,-0.5001542691720351,0.9538461538461539,1.0,1.0,3/9,26.90%,FLOT1;CAMK1;EHD1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),0.21191473627583998,0.5001057379467536,1.0,1.0,1.0,9/24,32.48%,AKT1;GPR37L1;NFE2L2;MAPK7;REST;SIRT1;FBXO7;ATF4;PRKN
prerank,GO_Biological_Process_2021__tRNA transcription by RNA polymerase III (GO:0042797),0.27189429988863023,0.4998807602690897,1.0,1.0,1.0,7/7,72.82%,GTF3C3;GTF3C4;GTF3C5;GTF3C2;GTF3C1;POLR2L;GTF3C6
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),-0.24555950848613398,-0.49725003266163287,1.0,1.0,1.0,3/29,14.90%,FSIP2;IFT122;SNX10
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),-0.2760487685077626,-0.49717033234639396,1.0,1.0,1.0,1/16,6.76%,AKR1C1
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),-0.277619432722061,-0.49712310182394576,0.9857142857142858,1.0,1.0,3/17,18.75%,HK2;PINK1;PML
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),-0.22656879740195,-0.4970573501343513,1.0,1.0,1.0,10/56,22.25%,EGF;VIL1;PTK6;MVP;TGFA;CDC37;TGFB1;PLCE1;ERBIN;PTPRR
prerank,GO_Biological_Process_2021__positive regulation of cellular respiration (GO:1901857),0.28127142772893676,0.4969632437313524,0.9714285714285714,1.0,1.0,2/8,16.88%,VCP;IFNLR1
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),-0.2746349011582144,-0.49613232144005126,1.0,1.0,1.0,2/10,32.10%,CLN3;AP4M1
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),-0.3276033742101598,-0.49594285777222663,0.9827586206896551,1.0,1.0,2/5,26.28%,SLIT3;SLIT2
prerank,GO_Biological_Process_2021__pexophagy (GO:0000425),0.294573250987142,0.49572255362886075,0.9696969696969697,1.0,1.0,7/7,70.55%,USP30;PEX5;PJVK;NBR1;ATM;MAP1LC3B;SQSTM1
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),-0.2210190610867578,-0.4951090988910832,1.0,1.0,1.0,9/59,23.50%,TGFBR2;SBK1;HIPK4;CDK5;PRKCD;GALNT16;HIPK3;GALNTL6;GALNT13
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase I (GO:0016479),-0.31252254190791706,-0.4949579447045732,0.9710144927536232,1.0,1.0,3/5,33.44%,MACROH2A2;NOP53;FLNA
prerank,GO_Biological_Process_2021__nonribosomal peptide biosynthetic process (GO:0019184),-0.29152019286433706,-0.49358226692165463,1.0,1.0,1.0,3/10,31.15%,GSS;CHAC2;GGCT
prerank,GO_Biological_Process_2021__left/right pattern formation (GO:0060972),-0.2938768687174975,-0.4927197894255725,0.9838709677419355,1.0,1.0,3/6,31.00%,AHI1;DNAAF1;CITED2
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),-0.27797850357295945,-0.49270172792500133,1.0,1.0,1.0,1/16,9.21%,APOD
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),0.22455180796110608,0.4924804672774842,1.0,1.0,1.0,15/15,77.56%,RRM2B;HPRT1;PRPSAP2;GART;PRPSAP1;RRM1;PPAT;NMNAT1;NMNAT2;PRPS2;PRPS1;ME1;MTHFD1;NMNAT3;PNP
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),0.23478421733269156,0.4907759630738239,1.0,1.0,1.0,5/13,29.99%,FBXO5;MARCHF5;SLC30A10;SIRT1;ZKSCAN3
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),-0.3049166461061701,-0.49064694558153055,0.9852941176470589,1.0,1.0,3/8,33.70%,AKAP8;AKAP8L;CDK9
prerank,GO_Biological_Process_2021__regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),0.31524600121482094,0.49043975346055196,0.9393939393939394,1.0,1.0,5/5,68.48%,TMEM108;ZDHHC17;DOK5;AGT;NTRK3
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),-0.2572704281781619,-0.4900992459047788,0.987012987012987,1.0,1.0,1/20,9.40%,POLR2I
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),-0.2572704281781619,-0.4900992459047788,0.987012987012987,1.0,1.0,1/20,9.40%,POLR2I
prerank,GO_Biological_Process_2021__protein deglutamylation (GO:0035608),-0.31033984087604516,-0.48992476194679724,0.9701492537313433,1.0,1.0,1/7,12.01%,FOLH1
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),-0.26833381250138566,-0.4893077498511014,1.0,1.0,1.0,1/14,11.75%,LPCAT4
prerank,GO_Biological_Process_2021__citrulline metabolic process (GO:0000052),0.2816265265198734,0.48913257928960996,0.9743589743589743,1.0,1.0,4/6,30.67%,DDAH1;CAD;ALDH18A1;CPS1
prerank,GO_Biological_Process_2021__regulation of response to reactive oxygen species (GO:1901031),0.3149941210637174,0.4890526534767933,1.0,1.0,1.0,2/5,23.26%,DHFR;BMP7
prerank,GO_Biological_Process_2021__regulation of pattern recognition receptor signaling pathway (GO:0062207),0.27670797695196797,0.4888996381612696,1.0,1.0,1.0,2/7,15.16%,SLC15A2;ZDHHC5
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),0.29897418696928046,0.488807793870145,0.9512195121951219,1.0,1.0,2/6,21.63%,PIK3R1;PTK2
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),-0.25578999906040395,-0.4879717605009733,1.0,1.0,1.0,3/19,23.96%,HAP1;CEP135;SEPTIN9
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),0.2795448558516558,0.4878382634377105,1.0,1.0,1.0,2/10,17.10%,SLC25A18;SLC25A22
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),0.2705548805184286,0.4870410305793929,1.0,1.0,1.0,9/9,72.96%,CEBPG;ARL8B;LYST;MICA;PLEKHM2;KIF5B;TUBB;TUBB4B;KLRD1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 9 signaling pathway (GO:0034163),-0.2900073438466031,-0.48651340408384897,0.9846153846153847,1.0,1.0,3/8,25.65%,SLC15A4;RSAD2;RTN4
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide biosynthetic process (GO:0009220),-0.3039943188054537,-0.48602427037343815,0.9836065573770492,1.0,1.0,3/7,31.05%,AK5;DHODH;CTPS1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),-0.30472398770530507,-0.48467623894234346,0.9701492537313433,1.0,1.0,1/8,14.53%,PINK1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),-0.23107074455018004,-0.4843423801531854,1.0,1.0,1.0,12/47,29.46%,RAMP3;AKAP5;ITGA3;PRKCH;STAC2;GPER1;CLN3;SORBS1;STX3;STX4;CNPY4;SQSTM1
prerank,GO_Biological_Process_2021__negative regulation of small molecule metabolic process (GO:0062014),0.2621006009397998,0.48403943963004864,0.972972972972973,1.0,1.0,1/9,15.18%,EP300
prerank,GO_Biological_Process_2021__nucleoside phosphate catabolic process (GO:1901292),0.23820295818827,0.48355780997358905,0.9782608695652174,1.0,1.0,6/13,28.33%,NUDT15;ENTPD1;ENPP3;ENTPD4;DCTPP1;ENTPD6
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),-0.3203092682187297,-0.48342235660487193,0.9850746268656716,1.0,1.0,1/5,17.02%,PPIB
prerank,GO_Biological_Process_2021__astrocyte differentiation (GO:0048708),-0.32421114639545456,-0.482170038641844,0.9722222222222222,1.0,1.0,3/6,30.31%,STAT3;CDK6;EIF2B5
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),-0.243665208361658,-0.4804392813960227,0.9859154929577465,1.0,1.0,3/23,22.17%,EMP2;FGF7;VCL
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",0.24549026429078386,0.48029511453102974,0.9666666666666667,1.0,1.0,7/14,34.16%,RBM17;SCNM1;CDK13;SRSF9;DDX5;SFPQ;RSRC1
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),-0.2725995633273275,-0.47983018983460995,1.0,1.0,1.0,1/12,11.36%,BTG1
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),0.23392829569115553,0.4790439731525356,1.0,1.0,1.0,1/17,5.53%,ESD
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),0.23392829569115553,0.4790439731525356,1.0,1.0,1.0,1/17,5.53%,ESD
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),-0.23095142830641882,-0.47898361517843013,1.0,1.0,1.0,6/29,24.46%,NLRP5;CRB2;RPS6KA6;TLE6;NIBAN2;PHLDB2
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),0.2855876926730748,0.47865067314594645,1.0,1.0,1.0,3/5,32.76%,DAG1;CLASP2;CLASP1
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),0.2855876926730748,0.47865067314594645,1.0,1.0,1.0,3/5,32.76%,DAG1;CLASP2;CLASP1
prerank,GO_Biological_Process_2021__regulation of striated muscle cell differentiation (GO:0051153),0.29521640091116164,0.4784625280986733,1.0,1.0,1.0,6/6,70.49%,HDAC9;DMPK;MESP1;RBM24;NRG1;HDAC5
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),0.23252987644318412,0.47842750351585656,1.0,1.0,1.0,13/13,76.76%,AAR2;SART3;CD2BP2;PRPF31;LSM2;PRPF3;PRPF19;SRSF12;PRPF8;USP4;SRSF10;DDX20;PRPF6
prerank,GO_Biological_Process_2021__response to mitochondrial depolarisation (GO:0098780),-0.3125102060068107,-0.47839986164133463,0.9636363636363636,1.0,1.0,2/5,30.62%,SQSTM1;ATG14
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),0.2283473406095297,0.47808538882109575,1.0,1.0,1.0,3/12,25.37%,PARP11;PARP1;PARP6
prerank,GO_Biological_Process_2021__aspartate metabolic process (GO:0006531),0.2859916321265874,0.4776989488072576,0.9777777777777777,1.0,1.0,2/5,23.25%,DDO;GOT2
prerank,GO_Biological_Process_2021__5S class rRNA transcription by RNA polymerase III (GO:0042791),0.2718805365730193,0.4771113435156802,1.0,1.0,1.0,6/6,72.82%,GTF3C3;GTF3C4;GTF3C5;GTF3C2;GTF3C1;GTF3C6
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),-0.24885659897906603,-0.47569367533397044,0.984375,1.0,1.0,5/19,28.02%,DCTN1;EMD;GPER1;CHMP2A;VPS4A
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.2218062369086778,0.4750731322833614,1.0,1.0,1.0,1/17,7.94%,AKT1
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),-0.24354370698380118,-0.4741879323724658,1.0,1.0,1.0,5/18,24.70%,RYR2;RARG;HES1;PDGFRA;TBX20
prerank,GO_Biological_Process_2021__regulation of endocytic recycling (GO:2001135),0.2689854191980558,0.4740618895256279,0.9642857142857143,1.0,1.0,9/9,73.11%,EIPR1;RAB11B;SORL1;ACTN2;EHD2;INPP5F;ATP9A;ARHGAP1;EHD1
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),-0.2920157522649502,-0.47291860872057667,1.0,1.0,1.0,4/9,28.41%,TMEFF2;TGFB1;TAF7;GSTP1
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),0.25918801255441914,0.47230158934405186,1.0,1.0,1.0,7/7,74.09%,TNRC6B;DDX6;EIF4E2;AGO2;EIF4G1;EIF4ENIF1;STAT3
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),0.25918801255441914,0.47230158934405186,1.0,1.0,1.0,7/7,74.09%,TNRC6B;DDX6;EIF4E2;AGO2;EIF4G1;EIF4ENIF1;STAT3
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),0.2588812437885751,0.47175571636238117,1.0,1.0,1.0,2/10,21.45%,PIK3C3;PORCN
prerank,GO_Biological_Process_2021__lymphocyte mediated immunity (GO:0002449),0.2527484839691594,0.4717441883866128,0.9736842105263158,1.0,1.0,3/10,23.08%,MSH2;BTN3A3;JAG1
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),-0.22859619918133647,-0.4714432542355322,0.9861111111111112,1.0,1.0,1/24,6.76%,AKR1C1
prerank,GO_Biological_Process_2021__isocitrate metabolic process (GO:0006102),0.2869001822231221,0.4714245001627947,0.9736842105263158,1.0,1.0,5/5,71.32%,IDH1;IDH3A;IDH3B;IDH3G;IDH2
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),-0.2568638545912322,-0.4709275448467415,1.0,1.0,1.0,4/18,27.72%,IL1RAPL1;RELN;PTPRD;DBNL
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),-0.20997913342495783,-0.47030673451131166,1.0,1.0,1.0,7/50,24.25%,ATG9A;MAP1LC3A;GABARAPL1;WDR45;GABARAPL2;ATG16L2;TMEM41B
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),-0.27082260755720977,-0.4695706160152388,1.0,1.0,1.0,7/11,33.70%,HPF1;NNMT;AKAP8;PARG;PARK7;AKAP8L;CDK9
prerank,GO_Biological_Process_2021__negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316),0.3115666919767147,0.46916812473600117,0.9767441860465116,1.0,1.0,6/6,68.85%,GMFG;CTNNA2;DNAI3;CORO1B;PICK1;GMFB
prerank,GO_Biological_Process_2021__negative regulation of actin nucleation (GO:0051126),0.3115666919767147,0.46916812473600117,0.9767441860465116,1.0,1.0,6/6,68.85%,GMFG;CTNNA2;DNAI3;CORO1B;PICK1;GMFB
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),0.28439809658803283,0.4690357669355979,0.972972972972973,1.0,1.0,7/7,71.57%,TGFBR1;RBPJ;BMPR1A;NOTCH1;NRG1;TGFB2;ENG
prerank,GO_Biological_Process_2021__histone-threonine phosphorylation (GO:0035405),-0.32758054208114923,-0.4687448595440933,0.9838709677419355,1.0,1.0,1/5,19.63%,PRKCB
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule catabolic process (GO:0034656),-0.2633148362588069,-0.4683762797550314,1.0,1.0,1.0,2/12,18.56%,ENTPD3;NUDT16
prerank,GO_Biological_Process_2021__astrocyte development (GO:0014002),-0.3045818890096644,-0.46831790221845326,1.0,1.0,1.0,3/5,37.83%,CDK6;EIF2B5;MT3
prerank,GO_Biological_Process_2021__oxaloacetate transport (GO:0015729),0.29098688990871024,0.4679488134991078,0.975609756097561,1.0,1.0,3/5,32.24%,SLC25A14;SLC13A5;SLC25A11
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),0.23059489435809366,0.4666409348100396,1.0,1.0,1.0,2/17,16.87%,EPS8;ABI2
prerank,GO_Biological_Process_2021__protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.2757309705896026,-0.4665158515602485,0.9836065573770492,1.0,1.0,5/10,35.63%,EMC1;EMC3;EMC9;EMC4;EMC6
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),-0.25159939845407653,-0.4645886228997151,0.9701492537313433,1.0,1.0,4/16,25.36%,NELL1;DAB2IP;RDX;PTTG1IP
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),0.24515977761559582,0.46349114397326496,1.0,1.0,1.0,5/11,36.27%,PANK2;SLC25A16;PPCS;PANK1;PANK4
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.24515977761559582,0.46349114397326496,1.0,1.0,1.0,5/11,36.27%,PANK2;SLC25A16;PPCS;PANK1;PANK4
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.24515977761559582,0.46349114397326496,1.0,1.0,1.0,5/11,36.27%,PANK2;SLC25A16;PPCS;PANK1;PANK4
prerank,GO_Biological_Process_2021__regulation of response to endoplasmic reticulum stress (GO:1905897),-0.2636164033518838,-0.4628414204308811,1.0,1.0,1.0,3/12,26.66%,NUPR1;ALOX5;AQP11
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.24379250625347682,-0.4617116543090048,1.0,1.0,1.0,2/19,14.22%,FBP1;DAB2IP
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum unfolded protein response (GO:1900101),-0.27971579357046605,-0.46145581111846357,0.9827586206896551,1.0,1.0,3/9,27.27%,COPS5;HSPA5;XBP1
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),0.2590754898486153,0.461020565877958,0.9696969696969697,1.0,1.0,10/10,74.11%,RNF20;CDC73;RNF40;UBE2E1;LEO1;WAC;RNF8;CTR9;DTX3L;PAF1
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),0.23889817205934472,0.45967047872769967,1.0,1.0,1.0,12/12,76.12%,AMIGO1;ARHGAP35;EPHB3;CDK5R1;EPHA4;MEGF8;NRCAM;EPHA3;EPHB2;SEMA5A;RTN4;CNTN4
prerank,GO_Biological_Process_2021__L-arginine transmembrane transport (GO:1903400),-0.3028644296465783,-0.4596407082137255,0.9818181818181818,1.0,1.0,2/5,20.31%,SLC7A2;SLC25A29
prerank,GO_Biological_Process_2021__oligosaccharide catabolic process (GO:0009313),0.24310231357262196,0.4593429791780496,0.9714285714285714,1.0,1.0,8/8,75.70%,NEU3;NEU1;MANBA;MAN2B1;GBA3;MAN2B2;MAN2C1;NEU4
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),-0.245198432908804,-0.4577074384974612,0.9880952380952381,1.0,1.0,1/18,11.66%,PRKCQ
prerank,GO_Biological_Process_2021__glucose import (GO:0046323),0.271098061054017,0.45734323563256085,1.0,1.0,1.0,8/8,72.90%,SLC2A10;SORT1;SLC2A1;SLC2A4;SLC27A1;SLC27A4;ZDHHC7;SLC2A3
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),-0.20262477280432412,-0.4563830785875159,1.0,1.0,1.0,12/72,26.28%,SH3GL2;WARS1;DBI;PAQR3;DAB2IP;XRCC1;TGFB1;MAPT;WWTR1;TINF2;BEX4;SLIT2
prerank,GO_Biological_Process_2021__response to DNA damage checkpoint signaling (GO:0072423),0.2614851598892492,0.4544671632368428,0.9743589743589743,1.0,1.0,1/5,21.32%,FBH1
prerank,GO_Biological_Process_2021__positive regulation of brown fat cell differentiation (GO:0090336),-0.2757108882250442,-0.45424584113306854,0.9859154929577465,1.0,1.0,1/11,14.17%,PIM1
prerank,GO_Biological_Process_2021__monosaccharide transmembrane transport (GO:0015749),-0.2572348694730248,-0.4539991654606383,0.9836065573770492,1.0,1.0,3/10,31.89%,SLC50A1;SLC5A9;SLC5A10
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),-0.25881091407773793,-0.45131771051457353,0.9857142857142858,1.0,1.0,1/11,12.53%,UBE2S
prerank,GO_Biological_Process_2021__alpha-amino acid biosynthetic process (GO:1901607),0.24965909520826163,0.45027727176377297,1.0,1.0,1.0,4/7,30.67%,SDSL;CAD;ALDH18A1;CPS1
prerank,GO_Biological_Process_2021__regulation of nuclear division (GO:0051783),0.19907829433809393,0.45002196456077076,1.0,1.0,1.0,15/15,80.11%,FBXO5;CDK13;CUL7;CDC25C;PRMT5;CUL9;RCC1;PIN1;OBSL1;FBXO43;BORA;CCDC8;CAV2;KIF20B;DAPK3
prerank,GO_Biological_Process_2021__positive regulation of receptor catabolic process (GO:2000646),0.2838125126543836,0.44946588305146534,1.0,1.0,1.0,5/5,71.63%,ITCH;APOE;PTPN1;ABCA2;DTX3L
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),-0.24782284875205618,-0.4478393967017726,1.0,1.0,1.0,3/11,32.29%,MYO9A;ZDHHC7;MSN
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),0.1960739921168077,0.44749463223531594,1.0,1.0,1.0,13/33,31.08%,IPO5;SESN2;CPEB3;SESN3;SLC38A9;RPTOR;LAMTOR3;SESN1;MTOR;CPEB4;CAPN2;LARS1;KLHL22
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),0.281534723628265,0.4439753259903181,0.96875,1.0,1.0,5/5,71.85%,NSMCE2;SLF2;SLF1;MACROH2A1;SMC5
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),0.281534723628265,0.4439753259903181,0.96875,1.0,1.0,5/5,71.85%,NSMCE2;SLF2;SLF1;MACROH2A1;SMC5
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),0.281534723628265,0.4439753259903181,0.96875,1.0,1.0,5/5,71.85%,NSMCE2;SLF2;SLF1;MACROH2A1;SMC5
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.2337048503916325,-0.44368950378149613,1.0,1.0,1.0,4/25,21.20%,CD44;SFRP2;CD74;CDKN2D
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),-0.28624799198073303,-0.44335020318376633,1.0,1.0,1.0,2/7,22.17%,TNFRSF1A;VCL
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),-0.29099306780828127,-0.4422268261781781,1.0,1.0,1.0,1/6,19.73%,JADE2
prerank,GO_Biological_Process_2021__negative regulation of telomere capping (GO:1904354),0.27167805618830676,0.4416482845263129,1.0,1.0,1.0,6/6,72.84%,ERCC4;ERCC1;TERF2;SMG6;ATM;NBN
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),0.2814904819765086,0.4416382069061424,1.0,1.0,1.0,9/9,71.86%,RYK;LRP6;NR4A2;MANF;LMX1B;CDNF;VEGFA;CTNNB1;WNT9B
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),-0.28025504759524467,-0.4408873107038983,0.9838709677419355,1.0,1.0,1/8,14.53%,PINK1
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.2358987341772153,0.44074788995042263,0.9743589743589743,1.0,1.0,11/11,76.42%,SEC61A1;SEC61A2;SEC63;SGTA;GET3;CHMP4B;SGTB;SEC61G;SEC61B;SEC62;HSPA5
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.24471749873118392,0.439597474488541,1.0,1.0,1.0,1/10,8.15%,HMGB1
prerank,GO_Biological_Process_2021__phagolysosome assembly (GO:0001845),0.23260759493670868,0.43954594853819867,1.0,1.0,1.0,11/11,76.75%,PIKFYVE;RAB7B;ARL8B;RAB14;PLA2G5;SYT7;RAB7A;RAB34;RAB39A;RAB20;CLN3
prerank,GO_Biological_Process_2021__protein localization to perinuclear region of cytoplasm (GO:1905719),0.26943025820584315,0.4377465306971812,1.0,1.0,1.0,1/6,14.66%,RNF26
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),-0.28547919832575913,-0.43763542085371077,1.0,1.0,1.0,1/7,21.84%,PNKD
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),-0.27678798904240753,-0.43727320605718434,0.9857142857142858,1.0,1.0,3/8,31.02%,PRKCB;CD36;PPARG
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),0.23887398106424973,0.4372146838819117,1.0,1.0,1.0,10/10,76.12%,AMIGO1;ARHGAP35;EPHB3;CDK5R1;EPHA4;NRCAM;EPHB2;SEMA5A;RTN4;CNTN4
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),0.22905236555962277,0.4369066386906788,1.0,1.0,1.0,3/9,21.78%,ZC3H14;RNF20;CCNT1
prerank,GO_Biological_Process_2021__neurotransmitter-gated ion channel clustering (GO:0072578),-0.2812465893665224,-0.43675355480722877,0.9850746268656716,1.0,1.0,4/6,34.25%,NLGN1;LHFPL4;SHISA7;SHANK3
prerank,GO_Biological_Process_2021__pyrimidine nucleobase biosynthetic process (GO:0019856),0.2796618748734563,0.4362203466417452,1.0,1.0,1.0,5/5,72.04%,CAD;UMPS;CTPS2;CTPS1;DHODH
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),-0.23988797728087718,-0.435829333773257,1.0,1.0,1.0,4/12,33.77%,CAMK1D;SLIT2;MST1;ADAM17
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),-0.2168707330748081,-0.4358193482599967,1.0,1.0,1.0,3/29,15.66%,BCL2L14;DAB2IP;BDNF
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),-0.23431907415265413,-0.4330478704940866,1.0,1.0,1.0,2/12,18.10%,HPF1;ALKBH4
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),-0.22289473307152186,-0.4325653048827469,1.0,1.0,1.0,7/23,27.82%,SLC7A2;PRAF2;CTNS;SLC1A6;ARL6IP5;SLC7A8;SLC7A1
prerank,GO_Biological_Process_2021__succinate transmembrane transport (GO:0071422),0.2672605790645881,0.4311574190125116,1.0,1.0,1.0,5/5,73.28%,SLC25A14;SLC13A3;SLC25A11;SLC25A30;SLC25A10
prerank,GO_Biological_Process_2021__positive regulation of myoblast fusion (GO:1901741),-0.27498908985319437,-0.4299973560545135,1.0,1.0,1.0,2/6,26.90%,FLOT1;EHD1
prerank,GO_Biological_Process_2021__glycosphingolipid catabolic process (GO:0046479),0.24310231357262188,0.42979178554994646,1.0,1.0,1.0,8/8,75.70%,NEU3;NEU1;HEXB;GM2A;GLA;GBA3;NAGA;NEU4
prerank,GO_Biological_Process_2021__phagosome-lysosome fusion (GO:0090385),0.23259581793326894,0.429322929376659,1.0,1.0,1.0,10/10,76.75%,PIKFYVE;RAB7B;ARL8B;PLA2G5;SYT7;RAB7A;RAB34;RAB39A;RAB20;CLN3
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),-0.20380519923215493,-0.4273824514427383,1.0,1.0,1.0,6/37,28.66%,WAS;FOXM1;PML;WRAP53;DDX11;RAD51AP1
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),-0.21517364434502206,-0.4250420720614583,1.0,1.0,1.0,4/25,24.29%,POLR2I;NELFE;POLR2J;SUPT5H
prerank,GO_Biological_Process_2021__response to angiotensin (GO:1990776),0.26489532526615023,0.42477844548476285,1.0,1.0,1.0,4/6,29.07%,NFKB1;ROCK2;RELA;SLC30A10
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),-0.2211097265629628,-0.4219360356958016,1.0,1.0,1.0,2/18,18.85%,SGPP2;SPHK1
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotaxis (GO:0090026),-0.2503800713776114,-0.4209168189542869,1.0,1.0,1.0,3/8,27.29%,CXCL17;CREB3;SERPINE1
prerank,GO_Biological_Process_2021__ketone body metabolic process (GO:1902224),0.24063385986229233,0.41982636963955733,1.0,1.0,1.0,9/9,75.95%,BDH2;BDH1;HMGCL;ACAT1;ACSS3;OXCT1;AACS;HMGCLL1;SLC27A5
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),-0.2486066184432684,-0.4192695074881848,0.9850746268656716,1.0,1.0,1/10,16.19%,ALKBH2
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),-0.2486066184432684,-0.4192695074881848,0.9850746268656716,1.0,1.0,1/10,16.19%,ALKBH2
prerank,GO_Biological_Process_2021__pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),-0.26937251913501464,-0.4191922578704718,0.9714285714285714,1.0,1.0,1/7,23.90%,MCM5
prerank,GO_Biological_Process_2021__regulation of mast cell activation involved in immune response (GO:0033006),-0.24979287419977048,-0.4163516023650919,1.0,1.0,1.0,1/7,16.30%,FES
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),0.24307629993418056,0.4156387750446697,1.0,1.0,1.0,10/10,75.70%,TAMM41;PGS1;LCLAT1;PLA2G5;PLA2G6;PLA2G4A;SLC27A1;HADHB;HADHA;PNPLA8
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),0.23950792284716235,0.4141780960311579,1.0,1.0,1.0,8/8,76.06%,EZR;CDC42;RAP2A;RHOA;OPHN1;CAMSAP3;MSN;MYO9A
prerank,GO_Biological_Process_2021__regulation of melanin biosynthetic process (GO:0048021),0.21967747557002643,0.41231228591989033,1.0,1.0,1.0,2/9,24.73%,ZEB2;RAPGEF2
prerank,GO_Biological_Process_2021__tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.19031702623316116,0.4103730653997838,1.0,1.0,1.0,15/15,80.98%,MMGT1;UBL4A;EMC8;EMC2;SGTA;GET3;EMC7;BAG6;EMC10;CAMLG;EMC6;EMC4;EMC9;EMC3;EMC1
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),-0.21877439785430294,-0.4103089540450361,1.0,1.0,1.0,3/20,21.86%,ANGPTL3;LRP2;HES1
prerank,GO_Biological_Process_2021__embryonic eye morphogenesis (GO:0048048),-0.25684493200402003,-0.40750367752115624,1.0,1.0,1.0,1/7,21.37%,RARG
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.24019498453189034,-0.40528077629727566,1.0,1.0,1.0,2/9,22.56%,SNX6;ZFYVE28
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),-0.1921459101652012,-0.404812446748958,1.0,1.0,1.0,8/34,30.71%,DLC1;PRKCD;TGFB1;NSMF;CALM3;PPP1R7;PPP1R16B;MFHAS1
prerank,GO_Biological_Process_2021__ketone body biosynthetic process (GO:0046951),0.24062167771984003,0.4036884254515846,1.0,1.0,1.0,8/8,75.95%,BDH2;BDH1;HMGCL;ACAT1;ACSS3;AACS;HMGCLL1;SLC27A5
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),-0.2117328159137079,-0.4035394111833762,1.0,1.0,1.0,5/29,23.26%,MAP1LC3A;GABARAPL1;LIX1;GABARAPL2;CLN3
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),-0.23404677678435798,-0.40009347271264184,1.0,1.0,1.0,1/13,14.17%,PIM1
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),0.2312495949293535,0.39905711120063,1.0,1.0,1.0,1/7,16.16%,NR1D2
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.18756014790052142,0.39785929658348596,1.0,1.0,1.0,18/18,81.26%,KCTD17;RAP1GDS1;BAK1;CAMK2D;BCAP31;THADA;ATP2A2;WFS1;BAX;BCL2;PACS2;HERPUD1;SELENOK;TMCO1;FIS1;PSEN1;CCDC47;PML
prerank,GO_Biological_Process_2021__bone marrow development (GO:0048539),-0.2537350807808656,-0.3949039211269086,1.0,1.0,1.0,1/5,18.80%,PTPRC
prerank,GO_Biological_Process_2021__ganglioside catabolic process (GO:0006689),0.24306539785381653,0.3921438820063125,1.0,1.0,1.0,5/5,75.70%,NEU3;NEU1;HEXB;GM2A;NEU4
prerank,GO_Biological_Process_2021__enzyme-directed rRNA pseudouridine synthesis (GO:0000455),-0.23513807443935242,-0.39210545235936345,1.0,1.0,1.0,2/6,27.76%,RPUSD1;RPUSD3
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),-0.20041305941255927,-0.3884682661015451,1.0,1.0,1.0,5/18,30.15%,PINK1;SREBF1;HDAC6;PARK7;SREBF2
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),0.2185997063737155,0.387273245334052,1.0,1.0,1.0,8/8,78.15%,TGFBR1;BMP7;BMPR1A;BMPR2;PTCH1;TGFB2;SIX4;HES1
prerank,"GO_Biological_Process_2021__posttranslational protein targeting to membrane, translocation (GO:0031204)",0.23585096689278118,0.38630337836820566,1.0,1.0,1.0,7/7,76.42%,SEC61A1;SEC61A2;SEC63;SEC61G;SEC61B;SEC62;HSPA5
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.21535076161597128,-0.38609763085075954,0.9852941176470589,1.0,1.0,1/13,16.34%,OGG1
prerank,GO_Biological_Process_2021__regulation of mitotic centrosome separation (GO:0046602),-0.25464534289194984,-0.38527005732675107,1.0,1.0,1.0,2/7,26.60%,KIF11;RANBP1
prerank,GO_Biological_Process_2021__regulation of tubulin deacetylation (GO:0090043),0.2213728865039991,0.38039242656101413,1.0,1.0,1.0,7/7,77.87%,EP300;PRKAA1;FNTA;PRKAA2;TPPP;BEX4;MAPT
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),-0.22332497906462995,-0.3803490579315033,1.0,1.0,1.0,1/10,17.10%,MICALL1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065),-0.2450422556980064,-0.380253687427038,1.0,1.0,1.0,2/7,28.44%,GPER1;ENG
prerank,GO_Biological_Process_2021__plus-end-directed organelle transport along microtubule (GO:0072386),-0.24281183909939785,-0.37544542034331335,1.0,1.0,1.0,1/6,22.14%,MAPT
prerank,GO_Biological_Process_2021__negative regulation of oligodendrocyte differentiation (GO:0048715),-0.23704649980984535,-0.3726091467700593,1.0,0.9998273612967884,1.0,1/6,21.86%,HES1
prerank,GO_Biological_Process_2021__negative regulation of glial cell differentiation (GO:0045686),-0.23704649980984535,-0.3726091467700593,1.0,0.9998273612967884,1.0,1/6,21.86%,HES1
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),0.21748595150103786,0.36629323983084144,1.0,1.0,1.0,8/8,78.26%,WAPL;ESPL1;RB1;CTCF;RAD21;CTNNB1;DDX11;AXIN2
prerank,GO_Biological_Process_2021__valine metabolic process (GO:0006573),0.21428117639435712,0.3623490776636775,1.0,1.0,1.0,3/5,28.15%,HIBCH;HIBADH;ALDH6A1
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide metabolic process (GO:0009218),-0.2413621949423032,-0.36000898946840365,1.0,0.9997557637080974,1.0,2/5,27.97%,AK5;DHODH
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),0.16347517730496453,0.3386853985448188,1.0,0.9999938578711381,1.0,21/21,83.67%,EXOSC6;POT1;PARP1;EXOSC5;TERF1;SMUG1;TERF2;EXOSC4;NEIL2;MPG;PARP3;UNG;TDG;NTHL1;NEIL1;ACD;TERF2IP;MBD4;TINF2;PARP2;OGG1
